data_2kzq_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2kzq _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 2.57 0 N-CA-C 109.807 -1.317 . . . . 0.0 109.807 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 12.6 mt -58.3 -40.71 82.7 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.683 -0.892 . . . . 0.0 110.465 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 5.1 tt -57.54 -50.42 73.14 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.49 -0.756 . . . . 0.0 109.943 179.602 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 8.6 m170 -61.06 -41.95 97.56 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.692 -0.63 . . . . 0.0 110.074 179.515 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 9.4 tp -58.12 -42.67 86.24 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.641 -0.662 . . . . 0.0 110.199 179.518 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 74.7 t60 -61.02 -49.16 78.53 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.713 -0.617 . . . . 0.0 110.001 179.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 15.8 mm-40 -60.08 -37.82 81.06 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.505 -0.747 . . . . 0.0 110.267 179.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -62.28 -39.75 93.97 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.498 -0.751 . . . . 0.0 110.377 179.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 56.4 mt -79.65 -44.08 23.31 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 O-C-N 121.317 -0.864 . . . . 0.0 110.203 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 49.9 t -66.65 -17.91 23.31 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 O-C-N 121.558 -0.714 . . . . 0.0 111.134 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -98.53 -6.23 30.6 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.141 -0.974 . . . . 0.0 111.053 179.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 75.7 t . . . . . 0 N--CA 1.498 1.936 0 O-C-N 120.935 -1.103 . . . . 0.0 110.282 179.615 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.504 2.245 0 CA-C-O 120.981 0.419 . . . . 0.0 111.253 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.42 ' N ' ' HD2' ' A' ' 28' ' ' PRO . 0.0 OUTLIER -59.45 -57.02 30.05 Favored Pre-proline 0 N--CA 1.501 2.097 0 O-C-N 121.306 -0.871 . . . . 0.0 110.616 179.815 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.42 ' HD2' ' N ' ' A' ' 27' ' ' SER . 45.7 Cg_endo -71.52 -27.53 18.76 Favored 'Trans proline' 0 N--CA 1.487 1.114 0 O-C-N 123.485 1.255 . . . . 0.0 110.895 179.681 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.36 -52.51 61.41 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.446 -0.784 . . . . 0.0 110.746 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 34.8 mm -60.52 -35.85 66.0 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.12 0 O-C-N 121.411 -0.806 . . . . 0.0 110.559 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 73.4 m -61.11 -27.82 68.65 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.541 -0.724 . . . . 0.0 110.566 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.36 7.52 33.34 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.299 -0.876 . . . . 0.0 110.689 179.559 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -101.22 -39.31 7.7 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.36 -0.837 . . . . 0.0 110.161 179.716 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 92.2 t . . . . . 0 N--CA 1.496 1.856 0 O-C-N 121.445 -0.784 . . . . 0.0 110.367 179.828 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 2.685 0 N-CA-C 109.165 -1.574 . . . . 0.0 109.165 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 7.1 tp -81.73 -31.73 31.9 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.606 -0.938 . . . . 0.0 109.91 179.153 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -56.03 -47.59 77.56 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.535 -0.728 . . . . 0.0 110.256 179.73 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -57.36 -42.99 83.14 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.547 -0.721 . . . . 0.0 110.036 179.46 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.1 tt -60.96 -41.46 96.38 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.676 -0.64 . . . . 0.0 110.224 179.451 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 67.9 t60 -60.8 -50.23 74.3 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.399 -0.813 . . . . 0.0 109.721 179.408 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 51.8 mm-40 -58.56 -35.89 73.08 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.531 -0.731 . . . . 0.0 110.007 179.382 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -58.54 -36.11 73.37 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.621 -0.674 . . . . 0.0 110.133 179.234 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.425 ' O ' HG11 ' A' ' 20' ' ' VAL . 7.4 mt -88.17 -31.81 5.83 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 O-C-N 121.515 -0.741 . . . . 0.0 109.96 179.502 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 54.9 t -68.6 -37.38 77.57 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 121.378 -0.826 . . . . 0.0 110.301 179.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -82.95 4.43 25.87 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.563 -0.71 . . . . 0.0 111.471 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.425 HG11 ' O ' ' A' ' 17' ' ' ILE . 0.8 OUTLIER . . . . . 0 N--CA 1.498 1.955 0 O-C-N 120.737 -1.227 . . . . 0.0 110.653 179.373 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.407 HD23 ' HB3' ' A' ' 29' ' ' ALA . 0.2 OUTLIER . . . . . 0 N--CA 1.501 2.085 0 CA-C-O 121.1 0.476 . . . . 0.0 110.675 . . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.41 ' N ' ' HD2' ' A' ' 28' ' ' PRO . 1.2 m -77.82 -51.77 1.73 Allowed Pre-proline 0 N--CA 1.497 1.913 0 O-C-N 121.297 -0.877 . . . . 0.0 111.064 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.41 ' HD2' ' N ' ' A' ' 27' ' ' SER . 49.5 Cg_endo -76.93 61.43 7.12 Favored 'Trans proline' 0 N--CA 1.487 1.13 0 O-C-N 123.446 1.235 . . . . 0.0 110.317 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.407 ' HB3' HD23 ' A' ' 26' ' ' LEU . . . -167.35 -51.9 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.515 -0.741 . . . . 0.0 109.944 -179.869 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 80.3 mt -68.35 -24.99 30.32 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 O-C-N 121.535 -0.728 . . . . 0.0 110.22 179.497 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 19.5 p -65.98 -41.83 90.63 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.448 -0.782 . . . . 0.0 110.211 179.471 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 5.9 tmtt? -70.2 -10.82 60.04 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.549 -0.72 . . . . 0.0 110.935 179.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 8.6 t80 -70.24 -43.25 70.97 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.316 -0.865 . . . . 0.0 110.361 179.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 38.8 t . . . . . 0 N--CA 1.498 1.936 0 O-C-N 121.35 -0.844 . . . . 0.0 110.263 -179.951 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.331 0 N-CA-C 108.49 -1.844 . . . . 0.0 108.49 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 7.4 mt -81.09 -35.57 31.52 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.67 -0.9 . . . . 0.0 109.878 179.192 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 2.5 tt -59.21 -42.9 92.03 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.633 -0.667 . . . . 0.0 110.069 179.507 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -76.35 -33.21 58.97 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.524 -0.735 . . . . 0.0 110.105 179.429 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -57.09 -47.72 80.34 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.445 -0.784 . . . . 0.0 110.472 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . 0.42 ' CE1' HG22 ' A' ' 18' ' ' VAL . 77.4 t60 -61.39 -52.21 65.55 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.381 -0.824 . . . . 0.0 109.823 179.625 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 4.3 tp-100 -60.02 -37.63 80.31 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.523 -0.735 . . . . 0.0 110.222 179.542 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -62.43 -39.42 93.27 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.573 -0.704 . . . . 0.0 110.665 179.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 76.5 mt -81.6 -41.82 18.97 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 O-C-N 121.166 -0.959 . . . . 0.0 110.29 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.42 HG22 ' CE1' ' A' ' 14' ' ' HIS . 76.8 t -65.26 -44.83 94.97 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 O-C-N 121.392 -0.818 . . . . 0.0 110.439 -179.901 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -65.73 -16.11 63.47 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.742 -0.599 . . . . 0.0 111.46 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 94.9 t . . . . . 0 N--CA 1.494 1.757 0 O-C-N 120.74 -1.225 . . . . 0.0 109.86 179.495 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 10.6 mt . . . . . 0 N--CA 1.503 2.195 0 CA-C-O 121.079 0.466 . . . . 0.0 111.105 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.586 ' HB2' ' HD3' ' A' ' 28' ' ' PRO . 2.2 m -59.29 -56.28 37.57 Favored Pre-proline 0 N--CA 1.497 1.887 0 O-C-N 121.277 -0.89 . . . . 0.0 110.592 -179.851 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.586 ' HD3' ' HB2' ' A' ' 27' ' ' SER . 53.2 Cg_endo -80.42 53.87 4.96 Favored 'Trans proline' 0 N--CA 1.485 1.018 0 O-C-N 123.386 1.203 . . . . 0.0 110.434 179.329 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -155.44 -54.11 0.09 Allowed 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.304 -0.873 . . . . 0.0 110.029 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 10.0 mt -79.48 -32.17 14.54 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 O-C-N 121.415 -0.803 . . . . 0.0 110.439 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 16.1 m -61.17 -38.59 87.02 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.553 -0.717 . . . . 0.0 110.333 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 2.1 pttt -93.2 18.37 9.56 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.467 -0.77 . . . . 0.0 110.606 179.394 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -113.39 -50.02 2.88 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.265 -0.897 . . . . 0.0 109.952 179.773 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 74.0 t . . . . . 0 N--CA 1.497 1.895 0 O-C-N 121.479 -0.763 . . . . 0.0 109.893 179.728 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 2.64 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -58.48 -35.24 71.89 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.682 -0.893 . . . . 0.0 110.207 179.629 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 4.8 tt -57.18 -46.28 82.96 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.471 -0.768 . . . . 0.0 109.965 179.464 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 22.3 m-70 -68.44 -42.73 78.43 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.527 -0.733 . . . . 0.0 109.877 179.449 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -60.35 -38.79 84.95 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.63 -0.669 . . . . 0.0 109.778 179.225 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 71.5 t60 -63.9 -52.72 58.61 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.627 -0.671 . . . . 0.0 109.624 179.255 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 29.9 tp60 -54.65 -39.04 67.61 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.697 -0.627 . . . . 0.0 110.149 179.559 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -58.12 -49.07 78.25 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.554 -0.717 . . . . 0.0 110.327 179.558 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 29.2 mt -72.09 -33.47 47.11 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.073 0 O-C-N 121.449 -0.782 . . . . 0.0 110.226 179.714 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 73.5 t -75.69 -10.92 13.84 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.093 0 O-C-N 121.51 -0.744 . . . . 0.0 111.086 179.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -111.49 20.96 16.7 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.892 -1.13 . . . . 0.0 110.674 179.886 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 73.0 t . . . . . 0 N--CA 1.497 1.896 0 O-C-N 121.139 -0.976 . . . . 0.0 109.721 179.481 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.1 mp . . . . . 0 N--CA 1.496 1.827 0 CA-C-O 120.798 0.333 . . . . 0.0 110.925 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.496 ' N ' ' HD2' ' A' ' 28' ' ' PRO . 0.8 OUTLIER -56.62 -52.8 70.73 Favored Pre-proline 0 N--CA 1.498 1.947 0 O-C-N 121.3 -0.875 . . . . 0.0 110.486 179.528 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.496 ' HD2' ' N ' ' A' ' 27' ' ' SER . 45.8 Cg_endo -71.79 -26.7 18.85 Favored 'Trans proline' 0 N--CA 1.488 1.185 0 O-C-N 123.53 1.279 . . . . 0.0 110.789 179.314 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -71.09 -33.52 70.27 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.495 -0.753 . . . . 0.0 110.507 179.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -84.97 -11.25 11.52 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 O-C-N 121.269 -0.894 . . . . 0.0 110.976 179.851 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 24.0 p -101.8 -38.89 7.65 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.08 -1.013 . . . . 0.0 110.532 179.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 2.1 tptt -90.23 39.11 0.95 Allowed 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.378 -0.826 . . . . 0.0 110.574 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -149.55 -49.93 0.14 Allowed 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.34 -0.85 . . . . 0.0 109.882 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 16.1 t . . . . . 0 N--CA 1.495 1.81 0 CA-C-O 121.416 0.627 . . . . 0.0 109.668 179.847 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.555 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 2.1 pp -66.64 -31.15 71.64 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.58 -0.953 . . . . 0.0 110.597 179.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.92 -44.31 93.28 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.202 -0.936 . . . . 0.0 109.973 179.663 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 5.5 m80 -70.34 -37.1 74.61 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.516 -0.74 . . . . 0.0 109.942 179.337 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.9 tp -59.6 -40.12 86.43 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.532 -0.73 . . . . 0.0 110.561 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . 0.422 ' CD2' HG21 ' A' ' 18' ' ' VAL . 3.3 t-80 -54.74 -51.91 64.17 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.611 -0.68 . . . . 0.0 109.958 179.771 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 12.1 tp-100 -62.63 -32.31 73.31 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.48 -0.763 . . . . 0.0 110.507 179.772 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -72.12 -47.68 49.41 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.314 -0.866 . . . . 0.0 110.559 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 39.0 mm -71.65 -40.41 70.64 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 O-C-N 121.408 -0.808 . . . . 0.0 110.429 -179.772 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.422 HG21 ' CD2' ' A' ' 14' ' ' HIS . 38.3 t -62.19 -30.1 48.06 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 O-C-N 121.36 -0.838 . . . . 0.0 110.199 179.771 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -76.8 -15.65 59.68 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.503 -0.748 . . . . 0.0 110.85 179.382 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 92.7 t . . . . . 0 N--CA 1.494 1.742 0 O-C-N 121.057 -1.027 . . . . 0.0 109.884 179.618 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.3 mp . . . . . 0 N--CA 1.495 1.812 0 CA-C-O 120.681 0.277 . . . . 0.0 111.195 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.607 ' HB3' ' HD3' ' A' ' 28' ' ' PRO . 0.5 OUTLIER -62.81 -53.37 56.71 Favored Pre-proline 0 N--CA 1.498 1.931 0 O-C-N 121.154 -0.966 . . . . 0.0 110.374 179.474 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.607 ' HD3' ' HB3' ' A' ' 27' ' ' SER . 45.7 Cg_endo -73.07 -31.33 9.81 Favored 'Trans proline' 0 N--CA 1.487 1.122 0 O-C-N 123.491 1.259 . . . . 0.0 110.69 179.681 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.55 -24.48 67.54 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.618 -0.676 . . . . 0.0 111.279 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 47.5 mm -105.63 -30.11 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 O-C-N 121.113 -0.992 . . . . 0.0 111.119 -179.62 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.548 HG22 ' HA ' ' A' ' 28' ' ' PRO . 4.8 t -85.17 -30.97 23.51 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.159 -0.963 . . . . 0.0 110.867 -179.796 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.3 tttt -89.4 10.88 20.92 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.193 -0.942 . . . . 0.0 110.979 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 6.8 m-85 -114.07 -38.43 4.17 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.105 -0.997 . . . . 0.0 110.539 179.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 60.8 t . . . . . 0 N--CA 1.494 1.728 0 O-C-N 121.312 -0.867 . . . . 0.0 109.696 179.852 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 2.673 0 N-CA-C 109.272 -1.531 . . . . 0.0 109.272 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -63.09 -35.64 80.95 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.652 -0.91 . . . . 0.0 109.972 179.371 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -56.98 -48.19 79.01 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.53 -0.731 . . . . 0.0 109.87 179.378 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 7.1 m-70 -63.88 -39.36 94.0 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.715 -0.616 . . . . 0.0 109.738 179.129 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 9.1 tp -58.96 -41.87 88.53 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.64 -0.663 . . . . 0.0 110.109 179.333 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 5.7 t-160 -62.16 -52.04 65.43 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.543 -0.723 . . . . 0.0 109.258 179.149 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 27.3 tp60 -58.72 -36.53 74.43 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.625 -0.672 . . . . 0.0 110.021 179.186 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -61.73 -45.31 94.48 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.643 -0.661 . . . . 0.0 110.474 179.731 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 38.8 mt -73.27 -37.5 52.03 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.018 0 O-C-N 121.352 -0.842 . . . . 0.0 109.84 179.637 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 54.8 t -75.73 -3.92 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 O-C-N 121.475 -0.766 . . . . 0.0 110.658 179.473 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -120.79 5.41 10.49 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.188 -0.945 . . . . 0.0 110.57 179.136 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 5.5 p . . . . . 0 N--CA 1.499 1.999 0 O-C-N 120.905 -1.122 . . . . 0.0 110.866 -179.93 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.504 2.228 0 CA-C-O 121.088 0.47 . . . . 0.0 111.231 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.488 ' CB ' ' CD ' ' A' ' 28' ' ' PRO . 0.5 OUTLIER -99.21 -63.98 0.08 OUTLIER Pre-proline 0 N--CA 1.497 1.887 0 O-C-N 121.184 -0.947 . . . . 0.0 110.571 179.69 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.488 ' CD ' ' CB ' ' A' ' 27' ' ' SER . 41.8 Cg_endo -67.66 -25.04 40.69 Favored 'Trans proline' 0 N--CA 1.489 1.235 0 O-C-N 123.222 1.117 . . . . 0.0 110.876 179.812 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.76 -32.16 73.54 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.37 -0.831 . . . . 0.0 110.312 179.292 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 97.1 mt -99.68 -42.34 10.38 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 121.501 -0.749 . . . . 0.0 110.035 179.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 62.8 m -63.88 -38.24 90.38 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.665 -0.647 . . . . 0.0 110.612 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 13.2 tttt -89.31 15.29 9.29 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.231 -0.918 . . . . 0.0 110.68 179.558 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 9.7 t80 -106.63 -44.09 4.56 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.296 -0.877 . . . . 0.0 110.019 179.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.9 t . . . . . 0 N--CA 1.496 1.862 0 O-C-N 121.383 -0.823 . . . . 0.0 109.734 179.805 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.427 0 N-CA-C 109.032 -1.627 . . . . 0.0 109.032 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.5 mt -62.8 -41.99 99.52 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.616 -0.932 . . . . 0.0 110.17 179.665 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 15.6 tp -59.45 -43.61 93.15 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.464 -0.772 . . . . 0.0 109.814 179.378 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 6.9 m170 -65.35 -44.94 86.08 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.628 -0.67 . . . . 0.0 109.748 179.271 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.91 -33.91 76.62 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.472 -0.767 . . . . 0.0 109.969 179.31 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . 0.447 ' NE2' HG23 ' A' ' 18' ' ' VAL . 8.1 t-160 -63.0 -51.7 65.84 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.625 -0.672 . . . . 0.0 109.88 179.549 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . 0.441 ' O ' ' HB2' ' A' ' 19' ' ' ASP . 0.3 OUTLIER -61.75 -36.03 79.81 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.496 -0.752 . . . . 0.0 109.993 179.497 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -59.36 -43.61 92.81 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.473 -0.767 . . . . 0.0 110.289 179.445 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 61.1 mt -81.87 -26.25 9.58 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.925 0 O-C-N 121.395 -0.816 . . . . 0.0 110.624 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.447 HG23 ' NE2' ' A' ' 14' ' ' HIS . 49.7 t -85.65 -7.44 10.92 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 121.031 -1.043 . . . . 0.0 110.693 179.79 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.441 ' HB2' ' O ' ' A' ' 15' ' ' GLN . 0.5 OUTLIER -122.53 32.24 5.83 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.101 -0.999 . . . . 0.0 109.667 178.896 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 13.0 p . . . . . 0 N--CA 1.5 2.052 0 O-C-N 121.416 -0.802 . . . . 0.0 110.646 179.987 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.6 mp . . . . . 0 N--CA 1.502 2.148 0 CA-C-O 120.827 0.346 . . . . 0.0 111.549 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.46 ' N ' ' HD2' ' A' ' 28' ' ' PRO . 1.4 m -69.88 -55.43 8.73 Favored Pre-proline 0 N--CA 1.498 1.939 0 O-C-N 121.113 -0.992 . . . . 0.0 110.27 179.333 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.46 ' HD2' ' N ' ' A' ' 27' ' ' SER . 45.6 Cg_endo -71.61 -20.23 27.07 Favored 'Trans proline' 0 N--CA 1.487 1.1 0 O-C-N 123.451 1.237 . . . . 0.0 110.681 179.182 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -70.85 -37.89 73.16 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.48 -0.763 . . . . 0.0 110.216 179.585 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 28.5 mm -74.35 -39.93 49.2 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 O-C-N 121.518 -0.739 . . . . 0.0 110.061 179.625 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 44.9 p -69.22 -39.48 78.53 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.381 -0.825 . . . . 0.0 110.206 179.692 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 26.9 mmtt -71.91 -29.77 64.67 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.428 -0.795 . . . . 0.0 110.638 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 92.4 t80 -86.44 -47.4 9.34 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.399 -0.813 . . . . 0.0 110.319 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 47.2 t . . . . . 0 N--CA 1.496 1.865 0 O-C-N 121.448 -0.783 . . . . 0.0 109.831 -179.894 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.376 0 N-CA-C 108.626 -1.789 . . . . 0.0 108.626 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 8.9 tp -73.49 -36.82 65.85 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.648 -0.913 . . . . 0.0 109.876 179.335 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 11.5 tp -64.56 -44.1 91.82 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.377 -0.827 . . . . 0.0 109.839 179.506 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -63.76 -42.92 97.73 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.59 -0.693 . . . . 0.0 109.832 179.443 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 5.2 tp -63.88 -40.72 97.19 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.542 -0.724 . . . . 0.0 110.238 179.505 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 7.3 t-80 -57.4 -54.22 49.33 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.643 -0.661 . . . . 0.0 109.922 179.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . 0.455 ' O ' ' HB2' ' A' ' 19' ' ' ASP . 19.5 tp60 -55.57 -40.14 71.6 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.672 -0.642 . . . . 0.0 110.089 179.577 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -66.67 -40.8 88.75 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.348 -0.845 . . . . 0.0 110.68 179.686 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 85.6 mt -77.07 -21.53 14.5 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 O-C-N 121.395 -0.816 . . . . 0.0 110.858 -179.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 24.3 t -93.16 -33.61 5.43 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 O-C-N 121.205 -0.934 . . . . 0.0 110.082 179.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.455 ' HB2' ' O ' ' A' ' 15' ' ' GLN . 2.4 m-20 -87.75 28.84 0.96 Allowed 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.278 -0.889 . . . . 0.0 110.439 179.271 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 12.5 p . . . . . 0 N--CA 1.495 1.825 0 O-C-N 121.242 -0.911 . . . . 0.0 110.344 179.577 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.495 1.807 0 CA-C-O 121.106 0.479 . . . . 0.0 110.192 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -60.28 -54.34 56.1 Favored Pre-proline 0 N--CA 1.498 1.939 0 O-C-N 121.397 -0.814 . . . . 0.0 110.656 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -77.61 55.32 5.13 Favored 'Trans proline' 0 N--CA 1.487 1.119 0 O-C-N 123.393 1.207 . . . . 0.0 110.318 179.473 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -162.74 -49.18 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.59 -0.694 . . . . 0.0 109.78 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 21.8 mt -83.13 -34.1 10.87 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 121.624 -0.673 . . . . 0.0 110.224 179.592 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 43.7 m -61.6 -43.35 99.03 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.568 -0.707 . . . . 0.0 109.931 179.48 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.8 tttp -70.51 -23.52 62.67 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.549 -0.719 . . . . 0.0 110.496 179.332 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -75.43 -27.58 59.03 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.415 -0.803 . . . . 0.0 110.365 179.646 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 57.9 t . . . . . 0 N--CA 1.497 1.884 0 O-C-N 121.269 -0.895 . . . . 0.0 110.543 -179.749 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.503 0 N-CA-C 109.275 -1.53 . . . . 0.0 109.275 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 8.0 tp -66.74 -32.03 73.06 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.577 -0.955 . . . . 0.0 110.237 179.475 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -58.19 -43.09 87.39 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.45 -0.781 . . . . 0.0 110.024 179.551 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -59.02 -43.75 91.61 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.6 -0.688 . . . . 0.0 109.696 179.29 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.2 tt -61.99 -38.39 88.42 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.751 -0.593 . . . . 0.0 110.057 179.207 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . 0.472 ' CD2' HG21 ' A' ' 18' ' ' VAL . 2.8 t-80 -61.38 -52.85 62.92 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.517 -0.74 . . . . 0.0 109.745 179.4 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 3.3 tp-100 -59.96 -36.35 76.9 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.516 -0.74 . . . . 0.0 110.227 179.669 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 9.9 t30 -59.48 -34.04 72.08 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.533 -0.729 . . . . 0.0 110.475 179.471 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.415 ' O ' HG12 ' A' ' 20' ' ' VAL . 38.0 mt -94.4 -36.84 7.38 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 121.398 -0.814 . . . . 0.0 110.317 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.472 HG21 ' CD2' ' A' ' 14' ' ' HIS . 92.0 t -74.2 -7.83 10.59 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.086 0 O-C-N 121.343 -0.848 . . . . 0.0 111.011 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -119.83 8.08 11.07 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.167 -0.958 . . . . 0.0 110.809 179.434 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.415 HG12 ' O ' ' A' ' 17' ' ' ILE . 9.2 p . . . . . 0 N--CA 1.498 1.959 0 O-C-N 120.982 -1.074 . . . . 0.0 110.874 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.0 mp . . . . . 0 N--CA 1.495 1.823 0 CA-C-O 121.311 0.577 . . . . 0.0 109.891 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.606 ' HB3' ' HD3' ' A' ' 28' ' ' PRO . 4.6 t -53.27 -55.82 30.44 Favored Pre-proline 0 N--CA 1.497 1.892 0 O-C-N 121.625 -0.672 . . . . 0.0 110.645 -179.881 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.606 ' HD3' ' HB3' ' A' ' 27' ' ' SER . 52.3 Cg_endo -77.37 59.27 6.6 Favored 'Trans proline' 0 N--CA 1.487 1.114 0 O-C-N 123.448 1.236 . . . . 0.0 110.075 179.247 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -167.87 -50.07 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.533 -0.73 . . . . 0.0 110.001 -179.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 15.6 mt -78.43 -33.71 17.56 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 O-C-N 121.483 -0.761 . . . . 0.0 110.299 179.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 7.9 p -61.33 -39.62 91.2 Favored 'General case' 0 N--CA 1.5 2.025 0 O-C-N 121.703 -0.623 . . . . 0.0 110.301 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -91.77 19.51 6.43 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.344 -0.848 . . . . 0.0 110.493 179.272 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 71.3 t80 -115.5 -47.03 2.84 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.366 -0.834 . . . . 0.0 109.989 179.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 59.5 t . . . . . 0 N--CA 1.497 1.879 0 O-C-N 121.341 -0.85 . . . . 0.0 109.845 179.838 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.469 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -62.21 -47.2 85.51 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.632 -0.922 . . . . 0.0 110.609 -179.832 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -58.58 -51.62 69.13 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.487 -0.758 . . . . 0.0 110.2 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -62.74 -40.82 98.41 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.653 -0.654 . . . . 0.0 110.037 179.558 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.7 tt -56.88 -42.2 79.39 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.642 -0.661 . . . . 0.0 110.13 179.588 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 7.2 t-80 -60.81 -49.07 78.98 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.521 -0.737 . . . . 0.0 109.799 179.412 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . 0.439 ' O ' ' HB2' ' A' ' 19' ' ' ASP . 17.8 mm-40 -67.17 -36.17 81.24 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.544 -0.722 . . . . 0.0 109.76 179.318 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -63.68 -18.32 63.87 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.501 -0.749 . . . . 0.0 110.905 179.487 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 87.2 mt -104.74 -46.53 9.47 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.082 -1.011 . . . . 0.0 109.908 179.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 54.0 t -71.21 -36.73 63.4 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 O-C-N 121.403 -0.811 . . . . 0.0 110.969 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.439 ' HB2' ' O ' ' A' ' 15' ' ' GLN . 0.3 OUTLIER -86.55 -1.94 58.06 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.398 -0.814 . . . . 0.0 111.41 -179.537 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 70.6 t . . . . . 0 N--CA 1.495 1.804 0 O-C-N 120.83 -1.169 . . . . 0.0 109.78 179.354 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.4 mp . . . . . 0 N--CA 1.501 2.086 0 CA-C-O 121.156 0.503 . . . . 0.0 110.818 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.437 ' HB2' ' HD3' ' A' ' 28' ' ' PRO . 3.1 m -56.18 -55.09 45.6 Favored Pre-proline 0 N--CA 1.499 1.998 0 O-C-N 121.527 -0.733 . . . . 0.0 111.094 -179.726 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.437 ' HD3' ' HB2' ' A' ' 27' ' ' SER . 46.3 Cg_endo -72.2 -27.06 17.13 Favored 'Trans proline' 0 N--CA 1.489 1.217 0 O-C-N 123.398 1.209 . . . . 0.0 111.068 179.827 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -72.87 -39.98 66.01 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.417 -0.802 . . . . 0.0 110.633 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 5.7 tt -79.49 -11.63 13.02 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 O-C-N 121.341 -0.849 . . . . 0.0 111.467 -179.691 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 23.3 p -101.0 -37.19 8.73 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.099 -1.001 . . . . 0.0 110.537 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 6.9 tptp -91.6 45.93 1.26 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.267 -0.896 . . . . 0.0 109.964 179.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -146.91 -53.59 0.23 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.549 -0.719 . . . . 0.0 109.739 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 49.0 t . . . . . 0 N--CA 1.496 1.874 0 O-C-N 121.443 -0.786 . . . . 0.0 109.75 179.612 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.548 0 N-CA-C 109.841 -1.304 . . . . 0.0 109.841 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -57.71 -38.54 75.44 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.65 -0.912 . . . . 0.0 110.8 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -56.82 -51.05 70.48 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.497 -0.752 . . . . 0.0 110.371 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 3.8 t60 -75.56 -30.8 59.79 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.284 -0.885 . . . . 0.0 110.103 179.39 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 61.1 tp -55.3 -41.88 72.94 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.472 -0.768 . . . . 0.0 109.962 179.578 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 2.6 t-80 -61.92 -46.44 89.32 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.608 -0.682 . . . . 0.0 109.665 179.222 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 28.3 mm-40 -60.51 -37.48 81.27 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.658 -0.651 . . . . 0.0 110.093 179.587 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -67.78 -47.98 67.61 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.548 -0.72 . . . . 0.0 110.386 179.651 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 74.8 mt -65.45 -48.57 82.49 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.99 0 O-C-N 121.393 -0.817 . . . . 0.0 109.991 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 27.2 t -61.97 -31.92 52.69 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 O-C-N 121.437 -0.789 . . . . 0.0 109.938 179.549 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -63.95 -25.4 68.12 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.631 -0.668 . . . . 0.0 109.963 178.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 61.2 t . . . . . 0 N--CA 1.491 1.624 0 O-C-N 121.107 -0.996 . . . . 0.0 109.479 179.036 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.2 mm? . . . . . 0 N--CA 1.502 2.17 0 CA-C-O 120.907 0.384 . . . . 0.0 111.254 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.463 ' N ' ' HD2' ' A' ' 28' ' ' PRO . 1.4 m -80.57 -54.82 0.77 Allowed Pre-proline 0 N--CA 1.498 1.958 0 O-C-N 121.238 -0.913 . . . . 0.0 110.801 179.796 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.463 ' HD2' ' N ' ' A' ' 27' ' ' SER . 43.8 Cg_endo -70.14 -11.83 31.06 Favored 'Trans proline' 0 N--CA 1.49 1.275 0 O-C-N 123.259 1.136 . . . . 0.0 111.172 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -90.21 -27.34 19.6 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.248 -0.907 . . . . 0.0 110.366 179.454 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.437 HG21 HD13 ' A' ' 30' ' ' ILE . 43.4 mm -104.77 -45.26 9.01 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 121.315 -0.866 . . . . 0.0 110.325 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 23.9 m -70.39 -34.55 72.69 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.602 -0.686 . . . . 0.0 110.84 -179.775 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 6.6 tttp -89.9 16.63 7.85 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.085 -1.009 . . . . 0.0 110.684 179.428 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -109.4 -40.88 4.77 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.292 -0.88 . . . . 0.0 109.987 179.496 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 87.2 t . . . . . 0 N--CA 1.496 1.837 0 O-C-N 121.437 -0.789 . . . . 0.0 110.018 179.848 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.41 0 N-CA-C 108.724 -1.751 . . . . 0.0 108.724 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.62 -39.08 93.47 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.649 -0.912 . . . . 0.0 109.738 179.141 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -58.31 -47.81 82.5 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.699 -0.625 . . . . 0.0 109.585 179.132 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 20.1 t-160 -67.81 -45.01 75.95 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.736 -0.602 . . . . 0.0 109.844 179.357 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 11.8 tp -57.25 -41.84 80.37 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.558 -0.714 . . . . 0.0 110.035 179.534 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 6.6 t-80 -61.06 -47.03 88.24 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.624 -0.672 . . . . 0.0 109.826 179.436 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 33.9 tp60 -55.88 -45.28 78.61 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.639 -0.663 . . . . 0.0 110.252 179.71 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 9.5 t-20 -63.74 -52.36 60.79 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.326 -0.859 . . . . 0.0 110.732 179.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 83.5 mt -57.75 -43.48 84.02 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.119 0 O-C-N 121.345 -0.847 . . . . 0.0 110.374 -179.737 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 17.9 t -71.51 -32.54 46.47 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 O-C-N 121.394 -0.816 . . . . 0.0 110.138 179.579 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -73.01 -10.91 60.3 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.423 -0.798 . . . . 0.0 110.991 179.591 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 61.6 t . . . . . 0 N--CA 1.493 1.707 0 O-C-N 120.832 -1.167 . . . . 0.0 109.925 179.487 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.5 2.038 0 CA-C-O 120.861 0.363 . . . . 0.0 111.019 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.473 ' N ' ' HD2' ' A' ' 28' ' ' PRO . 4.7 m -74.56 -52.75 3.65 Favored Pre-proline 0 N--CA 1.499 1.977 0 O-C-N 121.142 -0.974 . . . . 0.0 111.243 -179.816 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.473 ' HD2' ' N ' ' A' ' 27' ' ' SER . 44.9 Cg_endo -71.52 -9.65 25.48 Favored 'Trans proline' 0 N--CA 1.49 1.322 0 O-C-N 123.429 1.226 . . . . 0.0 111.243 179.855 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -94.03 -9.09 37.92 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.333 -0.854 . . . . 0.0 110.662 179.595 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.408 HG21 HD13 ' A' ' 30' ' ' ILE . 33.8 mm -118.03 -37.12 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 O-C-N 121.176 -0.952 . . . . 0.0 110.48 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 13.4 t -63.52 -24.43 67.81 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 121.349 -0.844 . . . . 0.0 111.252 -179.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 24.9 mmtt -99.12 -2.82 36.03 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.236 -0.915 . . . . 0.0 111.125 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 34.6 m-85 -107.94 0.29 21.86 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.313 -0.867 . . . . 0.0 111.16 -179.782 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 47.1 t . . . . . 0 N--CA 1.496 1.845 0 O-C-N 121.14 -0.975 . . . . 0.0 109.938 -179.979 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.432 0 N-CA-C 108.417 -1.873 . . . . 0.0 108.417 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -77.17 -34.87 56.32 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.549 -0.971 . . . . 0.0 109.754 178.924 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 5.6 tp -62.98 -44.63 95.52 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.443 -0.785 . . . . 0.0 109.969 179.49 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -64.05 -39.24 93.64 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.575 -0.703 . . . . 0.0 109.996 179.472 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.4 tp -68.42 -34.96 76.94 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.47 -0.769 . . . . 0.0 110.366 179.659 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . 0.437 ' CD2' HG21 ' A' ' 18' ' ' VAL . 12.5 t-80 -59.77 -61.82 2.33 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.316 -0.865 . . . . 0.0 109.575 179.504 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . 0.433 ' O ' ' HB2' ' A' ' 19' ' ' ASP . 2.8 tp60 -59.2 -26.44 64.84 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.388 -0.82 . . . . 0.0 110.639 179.492 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -78.02 -42.63 31.9 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.3 -0.875 . . . . 0.0 110.722 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 83.7 mt -82.69 -36.48 13.36 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.002 0 O-C-N 121.226 -0.921 . . . . 0.0 110.647 -179.646 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.437 HG21 ' CD2' ' A' ' 14' ' ' HIS . 48.1 t -64.67 -34.69 71.6 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 O-C-N 121.203 -0.936 . . . . 0.0 110.493 -179.864 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.433 ' HB2' ' O ' ' A' ' 15' ' ' GLN . 0.1 OUTLIER -85.81 18.38 2.95 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.319 -0.863 . . . . 0.0 111.04 179.674 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 13.1 t . . . . . 0 N--CA 1.494 1.769 0 O-C-N 121.109 -0.995 . . . . 0.0 110.251 179.705 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 8.7 mt . . . . . 0 N--CA 1.503 2.219 0 CA-C-O 121.191 0.52 . . . . 0.0 110.773 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.595 ' HB2' ' HD3' ' A' ' 28' ' ' PRO . 2.2 m -61.82 -51.73 73.71 Favored Pre-proline 0 N--CA 1.497 1.88 0 O-C-N 121.296 -0.878 . . . . 0.0 110.926 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.595 ' HD3' ' HB2' ' A' ' 27' ' ' SER . 43.4 Cg_endo -69.56 -28.5 26.14 Favored 'Trans proline' 0 N--CA 1.49 1.27 0 O-C-N 123.299 1.157 . . . . 0.0 110.924 179.851 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.43 -36.77 83.45 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.591 -0.693 . . . . 0.0 110.432 179.65 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 35.5 mt -92.27 -36.28 7.6 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 O-C-N 121.327 -0.858 . . . . 0.0 110.219 179.787 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 92.0 m -68.45 -39.79 81.35 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.562 -0.711 . . . . 0.0 110.462 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 4.1 tttt -86.21 19.87 2.54 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.26 -0.9 . . . . 0.0 110.84 179.611 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -116.31 -18.22 10.55 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.207 -0.933 . . . . 0.0 110.856 179.786 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 26.5 t . . . . . 0 N--CA 1.496 1.845 0 O-C-N 121.124 -0.985 . . . . 0.0 110.002 -179.843 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.372 0 N-CA-C 109.013 -1.635 . . . . 0.0 109.013 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.1 mp -64.08 -33.3 75.44 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.691 -0.887 . . . . 0.0 110.304 179.35 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 4.8 tp -65.49 -47.23 76.78 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.351 -0.843 . . . . 0.0 109.994 179.596 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -70.2 -43.74 70.1 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.379 -0.826 . . . . 0.0 110.453 179.789 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -61.69 -44.18 97.44 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.401 -0.812 . . . . 0.0 109.931 179.699 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 69.9 t60 -65.14 -51.48 60.98 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.506 -0.746 . . . . 0.0 109.705 179.317 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -56.87 -36.45 70.08 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.428 -0.795 . . . . 0.0 110.224 179.457 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 5.6 t30 -56.53 -41.9 77.54 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.339 -0.85 . . . . 0.0 109.993 179.2 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.444 ' HA ' HG11 ' A' ' 20' ' ' VAL . 7.3 mt -86.28 -20.42 7.89 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 O-C-N 121.485 -0.759 . . . . 0.0 110.404 179.462 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 78.3 t -87.48 -12.92 10.55 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 O-C-N 121.27 -0.894 . . . . 0.0 110.331 179.631 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -118.14 24.15 11.16 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.385 -0.822 . . . . 0.0 110.137 179.257 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.444 HG11 ' HA ' ' A' ' 17' ' ' ILE . 10.9 p . . . . . 0 N--CA 1.5 2.045 0 O-C-N 121.296 -0.877 . . . . 0.0 110.427 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.498 1.935 0 CA-C-O 121.36 0.6 . . . . 0.0 110.118 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.487 ' HB2' ' HD3' ' A' ' 28' ' ' PRO . 2.3 m -68.08 -52.84 21.68 Favored Pre-proline 0 N--CA 1.498 1.933 0 O-C-N 121.498 -0.751 . . . . 0.0 110.972 -179.846 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.487 ' HD3' ' HB2' ' A' ' 27' ' ' SER . 49.3 Cg_endo -76.74 60.1 6.55 Favored 'Trans proline' 0 N--CA 1.487 1.131 0 O-C-N 123.462 1.243 . . . . 0.0 110.493 179.815 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -157.93 -57.32 0.08 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.399 -0.813 . . . . 0.0 110.102 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 82.1 mt -69.33 -22.8 25.99 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 O-C-N 121.437 -0.789 . . . . 0.0 110.418 179.64 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 24.5 p -61.7 -41.7 97.94 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.416 -0.803 . . . . 0.0 110.249 179.436 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.27 -24.26 64.86 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.521 -0.737 . . . . 0.0 110.418 179.611 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -80.96 -29.36 35.36 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.412 -0.805 . . . . 0.0 110.182 179.512 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 88.2 t . . . . . 0 N--CA 1.497 1.876 0 O-C-N 121.453 -0.779 . . . . 0.0 110.519 -179.708 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.477 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 6.3 mt -74.88 -39.31 61.59 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.596 -0.944 . . . . 0.0 110.562 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 14.2 tp -58.14 -49.46 76.9 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.436 -0.79 . . . . 0.0 110.213 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 27.2 m-70 -63.21 -39.19 93.93 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.572 -0.705 . . . . 0.0 109.703 179.247 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 7.2 tp -63.17 -40.13 96.64 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.487 -0.758 . . . . 0.0 109.789 179.082 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 68.2 t60 -58.75 -54.06 51.39 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.575 -0.703 . . . . 0.0 109.71 179.391 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . 0.454 ' O ' ' HB2' ' A' ' 19' ' ' ASP . 23.3 tp60 -53.34 -38.64 63.43 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.643 -0.661 . . . . 0.0 110.015 179.45 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -66.81 -37.46 84.57 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.572 -0.705 . . . . 0.0 110.606 179.392 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 93.1 mt -82.04 -16.42 11.89 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.073 0 O-C-N 121.35 -0.844 . . . . 0.0 110.588 179.833 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 84.6 t -94.67 -53.04 8.8 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 121.165 -0.959 . . . . 0.0 109.489 179.64 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.454 ' HB2' ' O ' ' A' ' 15' ' ' GLN . 0.7 OUTLIER -59.12 -17.42 26.53 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.737 -0.602 . . . . 0.0 111.316 179.543 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 14.9 p . . . . . 0 N--CA 1.499 2.006 0 O-C-N 120.846 -1.159 . . . . 0.0 111.578 -179.842 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 5.0 mp . . . . . 0 N--CA 1.502 2.157 0 CA-C-O 120.953 0.406 . . . . 0.0 111.311 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.474 ' N ' ' HD2' ' A' ' 28' ' ' PRO . 0.7 OUTLIER -61.47 -54.32 53.53 Favored Pre-proline 0 N--CA 1.501 2.114 0 O-C-N 121.244 -0.91 . . . . 0.0 110.694 179.815 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.474 ' HD2' ' N ' ' A' ' 27' ' ' SER . 44.2 Cg_endo -71.39 -27.29 19.48 Favored 'Trans proline' 0 N--CA 1.487 1.126 0 O-C-N 123.481 1.253 . . . . 0.0 110.647 179.553 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.8 -36.24 78.52 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.585 -0.697 . . . . 0.0 110.181 179.497 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.461 HD12 HG23 ' A' ' 30' ' ' ILE . 0.4 OUTLIER -84.15 -30.76 7.53 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 121.354 -0.841 . . . . 0.0 109.938 179.4 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 53.9 m -71.01 -43.73 67.32 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.545 -0.722 . . . . 0.0 109.722 179.349 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 17.5 tttt -88.41 43.4 1.13 Allowed 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.516 -0.74 . . . . 0.0 109.957 179.348 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 21.5 t80 -151.93 -53.45 0.12 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.571 -0.706 . . . . 0.0 109.423 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 53.5 t . . . . . 0 N--CA 1.494 1.732 0 O-C-N 121.631 -0.668 . . . . 0.0 109.697 179.19 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.458 0 N-CA-C 109.261 -1.536 . . . . 0.0 109.261 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.4 mt -61.74 -35.77 79.03 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.755 -0.85 . . . . 0.0 110.492 179.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.8 tt -58.17 -47.75 82.42 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.438 -0.789 . . . . 0.0 109.935 179.645 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 24.1 m-70 -75.52 -42.06 53.61 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.6 -0.688 . . . . 0.0 109.87 179.456 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 11.4 tp -58.83 -42.66 89.75 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.464 -0.773 . . . . 0.0 110.403 179.701 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 6.1 t-80 -59.43 -51.84 68.18 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.563 -0.711 . . . . 0.0 109.933 179.591 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 34.3 tp60 -58.04 -36.53 72.87 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.622 -0.674 . . . . 0.0 110.392 179.731 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -66.42 -41.13 89.7 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.507 -0.745 . . . . 0.0 110.826 179.931 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 73.5 mt -76.15 -43.37 37.76 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 O-C-N 121.262 -0.899 . . . . 0.0 110.505 -179.55 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 38.0 t -67.72 -36.38 75.8 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 O-C-N 121.416 -0.803 . . . . 0.0 110.661 -179.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -66.99 -18.53 65.43 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.428 -0.795 . . . . 0.0 110.666 179.508 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 80.6 t . . . . . 0 N--CA 1.494 1.765 0 O-C-N 121.026 -1.046 . . . . 0.0 109.323 179.096 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.0 tp . . . . . 0 N--CA 1.496 1.869 0 CA-C-O 120.931 0.396 . . . . 0.0 110.383 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.532 ' N ' ' HD2' ' A' ' 28' ' ' PRO . 43.4 m -56.91 -51.36 82.12 Favored Pre-proline 0 N--CA 1.498 1.965 0 O-C-N 121.644 -0.66 . . . . 0.0 110.822 179.72 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.532 ' HD2' ' N ' ' A' ' 27' ' ' SER . 43.6 Cg_endo -69.74 -23.36 30.97 Favored 'Trans proline' 0 N--CA 1.489 1.237 0 O-C-N 123.408 1.215 . . . . 0.0 111.033 179.41 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -80.47 -42.81 21.92 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.452 -0.78 . . . . 0.0 110.581 179.821 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 11.9 tt -71.85 -29.13 32.46 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 O-C-N 121.324 -0.86 . . . . 0.0 111.083 -179.614 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 2.9 p -65.97 -37.03 84.93 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.317 -0.864 . . . . 0.0 109.909 179.547 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 9.6 tptp -87.0 -25.64 24.16 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.416 -0.803 . . . . 0.0 109.796 178.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 71.1 t80 -68.16 -41.1 82.05 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.464 -0.773 . . . . 0.0 110.456 179.656 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.9 p . . . . . 0 N--CA 1.499 1.982 0 O-C-N 121.335 -0.853 . . . . 0.0 110.405 179.693 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 2.617 0 N-CA-C 109.851 -1.3 . . . . 0.0 109.851 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.1 mp -58.73 -39.7 81.6 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.654 -0.909 . . . . 0.0 110.383 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -58.25 -48.37 80.63 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.526 -0.734 . . . . 0.0 109.829 179.392 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -66.76 -43.19 84.72 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.652 -0.655 . . . . 0.0 109.681 179.24 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.0 tt -58.07 -41.0 82.45 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.661 -0.649 . . . . 0.0 110.028 179.38 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 82.9 t60 -59.31 -46.0 89.78 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.529 -0.732 . . . . 0.0 109.808 179.368 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . 0.419 ' O ' ' HB2' ' A' ' 19' ' ' ASP . 0.4 OUTLIER -65.91 -34.27 77.73 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.501 -0.749 . . . . 0.0 109.662 179.193 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -64.94 -14.99 61.58 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.372 -0.83 . . . . 0.0 110.596 179.15 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.417 HG21 HD12 ' A' ' 17' ' ' ILE . 38.5 mm -107.81 -38.51 4.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.356 -0.84 . . . . 0.0 109.66 179.652 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 71.4 t -83.89 -42.6 17.37 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 O-C-N 121.495 -0.753 . . . . 0.0 110.743 -179.714 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.419 ' HB2' ' O ' ' A' ' 15' ' ' GLN . 0.2 OUTLIER -77.23 -2.8 36.48 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.551 -0.718 . . . . 0.0 111.452 -179.663 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 63.2 t . . . . . 0 N--CA 1.495 1.788 0 O-C-N 120.833 -1.167 . . . . 0.0 110.263 179.458 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.3 mp . . . . . 0 N--CA 1.498 1.971 0 CA-C-O 120.689 0.281 . . . . 0.0 111.213 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.516 ' N ' ' HD2' ' A' ' 28' ' ' PRO . 26.5 m -61.61 -51.04 79.57 Favored Pre-proline 0 N--CA 1.499 1.999 0 O-C-N 121.223 -0.923 . . . . 0.0 111.105 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.516 ' HD2' ' N ' ' A' ' 27' ' ' SER . 45.1 Cg_endo -70.72 -17.77 32.96 Favored 'Trans proline' 0 N--CA 1.49 1.269 0 O-C-N 123.417 1.22 . . . . 0.0 111.224 179.823 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -80.32 -41.38 24.94 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.265 -0.897 . . . . 0.0 110.501 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 32.3 mm -69.64 -43.23 80.43 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 O-C-N 121.345 -0.847 . . . . 0.0 110.718 -179.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 12.1 t -63.25 -31.78 73.02 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.475 -0.766 . . . . 0.0 110.626 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 45.0 tttt -73.49 -29.11 62.29 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.284 -0.885 . . . . 0.0 109.937 179.201 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 24.4 t80 -83.02 -45.05 14.53 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.566 -0.709 . . . . 0.0 109.701 179.282 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 3.4 p . . . . . 0 N--CA 1.497 1.88 0 O-C-N 121.547 -0.721 . . . . 0.0 110.115 179.731 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 2.696 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -65.94 -40.46 91.37 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.533 -0.981 . . . . 0.0 109.92 179.559 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.9 tt -61.01 -44.99 96.61 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.579 -0.7 . . . . 0.0 109.776 179.347 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -68.32 -44.47 75.31 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.578 -0.701 . . . . 0.0 109.763 179.409 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -63.35 -37.36 86.95 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.544 -0.722 . . . . 0.0 110.049 179.434 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . 0.442 ' CD2' HG21 ' A' ' 18' ' ' VAL . 14.1 t-80 -57.07 -58.08 9.75 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.576 -0.702 . . . . 0.0 109.645 179.538 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . 0.401 ' O ' ' HB2' ' A' ' 19' ' ' ASP . 0.1 OUTLIER -59.78 -38.95 83.3 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.353 -0.842 . . . . 0.0 110.031 179.19 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -59.22 -43.84 92.3 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.399 -0.813 . . . . 0.0 110.603 179.674 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 22.2 mm -81.87 -36.06 13.95 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 O-C-N 121.232 -0.917 . . . . 0.0 110.47 179.867 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.442 HG21 ' CD2' ' A' ' 14' ' ' HIS . 69.7 t -75.71 -8.6 11.85 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 O-C-N 121.493 -0.754 . . . . 0.0 111.663 -179.469 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.401 ' HB2' ' O ' ' A' ' 15' ' ' GLN . 0.4 OUTLIER -119.56 27.93 8.47 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 120.942 -1.099 . . . . 0.0 110.93 179.781 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 42.4 t . . . . . 0 N--CA 1.499 2.001 0 O-C-N 121.097 -1.002 . . . . 0.0 109.983 179.579 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.2 mt . . . . . 0 N--CA 1.497 1.894 0 CA-C-O 121.042 0.449 . . . . 0.0 110.425 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.45 ' CB ' ' CD ' ' A' ' 28' ' ' PRO . 0.0 OUTLIER -164.18 -61.49 0.01 OUTLIER Pre-proline 0 N--CA 1.498 1.934 0 O-C-N 121.416 -0.803 . . . . 0.0 110.144 179.828 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.45 ' CD ' ' CB ' ' A' ' 27' ' ' SER . 46.0 Cg_endo -71.85 -17.02 29.35 Favored 'Trans proline' 0 N--CA 1.489 1.252 0 O-C-N 123.08 1.042 . . . . 0.0 110.944 179.284 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -100.46 -12.09 19.63 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.4 -0.813 . . . . 0.0 111.002 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 73.6 mt -118.82 -49.08 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.177 -0.952 . . . . 0.0 110.231 -179.768 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 2.4 m -69.98 -31.15 68.71 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.595 -0.69 . . . . 0.0 110.504 -179.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.411 ' HB2' ' O ' ' A' ' 28' ' ' PRO . 12.8 mmtp -87.83 6.2 36.5 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.259 -0.9 . . . . 0.0 110.797 179.635 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -103.33 -41.25 6.09 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.286 -0.884 . . . . 0.0 110.066 179.752 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 16.6 t . . . . . 0 N--CA 1.496 1.864 0 O-C-N 121.446 -0.784 . . . . 0.0 109.451 179.469 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 2.606 0 N-CA-C 109.32 -1.512 . . . . 0.0 109.32 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.06 -41.56 96.84 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.504 -0.997 . . . . 0.0 110.038 179.485 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.26 -42.01 90.17 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.563 -0.711 . . . . 0.0 109.796 179.371 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 6.5 t-80 -65.27 -37.46 87.25 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.594 -0.691 . . . . 0.0 109.833 179.242 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.77 -42.53 99.11 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.465 -0.772 . . . . 0.0 109.399 179.006 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . 0.41 ' NE2' HG21 ' A' ' 18' ' ' VAL . 4.7 t-80 -67.08 -48.07 69.33 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.642 -0.661 . . . . 0.0 109.403 178.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 30.5 mm100 -60.17 -34.49 73.66 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.558 -0.714 . . . . 0.0 109.988 179.385 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 10.1 t30 -61.98 -50.35 72.43 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.429 -0.794 . . . . 0.0 110.137 179.421 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 49.7 mt -71.13 -19.47 21.07 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 O-C-N 121.262 -0.899 . . . . 0.0 110.793 179.783 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.41 HG21 ' NE2' ' A' ' 14' ' ' HIS . 47.0 t -97.24 -8.79 9.16 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 O-C-N 121.258 -0.901 . . . . 0.0 111.232 -179.592 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -123.03 27.84 7.47 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.06 -1.025 . . . . 0.0 110.886 179.592 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 39.3 t . . . . . 0 N--CA 1.497 1.906 0 O-C-N 121.14 -0.975 . . . . 0.0 109.381 179.254 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.501 2.115 0 CA-C-O 121.117 0.484 . . . . 0.0 110.609 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.513 ' CB ' ' CD ' ' A' ' 28' ' ' PRO . 0.4 OUTLIER -169.77 -63.04 0.01 OUTLIER Pre-proline 0 N--CA 1.498 1.944 0 O-C-N 121.54 -0.725 . . . . 0.0 110.186 179.69 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.513 ' CD ' ' CB ' ' A' ' 27' ' ' SER . 43.3 Cg_endo -69.48 -27.33 27.93 Favored 'Trans proline' 0 N--CA 1.49 1.265 0 O-C-N 123.393 1.207 . . . . 0.0 110.76 179.664 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.76 -37.22 83.47 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.579 -0.7 . . . . 0.0 110.289 179.51 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 58.9 mt -79.25 -39.42 21.06 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 121.466 -0.771 . . . . 0.0 109.873 179.52 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 99.8 m -65.0 -45.02 87.33 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.58 -0.7 . . . . 0.0 109.965 179.524 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -67.03 -20.99 65.94 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.485 -0.759 . . . . 0.0 110.785 179.651 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -72.65 -24.09 61.0 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.361 -0.837 . . . . 0.0 110.543 179.615 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 55.6 t . . . . . 0 N--CA 1.495 1.806 0 O-C-N 121.266 -0.896 . . . . 0.0 110.275 -179.965 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.492 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.36 -39.17 89.64 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.636 -0.92 . . . . 0.0 110.284 179.725 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.8 tt -59.03 -48.36 81.86 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.446 -0.784 . . . . 0.0 109.783 179.433 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 21.7 m170 -69.16 -44.3 72.56 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.679 -0.638 . . . . 0.0 109.672 179.213 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.7 mt -56.88 -41.87 78.8 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.605 -0.685 . . . . 0.0 110.06 179.489 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . 0.451 ' CD2' HG22 ' A' ' 18' ' ' VAL . 5.7 t-80 -63.17 -46.86 85.17 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.652 -0.655 . . . . 0.0 109.812 179.321 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 25.2 tp60 -54.1 -41.88 68.75 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.645 -0.659 . . . . 0.0 110.698 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -66.95 -47.82 70.45 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.395 -0.815 . . . . 0.0 110.384 179.781 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 74.4 mt -57.94 -38.6 67.38 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.111 0 O-C-N 121.422 -0.799 . . . . 0.0 109.91 179.83 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.451 HG22 ' CD2' ' A' ' 14' ' ' HIS . 47.5 t -72.22 -35.88 54.17 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.528 -0.732 . . . . 0.0 109.706 179.302 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -68.8 -15.52 63.53 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.734 -0.604 . . . . 0.0 110.966 179.516 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 47.7 t . . . . . 0 N--CA 1.493 1.722 0 O-C-N 121.135 -0.978 . . . . 0.0 109.481 179.322 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 23.8 mt . . . . . 0 N--CA 1.498 1.952 0 CA-C-O 120.618 0.246 . . . . 0.0 111.371 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.47 ' HB2' ' HD3' ' A' ' 28' ' ' PRO . 3.0 m -69.82 -59.44 4.53 Favored Pre-proline 0 N--CA 1.498 1.933 0 O-C-N 121.015 -1.053 . . . . 0.0 110.416 179.86 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.47 ' HD3' ' HB2' ' A' ' 27' ' ' SER . 45.8 Cg_endo -71.52 -25.73 20.82 Favored 'Trans proline' 0 N--CA 1.488 1.165 0 O-C-N 123.395 1.208 . . . . 0.0 110.62 179.402 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.29 -35.64 81.49 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.584 -0.697 . . . . 0.0 110.597 179.734 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 26.1 mm -79.54 -38.41 19.54 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 O-C-N 121.323 -0.861 . . . . 0.0 110.165 179.809 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 24.4 m -62.19 -38.65 89.94 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.432 -0.793 . . . . 0.0 109.958 179.623 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.7 tmtt? -69.92 -35.7 74.78 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.291 -0.88 . . . . 0.0 110.206 179.482 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 80.6 t80 -76.61 -41.1 47.26 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.587 -0.696 . . . . 0.0 110.118 179.671 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 47.1 t . . . . . 0 N--CA 1.495 1.796 0 O-C-N 121.458 -0.776 . . . . 0.0 109.837 179.871 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.515 0 N-CA-C 109.034 -1.626 . . . . 0.0 109.034 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 10.5 tp -87.81 -39.0 15.24 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.568 -0.96 . . . . 0.0 109.89 179.386 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.2 tt -59.63 -48.81 80.21 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.52 -0.737 . . . . 0.0 110.277 179.779 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 7.4 t-80 -61.57 -40.66 95.54 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.514 -0.741 . . . . 0.0 110.306 179.884 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 5.2 tp -56.5 -43.03 79.3 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.422 -0.799 . . . . 0.0 109.614 179.247 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . 0.406 ' CE1' HG21 ' A' ' 18' ' ' VAL . 76.4 t60 -66.77 -45.87 77.11 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.677 -0.639 . . . . 0.0 109.289 178.935 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 3.7 mm-40 -62.24 -35.84 80.17 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.548 -0.72 . . . . 0.0 110.081 179.247 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -60.5 -38.35 84.06 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.519 -0.738 . . . . 0.0 110.421 179.617 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 28.9 mt -86.16 -36.88 11.09 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 O-C-N 121.347 -0.846 . . . . 0.0 110.221 179.958 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.406 HG21 ' CE1' ' A' ' 14' ' ' HIS . 55.1 t -70.77 -34.11 55.19 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 O-C-N 121.324 -0.86 . . . . 0.0 110.512 179.888 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -89.37 14.39 11.3 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.379 -0.826 . . . . 0.0 111.352 -179.914 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.496 1.857 0 O-C-N 120.916 -1.115 . . . . 0.0 110.773 179.256 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.7 mm? . . . . . 0 N--CA 1.498 1.973 0 CA-C-O 121.051 0.453 . . . . 0.0 110.48 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.659 ' HB3' ' HD3' ' A' ' 28' ' ' PRO . 8.0 t -65.02 -52.95 45.41 Favored Pre-proline 0 N--CA 1.497 1.884 0 O-C-N 121.25 -0.906 . . . . 0.0 110.429 179.731 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.659 ' HD3' ' HB3' ' A' ' 27' ' ' SER . 53.2 Cg_endo -81.19 51.71 4.03 Favored 'Trans proline' 0 N--CA 1.484 0.954 0 O-C-N 123.191 1.101 . . . . 0.0 110.508 179.26 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -152.06 -59.36 0.15 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.306 -0.871 . . . . 0.0 109.767 179.855 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 15.8 mt -68.05 -35.53 72.05 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 O-C-N 121.553 -0.717 . . . . 0.0 109.793 179.432 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 1.8 m -70.58 -45.62 65.01 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.672 -0.643 . . . . 0.0 109.715 179.468 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 3.4 mttm -60.37 -32.14 71.0 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.65 -0.656 . . . . 0.0 110.404 179.638 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 88.9 t80 -72.97 -36.61 67.15 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.638 -0.663 . . . . 0.0 110.333 179.615 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 75.8 t . . . . . 0 N--CA 1.499 2.008 0 O-C-N 121.422 -0.798 . . . . 0.0 110.842 -179.885 . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 2.638 0 N-CA-C 110.211 -1.155 . . . . 0.0 110.211 . . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -64.37 -45.38 87.99 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.438 -1.036 . . . . 0.0 110.409 -179.958 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 13.9 tp -61.41 -44.83 96.46 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.518 -0.739 . . . . 0.0 110.085 179.668 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -64.03 -38.5 91.29 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.547 -0.721 . . . . 0.0 109.794 179.361 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 12.1 tp -60.14 -41.4 92.64 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.46 -0.775 . . . . 0.0 109.771 179.122 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 6.7 t-160 -62.5 -50.77 70.08 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.589 -0.694 . . . . 0.0 109.656 179.288 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 22.5 tp60 -57.72 -36.29 71.82 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.56 -0.713 . . . . 0.0 110.291 179.549 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -64.38 -35.86 82.28 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.446 -0.784 . . . . 0.0 110.796 179.696 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 34.3 mt -88.0 -32.37 6.07 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 121.236 -0.915 . . . . 0.0 110.675 -179.639 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -71.37 -42.8 73.78 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 121.284 -0.885 . . . . 0.0 110.224 -179.95 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -63.33 -24.45 67.86 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.427 -0.796 . . . . 0.0 110.814 179.585 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 44.5 t . . . . . 0 N--CA 1.498 1.943 0 O-C-N 121.444 -0.785 . . . . 0.0 110.59 179.705 . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.41 ' HG ' ' CB ' ' A' ' 29' ' ' ALA . 0.5 OUTLIER . . . . . 0 N--CA 1.497 1.906 0 CA-C-O 120.729 0.3 . . . . 0.0 111.369 . . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.528 ' HB3' ' HD3' ' A' ' 28' ' ' PRO . 12.8 t -62.75 -49.5 82.21 Favored Pre-proline 0 N--CA 1.501 2.116 0 O-C-N 121.119 -0.988 . . . . 0.0 111.185 179.738 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.528 ' HD3' ' HB3' ' A' ' 27' ' ' SER . 47.0 Cg_endo -72.76 -9.63 24.04 Favored 'Trans proline' 0 N--CA 1.489 1.246 0 O-C-N 123.314 1.165 . . . . 0.0 111.468 -179.858 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.41 ' CB ' ' HG ' ' A' ' 26' ' ' LEU . . . -99.72 -48.22 4.79 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.278 -0.889 . . . . 0.0 110.372 179.899 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.403 ' HB ' HD21 ' A' ' 26' ' ' LEU . 16.8 tt -62.08 -25.42 37.39 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 O-C-N 121.434 -0.791 . . . . 0.0 111.297 -179.789 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 6.1 t -68.46 -28.47 67.07 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.269 -0.894 . . . . 0.0 110.507 179.831 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -111.15 20.82 17.02 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.388 -0.82 . . . . 0.0 110.237 179.293 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -121.7 -45.75 2.27 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.335 -0.853 . . . . 0.0 110.447 -179.925 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 93.6 t . . . . . 0 N--CA 1.499 1.994 0 O-C-N 121.351 -0.843 . . . . 0.0 110.124 179.837 . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.448 0 N-CA-C 108.771 -1.732 . . . . 0.0 108.771 . . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.1 mp -64.14 -41.21 97.28 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.697 -0.884 . . . . 0.0 109.958 179.335 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.8 tt -58.2 -46.54 85.65 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.622 -0.674 . . . . 0.0 110.02 179.514 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 50.7 t60 -62.61 -39.59 94.26 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.683 -0.636 . . . . 0.0 109.755 179.312 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 6.8 tp -61.93 -39.74 93.09 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.557 -0.715 . . . . 0.0 110.251 179.501 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 5.8 t-80 -60.94 -53.05 62.08 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.571 -0.706 . . . . 0.0 109.865 179.633 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -56.8 -36.92 70.46 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.571 -0.706 . . . . 0.0 110.226 179.688 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.419 ' O ' ' HB ' ' A' ' 20' ' ' VAL . 0.7 OUTLIER -64.63 -47.8 77.2 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.378 -0.826 . . . . 0.0 110.194 179.429 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 68.6 mt -68.85 -36.78 75.76 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.042 0 O-C-N 121.447 -0.783 . . . . 0.0 110.494 179.909 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 21.0 t -75.47 -19.9 15.95 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 121.268 -0.895 . . . . 0.0 110.383 179.906 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -107.85 20.94 18.13 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.355 -0.84 . . . . 0.0 111.018 179.51 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.419 ' HB ' ' O ' ' A' ' 16' ' ' ASN . 3.7 p . . . . . 0 N--CA 1.497 1.917 0 O-C-N 120.812 -1.18 . . . . 0.0 111.065 179.448 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.469 ' HB3' ' HB1' ' A' ' 29' ' ' ALA . 1.4 mp . . . . . 0 N--CA 1.494 1.749 0 CA-C-O 121.332 0.587 . . . . 0.0 109.697 . . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.475 ' N ' ' HD2' ' A' ' 28' ' ' PRO . 0.1 OUTLIER -58.12 -52.46 74.37 Favored Pre-proline 0 N--CA 1.5 2.056 0 O-C-N 121.575 -0.703 . . . . 0.0 111.497 -179.56 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.475 ' HD2' ' N ' ' A' ' 27' ' ' SER . 44.9 Cg_endo -71.15 -12.45 30.22 Favored 'Trans proline' 0 N--CA 1.492 1.42 0 O-C-N 123.46 1.242 . . . . 0.0 111.761 -179.669 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.469 ' HB1' ' HB3' ' A' ' 26' ' ' LEU . . . -98.36 -40.41 8.32 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.265 -0.897 . . . . 0.0 110.299 179.769 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 5.9 tp -71.18 -24.34 24.1 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 O-C-N 121.414 -0.804 . . . . 0.0 110.798 179.878 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 1.9 p -64.64 -42.22 95.61 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.46 -0.775 . . . . 0.0 110.1 179.621 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 2.3 tptm -93.27 26.61 2.84 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.544 -0.722 . . . . 0.0 110.119 179.273 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 10.8 t80 -124.46 -47.81 1.84 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.485 -0.759 . . . . 0.0 110.245 -179.913 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 93.8 t . . . . . 0 N--CA 1.495 1.821 0 O-C-N 121.458 -0.776 . . . . 0.0 109.89 179.954 . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.349 0 N-CA-C 108.649 -1.78 . . . . 0.0 108.649 . . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 11.2 tp -80.77 -32.22 35.58 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.619 -0.93 . . . . 0.0 110.072 179.28 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.4 tt -60.88 -51.35 69.65 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.521 -0.737 . . . . 0.0 110.203 179.739 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 43.9 t60 -64.62 -37.61 88.17 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.56 -0.713 . . . . 0.0 110.307 179.646 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 6.7 tt -54.87 -39.02 68.23 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.493 -0.754 . . . . 0.0 110.269 179.65 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . 0.454 ' CE1' HG23 ' A' ' 18' ' ' VAL . 64.7 t60 -78.26 -51.29 10.37 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.427 -0.796 . . . . 0.0 109.847 179.474 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . 0.411 ' O ' ' HB2' ' A' ' 19' ' ' ASP . 0.8 OUTLIER -58.74 -47.01 86.11 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.623 -0.673 . . . . 0.0 110.484 -179.93 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 4.3 t30 -54.29 -33.37 58.55 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.484 -0.76 . . . . 0.0 111.0 179.885 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 38.4 mm -86.14 -45.51 16.85 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 121.122 -0.987 . . . . 0.0 110.073 179.816 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.454 HG23 ' CE1' ' A' ' 14' ' ' HIS . 52.7 t -63.6 -38.03 81.18 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 O-C-N 121.462 -0.774 . . . . 0.0 110.59 179.933 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.411 ' HB2' ' O ' ' A' ' 15' ' ' GLN . 1.7 m-20 -71.45 -12.74 61.55 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.584 -0.698 . . . . 0.0 111.394 -179.885 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 97.2 t . . . . . 0 N--CA 1.495 1.786 0 O-C-N 120.816 -1.178 . . . . 0.0 110.282 179.461 . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.444 ' HG ' ' HB1' ' A' ' 29' ' ' ALA . 0.1 OUTLIER . . . . . 0 N--CA 1.503 2.185 0 CA-C-O 121.065 0.46 . . . . 0.0 111.191 . . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.494 ' N ' ' HD2' ' A' ' 28' ' ' PRO . 0.0 OUTLIER -63.78 -51.79 62.53 Favored Pre-proline 0 N--CA 1.5 2.054 0 O-C-N 121.244 -0.91 . . . . 0.0 110.705 179.521 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.494 ' HD2' ' N ' ' A' ' 27' ' ' SER . 47.9 Cg_endo -73.46 -8.5 21.81 Favored 'Trans proline' 0 N--CA 1.489 1.261 0 O-C-N 123.434 1.228 . . . . 0.0 111.418 179.939 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.444 ' HB1' ' HG ' ' A' ' 26' ' ' LEU . . . -98.99 -45.68 5.87 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.232 -0.918 . . . . 0.0 110.196 179.842 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.466 HD12 HG22 ' A' ' 30' ' ' ILE . 0.3 OUTLIER -61.73 -31.22 50.24 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 O-C-N 121.438 -0.789 . . . . 0.0 110.4 179.866 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 4.3 p -66.43 -30.01 70.27 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.497 -0.752 . . . . 0.0 110.222 179.276 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 11.1 ttpt -100.74 18.23 19.92 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.507 -0.746 . . . . 0.0 110.414 179.454 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -107.61 -35.02 6.83 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.363 -0.836 . . . . 0.0 109.975 179.687 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 46.0 t . . . . . 0 N--CA 1.495 1.787 0 O-C-N 121.522 -0.736 . . . . 0.0 109.572 179.694 . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 2.721 0 N-CA-C 110.05 -1.22 . . . . 0.0 110.05 . . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -62.9 -31.46 72.53 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.569 -0.96 . . . . 0.0 110.473 179.711 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.7 mp -56.4 -39.41 72.98 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.454 -0.779 . . . . 0.0 110.15 179.537 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -85.14 -41.26 15.84 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.368 -0.832 . . . . 0.0 109.638 179.257 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 6.5 tt -56.34 -43.49 79.11 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.684 -0.635 . . . . 0.0 110.098 179.392 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . 0.478 ' CE1' HG22 ' A' ' 18' ' ' VAL . 66.2 t60 -64.68 -50.68 66.05 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.61 -0.681 . . . . 0.0 109.931 179.52 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -62.27 -36.36 81.82 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.465 -0.772 . . . . 0.0 110.025 179.484 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -57.11 -43.41 82.29 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.54 -0.725 . . . . 0.0 109.858 179.335 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 21.5 mm -80.82 -36.53 15.57 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 O-C-N 121.419 -0.801 . . . . 0.0 109.795 179.393 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.478 HG22 ' CE1' ' A' ' 14' ' ' HIS . 40.0 t -67.01 -21.53 28.39 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 O-C-N 121.444 -0.785 . . . . 0.0 110.977 179.983 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -106.0 10.34 32.28 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.215 -0.928 . . . . 0.0 111.159 179.787 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.497 1.896 0 O-C-N 120.847 -1.158 . . . . 0.0 110.505 179.306 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.8 mp . . . . . 0 N--CA 1.502 2.131 0 CA-C-O 121.155 0.502 . . . . 0.0 110.798 . . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.442 ' CB ' ' HD3' ' A' ' 28' ' ' PRO . 0.4 OUTLIER -60.71 -52.58 71.58 Favored Pre-proline 0 N--CA 1.499 2.013 0 O-C-N 121.351 -0.843 . . . . 0.0 110.027 179.409 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.442 ' HD3' ' CB ' ' A' ' 27' ' ' SER . 52.4 Cg_endo -80.85 44.16 1.69 Allowed 'Trans proline' 0 N--CA 1.485 1.017 0 O-C-N 123.514 1.271 . . . . 0.0 110.512 178.868 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -135.28 -54.69 0.8 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.242 -0.911 . . . . 0.0 109.353 179.789 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 2.2 mp -68.42 -42.74 84.19 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 O-C-N 121.558 -0.714 . . . . 0.0 109.339 178.907 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 14.3 t -67.18 -26.59 66.71 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.733 -0.605 . . . . 0.0 109.989 179.136 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 7.9 mmpt? -78.74 -32.58 46.78 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.336 -0.852 . . . . 0.0 109.885 179.209 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 87.2 t80 -66.31 -29.17 69.32 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.63 -0.668 . . . . 0.0 110.05 179.213 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 88.7 t . . . . . 0 N--CA 1.498 1.955 0 O-C-N 121.324 -0.86 . . . . 0.0 110.174 179.467 . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.418 0 N-CA-C 108.657 -1.777 . . . . 0.0 108.657 . . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.4 pp -90.71 -25.38 20.06 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.589 -0.947 . . . . 0.0 110.036 178.96 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -67.86 -42.2 81.71 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.38 -0.825 . . . . 0.0 109.812 179.499 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 4.3 t-160 -63.4 -37.31 86.8 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.548 -0.72 . . . . 0.0 109.919 179.313 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.2 tt -57.27 -42.15 81.05 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.595 -0.69 . . . . 0.0 109.869 179.237 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . 0.406 ' NE2' HG22 ' A' ' 18' ' ' VAL . 4.8 t-80 -65.96 -53.71 35.55 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.613 -0.679 . . . . 0.0 109.459 179.063 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . 0.417 ' O ' ' HB2' ' A' ' 19' ' ' ASP . 16.1 tp60 -58.72 -38.28 77.97 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.59 -0.694 . . . . 0.0 110.22 179.577 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 13.2 t30 -59.57 -42.1 91.71 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.61 -0.681 . . . . 0.0 110.595 179.764 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 43.8 mt -79.52 -30.62 13.75 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 O-C-N 121.27 -0.894 . . . . 0.0 110.238 179.815 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.406 HG22 ' NE2' ' A' ' 14' ' ' HIS . 31.6 t -78.16 -27.02 14.55 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.227 -0.921 . . . . 0.0 110.203 179.628 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.417 ' HB2' ' O ' ' A' ' 15' ' ' GLN . 0.9 OUTLIER -91.39 17.4 8.53 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.397 -0.814 . . . . 0.0 110.954 179.572 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.494 1.76 0 O-C-N 120.967 -1.083 . . . . 0.0 110.441 179.294 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.498 1.961 0 CA-C-O 120.724 0.297 . . . . 0.0 111.296 . . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.526 ' N ' ' HD2' ' A' ' 28' ' ' PRO . 0.4 OUTLIER -56.74 -51.7 79.39 Favored Pre-proline 0 N--CA 1.499 2.002 0 O-C-N 121.268 -0.895 . . . . 0.0 110.515 179.374 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.526 ' HD2' ' N ' ' A' ' 27' ' ' SER . 42.7 Cg_endo -70.58 -28.57 21.16 Favored 'Trans proline' 0 N--CA 1.487 1.095 0 O-C-N 123.343 1.181 . . . . 0.0 110.115 179.31 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -68.37 -38.55 81.49 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.591 -0.693 . . . . 0.0 110.107 179.345 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 6.0 tp -85.64 -29.05 6.27 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 121.446 -0.784 . . . . 0.0 110.605 179.646 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 77.7 m -75.13 -37.0 61.57 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.39 -0.819 . . . . 0.0 110.125 179.666 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 32.6 mtmt -89.82 22.26 3.2 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.36 -0.837 . . . . 0.0 110.57 179.495 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 5.1 t80 -112.56 -48.27 3.02 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.265 -0.897 . . . . 0.0 109.868 179.751 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 94.8 t . . . . . 0 N--CA 1.494 1.732 0 O-C-N 121.563 -0.711 . . . . 0.0 109.744 179.724 . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.435 0 N-CA-C 109.006 -1.638 . . . . 0.0 109.006 . . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -61.28 -41.0 96.21 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.715 -0.873 . . . . 0.0 110.114 179.464 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 4.5 tt -58.58 -47.17 85.18 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.482 -0.761 . . . . 0.0 109.879 179.466 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 14.1 m170 -66.01 -38.16 87.75 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.541 -0.724 . . . . 0.0 109.789 179.236 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -60.08 -40.36 89.29 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.538 -0.726 . . . . 0.0 109.86 179.313 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 6.8 t-160 -62.94 -51.5 66.66 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.693 -0.629 . . . . 0.0 109.425 179.158 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 6.4 tp60 -61.84 -37.32 84.05 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.572 -0.705 . . . . 0.0 110.086 179.279 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -60.11 -35.39 75.13 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.654 -0.654 . . . . 0.0 110.621 179.662 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 61.2 mt -88.23 -40.3 13.42 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 O-C-N 121.374 -0.829 . . . . 0.0 110.268 179.931 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 9.4 t -69.43 -33.54 57.89 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.875 0 O-C-N 121.378 -0.826 . . . . 0.0 110.61 -179.931 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -88.89 14.31 10.7 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.269 -0.894 . . . . 0.0 111.253 179.831 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.496 1.873 0 O-C-N 120.785 -1.197 . . . . 0.0 110.833 179.386 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.505 2.307 0 CA-C-O 121.017 0.436 . . . . 0.0 110.863 . . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.506 ' N ' ' HD2' ' A' ' 28' ' ' PRO . 0.6 OUTLIER -67.93 -50.18 33.67 Favored Pre-proline 0 N--CA 1.501 2.102 0 O-C-N 121.239 -0.913 . . . . 0.0 111.401 -179.907 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.506 ' HD2' ' N ' ' A' ' 27' ' ' SER . 44.1 Cg_endo -71.08 -20.71 28.37 Favored 'Trans proline' 0 N--CA 1.489 1.243 0 O-C-N 123.247 1.13 . . . . 0.0 111.115 -179.884 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -77.18 -43.82 32.42 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.405 -0.809 . . . . 0.0 110.564 179.915 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 4.9 tp -72.02 -28.63 30.38 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 O-C-N 121.277 -0.89 . . . . 0.0 111.009 -179.814 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 3.3 p -77.21 -35.49 55.6 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.322 -0.861 . . . . 0.0 110.119 179.637 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -86.87 12.04 11.95 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.36 -0.838 . . . . 0.0 110.744 179.406 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 89.6 t80 -112.87 -38.91 4.4 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.188 -0.945 . . . . 0.0 110.366 179.654 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 38.5 t . . . . . 0 N--CA 1.496 1.874 0 O-C-N 121.403 -0.811 . . . . 0.0 110.075 -179.873 . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 2.632 0 N-CA-C 109.767 -1.333 . . . . 0.0 109.767 . . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.86 -47.39 86.57 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.53 -0.983 . . . . 0.0 110.29 179.964 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 5.4 tt -58.25 -45.67 87.37 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.543 -0.723 . . . . 0.0 109.677 179.259 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 5.1 t-160 -68.11 -32.23 72.38 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.654 -0.654 . . . . 0.0 109.979 179.145 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.08 -43.88 98.21 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.615 -0.678 . . . . 0.0 109.966 179.494 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 2.7 t-80 -61.17 -55.85 27.47 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.472 -0.768 . . . . 0.0 109.458 179.34 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . 0.45 ' O ' ' HB2' ' A' ' 19' ' ' ASP . 3.3 tp60 -58.95 -37.77 77.5 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.585 -0.697 . . . . 0.0 110.296 179.746 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 14.8 t30 -63.31 -45.85 89.43 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.576 -0.703 . . . . 0.0 110.449 179.654 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 27.7 mm -73.14 -32.59 39.25 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 O-C-N 121.242 -0.911 . . . . 0.0 109.961 179.58 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 52.2 t -75.12 -18.33 16.14 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 O-C-N 121.374 -0.829 . . . . 0.0 110.533 179.731 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.45 ' HB2' ' O ' ' A' ' 15' ' ' GLN . 0.2 OUTLIER -103.35 19.44 19.68 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.263 -0.898 . . . . 0.0 110.795 179.266 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 1.5 p . . . . . 0 N--CA 1.495 1.801 0 O-C-N 120.784 -1.198 . . . . 0.0 110.65 179.473 . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.461 ' HB3' ' CB ' ' A' ' 29' ' ' ALA . 79.6 mt . . . . . 0 N--CA 1.499 1.986 0 CA-C-O 121.307 0.575 . . . . 0.0 110.331 . . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.548 ' HB2' ' HD3' ' A' ' 28' ' ' PRO . 3.6 m -52.53 -49.82 83.7 Favored Pre-proline 0 N--CA 1.5 2.058 0 O-C-N 121.673 -0.642 . . . . 0.0 111.555 -179.578 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.548 ' HD3' ' HB2' ' A' ' 27' ' ' SER . 44.3 Cg_endo -70.27 -12.56 32.16 Favored 'Trans proline' 0 N--CA 1.491 1.37 0 O-C-N 123.275 1.145 . . . . 0.0 111.613 -179.772 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.461 ' CB ' ' HB3' ' A' ' 26' ' ' LEU . . . -98.93 -41.41 7.61 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.305 -0.872 . . . . 0.0 110.249 179.635 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 16.7 tt -69.98 -23.36 25.33 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 O-C-N 121.422 -0.799 . . . . 0.0 110.951 -179.987 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 2.0 p -63.77 -46.14 86.61 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.387 -0.821 . . . . 0.0 110.158 179.689 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 5.9 mttp -90.13 18.97 5.34 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.546 -0.721 . . . . 0.0 110.306 179.258 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 13.0 t80 -116.25 -40.83 3.21 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.291 -0.881 . . . . 0.0 110.165 179.816 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 29.7 t . . . . . 0 N--CA 1.494 1.76 0 O-C-N 121.378 -0.826 . . . . 0.0 109.68 179.898 . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.45 0 N-CA-C 109.281 -1.527 . . . . 0.0 109.281 . . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 13.4 mt -85.72 -32.41 21.92 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.605 -0.938 . . . . 0.0 109.944 179.38 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 6.0 mp -60.14 -55.78 29.62 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.523 -0.736 . . . . 0.0 110.281 179.841 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 13.7 t-160 -60.35 -42.62 96.1 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.489 -0.757 . . . . 0.0 109.94 179.459 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 13.2 tp -59.82 -41.36 91.14 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.605 -0.684 . . . . 0.0 109.962 179.398 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 51.4 t60 -63.03 -47.74 81.76 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.627 -0.671 . . . . 0.0 110.095 179.571 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 34.4 tp60 -56.17 -42.4 76.99 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.544 -0.723 . . . . 0.0 110.369 179.969 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.443 ' O ' ' HB ' ' A' ' 20' ' ' VAL . 8.4 t-20 -62.46 -48.98 77.25 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.282 -0.886 . . . . 0.0 110.377 179.637 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 73.2 mt -65.73 -38.7 82.88 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.036 0 O-C-N 121.423 -0.798 . . . . 0.0 110.41 -179.958 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 21.3 t -70.92 -36.73 65.2 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 O-C-N 121.237 -0.914 . . . . 0.0 110.35 179.797 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -85.73 1.72 48.34 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.498 -0.751 . . . . 0.0 111.477 179.976 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.443 ' HB ' ' O ' ' A' ' 16' ' ' ASN . 1.0 OUTLIER . . . . . 0 N--CA 1.497 1.882 0 O-C-N 120.802 -1.186 . . . . 0.0 110.431 179.121 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.504 2.26 0 CA-C-O 120.83 0.348 . . . . 0.0 111.1 . . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.51 ' CB ' ' CD ' ' A' ' 28' ' ' PRO . 0.4 OUTLIER -175.16 -62.58 0.0 OUTLIER Pre-proline 0 N--CA 1.497 1.904 0 O-C-N 121.416 -0.802 . . . . 0.0 110.093 179.599 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.51 ' CD ' ' CB ' ' A' ' 27' ' ' SER . 43.6 Cg_endo -70.24 -31.96 17.43 Favored 'Trans proline' 0 N--CA 1.488 1.195 0 O-C-N 123.318 1.168 . . . . 0.0 110.339 179.174 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.422 ' O ' ' HB2' ' A' ' 33' ' ' TYR . . . -72.04 -13.12 61.51 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.618 -0.676 . . . . 0.0 111.037 179.477 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.2 tp -114.03 -28.27 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 O-C-N 121.067 -1.021 . . . . 0.0 111.395 -179.73 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 2.0 t -96.08 -20.19 18.84 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.059 -1.026 . . . . 0.0 110.958 -179.977 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -114.41 17.96 17.15 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.095 -1.003 . . . . 0.0 110.544 179.691 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.422 ' HB2' ' O ' ' A' ' 29' ' ' ALA . 7.2 m-85 -129.56 21.41 5.56 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.286 -0.884 . . . . 0.0 110.801 -179.935 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.3 t . . . . . 0 N--CA 1.496 1.857 0 O-C-N 121.285 -0.884 . . . . 0.0 110.094 -179.934 . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.355 0 N-CA-C 109.302 -1.519 . . . . 0.0 109.302 . . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -59.97 -41.98 93.13 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.664 -0.904 . . . . 0.0 110.507 179.945 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -60.94 -50.33 73.85 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.459 -0.776 . . . . 0.0 110.003 179.675 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 3.8 m80 -63.82 -42.5 97.65 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.605 -0.685 . . . . 0.0 110.255 179.679 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 9.3 tp -60.65 -42.88 97.87 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.504 -0.748 . . . . 0.0 110.011 179.538 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 66.6 t60 -59.64 -55.07 38.98 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.647 -0.658 . . . . 0.0 109.943 179.478 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -53.24 -37.29 61.93 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.631 -0.668 . . . . 0.0 110.383 179.699 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -65.98 -46.15 79.08 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.541 -0.724 . . . . 0.0 110.493 179.697 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 63.3 mt -72.47 -32.83 43.38 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.11 0 O-C-N 121.418 -0.801 . . . . 0.0 110.429 179.934 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 52.4 t -65.86 -48.18 82.96 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.491 -0.756 . . . . 0.0 110.328 -179.815 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -79.42 47.73 0.84 Allowed 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.145 -0.972 . . . . 0.0 110.855 179.953 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 51.3 t . . . . . 0 N--CA 1.496 1.843 0 O-C-N 121.335 -0.853 . . . . 0.0 109.536 179.319 . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.5 2.064 0 CA-C-O 120.744 0.307 . . . . 0.0 111.557 . . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.59 ' HB2' ' HD3' ' A' ' 28' ' ' PRO . 2.5 m -106.48 -62.3 0.04 OUTLIER Pre-proline 0 N--CA 1.495 1.81 0 O-C-N 121.114 -0.991 . . . . 0.0 110.443 179.715 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.59 ' HD3' ' HB2' ' A' ' 27' ' ' SER . 53.6 Cg_endo -79.81 63.75 8.78 Favored 'Trans proline' 0 N--CA 1.484 0.92 0 O-C-N 123.239 1.126 . . . . 0.0 110.033 179.357 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -166.41 -46.6 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.524 -0.735 . . . . 0.0 110.298 -179.7 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 47.6 mm -81.51 -38.8 16.56 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 O-C-N 121.535 -0.728 . . . . 0.0 110.265 -179.9 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 82.5 m -70.87 -42.26 70.28 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.464 -0.773 . . . . 0.0 110.031 179.732 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 7.2 mttp -69.7 -15.67 63.21 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.442 -0.786 . . . . 0.0 110.753 179.379 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -70.21 -42.49 72.25 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.377 -0.827 . . . . 0.0 110.38 179.847 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 26.6 t . . . . . 0 N--CA 1.497 1.9 0 O-C-N 121.457 -0.777 . . . . 0.0 110.347 179.729 . . . . . . . . 0 0 . 1 . 031 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.363 0 N-CA-C 108.699 -1.76 . . . . 0.0 108.699 . . . . . . . . . 0 0 . 1 . 031 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -62.25 -36.99 83.73 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.611 -0.935 . . . . 0.0 109.921 179.064 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -59.95 -47.41 85.92 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.553 -0.717 . . . . 0.0 110.096 179.43 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 26.5 t-80 -67.35 -43.92 80.32 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.518 -0.739 . . . . 0.0 109.531 179.272 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -59.95 -40.15 88.03 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.662 -0.649 . . . . 0.0 109.872 179.237 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 1.1 t-80 -58.68 -55.24 37.7 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.576 -0.703 . . . . 0.0 109.639 179.389 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.39 -37.36 72.56 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.611 -0.68 . . . . 0.0 110.58 179.895 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -59.58 -35.76 74.92 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.378 -0.826 . . . . 0.0 110.064 179.296 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 46.2 mm -82.58 -36.56 13.55 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.46 -0.775 . . . . 0.0 109.844 179.55 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 61.2 t -61.55 -23.23 30.13 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.048 0 O-C-N 121.448 -0.783 . . . . 0.0 110.758 -179.979 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -86.81 -21.42 26.47 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.252 -0.905 . . . . 0.0 110.614 179.81 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 47.5 t . . . . . 0 N--CA 1.496 1.868 0 O-C-N 121.112 -0.992 . . . . 0.0 109.595 179.346 . . . . . . . . 0 0 . 1 . 031 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.499 2.003 0 CA-C-O 121.273 0.558 . . . . 0.0 110.498 . . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.536 ' N ' ' CD ' ' A' ' 28' ' ' PRO . 0.3 OUTLIER -82.12 -40.39 0.94 Allowed Pre-proline 0 N--CA 1.496 1.867 0 O-C-N 121.445 -0.785 . . . . 0.0 112.012 -179.695 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.536 ' CD ' ' N ' ' A' ' 27' ' ' SER . 47.8 Cg_endo -75.86 64.56 6.79 Favored 'Trans proline' 0 N--CA 1.486 1.081 0 O-C-N 123.126 1.066 . . . . 0.0 110.614 -179.359 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -167.55 -49.67 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.708 -0.62 . . . . 0.0 109.789 179.892 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 49.2 mm -91.9 -29.88 4.66 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 121.612 -0.68 . . . . 0.0 110.23 179.633 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 31.9 m -61.35 -38.13 85.83 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.528 -0.733 . . . . 0.0 110.142 179.725 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.439 ' HA ' ' HE2' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -69.96 -27.53 64.81 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.394 -0.816 . . . . 0.0 110.47 179.609 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -78.77 -16.95 56.54 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.449 -0.782 . . . . 0.0 110.811 179.544 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 23.6 t . . . . . 0 N--CA 1.498 1.948 0 O-C-N 121.291 -0.881 . . . . 0.0 109.982 179.944 . . . . . . . . 0 0 . 1 . 032 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.415 0 N-CA-C 109.262 -1.535 . . . . 0.0 109.262 . . . . . . . . . 0 0 . 1 . 032 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -60.53 -34.83 74.69 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.595 -0.944 . . . . 0.0 110.287 179.7 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 6.4 tt -56.33 -45.19 80.44 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.577 -0.702 . . . . 0.0 110.153 179.503 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 27.6 m-70 -81.81 -42.55 19.53 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.438 -0.789 . . . . 0.0 110.008 179.521 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 7.2 tp -57.36 -37.32 72.42 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.65 -0.656 . . . . 0.0 110.484 179.801 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . 0.475 ' CD2' HG23 ' A' ' 18' ' ' VAL . 1.8 t-80 -56.83 -47.31 80.6 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.458 -0.776 . . . . 0.0 109.802 179.382 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 6.4 tp60 -59.53 -34.94 73.27 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.625 -0.672 . . . . 0.0 110.42 179.627 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 16.0 t30 -69.91 -35.21 74.41 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.459 -0.775 . . . . 0.0 110.403 179.551 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 32.5 mt -82.47 -16.07 11.76 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 O-C-N 121.241 -0.912 . . . . 0.0 110.879 179.962 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.475 HG23 ' CD2' ' A' ' 14' ' ' HIS . 74.7 t -99.38 -50.97 10.49 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.142 -0.974 . . . . 0.0 109.802 179.891 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 34.5 t0 -61.57 -21.7 64.53 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.602 -0.686 . . . . 0.0 110.604 179.376 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 8.3 p . . . . . 0 N--CA 1.5 2.059 0 O-C-N 121.296 -0.878 . . . . 0.0 110.935 179.53 . . . . . . . . 0 0 . 1 . 032 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 5.3 mp . . . . . 0 N--CA 1.5 2.036 0 CA-C-O 121.177 0.513 . . . . 0.0 111.194 . . . . . . . . . 0 0 . 1 . 032 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.555 ' HB3' ' HD3' ' A' ' 28' ' ' PRO . 3.7 t -164.21 -65.09 0.01 OUTLIER Pre-proline 0 N--CA 1.499 1.998 0 O-C-N 121.265 -0.897 . . . . 0.0 110.602 179.221 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.555 ' HD3' ' HB3' ' A' ' 27' ' ' SER . 47.1 Cg_endo -72.97 -20.54 21.9 Favored 'Trans proline' 0 N--CA 1.491 1.328 0 O-C-N 123.258 1.136 . . . . 0.0 111.113 179.888 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -73.44 -45.06 56.63 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.448 -0.783 . . . . 0.0 110.202 179.887 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 3.2 mt -68.07 -36.4 75.27 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 O-C-N 121.422 -0.799 . . . . 0.0 110.564 -179.967 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 20.3 p -71.47 -32.19 68.0 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.477 -0.764 . . . . 0.0 110.316 179.703 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.4 tttt -90.42 18.53 6.08 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.415 -0.803 . . . . 0.0 110.814 179.763 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -111.51 -50.8 2.9 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.296 -0.878 . . . . 0.0 109.766 179.627 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 45.9 t . . . . . 0 N--CA 1.496 1.826 0 O-C-N 121.445 -0.784 . . . . 0.0 109.845 179.791 . . . . . . . . 0 0 . 1 . 033 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.502 0 N-CA-C 109.237 -1.545 . . . . 0.0 109.237 . . . . . . . . . 0 0 . 1 . 033 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -70.1 -43.69 70.56 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.591 -0.947 . . . . 0.0 109.91 179.699 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 5.6 tt -58.35 -45.94 87.2 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.64 -0.663 . . . . 0.0 110.392 179.703 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 37.1 t60 -64.58 -40.62 95.87 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.473 -0.767 . . . . 0.0 110.2 179.765 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.422 ' O ' HD11 ' A' ' 17' ' ' ILE . 3.2 tp -60.28 -40.6 90.97 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.448 -0.782 . . . . 0.0 110.108 179.406 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . 0.443 ' CD2' HG22 ' A' ' 18' ' ' VAL . 18.3 t-80 -60.19 -58.64 7.67 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.388 -0.82 . . . . 0.0 109.778 179.625 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . 0.45 ' O ' ' HB2' ' A' ' 19' ' ' ASP . 0.7 OUTLIER -60.14 -26.04 65.97 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.452 -0.78 . . . . 0.0 110.692 179.613 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 -80.0 -46.38 16.72 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.35 -0.844 . . . . 0.0 110.577 -179.883 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.422 HD11 ' O ' ' A' ' 13' ' ' LEU . 1.3 mp -76.7 -33.58 22.14 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 121.286 -0.884 . . . . 0.0 110.401 -179.809 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.443 HG22 ' CD2' ' A' ' 14' ' ' HIS . 50.7 t -70.52 -29.43 38.53 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 O-C-N 121.125 -0.984 . . . . 0.0 110.364 179.826 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.45 ' HB2' ' O ' ' A' ' 15' ' ' GLN . 0.4 OUTLIER -88.26 3.27 50.14 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.461 -0.775 . . . . 0.0 111.211 179.772 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.496 1.828 0 O-C-N 120.947 -1.096 . . . . 0.0 110.722 179.611 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.496 1.863 0 CA-C-O 120.896 0.379 . . . . 0.0 110.808 . . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.434 ' CB ' ' HD3' ' A' ' 28' ' ' PRO . 0.0 OUTLIER -84.48 -56.5 0.41 Allowed Pre-proline 0 N--CA 1.499 2.019 0 O-C-N 121.2 -0.938 . . . . 0.0 110.223 179.823 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.434 ' HD3' ' CB ' ' A' ' 27' ' ' SER . 49.4 Cg_endo -77.58 -11.52 17.05 Favored 'Trans proline' 0 C--N 1.32 -0.926 0 O-C-N 123.32 1.168 . . . . 0.0 110.596 179.174 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -82.81 -43.55 16.54 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.274 -0.892 . . . . 0.0 110.33 179.935 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.434 HG22 ' O ' ' A' ' 27' ' ' SER . 4.0 tp -65.0 -30.5 50.56 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 O-C-N 121.498 -0.751 . . . . 0.0 110.674 -179.99 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 9.7 p -72.35 -25.73 61.65 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.376 -0.827 . . . . 0.0 110.229 179.345 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 2.5 tttm -99.24 16.39 23.05 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.389 -0.819 . . . . 0.0 110.643 179.63 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -110.19 -37.88 5.43 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.222 -0.923 . . . . 0.0 110.69 -179.759 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 52.8 t . . . . . 0 N--CA 1.498 1.961 0 O-C-N 121.421 -0.799 . . . . 0.0 110.224 -179.84 . . . . . . . . 0 0 . 1 . 034 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.521 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 . . . . . . . . . 0 0 . 1 . 034 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.34 -39.24 92.44 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.642 -0.917 . . . . 0.0 110.389 179.826 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 13.6 tp -58.68 -51.04 71.63 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.46 -0.775 . . . . 0.0 110.236 179.669 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -65.15 -43.15 92.76 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.548 -0.72 . . . . 0.0 109.816 179.482 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -60.63 -39.7 89.23 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.535 -0.728 . . . . 0.0 109.953 179.241 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 4.4 t-80 -59.31 -54.09 50.74 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.786 -0.572 . . . . 0.0 109.885 179.538 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.9 tp60 -57.31 -47.18 82.17 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.518 -0.739 . . . . 0.0 110.221 179.865 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -48.41 -45.89 36.64 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.496 -0.753 . . . . 0.0 110.519 179.512 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 18.4 mm -73.62 -42.37 55.35 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 121.37 -0.831 . . . . 0.0 110.114 179.653 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 40.5 t -65.67 -34.99 74.12 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 121.465 -0.772 . . . . 0.0 110.401 179.786 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 72.9 m-20 -67.59 -16.55 64.24 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.488 -0.758 . . . . 0.0 110.595 179.239 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 64.6 t . . . . . 0 N--CA 1.494 1.738 0 O-C-N 121.044 -1.035 . . . . 0.0 109.261 179.148 . . . . . . . . 0 0 . 1 . 034 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.497 1.886 0 CA-C-O 121.106 0.479 . . . . 0.0 110.23 . . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.589 ' HB2' ' HD3' ' A' ' 28' ' ' PRO . 48.2 m -57.03 -50.66 86.92 Favored Pre-proline 0 N--CA 1.497 1.913 0 O-C-N 121.738 -0.601 . . . . 0.0 110.915 179.881 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.589 ' HD3' ' HB2' ' A' ' 27' ' ' SER . 47.7 Cg_endo -71.3 -7.83 22.14 Favored 'Trans proline' 0 N--CA 1.491 1.362 0 O-C-N 123.421 1.221 . . . . 0.0 111.592 179.83 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -98.05 -39.29 9.0 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.199 -0.938 . . . . 0.0 110.357 179.944 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 49.4 mt -76.14 -35.4 28.39 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 O-C-N 121.389 -0.819 . . . . 0.0 110.71 -179.802 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 8.8 p -60.94 -37.46 82.42 Favored 'General case' 0 N--CA 1.501 2.122 0 O-C-N 121.441 -0.787 . . . . 0.0 110.336 179.747 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 26.9 mttt -89.86 13.69 13.9 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.392 -0.818 . . . . 0.0 110.617 179.273 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -108.03 -47.88 3.48 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.305 -0.872 . . . . 0.0 110.067 179.743 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 25.8 t . . . . . 0 N--CA 1.498 1.947 0 O-C-N 121.541 -0.725 . . . . 0.0 109.537 179.77 . . . . . . . . 0 0 . 1 . 035 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.498 2.792 0 N-CA-C 110.221 -1.151 . . . . 0.0 110.221 . . . . . . . . . 0 0 . 1 . 035 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 10.6 tp -58.73 -31.61 68.46 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.638 -0.919 . . . . 0.0 110.568 179.79 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 5.0 mp -56.91 -41.81 78.82 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.597 -0.689 . . . . 0.0 110.13 179.639 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 -80.05 -40.21 28.18 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.348 -0.845 . . . . 0.0 109.83 179.212 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.7 tt -60.49 -42.06 95.53 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.66 -0.65 . . . . 0.0 110.538 179.943 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 86.5 t60 -61.52 -51.37 68.89 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.479 -0.763 . . . . 0.0 110.281 179.95 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 12.2 tp60 -62.21 -30.23 70.94 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.341 -0.849 . . . . 0.0 110.011 179.436 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -66.52 -24.95 66.46 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.293 -0.879 . . . . 0.0 110.297 179.144 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 61.7 mt -101.39 -27.56 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 121.205 -0.935 . . . . 0.0 110.342 179.68 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 93.5 t -95.92 -13.23 8.26 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 O-C-N 121.383 -0.823 . . . . 0.0 111.142 -179.647 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -120.15 38.48 3.95 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.033 -1.042 . . . . 0.0 110.553 179.836 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 40.1 t . . . . . 0 N--CA 1.497 1.923 0 O-C-N 121.355 -0.841 . . . . 0.0 109.857 179.949 . . . . . . . . 0 0 . 1 . 035 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.499 2.025 0 CA-C-O 120.63 0.252 . . . . 0.0 111.306 . . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.504 ' N ' ' HD2' ' A' ' 28' ' ' PRO . 4.7 m -64.07 -52.19 57.47 Favored Pre-proline 0 N--CA 1.499 1.975 0 O-C-N 121.24 -0.912 . . . . 0.0 110.732 179.608 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.504 ' HD2' ' N ' ' A' ' 27' ' ' SER . 44.3 Cg_endo -71.27 -17.88 30.67 Favored 'Trans proline' 0 N--CA 1.489 1.207 0 O-C-N 123.413 1.217 . . . . 0.0 110.795 179.477 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -77.28 -28.19 53.36 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.454 -0.779 . . . . 0.0 110.263 179.547 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 89.6 mt -90.08 -29.07 4.96 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 121.3 -0.875 . . . . 0.0 110.605 179.961 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 32.6 p -65.02 -50.19 67.23 Favored 'General case' 0 N--CA 1.502 2.144 0 O-C-N 121.279 -0.888 . . . . 0.0 110.069 179.656 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.88 -17.04 64.36 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.447 -0.783 . . . . 0.0 110.439 179.226 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 81.8 t80 -82.18 -34.92 28.84 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.364 -0.835 . . . . 0.0 110.124 179.543 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 97.3 t . . . . . 0 N--CA 1.495 1.822 0 O-C-N 121.465 -0.772 . . . . 0.0 110.338 -179.982 . . . . . . . . 0 0 . 1 . 036 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.462 0 N-CA-C 108.951 -1.66 . . . . 0.0 108.951 . . . . . . . . . 0 0 . 1 . 036 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.1 mp -57.91 -37.52 74.2 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.651 -0.911 . . . . 0.0 110.111 179.501 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -57.14 -44.48 83.41 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.64 -0.663 . . . . 0.0 110.035 179.412 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 7.1 m170 -67.74 -43.76 79.18 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.582 -0.699 . . . . 0.0 110.227 179.636 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.2 tt -55.2 -44.42 75.31 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.646 -0.659 . . . . 0.0 110.456 179.956 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . 0.425 ' CD2' HG23 ' A' ' 18' ' ' VAL . 1.6 t-80 -60.35 -50.04 75.2 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.506 -0.746 . . . . 0.0 109.689 179.504 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 16.4 mm100 -64.69 -35.67 81.8 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.542 -0.724 . . . . 0.0 110.065 179.646 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -61.94 -38.06 87.05 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.576 -0.703 . . . . 0.0 110.6 179.658 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 24.1 mm -83.23 -45.17 18.86 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 O-C-N 121.37 -0.831 . . . . 0.0 110.341 -179.834 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.425 HG23 ' CD2' ' A' ' 14' ' ' HIS . 64.3 t -63.4 -35.69 73.29 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 O-C-N 121.497 -0.752 . . . . 0.0 110.712 -179.797 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -68.94 -24.84 64.32 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.385 -0.822 . . . . 0.0 110.733 -179.992 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 48.8 t . . . . . 0 N--CA 1.492 1.648 0 O-C-N 120.968 -1.082 . . . . 0.0 109.494 179.327 . . . . . . . . 0 0 . 1 . 036 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.497 1.902 0 CA-C-O 121.048 0.452 . . . . 0.0 110.505 . . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.559 ' HB2' ' HD3' ' A' ' 28' ' ' PRO . 0.7 OUTLIER -86.2 -49.85 0.51 Allowed Pre-proline 0 N--CA 1.5 2.049 0 O-C-N 121.453 -0.779 . . . . 0.0 111.268 -179.751 . . . . . . . . 3 3 . 1 . 036 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.559 ' HD3' ' HB2' ' A' ' 27' ' ' SER . 50.5 Cg_endo -77.21 64.52 7.87 Favored 'Trans proline' 0 N--CA 1.487 1.13 0 O-C-N 123.395 1.208 . . . . 0.0 110.55 -179.635 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -167.34 -49.48 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.644 -0.66 . . . . 0.0 109.729 179.864 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 46.4 mm -79.11 -38.12 20.06 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 121.562 -0.711 . . . . 0.0 110.113 179.758 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 29.7 p -65.01 -45.29 86.16 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.522 -0.736 . . . . 0.0 109.979 179.59 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 24.7 mmtt -64.69 -27.68 69.08 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.644 -0.66 . . . . 0.0 110.221 179.385 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -69.14 -35.39 76.32 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.463 -0.773 . . . . 0.0 109.801 179.212 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.9 t . . . . . 0 N--CA 1.495 1.81 0 O-C-N 121.53 -0.731 . . . . 0.0 109.504 179.448 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' SER . . . . . 0.444 ' O ' ' HB2' ' A' ' 2' ' ' ASP . 20.9 m . . . . . 0 N--CA 1.495 1.818 0 N-CA-C 110.169 -0.308 . . . . 0.0 110.169 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.444 ' HB2' ' O ' ' A' ' 1' ' ' SER . 16.4 m-20 62.18 173.27 0.13 Allowed 'General case' 0 N--CA 1.502 2.166 0 CA-C-O 121.42 0.628 . . . . 0.0 111.137 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 52.4 66.78 4.6 Favored Pre-proline 0 N--CA 1.501 2.085 0 O-C-N 121.607 -0.683 . . . . 0.0 110.697 -179.879 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -79.22 60.49 7.82 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 O-C-N 123.937 1.493 . . . . 0.0 110.562 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -154.26 -54.87 0.1 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.557 -0.714 . . . . 0.0 109.834 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 57.79 26.03 12.65 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 121.834 -0.542 . . . . 0.0 111.327 179.797 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 16.5 m -116.05 26.09 10.21 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.075 -1.016 . . . . 0.0 110.462 179.627 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 18.2 p -141.56 58.64 1.51 Allowed 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.352 -0.842 . . . . 0.0 109.93 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -85.18 -64.85 1.5 Allowed Glycine 0 N--CA 1.495 2.57 0 N-CA-C 109.807 -1.317 . . . . 0.0 109.807 -179.623 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 12.6 mt -58.3 -40.71 82.7 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.683 -0.892 . . . . 0.0 110.465 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 5.1 tt -57.54 -50.42 73.14 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.49 -0.756 . . . . 0.0 109.943 179.602 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 8.6 m170 -61.06 -41.95 97.56 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.692 -0.63 . . . . 0.0 110.074 179.515 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 9.4 tp -58.12 -42.67 86.24 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.641 -0.662 . . . . 0.0 110.199 179.518 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 74.7 t60 -61.02 -49.16 78.53 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.713 -0.617 . . . . 0.0 110.001 179.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 15.8 mm-40 -60.08 -37.82 81.06 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.505 -0.747 . . . . 0.0 110.267 179.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -62.28 -39.75 93.97 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.498 -0.751 . . . . 0.0 110.377 179.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 56.4 mt -79.65 -44.08 23.31 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 O-C-N 121.317 -0.864 . . . . 0.0 110.203 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 49.9 t -66.65 -17.91 23.31 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 O-C-N 121.558 -0.714 . . . . 0.0 111.134 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -98.53 -6.23 30.6 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.141 -0.974 . . . . 0.0 111.053 179.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 75.7 t -116.36 -50.69 4.59 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 O-C-N 120.935 -1.103 . . . . 0.0 110.282 179.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.59 -27.09 69.0 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.648 -0.657 . . . . 0.0 110.743 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -63.31 -31.22 72.32 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.298 -0.876 . . . . 0.0 110.159 179.702 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -98.17 -27.92 13.96 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.394 -0.816 . . . . 0.0 110.705 179.536 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 52.0 m-85 -108.05 27.57 9.13 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.232 -0.917 . . . . 0.0 110.956 -179.611 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -88.0 -62.97 1.4 Allowed Glycine 0 N--CA 1.494 2.526 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER 51.36 32.68 8.79 Favored 'General case' 0 N--CA 1.504 2.245 0 O-C-N 121.976 -0.72 . . . . 0.0 111.253 179.792 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.42 ' N ' ' HD2' ' A' ' 28' ' ' PRO . 0.0 OUTLIER -59.45 -57.02 30.05 Favored Pre-proline 0 N--CA 1.501 2.097 0 O-C-N 121.306 -0.871 . . . . 0.0 110.616 179.815 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.42 ' HD2' ' N ' ' A' ' 27' ' ' SER . 45.7 Cg_endo -71.52 -27.53 18.76 Favored 'Trans proline' 0 N--CA 1.487 1.114 0 O-C-N 123.485 1.255 . . . . 0.0 110.895 179.681 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.36 -52.51 61.41 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.446 -0.784 . . . . 0.0 110.746 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 34.8 mm -60.52 -35.85 66.0 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.12 0 O-C-N 121.411 -0.806 . . . . 0.0 110.559 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 73.4 m -61.11 -27.82 68.65 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.541 -0.724 . . . . 0.0 110.566 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.36 7.52 33.34 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.299 -0.876 . . . . 0.0 110.689 179.559 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -101.22 -39.31 7.7 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.36 -0.837 . . . . 0.0 110.161 179.716 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 92.2 t -71.82 -23.61 22.36 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 121.445 -0.784 . . . . 0.0 110.367 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.2 p -107.65 8.18 9.48 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 O-C-N 121.23 -0.919 . . . . 0.0 111.208 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.497 1.903 0 CA-C-O 117.908 -1.044 . . . . 0.0 110.477 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 7.6 p . . . . . 0 N--CA 1.495 1.81 0 CA-C-O 121.182 0.515 . . . . 0.0 110.183 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -115.88 -0.86 12.72 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.532 -0.73 . . . . 0.0 111.352 -179.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 50.58 69.65 2.48 Favored Pre-proline 0 N--CA 1.503 2.21 0 O-C-N 121.489 -0.757 . . . . 0.0 111.332 179.51 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -86.59 52.5 2.75 Favored 'Trans proline' 0 C--N 1.31 -1.456 0 C-N-CA 121.524 1.483 . . . . 0.0 110.811 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 59.15 19.6 7.56 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 121.462 -0.774 . . . . 0.0 111.375 -179.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 2.0 mt -120.18 10.59 11.4 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.145 -0.972 . . . . 0.0 110.657 179.56 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 91.5 p -159.84 52.82 0.35 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.226 -0.921 . . . . 0.0 109.876 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 5.8 t -125.54 22.46 7.63 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.193 -0.942 . . . . 0.0 111.044 -179.551 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -62.21 -54.96 30.68 Favored Glycine 0 N--CA 1.496 2.685 0 N-CA-C 109.165 -1.574 . . . . 0.0 109.165 179.405 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 7.1 tp -81.73 -31.73 31.9 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.606 -0.938 . . . . 0.0 109.91 179.153 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -56.03 -47.59 77.56 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.535 -0.728 . . . . 0.0 110.256 179.73 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -57.36 -42.99 83.14 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.547 -0.721 . . . . 0.0 110.036 179.46 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.1 tt -60.96 -41.46 96.38 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.676 -0.64 . . . . 0.0 110.224 179.451 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 67.9 t60 -60.8 -50.23 74.3 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.399 -0.813 . . . . 0.0 109.721 179.408 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 51.8 mm-40 -58.56 -35.89 73.08 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.531 -0.731 . . . . 0.0 110.007 179.382 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -58.54 -36.11 73.37 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.621 -0.674 . . . . 0.0 110.133 179.234 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.425 ' O ' HG11 ' A' ' 20' ' ' VAL . 7.4 mt -88.17 -31.81 5.83 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 O-C-N 121.515 -0.741 . . . . 0.0 109.96 179.502 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 54.9 t -68.6 -37.38 77.57 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 121.378 -0.826 . . . . 0.0 110.301 179.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.522 ' HA ' ' CD2' ' A' ' 22' ' ' TYR . 0.6 OUTLIER -82.95 4.43 25.87 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.563 -0.71 . . . . 0.0 111.471 -179.985 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.425 HG11 ' O ' ' A' ' 17' ' ' ILE . 0.8 OUTLIER -113.52 -14.14 11.03 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 O-C-N 120.737 -1.227 . . . . 0.0 110.653 179.373 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 29.3 mt-30 -102.13 -32.68 9.99 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.415 -0.803 . . . . 0.0 110.539 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . 0.522 ' CD2' ' HA ' ' A' ' 19' ' ' ASP . 2.7 p90 -62.23 -25.04 67.59 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.266 -0.896 . . . . 0.0 110.978 -179.753 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 5.8 tmm? -88.91 -36.4 15.95 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.115 -0.991 . . . . 0.0 110.721 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 48.5 m-85 -88.1 -30.89 19.53 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.379 -0.826 . . . . 0.0 111.797 -179.075 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -124.86 26.2 5.68 Favored Glycine 0 N--CA 1.497 2.763 0 C-N-CA 119.921 -1.133 . . . . 0.0 111.395 -179.108 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.495 ' HB2' ' HA ' ' A' ' 22' ' ' TYR . 0.2 OUTLIER -159.9 33.84 0.18 Allowed 'General case' 0 N--CA 1.501 2.085 0 O-C-N 120.899 -1.354 . . . . 0.0 110.675 179.475 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.41 ' N ' ' HD2' ' A' ' 28' ' ' PRO . 1.2 m -77.82 -51.77 1.73 Allowed Pre-proline 0 N--CA 1.497 1.913 0 O-C-N 121.297 -0.877 . . . . 0.0 111.064 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.41 ' HD2' ' N ' ' A' ' 27' ' ' SER . 49.5 Cg_endo -76.93 61.43 7.12 Favored 'Trans proline' 0 N--CA 1.487 1.13 0 O-C-N 123.446 1.235 . . . . 0.0 110.317 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.407 ' HB3' HD23 ' A' ' 26' ' ' LEU . . . -167.35 -51.9 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.515 -0.741 . . . . 0.0 109.944 -179.869 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 80.3 mt -68.35 -24.99 30.32 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 O-C-N 121.535 -0.728 . . . . 0.0 110.22 179.497 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 19.5 p -65.98 -41.83 90.63 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.448 -0.782 . . . . 0.0 110.211 179.471 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 5.9 tmtt? -70.2 -10.82 60.04 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.549 -0.72 . . . . 0.0 110.935 179.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 8.6 t80 -70.24 -43.25 70.97 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.316 -0.865 . . . . 0.0 110.361 179.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 38.8 t -94.68 45.46 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 O-C-N 121.35 -0.844 . . . . 0.0 110.263 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 59.5 t -139.97 52.8 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 O-C-N 121.154 -0.966 . . . . 0.0 109.471 179.499 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.751 0 CA-C-O 117.842 -1.075 . . . . 0.0 110.434 -179.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 13.4 m . . . . . 0 N--CA 1.497 1.911 0 CA-C-O 121.242 0.544 . . . . 0.0 110.01 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -132.62 40.0 3.31 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.4 -0.812 . . . . 0.0 110.588 -179.36 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.491 ' N ' ' HD3' ' A' ' 4' ' ' PRO . 0.2 OUTLIER 50.16 60.72 14.73 Favored Pre-proline 0 N--CA 1.503 2.183 0 O-C-N 121.626 -0.671 . . . . 0.0 110.941 179.893 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.491 ' HD3' ' N ' ' A' ' 3' ' ' LEU . 50.2 Cg_endo -85.1 37.64 0.61 Allowed 'Trans proline' 0 C--N 1.313 -1.303 0 O-C-N 123.646 1.34 . . . . 0.0 111.144 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -162.04 37.99 0.12 Allowed 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.272 -0.892 . . . . 0.0 110.474 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.9 pp -63.47 -31.07 72.12 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.368 -0.833 . . . . 0.0 110.741 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 5.2 t -133.19 15.06 4.18 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.273 -0.892 . . . . 0.0 110.726 179.546 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.455 ' HB ' ' CG ' ' A' ' 12' ' ' HIS . 21.8 p -135.79 52.55 1.99 Allowed 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.123 -0.986 . . . . 0.0 110.088 179.871 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -92.17 -77.49 1.36 Allowed Glycine 0 N--CA 1.491 2.331 0 N-CA-C 108.49 -1.844 . . . . 0.0 108.49 179.449 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 7.4 mt -81.09 -35.57 31.52 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.67 -0.9 . . . . 0.0 109.878 179.192 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 2.5 tt -59.21 -42.9 92.03 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.633 -0.667 . . . . 0.0 110.069 179.507 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . 0.455 ' CG ' ' HB ' ' A' ' 8' ' ' THR . 0.0 OUTLIER -76.35 -33.21 58.97 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.524 -0.735 . . . . 0.0 110.105 179.429 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -57.09 -47.72 80.34 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.445 -0.784 . . . . 0.0 110.472 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . 0.42 ' CE1' HG22 ' A' ' 18' ' ' VAL . 77.4 t60 -61.39 -52.21 65.55 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.381 -0.824 . . . . 0.0 109.823 179.625 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 4.3 tp-100 -60.02 -37.63 80.31 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.523 -0.735 . . . . 0.0 110.222 179.542 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -62.43 -39.42 93.27 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.573 -0.704 . . . . 0.0 110.665 179.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 76.5 mt -81.6 -41.82 18.97 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 O-C-N 121.166 -0.959 . . . . 0.0 110.29 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.42 HG22 ' CE1' ' A' ' 14' ' ' HIS . 76.8 t -65.26 -44.83 94.97 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 O-C-N 121.392 -0.818 . . . . 0.0 110.439 -179.901 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -65.73 -16.11 63.47 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.742 -0.599 . . . . 0.0 111.46 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 94.9 t -102.66 -38.21 5.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 120.74 -1.225 . . . . 0.0 109.86 179.495 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -66.53 -37.48 85.1 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.521 -0.737 . . . . 0.0 110.682 179.785 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -63.68 -34.44 77.87 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.227 -0.921 . . . . 0.0 110.286 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -96.2 21.33 9.05 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.377 -0.827 . . . . 0.0 110.651 179.452 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -109.52 33.55 4.28 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.157 -0.964 . . . . 0.0 110.51 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -121.21 -100.35 1.7 Allowed Glycine 0 N--CA 1.493 2.492 0 N-CA-C 109.317 -1.513 . . . . 0.0 109.317 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 10.6 mt 49.27 42.14 21.33 Favored 'General case' 0 N--CA 1.503 2.195 0 O-C-N 121.869 -0.783 . . . . 0.0 111.105 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.586 ' HB2' ' HD3' ' A' ' 28' ' ' PRO . 2.2 m -59.29 -56.28 37.57 Favored Pre-proline 0 N--CA 1.497 1.887 0 O-C-N 121.277 -0.89 . . . . 0.0 110.592 -179.851 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.586 ' HD3' ' HB2' ' A' ' 27' ' ' SER . 53.2 Cg_endo -80.42 53.87 4.96 Favored 'Trans proline' 0 N--CA 1.485 1.018 0 O-C-N 123.386 1.203 . . . . 0.0 110.434 179.329 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -155.44 -54.11 0.09 Allowed 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.304 -0.873 . . . . 0.0 110.029 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 10.0 mt -79.48 -32.17 14.54 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 O-C-N 121.415 -0.803 . . . . 0.0 110.439 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 16.1 m -61.17 -38.59 87.02 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.553 -0.717 . . . . 0.0 110.333 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 2.1 pttt -93.2 18.37 9.56 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.467 -0.77 . . . . 0.0 110.606 179.394 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -113.39 -50.02 2.88 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.265 -0.897 . . . . 0.0 109.952 179.773 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 74.0 t -85.17 -55.06 7.29 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 121.479 -0.763 . . . . 0.0 109.893 179.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.4 t 56.28 41.86 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.141 0 O-C-N 121.741 -0.6 . . . . 0.0 110.421 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.503 2.182 0 CA-C-O 118.074 -0.965 . . . . 0.0 111.288 179.644 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 46.2 m . . . . . 0 N--CA 1.494 1.732 0 CA-C-O 121.01 0.433 . . . . 0.0 110.13 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -125.99 38.03 4.23 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.461 -0.774 . . . . 0.0 110.744 -179.821 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.54 ' CB ' ' HD3' ' A' ' 4' ' ' PRO . 0.9 OUTLIER -71.09 -53.73 8.03 Favored Pre-proline 0 N--CA 1.496 1.846 0 O-C-N 121.222 -0.924 . . . . 0.0 110.018 179.309 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.54 ' HD3' ' CB ' ' A' ' 3' ' ' LEU . 52.3 Cg_endo -86.87 16.56 1.94 Allowed 'Trans proline' 0 CA--C 1.544 1.005 0 O-C-N 123.49 1.258 . . . . 0.0 111.307 179.34 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 59.46 17.52 6.07 Favored 'General case' 0 N--CA 1.505 2.315 0 O-C-N 121.37 -0.831 . . . . 0.0 111.728 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 51.39 39.06 23.44 Favored 'General case' 0 N--CA 1.504 2.227 0 O-C-N 121.259 -0.901 . . . . 0.0 111.779 179.558 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 43.3 t 55.88 76.69 0.27 Allowed 'General case' 0 N--CA 1.502 2.162 0 O-C-N 121.487 -0.758 . . . . 0.0 111.188 179.397 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 2.0 p -117.61 17.3 14.47 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.277 -0.889 . . . . 0.0 111.104 179.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -65.08 -66.11 2.62 Favored Glycine 0 N--CA 1.496 2.64 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -58.48 -35.24 71.89 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.682 -0.893 . . . . 0.0 110.207 179.629 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 4.8 tt -57.18 -46.28 82.96 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.471 -0.768 . . . . 0.0 109.965 179.464 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 22.3 m-70 -68.44 -42.73 78.43 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.527 -0.733 . . . . 0.0 109.877 179.449 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -60.35 -38.79 84.95 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.63 -0.669 . . . . 0.0 109.778 179.225 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 71.5 t60 -63.9 -52.72 58.61 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.627 -0.671 . . . . 0.0 109.624 179.255 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 29.9 tp60 -54.65 -39.04 67.61 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.697 -0.627 . . . . 0.0 110.149 179.559 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -58.12 -49.07 78.25 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.554 -0.717 . . . . 0.0 110.327 179.558 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 29.2 mt -72.09 -33.47 47.11 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.073 0 O-C-N 121.449 -0.782 . . . . 0.0 110.226 179.714 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.442 ' HA ' ' CD1' ' A' ' 22' ' ' TYR . 73.5 t -75.69 -10.92 13.84 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.093 0 O-C-N 121.51 -0.744 . . . . 0.0 111.086 179.825 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.509 ' HA ' ' HB2' ' A' ' 23' ' ' MET . 0.9 OUTLIER -111.49 20.96 16.7 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.892 -1.13 . . . . 0.0 110.674 179.886 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.421 ' O ' ' HB2' ' A' ' 24' ' ' TYR . 73.0 t -120.09 -54.38 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 O-C-N 121.139 -0.976 . . . . 0.0 109.721 179.481 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 42.4 mt-30 -82.4 -16.21 49.88 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.743 -0.598 . . . . 0.0 110.376 179.643 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . 0.442 ' CD1' ' HA ' ' A' ' 18' ' ' VAL . 18.7 m-85 -108.39 -46.26 3.73 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.463 -0.773 . . . . 0.0 110.353 -179.01 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' MET . . . . . 0.509 ' HB2' ' HA ' ' A' ' 19' ' ' ASP . 0.2 OUTLIER -68.08 -31.08 70.46 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.522 -0.736 . . . . 0.0 110.662 179.944 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.421 ' HB2' ' O ' ' A' ' 20' ' ' VAL . 0.3 OUTLIER -90.28 42.42 1.1 Allowed 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.179 -0.95 . . . . 0.0 110.261 179.594 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -159.18 45.84 0.44 Allowed Glycine 0 N--CA 1.494 2.525 0 N-CA-C 109.326 -1.51 . . . . 0.0 109.326 179.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.1 mp -107.76 18.31 21.5 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.402 -1.058 . . . . 0.0 110.925 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.496 ' N ' ' HD2' ' A' ' 28' ' ' PRO . 0.8 OUTLIER -56.62 -52.8 70.73 Favored Pre-proline 0 N--CA 1.498 1.947 0 O-C-N 121.3 -0.875 . . . . 0.0 110.486 179.528 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.496 ' HD2' ' N ' ' A' ' 27' ' ' SER . 45.8 Cg_endo -71.79 -26.7 18.85 Favored 'Trans proline' 0 N--CA 1.488 1.185 0 O-C-N 123.53 1.279 . . . . 0.0 110.789 179.314 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -71.09 -33.52 70.27 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.495 -0.753 . . . . 0.0 110.507 179.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -84.97 -11.25 11.52 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 O-C-N 121.269 -0.894 . . . . 0.0 110.976 179.851 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 24.0 p -101.8 -38.89 7.65 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.08 -1.013 . . . . 0.0 110.532 179.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 2.1 tptt -90.23 39.11 0.95 Allowed 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.378 -0.826 . . . . 0.0 110.574 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -149.55 -49.93 0.14 Allowed 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.34 -0.85 . . . . 0.0 109.882 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 16.1 t -80.88 73.26 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 CA-C-O 121.416 0.627 . . . . 0.0 109.668 179.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 18.3 t -129.6 41.11 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 O-C-N 121.59 -0.694 . . . . 0.0 109.724 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.499 1.992 0 CA-C-O 117.821 -1.085 . . . . 0.0 110.871 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 9.5 p . . . . . 0 N--CA 1.494 1.765 0 CA-C-O 121.013 0.435 . . . . 0.0 110.276 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -142.08 176.78 8.69 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.523 -0.736 . . . . 0.0 110.292 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.463 ' CB ' ' HD3' ' A' ' 4' ' ' PRO . 0.3 OUTLIER -57.83 -53.61 63.95 Favored Pre-proline 0 N--CA 1.502 2.147 0 O-C-N 121.531 -0.731 . . . . 0.0 111.374 -179.449 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.463 ' HD3' ' CB ' ' A' ' 3' ' ' LEU . 48.9 Cg_endo -81.74 -153.22 0.04 OUTLIER 'Trans proline' 0 C--N 1.319 -1.021 0 O-C-N 123.477 1.251 . . . . 0.0 110.029 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -167.59 -75.11 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.325 -0.86 . . . . 0.0 110.371 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.1 pp -103.73 -19.12 14.42 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.4 -0.813 . . . . 0.0 111.104 -179.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 69.7 m -99.64 48.04 0.94 Allowed 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.202 -0.936 . . . . 0.0 110.105 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 5.6 t -124.35 9.72 8.54 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.363 -0.836 . . . . 0.0 111.166 -179.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -77.48 -55.1 4.38 Favored Glycine 0 N--CA 1.494 2.555 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 179.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 2.1 pp -66.64 -31.15 71.64 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.58 -0.953 . . . . 0.0 110.597 179.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.92 -44.31 93.28 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.202 -0.936 . . . . 0.0 109.973 179.663 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 5.5 m80 -70.34 -37.1 74.61 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.516 -0.74 . . . . 0.0 109.942 179.337 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.9 tp -59.6 -40.12 86.43 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.532 -0.73 . . . . 0.0 110.561 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . 0.422 ' CD2' HG21 ' A' ' 18' ' ' VAL . 3.3 t-80 -54.74 -51.91 64.17 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.611 -0.68 . . . . 0.0 109.958 179.771 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 12.1 tp-100 -62.63 -32.31 73.31 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.48 -0.763 . . . . 0.0 110.507 179.772 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -72.12 -47.68 49.41 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.314 -0.866 . . . . 0.0 110.559 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 39.0 mm -71.65 -40.41 70.64 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 O-C-N 121.408 -0.808 . . . . 0.0 110.429 -179.772 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.422 HG21 ' CD2' ' A' ' 14' ' ' HIS . 38.3 t -62.19 -30.1 48.06 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 O-C-N 121.36 -0.838 . . . . 0.0 110.199 179.771 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -76.8 -15.65 59.68 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.503 -0.748 . . . . 0.0 110.85 179.382 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 92.7 t -103.4 -37.61 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.057 -1.027 . . . . 0.0 109.884 179.618 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . 0.48 ' CG ' ' HB3' ' A' ' 26' ' ' LEU . 8.1 tt0 -67.54 -35.27 78.75 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.511 -0.743 . . . . 0.0 110.614 179.85 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -68.61 -36.7 79.02 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.254 -0.903 . . . . 0.0 109.873 179.646 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 1.2 tmt? -77.08 -32.14 56.5 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.58 -0.7 . . . . 0.0 110.695 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -78.7 3.4 16.59 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.249 -0.907 . . . . 0.0 110.964 179.644 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 70.16 37.7 72.38 Favored Glycine 0 N--CA 1.493 2.471 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -179.817 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.48 ' HB3' ' CG ' ' A' ' 21' ' ' GLN . 2.3 mp -112.76 11.24 19.34 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.385 -1.068 . . . . 0.0 111.195 -179.731 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.607 ' HB3' ' HD3' ' A' ' 28' ' ' PRO . 0.5 OUTLIER -62.81 -53.37 56.71 Favored Pre-proline 0 N--CA 1.498 1.931 0 O-C-N 121.154 -0.966 . . . . 0.0 110.374 179.474 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.607 ' HD3' ' HB3' ' A' ' 27' ' ' SER . 45.7 Cg_endo -73.07 -31.33 9.81 Favored 'Trans proline' 0 N--CA 1.487 1.122 0 O-C-N 123.491 1.259 . . . . 0.0 110.69 179.681 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.55 -24.48 67.54 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.618 -0.676 . . . . 0.0 111.279 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 47.5 mm -105.63 -30.11 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 O-C-N 121.113 -0.992 . . . . 0.0 111.119 -179.62 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.548 HG22 ' HA ' ' A' ' 28' ' ' PRO . 4.8 t -85.17 -30.97 23.51 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.159 -0.963 . . . . 0.0 110.867 -179.796 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.3 tttt -89.4 10.88 20.92 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.193 -0.942 . . . . 0.0 110.979 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 6.8 m-85 -114.07 -38.43 4.17 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.105 -0.997 . . . . 0.0 110.539 179.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 60.8 t -89.31 -91.9 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.312 -0.867 . . . . 0.0 109.696 179.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 9.8 p 37.79 37.95 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.51 2.528 0 CA-C-O 121.467 0.651 . . . . 0.0 111.803 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.819 0 CA-C-O 117.94 -1.029 . . . . 0.0 110.293 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 24.3 t . . . . . 0 N--CA 1.495 1.811 0 CA-C-O 121.167 0.508 . . . . 0.0 110.41 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -145.85 144.39 30.21 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.43 -0.794 . . . . 0.0 110.303 179.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 18.2 tp -151.09 77.98 7.38 Favored Pre-proline 0 N--CA 1.495 1.802 0 O-C-N 121.5 -0.75 . . . . 0.0 110.15 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -90.09 -154.81 0.05 OUTLIER 'Trans proline' 0 C--N 1.309 -1.508 0 C-N-CA 121.726 1.617 . . . . 0.0 110.426 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -161.09 90.25 0.82 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.283 -0.886 . . . . 0.0 109.798 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 60.68 34.0 20.12 Favored 'General case' 0 N--CA 1.503 2.213 0 O-C-N 121.806 -0.559 . . . . 0.0 110.636 -179.588 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 22.8 t -151.87 64.58 0.85 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.452 -0.78 . . . . 0.0 109.614 179.697 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -108.27 9.02 28.04 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.293 -0.879 . . . . 0.0 111.11 -179.495 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -65.55 -54.89 23.41 Favored Glycine 0 N--CA 1.496 2.673 0 N-CA-C 109.272 -1.531 . . . . 0.0 109.272 179.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -63.09 -35.64 80.95 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.652 -0.91 . . . . 0.0 109.972 179.371 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -56.98 -48.19 79.01 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.53 -0.731 . . . . 0.0 109.87 179.378 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 7.1 m-70 -63.88 -39.36 94.0 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.715 -0.616 . . . . 0.0 109.738 179.129 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 9.1 tp -58.96 -41.87 88.53 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.64 -0.663 . . . . 0.0 110.109 179.333 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 5.7 t-160 -62.16 -52.04 65.43 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.543 -0.723 . . . . 0.0 109.258 179.149 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 27.3 tp60 -58.72 -36.53 74.43 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.625 -0.672 . . . . 0.0 110.021 179.186 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -61.73 -45.31 94.48 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.643 -0.661 . . . . 0.0 110.474 179.731 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 38.8 mt -73.27 -37.5 52.03 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.018 0 O-C-N 121.352 -0.842 . . . . 0.0 109.84 179.637 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 54.8 t -75.73 -3.92 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 O-C-N 121.475 -0.766 . . . . 0.0 110.658 179.473 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -120.79 5.41 10.49 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.188 -0.945 . . . . 0.0 110.57 179.136 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 5.5 p -102.68 -31.16 2.97 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 O-C-N 120.905 -1.122 . . . . 0.0 110.866 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -97.45 6.98 47.37 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.296 -0.878 . . . . 0.0 110.639 179.896 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . 0.442 ' CD2' ' N ' ' A' ' 22' ' ' TYR . 4.9 m-85 -133.08 -49.11 0.86 Allowed 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.4 -0.812 . . . . 0.0 109.316 -179.255 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.51 -31.78 63.89 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.51 -0.744 . . . . 0.0 109.549 178.734 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -85.19 4.65 33.58 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.392 -0.817 . . . . 0.0 110.973 179.485 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -84.47 -37.05 11.18 Favored Glycine 0 N--CA 1.493 2.489 0 N-CA-C 109.729 -1.348 . . . . 0.0 109.729 179.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 56.94 34.25 24.57 Favored 'General case' 0 N--CA 1.504 2.228 0 O-C-N 121.754 -0.851 . . . . 0.0 111.231 179.856 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.488 ' CB ' ' CD ' ' A' ' 28' ' ' PRO . 0.5 OUTLIER -99.21 -63.98 0.08 OUTLIER Pre-proline 0 N--CA 1.497 1.887 0 O-C-N 121.184 -0.947 . . . . 0.0 110.571 179.69 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.488 ' CD ' ' CB ' ' A' ' 27' ' ' SER . 41.8 Cg_endo -67.66 -25.04 40.69 Favored 'Trans proline' 0 N--CA 1.489 1.235 0 O-C-N 123.222 1.117 . . . . 0.0 110.876 179.812 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.76 -32.16 73.54 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.37 -0.831 . . . . 0.0 110.312 179.292 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 97.1 mt -99.68 -42.34 10.38 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 121.501 -0.749 . . . . 0.0 110.035 179.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 62.8 m -63.88 -38.24 90.38 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.665 -0.647 . . . . 0.0 110.612 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 13.2 tttt -89.31 15.29 9.29 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.231 -0.918 . . . . 0.0 110.68 179.558 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 9.7 t80 -106.63 -44.09 4.56 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.296 -0.877 . . . . 0.0 110.019 179.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.9 t -83.88 67.31 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 O-C-N 121.383 -0.823 . . . . 0.0 109.734 179.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 23.1 t -127.99 60.14 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 121.433 -0.792 . . . . 0.0 109.628 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 3.0 tpm_? . . . . . 0 N--CA 1.493 1.706 0 CA-C-O 117.817 -1.087 . . . . 0.0 110.476 -179.854 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 2.4 p . . . . . 0 N--CA 1.495 1.806 0 CA-C-O 121.152 0.501 . . . . 0.0 110.052 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -133.91 -173.25 3.2 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.487 -0.758 . . . . 0.0 110.366 -179.607 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.47 ' CB ' ' HD3' ' A' ' 4' ' ' PRO . 0.3 OUTLIER -60.42 -50.04 87.51 Favored Pre-proline 0 N--CA 1.501 2.106 0 O-C-N 121.484 -0.76 . . . . 0.0 111.263 -179.658 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.47 ' HD3' ' CB ' ' A' ' 3' ' ' LEU . 47.1 Cg_endo -88.36 -157.11 0.06 OUTLIER 'Trans proline' 0 C--N 1.318 -1.051 0 O-C-N 123.45 1.237 . . . . 0.0 110.416 -179.821 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -128.93 -59.61 1.12 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.228 -0.92 . . . . 0.0 110.215 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -112.3 39.95 2.33 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.424 -0.797 . . . . 0.0 109.97 179.625 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 5.1 t 54.37 72.37 0.46 Allowed 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.695 -0.628 . . . . 0.0 110.178 -179.704 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 1.4 m -86.88 40.07 0.88 Allowed 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.356 -0.84 . . . . 0.0 110.478 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -106.17 -52.19 0.79 Allowed Glycine 0 N--CA 1.492 2.427 0 N-CA-C 109.032 -1.627 . . . . 0.0 109.032 179.545 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.5 mt -62.8 -41.99 99.52 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.616 -0.932 . . . . 0.0 110.17 179.665 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 15.6 tp -59.45 -43.61 93.15 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.464 -0.772 . . . . 0.0 109.814 179.378 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 6.9 m170 -65.35 -44.94 86.08 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.628 -0.67 . . . . 0.0 109.748 179.271 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.91 -33.91 76.62 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.472 -0.767 . . . . 0.0 109.969 179.31 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . 0.447 ' NE2' HG23 ' A' ' 18' ' ' VAL . 8.1 t-160 -63.0 -51.7 65.84 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.625 -0.672 . . . . 0.0 109.88 179.549 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.441 ' O ' ' HB2' ' A' ' 19' ' ' ASP . 0.3 OUTLIER -61.75 -36.03 79.81 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.496 -0.752 . . . . 0.0 109.993 179.497 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -59.36 -43.61 92.81 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.473 -0.767 . . . . 0.0 110.289 179.445 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 61.1 mt -81.87 -26.25 9.58 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.925 0 O-C-N 121.395 -0.816 . . . . 0.0 110.624 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.447 HG23 ' NE2' ' A' ' 14' ' ' HIS . 49.7 t -85.65 -7.44 10.92 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 121.031 -1.043 . . . . 0.0 110.693 179.79 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.441 ' HB2' ' O ' ' A' ' 15' ' ' GLN . 0.5 OUTLIER -122.53 32.24 5.83 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.101 -0.999 . . . . 0.0 109.667 178.896 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.462 ' HA ' ' HG2' ' A' ' 23' ' ' MET . 13.0 p -123.81 -44.11 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 O-C-N 121.416 -0.802 . . . . 0.0 110.646 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 28.4 mt-30 -78.35 -12.89 60.03 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.348 -0.845 . . . . 0.0 110.134 179.35 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . 0.4 ' CD1' ' N ' ' A' ' 22' ' ' TYR . 10.4 m-85 -104.44 -25.43 12.81 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.657 -0.652 . . . . 0.0 109.704 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' MET . . . . . 0.462 ' HG2' ' HA ' ' A' ' 20' ' ' VAL . 0.5 OUTLIER -80.98 -21.25 40.46 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.385 -0.822 . . . . 0.0 110.376 179.292 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -110.44 20.17 18.02 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.23 -0.919 . . . . 0.0 110.891 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -81.1 -38.64 14.72 Favored Glycine 0 N--CA 1.496 2.686 0 N-CA-C 109.786 -1.325 . . . . 0.0 109.786 179.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.6 mp 58.25 26.07 13.43 Favored 'General case' 0 N--CA 1.502 2.148 0 O-C-N 121.688 -0.889 . . . . 0.0 111.549 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.46 ' N ' ' HD2' ' A' ' 28' ' ' PRO . 1.4 m -69.88 -55.43 8.73 Favored Pre-proline 0 N--CA 1.498 1.939 0 O-C-N 121.113 -0.992 . . . . 0.0 110.27 179.333 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.46 ' HD2' ' N ' ' A' ' 27' ' ' SER . 45.6 Cg_endo -71.61 -20.23 27.07 Favored 'Trans proline' 0 N--CA 1.487 1.1 0 O-C-N 123.451 1.237 . . . . 0.0 110.681 179.182 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -70.85 -37.89 73.16 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.48 -0.763 . . . . 0.0 110.216 179.585 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 28.5 mm -74.35 -39.93 49.2 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 O-C-N 121.518 -0.739 . . . . 0.0 110.061 179.625 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 44.9 p -69.22 -39.48 78.53 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.381 -0.825 . . . . 0.0 110.206 179.692 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 26.9 mmtt -71.91 -29.77 64.67 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.428 -0.795 . . . . 0.0 110.638 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 92.4 t80 -86.44 -47.4 9.34 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.399 -0.813 . . . . 0.0 110.319 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 47.2 t -80.14 82.15 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 121.448 -0.783 . . . . 0.0 109.831 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 9.6 p -157.04 36.75 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 CA-C-O 121.6 0.714 . . . . 0.0 109.926 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 19.9 mmt85 . . . . . 0 N--CA 1.497 1.881 0 CA-C-O 118.032 -0.985 . . . . 0.0 110.212 -179.733 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 47.1 m . . . . . 0 N--CA 1.495 1.784 0 CA-C-O 121.104 0.478 . . . . 0.0 110.067 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -128.7 131.35 47.95 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.545 -0.722 . . . . 0.0 110.259 -179.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.578 ' CB ' ' HD3' ' A' ' 4' ' ' PRO . 1.1 mp -99.97 -55.65 0.16 Allowed Pre-proline 0 N--CA 1.496 1.846 0 O-C-N 121.611 -0.68 . . . . 0.0 110.958 -179.846 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.578 ' HD3' ' CB ' ' A' ' 3' ' ' LEU . 47.5 Cg_endo -89.75 -159.85 0.09 OUTLIER 'Trans proline' 0 C--N 1.319 -0.979 0 O-C-N 123.317 1.167 . . . . 0.0 110.342 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -153.23 59.01 0.77 Allowed 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.31 -0.869 . . . . 0.0 110.048 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 3.1 tp -101.62 -33.6 9.83 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.448 -0.783 . . . . 0.0 110.964 -179.672 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 22.6 t -60.27 -44.42 95.33 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.437 -0.79 . . . . 0.0 111.035 -179.549 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 32.1 p -120.82 8.74 10.57 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.426 -0.796 . . . . 0.0 111.316 -179.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -107.85 -67.53 0.63 Allowed Glycine 0 N--CA 1.492 2.376 0 N-CA-C 108.626 -1.789 . . . . 0.0 108.626 179.604 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 8.9 tp -73.49 -36.82 65.85 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.648 -0.913 . . . . 0.0 109.876 179.335 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 11.5 tp -64.56 -44.1 91.82 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.377 -0.827 . . . . 0.0 109.839 179.506 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -63.76 -42.92 97.73 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.59 -0.693 . . . . 0.0 109.832 179.443 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 5.2 tp -63.88 -40.72 97.19 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.542 -0.724 . . . . 0.0 110.238 179.505 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 7.3 t-80 -57.4 -54.22 49.33 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.643 -0.661 . . . . 0.0 109.922 179.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.455 ' O ' ' HB2' ' A' ' 19' ' ' ASP . 19.5 tp60 -55.57 -40.14 71.6 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.672 -0.642 . . . . 0.0 110.089 179.577 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -66.67 -40.8 88.75 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.348 -0.845 . . . . 0.0 110.68 179.686 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 85.6 mt -77.07 -21.53 14.5 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 O-C-N 121.395 -0.816 . . . . 0.0 110.858 -179.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 24.3 t -93.16 -33.61 5.43 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 O-C-N 121.205 -0.934 . . . . 0.0 110.082 179.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.455 ' HB2' ' O ' ' A' ' 15' ' ' GLN . 2.4 m-20 -87.75 28.84 0.96 Allowed 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.278 -0.889 . . . . 0.0 110.439 179.271 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 12.5 p -103.53 -28.31 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.825 0 O-C-N 121.242 -0.911 . . . . 0.0 110.344 179.577 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . 0.503 ' HG2' HG21 ' A' ' 30' ' ' ILE . 13.6 mt-30 -101.78 -27.56 12.95 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.595 -0.691 . . . . 0.0 110.559 -179.711 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -101.14 -26.7 13.59 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.363 -0.836 . . . . 0.0 110.64 -179.187 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -97.43 16.5 20.0 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.228 -0.92 . . . . 0.0 111.3 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -97.53 13.77 28.83 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 120.867 -1.146 . . . . 0.0 111.035 179.699 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 73.56 31.45 60.75 Favored Glycine 0 N--CA 1.494 2.519 0 N-CA-C 109.71 -1.356 . . . . 0.0 109.71 -179.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -147.81 43.75 1.08 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.428 -1.042 . . . . 0.0 110.192 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -60.28 -54.34 56.1 Favored Pre-proline 0 N--CA 1.498 1.939 0 O-C-N 121.397 -0.814 . . . . 0.0 110.656 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -77.61 55.32 5.13 Favored 'Trans proline' 0 N--CA 1.487 1.119 0 O-C-N 123.393 1.207 . . . . 0.0 110.318 179.473 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -162.74 -49.18 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.59 -0.694 . . . . 0.0 109.78 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.503 HG21 ' HG2' ' A' ' 21' ' ' GLN . 21.8 mt -83.13 -34.1 10.87 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 121.624 -0.673 . . . . 0.0 110.224 179.592 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 43.7 m -61.6 -43.35 99.03 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.568 -0.707 . . . . 0.0 109.931 179.48 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.8 tttp -70.51 -23.52 62.67 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.549 -0.719 . . . . 0.0 110.496 179.332 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -75.43 -27.58 59.03 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.415 -0.803 . . . . 0.0 110.365 179.646 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 57.9 t -96.37 -44.71 12.9 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 O-C-N 121.269 -0.895 . . . . 0.0 110.543 -179.749 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 37.5 t 55.63 70.14 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.142 0 O-C-N 121.603 -0.686 . . . . 0.0 110.006 -179.68 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 2.5 ttp180 . . . . . 0 N--CA 1.495 1.778 0 CA-C-O 117.887 -1.054 . . . . 0.0 110.426 -179.907 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 60.1 p . . . . . 0 N--CA 1.495 1.815 0 CA-C-O 121.102 0.477 . . . . 0.0 110.309 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 35.7 m-20 -95.53 118.95 33.18 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.322 -0.861 . . . . 0.0 110.282 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.465 ' N ' ' HD2' ' A' ' 4' ' ' PRO . 3.0 mp -59.17 -51.18 83.48 Favored Pre-proline 0 N--CA 1.5 2.07 0 O-C-N 121.661 -0.65 . . . . 0.0 110.573 179.751 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.465 ' HD2' ' N ' ' A' ' 3' ' ' LEU . 50.1 Cg_endo -76.21 60.63 6.36 Favored 'Trans proline' 0 N--CA 1.486 1.087 0 O-C-N 123.535 1.282 . . . . 0.0 110.293 179.555 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -162.78 -53.6 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.417 -0.802 . . . . 0.0 110.129 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.2 pp -102.85 -17.86 15.35 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.55 -0.719 . . . . 0.0 111.092 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 10.1 m -85.18 -58.45 2.68 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.175 -0.953 . . . . 0.0 109.887 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 12.0 t 37.15 42.54 0.28 Allowed 'General case' 0 N--CA 1.504 2.241 0 CA-C-O 121.32 0.581 . . . . 0.0 111.906 179.701 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -94.73 -84.82 1.65 Allowed Glycine 0 N--CA 1.494 2.503 0 N-CA-C 109.275 -1.53 . . . . 0.0 109.275 179.564 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 8.0 tp -66.74 -32.03 73.06 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.577 -0.955 . . . . 0.0 110.237 179.475 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -58.19 -43.09 87.39 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.45 -0.781 . . . . 0.0 110.024 179.551 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -59.02 -43.75 91.61 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.6 -0.688 . . . . 0.0 109.696 179.29 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.2 tt -61.99 -38.39 88.42 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.751 -0.593 . . . . 0.0 110.057 179.207 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . 0.472 ' CD2' HG21 ' A' ' 18' ' ' VAL . 2.8 t-80 -61.38 -52.85 62.92 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.517 -0.74 . . . . 0.0 109.745 179.4 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 3.3 tp-100 -59.96 -36.35 76.9 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.516 -0.74 . . . . 0.0 110.227 179.669 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 9.9 t30 -59.48 -34.04 72.08 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.533 -0.729 . . . . 0.0 110.475 179.471 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.415 ' O ' HG12 ' A' ' 20' ' ' VAL . 38.0 mt -94.4 -36.84 7.38 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 121.398 -0.814 . . . . 0.0 110.317 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.472 HG21 ' CD2' ' A' ' 14' ' ' HIS . 92.0 t -74.2 -7.83 10.59 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.086 0 O-C-N 121.343 -0.848 . . . . 0.0 111.011 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -119.83 8.08 11.07 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.167 -0.958 . . . . 0.0 110.809 179.434 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.415 HG12 ' O ' ' A' ' 17' ' ' ILE . 9.2 p -105.93 -35.82 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 O-C-N 120.982 -1.074 . . . . 0.0 110.874 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -97.47 1.7 49.41 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.379 -0.826 . . . . 0.0 110.517 179.81 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 13.2 m-85 -127.37 -47.01 1.46 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.317 -0.865 . . . . 0.0 109.58 -179.334 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -75.43 -25.76 57.77 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.487 -0.758 . . . . 0.0 110.124 178.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -95.44 40.53 1.11 Allowed 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.31 -0.869 . . . . 0.0 110.513 179.786 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -76.42 -39.3 31.07 Favored Glycine 0 N--CA 1.496 2.681 0 N-CA-C 109.847 -1.301 . . . . 0.0 109.847 179.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.0 mp -93.88 48.97 1.3 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.322 -1.105 . . . . 0.0 109.891 179.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.606 ' HB3' ' HD3' ' A' ' 28' ' ' PRO . 4.6 t -53.27 -55.82 30.44 Favored Pre-proline 0 N--CA 1.497 1.892 0 O-C-N 121.625 -0.672 . . . . 0.0 110.645 -179.881 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.606 ' HD3' ' HB3' ' A' ' 27' ' ' SER . 52.3 Cg_endo -77.37 59.27 6.6 Favored 'Trans proline' 0 N--CA 1.487 1.114 0 O-C-N 123.448 1.236 . . . . 0.0 110.075 179.247 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -167.87 -50.07 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.533 -0.73 . . . . 0.0 110.001 -179.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 15.6 mt -78.43 -33.71 17.56 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 O-C-N 121.483 -0.761 . . . . 0.0 110.299 179.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 7.9 p -61.33 -39.62 91.2 Favored 'General case' 0 N--CA 1.5 2.025 0 O-C-N 121.703 -0.623 . . . . 0.0 110.301 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -91.77 19.51 6.43 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.344 -0.848 . . . . 0.0 110.493 179.272 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 71.3 t80 -115.5 -47.03 2.84 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.366 -0.834 . . . . 0.0 109.989 179.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 59.5 t -81.0 115.44 23.59 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 121.341 -0.85 . . . . 0.0 109.845 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 5.2 p -129.5 28.91 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 O-C-N 121.562 -0.712 . . . . 0.0 110.416 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 5.6 tmm_? . . . . . 0 N--CA 1.495 1.813 0 CA-C-O 117.881 -1.057 . . . . 0.0 110.352 179.871 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 2.1 p . . . . . 0 N--CA 1.496 1.828 0 CA-C-O 121.233 0.54 . . . . 0.0 110.096 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -128.04 135.3 49.68 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.415 -0.803 . . . . 0.0 110.269 -179.573 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.5 ' N ' ' HD3' ' A' ' 4' ' ' PRO . 0.6 OUTLIER 51.85 56.32 15.9 Favored Pre-proline 0 N--CA 1.5 2.055 0 O-C-N 121.79 -0.569 . . . . 0.0 111.072 -179.956 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.5 ' HD3' ' N ' ' A' ' 3' ' ' LEU . 49.0 Cg_endo -80.57 58.75 7.16 Favored 'Trans proline' 0 C--N 1.313 -1.294 0 O-C-N 123.709 1.373 . . . . 0.0 110.575 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -168.7 -54.69 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.366 -0.834 . . . . 0.0 110.408 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -104.52 41.12 1.36 Allowed 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.416 -0.802 . . . . 0.0 110.559 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 61.9 p -77.47 -19.91 55.2 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.318 -0.864 . . . . 0.0 110.835 179.599 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 8.8 t -115.48 57.56 0.74 Allowed 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.399 -0.813 . . . . 0.0 110.013 179.685 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -104.35 -62.93 0.67 Allowed Glycine 0 N--CA 1.493 2.469 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -62.21 -47.2 85.51 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.632 -0.922 . . . . 0.0 110.609 -179.832 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -58.58 -51.62 69.13 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.487 -0.758 . . . . 0.0 110.2 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -62.74 -40.82 98.41 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.653 -0.654 . . . . 0.0 110.037 179.558 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.7 tt -56.88 -42.2 79.39 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.642 -0.661 . . . . 0.0 110.13 179.588 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 7.2 t-80 -60.81 -49.07 78.98 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.521 -0.737 . . . . 0.0 109.799 179.412 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.439 ' O ' ' HB2' ' A' ' 19' ' ' ASP . 17.8 mm-40 -67.17 -36.17 81.24 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.544 -0.722 . . . . 0.0 109.76 179.318 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -63.68 -18.32 63.87 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.501 -0.749 . . . . 0.0 110.905 179.487 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 87.2 mt -104.74 -46.53 9.47 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.082 -1.011 . . . . 0.0 109.908 179.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 54.0 t -71.21 -36.73 63.4 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 O-C-N 121.403 -0.811 . . . . 0.0 110.969 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.439 ' HB2' ' O ' ' A' ' 15' ' ' GLN . 0.3 OUTLIER -86.55 -1.94 58.06 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.398 -0.814 . . . . 0.0 111.41 -179.537 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 70.6 t -113.51 -51.87 5.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 120.83 -1.169 . . . . 0.0 109.78 179.354 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 8.1 tp-100 -57.72 -34.11 69.13 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.595 -0.691 . . . . 0.0 110.923 179.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -61.83 -31.23 71.45 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.254 -0.904 . . . . 0.0 110.457 179.893 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -109.13 11.46 25.59 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.341 -0.849 . . . . 0.0 110.891 179.467 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -122.09 34.05 5.29 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.16 -0.962 . . . . 0.0 110.183 179.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -87.04 -68.32 1.33 Allowed Glycine 0 N--CA 1.494 2.503 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.4 mp 50.45 44.13 26.96 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.784 -0.833 . . . . 0.0 110.818 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.437 ' HB2' ' HD3' ' A' ' 28' ' ' PRO . 3.1 m -56.18 -55.09 45.6 Favored Pre-proline 0 N--CA 1.499 1.998 0 O-C-N 121.527 -0.733 . . . . 0.0 111.094 -179.726 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.437 ' HD3' ' HB2' ' A' ' 27' ' ' SER . 46.3 Cg_endo -72.2 -27.06 17.13 Favored 'Trans proline' 0 N--CA 1.489 1.217 0 O-C-N 123.398 1.209 . . . . 0.0 111.068 179.827 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -72.87 -39.98 66.01 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.417 -0.802 . . . . 0.0 110.633 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 5.7 tt -79.49 -11.63 13.02 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 O-C-N 121.341 -0.849 . . . . 0.0 111.467 -179.691 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 23.3 p -101.0 -37.19 8.73 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.099 -1.001 . . . . 0.0 110.537 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 6.9 tptp -91.6 45.93 1.26 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.267 -0.896 . . . . 0.0 109.964 179.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -146.91 -53.59 0.23 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.549 -0.719 . . . . 0.0 109.739 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 49.0 t -91.67 52.57 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 O-C-N 121.443 -0.786 . . . . 0.0 109.75 179.612 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 22.3 m -144.45 22.92 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.098 0 O-C-N 121.307 -0.871 . . . . 0.0 110.89 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.502 2.171 0 CA-C-O 118.255 -0.878 . . . . 0.0 111.083 -179.839 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.494 1.754 0 CA-C-O 121.069 0.461 . . . . 0.0 110.483 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -153.1 160.49 42.92 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.515 -0.74 . . . . 0.0 110.504 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.477 ' N ' ' HD3' ' A' ' 4' ' ' PRO . 0.4 OUTLIER 52.85 59.3 13.9 Favored Pre-proline 0 N--CA 1.501 2.095 0 O-C-N 121.778 -0.576 . . . . 0.0 111.153 -179.973 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.477 ' HD3' ' N ' ' A' ' 3' ' ' LEU . 46.8 Cg_endo -82.28 60.47 7.38 Favored 'Trans proline' 0 C--N 1.313 -1.305 0 O-C-N 123.742 1.391 . . . . 0.0 110.399 179.843 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -108.53 52.07 0.72 Allowed 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.454 -0.779 . . . . 0.0 110.088 179.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.2 tt -112.74 -58.02 2.2 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.445 -0.784 . . . . 0.0 110.601 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -165.58 50.13 0.09 Allowed 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.393 -0.817 . . . . 0.0 110.938 -179.847 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.468 HG21 ' HB3' ' A' ' 11' ' ' LEU . 0.2 OUTLIER 53.24 70.52 0.58 Allowed 'General case' 0 N--CA 1.504 2.258 0 O-C-N 121.418 -0.801 . . . . 0.0 110.244 179.652 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -79.99 -90.49 0.47 Allowed Glycine 0 N--CA 1.494 2.548 0 N-CA-C 109.841 -1.304 . . . . 0.0 109.841 -179.613 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -57.71 -38.54 75.44 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.65 -0.912 . . . . 0.0 110.8 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.468 ' HB3' HG21 ' A' ' 8' ' ' THR . 0.9 OUTLIER -56.82 -51.05 70.48 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.497 -0.752 . . . . 0.0 110.371 179.916 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . 0.401 ' HB2' ' CG2' ' A' ' 8' ' ' THR . 3.8 t60 -75.56 -30.8 59.79 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.284 -0.885 . . . . 0.0 110.103 179.39 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 61.1 tp -55.3 -41.88 72.94 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.472 -0.768 . . . . 0.0 109.962 179.578 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 2.6 t-80 -61.92 -46.44 89.32 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.608 -0.682 . . . . 0.0 109.665 179.222 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 28.3 mm-40 -60.51 -37.48 81.27 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.658 -0.651 . . . . 0.0 110.093 179.587 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -67.78 -47.98 67.61 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.548 -0.72 . . . . 0.0 110.386 179.651 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 74.8 mt -65.45 -48.57 82.49 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.99 0 O-C-N 121.393 -0.817 . . . . 0.0 109.991 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 27.2 t -61.97 -31.92 52.69 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 O-C-N 121.437 -0.789 . . . . 0.0 109.938 179.549 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -63.95 -25.4 68.12 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.631 -0.668 . . . . 0.0 109.963 178.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 61.2 t -92.02 -30.43 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.107 -0.996 . . . . 0.0 109.479 179.036 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -69.28 -39.93 78.06 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.585 -0.697 . . . . 0.0 110.317 179.663 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . 0.458 ' CD1' ' C ' ' A' ' 22' ' ' TYR . 0.1 OUTLIER -67.84 -31.27 71.0 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.296 -0.878 . . . . 0.0 110.118 179.672 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 2.5 ttt -84.8 -40.94 16.6 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.442 -0.786 . . . . 0.0 110.609 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 11.4 m-85 -99.63 25.43 7.14 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.264 -0.898 . . . . 0.0 110.959 -179.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -87.84 -34.11 10.39 Favored Glycine 0 N--CA 1.496 2.684 0 N-CA-C 109.894 -1.282 . . . . 0.0 109.894 179.788 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.2 mm? 58.96 25.68 14.07 Favored 'General case' 0 N--CA 1.502 2.17 0 O-C-N 121.616 -0.932 . . . . 0.0 111.254 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.463 ' N ' ' HD2' ' A' ' 28' ' ' PRO . 1.4 m -80.57 -54.82 0.77 Allowed Pre-proline 0 N--CA 1.498 1.958 0 O-C-N 121.238 -0.913 . . . . 0.0 110.801 179.796 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.463 ' HD2' ' N ' ' A' ' 27' ' ' SER . 43.8 Cg_endo -70.14 -11.83 31.06 Favored 'Trans proline' 0 N--CA 1.49 1.275 0 O-C-N 123.259 1.136 . . . . 0.0 111.172 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -90.21 -27.34 19.6 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.248 -0.907 . . . . 0.0 110.366 179.454 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.437 HG21 HD13 ' A' ' 30' ' ' ILE . 43.4 mm -104.77 -45.26 9.01 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 121.315 -0.866 . . . . 0.0 110.325 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 23.9 m -70.39 -34.55 72.69 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.602 -0.686 . . . . 0.0 110.84 -179.775 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 6.6 tttp -89.9 16.63 7.85 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.085 -1.009 . . . . 0.0 110.684 179.428 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -109.4 -40.88 4.77 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.292 -0.88 . . . . 0.0 109.987 179.496 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 87.2 t -108.21 98.09 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 121.437 -0.789 . . . . 0.0 110.018 179.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 26.3 t -128.05 63.86 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 O-C-N 121.542 -0.724 . . . . 0.0 109.683 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.495 1.816 0 CA-C-O 118.223 -0.894 . . . . 0.0 110.259 -179.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 9.2 t . . . . . 0 N--CA 1.496 1.829 0 CA-C-O 121.211 0.529 . . . . 0.0 109.945 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -135.16 77.39 1.67 Allowed 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.447 -0.783 . . . . 0.0 110.211 -179.657 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.408 ' HB3' ' HD3' ' A' ' 4' ' ' PRO . 0.4 OUTLIER -77.22 -54.02 1.57 Allowed Pre-proline 0 N--CA 1.499 1.991 0 O-C-N 121.474 -0.766 . . . . 0.0 110.933 -179.853 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.408 ' HD3' ' HB3' ' A' ' 3' ' ' LEU . 51.4 Cg_endo -77.96 61.45 7.65 Favored 'Trans proline' 0 N--CA 1.487 1.141 0 O-C-N 123.477 1.251 . . . . 0.0 110.464 -179.928 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -87.27 -49.96 6.91 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.328 -0.858 . . . . 0.0 110.589 -179.795 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -143.36 -68.35 0.34 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.36 -0.838 . . . . 0.0 110.516 -179.924 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 69.3 m -145.13 66.7 1.24 Allowed 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.248 -0.908 . . . . 0.0 110.378 -179.73 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 6.4 m -97.93 41.95 1.11 Allowed 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.254 -0.904 . . . . 0.0 110.327 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -102.87 -88.81 2.07 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 108.724 -1.751 . . . . 0.0 108.724 179.531 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.62 -39.08 93.47 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.649 -0.912 . . . . 0.0 109.738 179.141 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -58.31 -47.81 82.5 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.699 -0.625 . . . . 0.0 109.585 179.132 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 20.1 t-160 -67.81 -45.01 75.95 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.736 -0.602 . . . . 0.0 109.844 179.357 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 11.8 tp -57.25 -41.84 80.37 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.558 -0.714 . . . . 0.0 110.035 179.534 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 6.6 t-80 -61.06 -47.03 88.24 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.624 -0.672 . . . . 0.0 109.826 179.436 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 33.9 tp60 -55.88 -45.28 78.61 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.639 -0.663 . . . . 0.0 110.252 179.71 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 9.5 t-20 -63.74 -52.36 60.79 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.326 -0.859 . . . . 0.0 110.732 179.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 83.5 mt -57.75 -43.48 84.02 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.119 0 O-C-N 121.345 -0.847 . . . . 0.0 110.374 -179.737 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 17.9 t -71.51 -32.54 46.47 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 O-C-N 121.394 -0.816 . . . . 0.0 110.138 179.579 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -73.01 -10.91 60.3 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.423 -0.798 . . . . 0.0 110.991 179.591 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 61.6 t -104.43 -36.11 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 120.832 -1.167 . . . . 0.0 109.925 179.487 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.96 -36.92 70.0 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.525 -0.734 . . . . 0.0 110.863 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -61.96 -31.61 71.98 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.156 -0.965 . . . . 0.0 110.156 179.823 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -92.11 10.34 29.71 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.443 -0.786 . . . . 0.0 110.616 179.134 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -105.48 23.06 14.39 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.152 -0.967 . . . . 0.0 110.399 179.702 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -159.31 44.08 0.45 Allowed Glycine 0 N--CA 1.493 2.488 0 N-CA-C 109.721 -1.351 . . . . 0.0 109.721 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -152.72 22.12 0.6 Allowed 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.54 -0.977 . . . . 0.0 111.019 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.473 ' N ' ' HD2' ' A' ' 28' ' ' PRO . 4.7 m -74.56 -52.75 3.65 Favored Pre-proline 0 N--CA 1.499 1.977 0 O-C-N 121.142 -0.974 . . . . 0.0 111.243 -179.816 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.473 ' HD2' ' N ' ' A' ' 27' ' ' SER . 44.9 Cg_endo -71.52 -9.65 25.48 Favored 'Trans proline' 0 N--CA 1.49 1.322 0 O-C-N 123.429 1.226 . . . . 0.0 111.243 179.855 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -94.03 -9.09 37.92 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.333 -0.854 . . . . 0.0 110.662 179.595 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.408 HG21 HD13 ' A' ' 30' ' ' ILE . 33.8 mm -118.03 -37.12 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 O-C-N 121.176 -0.952 . . . . 0.0 110.48 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 13.4 t -63.52 -24.43 67.81 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 121.349 -0.844 . . . . 0.0 111.252 -179.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 24.9 mmtt -99.12 -2.82 36.03 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.236 -0.915 . . . . 0.0 111.125 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 34.6 m-85 -107.94 0.29 21.86 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.313 -0.867 . . . . 0.0 111.16 -179.782 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.421 ' O ' HG11 ' A' ' 35' ' ' VAL . 47.1 t -121.56 -58.7 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.14 -0.975 . . . . 0.0 109.938 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.421 HG11 ' O ' ' A' ' 34' ' ' VAL . 0.4 OUTLIER 55.63 20.42 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.252 0 O-C-N 121.907 -0.495 . . . . 0.0 111.513 179.933 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.5 2.072 0 CA-C-O 117.682 -1.152 . . . . 0.0 110.446 179.587 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 15.8 p . . . . . 0 N--CA 1.495 1.779 0 CA-C-O 121.046 0.451 . . . . 0.0 110.115 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -128.16 46.99 2.48 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.472 -0.767 . . . . 0.0 110.283 -179.672 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.47 ' N ' ' HD3' ' A' ' 4' ' ' PRO . 6.5 tp -155.63 57.19 1.5 Allowed Pre-proline 0 N--CA 1.497 1.925 0 O-C-N 121.36 -0.837 . . . . 0.0 110.425 179.896 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.47 ' HD3' ' N ' ' A' ' 3' ' ' LEU . 46.3 Cg_endo -78.06 -9.0 16.69 Favored 'Trans proline' 0 C--N 1.312 -1.366 0 O-C-N 123.775 1.408 . . . . 0.0 111.507 -179.787 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.451 ' O ' ' HA3' ' A' ' 9' ' ' GLY . . . -103.79 -30.35 10.44 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.335 -0.853 . . . . 0.0 110.742 179.86 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -89.64 -32.84 16.89 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.11 -0.994 . . . . 0.0 110.666 -179.886 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 43.0 m -79.95 -46.92 15.85 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.31 -0.869 . . . . 0.0 110.928 -179.684 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 11.8 p -125.62 26.63 6.68 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.503 -0.748 . . . . 0.0 111.264 -179.268 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.451 ' HA3' ' O ' ' A' ' 5' ' ' ALA . . . -102.47 -78.95 1.34 Allowed Glycine 0 N--CA 1.492 2.432 0 N-CA-C 108.417 -1.873 . . . . 0.0 108.417 179.137 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -77.17 -34.87 56.32 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.549 -0.971 . . . . 0.0 109.754 178.924 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 5.6 tp -62.98 -44.63 95.52 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.443 -0.785 . . . . 0.0 109.969 179.49 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -64.05 -39.24 93.64 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.575 -0.703 . . . . 0.0 109.996 179.472 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.4 tp -68.42 -34.96 76.94 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.47 -0.769 . . . . 0.0 110.366 179.659 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . 0.437 ' CD2' HG21 ' A' ' 18' ' ' VAL . 12.5 t-80 -59.77 -61.82 2.33 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.316 -0.865 . . . . 0.0 109.575 179.504 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.433 ' O ' ' HB2' ' A' ' 19' ' ' ASP . 2.8 tp60 -59.2 -26.44 64.84 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.388 -0.82 . . . . 0.0 110.639 179.492 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -78.02 -42.63 31.9 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.3 -0.875 . . . . 0.0 110.722 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 83.7 mt -82.69 -36.48 13.36 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.002 0 O-C-N 121.226 -0.921 . . . . 0.0 110.647 -179.646 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.437 HG21 ' CD2' ' A' ' 14' ' ' HIS . 48.1 t -64.67 -34.69 71.6 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 O-C-N 121.203 -0.936 . . . . 0.0 110.493 -179.864 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.509 ' HA ' ' CD2' ' A' ' 22' ' ' TYR . 0.1 OUTLIER -85.81 18.38 2.95 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.319 -0.863 . . . . 0.0 111.04 179.674 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 13.1 t -100.42 -44.89 11.55 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.109 -0.995 . . . . 0.0 110.251 179.705 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 6.5 mp0 -59.15 -26.65 64.94 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.695 -0.628 . . . . 0.0 110.687 179.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . 0.509 ' CD2' ' HA ' ' A' ' 19' ' ' ASP . 6.9 m-30 -69.06 -47.13 66.09 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.287 -0.883 . . . . 0.0 109.573 179.687 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -77.94 -32.73 51.7 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.691 -0.631 . . . . 0.0 110.161 179.702 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 55.3 m-85 -111.95 54.97 0.68 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.444 -0.785 . . . . 0.0 109.966 179.783 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -130.95 -69.48 0.1 Allowed Glycine 0 N--CA 1.496 2.636 0 N-CA-C 110.277 -1.129 . . . . 0.0 110.277 -179.539 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 8.7 mt 53.87 30.39 11.41 Favored 'General case' 0 N--CA 1.503 2.219 0 O-C-N 121.76 -0.847 . . . . 0.0 110.773 -179.284 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.595 ' HB2' ' HD3' ' A' ' 28' ' ' PRO . 2.2 m -61.82 -51.73 73.71 Favored Pre-proline 0 N--CA 1.497 1.88 0 O-C-N 121.296 -0.878 . . . . 0.0 110.926 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.595 ' HD3' ' HB2' ' A' ' 27' ' ' SER . 43.4 Cg_endo -69.56 -28.5 26.14 Favored 'Trans proline' 0 N--CA 1.49 1.27 0 O-C-N 123.299 1.157 . . . . 0.0 110.924 179.851 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.43 -36.77 83.45 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.591 -0.693 . . . . 0.0 110.432 179.65 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 35.5 mt -92.27 -36.28 7.6 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 O-C-N 121.327 -0.858 . . . . 0.0 110.219 179.787 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 92.0 m -68.45 -39.79 81.35 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.562 -0.711 . . . . 0.0 110.462 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 4.1 tttt -86.21 19.87 2.54 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.26 -0.9 . . . . 0.0 110.84 179.611 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -116.31 -18.22 10.55 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.207 -0.933 . . . . 0.0 110.856 179.786 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 26.5 t -121.31 -104.81 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.124 -0.985 . . . . 0.0 110.002 -179.843 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 52.1 t 50.45 66.35 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.204 0 O-C-N 121.22 -0.925 . . . . 0.0 110.053 -179.696 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.501 2.09 0 CA-C-O 118.177 -0.916 . . . . 0.0 110.75 -179.57 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 71.1 m . . . . . 0 N--CA 1.495 1.789 0 CA-C-O 121.03 0.443 . . . . 0.0 110.183 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.436 ' HB3' ' HD2' ' A' ' 4' ' ' PRO . 0.2 OUTLIER -155.48 -172.18 4.06 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.497 -0.752 . . . . 0.0 110.394 -179.862 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.514 ' CB ' ' HD3' ' A' ' 4' ' ' PRO . 0.4 OUTLIER -75.78 -52.31 2.76 Favored Pre-proline 0 N--CA 1.499 1.998 0 O-C-N 121.483 -0.761 . . . . 0.0 110.775 -179.962 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.514 ' HD3' ' CB ' ' A' ' 3' ' ' LEU . 46.6 Cg_endo -89.84 -166.13 0.21 Allowed 'Trans proline' 0 C--N 1.319 -0.987 0 O-C-N 123.516 1.272 . . . . 0.0 110.179 179.904 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -161.09 45.84 0.19 Allowed 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.379 -0.826 . . . . 0.0 110.727 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -78.28 -54.48 6.16 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.286 -0.884 . . . . 0.0 109.898 179.676 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.5 m -123.43 55.15 1.24 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.558 -0.714 . . . . 0.0 109.465 179.393 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 2.0 m -126.9 15.88 7.4 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.463 -0.773 . . . . 0.0 110.903 -179.399 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -105.27 -80.93 1.42 Allowed Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.013 -1.635 . . . . 0.0 109.013 179.615 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.1 mp -64.08 -33.3 75.44 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.691 -0.887 . . . . 0.0 110.304 179.35 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 4.8 tp -65.49 -47.23 76.78 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.351 -0.843 . . . . 0.0 109.994 179.596 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -70.2 -43.74 70.1 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.379 -0.826 . . . . 0.0 110.453 179.789 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -61.69 -44.18 97.44 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.401 -0.812 . . . . 0.0 109.931 179.699 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 69.9 t60 -65.14 -51.48 60.98 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.506 -0.746 . . . . 0.0 109.705 179.317 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -56.87 -36.45 70.08 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.428 -0.795 . . . . 0.0 110.224 179.457 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 5.6 t30 -56.53 -41.9 77.54 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.339 -0.85 . . . . 0.0 109.993 179.2 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.444 ' HA ' HG11 ' A' ' 20' ' ' VAL . 7.3 mt -86.28 -20.42 7.89 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 O-C-N 121.485 -0.759 . . . . 0.0 110.404 179.462 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 78.3 t -87.48 -12.92 10.55 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 O-C-N 121.27 -0.894 . . . . 0.0 110.331 179.631 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -118.14 24.15 11.16 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.385 -0.822 . . . . 0.0 110.137 179.257 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.444 HG11 ' HA ' ' A' ' 17' ' ' ILE . 10.9 p -115.74 -40.6 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.045 0 O-C-N 121.296 -0.877 . . . . 0.0 110.427 179.914 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 1.5 mm100 -89.24 -7.8 54.79 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.523 -0.736 . . . . 0.0 110.686 179.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 23.6 m-85 -115.34 -14.51 11.63 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.359 -0.838 . . . . 0.0 110.735 -179.085 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -108.33 21.47 17.28 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.161 -0.962 . . . . 0.0 110.386 179.294 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -103.33 25.42 9.59 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.179 -0.951 . . . . 0.0 110.369 179.595 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 144.94 62.48 0.02 OUTLIER Glycine 0 N--CA 1.493 2.489 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -153.36 63.89 0.75 Allowed 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.539 -0.977 . . . . 0.0 110.118 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.487 ' HB2' ' HD3' ' A' ' 28' ' ' PRO . 2.3 m -68.08 -52.84 21.68 Favored Pre-proline 0 N--CA 1.498 1.933 0 O-C-N 121.498 -0.751 . . . . 0.0 110.972 -179.846 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.487 ' HD3' ' HB2' ' A' ' 27' ' ' SER . 49.3 Cg_endo -76.74 60.1 6.55 Favored 'Trans proline' 0 N--CA 1.487 1.131 0 O-C-N 123.462 1.243 . . . . 0.0 110.493 179.815 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -157.93 -57.32 0.08 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.399 -0.813 . . . . 0.0 110.102 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 82.1 mt -69.33 -22.8 25.99 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 O-C-N 121.437 -0.789 . . . . 0.0 110.418 179.64 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 24.5 p -61.7 -41.7 97.94 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.416 -0.803 . . . . 0.0 110.249 179.436 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.27 -24.26 64.86 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.521 -0.737 . . . . 0.0 110.418 179.611 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -80.96 -29.36 35.36 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.412 -0.805 . . . . 0.0 110.182 179.512 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 88.2 t -93.13 -38.67 10.21 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.453 -0.779 . . . . 0.0 110.519 -179.708 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.413 ' O ' ' HB2' ' A' ' 36' ' ' ARG . 11.7 t -102.32 12.04 7.37 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 O-C-N 121.315 -0.866 . . . . 0.0 111.049 -179.556 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.413 ' HB2' ' O ' ' A' ' 35' ' ' VAL . 1.8 mpp_? . . . . . 0 N--CA 1.505 2.278 0 O-C-N 121.318 -0.864 . . . . 0.0 111.196 179.75 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 58.9 p . . . . . 0 N--CA 1.495 1.805 0 CA-C-O 120.945 0.402 . . . . 0.0 110.238 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 56.24 80.96 0.13 Allowed 'General case' 0 N--CA 1.502 2.151 0 CA-C-O 121.41 0.624 . . . . 0.0 110.698 179.679 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -160.32 93.05 1.63 Allowed Pre-proline 0 N--CA 1.495 1.815 0 O-C-N 121.431 -0.793 . . . . 0.0 110.224 179.701 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -84.26 64.26 6.89 Favored 'Trans proline' 0 C--N 1.307 -1.61 0 O-C-N 124.022 1.538 . . . . 0.0 110.466 -179.817 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 52.01 33.88 12.77 Favored 'General case' 0 N--CA 1.502 2.134 0 O-C-N 121.7 -0.625 . . . . 0.0 111.043 -179.795 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 55.7 32.93 20.33 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.522 -0.736 . . . . 0.0 110.952 -179.925 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 23.5 m -88.7 -9.95 50.18 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.251 -0.905 . . . . 0.0 111.002 179.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 12.5 p -103.16 39.95 1.48 Allowed 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.245 -0.909 . . . . 0.0 110.283 179.74 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -100.36 -47.22 1.72 Allowed Glycine 0 N--CA 1.493 2.477 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 179.842 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 6.3 mt -74.88 -39.31 61.59 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.596 -0.944 . . . . 0.0 110.562 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 14.2 tp -58.14 -49.46 76.9 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.436 -0.79 . . . . 0.0 110.213 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 27.2 m-70 -63.21 -39.19 93.93 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.572 -0.705 . . . . 0.0 109.703 179.247 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 7.2 tp -63.17 -40.13 96.64 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.487 -0.758 . . . . 0.0 109.789 179.082 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 68.2 t60 -58.75 -54.06 51.39 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.575 -0.703 . . . . 0.0 109.71 179.391 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.454 ' O ' ' HB2' ' A' ' 19' ' ' ASP . 23.3 tp60 -53.34 -38.64 63.43 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.643 -0.661 . . . . 0.0 110.015 179.45 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -66.81 -37.46 84.57 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.572 -0.705 . . . . 0.0 110.606 179.392 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 93.1 mt -82.04 -16.42 11.89 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.073 0 O-C-N 121.35 -0.844 . . . . 0.0 110.588 179.833 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 84.6 t -94.67 -53.04 8.8 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 121.165 -0.959 . . . . 0.0 109.489 179.64 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.454 ' HB2' ' O ' ' A' ' 15' ' ' GLN . 0.7 OUTLIER -59.12 -17.42 26.53 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.737 -0.602 . . . . 0.0 111.316 179.543 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 14.9 p -57.44 -27.31 28.54 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.006 0 O-C-N 120.846 -1.159 . . . . 0.0 111.578 -179.842 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -100.51 -15.94 17.69 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.321 -0.862 . . . . 0.0 111.574 -179.183 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 7.4 m-85 -112.01 -30.9 7.08 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.07 -1.018 . . . . 0.0 110.735 -179.121 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -87.97 16.26 6.2 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.184 -0.947 . . . . 0.0 110.806 179.35 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -98.6 29.98 3.46 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.048 -1.032 . . . . 0.0 110.622 179.737 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -98.6 17.81 57.85 Favored Glycine 0 N--CA 1.496 2.688 0 N-CA-C 110.424 -1.07 . . . . 0.0 110.424 179.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 5.0 mp 52.37 36.06 18.91 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 121.481 -1.011 . . . . 0.0 111.311 179.704 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.474 ' N ' ' HD2' ' A' ' 28' ' ' PRO . 0.7 OUTLIER -61.47 -54.32 53.53 Favored Pre-proline 0 N--CA 1.501 2.114 0 O-C-N 121.244 -0.91 . . . . 0.0 110.694 179.815 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.474 ' HD2' ' N ' ' A' ' 27' ' ' SER . 44.2 Cg_endo -71.39 -27.29 19.48 Favored 'Trans proline' 0 N--CA 1.487 1.126 0 O-C-N 123.481 1.253 . . . . 0.0 110.647 179.553 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.8 -36.24 78.52 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.585 -0.697 . . . . 0.0 110.181 179.497 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.461 HD12 HG23 ' A' ' 30' ' ' ILE . 0.4 OUTLIER -84.15 -30.76 7.53 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 121.354 -0.841 . . . . 0.0 109.938 179.4 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 53.9 m -71.01 -43.73 67.32 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.545 -0.722 . . . . 0.0 109.722 179.349 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 17.5 tttt -88.41 43.4 1.13 Allowed 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.516 -0.74 . . . . 0.0 109.957 179.348 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 21.5 t80 -151.93 -53.45 0.12 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.571 -0.706 . . . . 0.0 109.423 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 53.5 t -94.66 -34.04 5.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.631 -0.668 . . . . 0.0 109.697 179.19 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 21.9 t -112.13 52.34 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 121.338 -0.852 . . . . 0.0 109.799 179.732 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.505 2.284 0 CA-C-O 118.827 -0.606 . . . . 0.0 110.925 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 38.0 m . . . . . 0 N--CA 1.494 1.772 0 CA-C-O 121.009 0.433 . . . . 0.0 110.229 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -131.93 -171.46 2.63 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.573 -0.705 . . . . 0.0 110.47 -179.84 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.606 ' HB3' ' HD3' ' A' ' 4' ' ' PRO . 0.1 OUTLIER -164.96 -58.09 0.01 OUTLIER Pre-proline 0 N--CA 1.498 1.956 0 O-C-N 121.71 -0.619 . . . . 0.0 110.359 179.844 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.606 ' HD3' ' HB3' ' A' ' 3' ' ' LEU . 44.1 Cg_endo -70.29 -20.88 31.8 Favored 'Trans proline' 0 N--CA 1.49 1.315 0 O-C-N 123.197 1.104 . . . . 0.0 111.061 179.614 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -70.59 -20.8 62.73 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.387 -0.821 . . . . 0.0 110.747 179.709 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 6.3 tp -96.42 42.38 1.09 Allowed 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.27 -0.894 . . . . 0.0 110.396 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 30.8 p -84.26 -27.25 28.03 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.232 -0.918 . . . . 0.0 110.764 179.765 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 1.3 m -102.42 44.52 1.01 Allowed 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.384 -0.822 . . . . 0.0 110.228 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -98.65 -56.21 1.04 Allowed Glycine 0 N--CA 1.493 2.458 0 N-CA-C 109.261 -1.536 . . . . 0.0 109.261 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.4 mt -61.74 -35.77 79.03 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.755 -0.85 . . . . 0.0 110.492 179.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.8 tt -58.17 -47.75 82.42 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.438 -0.789 . . . . 0.0 109.935 179.645 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 24.1 m-70 -75.52 -42.06 53.61 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.6 -0.688 . . . . 0.0 109.87 179.456 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 11.4 tp -58.83 -42.66 89.75 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.464 -0.773 . . . . 0.0 110.403 179.701 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 6.1 t-80 -59.43 -51.84 68.18 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.563 -0.711 . . . . 0.0 109.933 179.591 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 34.3 tp60 -58.04 -36.53 72.87 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.622 -0.674 . . . . 0.0 110.392 179.731 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -66.42 -41.13 89.7 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.507 -0.745 . . . . 0.0 110.826 179.931 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 73.5 mt -76.15 -43.37 37.76 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 O-C-N 121.262 -0.899 . . . . 0.0 110.505 -179.55 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 38.0 t -67.72 -36.38 75.8 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 O-C-N 121.416 -0.803 . . . . 0.0 110.661 -179.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -66.99 -18.53 65.43 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.428 -0.795 . . . . 0.0 110.666 179.508 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 80.6 t -100.64 -35.84 4.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.026 -1.046 . . . . 0.0 109.323 179.096 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -67.23 -39.98 86.31 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.739 -0.601 . . . . 0.0 110.579 179.811 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . 0.43 ' CD1' ' C ' ' A' ' 22' ' ' TYR . 0.2 OUTLIER -63.02 -33.13 74.77 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.248 -0.907 . . . . 0.0 110.548 -179.792 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -87.91 -40.37 14.0 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.454 -0.779 . . . . 0.0 110.622 -179.819 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 33.0 m-85 -93.44 21.93 5.75 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.299 -0.875 . . . . 0.0 110.735 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -155.64 67.29 0.3 Allowed Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.317 -1.513 . . . . 0.0 109.317 179.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.0 tp -82.02 -35.7 28.55 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.561 -0.964 . . . . 0.0 110.383 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.532 ' N ' ' HD2' ' A' ' 28' ' ' PRO . 43.4 m -56.91 -51.36 82.12 Favored Pre-proline 0 N--CA 1.498 1.965 0 O-C-N 121.644 -0.66 . . . . 0.0 110.822 179.72 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.532 ' HD2' ' N ' ' A' ' 27' ' ' SER . 43.6 Cg_endo -69.74 -23.36 30.97 Favored 'Trans proline' 0 N--CA 1.489 1.237 0 O-C-N 123.408 1.215 . . . . 0.0 111.033 179.41 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -80.47 -42.81 21.92 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.452 -0.78 . . . . 0.0 110.581 179.821 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 11.9 tt -71.85 -29.13 32.46 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 O-C-N 121.324 -0.86 . . . . 0.0 111.083 -179.614 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 2.9 p -65.97 -37.03 84.93 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.317 -0.864 . . . . 0.0 109.909 179.547 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 9.6 tptp -87.0 -25.64 24.16 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.416 -0.803 . . . . 0.0 109.796 178.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 71.1 t80 -68.16 -41.1 82.05 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.464 -0.773 . . . . 0.0 110.456 179.656 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.9 p -67.23 -31.73 54.39 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 O-C-N 121.335 -0.853 . . . . 0.0 110.405 179.693 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 85.1 t -96.36 -4.14 10.15 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 O-C-N 121.346 -0.846 . . . . 0.0 110.69 179.671 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 10.6 mmt85 . . . . . 0 N--CA 1.501 2.116 0 O-C-N 121.57 -0.706 . . . . 0.0 110.482 -179.933 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 13.4 m . . . . . 0 N--CA 1.496 1.833 0 CA-C-O 121.223 0.535 . . . . 0.0 109.954 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -138.88 -170.37 2.84 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.497 -0.752 . . . . 0.0 110.269 -179.54 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.436 ' N ' ' HD3' ' A' ' 4' ' ' PRO . 0.3 OUTLIER 54.17 63.4 7.59 Favored Pre-proline 0 N--CA 1.502 2.152 0 O-C-N 121.696 -0.627 . . . . 0.0 110.892 179.949 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.436 ' HD3' ' N ' ' A' ' 3' ' ' LEU . 47.7 Cg_endo -83.17 63.14 7.7 Favored 'Trans proline' 0 C--N 1.312 -1.376 0 O-C-N 123.779 1.41 . . . . 0.0 110.494 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -122.2 55.95 1.12 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.394 -0.816 . . . . 0.0 110.092 179.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -77.73 -57.7 3.67 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.441 -0.787 . . . . 0.0 110.117 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 75.3 m -139.58 -88.05 0.2 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.412 -0.805 . . . . 0.0 110.13 179.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.429 HG22 ' HB2' ' A' ' 12' ' ' HIS . 3.9 m -148.94 54.94 0.99 Allowed 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.383 -0.823 . . . . 0.0 109.965 179.904 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -103.68 -85.26 1.85 Allowed Glycine 0 N--CA 1.495 2.617 0 N-CA-C 109.851 -1.3 . . . . 0.0 109.851 -179.619 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.1 mp -58.73 -39.7 81.6 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.654 -0.909 . . . . 0.0 110.383 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -58.25 -48.37 80.63 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.526 -0.734 . . . . 0.0 109.829 179.392 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . 0.429 ' HB2' HG22 ' A' ' 8' ' ' THR . 0.1 OUTLIER -66.76 -43.19 84.72 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.652 -0.655 . . . . 0.0 109.681 179.24 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.0 tt -58.07 -41.0 82.45 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.661 -0.649 . . . . 0.0 110.028 179.38 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 82.9 t60 -59.31 -46.0 89.78 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.529 -0.732 . . . . 0.0 109.808 179.368 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.419 ' O ' ' HB2' ' A' ' 19' ' ' ASP . 0.4 OUTLIER -65.91 -34.27 77.73 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.501 -0.749 . . . . 0.0 109.662 179.193 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -64.94 -14.99 61.58 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.372 -0.83 . . . . 0.0 110.596 179.15 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.417 HG21 HD12 ' A' ' 17' ' ' ILE . 38.5 mm -107.81 -38.51 4.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.356 -0.84 . . . . 0.0 109.66 179.652 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 71.4 t -83.89 -42.6 17.37 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 O-C-N 121.495 -0.753 . . . . 0.0 110.743 -179.714 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.419 ' HB2' ' O ' ' A' ' 15' ' ' GLN . 0.2 OUTLIER -77.23 -2.8 36.48 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.551 -0.718 . . . . 0.0 111.452 -179.663 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 63.2 t -108.68 -28.37 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 120.833 -1.167 . . . . 0.0 110.263 179.458 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 15.2 mt-30 -79.61 -37.39 36.25 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.169 -0.957 . . . . 0.0 110.216 179.438 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . 0.407 ' CD2' ' HA ' ' A' ' 19' ' ' ASP . 0.6 OUTLIER -64.08 -32.25 73.74 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.484 -0.76 . . . . 0.0 110.458 179.839 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -84.82 -13.74 50.15 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.5 -0.75 . . . . 0.0 110.991 179.837 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -98.9 43.03 1.07 Allowed 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.094 -1.004 . . . . 0.0 110.342 -180.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -160.56 50.67 0.36 Allowed Glycine 0 N--CA 1.494 2.547 0 N-CA-C 109.749 -1.341 . . . . 0.0 109.749 179.861 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.3 mp -112.05 -8.91 14.02 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.312 -1.11 . . . . 0.0 111.213 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.516 ' N ' ' HD2' ' A' ' 28' ' ' PRO . 26.5 m -61.61 -51.04 79.57 Favored Pre-proline 0 N--CA 1.499 1.999 0 O-C-N 121.223 -0.923 . . . . 0.0 111.105 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.516 ' HD2' ' N ' ' A' ' 27' ' ' SER . 45.1 Cg_endo -70.72 -17.77 32.96 Favored 'Trans proline' 0 N--CA 1.49 1.269 0 O-C-N 123.417 1.22 . . . . 0.0 111.224 179.823 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -80.32 -41.38 24.94 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.265 -0.897 . . . . 0.0 110.501 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 32.3 mm -69.64 -43.23 80.43 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 O-C-N 121.345 -0.847 . . . . 0.0 110.718 -179.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 12.1 t -63.25 -31.78 73.02 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.475 -0.766 . . . . 0.0 110.626 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 45.0 tttt -73.49 -29.11 62.29 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.284 -0.885 . . . . 0.0 109.937 179.201 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 24.4 t80 -83.02 -45.05 14.53 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.566 -0.709 . . . . 0.0 109.701 179.282 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 3.4 p -79.89 170.13 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 O-C-N 121.547 -0.721 . . . . 0.0 110.115 179.731 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 38.8 t 60.19 75.92 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.215 0 O-C-N 121.597 -0.689 . . . . 0.0 110.176 -179.723 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 14.1 ttp180 . . . . . 0 N--CA 1.496 1.826 0 CA-C-O 118.246 -0.883 . . . . 0.0 110.261 -179.963 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' SER . . . . . 0.448 ' O ' ' HB2' ' A' ' 2' ' ' ASP . 23.9 m . . . . . 0 N--CA 1.496 1.832 0 CA-C-O 120.803 0.335 . . . . 0.0 110.167 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.448 ' HB2' ' O ' ' A' ' 1' ' ' SER . 17.8 m-20 61.67 177.42 0.12 Allowed 'General case' 0 N--CA 1.502 2.166 0 CA-C-O 121.348 0.594 . . . . 0.0 110.946 -179.816 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.448 ' N ' ' HD3' ' A' ' 4' ' ' PRO . 0.4 OUTLIER 52.09 66.45 5.07 Favored Pre-proline 0 N--CA 1.5 2.06 0 O-C-N 121.684 -0.635 . . . . 0.0 110.63 -179.859 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.448 ' HD3' ' N ' ' A' ' 3' ' ' LEU . 46.2 Cg_endo -92.07 -157.58 0.06 OUTLIER 'Trans proline' 0 C--N 1.311 -1.396 0 C-N-CA 121.787 1.658 . . . . 0.0 110.531 -179.802 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 52.55 37.38 22.96 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.545 -0.722 . . . . 0.0 111.165 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 54.27 34.93 21.52 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.563 -0.71 . . . . 0.0 110.811 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 7.6 t 53.32 34.85 18.81 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.546 -0.721 . . . . 0.0 111.313 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 14.4 t -160.98 33.0 0.15 Allowed 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.148 -0.97 . . . . 0.0 110.914 179.752 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -67.28 -52.19 33.17 Favored Glycine 0 N--CA 1.496 2.696 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 179.617 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -65.94 -40.46 91.37 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.533 -0.981 . . . . 0.0 109.92 179.559 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.9 tt -61.01 -44.99 96.61 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.579 -0.7 . . . . 0.0 109.776 179.347 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -68.32 -44.47 75.31 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.578 -0.701 . . . . 0.0 109.763 179.409 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -63.35 -37.36 86.95 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.544 -0.722 . . . . 0.0 110.049 179.434 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . 0.442 ' CD2' HG21 ' A' ' 18' ' ' VAL . 14.1 t-80 -57.07 -58.08 9.75 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.576 -0.702 . . . . 0.0 109.645 179.538 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.401 ' O ' ' HB2' ' A' ' 19' ' ' ASP . 0.1 OUTLIER -59.78 -38.95 83.3 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.353 -0.842 . . . . 0.0 110.031 179.19 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -59.22 -43.84 92.3 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.399 -0.813 . . . . 0.0 110.603 179.674 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 22.2 mm -81.87 -36.06 13.95 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 O-C-N 121.232 -0.917 . . . . 0.0 110.47 179.867 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.534 ' HA ' ' CE1' ' A' ' 22' ' ' TYR . 69.7 t -75.71 -8.6 11.85 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 O-C-N 121.493 -0.754 . . . . 0.0 111.663 -179.469 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.401 ' HB2' ' O ' ' A' ' 15' ' ' GLN . 0.4 OUTLIER -119.56 27.93 8.47 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 120.942 -1.099 . . . . 0.0 110.93 179.781 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 42.4 t -130.81 -56.91 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 O-C-N 121.097 -1.002 . . . . 0.0 109.983 179.579 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -65.24 -10.38 31.48 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.745 -0.597 . . . . 0.0 110.9 179.52 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . 0.534 ' CE1' ' HA ' ' A' ' 18' ' ' VAL . 34.0 m-85 -103.85 -1.64 27.48 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.231 -0.918 . . . . 0.0 110.82 -179.539 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -132.33 26.33 4.48 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.233 -0.917 . . . . 0.0 110.582 179.807 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -120.62 15.63 11.94 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.145 -0.972 . . . . 0.0 111.009 179.864 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -117.33 37.85 3.18 Favored Glycine 0 N--CA 1.495 2.614 0 N-CA-C 109.986 -1.246 . . . . 0.0 109.986 179.837 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.2 mt -114.24 22.45 13.77 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.402 -1.058 . . . . 0.0 110.425 179.658 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.45 ' CB ' ' CD ' ' A' ' 28' ' ' PRO . 0.0 OUTLIER -164.18 -61.49 0.01 OUTLIER Pre-proline 0 N--CA 1.498 1.934 0 O-C-N 121.416 -0.803 . . . . 0.0 110.144 179.828 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.45 ' CD ' ' CB ' ' A' ' 27' ' ' SER . 46.0 Cg_endo -71.85 -17.02 29.35 Favored 'Trans proline' 0 N--CA 1.489 1.252 0 O-C-N 123.08 1.042 . . . . 0.0 110.944 179.284 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -100.46 -12.09 19.63 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.4 -0.813 . . . . 0.0 111.002 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 73.6 mt -118.82 -49.08 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.177 -0.952 . . . . 0.0 110.231 -179.768 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 2.4 m -69.98 -31.15 68.71 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.595 -0.69 . . . . 0.0 110.504 -179.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.411 ' HB2' ' O ' ' A' ' 28' ' ' PRO . 12.8 mmtp -87.83 6.2 36.5 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.259 -0.9 . . . . 0.0 110.797 179.635 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -103.33 -41.25 6.09 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.286 -0.884 . . . . 0.0 110.066 179.752 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 16.6 t -89.41 54.01 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 121.446 -0.784 . . . . 0.0 109.451 179.469 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 8.8 p -157.79 35.62 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 121.356 -0.84 . . . . 0.0 110.292 -179.663 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.496 1.855 0 CA-C-O 117.838 -1.077 . . . . 0.0 110.313 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.494 1.763 0 CA-C-O 120.965 0.412 . . . . 0.0 110.186 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -116.84 45.93 1.75 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.53 -0.731 . . . . 0.0 110.125 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.458 ' N ' ' HD3' ' A' ' 4' ' ' PRO . 0.7 OUTLIER -153.5 64.76 5.12 Favored Pre-proline 0 N--CA 1.496 1.829 0 O-C-N 121.54 -0.725 . . . . 0.0 110.157 179.941 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.458 ' HD3' ' N ' ' A' ' 3' ' ' LEU . 47.0 Cg_endo -87.53 74.57 2.45 Favored 'Trans proline' 0 C--N 1.311 -1.43 0 C-N-CA 121.523 1.482 . . . . 0.0 110.543 -179.609 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -115.45 -55.64 2.43 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.436 -0.79 . . . . 0.0 110.412 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER 54.15 43.45 30.64 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.642 -0.661 . . . . 0.0 110.758 179.967 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 12.5 m -80.32 -9.22 59.74 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.33 -0.856 . . . . 0.0 111.151 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 5.6 m 60.54 78.94 0.26 Allowed 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.579 -0.701 . . . . 0.0 110.287 -179.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -103.17 -78.39 1.28 Allowed Glycine 0 N--CA 1.495 2.606 0 N-CA-C 109.32 -1.512 . . . . 0.0 109.32 179.804 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.06 -41.56 96.84 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.504 -0.997 . . . . 0.0 110.038 179.485 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.26 -42.01 90.17 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.563 -0.711 . . . . 0.0 109.796 179.371 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 6.5 t-80 -65.27 -37.46 87.25 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.594 -0.691 . . . . 0.0 109.833 179.242 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.77 -42.53 99.11 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.465 -0.772 . . . . 0.0 109.399 179.006 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . 0.41 ' NE2' HG21 ' A' ' 18' ' ' VAL . 4.7 t-80 -67.08 -48.07 69.33 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.642 -0.661 . . . . 0.0 109.403 178.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 30.5 mm100 -60.17 -34.49 73.66 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.558 -0.714 . . . . 0.0 109.988 179.385 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 10.1 t30 -61.98 -50.35 72.43 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.429 -0.794 . . . . 0.0 110.137 179.421 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 49.7 mt -71.13 -19.47 21.07 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 O-C-N 121.262 -0.899 . . . . 0.0 110.793 179.783 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.41 HG21 ' NE2' ' A' ' 14' ' ' HIS . 47.0 t -97.24 -8.79 9.16 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 O-C-N 121.258 -0.901 . . . . 0.0 111.232 -179.592 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -123.03 27.84 7.47 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.06 -1.025 . . . . 0.0 110.886 179.592 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 39.3 t -124.31 -56.48 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 O-C-N 121.14 -0.975 . . . . 0.0 109.381 179.254 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 14.2 mp0 -68.11 -15.67 63.69 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.824 -0.547 . . . . 0.0 110.595 179.33 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 17.6 m-85 -105.33 -42.36 5.27 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.374 -0.829 . . . . 0.0 110.143 -179.637 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.58 -32.44 64.14 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.462 -0.774 . . . . 0.0 110.34 179.796 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -97.1 40.59 1.14 Allowed 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.292 -0.88 . . . . 0.0 110.38 179.523 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -81.32 -33.16 29.35 Favored Glycine 0 N--CA 1.497 2.734 0 N-CA-C 110.149 -1.18 . . . . 0.0 110.149 179.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 59.9 38.74 20.99 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.562 -0.963 . . . . 0.0 110.609 -179.895 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.513 ' CB ' ' CD ' ' A' ' 28' ' ' PRO . 0.4 OUTLIER -169.77 -63.04 0.01 OUTLIER Pre-proline 0 N--CA 1.498 1.944 0 O-C-N 121.54 -0.725 . . . . 0.0 110.186 179.69 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.513 ' CD ' ' CB ' ' A' ' 27' ' ' SER . 43.3 Cg_endo -69.48 -27.33 27.93 Favored 'Trans proline' 0 N--CA 1.49 1.265 0 O-C-N 123.393 1.207 . . . . 0.0 110.76 179.664 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.76 -37.22 83.47 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.579 -0.7 . . . . 0.0 110.289 179.51 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 58.9 mt -79.25 -39.42 21.06 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 121.466 -0.771 . . . . 0.0 109.873 179.52 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 99.8 m -65.0 -45.02 87.33 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.58 -0.7 . . . . 0.0 109.965 179.524 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -67.03 -20.99 65.94 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.485 -0.759 . . . . 0.0 110.785 179.651 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -72.65 -24.09 61.0 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.361 -0.837 . . . . 0.0 110.543 179.615 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 55.6 t -110.29 -65.97 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.266 -0.896 . . . . 0.0 110.275 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 36.6 t 54.2 72.55 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.159 0 O-C-N 121.693 -0.629 . . . . 0.0 110.167 -179.724 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 1.5 ttp180 . . . . . 0 N--CA 1.502 2.133 0 CA-C-O 118.171 -0.919 . . . . 0.0 110.721 -179.735 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 22.0 m . . . . . 0 N--CA 1.494 1.746 0 CA-C-O 120.838 0.351 . . . . 0.0 110.172 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.565 ' HB3' ' HA2' ' A' ' 9' ' ' GLY . 21.9 m-20 52.16 36.42 19.1 Favored 'General case' 0 N--CA 1.502 2.141 0 CA-C-O 121.305 0.574 . . . . 0.0 110.929 -179.813 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.574 ' HB2' ' HD3' ' A' ' 4' ' ' PRO . 7.7 mt -77.58 -51.11 1.92 Allowed Pre-proline 0 N--CA 1.497 1.922 0 O-C-N 121.286 -0.884 . . . . 0.0 110.825 -179.939 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.574 ' HD3' ' HB2' ' A' ' 3' ' ' LEU . 53.2 Cg_endo -84.08 18.22 1.57 Allowed 'Trans proline' 0 N--CA 1.484 0.945 0 O-C-N 123.382 1.201 . . . . 0.0 111.441 179.543 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 55.95 34.83 24.39 Favored 'General case' 0 N--CA 1.503 2.2 0 O-C-N 121.317 -0.864 . . . . 0.0 111.094 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 12.7 mt -73.31 -32.13 64.42 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.406 -0.809 . . . . 0.0 110.769 -179.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 37.4 m -123.48 -77.12 0.59 Allowed 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.371 -0.831 . . . . 0.0 110.504 -179.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -126.67 35.44 4.63 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.374 -0.829 . . . . 0.0 110.564 -179.828 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.565 ' HA2' ' HB3' ' A' ' 2' ' ' ASP . . . -71.72 -58.75 5.16 Favored Glycine 0 N--CA 1.493 2.492 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 179.66 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.36 -39.17 89.64 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.636 -0.92 . . . . 0.0 110.284 179.725 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.8 tt -59.03 -48.36 81.86 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.446 -0.784 . . . . 0.0 109.783 179.433 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 21.7 m170 -69.16 -44.3 72.56 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.679 -0.638 . . . . 0.0 109.672 179.213 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.7 mt -56.88 -41.87 78.8 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.605 -0.685 . . . . 0.0 110.06 179.489 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . 0.451 ' CD2' HG22 ' A' ' 18' ' ' VAL . 5.7 t-80 -63.17 -46.86 85.17 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.652 -0.655 . . . . 0.0 109.812 179.321 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 25.2 tp60 -54.1 -41.88 68.75 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.645 -0.659 . . . . 0.0 110.698 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -66.95 -47.82 70.45 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.395 -0.815 . . . . 0.0 110.384 179.781 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 74.4 mt -57.94 -38.6 67.38 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.111 0 O-C-N 121.422 -0.799 . . . . 0.0 109.91 179.83 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.451 HG22 ' CD2' ' A' ' 14' ' ' HIS . 47.5 t -72.22 -35.88 54.17 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.528 -0.732 . . . . 0.0 109.706 179.302 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -68.8 -15.52 63.53 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.734 -0.604 . . . . 0.0 110.966 179.516 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 47.7 t -102.56 -40.68 7.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.135 -0.978 . . . . 0.0 109.481 179.322 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.11 -39.44 94.04 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.689 -0.632 . . . . 0.0 110.75 179.883 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -63.49 -29.23 70.53 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.302 -0.873 . . . . 0.0 110.665 -179.83 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -103.6 17.97 22.92 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.362 -0.836 . . . . 0.0 111.032 179.709 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -118.53 24.33 10.97 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.116 -0.99 . . . . 0.0 110.672 179.82 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 61.51 39.87 97.92 Favored Glycine 0 N--CA 1.496 2.699 0 N-CA-C 110.153 -1.179 . . . . 0.0 110.153 179.821 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 23.8 mt -122.08 4.74 9.84 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.235 -1.156 . . . . 0.0 111.371 -179.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.47 ' HB2' ' HD3' ' A' ' 28' ' ' PRO . 3.0 m -69.82 -59.44 4.53 Favored Pre-proline 0 N--CA 1.498 1.933 0 O-C-N 121.015 -1.053 . . . . 0.0 110.416 179.86 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.47 ' HD3' ' HB2' ' A' ' 27' ' ' SER . 45.8 Cg_endo -71.52 -25.73 20.82 Favored 'Trans proline' 0 N--CA 1.488 1.165 0 O-C-N 123.395 1.208 . . . . 0.0 110.62 179.402 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.29 -35.64 81.49 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.584 -0.697 . . . . 0.0 110.597 179.734 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 26.1 mm -79.54 -38.41 19.54 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 O-C-N 121.323 -0.861 . . . . 0.0 110.165 179.809 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 24.4 m -62.19 -38.65 89.94 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.432 -0.793 . . . . 0.0 109.958 179.623 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.7 tmtt? -69.92 -35.7 74.78 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.291 -0.88 . . . . 0.0 110.206 179.482 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 80.6 t80 -76.61 -41.1 47.26 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.587 -0.696 . . . . 0.0 110.118 179.671 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 47.1 t -98.66 79.03 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.458 -0.776 . . . . 0.0 109.837 179.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 4.9 p -138.32 17.83 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 O-C-N 121.42 -0.8 . . . . 0.0 110.97 -179.777 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 30.8 mtp180 . . . . . 0 N--CA 1.495 1.8 0 O-C-N 121.185 -0.947 . . . . 0.0 110.303 179.921 . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 4.2 p . . . . . 0 N--CA 1.497 1.88 0 CA-C-O 121.139 0.495 . . . . 0.0 110.31 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -143.3 151.87 41.0 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.526 -0.734 . . . . 0.0 110.333 -179.913 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.447 ' N ' ' HD3' ' A' ' 4' ' ' PRO . 0.3 OUTLIER -143.91 66.31 14.76 Favored Pre-proline 0 N--CA 1.497 1.881 0 O-C-N 121.467 -0.771 . . . . 0.0 110.426 179.899 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.447 ' HD3' ' N ' ' A' ' 3' ' ' LEU . 48.1 Cg_endo -89.61 -151.66 0.04 OUTLIER 'Trans proline' 0 C--N 1.31 -1.456 0 C-N-CA 121.618 1.545 . . . . 0.0 109.991 179.942 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -61.87 -32.46 72.81 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.215 -0.928 . . . . 0.0 110.711 179.777 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.2 tp 58.49 27.1 15.09 Favored 'General case' 0 N--CA 1.503 2.178 0 O-C-N 121.59 -0.694 . . . . 0.0 111.248 179.994 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 4.2 m -112.05 -46.05 3.25 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.002 -1.061 . . . . 0.0 110.398 179.852 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 69.7 p -113.44 47.73 1.12 Allowed 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.533 -0.729 . . . . 0.0 110.211 179.808 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -95.71 -74.49 1.22 Allowed Glycine 0 N--CA 1.494 2.515 0 N-CA-C 109.034 -1.626 . . . . 0.0 109.034 179.721 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 10.5 tp -87.81 -39.0 15.24 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.568 -0.96 . . . . 0.0 109.89 179.386 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.2 tt -59.63 -48.81 80.21 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.52 -0.737 . . . . 0.0 110.277 179.779 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 7.4 t-80 -61.57 -40.66 95.54 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.514 -0.741 . . . . 0.0 110.306 179.884 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 5.2 tp -56.5 -43.03 79.3 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.422 -0.799 . . . . 0.0 109.614 179.247 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . 0.406 ' CE1' HG21 ' A' ' 18' ' ' VAL . 76.4 t60 -66.77 -45.87 77.11 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.677 -0.639 . . . . 0.0 109.289 178.935 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 3.7 mm-40 -62.24 -35.84 80.17 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.548 -0.72 . . . . 0.0 110.081 179.247 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -60.5 -38.35 84.06 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.519 -0.738 . . . . 0.0 110.421 179.617 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 28.9 mt -86.16 -36.88 11.09 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 O-C-N 121.347 -0.846 . . . . 0.0 110.221 179.958 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.406 HG21 ' CE1' ' A' ' 14' ' ' HIS . 55.1 t -70.77 -34.11 55.19 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 O-C-N 121.324 -0.86 . . . . 0.0 110.512 179.888 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.46 ' HA ' ' CD1' ' A' ' 22' ' ' TYR . 1.2 t70 -89.37 14.39 11.3 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.379 -0.826 . . . . 0.0 111.352 -179.914 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -118.93 -20.51 5.0 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 120.916 -1.115 . . . . 0.0 110.773 179.256 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -100.2 -29.22 12.6 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.269 -0.894 . . . . 0.0 110.311 179.78 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . 0.46 ' CD1' ' HA ' ' A' ' 19' ' ' ASP . 2.9 p90 -64.09 -22.97 67.15 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.413 -0.805 . . . . 0.0 110.89 179.891 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 1.9 ttp -93.6 -29.12 15.64 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.228 -0.92 . . . . 0.0 110.703 -179.975 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 41.3 m-85 -95.76 39.92 1.13 Allowed 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.281 -0.887 . . . . 0.0 110.649 179.999 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -83.01 -27.43 41.0 Favored Glycine 0 N--CA 1.495 2.62 0 N-CA-C 110.361 -1.096 . . . . 0.0 110.361 -179.872 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -97.31 42.7 1.08 Allowed 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.227 -1.161 . . . . 0.0 110.48 -179.876 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.659 ' HB3' ' HD3' ' A' ' 28' ' ' PRO . 8.0 t -65.02 -52.95 45.41 Favored Pre-proline 0 N--CA 1.497 1.884 0 O-C-N 121.25 -0.906 . . . . 0.0 110.429 179.731 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.659 ' HD3' ' HB3' ' A' ' 27' ' ' SER . 53.2 Cg_endo -81.19 51.71 4.03 Favored 'Trans proline' 0 N--CA 1.484 0.954 0 O-C-N 123.191 1.101 . . . . 0.0 110.508 179.26 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -152.06 -59.36 0.15 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.306 -0.871 . . . . 0.0 109.767 179.855 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 15.8 mt -68.05 -35.53 72.05 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 O-C-N 121.553 -0.717 . . . . 0.0 109.793 179.432 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 1.8 m -70.58 -45.62 65.01 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.672 -0.643 . . . . 0.0 109.715 179.468 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 3.4 mttm -60.37 -32.14 71.0 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.65 -0.656 . . . . 0.0 110.404 179.638 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 88.9 t80 -72.97 -36.61 67.15 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.638 -0.663 . . . . 0.0 110.333 179.615 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 75.8 t -76.79 -23.96 15.33 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 O-C-N 121.422 -0.798 . . . . 0.0 110.842 -179.885 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 25.6 t -104.2 58.87 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 O-C-N 121.212 -0.93 . . . . 0.0 109.918 179.988 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.497 1.919 0 CA-C-O 117.838 -1.077 . . . . 0.0 110.54 179.863 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 21.4 p . . . . . 0 N--CA 1.495 1.787 0 CA-C-O 121.008 0.432 . . . . 0.0 110.179 . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 26.5 m-20 -119.47 33.11 5.77 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.483 -0.761 . . . . 0.0 110.648 -179.793 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.559 ' HB3' ' HD3' ' A' ' 4' ' ' PRO . 0.9 OUTLIER -80.12 -50.95 1.13 Allowed Pre-proline 0 N--CA 1.497 1.891 0 O-C-N 121.411 -0.805 . . . . 0.0 110.84 179.837 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.559 ' HD3' ' HB3' ' A' ' 3' ' ' LEU . 51.3 Cg_endo -81.23 54.04 5.01 Favored 'Trans proline' 0 N--CA 1.485 0.984 0 O-C-N 123.365 1.192 . . . . 0.0 110.808 179.938 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -102.02 -42.61 6.04 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.12 -0.988 . . . . 0.0 110.252 179.757 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -96.15 36.83 1.29 Allowed 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.383 -0.823 . . . . 0.0 110.412 179.858 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 49.5 m -94.24 10.47 33.88 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.289 -0.882 . . . . 0.0 110.806 179.648 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 21.9 p -116.76 25.77 10.31 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.239 -0.913 . . . . 0.0 110.333 179.619 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -63.3 -50.99 58.27 Favored Glycine 0 N--CA 1.496 2.638 0 N-CA-C 110.211 -1.155 . . . . 0.0 110.211 -179.664 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -64.37 -45.38 87.99 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.438 -1.036 . . . . 0.0 110.409 -179.958 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 13.9 tp -61.41 -44.83 96.46 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.518 -0.739 . . . . 0.0 110.085 179.668 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -64.03 -38.5 91.29 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.547 -0.721 . . . . 0.0 109.794 179.361 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 12.1 tp -60.14 -41.4 92.64 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.46 -0.775 . . . . 0.0 109.771 179.122 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 6.7 t-160 -62.5 -50.77 70.08 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.589 -0.694 . . . . 0.0 109.656 179.288 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 22.5 tp60 -57.72 -36.29 71.82 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.56 -0.713 . . . . 0.0 110.291 179.549 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -64.38 -35.86 82.28 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.446 -0.784 . . . . 0.0 110.796 179.696 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 34.3 mt -88.0 -32.37 6.07 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 121.236 -0.915 . . . . 0.0 110.675 -179.639 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.403 HG11 ' CE2' ' A' ' 22' ' ' TYR . 0.4 OUTLIER -71.37 -42.8 73.78 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 121.284 -0.885 . . . . 0.0 110.224 -179.95 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.656 ' HA ' ' CD2' ' A' ' 22' ' ' TYR . 1.1 t70 -63.33 -24.45 67.86 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.427 -0.796 . . . . 0.0 110.814 179.585 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 44.5 t -60.38 -39.99 82.67 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 121.444 -0.785 . . . . 0.0 110.59 179.705 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 8.2 mm100 -64.81 -21.35 66.77 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.398 -0.814 . . . . 0.0 110.747 179.841 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . 0.656 ' CD2' ' HA ' ' A' ' 19' ' ' ASP . 1.5 m-85 -92.86 -49.56 5.99 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.176 -0.952 . . . . 0.0 109.526 179.766 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -72.02 -39.51 69.13 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.287 -0.883 . . . . 0.0 110.123 179.56 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -101.51 48.11 0.89 Allowed 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.539 -0.725 . . . . 0.0 109.93 179.648 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -179.95 -51.3 0.08 OUTLIER Glycine 0 N--CA 1.495 2.578 0 N-CA-C 109.902 -1.279 . . . . 0.0 109.902 -179.918 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.41 ' HG ' ' CB ' ' A' ' 29' ' ' ALA . 0.5 OUTLIER -94.78 23.36 5.52 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.504 -0.998 . . . . 0.0 111.369 -179.801 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.528 ' HB3' ' HD3' ' A' ' 28' ' ' PRO . 12.8 t -62.75 -49.5 82.21 Favored Pre-proline 0 N--CA 1.501 2.116 0 O-C-N 121.119 -0.988 . . . . 0.0 111.185 179.738 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.528 ' HD3' ' HB3' ' A' ' 27' ' ' SER . 47.0 Cg_endo -72.76 -9.63 24.04 Favored 'Trans proline' 0 N--CA 1.489 1.246 0 O-C-N 123.314 1.165 . . . . 0.0 111.468 -179.858 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.41 ' CB ' ' HG ' ' A' ' 26' ' ' LEU . . . -99.72 -48.22 4.79 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.278 -0.889 . . . . 0.0 110.372 179.899 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.403 ' HB ' HD21 ' A' ' 26' ' ' LEU . 16.8 tt -62.08 -25.42 37.39 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 O-C-N 121.434 -0.791 . . . . 0.0 111.297 -179.789 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 6.1 t -68.46 -28.47 67.07 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.269 -0.894 . . . . 0.0 110.507 179.831 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -111.15 20.82 17.02 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.388 -0.82 . . . . 0.0 110.237 179.293 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -121.7 -45.75 2.27 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.335 -0.853 . . . . 0.0 110.447 -179.925 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 93.6 t -64.87 -31.18 52.73 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 O-C-N 121.351 -0.843 . . . . 0.0 110.124 179.837 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 15.3 t -96.22 54.35 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 121.495 -0.753 . . . . 0.0 109.293 179.54 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.5 2.04 0 CA-C-O 117.874 -1.06 . . . . 0.0 110.476 -179.82 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 12.4 m . . . . . 0 N--CA 1.495 1.796 0 CA-C-O 121.267 0.556 . . . . 0.0 109.923 . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -138.12 164.13 29.9 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.47 -0.769 . . . . 0.0 110.339 -179.471 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.545 ' N ' ' HD3' ' A' ' 4' ' ' PRO . 5.5 tp -149.14 58.99 3.76 Favored Pre-proline 0 N--CA 1.495 1.815 0 O-C-N 121.574 -0.704 . . . . 0.0 110.404 179.782 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.545 ' HD3' ' N ' ' A' ' 3' ' ' LEU . 49.2 Cg_endo -88.09 -151.54 0.04 OUTLIER 'Trans proline' 0 C--N 1.316 -1.176 0 C-N-CA 121.376 1.384 . . . . 0.0 110.246 179.984 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -130.53 -53.99 1.09 Allowed 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.144 -0.973 . . . . 0.0 110.321 179.934 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -66.39 -35.12 79.53 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.483 -0.76 . . . . 0.0 110.593 179.981 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.4 m -91.29 18.74 6.67 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.281 -0.887 . . . . 0.0 110.932 179.652 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 22.4 m -114.62 47.33 1.26 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.147 -0.971 . . . . 0.0 109.895 179.637 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -103.21 -76.66 1.15 Allowed Glycine 0 N--CA 1.493 2.448 0 N-CA-C 108.771 -1.732 . . . . 0.0 108.771 179.688 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.1 mp -64.14 -41.21 97.28 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.697 -0.884 . . . . 0.0 109.958 179.335 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.8 tt -58.2 -46.54 85.65 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.622 -0.674 . . . . 0.0 110.02 179.514 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 50.7 t60 -62.61 -39.59 94.26 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.683 -0.636 . . . . 0.0 109.755 179.312 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 6.8 tp -61.93 -39.74 93.09 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.557 -0.715 . . . . 0.0 110.251 179.501 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 5.8 t-80 -60.94 -53.05 62.08 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.571 -0.706 . . . . 0.0 109.865 179.633 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -56.8 -36.92 70.46 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.571 -0.706 . . . . 0.0 110.226 179.688 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.419 ' O ' ' HB ' ' A' ' 20' ' ' VAL . 0.7 OUTLIER -64.63 -47.8 77.2 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.378 -0.826 . . . . 0.0 110.194 179.429 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 68.6 mt -68.85 -36.78 75.76 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.042 0 O-C-N 121.447 -0.783 . . . . 0.0 110.494 179.909 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 21.0 t -75.47 -19.9 15.95 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 121.268 -0.895 . . . . 0.0 110.383 179.906 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.528 ' HA ' ' CD1' ' A' ' 22' ' ' TYR . 0.8 OUTLIER -107.85 20.94 18.13 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.355 -0.84 . . . . 0.0 111.018 179.51 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.419 ' HB ' ' O ' ' A' ' 16' ' ' ASN . 3.7 p -117.58 -32.97 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 O-C-N 120.812 -1.18 . . . . 0.0 111.065 179.448 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 6.1 mt-30 -88.08 -35.09 17.69 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.306 -0.871 . . . . 0.0 110.108 179.699 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . 0.528 ' CD1' ' HA ' ' A' ' 19' ' ' ASP . 1.5 p90 -62.49 -28.59 69.94 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.374 -0.829 . . . . 0.0 110.395 179.626 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 3.6 ttp -90.16 0.22 57.28 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.35 -0.844 . . . . 0.0 111.081 179.752 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -107.96 22.48 15.9 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.143 -0.973 . . . . 0.0 110.817 179.859 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -118.28 12.37 12.64 Favored Glycine 0 N--CA 1.495 2.599 0 N-CA-C 110.044 -1.222 . . . . 0.0 110.044 179.475 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.469 ' HB3' ' HB1' ' A' ' 29' ' ' ALA . 1.4 mp -140.4 66.87 1.37 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.269 -1.136 . . . . 0.0 109.697 179.986 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.475 ' N ' ' HD2' ' A' ' 28' ' ' PRO . 0.1 OUTLIER -58.12 -52.46 74.37 Favored Pre-proline 0 N--CA 1.5 2.056 0 O-C-N 121.575 -0.703 . . . . 0.0 111.497 -179.56 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.475 ' HD2' ' N ' ' A' ' 27' ' ' SER . 44.9 Cg_endo -71.15 -12.45 30.22 Favored 'Trans proline' 0 N--CA 1.492 1.42 0 O-C-N 123.46 1.242 . . . . 0.0 111.761 -179.669 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.469 ' HB1' ' HB3' ' A' ' 26' ' ' LEU . . . -98.36 -40.41 8.32 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.265 -0.897 . . . . 0.0 110.299 179.769 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 5.9 tp -71.18 -24.34 24.1 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 O-C-N 121.414 -0.804 . . . . 0.0 110.798 179.878 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 1.9 p -64.64 -42.22 95.61 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.46 -0.775 . . . . 0.0 110.1 179.621 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 2.3 tptm -93.27 26.61 2.84 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.544 -0.722 . . . . 0.0 110.119 179.273 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 10.8 t80 -124.46 -47.81 1.84 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.485 -0.759 . . . . 0.0 110.245 -179.913 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 93.8 t -81.89 103.52 9.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.458 -0.776 . . . . 0.0 109.89 179.954 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 6.7 p -132.66 21.0 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 121.461 -0.774 . . . . 0.0 110.839 -179.921 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.496 1.836 0 CA-C-O 117.866 -1.064 . . . . 0.0 110.481 179.873 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 3.7 p . . . . . 0 N--CA 1.496 1.853 0 CA-C-O 121.042 0.449 . . . . 0.0 110.475 . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -143.11 135.46 27.3 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.427 -0.796 . . . . 0.0 110.532 -179.898 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.544 ' CB ' ' HD3' ' A' ' 4' ' ' PRO . 0.5 OUTLIER -92.97 -57.45 0.23 Allowed Pre-proline 0 N--CA 1.496 1.858 0 O-C-N 121.497 -0.752 . . . . 0.0 110.415 179.518 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.544 ' HD3' ' CB ' ' A' ' 3' ' ' LEU . 51.7 Cg_endo -83.89 60.28 6.43 Favored 'Trans proline' 0 N--CA 1.483 0.87 0 O-C-N 123.417 1.219 . . . . 0.0 110.18 179.49 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -84.18 -54.65 4.67 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.347 -0.846 . . . . 0.0 110.561 -179.53 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 3.3 tp -151.73 23.24 0.69 Allowed 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.392 -0.817 . . . . 0.0 111.318 -179.725 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 20.0 m 46.83 47.64 15.24 Favored 'General case' 0 N--CA 1.504 2.254 0 O-C-N 121.292 -0.88 . . . . 0.0 111.038 179.718 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 13.4 p -102.54 36.25 2.22 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.307 -0.87 . . . . 0.0 110.747 -179.716 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -92.56 -86.62 1.54 Allowed Glycine 0 N--CA 1.491 2.349 0 N-CA-C 108.649 -1.78 . . . . 0.0 108.649 179.332 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 11.2 tp -80.77 -32.22 35.58 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.619 -0.93 . . . . 0.0 110.072 179.28 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.4 tt -60.88 -51.35 69.65 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.521 -0.737 . . . . 0.0 110.203 179.739 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 43.9 t60 -64.62 -37.61 88.17 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.56 -0.713 . . . . 0.0 110.307 179.646 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 6.7 tt -54.87 -39.02 68.23 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.493 -0.754 . . . . 0.0 110.269 179.65 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . 0.454 ' CE1' HG23 ' A' ' 18' ' ' VAL . 64.7 t60 -78.26 -51.29 10.37 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.427 -0.796 . . . . 0.0 109.847 179.474 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.411 ' O ' ' HB2' ' A' ' 19' ' ' ASP . 0.8 OUTLIER -58.74 -47.01 86.11 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.623 -0.673 . . . . 0.0 110.484 -179.93 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 4.3 t30 -54.29 -33.37 58.55 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.484 -0.76 . . . . 0.0 111.0 179.885 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 38.4 mm -86.14 -45.51 16.85 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 121.122 -0.987 . . . . 0.0 110.073 179.816 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.454 HG23 ' CE1' ' A' ' 14' ' ' HIS . 52.7 t -63.6 -38.03 81.18 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 O-C-N 121.462 -0.774 . . . . 0.0 110.59 179.933 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.517 ' HA ' ' CD2' ' A' ' 22' ' ' TYR . 1.7 m-20 -71.45 -12.74 61.55 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.584 -0.698 . . . . 0.0 111.394 -179.885 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.457 ' O ' ' HB2' ' A' ' 24' ' ' TYR . 97.2 t -102.62 -5.42 9.28 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 120.816 -1.178 . . . . 0.0 110.282 179.461 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 15.6 mm-40 -101.84 -38.04 8.01 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.262 -0.899 . . . . 0.0 109.907 179.424 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . 0.517 ' CD2' ' HA ' ' A' ' 19' ' ' ASP . 1.4 p90 -65.15 -29.29 70.12 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.369 -0.832 . . . . 0.0 110.148 179.447 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -92.46 -32.55 14.85 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.535 -0.728 . . . . 0.0 110.589 -179.934 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.457 ' HB2' ' O ' ' A' ' 20' ' ' VAL . 88.9 m-85 -105.38 51.17 0.76 Allowed 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.278 -0.889 . . . . 0.0 110.038 -179.945 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 160.46 -40.15 0.44 Allowed Glycine 0 N--CA 1.495 2.613 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -179.72 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.444 ' HG ' ' HB1' ' A' ' 29' ' ' ALA . 0.1 OUTLIER 64.98 29.08 12.43 Favored 'General case' 0 N--CA 1.503 2.185 0 O-C-N 121.827 -0.807 . . . . 0.0 111.191 179.874 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.494 ' N ' ' HD2' ' A' ' 28' ' ' PRO . 0.0 OUTLIER -63.78 -51.79 62.53 Favored Pre-proline 0 N--CA 1.5 2.054 0 O-C-N 121.244 -0.91 . . . . 0.0 110.705 179.521 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.494 ' HD2' ' N ' ' A' ' 27' ' ' SER . 47.9 Cg_endo -73.46 -8.5 21.81 Favored 'Trans proline' 0 N--CA 1.489 1.261 0 O-C-N 123.434 1.228 . . . . 0.0 111.418 179.939 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.444 ' HB1' ' HG ' ' A' ' 26' ' ' LEU . . . -98.99 -45.68 5.87 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.232 -0.918 . . . . 0.0 110.196 179.842 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.466 HD12 HG22 ' A' ' 30' ' ' ILE . 0.3 OUTLIER -61.73 -31.22 50.24 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 O-C-N 121.438 -0.789 . . . . 0.0 110.4 179.866 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 4.3 p -66.43 -30.01 70.27 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.497 -0.752 . . . . 0.0 110.222 179.276 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 11.1 ttpt -100.74 18.23 19.92 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.507 -0.746 . . . . 0.0 110.414 179.454 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -107.61 -35.02 6.83 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.363 -0.836 . . . . 0.0 109.975 179.687 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.456 HG12 HG23 ' A' ' 35' ' ' VAL . 46.0 t -85.81 159.53 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.522 -0.736 . . . . 0.0 109.572 179.694 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.456 HG23 HG12 ' A' ' 34' ' ' VAL . 12.7 t 59.76 56.75 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.122 0 O-C-N 121.602 -0.686 . . . . 0.0 109.98 -179.613 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.5 2.028 0 CA-C-O 117.697 -1.144 . . . . 0.0 110.498 -179.882 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 7.3 p . . . . . 0 N--CA 1.494 1.756 0 CA-C-O 121.069 0.461 . . . . 0.0 110.215 . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -118.73 -167.27 1.35 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.647 -0.658 . . . . 0.0 109.974 -179.878 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER 51.25 71.66 1.46 Allowed Pre-proline 0 N--CA 1.5 2.026 0 O-C-N 121.684 -0.635 . . . . 0.0 110.621 179.971 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -89.56 -157.51 0.07 OUTLIER 'Trans proline' 0 C--N 1.308 -1.581 0 O-C-N 124.03 1.542 . . . . 0.0 110.186 -179.888 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -102.55 46.82 0.91 Allowed 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.385 -0.822 . . . . 0.0 110.139 179.743 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.6 mp -103.75 8.15 37.24 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.56 -0.713 . . . . 0.0 110.813 179.856 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 69.5 m -108.08 40.57 1.72 Allowed 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.169 -0.957 . . . . 0.0 110.096 179.631 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.458 HG22 ' HB2' ' A' ' 12' ' ' HIS . 90.4 m -129.9 -95.7 0.38 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.303 -0.873 . . . . 0.0 109.823 179.738 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 55.95 -103.34 0.23 Allowed Glycine 0 N--CA 1.497 2.721 0 N-CA-C 110.05 -1.22 . . . . 0.0 110.05 179.782 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -62.9 -31.46 72.53 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.569 -0.96 . . . . 0.0 110.473 179.711 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.7 mp -56.4 -39.41 72.98 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.454 -0.779 . . . . 0.0 110.15 179.537 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . 0.458 ' HB2' HG22 ' A' ' 8' ' ' THR . 0.1 OUTLIER -85.14 -41.26 15.84 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.368 -0.832 . . . . 0.0 109.638 179.257 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 6.5 tt -56.34 -43.49 79.11 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.684 -0.635 . . . . 0.0 110.098 179.392 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . 0.478 ' CE1' HG22 ' A' ' 18' ' ' VAL . 66.2 t60 -64.68 -50.68 66.05 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.61 -0.681 . . . . 0.0 109.931 179.52 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -62.27 -36.36 81.82 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.465 -0.772 . . . . 0.0 110.025 179.484 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -57.11 -43.41 82.29 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.54 -0.725 . . . . 0.0 109.858 179.335 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 21.5 mm -80.82 -36.53 15.57 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 O-C-N 121.419 -0.801 . . . . 0.0 109.795 179.393 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.478 HG22 ' CE1' ' A' ' 14' ' ' HIS . 40.0 t -67.01 -21.53 28.39 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 O-C-N 121.444 -0.785 . . . . 0.0 110.977 179.983 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.543 ' HA ' ' CD1' ' A' ' 22' ' ' TYR . 0.4 OUTLIER -106.0 10.34 32.28 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.215 -0.928 . . . . 0.0 111.159 179.787 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.432 ' O ' ' HB2' ' A' ' 24' ' ' TYR . 0.8 OUTLIER -114.88 -26.67 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 O-C-N 120.847 -1.158 . . . . 0.0 110.505 179.306 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 41.4 mt-30 -87.98 -39.99 14.26 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.427 -0.795 . . . . 0.0 110.096 179.887 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . 0.543 ' CD1' ' HA ' ' A' ' 19' ' ' ASP . 1.8 p90 -60.99 -27.43 68.29 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.473 -0.767 . . . . 0.0 110.434 179.654 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 2.5 ttp -95.75 -28.06 14.95 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.378 -0.826 . . . . 0.0 111.109 -179.818 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.432 ' HB2' ' O ' ' A' ' 20' ' ' VAL . 55.9 m-85 -110.13 52.65 0.72 Allowed 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.128 -0.982 . . . . 0.0 110.419 -179.723 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 145.46 -22.88 1.86 Allowed Glycine 0 N--CA 1.496 2.676 0 N-CA-C 110.542 -1.023 . . . . 0.0 110.542 -180.0 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.8 mp 58.29 40.41 24.61 Favored 'General case' 0 N--CA 1.502 2.131 0 O-C-N 121.468 -1.019 . . . . 0.0 110.798 -179.685 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.442 ' CB ' ' HD3' ' A' ' 28' ' ' PRO . 0.4 OUTLIER -60.71 -52.58 71.58 Favored Pre-proline 0 N--CA 1.499 2.013 0 O-C-N 121.351 -0.843 . . . . 0.0 110.027 179.409 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.442 ' HD3' ' CB ' ' A' ' 27' ' ' SER . 52.4 Cg_endo -80.85 44.16 1.69 Allowed 'Trans proline' 0 N--CA 1.485 1.017 0 O-C-N 123.514 1.271 . . . . 0.0 110.512 178.868 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -135.28 -54.69 0.8 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.242 -0.911 . . . . 0.0 109.353 179.789 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 2.2 mp -68.42 -42.74 84.19 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 O-C-N 121.558 -0.714 . . . . 0.0 109.339 178.907 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 14.3 t -67.18 -26.59 66.71 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.733 -0.605 . . . . 0.0 109.989 179.136 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 7.9 mmpt? -78.74 -32.58 46.78 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.336 -0.852 . . . . 0.0 109.885 179.209 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 87.2 t80 -66.31 -29.17 69.32 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.63 -0.668 . . . . 0.0 110.05 179.213 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 88.7 t -61.89 -26.58 40.29 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 O-C-N 121.324 -0.86 . . . . 0.0 110.174 179.467 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.6 t -113.23 20.82 6.48 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 O-C-N 121.416 -0.803 . . . . 0.0 110.244 179.707 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 2.4 ttm-85 . . . . . 0 N--CA 1.496 1.842 0 CA-C-O 117.779 -1.105 . . . . 0.0 110.294 -179.946 . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 8.1 t . . . . . 0 N--CA 1.495 1.795 0 CA-C-O 121.045 0.45 . . . . 0.0 110.403 . . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -110.33 42.5 1.55 Allowed 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.554 -0.716 . . . . 0.0 110.397 179.986 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.473 ' N ' ' HD3' ' A' ' 4' ' ' PRO . 15.9 tp 49.45 64.07 9.2 Favored Pre-proline 0 N--CA 1.5 2.055 0 O-C-N 121.669 -0.644 . . . . 0.0 110.994 179.863 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.473 ' HD3' ' N ' ' A' ' 3' ' ' LEU . 46.6 Cg_endo -91.15 -161.11 0.09 OUTLIER 'Trans proline' 0 C--N 1.312 -1.367 0 O-C-N 123.835 1.44 . . . . 0.0 110.397 179.939 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 66.81 0.95 2.07 Favored 'General case' 0 N--CA 1.506 2.348 0 O-C-N 121.734 -0.604 . . . . 0.0 111.969 -179.992 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -134.73 2.86 3.21 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 120.877 -1.14 . . . . 0.0 111.068 179.856 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 49.6 m -145.99 77.62 1.5 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.186 -0.946 . . . . 0.0 109.195 179.807 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.466 ' HB ' ' HB2' ' A' ' 12' ' ' HIS . 25.9 p 39.75 50.93 2.35 Favored 'General case' 0 N--CA 1.503 2.22 0 CA-C-O 121.275 0.559 . . . . 0.0 111.244 -179.487 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -89.44 -75.47 1.3 Allowed Glycine 0 N--CA 1.492 2.418 0 N-CA-C 108.657 -1.777 . . . . 0.0 108.657 179.659 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.4 pp -90.71 -25.38 20.06 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.589 -0.947 . . . . 0.0 110.036 178.96 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -67.86 -42.2 81.71 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.38 -0.825 . . . . 0.0 109.812 179.499 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . 0.466 ' HB2' ' HB ' ' A' ' 8' ' ' THR . 4.3 t-160 -63.4 -37.31 86.8 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.548 -0.72 . . . . 0.0 109.919 179.313 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.2 tt -57.27 -42.15 81.05 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.595 -0.69 . . . . 0.0 109.869 179.237 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . 0.406 ' NE2' HG22 ' A' ' 18' ' ' VAL . 4.8 t-80 -65.96 -53.71 35.55 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.613 -0.679 . . . . 0.0 109.459 179.063 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.417 ' O ' ' HB2' ' A' ' 19' ' ' ASP . 16.1 tp60 -58.72 -38.28 77.97 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.59 -0.694 . . . . 0.0 110.22 179.577 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 13.2 t30 -59.57 -42.1 91.71 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.61 -0.681 . . . . 0.0 110.595 179.764 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 43.8 mt -79.52 -30.62 13.75 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 O-C-N 121.27 -0.894 . . . . 0.0 110.238 179.815 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.406 HG22 ' NE2' ' A' ' 14' ' ' HIS . 31.6 t -78.16 -27.02 14.55 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.227 -0.921 . . . . 0.0 110.203 179.628 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.48 ' HA ' ' CD1' ' A' ' 22' ' ' TYR . 0.9 OUTLIER -91.39 17.4 8.53 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.397 -0.814 . . . . 0.0 110.954 179.572 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -117.86 -31.62 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 120.967 -1.083 . . . . 0.0 110.441 179.294 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 27.5 mm100 -89.81 -30.75 17.75 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.365 -0.835 . . . . 0.0 110.458 179.867 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . 0.48 ' CD1' ' HA ' ' A' ' 19' ' ' ASP . 1.8 p90 -61.15 -28.5 69.16 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.357 -0.84 . . . . 0.0 110.202 179.732 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 5.9 ttt -75.93 -25.14 55.7 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.362 -0.836 . . . . 0.0 110.286 179.227 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 31.6 m-85 -110.01 31.43 5.87 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.504 -0.747 . . . . 0.0 110.412 179.815 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 175.77 69.82 0.05 OUTLIER Glycine 0 N--CA 1.494 2.553 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 -179.962 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -105.03 12.04 32.69 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.537 -0.978 . . . . 0.0 111.296 -179.825 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.526 ' N ' ' HD2' ' A' ' 28' ' ' PRO . 0.4 OUTLIER -56.74 -51.7 79.39 Favored Pre-proline 0 N--CA 1.499 2.002 0 O-C-N 121.268 -0.895 . . . . 0.0 110.515 179.374 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.526 ' HD2' ' N ' ' A' ' 27' ' ' SER . 42.7 Cg_endo -70.58 -28.57 21.16 Favored 'Trans proline' 0 N--CA 1.487 1.095 0 O-C-N 123.343 1.181 . . . . 0.0 110.115 179.31 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -68.37 -38.55 81.49 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.591 -0.693 . . . . 0.0 110.107 179.345 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 6.0 tp -85.64 -29.05 6.27 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 121.446 -0.784 . . . . 0.0 110.605 179.646 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 77.7 m -75.13 -37.0 61.57 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.39 -0.819 . . . . 0.0 110.125 179.666 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 32.6 mtmt -89.82 22.26 3.2 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.36 -0.837 . . . . 0.0 110.57 179.495 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 5.1 t80 -112.56 -48.27 3.02 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.265 -0.897 . . . . 0.0 109.868 179.751 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 94.8 t -84.02 -51.75 13.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.563 -0.711 . . . . 0.0 109.744 179.724 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.562 ' O ' ' HG3' ' A' ' 36' ' ' ARG . 18.7 t 52.7 43.82 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.111 0 O-C-N 121.675 -0.641 . . . . 0.0 110.467 179.955 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.562 ' HG3' ' O ' ' A' ' 35' ' ' VAL . 2.6 ptt85 . . . . . 0 N--CA 1.51 2.572 0 CA-C-O 117.886 -1.054 . . . . 0.0 112.336 179.964 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 48.8 m . . . . . 0 N--CA 1.495 1.788 0 CA-C-O 120.975 0.417 . . . . 0.0 110.116 . . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -148.49 164.29 34.61 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.548 -0.72 . . . . 0.0 110.612 -179.812 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.427 ' N ' ' HD2' ' A' ' 4' ' ' PRO . 1.0 OUTLIER -62.63 -51.99 68.33 Favored Pre-proline 0 N--CA 1.497 1.879 0 O-C-N 121.635 -0.666 . . . . 0.0 110.587 179.657 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.427 ' HD2' ' N ' ' A' ' 3' ' ' LEU . 52.3 Cg_endo -77.24 55.62 5.14 Favored 'Trans proline' 0 N--CA 1.489 1.208 0 O-C-N 123.543 1.286 . . . . 0.0 110.586 179.573 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -156.3 42.35 0.38 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.243 -0.911 . . . . 0.0 110.276 179.849 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -131.1 -57.35 1.03 Allowed 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.488 -0.758 . . . . 0.0 110.537 -179.864 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 20.6 m -131.38 18.09 4.87 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.424 -0.797 . . . . 0.0 111.313 -179.709 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 27.2 p -122.88 21.65 9.86 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.213 -0.929 . . . . 0.0 110.367 179.487 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -103.77 -77.01 1.15 Allowed Glycine 0 N--CA 1.493 2.435 0 N-CA-C 109.006 -1.638 . . . . 0.0 109.006 179.828 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -61.28 -41.0 96.21 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.715 -0.873 . . . . 0.0 110.114 179.464 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 4.5 tt -58.58 -47.17 85.18 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.482 -0.761 . . . . 0.0 109.879 179.466 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 14.1 m170 -66.01 -38.16 87.75 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.541 -0.724 . . . . 0.0 109.789 179.236 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -60.08 -40.36 89.29 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.538 -0.726 . . . . 0.0 109.86 179.313 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 6.8 t-160 -62.94 -51.5 66.66 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.693 -0.629 . . . . 0.0 109.425 179.158 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 6.4 tp60 -61.84 -37.32 84.05 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.572 -0.705 . . . . 0.0 110.086 179.279 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -60.11 -35.39 75.13 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.654 -0.654 . . . . 0.0 110.621 179.662 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 61.2 mt -88.23 -40.3 13.42 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 O-C-N 121.374 -0.829 . . . . 0.0 110.268 179.931 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 9.4 t -69.43 -33.54 57.89 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.875 0 O-C-N 121.378 -0.826 . . . . 0.0 110.61 -179.931 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.463 ' HA ' ' CD1' ' A' ' 22' ' ' TYR . 2.2 t70 -88.89 14.31 10.7 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.269 -0.894 . . . . 0.0 111.253 179.831 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -119.43 -23.83 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 120.785 -1.197 . . . . 0.0 110.833 179.386 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -100.72 -29.51 12.24 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.396 -0.815 . . . . 0.0 110.669 -179.924 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . 0.463 ' CD1' ' HA ' ' A' ' 19' ' ' ASP . 3.7 p90 -61.3 -28.25 69.06 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.332 -0.855 . . . . 0.0 110.206 179.582 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 2.2 tpp -86.17 -13.67 46.35 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.326 -0.859 . . . . 0.0 110.691 179.323 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 29.1 m-85 -115.1 25.98 10.47 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.205 -0.934 . . . . 0.0 110.861 -179.723 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -177.45 -70.83 0.06 OUTLIER Glycine 0 N--CA 1.495 2.6 0 C-N-CA 119.801 -1.19 . . . . 0.0 110.434 179.833 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 56.98 28.75 15.25 Favored 'General case' 0 N--CA 1.505 2.307 0 O-C-N 121.555 -0.968 . . . . 0.0 110.863 -179.409 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.506 ' N ' ' HD2' ' A' ' 28' ' ' PRO . 0.6 OUTLIER -67.93 -50.18 33.67 Favored Pre-proline 0 N--CA 1.501 2.102 0 O-C-N 121.239 -0.913 . . . . 0.0 111.401 -179.907 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.506 ' HD2' ' N ' ' A' ' 27' ' ' SER . 44.1 Cg_endo -71.08 -20.71 28.37 Favored 'Trans proline' 0 N--CA 1.489 1.243 0 O-C-N 123.247 1.13 . . . . 0.0 111.115 -179.884 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -77.18 -43.82 32.42 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.405 -0.809 . . . . 0.0 110.564 179.915 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 4.9 tp -72.02 -28.63 30.38 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 O-C-N 121.277 -0.89 . . . . 0.0 111.009 -179.814 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 3.3 p -77.21 -35.49 55.6 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.322 -0.861 . . . . 0.0 110.119 179.637 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -86.87 12.04 11.95 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.36 -0.838 . . . . 0.0 110.744 179.406 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 89.6 t80 -112.87 -38.91 4.4 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.188 -0.945 . . . . 0.0 110.366 179.654 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 38.5 t -94.21 92.5 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 O-C-N 121.403 -0.811 . . . . 0.0 110.075 -179.873 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 5.0 p -128.9 21.98 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 121.435 -0.791 . . . . 0.0 110.565 179.896 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? . . . . . 0 N--CA 1.496 1.857 0 CA-C-O 117.892 -1.051 . . . . 0.0 110.253 179.922 . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 9.6 p . . . . . 0 N--CA 1.496 1.862 0 CA-C-O 121.165 0.507 . . . . 0.0 110.357 . . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -88.04 81.52 7.42 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.409 -0.807 . . . . 0.0 110.291 -179.875 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.446 ' N ' ' HD2' ' A' ' 4' ' ' PRO . 0.4 OUTLIER -78.43 -55.1 1.11 Allowed Pre-proline 0 N--CA 1.498 1.944 0 O-C-N 121.514 -0.741 . . . . 0.0 110.579 179.899 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.446 ' HD2' ' N ' ' A' ' 3' ' ' LEU . 44.7 Cg_endo -71.64 -29.9 15.43 Favored 'Trans proline' 0 N--CA 1.488 1.185 0 O-C-N 123.532 1.28 . . . . 0.0 110.504 179.663 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -107.34 35.3 3.11 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.506 -0.746 . . . . 0.0 109.923 179.257 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.7 tt -72.16 -50.12 30.38 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.467 -0.77 . . . . 0.0 110.568 -179.857 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 78.2 p -138.69 32.74 2.24 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.317 -0.864 . . . . 0.0 110.937 -179.706 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 6.5 m 53.19 58.68 5.04 Favored 'General case' 0 N--CA 1.503 2.191 0 O-C-N 121.349 -0.844 . . . . 0.0 110.121 -179.886 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -108.02 -62.9 0.56 Allowed Glycine 0 N--CA 1.495 2.632 0 N-CA-C 109.767 -1.333 . . . . 0.0 109.767 -179.61 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.86 -47.39 86.57 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.53 -0.983 . . . . 0.0 110.29 179.964 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 5.4 tt -58.25 -45.67 87.37 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.543 -0.723 . . . . 0.0 109.677 179.259 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 5.1 t-160 -68.11 -32.23 72.38 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.654 -0.654 . . . . 0.0 109.979 179.145 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.08 -43.88 98.21 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.615 -0.678 . . . . 0.0 109.966 179.494 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 2.7 t-80 -61.17 -55.85 27.47 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.472 -0.768 . . . . 0.0 109.458 179.34 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.45 ' O ' ' HB2' ' A' ' 19' ' ' ASP . 3.3 tp60 -58.95 -37.77 77.5 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.585 -0.697 . . . . 0.0 110.296 179.746 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 14.8 t30 -63.31 -45.85 89.43 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.576 -0.703 . . . . 0.0 110.449 179.654 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 27.7 mm -73.14 -32.59 39.25 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 O-C-N 121.242 -0.911 . . . . 0.0 109.961 179.58 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 52.2 t -75.12 -18.33 16.14 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 O-C-N 121.374 -0.829 . . . . 0.0 110.533 179.731 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.549 ' HA ' ' CD1' ' A' ' 22' ' ' TYR . 0.2 OUTLIER -103.35 19.44 19.68 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.263 -0.898 . . . . 0.0 110.795 179.266 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 1.5 p -115.81 -35.63 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 120.784 -1.198 . . . . 0.0 110.65 179.473 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -83.49 -35.17 25.09 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.275 -0.891 . . . . 0.0 110.04 179.641 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . 0.549 ' CD1' ' HA ' ' A' ' 19' ' ' ASP . 1.2 p90 -64.63 -25.22 67.87 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.424 -0.797 . . . . 0.0 110.323 179.652 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -92.06 7.05 44.13 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.348 -0.845 . . . . 0.0 110.694 179.337 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -97.53 40.62 1.15 Allowed 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.108 -0.995 . . . . 0.0 110.255 179.72 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 68.21 23.12 74.76 Favored Glycine 0 N--CA 1.496 2.646 0 N-CA-C 110.394 -1.082 . . . . 0.0 110.394 179.969 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.461 ' HB3' ' CB ' ' A' ' 29' ' ' ALA . 79.6 mt 48.67 68.87 0.63 Allowed 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.682 -0.893 . . . . 0.0 110.331 179.997 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.548 ' HB2' ' HD3' ' A' ' 28' ' ' PRO . 3.6 m -52.53 -49.82 83.7 Favored Pre-proline 0 N--CA 1.5 2.058 0 O-C-N 121.673 -0.642 . . . . 0.0 111.555 -179.578 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.548 ' HD3' ' HB2' ' A' ' 27' ' ' SER . 44.3 Cg_endo -70.27 -12.56 32.16 Favored 'Trans proline' 0 N--CA 1.491 1.37 0 O-C-N 123.275 1.145 . . . . 0.0 111.613 -179.772 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.461 ' CB ' ' HB3' ' A' ' 26' ' ' LEU . . . -98.93 -41.41 7.61 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.305 -0.872 . . . . 0.0 110.249 179.635 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 16.7 tt -69.98 -23.36 25.33 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 O-C-N 121.422 -0.799 . . . . 0.0 110.951 -179.987 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 2.0 p -63.77 -46.14 86.61 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.387 -0.821 . . . . 0.0 110.158 179.689 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 5.9 mttp -90.13 18.97 5.34 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.546 -0.721 . . . . 0.0 110.306 179.258 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 13.0 t80 -116.25 -40.83 3.21 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.291 -0.881 . . . . 0.0 110.165 179.816 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 29.7 t -93.3 81.82 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.378 -0.826 . . . . 0.0 109.68 179.898 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 5.3 p -124.02 19.14 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 O-C-N 121.412 -0.805 . . . . 0.0 110.739 -179.835 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 7.0 ptt-85 . . . . . 0 N--CA 1.497 1.916 0 CA-C-O 117.825 -1.083 . . . . 0.0 110.802 179.722 . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 75.3 m . . . . . 0 N--CA 1.496 1.836 0 CA-C-O 121.126 0.489 . . . . 0.0 110.52 . . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -105.54 37.55 2.19 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.558 -0.714 . . . . 0.0 110.212 179.651 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.52 ' CB ' ' HD3' ' A' ' 4' ' ' PRO . 0.2 OUTLIER -74.92 -56.25 2.15 Favored Pre-proline 0 N--CA 1.498 1.942 0 O-C-N 121.21 -0.931 . . . . 0.0 110.463 179.841 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.52 ' HD3' ' CB ' ' A' ' 3' ' ' LEU . 52.3 Cg_endo -82.17 51.11 3.67 Favored 'Trans proline' 0 C--N 1.32 -0.947 0 O-C-N 123.525 1.277 . . . . 0.0 110.233 179.373 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -145.28 -52.82 0.28 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.356 -0.84 . . . . 0.0 110.292 -179.717 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 16.0 mt 53.0 43.06 32.23 Favored 'General case' 0 N--CA 1.503 2.182 0 O-C-N 121.662 -0.648 . . . . 0.0 110.726 179.884 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 9.2 t -144.14 -53.05 0.33 Allowed 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.434 -0.791 . . . . 0.0 110.084 179.972 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.532 ' HB ' ' HB2' ' A' ' 12' ' ' HIS . 0.8 OUTLIER -111.15 30.39 6.94 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.556 -0.715 . . . . 0.0 110.149 179.708 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -70.67 -74.01 0.73 Allowed Glycine 0 N--CA 1.493 2.45 0 N-CA-C 109.281 -1.527 . . . . 0.0 109.281 179.906 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 13.4 mt -85.72 -32.41 21.92 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.605 -0.938 . . . . 0.0 109.944 179.38 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 6.0 mp -60.14 -55.78 29.62 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.523 -0.736 . . . . 0.0 110.281 179.841 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . 0.532 ' HB2' ' HB ' ' A' ' 8' ' ' THR . 13.7 t-160 -60.35 -42.62 96.1 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.489 -0.757 . . . . 0.0 109.94 179.459 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 13.2 tp -59.82 -41.36 91.14 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.605 -0.684 . . . . 0.0 109.962 179.398 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 51.4 t60 -63.03 -47.74 81.76 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.627 -0.671 . . . . 0.0 110.095 179.571 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 34.4 tp60 -56.17 -42.4 76.99 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.544 -0.723 . . . . 0.0 110.369 179.969 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.443 ' O ' ' HB ' ' A' ' 20' ' ' VAL . 8.4 t-20 -62.46 -48.98 77.25 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.282 -0.886 . . . . 0.0 110.377 179.637 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 73.2 mt -65.73 -38.7 82.88 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.036 0 O-C-N 121.423 -0.798 . . . . 0.0 110.41 -179.958 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 21.3 t -70.92 -36.73 65.2 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 O-C-N 121.237 -0.914 . . . . 0.0 110.35 179.797 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.579 ' HA ' ' CD2' ' A' ' 22' ' ' TYR . 1.7 m-20 -85.73 1.72 48.34 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.498 -0.751 . . . . 0.0 111.477 179.976 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.443 ' HB ' ' O ' ' A' ' 16' ' ' ASN . 1.0 OUTLIER -108.35 -16.17 8.84 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 O-C-N 120.802 -1.186 . . . . 0.0 110.431 179.121 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 24.8 mt-30 -96.43 -37.92 10.24 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.469 -0.77 . . . . 0.0 110.15 179.888 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . 0.579 ' CD2' ' HA ' ' A' ' 19' ' ' ASP . 1.6 p90 -62.99 -32.75 74.17 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.46 -0.775 . . . . 0.0 110.228 179.693 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -72.91 -27.62 61.98 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.489 -0.757 . . . . 0.0 110.606 179.85 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 28.1 m-85 -99.12 24.08 8.3 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.326 -0.859 . . . . 0.0 110.802 179.958 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -131.01 -87.81 0.44 Allowed Glycine 0 N--CA 1.494 2.537 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 179.89 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 57.93 23.08 9.43 Favored 'General case' 0 N--CA 1.504 2.26 0 O-C-N 121.701 -0.882 . . . . 0.0 111.1 -179.77 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.51 ' CB ' ' CD ' ' A' ' 28' ' ' PRO . 0.4 OUTLIER -175.16 -62.58 0.0 OUTLIER Pre-proline 0 N--CA 1.497 1.904 0 O-C-N 121.416 -0.802 . . . . 0.0 110.093 179.599 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.51 ' CD ' ' CB ' ' A' ' 27' ' ' SER . 43.6 Cg_endo -70.24 -31.96 17.43 Favored 'Trans proline' 0 N--CA 1.488 1.195 0 O-C-N 123.318 1.168 . . . . 0.0 110.339 179.174 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.422 ' O ' ' HB2' ' A' ' 33' ' ' TYR . . . -72.04 -13.12 61.51 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.618 -0.676 . . . . 0.0 111.037 179.477 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.2 tp -114.03 -28.27 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 O-C-N 121.067 -1.021 . . . . 0.0 111.395 -179.73 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 2.0 t -96.08 -20.19 18.84 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.059 -1.026 . . . . 0.0 110.958 -179.977 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -114.41 17.96 17.15 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.095 -1.003 . . . . 0.0 110.544 179.691 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.422 ' HB2' ' O ' ' A' ' 29' ' ' ALA . 7.2 m-85 -129.56 21.41 5.56 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.286 -0.884 . . . . 0.0 110.801 -179.935 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.3 t -122.92 35.52 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 121.285 -0.884 . . . . 0.0 110.094 -179.934 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 48.7 t -132.17 66.76 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 O-C-N 121.142 -0.974 . . . . 0.0 109.505 179.572 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.496 1.844 0 CA-C-O 118.233 -0.889 . . . . 0.0 110.362 -179.941 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.495 1.776 0 CA-C-O 120.899 0.38 . . . . 0.0 110.096 . . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -133.45 32.56 3.63 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.561 -0.712 . . . . 0.0 110.793 -179.704 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.406 ' N ' ' HD3' ' A' ' 4' ' ' PRO . 3.6 tp 50.01 62.21 12.25 Favored Pre-proline 0 N--CA 1.502 2.139 0 O-C-N 121.587 -0.695 . . . . 0.0 110.976 179.803 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.406 ' HD3' ' N ' ' A' ' 3' ' ' LEU . 47.9 Cg_endo -80.7 59.13 7.33 Favored 'Trans proline' 0 C--N 1.311 -1.433 0 O-C-N 123.85 1.447 . . . . 0.0 110.525 179.974 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -162.9 -46.64 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.402 -0.811 . . . . 0.0 110.476 179.889 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 56.44 36.64 27.87 Favored 'General case' 0 N--CA 1.502 2.155 0 O-C-N 121.743 -0.598 . . . . 0.0 110.373 -179.855 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.2 m 54.71 29.95 12.58 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.626 -0.671 . . . . 0.0 110.775 -179.541 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 52.6 m -118.26 1.87 11.9 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.325 -0.859 . . . . 0.0 110.614 179.685 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -105.32 -62.69 0.64 Allowed Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.302 -1.519 . . . . 0.0 109.302 179.804 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -59.97 -41.98 93.13 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.664 -0.904 . . . . 0.0 110.507 179.945 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -60.94 -50.33 73.85 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.459 -0.776 . . . . 0.0 110.003 179.675 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 3.8 m80 -63.82 -42.5 97.65 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.605 -0.685 . . . . 0.0 110.255 179.679 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 9.3 tp -60.65 -42.88 97.87 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.504 -0.748 . . . . 0.0 110.011 179.538 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 66.6 t60 -59.64 -55.07 38.98 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.647 -0.658 . . . . 0.0 109.943 179.478 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -53.24 -37.29 61.93 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.631 -0.668 . . . . 0.0 110.383 179.699 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -65.98 -46.15 79.08 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.541 -0.724 . . . . 0.0 110.493 179.697 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 63.3 mt -72.47 -32.83 43.38 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.11 0 O-C-N 121.418 -0.801 . . . . 0.0 110.429 179.934 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.432 ' O ' ' CD2' ' A' ' 22' ' ' TYR . 52.4 t -65.86 -48.18 82.96 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.491 -0.756 . . . . 0.0 110.328 -179.815 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -79.42 47.73 0.84 Allowed 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.145 -0.972 . . . . 0.0 110.855 179.953 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 51.3 t -135.5 -46.9 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 O-C-N 121.335 -0.853 . . . . 0.0 109.536 179.319 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 32.2 mt-30 -85.84 -23.14 27.26 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.395 -0.815 . . . . 0.0 110.284 179.613 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . 0.438 ' CD1' ' N ' ' A' ' 22' ' ' TYR . 2.6 m-85 -93.95 -33.27 13.53 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.259 -0.901 . . . . 0.0 109.866 -179.97 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -92.19 -37.35 12.76 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.318 -0.864 . . . . 0.0 110.023 179.585 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -102.48 19.65 18.53 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.399 -0.813 . . . . 0.0 111.066 179.839 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -163.95 33.54 0.28 Allowed Glycine 0 N--CA 1.496 2.689 0 C-N-CA 119.77 -1.205 . . . . 0.0 111.007 179.831 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -150.92 17.89 0.78 Allowed 'General case' 0 N--CA 1.5 2.064 0 O-C-N 120.839 -1.389 . . . . 0.0 111.557 179.519 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.59 ' HB2' ' HD3' ' A' ' 28' ' ' PRO . 2.5 m -106.48 -62.3 0.04 OUTLIER Pre-proline 0 N--CA 1.495 1.81 0 O-C-N 121.114 -0.991 . . . . 0.0 110.443 179.715 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.59 ' HD3' ' HB2' ' A' ' 27' ' ' SER . 53.6 Cg_endo -79.81 63.75 8.78 Favored 'Trans proline' 0 N--CA 1.484 0.92 0 O-C-N 123.239 1.126 . . . . 0.0 110.033 179.357 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -166.41 -46.6 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.524 -0.735 . . . . 0.0 110.298 -179.7 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 47.6 mm -81.51 -38.8 16.56 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 O-C-N 121.535 -0.728 . . . . 0.0 110.265 -179.9 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 82.5 m -70.87 -42.26 70.28 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.464 -0.773 . . . . 0.0 110.031 179.732 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 7.2 mttp -69.7 -15.67 63.21 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.442 -0.786 . . . . 0.0 110.753 179.379 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -70.21 -42.49 72.25 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.377 -0.827 . . . . 0.0 110.38 179.847 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.456 ' O ' HG12 ' A' ' 35' ' ' VAL . 26.6 t -104.09 18.07 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 121.457 -0.777 . . . . 0.0 110.347 179.729 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.456 HG12 ' O ' ' A' ' 34' ' ' VAL . 0.3 OUTLIER 52.05 23.67 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.316 0 O-C-N 121.602 -0.686 . . . . 0.0 111.421 -179.91 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.498 1.954 0 CA-C-O 117.82 -1.086 . . . . 0.0 110.526 179.624 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 4.0 p . . . . . 0 N--CA 1.496 1.862 0 CA-C-O 121.214 0.531 . . . . 0.0 109.945 . . . . . . . . . 0 0 . 1 . 031 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -116.42 86.88 2.57 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.515 -0.741 . . . . 0.0 110.277 -179.546 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.515 ' N ' ' HD3' ' A' ' 4' ' ' PRO . 0.5 OUTLIER -146.3 57.23 3.7 Favored Pre-proline 0 N--CA 1.496 1.853 0 O-C-N 121.548 -0.72 . . . . 0.0 110.529 179.873 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.515 ' HD3' ' N ' ' A' ' 3' ' ' LEU . 48.5 Cg_endo -81.19 -42.36 0.12 Allowed 'Trans proline' 0 C--N 1.314 -1.266 0 O-C-N 123.797 1.419 . . . . 0.0 111.224 179.991 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -155.16 -44.48 0.08 Allowed 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.528 -0.733 . . . . 0.0 110.654 -179.852 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -154.12 -39.62 0.09 Allowed 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.291 -0.88 . . . . 0.0 111.402 -179.761 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 19.3 p 45.77 42.56 8.86 Favored 'General case' 0 N--CA 1.506 2.346 0 O-C-N 121.639 -0.663 . . . . 0.0 111.432 -179.801 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.431 HG23 ' HB2' ' A' ' 12' ' ' HIS . 2.9 m 57.14 35.37 26.18 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.491 -0.756 . . . . 0.0 110.818 179.617 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -102.54 -86.41 1.94 Allowed Glycine 0 N--CA 1.491 2.363 0 N-CA-C 108.699 -1.76 . . . . 0.0 108.699 179.502 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -62.25 -36.99 83.73 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.611 -0.935 . . . . 0.0 109.921 179.064 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -59.95 -47.41 85.92 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.553 -0.717 . . . . 0.0 110.096 179.43 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . 0.431 ' HB2' HG23 ' A' ' 8' ' ' THR . 26.5 t-80 -67.35 -43.92 80.32 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.518 -0.739 . . . . 0.0 109.531 179.272 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -59.95 -40.15 88.03 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.662 -0.649 . . . . 0.0 109.872 179.237 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 1.1 t-80 -58.68 -55.24 37.7 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.576 -0.703 . . . . 0.0 109.639 179.389 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.39 -37.36 72.56 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.611 -0.68 . . . . 0.0 110.58 179.895 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -59.58 -35.76 74.92 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.378 -0.826 . . . . 0.0 110.064 179.296 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 46.2 mm -82.58 -36.56 13.55 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.46 -0.775 . . . . 0.0 109.844 179.55 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.406 ' O ' ' HB3' ' A' ' 22' ' ' TYR . 61.2 t -61.55 -23.23 30.13 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.048 0 O-C-N 121.448 -0.783 . . . . 0.0 110.758 -179.979 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -86.81 -21.42 26.47 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.252 -0.905 . . . . 0.0 110.614 179.81 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 47.5 t -102.64 -43.35 9.26 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 O-C-N 121.112 -0.992 . . . . 0.0 109.595 179.346 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . 0.514 ' HG2' ' HB3' ' A' ' 27' ' ' SER . 26.9 tt0 -59.6 -41.05 89.45 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.715 -0.616 . . . . 0.0 110.626 179.901 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . 0.406 ' HB3' ' O ' ' A' ' 18' ' ' VAL . 0.1 OUTLIER -58.26 -34.73 70.81 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.148 -0.97 . . . . 0.0 111.108 -179.656 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 3.0 ttp -109.06 27.89 9.05 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.207 -0.933 . . . . 0.0 111.167 179.965 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.462 ' CB ' ' HB2' ' A' ' 27' ' ' SER . 0.2 OUTLIER -78.62 -4.05 46.95 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.279 -0.888 . . . . 0.0 110.686 179.166 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 108.8 -43.06 1.79 Allowed Glycine 0 N--CA 1.495 2.61 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 179.939 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -161.97 31.7 0.12 Allowed 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.591 -0.946 . . . . 0.0 110.498 179.987 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.536 ' N ' ' CD ' ' A' ' 28' ' ' PRO . 0.3 OUTLIER -82.12 -40.39 0.94 Allowed Pre-proline 0 N--CA 1.496 1.867 0 O-C-N 121.445 -0.785 . . . . 0.0 112.012 -179.695 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.536 ' CD ' ' N ' ' A' ' 27' ' ' SER . 47.8 Cg_endo -75.86 64.56 6.79 Favored 'Trans proline' 0 N--CA 1.486 1.081 0 O-C-N 123.126 1.066 . . . . 0.0 110.614 -179.359 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -167.55 -49.67 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.708 -0.62 . . . . 0.0 109.789 179.892 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 49.2 mm -91.9 -29.88 4.66 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 121.612 -0.68 . . . . 0.0 110.23 179.633 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 31.9 m -61.35 -38.13 85.83 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.528 -0.733 . . . . 0.0 110.142 179.725 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.439 ' HA ' ' HE2' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -69.96 -27.53 64.81 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.394 -0.816 . . . . 0.0 110.47 179.609 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -78.77 -16.95 56.54 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.449 -0.782 . . . . 0.0 110.811 179.544 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.47 HG12 HG23 ' A' ' 35' ' ' VAL . 23.6 t -116.34 157.6 17.14 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 O-C-N 121.291 -0.881 . . . . 0.0 109.982 179.944 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.47 HG23 HG12 ' A' ' 34' ' ' VAL . 14.4 t 59.27 74.55 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.147 0 O-C-N 121.573 -0.704 . . . . 0.0 110.423 180.0 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.501 2.077 0 CA-C-O 118.367 -0.825 . . . . 0.0 110.873 179.993 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.494 1.761 0 CA-C-O 121.162 0.506 . . . . 0.0 110.017 . . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -150.47 130.65 13.59 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.46 -0.775 . . . . 0.0 110.31 -179.826 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -77.82 -52.39 1.63 Allowed Pre-proline 0 N--CA 1.499 2.0 0 O-C-N 121.442 -0.786 . . . . 0.0 111.182 -179.605 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -77.74 64.25 8.13 Favored 'Trans proline' 0 N--CA 1.486 1.086 0 O-C-N 123.399 1.21 . . . . 0.0 110.666 -179.788 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -84.31 -35.61 23.16 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.457 -0.777 . . . . 0.0 110.594 179.941 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 57.01 34.03 24.29 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.561 -0.712 . . . . 0.0 110.501 -179.767 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -100.45 37.52 1.67 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.45 -0.781 . . . . 0.0 110.305 179.858 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 2.4 m -121.21 13.54 11.19 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.266 -0.896 . . . . 0.0 110.609 179.866 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -100.44 -79.31 1.42 Allowed Glycine 0 N--CA 1.492 2.415 0 N-CA-C 109.262 -1.535 . . . . 0.0 109.262 -179.975 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -60.53 -34.83 74.69 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.595 -0.944 . . . . 0.0 110.287 179.7 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 6.4 tt -56.33 -45.19 80.44 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.577 -0.702 . . . . 0.0 110.153 179.503 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 27.6 m-70 -81.81 -42.55 19.53 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.438 -0.789 . . . . 0.0 110.008 179.521 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 7.2 tp -57.36 -37.32 72.42 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.65 -0.656 . . . . 0.0 110.484 179.801 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . 0.475 ' CD2' HG23 ' A' ' 18' ' ' VAL . 1.8 t-80 -56.83 -47.31 80.6 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.458 -0.776 . . . . 0.0 109.802 179.382 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 6.4 tp60 -59.53 -34.94 73.27 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.625 -0.672 . . . . 0.0 110.42 179.627 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 16.0 t30 -69.91 -35.21 74.41 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.459 -0.775 . . . . 0.0 110.403 179.551 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 32.5 mt -82.47 -16.07 11.76 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 O-C-N 121.241 -0.912 . . . . 0.0 110.879 179.962 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.475 HG23 ' CD2' ' A' ' 14' ' ' HIS . 74.7 t -99.38 -50.97 10.49 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.142 -0.974 . . . . 0.0 109.802 179.891 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.522 ' HA ' ' CD2' ' A' ' 22' ' ' TYR . 34.5 t0 -61.57 -21.7 64.53 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.602 -0.686 . . . . 0.0 110.604 179.376 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 8.3 p -52.85 -31.35 16.61 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.059 0 O-C-N 121.296 -0.878 . . . . 0.0 110.935 179.53 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -82.08 -21.92 36.57 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.374 -0.828 . . . . 0.0 110.861 179.996 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . 0.522 ' CD2' ' HA ' ' A' ' 19' ' ' ASP . 1.4 m-85 -100.66 -49.92 4.04 Favored 'General case' 0 N--CA 1.502 2.151 0 O-C-N 121.259 -0.901 . . . . 0.0 109.816 -179.814 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -60.5 -38.3 83.91 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.395 -0.816 . . . . 0.0 109.982 179.421 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -89.42 15.76 8.67 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.461 -0.774 . . . . 0.0 110.708 179.298 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -90.91 -4.39 69.41 Favored Glycine 0 N--CA 1.495 2.629 0 N-CA-C 110.407 -1.077 . . . . 0.0 110.407 179.639 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 5.3 mp 54.46 48.58 20.24 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.322 -1.105 . . . . 0.0 111.194 179.809 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.555 ' HB3' ' HD3' ' A' ' 28' ' ' PRO . 3.7 t -164.21 -65.09 0.01 OUTLIER Pre-proline 0 N--CA 1.499 1.998 0 O-C-N 121.265 -0.897 . . . . 0.0 110.602 179.221 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.555 ' HD3' ' HB3' ' A' ' 27' ' ' SER . 47.1 Cg_endo -72.97 -20.54 21.9 Favored 'Trans proline' 0 N--CA 1.491 1.328 0 O-C-N 123.258 1.136 . . . . 0.0 111.113 179.888 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -73.44 -45.06 56.63 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.448 -0.783 . . . . 0.0 110.202 179.887 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 3.2 mt -68.07 -36.4 75.27 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 O-C-N 121.422 -0.799 . . . . 0.0 110.564 -179.967 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 20.3 p -71.47 -32.19 68.0 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.477 -0.764 . . . . 0.0 110.316 179.703 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.4 tttt -90.42 18.53 6.08 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.415 -0.803 . . . . 0.0 110.814 179.763 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -111.51 -50.8 2.9 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.296 -0.878 . . . . 0.0 109.766 179.627 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 45.9 t -81.52 79.83 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 121.445 -0.784 . . . . 0.0 109.845 179.791 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 6.8 p -123.2 21.86 4.5 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 121.423 -0.798 . . . . 0.0 110.689 -179.954 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.497 1.906 0 O-C-N 121.27 -0.894 . . . . 0.0 110.3 179.627 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 2.5 t . . . . . 0 N--CA 1.494 1.733 0 CA-C-O 121.143 0.496 . . . . 0.0 110.137 . . . . . . . . . 0 0 . 1 . 033 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -109.23 21.2 17.42 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.507 -0.746 . . . . 0.0 110.492 179.932 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.405 ' N ' ' HD3' ' A' ' 4' ' ' PRO . 0.5 OUTLIER -158.0 58.42 1.4 Allowed Pre-proline 0 N--CA 1.495 1.823 0 O-C-N 121.392 -0.818 . . . . 0.0 109.95 179.865 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.405 ' HD3' ' N ' ' A' ' 3' ' ' LEU . 45.6 Cg_endo -75.04 -29.16 8.46 Favored 'Trans proline' 0 C--N 1.311 -1.404 0 O-C-N 123.793 1.417 . . . . 0.0 111.185 -179.628 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -154.72 -75.02 0.11 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.425 -0.797 . . . . 0.0 109.983 179.744 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.403 HD22 ' HA ' ' A' ' 6' ' ' LEU . 0.4 OUTLIER -168.86 -61.47 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.505 -0.747 . . . . 0.0 109.938 179.679 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 21.6 t -164.94 -65.13 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.492 -0.755 . . . . 0.0 110.189 179.779 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 1.5 m 58.15 45.39 17.62 Favored 'General case' 0 N--CA 1.502 2.165 0 O-C-N 121.889 -0.507 . . . . 0.0 110.657 179.84 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -105.47 -74.52 0.94 Allowed Glycine 0 N--CA 1.494 2.502 0 N-CA-C 109.237 -1.545 . . . . 0.0 109.237 179.786 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -70.1 -43.69 70.56 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.591 -0.947 . . . . 0.0 109.91 179.699 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 5.6 tt -58.35 -45.94 87.2 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.64 -0.663 . . . . 0.0 110.392 179.703 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 37.1 t60 -64.58 -40.62 95.87 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.473 -0.767 . . . . 0.0 110.2 179.765 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.422 ' O ' HD11 ' A' ' 17' ' ' ILE . 3.2 tp -60.28 -40.6 90.97 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.448 -0.782 . . . . 0.0 110.108 179.406 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . 0.443 ' CD2' HG22 ' A' ' 18' ' ' VAL . 18.3 t-80 -60.19 -58.64 7.67 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.388 -0.82 . . . . 0.0 109.778 179.625 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.45 ' O ' ' HB2' ' A' ' 19' ' ' ASP . 0.7 OUTLIER -60.14 -26.04 65.97 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.452 -0.78 . . . . 0.0 110.692 179.613 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 -80.0 -46.38 16.72 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.35 -0.844 . . . . 0.0 110.577 -179.883 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.422 HD11 ' O ' ' A' ' 13' ' ' LEU . 1.3 mp -76.7 -33.58 22.14 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 121.286 -0.884 . . . . 0.0 110.401 -179.809 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.443 HG22 ' CD2' ' A' ' 14' ' ' HIS . 50.7 t -70.52 -29.43 38.53 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 O-C-N 121.125 -0.984 . . . . 0.0 110.364 179.826 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.469 ' HA ' ' CD2' ' A' ' 22' ' ' TYR . 0.4 OUTLIER -88.26 3.27 50.14 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.461 -0.775 . . . . 0.0 111.211 179.772 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -113.06 -13.96 11.14 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 120.947 -1.096 . . . . 0.0 110.722 179.611 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 11.5 mt-30 -103.71 -35.05 8.37 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.286 -0.884 . . . . 0.0 110.559 -179.802 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . 0.469 ' CD2' ' HA ' ' A' ' 19' ' ' ASP . 2.1 p90 -56.7 -33.38 66.4 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.477 -0.765 . . . . 0.0 110.725 -179.841 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.48 -36.88 63.28 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.311 -0.868 . . . . 0.0 110.357 179.813 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -74.02 -10.27 59.47 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.486 -0.759 . . . . 0.0 111.236 179.85 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -92.48 10.62 73.83 Favored Glycine 0 N--CA 1.495 2.602 0 N-CA-C 110.224 -1.15 . . . . 0.0 110.224 179.646 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -147.27 25.98 1.09 Allowed 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.174 -1.192 . . . . 0.0 110.808 179.873 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.434 ' CB ' ' HD3' ' A' ' 28' ' ' PRO . 0.0 OUTLIER -84.48 -56.5 0.41 Allowed Pre-proline 0 N--CA 1.499 2.019 0 O-C-N 121.2 -0.938 . . . . 0.0 110.223 179.823 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.434 ' HD3' ' CB ' ' A' ' 27' ' ' SER . 49.4 Cg_endo -77.58 -11.52 17.05 Favored 'Trans proline' 0 C--N 1.32 -0.926 0 O-C-N 123.32 1.168 . . . . 0.0 110.596 179.174 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -82.81 -43.55 16.54 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.274 -0.892 . . . . 0.0 110.33 179.935 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.434 HG22 ' O ' ' A' ' 27' ' ' SER . 4.0 tp -65.0 -30.5 50.56 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 O-C-N 121.498 -0.751 . . . . 0.0 110.674 -179.99 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 9.7 p -72.35 -25.73 61.65 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.376 -0.827 . . . . 0.0 110.229 179.345 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 2.5 tttm -99.24 16.39 23.05 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.389 -0.819 . . . . 0.0 110.643 179.63 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -110.19 -37.88 5.43 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.222 -0.923 . . . . 0.0 110.69 -179.759 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 52.8 t -78.93 -45.9 24.22 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 O-C-N 121.421 -0.799 . . . . 0.0 110.224 -179.84 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.416 ' O ' ' CG1' ' A' ' 35' ' ' VAL . 0.4 OUTLIER 61.18 15.83 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.278 0 O-C-N 121.871 -0.518 . . . . 0.0 111.458 -179.899 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 77.5 mtm-85 . . . . . 0 N--CA 1.502 2.166 0 CA-C-O 117.657 -1.163 . . . . 0.0 110.442 179.638 . . . . . . . . 0 0 . 1 . 034 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 30.2 m . . . . . 0 N--CA 1.494 1.771 0 CA-C-O 121.075 0.464 . . . . 0.0 110.171 . . . . . . . . . 0 0 . 1 . 034 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -146.42 155.54 42.65 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.53 -0.731 . . . . 0.0 110.202 -179.945 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.531 ' CB ' ' HD3' ' A' ' 4' ' ' PRO . 0.1 OUTLIER -161.53 -61.68 0.02 OUTLIER Pre-proline 0 N--CA 1.497 1.887 0 O-C-N 121.554 -0.716 . . . . 0.0 110.761 179.94 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.531 ' HD3' ' CB ' ' A' ' 3' ' ' LEU . 50.8 Cg_endo -78.52 63.29 8.43 Favored 'Trans proline' 0 N--CA 1.486 1.071 0 O-C-N 123.417 1.22 . . . . 0.0 110.606 -179.979 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -93.93 -41.85 9.38 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.24 -0.912 . . . . 0.0 110.454 179.958 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.1 mt -120.37 -53.73 2.11 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.455 -0.778 . . . . 0.0 110.248 179.987 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.1 t 57.4 61.94 2.33 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.7 -0.625 . . . . 0.0 110.598 -179.9 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 6.9 m 54.42 55.37 8.15 Favored 'General case' 0 N--CA 1.503 2.216 0 O-C-N 121.671 -0.643 . . . . 0.0 110.821 179.69 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -102.98 -71.91 0.9 Allowed Glycine 0 N--CA 1.494 2.521 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 179.842 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.34 -39.24 92.44 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.642 -0.917 . . . . 0.0 110.389 179.826 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 13.6 tp -58.68 -51.04 71.63 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.46 -0.775 . . . . 0.0 110.236 179.669 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -65.15 -43.15 92.76 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.548 -0.72 . . . . 0.0 109.816 179.482 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -60.63 -39.7 89.23 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.535 -0.728 . . . . 0.0 109.953 179.241 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 4.4 t-80 -59.31 -54.09 50.74 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.786 -0.572 . . . . 0.0 109.885 179.538 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.9 tp60 -57.31 -47.18 82.17 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.518 -0.739 . . . . 0.0 110.221 179.865 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -48.41 -45.89 36.64 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.496 -0.753 . . . . 0.0 110.519 179.512 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 18.4 mm -73.62 -42.37 55.35 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 121.37 -0.831 . . . . 0.0 110.114 179.653 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 40.5 t -65.67 -34.99 74.12 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 121.465 -0.772 . . . . 0.0 110.401 179.786 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 72.9 m-20 -67.59 -16.55 64.24 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.488 -0.758 . . . . 0.0 110.595 179.239 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 64.6 t -104.05 -37.83 4.68 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.044 -1.035 . . . . 0.0 109.261 179.148 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 33.5 mt-30 -68.05 -36.8 80.47 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.606 -0.684 . . . . 0.0 110.923 179.963 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -61.61 -29.78 70.27 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.08 -1.013 . . . . 0.0 110.486 -179.986 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 5.6 tpt -103.31 18.69 21.2 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.354 -0.841 . . . . 0.0 110.731 179.375 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -105.16 15.24 27.82 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.017 -1.052 . . . . 0.0 111.29 -179.998 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 62.91 32.53 84.26 Favored Glycine 0 N--CA 1.497 2.738 0 N-CA-C 110.602 -0.999 . . . . 0.0 110.602 179.564 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -93.97 -42.76 8.88 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.322 -1.105 . . . . 0.0 110.23 179.813 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.589 ' HB2' ' HD3' ' A' ' 28' ' ' PRO . 48.2 m -57.03 -50.66 86.92 Favored Pre-proline 0 N--CA 1.497 1.913 0 O-C-N 121.738 -0.601 . . . . 0.0 110.915 179.881 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.589 ' HD3' ' HB2' ' A' ' 27' ' ' SER . 47.7 Cg_endo -71.3 -7.83 22.14 Favored 'Trans proline' 0 N--CA 1.491 1.362 0 O-C-N 123.421 1.221 . . . . 0.0 111.592 179.83 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -98.05 -39.29 9.0 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.199 -0.938 . . . . 0.0 110.357 179.944 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 49.4 mt -76.14 -35.4 28.39 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 O-C-N 121.389 -0.819 . . . . 0.0 110.71 -179.802 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 8.8 p -60.94 -37.46 82.42 Favored 'General case' 0 N--CA 1.501 2.122 0 O-C-N 121.441 -0.787 . . . . 0.0 110.336 179.747 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 26.9 mttt -89.86 13.69 13.9 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.392 -0.818 . . . . 0.0 110.617 179.273 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -108.03 -47.88 3.48 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.305 -0.872 . . . . 0.0 110.067 179.743 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 25.8 t -81.12 72.86 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 O-C-N 121.541 -0.725 . . . . 0.0 109.537 179.77 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 21.9 t -126.16 63.46 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 121.478 -0.763 . . . . 0.0 110.081 -179.617 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.498 1.941 0 CA-C-O 118.294 -0.86 . . . . 0.0 110.258 179.941 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 16.7 t . . . . . 0 N--CA 1.495 1.801 0 CA-C-O 121.121 0.486 . . . . 0.0 110.446 . . . . . . . . . 0 0 . 1 . 035 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -154.24 164.52 38.43 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.625 -0.672 . . . . 0.0 110.198 179.949 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.503 ' N ' ' HD3' ' A' ' 4' ' ' PRO . 0.4 OUTLIER 50.89 57.48 17.31 Favored Pre-proline 0 N--CA 1.502 2.133 0 O-C-N 121.746 -0.596 . . . . 0.0 111.106 179.917 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.503 ' HD3' ' N ' ' A' ' 3' ' ' LEU . 49.2 Cg_endo -81.82 59.68 7.25 Favored 'Trans proline' 0 C--N 1.312 -1.348 0 O-C-N 123.707 1.372 . . . . 0.0 110.753 -179.914 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -89.3 -26.46 21.12 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.323 -0.861 . . . . 0.0 110.634 179.803 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER 55.91 29.07 13.51 Favored 'General case' 0 N--CA 1.503 2.196 0 O-C-N 121.649 -0.657 . . . . 0.0 110.951 -179.919 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -167.22 43.56 0.05 OUTLIER 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.361 -0.837 . . . . 0.0 110.377 179.686 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.578 HG21 ' HB2' ' A' ' 12' ' ' HIS . 97.4 m -141.96 -93.48 0.13 Allowed 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.176 -0.952 . . . . 0.0 109.806 179.915 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 56.19 -105.21 0.44 Allowed Glycine 0 N--CA 1.498 2.792 0 N-CA-C 110.221 -1.151 . . . . 0.0 110.221 179.61 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 10.6 tp -58.73 -31.61 68.46 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.638 -0.919 . . . . 0.0 110.568 179.79 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 5.0 mp -56.91 -41.81 78.82 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.597 -0.689 . . . . 0.0 110.13 179.639 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . 0.578 ' HB2' HG21 ' A' ' 8' ' ' THR . 1.6 t-80 -80.05 -40.21 28.18 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.348 -0.845 . . . . 0.0 109.83 179.212 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.7 tt -60.49 -42.06 95.53 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.66 -0.65 . . . . 0.0 110.538 179.943 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 86.5 t60 -61.52 -51.37 68.89 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.479 -0.763 . . . . 0.0 110.281 179.95 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 12.2 tp60 -62.21 -30.23 70.94 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.341 -0.849 . . . . 0.0 110.011 179.436 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -66.52 -24.95 66.46 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.293 -0.879 . . . . 0.0 110.297 179.144 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 61.7 mt -101.39 -27.56 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 121.205 -0.935 . . . . 0.0 110.342 179.68 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.429 ' HA ' ' HE2' ' A' ' 22' ' ' TYR . 93.5 t -95.92 -13.23 8.26 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 O-C-N 121.383 -0.823 . . . . 0.0 111.142 -179.647 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.417 ' O ' ' HG2' ' A' ' 23' ' ' MET . 0.2 OUTLIER -120.15 38.48 3.95 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.033 -1.042 . . . . 0.0 110.553 179.836 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 40.1 t -140.09 -55.73 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 O-C-N 121.355 -0.841 . . . . 0.0 109.857 179.949 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -65.2 -14.33 60.39 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.755 -0.591 . . . . 0.0 110.417 179.149 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . 0.429 ' HE2' ' HA ' ' A' ' 18' ' ' VAL . 26.9 m-85 -102.36 -22.65 14.07 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.48 -0.763 . . . . 0.0 110.379 -179.424 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 23' ' ' MET . . . . . 0.417 ' HG2' ' O ' ' A' ' 19' ' ' ASP . 0.4 OUTLIER -96.93 -18.55 19.4 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.389 -0.819 . . . . 0.0 110.733 179.555 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -116.27 31.6 6.63 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.151 -0.968 . . . . 0.0 110.801 -179.887 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 149.92 76.79 0.02 OUTLIER Glycine 0 N--CA 1.494 2.548 0 N-CA-C 109.814 -1.314 . . . . 0.0 109.814 179.764 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -102.7 -2.03 28.95 Favored 'General case' 0 N--CA 1.499 2.025 0 O-C-N 121.494 -1.003 . . . . 0.0 111.306 179.821 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.504 ' N ' ' HD2' ' A' ' 28' ' ' PRO . 4.7 m -64.07 -52.19 57.47 Favored Pre-proline 0 N--CA 1.499 1.975 0 O-C-N 121.24 -0.912 . . . . 0.0 110.732 179.608 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.504 ' HD2' ' N ' ' A' ' 27' ' ' SER . 44.3 Cg_endo -71.27 -17.88 30.67 Favored 'Trans proline' 0 N--CA 1.489 1.207 0 O-C-N 123.413 1.217 . . . . 0.0 110.795 179.477 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -77.28 -28.19 53.36 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.454 -0.779 . . . . 0.0 110.263 179.547 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 89.6 mt -90.08 -29.07 4.96 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 121.3 -0.875 . . . . 0.0 110.605 179.961 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 32.6 p -65.02 -50.19 67.23 Favored 'General case' 0 N--CA 1.502 2.144 0 O-C-N 121.279 -0.888 . . . . 0.0 110.069 179.656 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.88 -17.04 64.36 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.447 -0.783 . . . . 0.0 110.439 179.226 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 81.8 t80 -82.18 -34.92 28.84 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.364 -0.835 . . . . 0.0 110.124 179.543 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 97.3 t -83.46 -41.2 16.66 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 121.465 -0.772 . . . . 0.0 110.338 -179.982 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.3 p -92.14 -11.01 9.55 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 O-C-N 121.299 -0.875 . . . . 0.0 111.17 179.934 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 8.9 ttp85 . . . . . 0 N--CA 1.504 2.226 0 CA-C-O 118.08 -0.962 . . . . 0.0 111.091 179.983 . . . . . . . . 0 0 . 1 . 036 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 50.0 m . . . . . 0 N--CA 1.495 1.778 0 CA-C-O 120.968 0.413 . . . . 0.0 110.144 . . . . . . . . . 0 0 . 1 . 036 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -130.09 161.86 30.09 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.603 -0.686 . . . . 0.0 110.212 -179.965 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER 57.81 78.1 0.38 Allowed Pre-proline 0 N--CA 1.499 2.006 0 O-C-N 121.758 -0.589 . . . . 0.0 110.35 -179.881 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -91.47 -161.8 0.1 OUTLIER 'Trans proline' 0 C--N 1.309 -1.512 0 C-N-CA 121.894 1.729 . . . . 0.0 110.524 -179.769 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -168.0 87.11 0.23 Allowed 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.47 -0.769 . . . . 0.0 109.709 179.94 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -98.31 26.88 5.04 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.54 -0.725 . . . . 0.0 111.149 -179.566 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 68.7 m 48.89 59.07 4.68 Favored 'General case' 0 N--CA 1.502 2.141 0 O-C-N 121.458 -0.776 . . . . 0.0 110.891 179.533 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 22.6 p -111.05 30.87 6.49 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.352 -0.842 . . . . 0.0 110.694 -179.837 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -100.95 -86.66 1.94 Allowed Glycine 0 N--CA 1.493 2.462 0 N-CA-C 108.951 -1.66 . . . . 0.0 108.951 179.838 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.1 mp -57.91 -37.52 74.2 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.651 -0.911 . . . . 0.0 110.111 179.501 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -57.14 -44.48 83.41 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.64 -0.663 . . . . 0.0 110.035 179.412 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 7.1 m170 -67.74 -43.76 79.18 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.582 -0.699 . . . . 0.0 110.227 179.636 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.2 tt -55.2 -44.42 75.31 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.646 -0.659 . . . . 0.0 110.456 179.956 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . 0.425 ' CD2' HG23 ' A' ' 18' ' ' VAL . 1.6 t-80 -60.35 -50.04 75.2 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.506 -0.746 . . . . 0.0 109.689 179.504 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 16.4 mm100 -64.69 -35.67 81.8 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.542 -0.724 . . . . 0.0 110.065 179.646 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -61.94 -38.06 87.05 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.576 -0.703 . . . . 0.0 110.6 179.658 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 24.1 mm -83.23 -45.17 18.86 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 O-C-N 121.37 -0.831 . . . . 0.0 110.341 -179.834 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.425 HG23 ' CD2' ' A' ' 14' ' ' HIS . 64.3 t -63.4 -35.69 73.29 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 O-C-N 121.497 -0.752 . . . . 0.0 110.712 -179.797 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -68.94 -24.84 64.32 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.385 -0.822 . . . . 0.0 110.733 -179.992 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 48.8 t -96.65 -36.98 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 120.968 -1.082 . . . . 0.0 109.494 179.327 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.1 -39.43 94.67 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.718 -0.614 . . . . 0.0 110.545 179.616 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . 0.434 ' CD1' ' C ' ' A' ' 22' ' ' TYR . 0.1 OUTLIER -66.46 -30.92 71.38 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.25 -0.907 . . . . 0.0 110.234 179.827 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 1.5 ttp -90.52 -31.55 16.7 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.345 -0.847 . . . . 0.0 110.972 -179.856 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 41.4 m-85 -102.59 25.66 8.85 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.179 -0.951 . . . . 0.0 111.157 -179.512 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -158.3 49.37 0.42 Allowed Glycine 0 N--CA 1.495 2.577 0 N-CA-C 109.995 -1.242 . . . . 0.0 109.995 179.746 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -128.29 29.46 5.34 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.37 -1.077 . . . . 0.0 110.505 179.828 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.559 ' HB2' ' HD3' ' A' ' 28' ' ' PRO . 0.7 OUTLIER -86.2 -49.85 0.51 Allowed Pre-proline 0 N--CA 1.5 2.049 0 O-C-N 121.453 -0.779 . . . . 0.0 111.268 -179.751 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.559 ' HD3' ' HB2' ' A' ' 27' ' ' SER . 50.5 Cg_endo -77.21 64.52 7.87 Favored 'Trans proline' 0 N--CA 1.487 1.13 0 O-C-N 123.395 1.208 . . . . 0.0 110.55 -179.635 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -167.34 -49.48 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.644 -0.66 . . . . 0.0 109.729 179.864 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 46.4 mm -79.11 -38.12 20.06 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 121.562 -0.711 . . . . 0.0 110.113 179.758 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 29.7 p -65.01 -45.29 86.16 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.522 -0.736 . . . . 0.0 109.979 179.59 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 24.7 mmtt -64.69 -27.68 69.08 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.644 -0.66 . . . . 0.0 110.221 179.385 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -69.14 -35.39 76.32 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.463 -0.773 . . . . 0.0 109.801 179.212 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.9 t -84.94 164.99 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 121.53 -0.731 . . . . 0.0 109.504 179.448 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 11.3 t 59.04 66.68 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.149 0 O-C-N 121.591 -0.693 . . . . 0.0 110.058 -179.867 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.778 0 CA-C-O 118.414 -0.803 . . . . 0.0 110.532 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 2.57 0 N-CA-C 109.807 -1.317 . . . . 0.0 109.807 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 12.6 mt -58.3 -40.71 82.7 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.683 -0.892 . . . . 0.0 110.465 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 5.1 tt -57.54 -50.42 73.14 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.49 -0.756 . . . . 0.0 109.943 179.602 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 8.6 m170 -61.06 -41.95 97.56 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.692 -0.63 . . . . 0.0 110.074 179.515 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 9.4 tp -58.12 -42.67 86.24 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.641 -0.662 . . . . 0.0 110.199 179.518 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' HIS . . . . . 0.505 ' CE1' HG21 ' A' ' 18' ' ' VAL . 74.7 t60 -61.02 -49.16 78.53 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.713 -0.617 . . . . 0.0 110.001 179.596 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 15.8 mm-40 -60.08 -37.82 81.06 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.505 -0.747 . . . . 0.0 110.267 179.677 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -62.28 -39.75 93.97 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.498 -0.751 . . . . 0.0 110.377 179.626 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 56.4 mt -79.65 -44.08 23.31 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 O-C-N 121.317 -0.864 . . . . 0.0 110.203 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.505 HG21 ' CE1' ' A' ' 14' ' ' HIS . 49.9 t -66.65 -17.91 23.31 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 O-C-N 121.558 -0.714 . . . . 0.0 111.134 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -98.53 -6.23 30.6 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.141 -0.974 . . . . 0.0 111.053 179.829 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 75.7 t . . . . . 0 N--CA 1.498 1.936 0 O-C-N 120.935 -1.103 . . . . 0.0 110.282 179.615 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.504 2.245 0 CA-C-O 120.981 0.419 . . . . 0.0 111.253 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.434 ' N ' ' HD2' ' A' ' 28' ' ' PRO . 0.0 OUTLIER -59.45 -57.02 30.05 Favored Pre-proline 0 N--CA 1.501 2.097 0 O-C-N 121.306 -0.871 . . . . 0.0 110.616 179.815 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.434 ' HD2' ' N ' ' A' ' 27' ' ' SER . 45.7 Cg_endo -71.52 -27.53 18.76 Favored 'Trans proline' 0 N--CA 1.487 1.114 0 O-C-N 123.485 1.255 . . . . 0.0 110.895 179.681 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.36 -52.51 61.41 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.446 -0.784 . . . . 0.0 110.746 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 34.8 mm -60.52 -35.85 66.0 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.12 0 O-C-N 121.411 -0.806 . . . . 0.0 110.559 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 73.4 m -61.11 -27.82 68.65 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.541 -0.724 . . . . 0.0 110.566 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.36 7.52 33.34 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.299 -0.876 . . . . 0.0 110.689 179.559 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -101.22 -39.31 7.7 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.36 -0.837 . . . . 0.0 110.161 179.716 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 92.2 t . . . . . 0 N--CA 1.496 1.856 0 O-C-N 121.445 -0.784 . . . . 0.0 110.367 179.828 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 2.685 0 N-CA-C 109.165 -1.574 . . . . 0.0 109.165 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 7.1 tp -81.73 -31.73 31.9 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.606 -0.938 . . . . 0.0 109.91 179.153 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -56.03 -47.59 77.56 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.535 -0.728 . . . . 0.0 110.256 179.73 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -57.36 -42.99 83.14 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.547 -0.721 . . . . 0.0 110.036 179.46 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.1 tt -60.96 -41.46 96.38 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.676 -0.64 . . . . 0.0 110.224 179.451 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' HIS . . . . . 0.607 ' NE2' HG21 ' A' ' 18' ' ' VAL . 67.9 t60 -60.8 -50.23 74.3 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.399 -0.813 . . . . 0.0 109.721 179.408 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 51.8 mm-40 -58.56 -35.89 73.08 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.531 -0.731 . . . . 0.0 110.007 179.382 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -58.54 -36.11 73.37 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.621 -0.674 . . . . 0.0 110.133 179.234 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.579 ' O ' HG12 ' A' ' 20' ' ' VAL . 7.4 mt -88.17 -31.81 5.83 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 O-C-N 121.515 -0.741 . . . . 0.0 109.96 179.502 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.607 HG21 ' NE2' ' A' ' 14' ' ' HIS . 54.9 t -68.6 -37.38 77.57 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 121.378 -0.826 . . . . 0.0 110.301 179.855 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -82.95 4.43 25.87 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.563 -0.71 . . . . 0.0 111.471 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.579 HG12 ' O ' ' A' ' 17' ' ' ILE . 0.8 OUTLIER . . . . . 0 N--CA 1.498 1.955 0 O-C-N 120.737 -1.227 . . . . 0.0 110.653 179.373 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.501 2.085 0 CA-C-O 121.1 0.476 . . . . 0.0 110.675 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.44 ' HB2' ' HD3' ' A' ' 28' ' ' PRO . 1.2 m -77.82 -51.77 1.73 Allowed Pre-proline 0 N--CA 1.497 1.913 0 O-C-N 121.297 -0.877 . . . . 0.0 111.064 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.44 ' HD3' ' HB2' ' A' ' 27' ' ' SER . 49.5 Cg_endo -76.93 61.43 7.12 Favored 'Trans proline' 0 N--CA 1.487 1.13 0 O-C-N 123.446 1.235 . . . . 0.0 110.317 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -167.35 -51.9 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.515 -0.741 . . . . 0.0 109.944 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 80.3 mt -68.35 -24.99 30.32 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 O-C-N 121.535 -0.728 . . . . 0.0 110.22 179.497 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 19.5 p -65.98 -41.83 90.63 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.448 -0.782 . . . . 0.0 110.211 179.471 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 5.9 tmtt? -70.2 -10.82 60.04 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.549 -0.72 . . . . 0.0 110.935 179.787 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 8.6 t80 -70.24 -43.25 70.97 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.316 -0.865 . . . . 0.0 110.361 179.757 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.501 HG12 ' O ' ' A' ' 34' ' ' VAL . 38.8 t . . . . . 0 N--CA 1.498 1.936 0 O-C-N 121.35 -0.844 . . . . 0.0 110.263 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.331 0 N-CA-C 108.49 -1.844 . . . . 0.0 108.49 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 7.4 mt -81.09 -35.57 31.52 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.67 -0.9 . . . . 0.0 109.878 179.192 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 2.5 tt -59.21 -42.9 92.03 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.633 -0.667 . . . . 0.0 110.069 179.507 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -76.35 -33.21 58.97 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.524 -0.735 . . . . 0.0 110.105 179.429 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.402 HD22 ' HA ' ' A' ' 13' ' ' LEU . 0.1 OUTLIER -57.09 -47.72 80.34 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.445 -0.784 . . . . 0.0 110.472 179.912 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 14' ' ' HIS . . . . . 0.416 ' CE1' HG21 ' A' ' 18' ' ' VAL . 77.4 t60 -61.39 -52.21 65.55 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.381 -0.824 . . . . 0.0 109.823 179.625 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 4.3 tp-100 -60.02 -37.63 80.31 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.523 -0.735 . . . . 0.0 110.222 179.542 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -62.43 -39.42 93.27 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.573 -0.704 . . . . 0.0 110.665 179.676 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 76.5 mt -81.6 -41.82 18.97 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 O-C-N 121.166 -0.959 . . . . 0.0 110.29 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.416 HG21 ' CE1' ' A' ' 14' ' ' HIS . 76.8 t -65.26 -44.83 94.97 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 O-C-N 121.392 -0.818 . . . . 0.0 110.439 -179.901 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -65.73 -16.11 63.47 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.742 -0.599 . . . . 0.0 111.46 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 94.9 t . . . . . 0 N--CA 1.494 1.757 0 O-C-N 120.74 -1.225 . . . . 0.0 109.86 179.495 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 10.6 mt . . . . . 0 N--CA 1.503 2.195 0 CA-C-O 121.079 0.466 . . . . 0.0 111.105 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.632 ' HB2' ' HD3' ' A' ' 28' ' ' PRO . 2.2 m -59.29 -56.28 37.57 Favored Pre-proline 0 N--CA 1.497 1.887 0 O-C-N 121.277 -0.89 . . . . 0.0 110.592 -179.851 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.632 ' HD3' ' HB2' ' A' ' 27' ' ' SER . 53.2 Cg_endo -80.42 53.87 4.96 Favored 'Trans proline' 0 N--CA 1.485 1.018 0 O-C-N 123.386 1.203 . . . . 0.0 110.434 179.329 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -155.44 -54.11 0.09 Allowed 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.304 -0.873 . . . . 0.0 110.029 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 10.0 mt -79.48 -32.17 14.54 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 O-C-N 121.415 -0.803 . . . . 0.0 110.439 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 16.1 m -61.17 -38.59 87.02 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.553 -0.717 . . . . 0.0 110.333 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 2.1 pttt -93.2 18.37 9.56 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.467 -0.77 . . . . 0.0 110.606 179.394 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -113.39 -50.02 2.88 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.265 -0.897 . . . . 0.0 109.952 179.773 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 74.0 t . . . . . 0 N--CA 1.497 1.895 0 O-C-N 121.479 -0.763 . . . . 0.0 109.893 179.728 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 2.64 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -58.48 -35.24 71.89 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.682 -0.893 . . . . 0.0 110.207 179.629 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 4.8 tt -57.18 -46.28 82.96 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.471 -0.768 . . . . 0.0 109.965 179.464 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 22.3 m-70 -68.44 -42.73 78.43 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.527 -0.733 . . . . 0.0 109.877 179.449 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -60.35 -38.79 84.95 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.63 -0.669 . . . . 0.0 109.778 179.225 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' HIS . . . . . 0.519 ' NE2' HG21 ' A' ' 18' ' ' VAL . 71.5 t60 -63.9 -52.72 58.61 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.627 -0.671 . . . . 0.0 109.624 179.255 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 29.9 tp60 -54.65 -39.04 67.61 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.697 -0.627 . . . . 0.0 110.149 179.559 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.614 ' O ' HG23 ' A' ' 20' ' ' VAL . 1.8 t30 -58.12 -49.07 78.25 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.554 -0.717 . . . . 0.0 110.327 179.558 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 29.2 mt -72.09 -33.47 47.11 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.073 0 O-C-N 121.449 -0.782 . . . . 0.0 110.226 179.714 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.519 HG21 ' NE2' ' A' ' 14' ' ' HIS . 73.5 t -75.69 -10.92 13.84 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.093 0 O-C-N 121.51 -0.744 . . . . 0.0 111.086 179.825 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -111.49 20.96 16.7 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.892 -1.13 . . . . 0.0 110.674 179.886 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.614 HG23 ' O ' ' A' ' 16' ' ' ASN . 73.0 t . . . . . 0 N--CA 1.497 1.896 0 O-C-N 121.139 -0.976 . . . . 0.0 109.721 179.481 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.1 mp . . . . . 0 N--CA 1.496 1.827 0 CA-C-O 120.798 0.333 . . . . 0.0 110.925 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.508 ' N ' ' HD2' ' A' ' 28' ' ' PRO . 0.8 OUTLIER -56.62 -52.8 70.73 Favored Pre-proline 0 N--CA 1.498 1.947 0 O-C-N 121.3 -0.875 . . . . 0.0 110.486 179.528 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.508 ' HD2' ' N ' ' A' ' 27' ' ' SER . 45.8 Cg_endo -71.79 -26.7 18.85 Favored 'Trans proline' 0 N--CA 1.488 1.185 0 O-C-N 123.53 1.279 . . . . 0.0 110.789 179.314 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -71.09 -33.52 70.27 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.495 -0.753 . . . . 0.0 110.507 179.736 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -84.97 -11.25 11.52 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 O-C-N 121.269 -0.894 . . . . 0.0 110.976 179.851 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 24.0 p -101.8 -38.89 7.65 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.08 -1.013 . . . . 0.0 110.532 179.812 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 2.1 tptt -90.23 39.11 0.95 Allowed 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.378 -0.826 . . . . 0.0 110.574 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -149.55 -49.93 0.14 Allowed 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.34 -0.85 . . . . 0.0 109.882 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 16.1 t . . . . . 0 N--CA 1.495 1.81 0 CA-C-O 121.416 0.627 . . . . 0.0 109.668 179.847 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.555 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 2.1 pp -66.64 -31.15 71.64 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.58 -0.953 . . . . 0.0 110.597 179.791 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.92 -44.31 93.28 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.202 -0.936 . . . . 0.0 109.973 179.663 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 5.5 m80 -70.34 -37.1 74.61 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.516 -0.74 . . . . 0.0 109.942 179.337 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.9 tp -59.6 -40.12 86.43 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.532 -0.73 . . . . 0.0 110.561 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' HIS . . . . . 0.412 ' CD2' HG21 ' A' ' 18' ' ' VAL . 3.3 t-80 -54.74 -51.91 64.17 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.611 -0.68 . . . . 0.0 109.958 179.771 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 12.1 tp-100 -62.63 -32.31 73.31 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.48 -0.763 . . . . 0.0 110.507 179.772 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -72.12 -47.68 49.41 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.314 -0.866 . . . . 0.0 110.559 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 39.0 mm -71.65 -40.41 70.64 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 O-C-N 121.408 -0.808 . . . . 0.0 110.429 -179.772 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.412 HG21 ' CD2' ' A' ' 14' ' ' HIS . 38.3 t -62.19 -30.1 48.06 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 O-C-N 121.36 -0.838 . . . . 0.0 110.199 179.771 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -76.8 -15.65 59.68 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.503 -0.748 . . . . 0.0 110.85 179.382 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 92.7 t . . . . . 0 N--CA 1.494 1.742 0 O-C-N 121.057 -1.027 . . . . 0.0 109.884 179.618 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.3 mp . . . . . 0 N--CA 1.495 1.812 0 CA-C-O 120.681 0.277 . . . . 0.0 111.195 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.625 ' HB3' ' HD3' ' A' ' 28' ' ' PRO . 0.5 OUTLIER -62.81 -53.37 56.71 Favored Pre-proline 0 N--CA 1.498 1.931 0 O-C-N 121.154 -0.966 . . . . 0.0 110.374 179.474 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.782 ' HA ' HG22 ' A' ' 31' ' ' THR . 45.7 Cg_endo -73.07 -31.33 9.81 Favored 'Trans proline' 0 N--CA 1.487 1.122 0 O-C-N 123.491 1.259 . . . . 0.0 110.69 179.681 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.55 -24.48 67.54 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.618 -0.676 . . . . 0.0 111.279 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 47.5 mm -105.63 -30.11 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 O-C-N 121.113 -0.992 . . . . 0.0 111.119 -179.62 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.782 HG22 ' HA ' ' A' ' 28' ' ' PRO . 4.8 t -85.17 -30.97 23.51 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.159 -0.963 . . . . 0.0 110.867 -179.796 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.3 tttt -89.4 10.88 20.92 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.193 -0.942 . . . . 0.0 110.979 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 6.8 m-85 -114.07 -38.43 4.17 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.105 -0.997 . . . . 0.0 110.539 179.833 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 60.8 t . . . . . 0 N--CA 1.494 1.728 0 O-C-N 121.312 -0.867 . . . . 0.0 109.696 179.852 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 2.673 0 N-CA-C 109.272 -1.531 . . . . 0.0 109.272 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.463 ' HA ' HD13 ' A' ' 10' ' ' LEU . 0.4 OUTLIER -63.09 -35.64 80.95 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.652 -0.91 . . . . 0.0 109.972 179.371 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -56.98 -48.19 79.01 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.53 -0.731 . . . . 0.0 109.87 179.378 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 7.1 m-70 -63.88 -39.36 94.0 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.715 -0.616 . . . . 0.0 109.738 179.129 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 9.1 tp -58.96 -41.87 88.53 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.64 -0.663 . . . . 0.0 110.109 179.333 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' HIS . . . . . 0.531 ' NE2' HG21 ' A' ' 18' ' ' VAL . 5.7 t-160 -62.16 -52.04 65.43 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.543 -0.723 . . . . 0.0 109.258 179.149 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 27.3 tp60 -58.72 -36.53 74.43 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.625 -0.672 . . . . 0.0 110.021 179.186 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -61.73 -45.31 94.48 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.643 -0.661 . . . . 0.0 110.474 179.731 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.462 ' O ' HG12 ' A' ' 20' ' ' VAL . 38.8 mt -73.27 -37.5 52.03 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.018 0 O-C-N 121.352 -0.842 . . . . 0.0 109.84 179.637 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.531 HG21 ' NE2' ' A' ' 14' ' ' HIS . 54.8 t -75.73 -3.92 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 O-C-N 121.475 -0.766 . . . . 0.0 110.658 179.473 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -120.79 5.41 10.49 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.188 -0.945 . . . . 0.0 110.57 179.136 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.462 HG12 ' O ' ' A' ' 17' ' ' ILE . 5.5 p . . . . . 0 N--CA 1.499 1.999 0 O-C-N 120.905 -1.122 . . . . 0.0 110.866 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.504 2.228 0 CA-C-O 121.088 0.47 . . . . 0.0 111.231 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.488 ' CB ' ' CD ' ' A' ' 28' ' ' PRO . 0.5 OUTLIER -99.21 -63.98 0.08 OUTLIER Pre-proline 0 N--CA 1.497 1.887 0 O-C-N 121.184 -0.947 . . . . 0.0 110.571 179.69 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.488 ' CD ' ' CB ' ' A' ' 27' ' ' SER . 41.8 Cg_endo -67.66 -25.04 40.69 Favored 'Trans proline' 0 N--CA 1.489 1.235 0 O-C-N 123.222 1.117 . . . . 0.0 110.876 179.812 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.76 -32.16 73.54 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.37 -0.831 . . . . 0.0 110.312 179.292 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 97.1 mt -99.68 -42.34 10.38 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 121.501 -0.749 . . . . 0.0 110.035 179.675 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 62.8 m -63.88 -38.24 90.38 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.665 -0.647 . . . . 0.0 110.612 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 13.2 tttt -89.31 15.29 9.29 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.231 -0.918 . . . . 0.0 110.68 179.558 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 9.7 t80 -106.63 -44.09 4.56 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.296 -0.877 . . . . 0.0 110.019 179.754 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.9 t . . . . . 0 N--CA 1.496 1.862 0 O-C-N 121.383 -0.823 . . . . 0.0 109.734 179.805 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.427 0 N-CA-C 109.032 -1.627 . . . . 0.0 109.032 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.5 mt -62.8 -41.99 99.52 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.616 -0.932 . . . . 0.0 110.17 179.665 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 15.6 tp -59.45 -43.61 93.15 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.464 -0.772 . . . . 0.0 109.814 179.378 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 6.9 m170 -65.35 -44.94 86.08 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.628 -0.67 . . . . 0.0 109.748 179.271 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.91 -33.91 76.62 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.472 -0.767 . . . . 0.0 109.969 179.31 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' HIS . . . . . 0.517 ' NE2' HG21 ' A' ' 18' ' ' VAL . 8.1 t-160 -63.0 -51.7 65.84 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.625 -0.672 . . . . 0.0 109.88 179.549 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.46 ' O ' ' HB2' ' A' ' 19' ' ' ASP . 0.3 OUTLIER -61.75 -36.03 79.81 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.496 -0.752 . . . . 0.0 109.993 179.497 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -59.36 -43.61 92.81 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.473 -0.767 . . . . 0.0 110.289 179.445 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.503 ' O ' HG12 ' A' ' 20' ' ' VAL . 61.1 mt -81.87 -26.25 9.58 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.925 0 O-C-N 121.395 -0.816 . . . . 0.0 110.624 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.517 HG21 ' NE2' ' A' ' 14' ' ' HIS . 49.7 t -85.65 -7.44 10.92 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 121.031 -1.043 . . . . 0.0 110.693 179.79 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.46 ' HB2' ' O ' ' A' ' 15' ' ' GLN . 0.5 OUTLIER -122.53 32.24 5.83 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.101 -0.999 . . . . 0.0 109.667 178.896 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.503 HG12 ' O ' ' A' ' 17' ' ' ILE . 13.0 p . . . . . 0 N--CA 1.5 2.052 0 O-C-N 121.416 -0.802 . . . . 0.0 110.646 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.6 mp . . . . . 0 N--CA 1.502 2.148 0 CA-C-O 120.827 0.346 . . . . 0.0 111.549 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.473 ' N ' ' HD2' ' A' ' 28' ' ' PRO . 1.4 m -69.88 -55.43 8.73 Favored Pre-proline 0 N--CA 1.498 1.939 0 O-C-N 121.113 -0.992 . . . . 0.0 110.27 179.333 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.473 ' HD2' ' N ' ' A' ' 27' ' ' SER . 45.6 Cg_endo -71.61 -20.23 27.07 Favored 'Trans proline' 0 N--CA 1.487 1.1 0 O-C-N 123.451 1.237 . . . . 0.0 110.681 179.182 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -70.85 -37.89 73.16 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.48 -0.763 . . . . 0.0 110.216 179.585 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 28.5 mm -74.35 -39.93 49.2 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 O-C-N 121.518 -0.739 . . . . 0.0 110.061 179.625 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 44.9 p -69.22 -39.48 78.53 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.381 -0.825 . . . . 0.0 110.206 179.692 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 26.9 mmtt -71.91 -29.77 64.67 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.428 -0.795 . . . . 0.0 110.638 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 92.4 t80 -86.44 -47.4 9.34 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.399 -0.813 . . . . 0.0 110.319 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 47.2 t . . . . . 0 N--CA 1.496 1.865 0 O-C-N 121.448 -0.783 . . . . 0.0 109.831 -179.894 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.376 0 N-CA-C 108.626 -1.789 . . . . 0.0 108.626 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 8.9 tp -73.49 -36.82 65.85 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.648 -0.913 . . . . 0.0 109.876 179.335 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 11.5 tp -64.56 -44.1 91.82 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.377 -0.827 . . . . 0.0 109.839 179.506 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -63.76 -42.92 97.73 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.59 -0.693 . . . . 0.0 109.832 179.443 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 5.2 tp -63.88 -40.72 97.19 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.542 -0.724 . . . . 0.0 110.238 179.505 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' HIS . . . . . 0.497 ' NE2' HG21 ' A' ' 18' ' ' VAL . 7.3 t-80 -57.4 -54.22 49.33 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.643 -0.661 . . . . 0.0 109.922 179.685 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.447 ' O ' ' HB2' ' A' ' 19' ' ' ASP . 19.5 tp60 -55.57 -40.14 71.6 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.672 -0.642 . . . . 0.0 110.089 179.577 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -66.67 -40.8 88.75 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.348 -0.845 . . . . 0.0 110.68 179.686 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.413 ' O ' HG12 ' A' ' 20' ' ' VAL . 85.6 mt -77.07 -21.53 14.5 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 O-C-N 121.395 -0.816 . . . . 0.0 110.858 -179.81 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.497 HG21 ' NE2' ' A' ' 14' ' ' HIS . 24.3 t -93.16 -33.61 5.43 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 O-C-N 121.205 -0.934 . . . . 0.0 110.082 179.828 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.447 ' HB2' ' O ' ' A' ' 15' ' ' GLN . 2.4 m-20 -87.75 28.84 0.96 Allowed 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.278 -0.889 . . . . 0.0 110.439 179.271 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.413 HG12 ' O ' ' A' ' 17' ' ' ILE . 12.5 p . . . . . 0 N--CA 1.495 1.825 0 O-C-N 121.242 -0.911 . . . . 0.0 110.344 179.577 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.495 1.807 0 CA-C-O 121.106 0.479 . . . . 0.0 110.192 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.404 ' CB ' ' HD3' ' A' ' 28' ' ' PRO . 0.4 OUTLIER -60.28 -54.34 56.1 Favored Pre-proline 0 N--CA 1.498 1.939 0 O-C-N 121.397 -0.814 . . . . 0.0 110.656 -179.909 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.404 ' HD3' ' CB ' ' A' ' 27' ' ' SER . 49.9 Cg_endo -77.61 55.32 5.13 Favored 'Trans proline' 0 N--CA 1.487 1.119 0 O-C-N 123.393 1.207 . . . . 0.0 110.318 179.473 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -162.74 -49.18 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.59 -0.694 . . . . 0.0 109.78 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 21.8 mt -83.13 -34.1 10.87 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 121.624 -0.673 . . . . 0.0 110.224 179.592 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 43.7 m -61.6 -43.35 99.03 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.568 -0.707 . . . . 0.0 109.931 179.48 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.8 tttp -70.51 -23.52 62.67 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.549 -0.719 . . . . 0.0 110.496 179.332 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -75.43 -27.58 59.03 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.415 -0.803 . . . . 0.0 110.365 179.646 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 57.9 t . . . . . 0 N--CA 1.497 1.884 0 O-C-N 121.269 -0.895 . . . . 0.0 110.543 -179.749 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.503 0 N-CA-C 109.275 -1.53 . . . . 0.0 109.275 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 8.0 tp -66.74 -32.03 73.06 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.577 -0.955 . . . . 0.0 110.237 179.475 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.415 HD22 ' HA ' ' A' ' 11' ' ' LEU . 0.1 OUTLIER -58.19 -43.09 87.39 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.45 -0.781 . . . . 0.0 110.024 179.551 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -59.02 -43.75 91.61 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.6 -0.688 . . . . 0.0 109.696 179.29 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.2 tt -61.99 -38.39 88.42 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.751 -0.593 . . . . 0.0 110.057 179.207 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' HIS . . . . . 0.591 ' NE2' HG21 ' A' ' 18' ' ' VAL . 2.8 t-80 -61.38 -52.85 62.92 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.517 -0.74 . . . . 0.0 109.745 179.4 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.406 ' O ' ' HB2' ' A' ' 19' ' ' ASP . 3.3 tp-100 -59.96 -36.35 76.9 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.516 -0.74 . . . . 0.0 110.227 179.669 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 9.9 t30 -59.48 -34.04 72.08 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.533 -0.729 . . . . 0.0 110.475 179.471 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.467 ' O ' HG12 ' A' ' 20' ' ' VAL . 38.0 mt -94.4 -36.84 7.38 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 121.398 -0.814 . . . . 0.0 110.317 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.591 HG21 ' NE2' ' A' ' 14' ' ' HIS . 92.0 t -74.2 -7.83 10.59 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.086 0 O-C-N 121.343 -0.848 . . . . 0.0 111.011 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.406 ' HB2' ' O ' ' A' ' 15' ' ' GLN . 1.0 OUTLIER -119.83 8.08 11.07 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.167 -0.958 . . . . 0.0 110.809 179.434 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.467 HG12 ' O ' ' A' ' 17' ' ' ILE . 9.2 p . . . . . 0 N--CA 1.498 1.959 0 O-C-N 120.982 -1.074 . . . . 0.0 110.874 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.0 mp . . . . . 0 N--CA 1.495 1.823 0 CA-C-O 121.311 0.577 . . . . 0.0 109.891 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.621 ' HB3' ' HD3' ' A' ' 28' ' ' PRO . 4.6 t -53.27 -55.82 30.44 Favored Pre-proline 0 N--CA 1.497 1.892 0 O-C-N 121.625 -0.672 . . . . 0.0 110.645 -179.881 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.621 ' HD3' ' HB3' ' A' ' 27' ' ' SER . 52.3 Cg_endo -77.37 59.27 6.6 Favored 'Trans proline' 0 N--CA 1.487 1.114 0 O-C-N 123.448 1.236 . . . . 0.0 110.075 179.247 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -167.87 -50.07 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.533 -0.73 . . . . 0.0 110.001 -179.725 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 15.6 mt -78.43 -33.71 17.56 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 O-C-N 121.483 -0.761 . . . . 0.0 110.299 179.789 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 7.9 p -61.33 -39.62 91.2 Favored 'General case' 0 N--CA 1.5 2.025 0 O-C-N 121.703 -0.623 . . . . 0.0 110.301 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -91.77 19.51 6.43 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.344 -0.848 . . . . 0.0 110.493 179.272 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 71.3 t80 -115.5 -47.03 2.84 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.366 -0.834 . . . . 0.0 109.989 179.862 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 59.5 t . . . . . 0 N--CA 1.497 1.879 0 O-C-N 121.341 -0.85 . . . . 0.0 109.845 179.838 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.469 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -62.21 -47.2 85.51 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.632 -0.922 . . . . 0.0 110.609 -179.832 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -58.58 -51.62 69.13 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.487 -0.758 . . . . 0.0 110.2 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -62.74 -40.82 98.41 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.653 -0.654 . . . . 0.0 110.037 179.558 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.7 tt -56.88 -42.2 79.39 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.642 -0.661 . . . . 0.0 110.13 179.588 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 7.2 t-80 -60.81 -49.07 78.98 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.521 -0.737 . . . . 0.0 109.799 179.412 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.457 ' O ' ' HB2' ' A' ' 19' ' ' ASP . 17.8 mm-40 -67.17 -36.17 81.24 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.544 -0.722 . . . . 0.0 109.76 179.318 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -63.68 -18.32 63.87 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.501 -0.749 . . . . 0.0 110.905 179.487 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 87.2 mt -104.74 -46.53 9.47 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.082 -1.011 . . . . 0.0 109.908 179.859 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 54.0 t -71.21 -36.73 63.4 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 O-C-N 121.403 -0.811 . . . . 0.0 110.969 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.457 ' HB2' ' O ' ' A' ' 15' ' ' GLN . 0.3 OUTLIER -86.55 -1.94 58.06 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.398 -0.814 . . . . 0.0 111.41 -179.537 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 70.6 t . . . . . 0 N--CA 1.495 1.804 0 O-C-N 120.83 -1.169 . . . . 0.0 109.78 179.354 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.544 ' HB3' ' HB3' ' A' ' 29' ' ' ALA . 3.4 mp . . . . . 0 N--CA 1.501 2.086 0 CA-C-O 121.156 0.503 . . . . 0.0 110.818 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.483 ' HB2' ' HD3' ' A' ' 28' ' ' PRO . 3.1 m -56.18 -55.09 45.6 Favored Pre-proline 0 N--CA 1.499 1.998 0 O-C-N 121.527 -0.733 . . . . 0.0 111.094 -179.726 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.483 ' HD3' ' HB2' ' A' ' 27' ' ' SER . 46.3 Cg_endo -72.2 -27.06 17.13 Favored 'Trans proline' 0 N--CA 1.489 1.217 0 O-C-N 123.398 1.209 . . . . 0.0 111.068 179.827 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.544 ' HB3' ' HB3' ' A' ' 26' ' ' LEU . . . -72.87 -39.98 66.01 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.417 -0.802 . . . . 0.0 110.633 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 5.7 tt -79.49 -11.63 13.02 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 O-C-N 121.341 -0.849 . . . . 0.0 111.467 -179.691 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 23.3 p -101.0 -37.19 8.73 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.099 -1.001 . . . . 0.0 110.537 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 6.9 tptp -91.6 45.93 1.26 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.267 -0.896 . . . . 0.0 109.964 179.672 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -146.91 -53.59 0.23 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.549 -0.719 . . . . 0.0 109.739 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.498 HG12 ' O ' ' A' ' 34' ' ' VAL . 49.0 t . . . . . 0 N--CA 1.496 1.874 0 O-C-N 121.443 -0.786 . . . . 0.0 109.75 179.612 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.548 0 N-CA-C 109.841 -1.304 . . . . 0.0 109.841 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -57.71 -38.54 75.44 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.65 -0.912 . . . . 0.0 110.8 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -56.82 -51.05 70.48 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.497 -0.752 . . . . 0.0 110.371 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 3.8 t60 -75.56 -30.8 59.79 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.284 -0.885 . . . . 0.0 110.103 179.39 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 61.1 tp -55.3 -41.88 72.94 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.472 -0.768 . . . . 0.0 109.962 179.578 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' HIS . . . . . 0.406 ' NE2' HG21 ' A' ' 18' ' ' VAL . 2.6 t-80 -61.92 -46.44 89.32 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.608 -0.682 . . . . 0.0 109.665 179.222 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 28.3 mm-40 -60.51 -37.48 81.27 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.658 -0.651 . . . . 0.0 110.093 179.587 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -67.78 -47.98 67.61 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.548 -0.72 . . . . 0.0 110.386 179.651 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 74.8 mt -65.45 -48.57 82.49 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.99 0 O-C-N 121.393 -0.817 . . . . 0.0 109.991 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.406 HG21 ' NE2' ' A' ' 14' ' ' HIS . 27.2 t -61.97 -31.92 52.69 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 O-C-N 121.437 -0.789 . . . . 0.0 109.938 179.549 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -63.95 -25.4 68.12 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.631 -0.668 . . . . 0.0 109.963 178.929 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 61.2 t . . . . . 0 N--CA 1.491 1.624 0 O-C-N 121.107 -0.996 . . . . 0.0 109.479 179.036 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.593 HD13 ' HB3' ' A' ' 29' ' ' ALA . 1.2 mm? . . . . . 0 N--CA 1.502 2.17 0 CA-C-O 120.907 0.384 . . . . 0.0 111.254 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.479 ' N ' ' HD2' ' A' ' 28' ' ' PRO . 1.4 m -80.57 -54.82 0.77 Allowed Pre-proline 0 N--CA 1.498 1.958 0 O-C-N 121.238 -0.913 . . . . 0.0 110.801 179.796 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.479 ' HD2' ' N ' ' A' ' 27' ' ' SER . 43.8 Cg_endo -70.14 -11.83 31.06 Favored 'Trans proline' 0 N--CA 1.49 1.275 0 O-C-N 123.259 1.136 . . . . 0.0 111.172 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.593 ' HB3' HD13 ' A' ' 26' ' ' LEU . . . -90.21 -27.34 19.6 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.248 -0.907 . . . . 0.0 110.366 179.454 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 43.4 mm -104.77 -45.26 9.01 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 121.315 -0.866 . . . . 0.0 110.325 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 23.9 m -70.39 -34.55 72.69 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.602 -0.686 . . . . 0.0 110.84 -179.775 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 6.6 tttp -89.9 16.63 7.85 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.085 -1.009 . . . . 0.0 110.684 179.428 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -109.4 -40.88 4.77 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.292 -0.88 . . . . 0.0 109.987 179.496 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 87.2 t . . . . . 0 N--CA 1.496 1.837 0 O-C-N 121.437 -0.789 . . . . 0.0 110.018 179.848 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.41 0 N-CA-C 108.724 -1.751 . . . . 0.0 108.724 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.62 -39.08 93.47 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.649 -0.912 . . . . 0.0 109.738 179.141 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -58.31 -47.81 82.5 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.699 -0.625 . . . . 0.0 109.585 179.132 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 20.1 t-160 -67.81 -45.01 75.95 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.736 -0.602 . . . . 0.0 109.844 179.357 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 11.8 tp -57.25 -41.84 80.37 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.558 -0.714 . . . . 0.0 110.035 179.534 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' HIS . . . . . 0.544 ' NE2' HG21 ' A' ' 18' ' ' VAL . 6.6 t-80 -61.06 -47.03 88.24 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.624 -0.672 . . . . 0.0 109.826 179.436 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 33.9 tp60 -55.88 -45.28 78.61 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.639 -0.663 . . . . 0.0 110.252 179.71 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.596 ' O ' HG23 ' A' ' 20' ' ' VAL . 9.5 t-20 -63.74 -52.36 60.79 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.326 -0.859 . . . . 0.0 110.732 179.773 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 83.5 mt -57.75 -43.48 84.02 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.119 0 O-C-N 121.345 -0.847 . . . . 0.0 110.374 -179.737 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.544 HG21 ' NE2' ' A' ' 14' ' ' HIS . 17.9 t -71.51 -32.54 46.47 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 O-C-N 121.394 -0.816 . . . . 0.0 110.138 179.579 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -73.01 -10.91 60.3 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.423 -0.798 . . . . 0.0 110.991 179.591 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.596 HG23 ' O ' ' A' ' 16' ' ' ASN . 61.6 t . . . . . 0 N--CA 1.493 1.707 0 O-C-N 120.832 -1.167 . . . . 0.0 109.925 179.487 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.5 2.038 0 CA-C-O 120.861 0.363 . . . . 0.0 111.019 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.503 ' HB2' ' HD3' ' A' ' 28' ' ' PRO . 4.7 m -74.56 -52.75 3.65 Favored Pre-proline 0 N--CA 1.499 1.977 0 O-C-N 121.142 -0.974 . . . . 0.0 111.243 -179.816 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.503 ' HD3' ' HB2' ' A' ' 27' ' ' SER . 44.9 Cg_endo -71.52 -9.65 25.48 Favored 'Trans proline' 0 N--CA 1.49 1.322 0 O-C-N 123.429 1.226 . . . . 0.0 111.243 179.855 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -94.03 -9.09 37.92 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.333 -0.854 . . . . 0.0 110.662 179.595 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 33.8 mm -118.03 -37.12 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 O-C-N 121.176 -0.952 . . . . 0.0 110.48 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 13.4 t -63.52 -24.43 67.81 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 121.349 -0.844 . . . . 0.0 111.252 -179.901 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 24.9 mmtt -99.12 -2.82 36.03 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.236 -0.915 . . . . 0.0 111.125 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 34.6 m-85 -107.94 0.29 21.86 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.313 -0.867 . . . . 0.0 111.16 -179.782 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 47.1 t . . . . . 0 N--CA 1.496 1.845 0 O-C-N 121.14 -0.975 . . . . 0.0 109.938 -179.979 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.432 0 N-CA-C 108.417 -1.873 . . . . 0.0 108.417 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -77.17 -34.87 56.32 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.549 -0.971 . . . . 0.0 109.754 178.924 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 5.6 tp -62.98 -44.63 95.52 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.443 -0.785 . . . . 0.0 109.969 179.49 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -64.05 -39.24 93.64 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.575 -0.703 . . . . 0.0 109.996 179.472 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.4 tp -68.42 -34.96 76.94 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.47 -0.769 . . . . 0.0 110.366 179.659 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' HIS . . . . . 0.491 ' CD2' HG21 ' A' ' 18' ' ' VAL . 12.5 t-80 -59.77 -61.82 2.33 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.316 -0.865 . . . . 0.0 109.575 179.504 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.45 ' O ' ' HB2' ' A' ' 19' ' ' ASP . 2.8 tp60 -59.2 -26.44 64.84 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.388 -0.82 . . . . 0.0 110.639 179.492 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.613 ' O ' HG23 ' A' ' 20' ' ' VAL . 1.6 t30 -78.02 -42.63 31.9 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.3 -0.875 . . . . 0.0 110.722 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.406 ' O ' ' HB ' ' A' ' 20' ' ' VAL . 83.7 mt -82.69 -36.48 13.36 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.002 0 O-C-N 121.226 -0.921 . . . . 0.0 110.647 -179.646 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.491 HG21 ' CD2' ' A' ' 14' ' ' HIS . 48.1 t -64.67 -34.69 71.6 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 O-C-N 121.203 -0.936 . . . . 0.0 110.493 -179.864 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.45 ' HB2' ' O ' ' A' ' 15' ' ' GLN . 0.1 OUTLIER -85.81 18.38 2.95 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.319 -0.863 . . . . 0.0 111.04 179.674 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.613 HG23 ' O ' ' A' ' 16' ' ' ASN . 13.1 t . . . . . 0 N--CA 1.494 1.769 0 O-C-N 121.109 -0.995 . . . . 0.0 110.251 179.705 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 8.7 mt . . . . . 0 N--CA 1.503 2.219 0 CA-C-O 121.191 0.52 . . . . 0.0 110.773 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.604 ' HB2' ' HD3' ' A' ' 28' ' ' PRO . 2.2 m -61.82 -51.73 73.71 Favored Pre-proline 0 N--CA 1.497 1.88 0 O-C-N 121.296 -0.878 . . . . 0.0 110.926 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.604 ' HD3' ' HB2' ' A' ' 27' ' ' SER . 43.4 Cg_endo -69.56 -28.5 26.14 Favored 'Trans proline' 0 N--CA 1.49 1.27 0 O-C-N 123.299 1.157 . . . . 0.0 110.924 179.851 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.43 -36.77 83.45 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.591 -0.693 . . . . 0.0 110.432 179.65 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 35.5 mt -92.27 -36.28 7.6 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 O-C-N 121.327 -0.858 . . . . 0.0 110.219 179.787 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 92.0 m -68.45 -39.79 81.35 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.562 -0.711 . . . . 0.0 110.462 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 4.1 tttt -86.21 19.87 2.54 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.26 -0.9 . . . . 0.0 110.84 179.611 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -116.31 -18.22 10.55 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.207 -0.933 . . . . 0.0 110.856 179.786 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 26.5 t . . . . . 0 N--CA 1.496 1.845 0 O-C-N 121.124 -0.985 . . . . 0.0 110.002 -179.843 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.372 0 N-CA-C 109.013 -1.635 . . . . 0.0 109.013 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.1 mp -64.08 -33.3 75.44 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.691 -0.887 . . . . 0.0 110.304 179.35 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 4.8 tp -65.49 -47.23 76.78 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.351 -0.843 . . . . 0.0 109.994 179.596 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -70.2 -43.74 70.1 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.379 -0.826 . . . . 0.0 110.453 179.789 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -61.69 -44.18 97.44 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.401 -0.812 . . . . 0.0 109.931 179.699 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' HIS . . . . . 0.481 ' CE1' HG21 ' A' ' 18' ' ' VAL . 69.9 t60 -65.14 -51.48 60.98 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.506 -0.746 . . . . 0.0 109.705 179.317 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.431 ' HA ' ' HB ' ' A' ' 18' ' ' VAL . 0.8 OUTLIER -56.87 -36.45 70.08 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.428 -0.795 . . . . 0.0 110.224 179.457 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 5.6 t30 -56.53 -41.9 77.54 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.339 -0.85 . . . . 0.0 109.993 179.2 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.434 ' O ' HG12 ' A' ' 20' ' ' VAL . 7.3 mt -86.28 -20.42 7.89 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 O-C-N 121.485 -0.759 . . . . 0.0 110.404 179.462 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.481 HG21 ' CE1' ' A' ' 14' ' ' HIS . 78.3 t -87.48 -12.92 10.55 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 O-C-N 121.27 -0.894 . . . . 0.0 110.331 179.631 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -118.14 24.15 11.16 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.385 -0.822 . . . . 0.0 110.137 179.257 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.434 HG12 ' O ' ' A' ' 17' ' ' ILE . 10.9 p . . . . . 0 N--CA 1.5 2.045 0 O-C-N 121.296 -0.877 . . . . 0.0 110.427 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.498 1.935 0 CA-C-O 121.36 0.6 . . . . 0.0 110.118 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.533 ' HB2' ' HD3' ' A' ' 28' ' ' PRO . 2.3 m -68.08 -52.84 21.68 Favored Pre-proline 0 N--CA 1.498 1.933 0 O-C-N 121.498 -0.751 . . . . 0.0 110.972 -179.846 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.533 ' HD3' ' HB2' ' A' ' 27' ' ' SER . 49.3 Cg_endo -76.74 60.1 6.55 Favored 'Trans proline' 0 N--CA 1.487 1.131 0 O-C-N 123.462 1.243 . . . . 0.0 110.493 179.815 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -157.93 -57.32 0.08 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.399 -0.813 . . . . 0.0 110.102 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 82.1 mt -69.33 -22.8 25.99 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 O-C-N 121.437 -0.789 . . . . 0.0 110.418 179.64 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 24.5 p -61.7 -41.7 97.94 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.416 -0.803 . . . . 0.0 110.249 179.436 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.27 -24.26 64.86 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.521 -0.737 . . . . 0.0 110.418 179.611 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -80.96 -29.36 35.36 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.412 -0.805 . . . . 0.0 110.182 179.512 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 88.2 t . . . . . 0 N--CA 1.497 1.876 0 O-C-N 121.453 -0.779 . . . . 0.0 110.519 -179.708 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.477 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 6.3 mt -74.88 -39.31 61.59 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.596 -0.944 . . . . 0.0 110.562 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 14.2 tp -58.14 -49.46 76.9 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.436 -0.79 . . . . 0.0 110.213 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 27.2 m-70 -63.21 -39.19 93.93 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.572 -0.705 . . . . 0.0 109.703 179.247 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 7.2 tp -63.17 -40.13 96.64 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.487 -0.758 . . . . 0.0 109.789 179.082 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' HIS . . . . . 0.519 ' NE2' HG21 ' A' ' 18' ' ' VAL . 68.2 t60 -58.75 -54.06 51.39 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.575 -0.703 . . . . 0.0 109.71 179.391 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.447 ' O ' ' HB2' ' A' ' 19' ' ' ASP . 23.3 tp60 -53.34 -38.64 63.43 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.643 -0.661 . . . . 0.0 110.015 179.45 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -66.81 -37.46 84.57 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.572 -0.705 . . . . 0.0 110.606 179.392 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.409 ' O ' HG12 ' A' ' 20' ' ' VAL . 93.1 mt -82.04 -16.42 11.89 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.073 0 O-C-N 121.35 -0.844 . . . . 0.0 110.588 179.833 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.519 HG21 ' NE2' ' A' ' 14' ' ' HIS . 84.6 t -94.67 -53.04 8.8 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 121.165 -0.959 . . . . 0.0 109.489 179.64 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.447 ' HB2' ' O ' ' A' ' 15' ' ' GLN . 0.7 OUTLIER -59.12 -17.42 26.53 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.737 -0.602 . . . . 0.0 111.316 179.543 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.409 HG12 ' O ' ' A' ' 17' ' ' ILE . 14.9 p . . . . . 0 N--CA 1.499 2.006 0 O-C-N 120.846 -1.159 . . . . 0.0 111.578 -179.842 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 5.0 mp . . . . . 0 N--CA 1.502 2.157 0 CA-C-O 120.953 0.406 . . . . 0.0 111.311 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.487 ' N ' ' HD2' ' A' ' 28' ' ' PRO . 0.7 OUTLIER -61.47 -54.32 53.53 Favored Pre-proline 0 N--CA 1.501 2.114 0 O-C-N 121.244 -0.91 . . . . 0.0 110.694 179.815 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.487 ' HD2' ' N ' ' A' ' 27' ' ' SER . 44.2 Cg_endo -71.39 -27.29 19.48 Favored 'Trans proline' 0 N--CA 1.487 1.126 0 O-C-N 123.481 1.253 . . . . 0.0 110.647 179.553 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.8 -36.24 78.52 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.585 -0.697 . . . . 0.0 110.181 179.497 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -84.15 -30.76 7.53 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 121.354 -0.841 . . . . 0.0 109.938 179.4 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 53.9 m -71.01 -43.73 67.32 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.545 -0.722 . . . . 0.0 109.722 179.349 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 17.5 tttt -88.41 43.4 1.13 Allowed 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.516 -0.74 . . . . 0.0 109.957 179.348 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 21.5 t80 -151.93 -53.45 0.12 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.571 -0.706 . . . . 0.0 109.423 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 53.5 t . . . . . 0 N--CA 1.494 1.732 0 O-C-N 121.631 -0.668 . . . . 0.0 109.697 179.19 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.458 0 N-CA-C 109.261 -1.536 . . . . 0.0 109.261 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.4 mt -61.74 -35.77 79.03 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.755 -0.85 . . . . 0.0 110.492 179.867 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.8 tt -58.17 -47.75 82.42 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.438 -0.789 . . . . 0.0 109.935 179.645 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 24.1 m-70 -75.52 -42.06 53.61 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.6 -0.688 . . . . 0.0 109.87 179.456 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 11.4 tp -58.83 -42.66 89.75 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.464 -0.773 . . . . 0.0 110.403 179.701 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' HIS . . . . . 0.53 ' NE2' HG21 ' A' ' 18' ' ' VAL . 6.1 t-80 -59.43 -51.84 68.18 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.563 -0.711 . . . . 0.0 109.933 179.591 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 34.3 tp60 -58.04 -36.53 72.87 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.622 -0.674 . . . . 0.0 110.392 179.731 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -66.42 -41.13 89.7 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.507 -0.745 . . . . 0.0 110.826 179.931 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 73.5 mt -76.15 -43.37 37.76 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 O-C-N 121.262 -0.899 . . . . 0.0 110.505 -179.55 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.53 HG21 ' NE2' ' A' ' 14' ' ' HIS . 38.0 t -67.72 -36.38 75.8 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 O-C-N 121.416 -0.803 . . . . 0.0 110.661 -179.873 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -66.99 -18.53 65.43 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.428 -0.795 . . . . 0.0 110.666 179.508 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 80.6 t . . . . . 0 N--CA 1.494 1.765 0 O-C-N 121.026 -1.046 . . . . 0.0 109.323 179.096 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.0 tp . . . . . 0 N--CA 1.496 1.869 0 CA-C-O 120.931 0.396 . . . . 0.0 110.383 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.561 ' HB2' ' HD3' ' A' ' 28' ' ' PRO . 43.4 m -56.91 -51.36 82.12 Favored Pre-proline 0 N--CA 1.498 1.965 0 O-C-N 121.644 -0.66 . . . . 0.0 110.822 179.72 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.561 ' HD3' ' HB2' ' A' ' 27' ' ' SER . 43.6 Cg_endo -69.74 -23.36 30.97 Favored 'Trans proline' 0 N--CA 1.489 1.237 0 O-C-N 123.408 1.215 . . . . 0.0 111.033 179.41 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -80.47 -42.81 21.92 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.452 -0.78 . . . . 0.0 110.581 179.821 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.406 HG22 ' O ' ' A' ' 27' ' ' SER . 11.9 tt -71.85 -29.13 32.46 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 O-C-N 121.324 -0.86 . . . . 0.0 111.083 -179.614 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 2.9 p -65.97 -37.03 84.93 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.317 -0.864 . . . . 0.0 109.909 179.547 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 9.6 tptp -87.0 -25.64 24.16 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.416 -0.803 . . . . 0.0 109.796 178.987 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 71.1 t80 -68.16 -41.1 82.05 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.464 -0.773 . . . . 0.0 110.456 179.656 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.9 p . . . . . 0 N--CA 1.499 1.982 0 O-C-N 121.335 -0.853 . . . . 0.0 110.405 179.693 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 2.617 0 N-CA-C 109.851 -1.3 . . . . 0.0 109.851 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.1 mp -58.73 -39.7 81.6 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.654 -0.909 . . . . 0.0 110.383 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -58.25 -48.37 80.63 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.526 -0.734 . . . . 0.0 109.829 179.392 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -66.76 -43.19 84.72 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.652 -0.655 . . . . 0.0 109.681 179.24 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.0 tt -58.07 -41.0 82.45 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.661 -0.649 . . . . 0.0 110.028 179.38 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' HIS . . . . . 0.433 ' CE1' HG21 ' A' ' 18' ' ' VAL . 82.9 t60 -59.31 -46.0 89.78 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.529 -0.732 . . . . 0.0 109.808 179.368 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.435 ' O ' ' HB2' ' A' ' 19' ' ' ASP . 0.4 OUTLIER -65.91 -34.27 77.73 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.501 -0.749 . . . . 0.0 109.662 179.193 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -64.94 -14.99 61.58 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.372 -0.83 . . . . 0.0 110.596 179.15 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 38.5 mm -107.81 -38.51 4.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.356 -0.84 . . . . 0.0 109.66 179.652 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.433 HG21 ' CE1' ' A' ' 14' ' ' HIS . 71.4 t -83.89 -42.6 17.37 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 O-C-N 121.495 -0.753 . . . . 0.0 110.743 -179.714 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.435 ' HB2' ' O ' ' A' ' 15' ' ' GLN . 0.2 OUTLIER -77.23 -2.8 36.48 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.551 -0.718 . . . . 0.0 111.452 -179.663 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 63.2 t . . . . . 0 N--CA 1.495 1.788 0 O-C-N 120.833 -1.167 . . . . 0.0 110.263 179.458 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.3 mp . . . . . 0 N--CA 1.498 1.971 0 CA-C-O 120.689 0.281 . . . . 0.0 111.213 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.534 ' HB2' ' HD3' ' A' ' 28' ' ' PRO . 26.5 m -61.61 -51.04 79.57 Favored Pre-proline 0 N--CA 1.499 1.999 0 O-C-N 121.223 -0.923 . . . . 0.0 111.105 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.534 ' HD3' ' HB2' ' A' ' 27' ' ' SER . 45.1 Cg_endo -70.72 -17.77 32.96 Favored 'Trans proline' 0 N--CA 1.49 1.269 0 O-C-N 123.417 1.22 . . . . 0.0 111.224 179.823 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -80.32 -41.38 24.94 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.265 -0.897 . . . . 0.0 110.501 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 32.3 mm -69.64 -43.23 80.43 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 O-C-N 121.345 -0.847 . . . . 0.0 110.718 -179.852 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.542 ' HA ' HG12 ' A' ' 34' ' ' VAL . 12.1 t -63.25 -31.78 73.02 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.475 -0.766 . . . . 0.0 110.626 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 45.0 tttt -73.49 -29.11 62.29 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.284 -0.885 . . . . 0.0 109.937 179.201 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 24.4 t80 -83.02 -45.05 14.53 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.566 -0.709 . . . . 0.0 109.701 179.282 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.542 HG12 ' HA ' ' A' ' 31' ' ' THR . 3.4 p . . . . . 0 N--CA 1.497 1.88 0 O-C-N 121.547 -0.721 . . . . 0.0 110.115 179.731 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 2.696 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -65.94 -40.46 91.37 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.533 -0.981 . . . . 0.0 109.92 179.559 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.9 tt -61.01 -44.99 96.61 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.579 -0.7 . . . . 0.0 109.776 179.347 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -68.32 -44.47 75.31 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.578 -0.701 . . . . 0.0 109.763 179.409 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -63.35 -37.36 86.95 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.544 -0.722 . . . . 0.0 110.049 179.434 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' HIS . . . . . 0.465 ' CD2' HG21 ' A' ' 18' ' ' VAL . 14.1 t-80 -57.07 -58.08 9.75 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.576 -0.702 . . . . 0.0 109.645 179.538 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.424 ' O ' ' HB2' ' A' ' 19' ' ' ASP . 0.1 OUTLIER -59.78 -38.95 83.3 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.353 -0.842 . . . . 0.0 110.031 179.19 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -59.22 -43.84 92.3 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.399 -0.813 . . . . 0.0 110.603 179.674 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 22.2 mm -81.87 -36.06 13.95 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 O-C-N 121.232 -0.917 . . . . 0.0 110.47 179.867 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.465 HG21 ' CD2' ' A' ' 14' ' ' HIS . 69.7 t -75.71 -8.6 11.85 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 O-C-N 121.493 -0.754 . . . . 0.0 111.663 -179.469 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.424 ' HB2' ' O ' ' A' ' 15' ' ' GLN . 0.4 OUTLIER -119.56 27.93 8.47 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 120.942 -1.099 . . . . 0.0 110.93 179.781 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 42.4 t . . . . . 0 N--CA 1.499 2.001 0 O-C-N 121.097 -1.002 . . . . 0.0 109.983 179.579 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.422 ' HA ' HD12 ' A' ' 30' ' ' ILE . 1.2 mt . . . . . 0 N--CA 1.497 1.894 0 CA-C-O 121.042 0.449 . . . . 0.0 110.425 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.45 ' CB ' ' CD ' ' A' ' 28' ' ' PRO . 0.0 OUTLIER -164.18 -61.49 0.01 OUTLIER Pre-proline 0 N--CA 1.498 1.934 0 O-C-N 121.416 -0.803 . . . . 0.0 110.144 179.828 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.45 ' CD ' ' CB ' ' A' ' 27' ' ' SER . 46.0 Cg_endo -71.85 -17.02 29.35 Favored 'Trans proline' 0 N--CA 1.489 1.252 0 O-C-N 123.08 1.042 . . . . 0.0 110.944 179.284 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -100.46 -12.09 19.63 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.4 -0.813 . . . . 0.0 111.002 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.422 HD12 ' HA ' ' A' ' 26' ' ' LEU . 73.6 mt -118.82 -49.08 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.177 -0.952 . . . . 0.0 110.231 -179.768 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 2.4 m -69.98 -31.15 68.71 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.595 -0.69 . . . . 0.0 110.504 -179.854 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.436 ' HG3' ' HA ' ' A' ' 28' ' ' PRO . 12.8 mmtp -87.83 6.2 36.5 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.259 -0.9 . . . . 0.0 110.797 179.635 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -103.33 -41.25 6.09 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.286 -0.884 . . . . 0.0 110.066 179.752 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 16.6 t . . . . . 0 N--CA 1.496 1.864 0 O-C-N 121.446 -0.784 . . . . 0.0 109.451 179.469 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 2.606 0 N-CA-C 109.32 -1.512 . . . . 0.0 109.32 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.456 ' HA ' HD22 ' A' ' 10' ' ' LEU . 0.2 OUTLIER -61.06 -41.56 96.84 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.504 -0.997 . . . . 0.0 110.038 179.485 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.471 HD22 ' HA ' ' A' ' 11' ' ' LEU . 0.2 OUTLIER -59.26 -42.01 90.17 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.563 -0.711 . . . . 0.0 109.796 179.371 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 6.5 t-80 -65.27 -37.46 87.25 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.594 -0.691 . . . . 0.0 109.833 179.242 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.466 ' HA ' HD22 ' A' ' 13' ' ' LEU . 0.2 OUTLIER -61.77 -42.53 99.11 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.465 -0.772 . . . . 0.0 109.399 179.006 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 14' ' ' HIS . . . . . 0.443 ' NE2' HG21 ' A' ' 18' ' ' VAL . 4.7 t-80 -67.08 -48.07 69.33 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.642 -0.661 . . . . 0.0 109.403 178.98 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 30.5 mm100 -60.17 -34.49 73.66 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.558 -0.714 . . . . 0.0 109.988 179.385 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.49 ' O ' HG23 ' A' ' 20' ' ' VAL . 10.1 t30 -61.98 -50.35 72.43 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.429 -0.794 . . . . 0.0 110.137 179.421 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 49.7 mt -71.13 -19.47 21.07 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 O-C-N 121.262 -0.899 . . . . 0.0 110.793 179.783 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.443 HG21 ' NE2' ' A' ' 14' ' ' HIS . 47.0 t -97.24 -8.79 9.16 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 O-C-N 121.258 -0.901 . . . . 0.0 111.232 -179.592 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -123.03 27.84 7.47 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.06 -1.025 . . . . 0.0 110.886 179.592 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.49 HG23 ' O ' ' A' ' 16' ' ' ASN . 39.3 t . . . . . 0 N--CA 1.497 1.906 0 O-C-N 121.14 -0.975 . . . . 0.0 109.381 179.254 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.501 2.115 0 CA-C-O 121.117 0.484 . . . . 0.0 110.609 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.513 ' CB ' ' CD ' ' A' ' 28' ' ' PRO . 0.4 OUTLIER -169.77 -63.04 0.01 OUTLIER Pre-proline 0 N--CA 1.498 1.944 0 O-C-N 121.54 -0.725 . . . . 0.0 110.186 179.69 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.513 ' CD ' ' CB ' ' A' ' 27' ' ' SER . 43.3 Cg_endo -69.48 -27.33 27.93 Favored 'Trans proline' 0 N--CA 1.49 1.265 0 O-C-N 123.393 1.207 . . . . 0.0 110.76 179.664 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.76 -37.22 83.47 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.579 -0.7 . . . . 0.0 110.289 179.51 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 58.9 mt -79.25 -39.42 21.06 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 121.466 -0.771 . . . . 0.0 109.873 179.52 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 99.8 m -65.0 -45.02 87.33 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.58 -0.7 . . . . 0.0 109.965 179.524 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -67.03 -20.99 65.94 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.485 -0.759 . . . . 0.0 110.785 179.651 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -72.65 -24.09 61.0 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.361 -0.837 . . . . 0.0 110.543 179.615 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 55.6 t . . . . . 0 N--CA 1.495 1.806 0 O-C-N 121.266 -0.896 . . . . 0.0 110.275 -179.965 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.492 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.36 -39.17 89.64 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.636 -0.92 . . . . 0.0 110.284 179.725 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.8 tt -59.03 -48.36 81.86 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.446 -0.784 . . . . 0.0 109.783 179.433 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 21.7 m170 -69.16 -44.3 72.56 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.679 -0.638 . . . . 0.0 109.672 179.213 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.7 mt -56.88 -41.87 78.8 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.605 -0.685 . . . . 0.0 110.06 179.489 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' HIS . . . . . 0.602 ' O ' HG23 ' A' ' 18' ' ' VAL . 5.7 t-80 -63.17 -46.86 85.17 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.652 -0.655 . . . . 0.0 109.812 179.321 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 25.2 tp60 -54.1 -41.88 68.75 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.645 -0.659 . . . . 0.0 110.698 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.48 ' O ' HG23 ' A' ' 20' ' ' VAL . 7.5 t-20 -66.95 -47.82 70.45 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.395 -0.815 . . . . 0.0 110.384 179.781 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 74.4 mt -57.94 -38.6 67.38 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.111 0 O-C-N 121.422 -0.799 . . . . 0.0 109.91 179.83 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.602 HG23 ' O ' ' A' ' 14' ' ' HIS . 47.5 t -72.22 -35.88 54.17 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.528 -0.732 . . . . 0.0 109.706 179.302 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -68.8 -15.52 63.53 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.734 -0.604 . . . . 0.0 110.966 179.516 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.48 HG23 ' O ' ' A' ' 16' ' ' ASN . 47.7 t . . . . . 0 N--CA 1.493 1.722 0 O-C-N 121.135 -0.978 . . . . 0.0 109.481 179.322 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 23.8 mt . . . . . 0 N--CA 1.498 1.952 0 CA-C-O 120.618 0.246 . . . . 0.0 111.371 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.523 ' HB2' ' HD3' ' A' ' 28' ' ' PRO . 3.0 m -69.82 -59.44 4.53 Favored Pre-proline 0 N--CA 1.498 1.933 0 O-C-N 121.015 -1.053 . . . . 0.0 110.416 179.86 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.523 ' HD3' ' HB2' ' A' ' 27' ' ' SER . 45.8 Cg_endo -71.52 -25.73 20.82 Favored 'Trans proline' 0 N--CA 1.488 1.165 0 O-C-N 123.395 1.208 . . . . 0.0 110.62 179.402 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.29 -35.64 81.49 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.584 -0.697 . . . . 0.0 110.597 179.734 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 26.1 mm -79.54 -38.41 19.54 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 O-C-N 121.323 -0.861 . . . . 0.0 110.165 179.809 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 24.4 m -62.19 -38.65 89.94 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.432 -0.793 . . . . 0.0 109.958 179.623 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.7 tmtt? -69.92 -35.7 74.78 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.291 -0.88 . . . . 0.0 110.206 179.482 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 80.6 t80 -76.61 -41.1 47.26 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.587 -0.696 . . . . 0.0 110.118 179.671 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 47.1 t . . . . . 0 N--CA 1.495 1.796 0 O-C-N 121.458 -0.776 . . . . 0.0 109.837 179.871 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.515 0 N-CA-C 109.034 -1.626 . . . . 0.0 109.034 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 10.5 tp -87.81 -39.0 15.24 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.568 -0.96 . . . . 0.0 109.89 179.386 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.2 tt -59.63 -48.81 80.21 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.52 -0.737 . . . . 0.0 110.277 179.779 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 7.4 t-80 -61.57 -40.66 95.54 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.514 -0.741 . . . . 0.0 110.306 179.884 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 5.2 tp -56.5 -43.03 79.3 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.422 -0.799 . . . . 0.0 109.614 179.247 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 14' ' ' HIS . . . . . 0.519 ' NE2' HG21 ' A' ' 18' ' ' VAL . 76.4 t60 -66.77 -45.87 77.11 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.677 -0.639 . . . . 0.0 109.289 178.935 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 3.7 mm-40 -62.24 -35.84 80.17 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.548 -0.72 . . . . 0.0 110.081 179.247 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -60.5 -38.35 84.06 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.519 -0.738 . . . . 0.0 110.421 179.617 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.555 ' O ' HG12 ' A' ' 20' ' ' VAL . 28.9 mt -86.16 -36.88 11.09 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 O-C-N 121.347 -0.846 . . . . 0.0 110.221 179.958 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.519 HG21 ' NE2' ' A' ' 14' ' ' HIS . 55.1 t -70.77 -34.11 55.19 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 O-C-N 121.324 -0.86 . . . . 0.0 110.512 179.888 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -89.37 14.39 11.3 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.379 -0.826 . . . . 0.0 111.352 -179.914 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.555 HG12 ' O ' ' A' ' 17' ' ' ILE . 0.8 OUTLIER . . . . . 0 N--CA 1.496 1.857 0 O-C-N 120.916 -1.115 . . . . 0.0 110.773 179.256 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.484 HD13 ' HA ' ' A' ' 26' ' ' LEU . 3.7 mm? . . . . . 0 N--CA 1.498 1.973 0 CA-C-O 121.051 0.453 . . . . 0.0 110.48 . . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.677 ' HB3' ' HD3' ' A' ' 28' ' ' PRO . 8.0 t -65.02 -52.95 45.41 Favored Pre-proline 0 N--CA 1.497 1.884 0 O-C-N 121.25 -0.906 . . . . 0.0 110.429 179.731 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.677 ' HD3' ' HB3' ' A' ' 27' ' ' SER . 53.2 Cg_endo -81.19 51.71 4.03 Favored 'Trans proline' 0 N--CA 1.484 0.954 0 O-C-N 123.191 1.101 . . . . 0.0 110.508 179.26 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -152.06 -59.36 0.15 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.306 -0.871 . . . . 0.0 109.767 179.855 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 15.8 mt -68.05 -35.53 72.05 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 O-C-N 121.553 -0.717 . . . . 0.0 109.793 179.432 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 1.8 m -70.58 -45.62 65.01 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.672 -0.643 . . . . 0.0 109.715 179.468 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 3.4 mttm -60.37 -32.14 71.0 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.65 -0.656 . . . . 0.0 110.404 179.638 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 88.9 t80 -72.97 -36.61 67.15 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.638 -0.663 . . . . 0.0 110.333 179.615 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 75.8 t . . . . . 0 N--CA 1.499 2.008 0 O-C-N 121.422 -0.798 . . . . 0.0 110.842 -179.885 . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 2.638 0 N-CA-C 110.211 -1.155 . . . . 0.0 110.211 . . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.431 ' HA ' HD13 ' A' ' 10' ' ' LEU . 3.5 mm? -64.37 -45.38 87.99 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.438 -1.036 . . . . 0.0 110.409 -179.958 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 13.9 tp -61.41 -44.83 96.46 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.518 -0.739 . . . . 0.0 110.085 179.668 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -64.03 -38.5 91.29 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.547 -0.721 . . . . 0.0 109.794 179.361 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 12.1 tp -60.14 -41.4 92.64 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.46 -0.775 . . . . 0.0 109.771 179.122 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 6.7 t-160 -62.5 -50.77 70.08 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.589 -0.694 . . . . 0.0 109.656 179.288 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 22.5 tp60 -57.72 -36.29 71.82 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.56 -0.713 . . . . 0.0 110.291 179.549 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.629 ' O ' HG23 ' A' ' 20' ' ' VAL . 0.7 OUTLIER -64.38 -35.86 82.28 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.446 -0.784 . . . . 0.0 110.796 179.696 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 34.3 mt -88.0 -32.37 6.07 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 121.236 -0.915 . . . . 0.0 110.675 -179.639 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -71.37 -42.8 73.78 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 121.284 -0.885 . . . . 0.0 110.224 -179.95 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -63.33 -24.45 67.86 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.427 -0.796 . . . . 0.0 110.814 179.585 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.629 HG23 ' O ' ' A' ' 16' ' ' ASN . 44.5 t . . . . . 0 N--CA 1.498 1.943 0 O-C-N 121.444 -0.785 . . . . 0.0 110.59 179.705 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.904 ' HG ' ' HB3' ' A' ' 29' ' ' ALA . 0.5 OUTLIER . . . . . 0 N--CA 1.497 1.906 0 CA-C-O 120.729 0.3 . . . . 0.0 111.369 . . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.543 ' HB3' ' HD3' ' A' ' 28' ' ' PRO . 12.8 t -62.75 -49.5 82.21 Favored Pre-proline 0 N--CA 1.501 2.116 0 O-C-N 121.119 -0.988 . . . . 0.0 111.185 179.738 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.543 ' HD3' ' HB3' ' A' ' 27' ' ' SER . 47.0 Cg_endo -72.76 -9.63 24.04 Favored 'Trans proline' 0 N--CA 1.489 1.246 0 O-C-N 123.314 1.165 . . . . 0.0 111.468 -179.858 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.904 ' HB3' ' HG ' ' A' ' 26' ' ' LEU . . . -99.72 -48.22 4.79 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.278 -0.889 . . . . 0.0 110.372 179.899 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.634 ' HB ' HD23 ' A' ' 26' ' ' LEU . 16.8 tt -62.08 -25.42 37.39 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 O-C-N 121.434 -0.791 . . . . 0.0 111.297 -179.789 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 6.1 t -68.46 -28.47 67.07 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.269 -0.894 . . . . 0.0 110.507 179.831 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -111.15 20.82 17.02 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.388 -0.82 . . . . 0.0 110.237 179.293 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -121.7 -45.75 2.27 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.335 -0.853 . . . . 0.0 110.447 -179.925 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 93.6 t . . . . . 0 N--CA 1.499 1.994 0 O-C-N 121.351 -0.843 . . . . 0.0 110.124 179.837 . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.448 0 N-CA-C 108.771 -1.732 . . . . 0.0 108.771 . . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.1 mp -64.14 -41.21 97.28 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.697 -0.884 . . . . 0.0 109.958 179.335 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.8 tt -58.2 -46.54 85.65 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.622 -0.674 . . . . 0.0 110.02 179.514 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 50.7 t60 -62.61 -39.59 94.26 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.683 -0.636 . . . . 0.0 109.755 179.312 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 6.8 tp -61.93 -39.74 93.09 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.557 -0.715 . . . . 0.0 110.251 179.501 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 14' ' ' HIS . . . . . 0.546 ' NE2' HG21 ' A' ' 18' ' ' VAL . 5.8 t-80 -60.94 -53.05 62.08 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.571 -0.706 . . . . 0.0 109.865 179.633 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -56.8 -36.92 70.46 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.571 -0.706 . . . . 0.0 110.226 179.688 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.437 ' O ' ' HB ' ' A' ' 20' ' ' VAL . 0.7 OUTLIER -64.63 -47.8 77.2 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.378 -0.826 . . . . 0.0 110.194 179.429 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.477 ' O ' HG12 ' A' ' 20' ' ' VAL . 68.6 mt -68.85 -36.78 75.76 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.042 0 O-C-N 121.447 -0.783 . . . . 0.0 110.494 179.909 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.546 HG21 ' NE2' ' A' ' 14' ' ' HIS . 21.0 t -75.47 -19.9 15.95 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 121.268 -0.895 . . . . 0.0 110.383 179.906 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -107.85 20.94 18.13 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.355 -0.84 . . . . 0.0 111.018 179.51 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.477 HG12 ' O ' ' A' ' 17' ' ' ILE . 3.7 p . . . . . 0 N--CA 1.497 1.917 0 O-C-N 120.812 -1.18 . . . . 0.0 111.065 179.448 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.912 ' HB3' ' HB3' ' A' ' 29' ' ' ALA . 1.4 mp . . . . . 0 N--CA 1.494 1.749 0 CA-C-O 121.332 0.587 . . . . 0.0 109.697 . . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.485 ' N ' ' HD2' ' A' ' 28' ' ' PRO . 0.1 OUTLIER -58.12 -52.46 74.37 Favored Pre-proline 0 N--CA 1.5 2.056 0 O-C-N 121.575 -0.703 . . . . 0.0 111.497 -179.56 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.485 ' HD2' ' N ' ' A' ' 27' ' ' SER . 44.9 Cg_endo -71.15 -12.45 30.22 Favored 'Trans proline' 0 N--CA 1.492 1.42 0 O-C-N 123.46 1.242 . . . . 0.0 111.761 -179.669 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.912 ' HB3' ' HB3' ' A' ' 26' ' ' LEU . . . -98.36 -40.41 8.32 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.265 -0.897 . . . . 0.0 110.299 179.769 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 5.9 tp -71.18 -24.34 24.1 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 O-C-N 121.414 -0.804 . . . . 0.0 110.798 179.878 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 1.9 p -64.64 -42.22 95.61 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.46 -0.775 . . . . 0.0 110.1 179.621 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 2.3 tptm -93.27 26.61 2.84 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.544 -0.722 . . . . 0.0 110.119 179.273 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 10.8 t80 -124.46 -47.81 1.84 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.485 -0.759 . . . . 0.0 110.245 -179.913 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 93.8 t . . . . . 0 N--CA 1.495 1.821 0 O-C-N 121.458 -0.776 . . . . 0.0 109.89 179.954 . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.349 0 N-CA-C 108.649 -1.78 . . . . 0.0 108.649 . . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 11.2 tp -80.77 -32.22 35.58 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.619 -0.93 . . . . 0.0 110.072 179.28 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.4 tt -60.88 -51.35 69.65 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.521 -0.737 . . . . 0.0 110.203 179.739 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 43.9 t60 -64.62 -37.61 88.17 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.56 -0.713 . . . . 0.0 110.307 179.646 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 6.7 tt -54.87 -39.02 68.23 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.493 -0.754 . . . . 0.0 110.269 179.65 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 14' ' ' HIS . . . . . 0.46 ' CE1' HG21 ' A' ' 18' ' ' VAL . 64.7 t60 -78.26 -51.29 10.37 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.427 -0.796 . . . . 0.0 109.847 179.474 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.407 ' O ' ' HB2' ' A' ' 19' ' ' ASP . 0.8 OUTLIER -58.74 -47.01 86.11 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.623 -0.673 . . . . 0.0 110.484 -179.93 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 4.3 t30 -54.29 -33.37 58.55 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.484 -0.76 . . . . 0.0 111.0 179.885 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 38.4 mm -86.14 -45.51 16.85 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 121.122 -0.987 . . . . 0.0 110.073 179.816 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.46 HG21 ' CE1' ' A' ' 14' ' ' HIS . 52.7 t -63.6 -38.03 81.18 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 O-C-N 121.462 -0.774 . . . . 0.0 110.59 179.933 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.407 ' HB2' ' O ' ' A' ' 15' ' ' GLN . 1.7 m-20 -71.45 -12.74 61.55 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.584 -0.698 . . . . 0.0 111.394 -179.885 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 97.2 t . . . . . 0 N--CA 1.495 1.786 0 O-C-N 120.816 -1.178 . . . . 0.0 110.282 179.461 . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.471 ' HG ' ' HB3' ' A' ' 29' ' ' ALA . 0.1 OUTLIER . . . . . 0 N--CA 1.503 2.185 0 CA-C-O 121.065 0.46 . . . . 0.0 111.191 . . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.51 ' N ' ' HD2' ' A' ' 28' ' ' PRO . 0.0 OUTLIER -63.78 -51.79 62.53 Favored Pre-proline 0 N--CA 1.5 2.054 0 O-C-N 121.244 -0.91 . . . . 0.0 110.705 179.521 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.51 ' HD2' ' N ' ' A' ' 27' ' ' SER . 47.9 Cg_endo -73.46 -8.5 21.81 Favored 'Trans proline' 0 N--CA 1.489 1.261 0 O-C-N 123.434 1.228 . . . . 0.0 111.418 179.939 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.471 ' HB3' ' HG ' ' A' ' 26' ' ' LEU . . . -98.99 -45.68 5.87 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.232 -0.918 . . . . 0.0 110.196 179.842 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.521 HD13 ' O ' ' A' ' 30' ' ' ILE . 0.3 OUTLIER -61.73 -31.22 50.24 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 O-C-N 121.438 -0.789 . . . . 0.0 110.4 179.866 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 4.3 p -66.43 -30.01 70.27 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.497 -0.752 . . . . 0.0 110.222 179.276 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 11.1 ttpt -100.74 18.23 19.92 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.507 -0.746 . . . . 0.0 110.414 179.454 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -107.61 -35.02 6.83 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.363 -0.836 . . . . 0.0 109.975 179.687 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 46.0 t . . . . . 0 N--CA 1.495 1.787 0 O-C-N 121.522 -0.736 . . . . 0.0 109.572 179.694 . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 2.721 0 N-CA-C 110.05 -1.22 . . . . 0.0 110.05 . . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -62.9 -31.46 72.53 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.569 -0.96 . . . . 0.0 110.473 179.711 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.7 mp -56.4 -39.41 72.98 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.454 -0.779 . . . . 0.0 110.15 179.537 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -85.14 -41.26 15.84 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.368 -0.832 . . . . 0.0 109.638 179.257 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 6.5 tt -56.34 -43.49 79.11 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.684 -0.635 . . . . 0.0 110.098 179.392 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 14' ' ' HIS . . . . . 0.46 ' CE1' HG21 ' A' ' 18' ' ' VAL . 66.2 t60 -64.68 -50.68 66.05 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.61 -0.681 . . . . 0.0 109.931 179.52 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -62.27 -36.36 81.82 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.465 -0.772 . . . . 0.0 110.025 179.484 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -57.11 -43.41 82.29 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.54 -0.725 . . . . 0.0 109.858 179.335 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 21.5 mm -80.82 -36.53 15.57 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 O-C-N 121.419 -0.801 . . . . 0.0 109.795 179.393 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.46 HG21 ' CE1' ' A' ' 14' ' ' HIS . 40.0 t -67.01 -21.53 28.39 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 O-C-N 121.444 -0.785 . . . . 0.0 110.977 179.983 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -106.0 10.34 32.28 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.215 -0.928 . . . . 0.0 111.159 179.787 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.497 1.896 0 O-C-N 120.847 -1.158 . . . . 0.0 110.505 179.306 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.406 ' O ' HD12 ' A' ' 30' ' ' ILE . 2.8 mp . . . . . 0 N--CA 1.502 2.131 0 CA-C-O 121.155 0.502 . . . . 0.0 110.798 . . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.45 ' CB ' ' HD3' ' A' ' 28' ' ' PRO . 0.4 OUTLIER -60.71 -52.58 71.58 Favored Pre-proline 0 N--CA 1.499 2.013 0 O-C-N 121.351 -0.843 . . . . 0.0 110.027 179.409 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.45 ' HD3' ' CB ' ' A' ' 27' ' ' SER . 52.4 Cg_endo -80.85 44.16 1.69 Allowed 'Trans proline' 0 N--CA 1.485 1.017 0 O-C-N 123.514 1.271 . . . . 0.0 110.512 178.868 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -135.28 -54.69 0.8 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.242 -0.911 . . . . 0.0 109.353 179.789 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.406 HD12 ' O ' ' A' ' 26' ' ' LEU . 2.2 mp -68.42 -42.74 84.19 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 O-C-N 121.558 -0.714 . . . . 0.0 109.339 178.907 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 14.3 t -67.18 -26.59 66.71 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.733 -0.605 . . . . 0.0 109.989 179.136 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 7.9 mmpt? -78.74 -32.58 46.78 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.336 -0.852 . . . . 0.0 109.885 179.209 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 87.2 t80 -66.31 -29.17 69.32 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.63 -0.668 . . . . 0.0 110.05 179.213 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 88.7 t . . . . . 0 N--CA 1.498 1.955 0 O-C-N 121.324 -0.86 . . . . 0.0 110.174 179.467 . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.418 0 N-CA-C 108.657 -1.777 . . . . 0.0 108.657 . . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.4 pp -90.71 -25.38 20.06 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.589 -0.947 . . . . 0.0 110.036 178.96 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -67.86 -42.2 81.71 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.38 -0.825 . . . . 0.0 109.812 179.499 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 4.3 t-160 -63.4 -37.31 86.8 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.548 -0.72 . . . . 0.0 109.919 179.313 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.2 tt -57.27 -42.15 81.05 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.595 -0.69 . . . . 0.0 109.869 179.237 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 14' ' ' HIS . . . . . 0.548 ' NE2' HG21 ' A' ' 18' ' ' VAL . 4.8 t-80 -65.96 -53.71 35.55 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.613 -0.679 . . . . 0.0 109.459 179.063 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.407 ' O ' ' HB2' ' A' ' 19' ' ' ASP . 16.1 tp60 -58.72 -38.28 77.97 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.59 -0.694 . . . . 0.0 110.22 179.577 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 13.2 t30 -59.57 -42.1 91.71 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.61 -0.681 . . . . 0.0 110.595 179.764 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.526 ' O ' HG12 ' A' ' 20' ' ' VAL . 43.8 mt -79.52 -30.62 13.75 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 O-C-N 121.27 -0.894 . . . . 0.0 110.238 179.815 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.548 HG21 ' NE2' ' A' ' 14' ' ' HIS . 31.6 t -78.16 -27.02 14.55 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.227 -0.921 . . . . 0.0 110.203 179.628 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.407 ' HB2' ' O ' ' A' ' 15' ' ' GLN . 0.9 OUTLIER -91.39 17.4 8.53 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.397 -0.814 . . . . 0.0 110.954 179.572 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.526 HG12 ' O ' ' A' ' 17' ' ' ILE . 1.0 OUTLIER . . . . . 0 N--CA 1.494 1.76 0 O-C-N 120.967 -1.083 . . . . 0.0 110.441 179.294 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.498 1.961 0 CA-C-O 120.724 0.297 . . . . 0.0 111.296 . . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.541 ' N ' ' HD2' ' A' ' 28' ' ' PRO . 0.4 OUTLIER -56.74 -51.7 79.39 Favored Pre-proline 0 N--CA 1.499 2.002 0 O-C-N 121.268 -0.895 . . . . 0.0 110.515 179.374 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.541 ' HD2' ' N ' ' A' ' 27' ' ' SER . 42.7 Cg_endo -70.58 -28.57 21.16 Favored 'Trans proline' 0 N--CA 1.487 1.095 0 O-C-N 123.343 1.181 . . . . 0.0 110.115 179.31 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.407 ' O ' ' HB2' ' A' ' 33' ' ' TYR . . . -68.37 -38.55 81.49 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.591 -0.693 . . . . 0.0 110.107 179.345 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.439 HG22 ' O ' ' A' ' 27' ' ' SER . 6.0 tp -85.64 -29.05 6.27 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 121.446 -0.784 . . . . 0.0 110.605 179.646 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 77.7 m -75.13 -37.0 61.57 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.39 -0.819 . . . . 0.0 110.125 179.666 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 32.6 mtmt -89.82 22.26 3.2 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.36 -0.837 . . . . 0.0 110.57 179.495 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.407 ' HB2' ' O ' ' A' ' 29' ' ' ALA . 5.1 t80 -112.56 -48.27 3.02 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.265 -0.897 . . . . 0.0 109.868 179.751 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 94.8 t . . . . . 0 N--CA 1.494 1.732 0 O-C-N 121.563 -0.711 . . . . 0.0 109.744 179.724 . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.435 0 N-CA-C 109.006 -1.638 . . . . 0.0 109.006 . . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -61.28 -41.0 96.21 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.715 -0.873 . . . . 0.0 110.114 179.464 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 4.5 tt -58.58 -47.17 85.18 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.482 -0.761 . . . . 0.0 109.879 179.466 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 14.1 m170 -66.01 -38.16 87.75 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.541 -0.724 . . . . 0.0 109.789 179.236 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -60.08 -40.36 89.29 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.538 -0.726 . . . . 0.0 109.86 179.313 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 14' ' ' HIS . . . . . 0.554 ' NE2' HG21 ' A' ' 18' ' ' VAL . 6.8 t-160 -62.94 -51.5 66.66 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.693 -0.629 . . . . 0.0 109.425 179.158 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 6.4 tp60 -61.84 -37.32 84.05 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.572 -0.705 . . . . 0.0 110.086 179.279 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -60.11 -35.39 75.13 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.654 -0.654 . . . . 0.0 110.621 179.662 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.538 ' O ' HG12 ' A' ' 20' ' ' VAL . 61.2 mt -88.23 -40.3 13.42 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 O-C-N 121.374 -0.829 . . . . 0.0 110.268 179.931 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.554 HG21 ' NE2' ' A' ' 14' ' ' HIS . 9.4 t -69.43 -33.54 57.89 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.875 0 O-C-N 121.378 -0.826 . . . . 0.0 110.61 -179.931 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -88.89 14.31 10.7 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.269 -0.894 . . . . 0.0 111.253 179.831 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.538 HG12 ' O ' ' A' ' 17' ' ' ILE . 0.5 OUTLIER . . . . . 0 N--CA 1.496 1.873 0 O-C-N 120.785 -1.197 . . . . 0.0 110.833 179.386 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.505 2.307 0 CA-C-O 121.017 0.436 . . . . 0.0 110.863 . . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.523 ' N ' ' HD2' ' A' ' 28' ' ' PRO . 0.6 OUTLIER -67.93 -50.18 33.67 Favored Pre-proline 0 N--CA 1.501 2.102 0 O-C-N 121.239 -0.913 . . . . 0.0 111.401 -179.907 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.523 ' HD2' ' N ' ' A' ' 27' ' ' SER . 44.1 Cg_endo -71.08 -20.71 28.37 Favored 'Trans proline' 0 N--CA 1.489 1.243 0 O-C-N 123.247 1.13 . . . . 0.0 111.115 -179.884 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -77.18 -43.82 32.42 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.405 -0.809 . . . . 0.0 110.564 179.915 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.428 HG22 ' O ' ' A' ' 27' ' ' SER . 4.9 tp -72.02 -28.63 30.38 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 O-C-N 121.277 -0.89 . . . . 0.0 111.009 -179.814 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 3.3 p -77.21 -35.49 55.6 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.322 -0.861 . . . . 0.0 110.119 179.637 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -86.87 12.04 11.95 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.36 -0.838 . . . . 0.0 110.744 179.406 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 89.6 t80 -112.87 -38.91 4.4 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.188 -0.945 . . . . 0.0 110.366 179.654 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 38.5 t . . . . . 0 N--CA 1.496 1.874 0 O-C-N 121.403 -0.811 . . . . 0.0 110.075 -179.873 . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 2.632 0 N-CA-C 109.767 -1.333 . . . . 0.0 109.767 . . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.453 ' HA ' HD22 ' A' ' 10' ' ' LEU . 0.2 OUTLIER -60.86 -47.39 86.57 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.53 -0.983 . . . . 0.0 110.29 179.964 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 5.4 tt -58.25 -45.67 87.37 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.543 -0.723 . . . . 0.0 109.677 179.259 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 5.1 t-160 -68.11 -32.23 72.38 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.654 -0.654 . . . . 0.0 109.979 179.145 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.405 HD22 ' HA ' ' A' ' 13' ' ' LEU . 0.2 OUTLIER -61.08 -43.88 98.21 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.615 -0.678 . . . . 0.0 109.966 179.494 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 2.7 t-80 -61.17 -55.85 27.47 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.472 -0.768 . . . . 0.0 109.458 179.34 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.45 ' O ' ' HB2' ' A' ' 19' ' ' ASP . 3.3 tp60 -58.95 -37.77 77.5 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.585 -0.697 . . . . 0.0 110.296 179.746 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 14.8 t30 -63.31 -45.85 89.43 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.576 -0.703 . . . . 0.0 110.449 179.654 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.49 ' O ' HG12 ' A' ' 20' ' ' VAL . 27.7 mm -73.14 -32.59 39.25 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 O-C-N 121.242 -0.911 . . . . 0.0 109.961 179.58 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 52.2 t -75.12 -18.33 16.14 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 O-C-N 121.374 -0.829 . . . . 0.0 110.533 179.731 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.45 ' HB2' ' O ' ' A' ' 15' ' ' GLN . 0.2 OUTLIER -103.35 19.44 19.68 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.263 -0.898 . . . . 0.0 110.795 179.266 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.49 HG12 ' O ' ' A' ' 17' ' ' ILE . 1.5 p . . . . . 0 N--CA 1.495 1.801 0 O-C-N 120.784 -1.198 . . . . 0.0 110.65 179.473 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.76 ' HB3' ' HB3' ' A' ' 29' ' ' ALA . 79.6 mt . . . . . 0 N--CA 1.499 1.986 0 CA-C-O 121.307 0.575 . . . . 0.0 110.331 . . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.554 ' HB2' ' HD3' ' A' ' 28' ' ' PRO . 3.6 m -52.53 -49.82 83.7 Favored Pre-proline 0 N--CA 1.5 2.058 0 O-C-N 121.673 -0.642 . . . . 0.0 111.555 -179.578 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.554 ' HD3' ' HB2' ' A' ' 27' ' ' SER . 44.3 Cg_endo -70.27 -12.56 32.16 Favored 'Trans proline' 0 N--CA 1.491 1.37 0 O-C-N 123.275 1.145 . . . . 0.0 111.613 -179.772 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.76 ' HB3' ' HB3' ' A' ' 26' ' ' LEU . . . -98.93 -41.41 7.61 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.305 -0.872 . . . . 0.0 110.249 179.635 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 16.7 tt -69.98 -23.36 25.33 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 O-C-N 121.422 -0.799 . . . . 0.0 110.951 -179.987 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 2.0 p -63.77 -46.14 86.61 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.387 -0.821 . . . . 0.0 110.158 179.689 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 5.9 mttp -90.13 18.97 5.34 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.546 -0.721 . . . . 0.0 110.306 179.258 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 13.0 t80 -116.25 -40.83 3.21 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.291 -0.881 . . . . 0.0 110.165 179.816 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 29.7 t . . . . . 0 N--CA 1.494 1.76 0 O-C-N 121.378 -0.826 . . . . 0.0 109.68 179.898 . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.45 0 N-CA-C 109.281 -1.527 . . . . 0.0 109.281 . . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 13.4 mt -85.72 -32.41 21.92 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.605 -0.938 . . . . 0.0 109.944 179.38 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 6.0 mp -60.14 -55.78 29.62 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.523 -0.736 . . . . 0.0 110.281 179.841 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 13.7 t-160 -60.35 -42.62 96.1 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.489 -0.757 . . . . 0.0 109.94 179.459 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 13.2 tp -59.82 -41.36 91.14 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.605 -0.684 . . . . 0.0 109.962 179.398 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 14' ' ' HIS . . . . . 0.508 ' NE2' HG21 ' A' ' 18' ' ' VAL . 51.4 t60 -63.03 -47.74 81.76 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.627 -0.671 . . . . 0.0 110.095 179.571 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 34.4 tp60 -56.17 -42.4 76.99 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.544 -0.723 . . . . 0.0 110.369 179.969 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.459 ' O ' ' HB ' ' A' ' 20' ' ' VAL . 8.4 t-20 -62.46 -48.98 77.25 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.282 -0.886 . . . . 0.0 110.377 179.637 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.513 ' O ' HG12 ' A' ' 20' ' ' VAL . 73.2 mt -65.73 -38.7 82.88 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.036 0 O-C-N 121.423 -0.798 . . . . 0.0 110.41 -179.958 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.508 HG21 ' NE2' ' A' ' 14' ' ' HIS . 21.3 t -70.92 -36.73 65.2 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 O-C-N 121.237 -0.914 . . . . 0.0 110.35 179.797 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -85.73 1.72 48.34 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.498 -0.751 . . . . 0.0 111.477 179.976 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.513 HG12 ' O ' ' A' ' 17' ' ' ILE . 1.0 OUTLIER . . . . . 0 N--CA 1.497 1.882 0 O-C-N 120.802 -1.186 . . . . 0.0 110.431 179.121 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.504 2.26 0 CA-C-O 120.83 0.348 . . . . 0.0 111.1 . . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.51 ' CB ' ' CD ' ' A' ' 28' ' ' PRO . 0.4 OUTLIER -175.16 -62.58 0.0 OUTLIER Pre-proline 0 N--CA 1.497 1.904 0 O-C-N 121.416 -0.802 . . . . 0.0 110.093 179.599 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.51 ' CD ' ' CB ' ' A' ' 27' ' ' SER . 43.6 Cg_endo -70.24 -31.96 17.43 Favored 'Trans proline' 0 N--CA 1.488 1.195 0 O-C-N 123.318 1.168 . . . . 0.0 110.339 179.174 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.44 ' O ' ' HB2' ' A' ' 33' ' ' TYR . . . -72.04 -13.12 61.51 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.618 -0.676 . . . . 0.0 111.037 179.477 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.489 HG22 ' O ' ' A' ' 27' ' ' SER . 9.2 tp -114.03 -28.27 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 O-C-N 121.067 -1.021 . . . . 0.0 111.395 -179.73 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 2.0 t -96.08 -20.19 18.84 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.059 -1.026 . . . . 0.0 110.958 -179.977 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -114.41 17.96 17.15 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.095 -1.003 . . . . 0.0 110.544 179.691 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.44 ' HB2' ' O ' ' A' ' 29' ' ' ALA . 7.2 m-85 -129.56 21.41 5.56 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.286 -0.884 . . . . 0.0 110.801 -179.935 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.463 HG12 ' O ' ' A' ' 34' ' ' VAL . 21.3 t . . . . . 0 N--CA 1.496 1.857 0 O-C-N 121.285 -0.884 . . . . 0.0 110.094 -179.934 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.355 0 N-CA-C 109.302 -1.519 . . . . 0.0 109.302 . . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -59.97 -41.98 93.13 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.664 -0.904 . . . . 0.0 110.507 179.945 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -60.94 -50.33 73.85 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.459 -0.776 . . . . 0.0 110.003 179.675 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 3.8 m80 -63.82 -42.5 97.65 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.605 -0.685 . . . . 0.0 110.255 179.679 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 9.3 tp -60.65 -42.88 97.87 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.504 -0.748 . . . . 0.0 110.011 179.538 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 14' ' ' HIS . . . . . 0.548 ' NE2' HG21 ' A' ' 18' ' ' VAL . 66.6 t60 -59.64 -55.07 38.98 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.647 -0.658 . . . . 0.0 109.943 179.478 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -53.24 -37.29 61.93 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.631 -0.668 . . . . 0.0 110.383 179.699 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.539 ' O ' HG23 ' A' ' 20' ' ' VAL . 0.7 OUTLIER -65.98 -46.15 79.08 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.541 -0.724 . . . . 0.0 110.493 179.697 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 63.3 mt -72.47 -32.83 43.38 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.11 0 O-C-N 121.418 -0.801 . . . . 0.0 110.429 179.934 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.548 HG21 ' NE2' ' A' ' 14' ' ' HIS . 52.4 t -65.86 -48.18 82.96 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.491 -0.756 . . . . 0.0 110.328 -179.815 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -79.42 47.73 0.84 Allowed 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.145 -0.972 . . . . 0.0 110.855 179.953 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.539 HG23 ' O ' ' A' ' 16' ' ' ASN . 51.3 t . . . . . 0 N--CA 1.496 1.843 0 O-C-N 121.335 -0.853 . . . . 0.0 109.536 179.319 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.5 2.064 0 CA-C-O 120.744 0.307 . . . . 0.0 111.557 . . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.649 ' HB2' ' HD3' ' A' ' 28' ' ' PRO . 2.5 m -106.48 -62.3 0.04 OUTLIER Pre-proline 0 N--CA 1.495 1.81 0 O-C-N 121.114 -0.991 . . . . 0.0 110.443 179.715 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.649 ' HD3' ' HB2' ' A' ' 27' ' ' SER . 53.6 Cg_endo -79.81 63.75 8.78 Favored 'Trans proline' 0 N--CA 1.484 0.92 0 O-C-N 123.239 1.126 . . . . 0.0 110.033 179.357 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -166.41 -46.6 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.524 -0.735 . . . . 0.0 110.298 -179.7 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 47.6 mm -81.51 -38.8 16.56 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 O-C-N 121.535 -0.728 . . . . 0.0 110.265 -179.9 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 82.5 m -70.87 -42.26 70.28 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.464 -0.773 . . . . 0.0 110.031 179.732 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 7.2 mttp -69.7 -15.67 63.21 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.442 -0.786 . . . . 0.0 110.753 179.379 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -70.21 -42.49 72.25 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.377 -0.827 . . . . 0.0 110.38 179.847 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.522 HG12 ' O ' ' A' ' 34' ' ' VAL . 26.6 t . . . . . 0 N--CA 1.497 1.9 0 O-C-N 121.457 -0.777 . . . . 0.0 110.347 179.729 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.363 0 N-CA-C 108.699 -1.76 . . . . 0.0 108.699 . . . . . . . . . 0 0 . 1 . 031 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -62.25 -36.99 83.73 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.611 -0.935 . . . . 0.0 109.921 179.064 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -59.95 -47.41 85.92 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.553 -0.717 . . . . 0.0 110.096 179.43 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 26.5 t-80 -67.35 -43.92 80.32 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.518 -0.739 . . . . 0.0 109.531 179.272 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -59.95 -40.15 88.03 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.662 -0.649 . . . . 0.0 109.872 179.237 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 14' ' ' HIS . . . . . 0.714 ' O ' HG23 ' A' ' 18' ' ' VAL . 1.1 t-80 -58.68 -55.24 37.7 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.576 -0.703 . . . . 0.0 109.639 179.389 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.39 -37.36 72.56 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.611 -0.68 . . . . 0.0 110.58 179.895 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -59.58 -35.76 74.92 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.378 -0.826 . . . . 0.0 110.064 179.296 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 46.2 mm -82.58 -36.56 13.55 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.46 -0.775 . . . . 0.0 109.844 179.55 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.714 HG23 ' O ' ' A' ' 14' ' ' HIS . 61.2 t -61.55 -23.23 30.13 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.048 0 O-C-N 121.448 -0.783 . . . . 0.0 110.758 -179.979 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -86.81 -21.42 26.47 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.252 -0.905 . . . . 0.0 110.614 179.81 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 47.5 t . . . . . 0 N--CA 1.496 1.868 0 O-C-N 121.112 -0.992 . . . . 0.0 109.595 179.346 . . . . . . . . 0 0 . 1 . 031 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.499 2.003 0 CA-C-O 121.273 0.558 . . . . 0.0 110.498 . . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.536 ' N ' ' CD ' ' A' ' 28' ' ' PRO . 0.3 OUTLIER -82.12 -40.39 0.94 Allowed Pre-proline 0 N--CA 1.496 1.867 0 O-C-N 121.445 -0.785 . . . . 0.0 112.012 -179.695 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.536 ' CD ' ' N ' ' A' ' 27' ' ' SER . 47.8 Cg_endo -75.86 64.56 6.79 Favored 'Trans proline' 0 N--CA 1.486 1.081 0 O-C-N 123.126 1.066 . . . . 0.0 110.614 -179.359 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -167.55 -49.67 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.708 -0.62 . . . . 0.0 109.789 179.892 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 49.2 mm -91.9 -29.88 4.66 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 121.612 -0.68 . . . . 0.0 110.23 179.633 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 31.9 m -61.35 -38.13 85.83 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.528 -0.733 . . . . 0.0 110.142 179.725 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.96 -27.53 64.81 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.394 -0.816 . . . . 0.0 110.47 179.609 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -78.77 -16.95 56.54 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.449 -0.782 . . . . 0.0 110.811 179.544 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 23.6 t . . . . . 0 N--CA 1.498 1.948 0 O-C-N 121.291 -0.881 . . . . 0.0 109.982 179.944 . . . . . . . . 0 0 . 1 . 032 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.415 0 N-CA-C 109.262 -1.535 . . . . 0.0 109.262 . . . . . . . . . 0 0 . 1 . 032 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -60.53 -34.83 74.69 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.595 -0.944 . . . . 0.0 110.287 179.7 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 6.4 tt -56.33 -45.19 80.44 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.577 -0.702 . . . . 0.0 110.153 179.503 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 27.6 m-70 -81.81 -42.55 19.53 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.438 -0.789 . . . . 0.0 110.008 179.521 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 7.2 tp -57.36 -37.32 72.42 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.65 -0.656 . . . . 0.0 110.484 179.801 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -56.83 -47.31 80.6 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.458 -0.776 . . . . 0.0 109.802 179.382 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 6.4 tp60 -59.53 -34.94 73.27 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.625 -0.672 . . . . 0.0 110.42 179.627 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 16.0 t30 -69.91 -35.21 74.41 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.459 -0.775 . . . . 0.0 110.403 179.551 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 32.5 mt -82.47 -16.07 11.76 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 O-C-N 121.241 -0.912 . . . . 0.0 110.879 179.962 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 74.7 t -99.38 -50.97 10.49 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.142 -0.974 . . . . 0.0 109.802 179.891 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 34.5 t0 -61.57 -21.7 64.53 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.602 -0.686 . . . . 0.0 110.604 179.376 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 8.3 p . . . . . 0 N--CA 1.5 2.059 0 O-C-N 121.296 -0.878 . . . . 0.0 110.935 179.53 . . . . . . . . 0 0 . 1 . 032 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 5.3 mp . . . . . 0 N--CA 1.5 2.036 0 CA-C-O 121.177 0.513 . . . . 0.0 111.194 . . . . . . . . . 0 0 . 1 . 032 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.58 ' HB3' ' HD3' ' A' ' 28' ' ' PRO . 3.7 t -164.21 -65.09 0.01 OUTLIER Pre-proline 0 N--CA 1.499 1.998 0 O-C-N 121.265 -0.897 . . . . 0.0 110.602 179.221 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.58 ' HD3' ' HB3' ' A' ' 27' ' ' SER . 47.1 Cg_endo -72.97 -20.54 21.9 Favored 'Trans proline' 0 N--CA 1.491 1.328 0 O-C-N 123.258 1.136 . . . . 0.0 111.113 179.888 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -73.44 -45.06 56.63 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.448 -0.783 . . . . 0.0 110.202 179.887 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 3.2 mt -68.07 -36.4 75.27 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 O-C-N 121.422 -0.799 . . . . 0.0 110.564 -179.967 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 20.3 p -71.47 -32.19 68.0 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.477 -0.764 . . . . 0.0 110.316 179.703 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.4 tttt -90.42 18.53 6.08 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.415 -0.803 . . . . 0.0 110.814 179.763 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -111.51 -50.8 2.9 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.296 -0.878 . . . . 0.0 109.766 179.627 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 45.9 t . . . . . 0 N--CA 1.496 1.826 0 O-C-N 121.445 -0.784 . . . . 0.0 109.845 179.791 . . . . . . . . 0 0 . 1 . 033 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.502 0 N-CA-C 109.237 -1.545 . . . . 0.0 109.237 . . . . . . . . . 0 0 . 1 . 033 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.442 ' HA ' HD13 ' A' ' 10' ' ' LEU . 3.1 mm? -70.1 -43.69 70.56 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.591 -0.947 . . . . 0.0 109.91 179.699 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 5.6 tt -58.35 -45.94 87.2 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.64 -0.663 . . . . 0.0 110.392 179.703 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 37.1 t60 -64.58 -40.62 95.87 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.473 -0.767 . . . . 0.0 110.2 179.765 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.713 ' HG ' HD13 ' A' ' 17' ' ' ILE . 3.2 tp -60.28 -40.6 90.97 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.448 -0.782 . . . . 0.0 110.108 179.406 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 14' ' ' HIS . . . . . 0.489 ' CD2' HG21 ' A' ' 18' ' ' VAL . 18.3 t-80 -60.19 -58.64 7.67 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.388 -0.82 . . . . 0.0 109.778 179.625 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.452 ' O ' ' HB2' ' A' ' 19' ' ' ASP . 0.7 OUTLIER -60.14 -26.04 65.97 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.452 -0.78 . . . . 0.0 110.692 179.613 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 -80.0 -46.38 16.72 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.35 -0.844 . . . . 0.0 110.577 -179.883 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.713 HD13 ' HG ' ' A' ' 13' ' ' LEU . 1.3 mp -76.7 -33.58 22.14 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 121.286 -0.884 . . . . 0.0 110.401 -179.809 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.489 HG21 ' CD2' ' A' ' 14' ' ' HIS . 50.7 t -70.52 -29.43 38.53 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 O-C-N 121.125 -0.984 . . . . 0.0 110.364 179.826 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.452 ' HB2' ' O ' ' A' ' 15' ' ' GLN . 0.4 OUTLIER -88.26 3.27 50.14 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.461 -0.775 . . . . 0.0 111.211 179.772 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.546 HG12 ' O ' ' A' ' 17' ' ' ILE . 0.8 OUTLIER . . . . . 0 N--CA 1.496 1.828 0 O-C-N 120.947 -1.096 . . . . 0.0 110.722 179.611 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.496 1.863 0 CA-C-O 120.896 0.379 . . . . 0.0 110.808 . . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.468 ' O ' HG22 ' A' ' 30' ' ' ILE . 0.0 OUTLIER -84.48 -56.5 0.41 Allowed Pre-proline 0 N--CA 1.499 2.019 0 O-C-N 121.2 -0.938 . . . . 0.0 110.223 179.823 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.443 ' HD3' ' CB ' ' A' ' 27' ' ' SER . 49.4 Cg_endo -77.58 -11.52 17.05 Favored 'Trans proline' 0 C--N 1.32 -0.926 0 O-C-N 123.32 1.168 . . . . 0.0 110.596 179.174 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -82.81 -43.55 16.54 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.274 -0.892 . . . . 0.0 110.33 179.935 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.468 HG22 ' O ' ' A' ' 27' ' ' SER . 4.0 tp -65.0 -30.5 50.56 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 O-C-N 121.498 -0.751 . . . . 0.0 110.674 -179.99 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 9.7 p -72.35 -25.73 61.65 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.376 -0.827 . . . . 0.0 110.229 179.345 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 2.5 tttm -99.24 16.39 23.05 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.389 -0.819 . . . . 0.0 110.643 179.63 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -110.19 -37.88 5.43 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.222 -0.923 . . . . 0.0 110.69 -179.759 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 52.8 t . . . . . 0 N--CA 1.498 1.961 0 O-C-N 121.421 -0.799 . . . . 0.0 110.224 -179.84 . . . . . . . . 0 0 . 1 . 034 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.521 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 . . . . . . . . . 0 0 . 1 . 034 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.423 ' HA ' HD22 ' A' ' 10' ' ' LEU . 0.2 OUTLIER -62.34 -39.24 92.44 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.642 -0.917 . . . . 0.0 110.389 179.826 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 13.6 tp -58.68 -51.04 71.63 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.46 -0.775 . . . . 0.0 110.236 179.669 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -65.15 -43.15 92.76 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.548 -0.72 . . . . 0.0 109.816 179.482 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -60.63 -39.7 89.23 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.535 -0.728 . . . . 0.0 109.953 179.241 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 14' ' ' HIS . . . . . 0.579 ' NE2' HG21 ' A' ' 18' ' ' VAL . 4.4 t-80 -59.31 -54.09 50.74 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.786 -0.572 . . . . 0.0 109.885 179.538 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.9 tp60 -57.31 -47.18 82.17 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.518 -0.739 . . . . 0.0 110.221 179.865 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -48.41 -45.89 36.64 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.496 -0.753 . . . . 0.0 110.519 179.512 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.434 HD13 ' HA ' ' A' ' 17' ' ' ILE . 18.4 mm -73.62 -42.37 55.35 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 121.37 -0.831 . . . . 0.0 110.114 179.653 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.579 HG21 ' NE2' ' A' ' 14' ' ' HIS . 40.5 t -65.67 -34.99 74.12 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 121.465 -0.772 . . . . 0.0 110.401 179.786 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 72.9 m-20 -67.59 -16.55 64.24 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.488 -0.758 . . . . 0.0 110.595 179.239 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 64.6 t . . . . . 0 N--CA 1.494 1.738 0 O-C-N 121.044 -1.035 . . . . 0.0 109.261 179.148 . . . . . . . . 0 0 . 1 . 034 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.497 1.886 0 CA-C-O 121.106 0.479 . . . . 0.0 110.23 . . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.608 ' HB2' ' HD3' ' A' ' 28' ' ' PRO . 48.2 m -57.03 -50.66 86.92 Favored Pre-proline 0 N--CA 1.497 1.913 0 O-C-N 121.738 -0.601 . . . . 0.0 110.915 179.881 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.608 ' HD3' ' HB2' ' A' ' 27' ' ' SER . 47.7 Cg_endo -71.3 -7.83 22.14 Favored 'Trans proline' 0 N--CA 1.491 1.362 0 O-C-N 123.421 1.221 . . . . 0.0 111.592 179.83 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -98.05 -39.29 9.0 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.199 -0.938 . . . . 0.0 110.357 179.944 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 49.4 mt -76.14 -35.4 28.39 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 O-C-N 121.389 -0.819 . . . . 0.0 110.71 -179.802 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 8.8 p -60.94 -37.46 82.42 Favored 'General case' 0 N--CA 1.501 2.122 0 O-C-N 121.441 -0.787 . . . . 0.0 110.336 179.747 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 26.9 mttt -89.86 13.69 13.9 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.392 -0.818 . . . . 0.0 110.617 179.273 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -108.03 -47.88 3.48 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.305 -0.872 . . . . 0.0 110.067 179.743 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 25.8 t . . . . . 0 N--CA 1.498 1.947 0 O-C-N 121.541 -0.725 . . . . 0.0 109.537 179.77 . . . . . . . . 0 0 . 1 . 035 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.498 2.792 0 N-CA-C 110.221 -1.151 . . . . 0.0 110.221 . . . . . . . . . 0 0 . 1 . 035 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 10.6 tp -58.73 -31.61 68.46 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.638 -0.919 . . . . 0.0 110.568 179.79 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 5.0 mp -56.91 -41.81 78.82 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.597 -0.689 . . . . 0.0 110.13 179.639 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 -80.05 -40.21 28.18 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.348 -0.845 . . . . 0.0 109.83 179.212 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.7 tt -60.49 -42.06 95.53 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.66 -0.65 . . . . 0.0 110.538 179.943 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 14' ' ' HIS . . . . . 0.539 ' CE1' HG21 ' A' ' 18' ' ' VAL . 86.5 t60 -61.52 -51.37 68.89 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.479 -0.763 . . . . 0.0 110.281 179.95 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 12.2 tp60 -62.21 -30.23 70.94 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.341 -0.849 . . . . 0.0 110.011 179.436 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -66.52 -24.95 66.46 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.293 -0.879 . . . . 0.0 110.297 179.144 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 61.7 mt -101.39 -27.56 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 121.205 -0.935 . . . . 0.0 110.342 179.68 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.539 HG21 ' CE1' ' A' ' 14' ' ' HIS . 93.5 t -95.92 -13.23 8.26 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 O-C-N 121.383 -0.823 . . . . 0.0 111.142 -179.647 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -120.15 38.48 3.95 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.033 -1.042 . . . . 0.0 110.553 179.836 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 40.1 t . . . . . 0 N--CA 1.497 1.923 0 O-C-N 121.355 -0.841 . . . . 0.0 109.857 179.949 . . . . . . . . 0 0 . 1 . 035 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.499 2.025 0 CA-C-O 120.63 0.252 . . . . 0.0 111.306 . . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.519 ' N ' ' HD2' ' A' ' 28' ' ' PRO . 4.7 m -64.07 -52.19 57.47 Favored Pre-proline 0 N--CA 1.499 1.975 0 O-C-N 121.24 -0.912 . . . . 0.0 110.732 179.608 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.519 ' HD2' ' N ' ' A' ' 27' ' ' SER . 44.3 Cg_endo -71.27 -17.88 30.67 Favored 'Trans proline' 0 N--CA 1.489 1.207 0 O-C-N 123.413 1.217 . . . . 0.0 110.795 179.477 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -77.28 -28.19 53.36 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.454 -0.779 . . . . 0.0 110.263 179.547 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 89.6 mt -90.08 -29.07 4.96 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 121.3 -0.875 . . . . 0.0 110.605 179.961 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 32.6 p -65.02 -50.19 67.23 Favored 'General case' 0 N--CA 1.502 2.144 0 O-C-N 121.279 -0.888 . . . . 0.0 110.069 179.656 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.88 -17.04 64.36 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.447 -0.783 . . . . 0.0 110.439 179.226 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 81.8 t80 -82.18 -34.92 28.84 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.364 -0.835 . . . . 0.0 110.124 179.543 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 97.3 t . . . . . 0 N--CA 1.495 1.822 0 O-C-N 121.465 -0.772 . . . . 0.0 110.338 -179.982 . . . . . . . . 0 0 . 1 . 036 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.462 0 N-CA-C 108.951 -1.66 . . . . 0.0 108.951 . . . . . . . . . 0 0 . 1 . 036 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.1 mp -57.91 -37.52 74.2 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.651 -0.911 . . . . 0.0 110.111 179.501 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.411 HD13 ' HA ' ' A' ' 11' ' ' LEU . 0.5 OUTLIER -57.14 -44.48 83.41 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.64 -0.663 . . . . 0.0 110.035 179.412 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 7.1 m170 -67.74 -43.76 79.18 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.582 -0.699 . . . . 0.0 110.227 179.636 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.2 tt -55.2 -44.42 75.31 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.646 -0.659 . . . . 0.0 110.456 179.956 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 -60.35 -50.04 75.2 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.506 -0.746 . . . . 0.0 109.689 179.504 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 16.4 mm100 -64.69 -35.67 81.8 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.542 -0.724 . . . . 0.0 110.065 179.646 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -61.94 -38.06 87.05 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.576 -0.703 . . . . 0.0 110.6 179.658 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.412 HD13 ' HA ' ' A' ' 17' ' ' ILE . 24.1 mm -83.23 -45.17 18.86 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 O-C-N 121.37 -0.831 . . . . 0.0 110.341 -179.834 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 64.3 t -63.4 -35.69 73.29 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 O-C-N 121.497 -0.752 . . . . 0.0 110.712 -179.797 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -68.94 -24.84 64.32 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.385 -0.822 . . . . 0.0 110.733 -179.992 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 48.8 t . . . . . 0 N--CA 1.492 1.648 0 O-C-N 120.968 -1.082 . . . . 0.0 109.494 179.327 . . . . . . . . 0 0 . 1 . 036 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.497 1.902 0 CA-C-O 121.048 0.452 . . . . 0.0 110.505 . . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.556 ' HB2' ' HD3' ' A' ' 28' ' ' PRO . 0.7 OUTLIER -86.2 -49.85 0.51 Allowed Pre-proline 0 N--CA 1.5 2.049 0 O-C-N 121.453 -0.779 . . . . 0.0 111.268 -179.751 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.556 ' HD3' ' HB2' ' A' ' 27' ' ' SER . 50.5 Cg_endo -77.21 64.52 7.87 Favored 'Trans proline' 0 N--CA 1.487 1.13 0 O-C-N 123.395 1.208 . . . . 0.0 110.55 -179.635 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -167.34 -49.48 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.644 -0.66 . . . . 0.0 109.729 179.864 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.41 ' O ' HG23 ' A' ' 34' ' ' VAL . 46.4 mm -79.11 -38.12 20.06 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 121.562 -0.711 . . . . 0.0 110.113 179.758 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 29.7 p -65.01 -45.29 86.16 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.522 -0.736 . . . . 0.0 109.979 179.59 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 24.7 mmtt -64.69 -27.68 69.08 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.644 -0.66 . . . . 0.0 110.221 179.385 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -69.14 -35.39 76.32 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.463 -0.773 . . . . 0.0 109.801 179.212 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.41 HG23 ' O ' ' A' ' 30' ' ' ILE . 21.9 t . . . . . 0 N--CA 1.495 1.81 0 O-C-N 121.53 -0.731 . . . . 0.0 109.504 179.448 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' SER . . . . . 0.438 ' O ' ' HB2' ' A' ' 2' ' ' ASP . 20.9 m . . . . . 0 N--CA 1.495 1.818 0 N-CA-C 110.169 -0.308 . . . . 0.0 110.169 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.438 ' HB2' ' O ' ' A' ' 1' ' ' SER . 16.4 m-20 62.18 173.27 0.13 Allowed 'General case' 0 N--CA 1.502 2.166 0 CA-C-O 121.42 0.628 . . . . 0.0 111.137 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 52.4 66.78 4.6 Favored Pre-proline 0 N--CA 1.501 2.085 0 O-C-N 121.607 -0.683 . . . . 0.0 110.697 -179.879 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -79.22 60.49 7.82 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 O-C-N 123.937 1.493 . . . . 0.0 110.562 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -154.26 -54.87 0.1 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.557 -0.714 . . . . 0.0 109.834 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 57.79 26.03 12.65 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 121.834 -0.542 . . . . 0.0 111.327 179.797 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 16.5 m -116.05 26.09 10.21 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.075 -1.016 . . . . 0.0 110.462 179.627 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 18.2 p -141.56 58.64 1.51 Allowed 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.352 -0.842 . . . . 0.0 109.93 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -85.18 -64.85 1.5 Allowed Glycine 0 N--CA 1.495 2.57 0 N-CA-C 109.807 -1.317 . . . . 0.0 109.807 -179.623 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 12.6 mt -58.3 -40.71 82.7 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.683 -0.892 . . . . 0.0 110.465 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 5.1 tt -57.54 -50.42 73.14 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.49 -0.756 . . . . 0.0 109.943 179.602 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -61.06 -41.95 97.56 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.692 -0.63 . . . . 0.0 110.074 179.515 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 9.4 tp -58.12 -42.67 86.24 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.641 -0.662 . . . . 0.0 110.199 179.518 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' HIS . . . . . 0.505 ' CE1' HG21 ' A' ' 18' ' ' VAL . 74.7 t60 -61.02 -49.16 78.53 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.713 -0.617 . . . . 0.0 110.001 179.596 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 15.8 mm-40 -60.08 -37.82 81.06 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.505 -0.747 . . . . 0.0 110.267 179.677 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -62.28 -39.75 93.97 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.498 -0.751 . . . . 0.0 110.377 179.626 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 56.4 mt -79.65 -44.08 23.31 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 O-C-N 121.317 -0.864 . . . . 0.0 110.203 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.505 HG21 ' CE1' ' A' ' 14' ' ' HIS . 49.9 t -66.65 -17.91 23.31 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 O-C-N 121.558 -0.714 . . . . 0.0 111.134 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -98.53 -6.23 30.6 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.141 -0.974 . . . . 0.0 111.053 179.829 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 75.7 t -116.36 -50.69 4.59 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 O-C-N 120.935 -1.103 . . . . 0.0 110.282 179.615 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.59 -27.09 69.0 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.648 -0.657 . . . . 0.0 110.743 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -63.31 -31.22 72.32 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.298 -0.876 . . . . 0.0 110.159 179.702 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -98.17 -27.92 13.96 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.394 -0.816 . . . . 0.0 110.705 179.536 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 52.0 m-85 -108.05 27.57 9.13 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.232 -0.917 . . . . 0.0 110.956 -179.611 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -88.0 -62.97 1.4 Allowed Glycine 0 N--CA 1.494 2.526 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER 51.36 32.68 8.79 Favored 'General case' 0 N--CA 1.504 2.245 0 O-C-N 121.976 -0.72 . . . . 0.0 111.253 179.792 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.434 ' N ' ' HD2' ' A' ' 28' ' ' PRO . 0.0 OUTLIER -59.45 -57.02 30.05 Favored Pre-proline 0 N--CA 1.501 2.097 0 O-C-N 121.306 -0.871 . . . . 0.0 110.616 179.815 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.434 ' HD2' ' N ' ' A' ' 27' ' ' SER . 45.7 Cg_endo -71.52 -27.53 18.76 Favored 'Trans proline' 0 N--CA 1.487 1.114 0 O-C-N 123.485 1.255 . . . . 0.0 110.895 179.681 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.36 -52.51 61.41 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.446 -0.784 . . . . 0.0 110.746 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 34.8 mm -60.52 -35.85 66.0 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.12 0 O-C-N 121.411 -0.806 . . . . 0.0 110.559 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 73.4 m -61.11 -27.82 68.65 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.541 -0.724 . . . . 0.0 110.566 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.36 7.52 33.34 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.299 -0.876 . . . . 0.0 110.689 179.559 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -101.22 -39.31 7.7 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.36 -0.837 . . . . 0.0 110.161 179.716 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 92.2 t -71.82 -23.61 22.36 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 121.445 -0.784 . . . . 0.0 110.367 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.2 p -107.65 8.18 9.48 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 O-C-N 121.23 -0.919 . . . . 0.0 111.208 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.497 1.903 0 CA-C-O 117.908 -1.044 . . . . 0.0 110.477 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 7.6 p . . . . . 0 N--CA 1.495 1.81 0 CA-C-O 121.182 0.515 . . . . 0.0 110.183 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -115.88 -0.86 12.72 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.532 -0.73 . . . . 0.0 111.352 -179.835 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 50.58 69.65 2.48 Favored Pre-proline 0 N--CA 1.503 2.21 0 O-C-N 121.489 -0.757 . . . . 0.0 111.332 179.51 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.433 ' O ' ' HB3' ' A' ' 5' ' ' ALA . 48.3 Cg_endo -86.59 52.5 2.75 Favored 'Trans proline' 0 C--N 1.31 -1.456 0 C-N-CA 121.524 1.483 . . . . 0.0 110.811 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.433 ' HB3' ' O ' ' A' ' 4' ' ' PRO . . . 59.15 19.6 7.56 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 121.462 -0.774 . . . . 0.0 111.375 -179.848 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 2.0 mt -120.18 10.59 11.4 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.145 -0.972 . . . . 0.0 110.657 179.56 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 91.5 p -159.84 52.82 0.35 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.226 -0.921 . . . . 0.0 109.876 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 5.8 t -125.54 22.46 7.63 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.193 -0.942 . . . . 0.0 111.044 -179.551 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -62.21 -54.96 30.68 Favored Glycine 0 N--CA 1.496 2.685 0 N-CA-C 109.165 -1.574 . . . . 0.0 109.165 179.405 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 7.1 tp -81.73 -31.73 31.9 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.606 -0.938 . . . . 0.0 109.91 179.153 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -56.03 -47.59 77.56 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.535 -0.728 . . . . 0.0 110.256 179.73 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -57.36 -42.99 83.14 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.547 -0.721 . . . . 0.0 110.036 179.46 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.1 tt -60.96 -41.46 96.38 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.676 -0.64 . . . . 0.0 110.224 179.451 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' HIS . . . . . 0.607 ' NE2' HG21 ' A' ' 18' ' ' VAL . 67.9 t60 -60.8 -50.23 74.3 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.399 -0.813 . . . . 0.0 109.721 179.408 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 51.8 mm-40 -58.56 -35.89 73.08 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.531 -0.731 . . . . 0.0 110.007 179.382 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -58.54 -36.11 73.37 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.621 -0.674 . . . . 0.0 110.133 179.234 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.579 ' O ' HG12 ' A' ' 20' ' ' VAL . 7.4 mt -88.17 -31.81 5.83 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 O-C-N 121.515 -0.741 . . . . 0.0 109.96 179.502 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.607 HG21 ' NE2' ' A' ' 14' ' ' HIS . 54.9 t -68.6 -37.38 77.57 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 121.378 -0.826 . . . . 0.0 110.301 179.855 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.58 ' HA ' ' CD2' ' A' ' 22' ' ' TYR . 0.6 OUTLIER -82.95 4.43 25.87 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.563 -0.71 . . . . 0.0 111.471 -179.985 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.579 HG12 ' O ' ' A' ' 17' ' ' ILE . 0.8 OUTLIER -113.52 -14.14 11.03 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 O-C-N 120.737 -1.227 . . . . 0.0 110.653 179.373 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 29.3 mt-30 -102.13 -32.68 9.99 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.415 -0.803 . . . . 0.0 110.539 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' TYR . . . . . 0.58 ' CD2' ' HA ' ' A' ' 19' ' ' ASP . 2.7 p90 -62.23 -25.04 67.59 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.266 -0.896 . . . . 0.0 110.978 -179.753 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 5.8 tmm? -88.91 -36.4 15.95 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.115 -0.991 . . . . 0.0 110.721 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 48.5 m-85 -88.1 -30.89 19.53 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.379 -0.826 . . . . 0.0 111.797 -179.075 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -124.86 26.2 5.68 Favored Glycine 0 N--CA 1.497 2.763 0 C-N-CA 119.921 -1.133 . . . . 0.0 111.395 -179.108 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.562 ' HB2' ' HA ' ' A' ' 22' ' ' TYR . 0.2 OUTLIER -159.9 33.84 0.18 Allowed 'General case' 0 N--CA 1.501 2.085 0 O-C-N 120.899 -1.354 . . . . 0.0 110.675 179.475 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.44 ' HB2' ' HD3' ' A' ' 28' ' ' PRO . 1.2 m -77.82 -51.77 1.73 Allowed Pre-proline 0 N--CA 1.497 1.913 0 O-C-N 121.297 -0.877 . . . . 0.0 111.064 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.44 ' HD3' ' HB2' ' A' ' 27' ' ' SER . 49.5 Cg_endo -76.93 61.43 7.12 Favored 'Trans proline' 0 N--CA 1.487 1.13 0 O-C-N 123.446 1.235 . . . . 0.0 110.317 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -167.35 -51.9 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.515 -0.741 . . . . 0.0 109.944 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 80.3 mt -68.35 -24.99 30.32 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 O-C-N 121.535 -0.728 . . . . 0.0 110.22 179.497 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 19.5 p -65.98 -41.83 90.63 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.448 -0.782 . . . . 0.0 110.211 179.471 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 5.9 tmtt? -70.2 -10.82 60.04 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.549 -0.72 . . . . 0.0 110.935 179.787 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 8.6 t80 -70.24 -43.25 70.97 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.316 -0.865 . . . . 0.0 110.361 179.757 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.501 HG12 ' O ' ' A' ' 34' ' ' VAL . 38.8 t -94.68 45.46 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 O-C-N 121.35 -0.844 . . . . 0.0 110.263 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.541 ' O ' HG12 ' A' ' 35' ' ' VAL . 59.5 t -139.97 52.8 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 O-C-N 121.154 -0.966 . . . . 0.0 109.471 179.499 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.751 0 CA-C-O 117.842 -1.075 . . . . 0.0 110.434 -179.829 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 13.4 m . . . . . 0 N--CA 1.497 1.911 0 CA-C-O 121.242 0.544 . . . . 0.0 110.01 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -132.62 40.0 3.31 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.4 -0.812 . . . . 0.0 110.588 -179.36 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.49 ' N ' ' HD3' ' A' ' 4' ' ' PRO . 0.2 OUTLIER 50.16 60.72 14.73 Favored Pre-proline 0 N--CA 1.503 2.183 0 O-C-N 121.626 -0.671 . . . . 0.0 110.941 179.893 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.49 ' HD3' ' N ' ' A' ' 3' ' ' LEU . 50.2 Cg_endo -85.1 37.64 0.61 Allowed 'Trans proline' 0 C--N 1.313 -1.303 0 O-C-N 123.646 1.34 . . . . 0.0 111.144 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -162.04 37.99 0.12 Allowed 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.272 -0.892 . . . . 0.0 110.474 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.588 HD12 ' HB2' ' A' ' 7' ' ' SER . 1.9 pp -63.47 -31.07 72.12 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.368 -0.833 . . . . 0.0 110.741 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.588 ' HB2' HD12 ' A' ' 6' ' ' LEU . 5.2 t -133.19 15.06 4.18 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.273 -0.892 . . . . 0.0 110.726 179.546 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.463 ' HB ' ' CG ' ' A' ' 12' ' ' HIS . 21.8 p -135.79 52.55 1.99 Allowed 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.123 -0.986 . . . . 0.0 110.088 179.871 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -92.17 -77.49 1.36 Allowed Glycine 0 N--CA 1.491 2.331 0 N-CA-C 108.49 -1.844 . . . . 0.0 108.49 179.449 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 7.4 mt -81.09 -35.57 31.52 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.67 -0.9 . . . . 0.0 109.878 179.192 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 2.5 tt -59.21 -42.9 92.03 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.633 -0.667 . . . . 0.0 110.069 179.507 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' HIS . . . . . 0.463 ' CG ' ' HB ' ' A' ' 8' ' ' THR . 0.0 OUTLIER -76.35 -33.21 58.97 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.524 -0.735 . . . . 0.0 110.105 179.429 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.402 HD22 ' HA ' ' A' ' 13' ' ' LEU . 0.1 OUTLIER -57.09 -47.72 80.34 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.445 -0.784 . . . . 0.0 110.472 179.912 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 14' ' ' HIS . . . . . 0.416 ' CE1' HG21 ' A' ' 18' ' ' VAL . 77.4 t60 -61.39 -52.21 65.55 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.381 -0.824 . . . . 0.0 109.823 179.625 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 4.3 tp-100 -60.02 -37.63 80.31 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.523 -0.735 . . . . 0.0 110.222 179.542 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -62.43 -39.42 93.27 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.573 -0.704 . . . . 0.0 110.665 179.676 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 76.5 mt -81.6 -41.82 18.97 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 O-C-N 121.166 -0.959 . . . . 0.0 110.29 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.416 HG21 ' CE1' ' A' ' 14' ' ' HIS . 76.8 t -65.26 -44.83 94.97 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 O-C-N 121.392 -0.818 . . . . 0.0 110.439 -179.901 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -65.73 -16.11 63.47 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.742 -0.599 . . . . 0.0 111.46 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 94.9 t -102.66 -38.21 5.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 120.74 -1.225 . . . . 0.0 109.86 179.495 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -66.53 -37.48 85.1 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.521 -0.737 . . . . 0.0 110.682 179.785 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -63.68 -34.44 77.87 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.227 -0.921 . . . . 0.0 110.286 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -96.2 21.33 9.05 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.377 -0.827 . . . . 0.0 110.651 179.452 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -109.52 33.55 4.28 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.157 -0.964 . . . . 0.0 110.51 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -121.21 -100.35 1.7 Allowed Glycine 0 N--CA 1.493 2.492 0 N-CA-C 109.317 -1.513 . . . . 0.0 109.317 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 10.6 mt 49.27 42.14 21.33 Favored 'General case' 0 N--CA 1.503 2.195 0 O-C-N 121.869 -0.783 . . . . 0.0 111.105 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.632 ' HB2' ' HD3' ' A' ' 28' ' ' PRO . 2.2 m -59.29 -56.28 37.57 Favored Pre-proline 0 N--CA 1.497 1.887 0 O-C-N 121.277 -0.89 . . . . 0.0 110.592 -179.851 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.632 ' HD3' ' HB2' ' A' ' 27' ' ' SER . 53.2 Cg_endo -80.42 53.87 4.96 Favored 'Trans proline' 0 N--CA 1.485 1.018 0 O-C-N 123.386 1.203 . . . . 0.0 110.434 179.329 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -155.44 -54.11 0.09 Allowed 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.304 -0.873 . . . . 0.0 110.029 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 10.0 mt -79.48 -32.17 14.54 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 O-C-N 121.415 -0.803 . . . . 0.0 110.439 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 16.1 m -61.17 -38.59 87.02 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.553 -0.717 . . . . 0.0 110.333 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 2.1 pttt -93.2 18.37 9.56 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.467 -0.77 . . . . 0.0 110.606 179.394 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -113.39 -50.02 2.88 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.265 -0.897 . . . . 0.0 109.952 179.773 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 74.0 t -85.17 -55.06 7.29 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 121.479 -0.763 . . . . 0.0 109.893 179.728 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.4 t 56.28 41.86 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.141 0 O-C-N 121.741 -0.6 . . . . 0.0 110.421 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.503 2.182 0 CA-C-O 118.074 -0.965 . . . . 0.0 111.288 179.644 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 46.2 m . . . . . 0 N--CA 1.494 1.732 0 CA-C-O 121.01 0.433 . . . . 0.0 110.13 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -125.99 38.03 4.23 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.461 -0.774 . . . . 0.0 110.744 -179.821 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.54 ' CB ' ' HD3' ' A' ' 4' ' ' PRO . 0.9 OUTLIER -71.09 -53.73 8.03 Favored Pre-proline 0 N--CA 1.496 1.846 0 O-C-N 121.222 -0.924 . . . . 0.0 110.018 179.309 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.54 ' HD3' ' CB ' ' A' ' 3' ' ' LEU . 52.3 Cg_endo -86.87 16.56 1.94 Allowed 'Trans proline' 0 CA--C 1.544 1.005 0 O-C-N 123.49 1.258 . . . . 0.0 111.307 179.34 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.432 ' HB3' ' O ' ' A' ' 4' ' ' PRO . . . 59.46 17.52 6.07 Favored 'General case' 0 N--CA 1.505 2.315 0 O-C-N 121.37 -0.831 . . . . 0.0 111.728 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 51.39 39.06 23.44 Favored 'General case' 0 N--CA 1.504 2.227 0 O-C-N 121.259 -0.901 . . . . 0.0 111.779 179.558 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 43.3 t 55.88 76.69 0.27 Allowed 'General case' 0 N--CA 1.502 2.162 0 O-C-N 121.487 -0.758 . . . . 0.0 111.188 179.397 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 2.0 p -117.61 17.3 14.47 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.277 -0.889 . . . . 0.0 111.104 179.749 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -65.08 -66.11 2.62 Favored Glycine 0 N--CA 1.496 2.64 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -58.48 -35.24 71.89 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.682 -0.893 . . . . 0.0 110.207 179.629 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 4.8 tt -57.18 -46.28 82.96 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.471 -0.768 . . . . 0.0 109.965 179.464 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 22.3 m-70 -68.44 -42.73 78.43 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.527 -0.733 . . . . 0.0 109.877 179.449 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -60.35 -38.79 84.95 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.63 -0.669 . . . . 0.0 109.778 179.225 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' HIS . . . . . 0.519 ' NE2' HG21 ' A' ' 18' ' ' VAL . 71.5 t60 -63.9 -52.72 58.61 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.627 -0.671 . . . . 0.0 109.624 179.255 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 29.9 tp60 -54.65 -39.04 67.61 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.697 -0.627 . . . . 0.0 110.149 179.559 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.614 ' O ' HG23 ' A' ' 20' ' ' VAL . 1.8 t30 -58.12 -49.07 78.25 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.554 -0.717 . . . . 0.0 110.327 179.558 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 29.2 mt -72.09 -33.47 47.11 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.073 0 O-C-N 121.449 -0.782 . . . . 0.0 110.226 179.714 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.519 HG21 ' NE2' ' A' ' 14' ' ' HIS . 73.5 t -75.69 -10.92 13.84 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.093 0 O-C-N 121.51 -0.744 . . . . 0.0 111.086 179.825 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.578 ' HA ' ' HB2' ' A' ' 23' ' ' MET . 0.9 OUTLIER -111.49 20.96 16.7 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.892 -1.13 . . . . 0.0 110.674 179.886 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.614 HG23 ' O ' ' A' ' 16' ' ' ASN . 73.0 t -120.09 -54.38 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 O-C-N 121.139 -0.976 . . . . 0.0 109.721 179.481 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 42.4 mt-30 -82.4 -16.21 49.88 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.743 -0.598 . . . . 0.0 110.376 179.643 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' TYR . . . . . 0.502 ' CD1' ' HA ' ' A' ' 18' ' ' VAL . 18.7 m-85 -108.39 -46.26 3.73 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.463 -0.773 . . . . 0.0 110.353 -179.01 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' MET . . . . . 0.578 ' HB2' ' HA ' ' A' ' 19' ' ' ASP . 0.2 OUTLIER -68.08 -31.08 70.46 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.522 -0.736 . . . . 0.0 110.662 179.944 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.446 ' HB2' ' O ' ' A' ' 20' ' ' VAL . 0.3 OUTLIER -90.28 42.42 1.1 Allowed 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.179 -0.95 . . . . 0.0 110.261 179.594 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -159.18 45.84 0.44 Allowed Glycine 0 N--CA 1.494 2.525 0 N-CA-C 109.326 -1.51 . . . . 0.0 109.326 179.646 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.1 mp -107.76 18.31 21.5 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.402 -1.058 . . . . 0.0 110.925 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.508 ' N ' ' HD2' ' A' ' 28' ' ' PRO . 0.8 OUTLIER -56.62 -52.8 70.73 Favored Pre-proline 0 N--CA 1.498 1.947 0 O-C-N 121.3 -0.875 . . . . 0.0 110.486 179.528 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.508 ' HD2' ' N ' ' A' ' 27' ' ' SER . 45.8 Cg_endo -71.79 -26.7 18.85 Favored 'Trans proline' 0 N--CA 1.488 1.185 0 O-C-N 123.53 1.279 . . . . 0.0 110.789 179.314 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -71.09 -33.52 70.27 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.495 -0.753 . . . . 0.0 110.507 179.736 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -84.97 -11.25 11.52 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 O-C-N 121.269 -0.894 . . . . 0.0 110.976 179.851 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 24.0 p -101.8 -38.89 7.65 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.08 -1.013 . . . . 0.0 110.532 179.812 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 2.1 tptt -90.23 39.11 0.95 Allowed 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.378 -0.826 . . . . 0.0 110.574 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -149.55 -49.93 0.14 Allowed 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.34 -0.85 . . . . 0.0 109.882 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 16.1 t -80.88 73.26 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 CA-C-O 121.416 0.627 . . . . 0.0 109.668 179.847 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.426 ' O ' HG12 ' A' ' 35' ' ' VAL . 18.3 t -129.6 41.11 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 O-C-N 121.59 -0.694 . . . . 0.0 109.724 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.499 1.992 0 CA-C-O 117.821 -1.085 . . . . 0.0 110.871 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 9.5 p . . . . . 0 N--CA 1.494 1.765 0 CA-C-O 121.013 0.435 . . . . 0.0 110.276 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -142.08 176.78 8.69 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.523 -0.736 . . . . 0.0 110.292 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.471 ' CB ' ' HD3' ' A' ' 4' ' ' PRO . 0.3 OUTLIER -57.83 -53.61 63.95 Favored Pre-proline 0 N--CA 1.502 2.147 0 O-C-N 121.531 -0.731 . . . . 0.0 111.374 -179.449 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.471 ' HD3' ' CB ' ' A' ' 3' ' ' LEU . 48.9 Cg_endo -81.74 -153.22 0.04 OUTLIER 'Trans proline' 0 C--N 1.319 -1.021 0 O-C-N 123.477 1.251 . . . . 0.0 110.029 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -167.59 -75.11 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.325 -0.86 . . . . 0.0 110.371 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.1 pp -103.73 -19.12 14.42 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.4 -0.813 . . . . 0.0 111.104 -179.859 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 69.7 m -99.64 48.04 0.94 Allowed 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.202 -0.936 . . . . 0.0 110.105 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 5.6 t -124.35 9.72 8.54 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.363 -0.836 . . . . 0.0 111.166 -179.797 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -77.48 -55.1 4.38 Favored Glycine 0 N--CA 1.494 2.555 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 179.795 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 2.1 pp -66.64 -31.15 71.64 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.58 -0.953 . . . . 0.0 110.597 179.791 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.92 -44.31 93.28 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.202 -0.936 . . . . 0.0 109.973 179.663 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 5.5 m80 -70.34 -37.1 74.61 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.516 -0.74 . . . . 0.0 109.942 179.337 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.9 tp -59.6 -40.12 86.43 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.532 -0.73 . . . . 0.0 110.561 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' HIS . . . . . 0.412 ' CD2' HG21 ' A' ' 18' ' ' VAL . 3.3 t-80 -54.74 -51.91 64.17 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.611 -0.68 . . . . 0.0 109.958 179.771 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 12.1 tp-100 -62.63 -32.31 73.31 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.48 -0.763 . . . . 0.0 110.507 179.772 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -72.12 -47.68 49.41 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.314 -0.866 . . . . 0.0 110.559 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 39.0 mm -71.65 -40.41 70.64 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 O-C-N 121.408 -0.808 . . . . 0.0 110.429 -179.772 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.412 HG21 ' CD2' ' A' ' 14' ' ' HIS . 38.3 t -62.19 -30.1 48.06 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 O-C-N 121.36 -0.838 . . . . 0.0 110.199 179.771 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -76.8 -15.65 59.68 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.503 -0.748 . . . . 0.0 110.85 179.382 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 92.7 t -103.4 -37.61 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.057 -1.027 . . . . 0.0 109.884 179.618 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' GLN . . . . . 0.508 ' CG ' ' HB3' ' A' ' 26' ' ' LEU . 8.9 tt0 -67.54 -35.27 78.75 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.511 -0.743 . . . . 0.0 110.614 179.85 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -68.61 -36.7 79.02 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.254 -0.903 . . . . 0.0 109.873 179.646 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 1.2 tmt? -77.08 -32.14 56.5 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.58 -0.7 . . . . 0.0 110.695 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.462 ' HB3' HD13 ' A' ' 26' ' ' LEU . 1.8 m-85 -78.7 3.4 16.59 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.249 -0.907 . . . . 0.0 110.964 179.644 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 70.16 37.7 72.38 Favored Glycine 0 N--CA 1.493 2.471 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -179.817 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.508 ' HB3' ' CG ' ' A' ' 21' ' ' GLN . 2.3 mp -112.76 11.24 19.34 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.385 -1.068 . . . . 0.0 111.195 -179.731 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.625 ' HB3' ' HD3' ' A' ' 28' ' ' PRO . 0.5 OUTLIER -62.81 -53.37 56.71 Favored Pre-proline 0 N--CA 1.498 1.931 0 O-C-N 121.154 -0.966 . . . . 0.0 110.374 179.474 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.782 ' HA ' HG22 ' A' ' 31' ' ' THR . 45.7 Cg_endo -73.07 -31.33 9.81 Favored 'Trans proline' 0 N--CA 1.487 1.122 0 O-C-N 123.491 1.259 . . . . 0.0 110.69 179.681 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.55 -24.48 67.54 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.618 -0.676 . . . . 0.0 111.279 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 47.5 mm -105.63 -30.11 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 O-C-N 121.113 -0.992 . . . . 0.0 111.119 -179.62 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.782 HG22 ' HA ' ' A' ' 28' ' ' PRO . 4.8 t -85.17 -30.97 23.51 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.159 -0.963 . . . . 0.0 110.867 -179.796 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.3 tttt -89.4 10.88 20.92 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.193 -0.942 . . . . 0.0 110.979 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 6.8 m-85 -114.07 -38.43 4.17 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.105 -0.997 . . . . 0.0 110.539 179.833 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.497 ' O ' HG12 ' A' ' 35' ' ' VAL . 60.8 t -89.31 -91.9 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.312 -0.867 . . . . 0.0 109.696 179.852 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.497 HG12 ' O ' ' A' ' 34' ' ' VAL . 9.8 p 37.79 37.95 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.51 2.528 0 CA-C-O 121.467 0.651 . . . . 0.0 111.803 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.819 0 CA-C-O 117.94 -1.029 . . . . 0.0 110.293 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 24.3 t . . . . . 0 N--CA 1.495 1.811 0 CA-C-O 121.167 0.508 . . . . 0.0 110.41 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -145.85 144.39 30.21 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.43 -0.794 . . . . 0.0 110.303 179.789 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 18.2 tp -151.09 77.98 7.38 Favored Pre-proline 0 N--CA 1.495 1.802 0 O-C-N 121.5 -0.75 . . . . 0.0 110.15 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -90.09 -154.81 0.05 OUTLIER 'Trans proline' 0 C--N 1.309 -1.508 0 C-N-CA 121.726 1.617 . . . . 0.0 110.426 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -161.09 90.25 0.82 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.283 -0.886 . . . . 0.0 109.798 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 60.68 34.0 20.12 Favored 'General case' 0 N--CA 1.503 2.213 0 O-C-N 121.806 -0.559 . . . . 0.0 110.636 -179.588 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 22.8 t -151.87 64.58 0.85 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.452 -0.78 . . . . 0.0 109.614 179.697 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -108.27 9.02 28.04 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.293 -0.879 . . . . 0.0 111.11 -179.495 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -65.55 -54.89 23.41 Favored Glycine 0 N--CA 1.496 2.673 0 N-CA-C 109.272 -1.531 . . . . 0.0 109.272 179.684 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.463 ' HA ' HD13 ' A' ' 10' ' ' LEU . 0.4 OUTLIER -63.09 -35.64 80.95 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.652 -0.91 . . . . 0.0 109.972 179.371 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -56.98 -48.19 79.01 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.53 -0.731 . . . . 0.0 109.87 179.378 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 6.5 m80 -63.88 -39.36 94.0 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.715 -0.616 . . . . 0.0 109.738 179.129 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 9.1 tp -58.96 -41.87 88.53 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.64 -0.663 . . . . 0.0 110.109 179.333 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' HIS . . . . . 0.531 ' NE2' HG21 ' A' ' 18' ' ' VAL . 5.7 t-160 -62.16 -52.04 65.43 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.543 -0.723 . . . . 0.0 109.258 179.149 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 27.3 tp60 -58.72 -36.53 74.43 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.625 -0.672 . . . . 0.0 110.021 179.186 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -61.73 -45.31 94.48 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.643 -0.661 . . . . 0.0 110.474 179.731 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.462 ' O ' HG12 ' A' ' 20' ' ' VAL . 38.8 mt -73.27 -37.5 52.03 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.018 0 O-C-N 121.352 -0.842 . . . . 0.0 109.84 179.637 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.531 HG21 ' NE2' ' A' ' 14' ' ' HIS . 54.8 t -75.73 -3.92 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 O-C-N 121.475 -0.766 . . . . 0.0 110.658 179.473 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -120.79 5.41 10.49 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.188 -0.945 . . . . 0.0 110.57 179.136 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.462 HG12 ' O ' ' A' ' 17' ' ' ILE . 5.5 p -102.68 -31.16 2.97 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 O-C-N 120.905 -1.122 . . . . 0.0 110.866 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -97.45 6.98 47.37 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.296 -0.878 . . . . 0.0 110.639 179.896 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' TYR . . . . . 0.442 ' CD2' ' N ' ' A' ' 22' ' ' TYR . 4.9 m-85 -133.08 -49.11 0.86 Allowed 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.4 -0.812 . . . . 0.0 109.316 -179.255 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.51 -31.78 63.89 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.51 -0.744 . . . . 0.0 109.549 178.734 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -85.19 4.65 33.58 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.392 -0.817 . . . . 0.0 110.973 179.485 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -84.47 -37.05 11.18 Favored Glycine 0 N--CA 1.493 2.489 0 N-CA-C 109.729 -1.348 . . . . 0.0 109.729 179.711 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 56.94 34.25 24.57 Favored 'General case' 0 N--CA 1.504 2.228 0 O-C-N 121.754 -0.851 . . . . 0.0 111.231 179.856 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.488 ' CB ' ' CD ' ' A' ' 28' ' ' PRO . 0.5 OUTLIER -99.21 -63.98 0.08 OUTLIER Pre-proline 0 N--CA 1.497 1.887 0 O-C-N 121.184 -0.947 . . . . 0.0 110.571 179.69 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.488 ' CD ' ' CB ' ' A' ' 27' ' ' SER . 41.8 Cg_endo -67.66 -25.04 40.69 Favored 'Trans proline' 0 N--CA 1.489 1.235 0 O-C-N 123.222 1.117 . . . . 0.0 110.876 179.812 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.76 -32.16 73.54 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.37 -0.831 . . . . 0.0 110.312 179.292 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 97.1 mt -99.68 -42.34 10.38 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 121.501 -0.749 . . . . 0.0 110.035 179.675 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 62.8 m -63.88 -38.24 90.38 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.665 -0.647 . . . . 0.0 110.612 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 13.2 tttt -89.31 15.29 9.29 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.231 -0.918 . . . . 0.0 110.68 179.558 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 9.7 t80 -106.63 -44.09 4.56 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.296 -0.877 . . . . 0.0 110.019 179.754 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.9 t -83.88 67.31 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 O-C-N 121.383 -0.823 . . . . 0.0 109.734 179.805 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 23.1 t -127.99 60.14 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 121.433 -0.792 . . . . 0.0 109.628 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 3.0 tpm_? . . . . . 0 N--CA 1.493 1.706 0 CA-C-O 117.817 -1.087 . . . . 0.0 110.476 -179.854 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 2.4 p . . . . . 0 N--CA 1.495 1.806 0 CA-C-O 121.152 0.501 . . . . 0.0 110.052 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -133.91 -173.25 3.2 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.487 -0.758 . . . . 0.0 110.366 -179.607 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.472 ' CB ' ' HD3' ' A' ' 4' ' ' PRO . 0.3 OUTLIER -60.42 -50.04 87.51 Favored Pre-proline 0 N--CA 1.501 2.106 0 O-C-N 121.484 -0.76 . . . . 0.0 111.263 -179.658 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.472 ' HD3' ' CB ' ' A' ' 3' ' ' LEU . 47.1 Cg_endo -88.36 -157.11 0.06 OUTLIER 'Trans proline' 0 C--N 1.318 -1.051 0 O-C-N 123.45 1.237 . . . . 0.0 110.416 -179.821 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -128.93 -59.61 1.12 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.228 -0.92 . . . . 0.0 110.215 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -112.3 39.95 2.33 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.424 -0.797 . . . . 0.0 109.97 179.625 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 5.1 t 54.37 72.37 0.46 Allowed 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.695 -0.628 . . . . 0.0 110.178 -179.704 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.424 HG22 ' CD2' ' A' ' 12' ' ' HIS . 1.4 m -86.88 40.07 0.88 Allowed 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.356 -0.84 . . . . 0.0 110.478 -179.871 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -106.17 -52.19 0.79 Allowed Glycine 0 N--CA 1.492 2.427 0 N-CA-C 109.032 -1.627 . . . . 0.0 109.032 179.545 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.5 mt -62.8 -41.99 99.52 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.616 -0.932 . . . . 0.0 110.17 179.665 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 15.6 tp -59.45 -43.61 93.15 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.464 -0.772 . . . . 0.0 109.814 179.378 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' HIS . . . . . 0.424 ' CD2' HG22 ' A' ' 8' ' ' THR . 6.9 m170 -65.35 -44.94 86.08 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.628 -0.67 . . . . 0.0 109.748 179.271 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.91 -33.91 76.62 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.472 -0.767 . . . . 0.0 109.969 179.31 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' HIS . . . . . 0.517 ' NE2' HG21 ' A' ' 18' ' ' VAL . 8.1 t-160 -63.0 -51.7 65.84 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.625 -0.672 . . . . 0.0 109.88 179.549 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.46 ' O ' ' HB2' ' A' ' 19' ' ' ASP . 0.3 OUTLIER -61.75 -36.03 79.81 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.496 -0.752 . . . . 0.0 109.993 179.497 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -59.36 -43.61 92.81 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.473 -0.767 . . . . 0.0 110.289 179.445 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.503 ' O ' HG12 ' A' ' 20' ' ' VAL . 61.1 mt -81.87 -26.25 9.58 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.925 0 O-C-N 121.395 -0.816 . . . . 0.0 110.624 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.517 HG21 ' NE2' ' A' ' 14' ' ' HIS . 49.7 t -85.65 -7.44 10.92 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 121.031 -1.043 . . . . 0.0 110.693 179.79 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.46 ' HB2' ' O ' ' A' ' 15' ' ' GLN . 0.5 OUTLIER -122.53 32.24 5.83 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.101 -0.999 . . . . 0.0 109.667 178.896 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.507 ' HA ' ' HG2' ' A' ' 23' ' ' MET . 13.0 p -123.81 -44.11 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 O-C-N 121.416 -0.802 . . . . 0.0 110.646 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' GLN . . . . . 0.5 ' N ' HG13 ' A' ' 20' ' ' VAL . 28.4 mt-30 -78.35 -12.89 60.03 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.348 -0.845 . . . . 0.0 110.134 179.35 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' TYR . . . . . 0.4 ' CD1' ' N ' ' A' ' 22' ' ' TYR . 10.4 m-85 -104.44 -25.43 12.81 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.657 -0.652 . . . . 0.0 109.704 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' MET . . . . . 0.507 ' HG2' ' HA ' ' A' ' 20' ' ' VAL . 0.5 OUTLIER -80.98 -21.25 40.46 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.385 -0.822 . . . . 0.0 110.376 179.292 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -110.44 20.17 18.02 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.23 -0.919 . . . . 0.0 110.891 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -81.1 -38.64 14.72 Favored Glycine 0 N--CA 1.496 2.686 0 N-CA-C 109.786 -1.325 . . . . 0.0 109.786 179.767 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.6 mp 58.25 26.07 13.43 Favored 'General case' 0 N--CA 1.502 2.148 0 O-C-N 121.688 -0.889 . . . . 0.0 111.549 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.473 ' N ' ' HD2' ' A' ' 28' ' ' PRO . 1.4 m -69.88 -55.43 8.73 Favored Pre-proline 0 N--CA 1.498 1.939 0 O-C-N 121.113 -0.992 . . . . 0.0 110.27 179.333 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.473 ' HD2' ' N ' ' A' ' 27' ' ' SER . 45.6 Cg_endo -71.61 -20.23 27.07 Favored 'Trans proline' 0 N--CA 1.487 1.1 0 O-C-N 123.451 1.237 . . . . 0.0 110.681 179.182 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -70.85 -37.89 73.16 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.48 -0.763 . . . . 0.0 110.216 179.585 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 28.5 mm -74.35 -39.93 49.2 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 O-C-N 121.518 -0.739 . . . . 0.0 110.061 179.625 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 44.9 p -69.22 -39.48 78.53 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.381 -0.825 . . . . 0.0 110.206 179.692 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 26.9 mmtt -71.91 -29.77 64.67 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.428 -0.795 . . . . 0.0 110.638 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 92.4 t80 -86.44 -47.4 9.34 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.399 -0.813 . . . . 0.0 110.319 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 47.2 t -80.14 82.15 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 121.448 -0.783 . . . . 0.0 109.831 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.446 ' O ' HG22 ' A' ' 35' ' ' VAL . 9.6 p -157.04 36.75 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 CA-C-O 121.6 0.714 . . . . 0.0 109.926 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 19.9 mmt85 . . . . . 0 N--CA 1.497 1.881 0 CA-C-O 118.032 -0.985 . . . . 0.0 110.212 -179.733 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 47.1 m . . . . . 0 N--CA 1.495 1.784 0 CA-C-O 121.104 0.478 . . . . 0.0 110.067 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -128.7 131.35 47.95 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.545 -0.722 . . . . 0.0 110.259 -179.823 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.577 ' CB ' ' HD3' ' A' ' 4' ' ' PRO . 1.1 mp -99.97 -55.65 0.16 Allowed Pre-proline 0 N--CA 1.496 1.846 0 O-C-N 121.611 -0.68 . . . . 0.0 110.958 -179.846 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.577 ' HD3' ' CB ' ' A' ' 3' ' ' LEU . 47.5 Cg_endo -89.75 -159.85 0.09 OUTLIER 'Trans proline' 0 C--N 1.319 -0.979 0 O-C-N 123.317 1.167 . . . . 0.0 110.342 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -153.23 59.01 0.77 Allowed 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.31 -0.869 . . . . 0.0 110.048 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.706 HD11 HD22 ' A' ' 10' ' ' LEU . 3.1 tp -101.62 -33.6 9.83 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.448 -0.783 . . . . 0.0 110.964 -179.672 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 22.6 t -60.27 -44.42 95.33 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.437 -0.79 . . . . 0.0 111.035 -179.549 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 32.1 p -120.82 8.74 10.57 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.426 -0.796 . . . . 0.0 111.316 -179.735 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -107.85 -67.53 0.63 Allowed Glycine 0 N--CA 1.492 2.376 0 N-CA-C 108.626 -1.789 . . . . 0.0 108.626 179.604 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.706 HD22 HD11 ' A' ' 6' ' ' LEU . 8.9 tp -73.49 -36.82 65.85 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.648 -0.913 . . . . 0.0 109.876 179.335 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 11.5 tp -64.56 -44.1 91.82 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.377 -0.827 . . . . 0.0 109.839 179.506 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -63.76 -42.92 97.73 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.59 -0.693 . . . . 0.0 109.832 179.443 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 5.2 tp -63.88 -40.72 97.19 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.542 -0.724 . . . . 0.0 110.238 179.505 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' HIS . . . . . 0.497 ' NE2' HG21 ' A' ' 18' ' ' VAL . 7.3 t-80 -57.4 -54.22 49.33 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.643 -0.661 . . . . 0.0 109.922 179.685 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.447 ' O ' ' HB2' ' A' ' 19' ' ' ASP . 19.5 tp60 -55.57 -40.14 71.6 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.672 -0.642 . . . . 0.0 110.089 179.577 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -66.67 -40.8 88.75 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.348 -0.845 . . . . 0.0 110.68 179.686 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.413 ' O ' HG12 ' A' ' 20' ' ' VAL . 85.6 mt -77.07 -21.53 14.5 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 O-C-N 121.395 -0.816 . . . . 0.0 110.858 -179.81 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.497 HG21 ' NE2' ' A' ' 14' ' ' HIS . 24.3 t -93.16 -33.61 5.43 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 O-C-N 121.205 -0.934 . . . . 0.0 110.082 179.828 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.447 ' HB2' ' O ' ' A' ' 15' ' ' GLN . 2.4 m-20 -87.75 28.84 0.96 Allowed 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.278 -0.889 . . . . 0.0 110.439 179.271 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.413 HG12 ' O ' ' A' ' 17' ' ' ILE . 12.5 p -103.53 -28.31 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.825 0 O-C-N 121.242 -0.911 . . . . 0.0 110.344 179.577 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' GLN . . . . . 0.469 ' HG2' HG21 ' A' ' 30' ' ' ILE . 13.6 mt-30 -101.78 -27.56 12.95 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.595 -0.691 . . . . 0.0 110.559 -179.711 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -101.14 -26.7 13.59 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.363 -0.836 . . . . 0.0 110.64 -179.187 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -97.43 16.5 20.0 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.228 -0.92 . . . . 0.0 111.3 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -97.53 13.77 28.83 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 120.867 -1.146 . . . . 0.0 111.035 179.699 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 73.56 31.45 60.75 Favored Glycine 0 N--CA 1.494 2.519 0 N-CA-C 109.71 -1.356 . . . . 0.0 109.71 -179.781 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -147.81 43.75 1.08 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.428 -1.042 . . . . 0.0 110.192 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.404 ' CB ' ' HD3' ' A' ' 28' ' ' PRO . 0.4 OUTLIER -60.28 -54.34 56.1 Favored Pre-proline 0 N--CA 1.498 1.939 0 O-C-N 121.397 -0.814 . . . . 0.0 110.656 -179.909 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.404 ' HD3' ' CB ' ' A' ' 27' ' ' SER . 49.9 Cg_endo -77.61 55.32 5.13 Favored 'Trans proline' 0 N--CA 1.487 1.119 0 O-C-N 123.393 1.207 . . . . 0.0 110.318 179.473 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -162.74 -49.18 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.59 -0.694 . . . . 0.0 109.78 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.469 HG21 ' HG2' ' A' ' 21' ' ' GLN . 21.8 mt -83.13 -34.1 10.87 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 121.624 -0.673 . . . . 0.0 110.224 179.592 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 43.7 m -61.6 -43.35 99.03 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.568 -0.707 . . . . 0.0 109.931 179.48 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.8 tttp -70.51 -23.52 62.67 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.549 -0.719 . . . . 0.0 110.496 179.332 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -75.43 -27.58 59.03 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.415 -0.803 . . . . 0.0 110.365 179.646 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 57.9 t -96.37 -44.71 12.9 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 O-C-N 121.269 -0.895 . . . . 0.0 110.543 -179.749 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 37.5 t 55.63 70.14 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.142 0 O-C-N 121.603 -0.686 . . . . 0.0 110.006 -179.68 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 2.5 ttp180 . . . . . 0 N--CA 1.495 1.778 0 CA-C-O 117.887 -1.054 . . . . 0.0 110.426 -179.907 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 60.1 p . . . . . 0 N--CA 1.495 1.815 0 CA-C-O 121.102 0.477 . . . . 0.0 110.309 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 35.7 m-20 -95.53 118.95 33.18 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.322 -0.861 . . . . 0.0 110.282 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.484 ' N ' ' HD2' ' A' ' 4' ' ' PRO . 3.0 mp -59.17 -51.18 83.48 Favored Pre-proline 0 N--CA 1.5 2.07 0 O-C-N 121.661 -0.65 . . . . 0.0 110.573 179.751 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.484 ' HD2' ' N ' ' A' ' 3' ' ' LEU . 50.1 Cg_endo -76.21 60.63 6.36 Favored 'Trans proline' 0 N--CA 1.486 1.087 0 O-C-N 123.535 1.282 . . . . 0.0 110.293 179.555 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -162.78 -53.6 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.417 -0.802 . . . . 0.0 110.129 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.2 pp -102.85 -17.86 15.35 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.55 -0.719 . . . . 0.0 111.092 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.469 ' O ' HG22 ' A' ' 8' ' ' THR . 10.1 m -85.18 -58.45 2.68 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.175 -0.953 . . . . 0.0 109.887 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.469 HG22 ' O ' ' A' ' 7' ' ' SER . 12.0 t 37.15 42.54 0.28 Allowed 'General case' 0 N--CA 1.504 2.241 0 CA-C-O 121.32 0.581 . . . . 0.0 111.906 179.701 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -94.73 -84.82 1.65 Allowed Glycine 0 N--CA 1.494 2.503 0 N-CA-C 109.275 -1.53 . . . . 0.0 109.275 179.564 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 8.0 tp -66.74 -32.03 73.06 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.577 -0.955 . . . . 0.0 110.237 179.475 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.415 HD22 ' HA ' ' A' ' 11' ' ' LEU . 0.1 OUTLIER -58.19 -43.09 87.39 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.45 -0.781 . . . . 0.0 110.024 179.551 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -59.02 -43.75 91.61 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.6 -0.688 . . . . 0.0 109.696 179.29 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.2 tt -61.99 -38.39 88.42 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.751 -0.593 . . . . 0.0 110.057 179.207 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' HIS . . . . . 0.591 ' NE2' HG21 ' A' ' 18' ' ' VAL . 2.8 t-80 -61.38 -52.85 62.92 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.517 -0.74 . . . . 0.0 109.745 179.4 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.406 ' O ' ' HB2' ' A' ' 19' ' ' ASP . 3.3 tp-100 -59.96 -36.35 76.9 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.516 -0.74 . . . . 0.0 110.227 179.669 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 9.9 t30 -59.48 -34.04 72.08 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.533 -0.729 . . . . 0.0 110.475 179.471 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.467 ' O ' HG12 ' A' ' 20' ' ' VAL . 38.0 mt -94.4 -36.84 7.38 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 121.398 -0.814 . . . . 0.0 110.317 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.591 HG21 ' NE2' ' A' ' 14' ' ' HIS . 92.0 t -74.2 -7.83 10.59 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.086 0 O-C-N 121.343 -0.848 . . . . 0.0 111.011 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.406 ' HB2' ' O ' ' A' ' 15' ' ' GLN . 1.0 OUTLIER -119.83 8.08 11.07 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.167 -0.958 . . . . 0.0 110.809 179.434 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.467 HG12 ' O ' ' A' ' 17' ' ' ILE . 9.2 p -105.93 -35.82 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 O-C-N 120.982 -1.074 . . . . 0.0 110.874 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -97.47 1.7 49.41 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.379 -0.826 . . . . 0.0 110.517 179.81 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 13.2 m-85 -127.37 -47.01 1.46 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.317 -0.865 . . . . 0.0 109.58 -179.334 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -75.43 -25.76 57.77 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.487 -0.758 . . . . 0.0 110.124 178.956 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -95.44 40.53 1.11 Allowed 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.31 -0.869 . . . . 0.0 110.513 179.786 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -76.42 -39.3 31.07 Favored Glycine 0 N--CA 1.496 2.681 0 N-CA-C 109.847 -1.301 . . . . 0.0 109.847 179.794 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.0 mp -93.88 48.97 1.3 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.322 -1.105 . . . . 0.0 109.891 179.773 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.621 ' HB3' ' HD3' ' A' ' 28' ' ' PRO . 4.6 t -53.27 -55.82 30.44 Favored Pre-proline 0 N--CA 1.497 1.892 0 O-C-N 121.625 -0.672 . . . . 0.0 110.645 -179.881 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.621 ' HD3' ' HB3' ' A' ' 27' ' ' SER . 52.3 Cg_endo -77.37 59.27 6.6 Favored 'Trans proline' 0 N--CA 1.487 1.114 0 O-C-N 123.448 1.236 . . . . 0.0 110.075 179.247 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -167.87 -50.07 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.533 -0.73 . . . . 0.0 110.001 -179.725 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 15.6 mt -78.43 -33.71 17.56 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 O-C-N 121.483 -0.761 . . . . 0.0 110.299 179.789 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 7.9 p -61.33 -39.62 91.2 Favored 'General case' 0 N--CA 1.5 2.025 0 O-C-N 121.703 -0.623 . . . . 0.0 110.301 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -91.77 19.51 6.43 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.344 -0.848 . . . . 0.0 110.493 179.272 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 71.3 t80 -115.5 -47.03 2.84 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.366 -0.834 . . . . 0.0 109.989 179.862 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 59.5 t -81.0 115.44 23.59 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 121.341 -0.85 . . . . 0.0 109.845 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 5.2 p -129.5 28.91 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 O-C-N 121.562 -0.712 . . . . 0.0 110.416 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 5.6 tmm_? . . . . . 0 N--CA 1.495 1.813 0 CA-C-O 117.881 -1.057 . . . . 0.0 110.352 179.871 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 2.1 p . . . . . 0 N--CA 1.496 1.828 0 CA-C-O 121.233 0.54 . . . . 0.0 110.096 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -128.04 135.3 49.68 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.415 -0.803 . . . . 0.0 110.269 -179.573 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.506 ' N ' ' HD3' ' A' ' 4' ' ' PRO . 0.6 OUTLIER 51.85 56.32 15.9 Favored Pre-proline 0 N--CA 1.5 2.055 0 O-C-N 121.79 -0.569 . . . . 0.0 111.072 -179.956 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.506 ' HD3' ' N ' ' A' ' 3' ' ' LEU . 49.0 Cg_endo -80.57 58.75 7.16 Favored 'Trans proline' 0 C--N 1.313 -1.294 0 O-C-N 123.709 1.373 . . . . 0.0 110.575 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -168.7 -54.69 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.366 -0.834 . . . . 0.0 110.408 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -104.52 41.12 1.36 Allowed 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.416 -0.802 . . . . 0.0 110.559 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 61.9 p -77.47 -19.91 55.2 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.318 -0.864 . . . . 0.0 110.835 179.599 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.452 HG23 ' O ' ' A' ' 8' ' ' THR . 8.8 t -115.48 57.56 0.74 Allowed 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.399 -0.813 . . . . 0.0 110.013 179.685 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -104.35 -62.93 0.67 Allowed Glycine 0 N--CA 1.493 2.469 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -62.21 -47.2 85.51 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.632 -0.922 . . . . 0.0 110.609 -179.832 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -58.58 -51.62 69.13 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.487 -0.758 . . . . 0.0 110.2 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -62.74 -40.82 98.41 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.653 -0.654 . . . . 0.0 110.037 179.558 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.7 tt -56.88 -42.2 79.39 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.642 -0.661 . . . . 0.0 110.13 179.588 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 7.2 t-80 -60.81 -49.07 78.98 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.521 -0.737 . . . . 0.0 109.799 179.412 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.457 ' O ' ' HB2' ' A' ' 19' ' ' ASP . 17.8 mm-40 -67.17 -36.17 81.24 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.544 -0.722 . . . . 0.0 109.76 179.318 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -63.68 -18.32 63.87 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.501 -0.749 . . . . 0.0 110.905 179.487 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 87.2 mt -104.74 -46.53 9.47 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.082 -1.011 . . . . 0.0 109.908 179.859 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 54.0 t -71.21 -36.73 63.4 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 O-C-N 121.403 -0.811 . . . . 0.0 110.969 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.457 ' HB2' ' O ' ' A' ' 15' ' ' GLN . 0.3 OUTLIER -86.55 -1.94 58.06 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.398 -0.814 . . . . 0.0 111.41 -179.537 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 70.6 t -113.51 -51.87 5.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 120.83 -1.169 . . . . 0.0 109.78 179.354 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 8.1 tp-100 -57.72 -34.11 69.13 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.595 -0.691 . . . . 0.0 110.923 179.744 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -61.83 -31.23 71.45 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.254 -0.904 . . . . 0.0 110.457 179.893 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -109.13 11.46 25.59 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.341 -0.849 . . . . 0.0 110.891 179.467 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -122.09 34.05 5.29 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.16 -0.962 . . . . 0.0 110.183 179.848 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -87.04 -68.32 1.33 Allowed Glycine 0 N--CA 1.494 2.503 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.544 ' HB3' ' HB3' ' A' ' 29' ' ' ALA . 3.4 mp 50.45 44.13 26.96 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.784 -0.833 . . . . 0.0 110.818 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.483 ' HB2' ' HD3' ' A' ' 28' ' ' PRO . 3.1 m -56.18 -55.09 45.6 Favored Pre-proline 0 N--CA 1.499 1.998 0 O-C-N 121.527 -0.733 . . . . 0.0 111.094 -179.726 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.483 ' HD3' ' HB2' ' A' ' 27' ' ' SER . 46.3 Cg_endo -72.2 -27.06 17.13 Favored 'Trans proline' 0 N--CA 1.489 1.217 0 O-C-N 123.398 1.209 . . . . 0.0 111.068 179.827 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.544 ' HB3' ' HB3' ' A' ' 26' ' ' LEU . . . -72.87 -39.98 66.01 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.417 -0.802 . . . . 0.0 110.633 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 5.7 tt -79.49 -11.63 13.02 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 O-C-N 121.341 -0.849 . . . . 0.0 111.467 -179.691 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 23.3 p -101.0 -37.19 8.73 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.099 -1.001 . . . . 0.0 110.537 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 6.9 tptp -91.6 45.93 1.26 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.267 -0.896 . . . . 0.0 109.964 179.672 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -146.91 -53.59 0.23 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.549 -0.719 . . . . 0.0 109.739 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.498 HG12 ' O ' ' A' ' 34' ' ' VAL . 49.0 t -91.67 52.57 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 O-C-N 121.443 -0.786 . . . . 0.0 109.75 179.612 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 22.3 m -144.45 22.92 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.098 0 O-C-N 121.307 -0.871 . . . . 0.0 110.89 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.502 2.171 0 CA-C-O 118.255 -0.878 . . . . 0.0 111.083 -179.839 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.494 1.754 0 CA-C-O 121.069 0.461 . . . . 0.0 110.483 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -153.1 160.49 42.92 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.515 -0.74 . . . . 0.0 110.504 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.476 ' N ' ' HD3' ' A' ' 4' ' ' PRO . 0.4 OUTLIER 52.85 59.3 13.9 Favored Pre-proline 0 N--CA 1.501 2.095 0 O-C-N 121.778 -0.576 . . . . 0.0 111.153 -179.973 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.476 ' HD3' ' N ' ' A' ' 3' ' ' LEU . 46.8 Cg_endo -82.28 60.47 7.38 Favored 'Trans proline' 0 C--N 1.313 -1.305 0 O-C-N 123.742 1.391 . . . . 0.0 110.399 179.843 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -108.53 52.07 0.72 Allowed 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.454 -0.779 . . . . 0.0 110.088 179.801 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.2 tt -112.74 -58.02 2.2 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.445 -0.784 . . . . 0.0 110.601 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -165.58 50.13 0.09 Allowed 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.393 -0.817 . . . . 0.0 110.938 -179.847 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.457 HG22 ' HB2' ' A' ' 12' ' ' HIS . 0.2 OUTLIER 53.24 70.52 0.58 Allowed 'General case' 0 N--CA 1.504 2.258 0 O-C-N 121.418 -0.801 . . . . 0.0 110.244 179.652 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -79.99 -90.49 0.47 Allowed Glycine 0 N--CA 1.494 2.548 0 N-CA-C 109.841 -1.304 . . . . 0.0 109.841 -179.613 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -57.71 -38.54 75.44 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.65 -0.912 . . . . 0.0 110.8 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -56.82 -51.05 70.48 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.497 -0.752 . . . . 0.0 110.371 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' HIS . . . . . 0.457 ' HB2' HG22 ' A' ' 8' ' ' THR . 3.8 t60 -75.56 -30.8 59.79 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.284 -0.885 . . . . 0.0 110.103 179.39 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 61.1 tp -55.3 -41.88 72.94 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.472 -0.768 . . . . 0.0 109.962 179.578 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' HIS . . . . . 0.406 ' NE2' HG21 ' A' ' 18' ' ' VAL . 2.6 t-80 -61.92 -46.44 89.32 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.608 -0.682 . . . . 0.0 109.665 179.222 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 28.3 mm-40 -60.51 -37.48 81.27 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.658 -0.651 . . . . 0.0 110.093 179.587 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -67.78 -47.98 67.61 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.548 -0.72 . . . . 0.0 110.386 179.651 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 74.8 mt -65.45 -48.57 82.49 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.99 0 O-C-N 121.393 -0.817 . . . . 0.0 109.991 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.406 HG21 ' NE2' ' A' ' 14' ' ' HIS . 27.2 t -61.97 -31.92 52.69 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 O-C-N 121.437 -0.789 . . . . 0.0 109.938 179.549 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.405 ' HA ' ' HD2' ' A' ' 22' ' ' TYR . 29.1 t70 -63.95 -25.4 68.12 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.631 -0.668 . . . . 0.0 109.963 178.929 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 61.2 t -92.02 -30.43 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.107 -0.996 . . . . 0.0 109.479 179.036 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -69.28 -39.93 78.06 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.585 -0.697 . . . . 0.0 110.317 179.663 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' TYR . . . . . 0.458 ' CD1' ' C ' ' A' ' 22' ' ' TYR . 0.1 OUTLIER -67.84 -31.27 71.0 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.296 -0.878 . . . . 0.0 110.118 179.672 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 2.5 ttt -84.8 -40.94 16.6 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.442 -0.786 . . . . 0.0 110.609 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 11.4 m-85 -99.63 25.43 7.14 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.264 -0.898 . . . . 0.0 110.959 -179.83 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -87.84 -34.11 10.39 Favored Glycine 0 N--CA 1.496 2.684 0 N-CA-C 109.894 -1.282 . . . . 0.0 109.894 179.788 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.593 HD13 ' HB3' ' A' ' 29' ' ' ALA . 1.2 mm? 58.96 25.68 14.07 Favored 'General case' 0 N--CA 1.502 2.17 0 O-C-N 121.616 -0.932 . . . . 0.0 111.254 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.479 ' N ' ' HD2' ' A' ' 28' ' ' PRO . 1.4 m -80.57 -54.82 0.77 Allowed Pre-proline 0 N--CA 1.498 1.958 0 O-C-N 121.238 -0.913 . . . . 0.0 110.801 179.796 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.479 ' HD2' ' N ' ' A' ' 27' ' ' SER . 43.8 Cg_endo -70.14 -11.83 31.06 Favored 'Trans proline' 0 N--CA 1.49 1.275 0 O-C-N 123.259 1.136 . . . . 0.0 111.172 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.593 ' HB3' HD13 ' A' ' 26' ' ' LEU . . . -90.21 -27.34 19.6 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.248 -0.907 . . . . 0.0 110.366 179.454 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 43.4 mm -104.77 -45.26 9.01 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 121.315 -0.866 . . . . 0.0 110.325 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 23.9 m -70.39 -34.55 72.69 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.602 -0.686 . . . . 0.0 110.84 -179.775 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 6.6 tttp -89.9 16.63 7.85 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.085 -1.009 . . . . 0.0 110.684 179.428 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -109.4 -40.88 4.77 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.292 -0.88 . . . . 0.0 109.987 179.496 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 87.2 t -108.21 98.09 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 121.437 -0.789 . . . . 0.0 110.018 179.848 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 26.3 t -128.05 63.86 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 O-C-N 121.542 -0.724 . . . . 0.0 109.683 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.495 1.816 0 CA-C-O 118.223 -0.894 . . . . 0.0 110.259 -179.907 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 9.2 t . . . . . 0 N--CA 1.496 1.829 0 CA-C-O 121.211 0.529 . . . . 0.0 109.945 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -135.16 77.39 1.67 Allowed 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.447 -0.783 . . . . 0.0 110.211 -179.657 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.423 ' HB3' ' HD3' ' A' ' 4' ' ' PRO . 0.4 OUTLIER -77.22 -54.02 1.57 Allowed Pre-proline 0 N--CA 1.499 1.991 0 O-C-N 121.474 -0.766 . . . . 0.0 110.933 -179.853 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.423 ' HD3' ' HB3' ' A' ' 3' ' ' LEU . 51.4 Cg_endo -77.96 61.45 7.65 Favored 'Trans proline' 0 N--CA 1.487 1.141 0 O-C-N 123.477 1.251 . . . . 0.0 110.464 -179.928 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -87.27 -49.96 6.91 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.328 -0.858 . . . . 0.0 110.589 -179.795 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -143.36 -68.35 0.34 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.36 -0.838 . . . . 0.0 110.516 -179.924 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 69.3 m -145.13 66.7 1.24 Allowed 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.248 -0.908 . . . . 0.0 110.378 -179.73 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.422 HG22 ' HB2' ' A' ' 12' ' ' HIS . 6.4 m -97.93 41.95 1.11 Allowed 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.254 -0.904 . . . . 0.0 110.327 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -102.87 -88.81 2.07 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 108.724 -1.751 . . . . 0.0 108.724 179.531 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.62 -39.08 93.47 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.649 -0.912 . . . . 0.0 109.738 179.141 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -58.31 -47.81 82.5 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.699 -0.625 . . . . 0.0 109.585 179.132 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' HIS . . . . . 0.422 ' HB2' HG22 ' A' ' 8' ' ' THR . 20.1 t-160 -67.81 -45.01 75.95 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.736 -0.602 . . . . 0.0 109.844 179.357 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 11.8 tp -57.25 -41.84 80.37 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.558 -0.714 . . . . 0.0 110.035 179.534 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' HIS . . . . . 0.544 ' NE2' HG21 ' A' ' 18' ' ' VAL . 6.6 t-80 -61.06 -47.03 88.24 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.624 -0.672 . . . . 0.0 109.826 179.436 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 33.9 tp60 -55.88 -45.28 78.61 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.639 -0.663 . . . . 0.0 110.252 179.71 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.596 ' O ' HG23 ' A' ' 20' ' ' VAL . 9.5 t-20 -63.74 -52.36 60.79 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.326 -0.859 . . . . 0.0 110.732 179.773 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 83.5 mt -57.75 -43.48 84.02 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.119 0 O-C-N 121.345 -0.847 . . . . 0.0 110.374 -179.737 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.544 HG21 ' NE2' ' A' ' 14' ' ' HIS . 17.9 t -71.51 -32.54 46.47 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 O-C-N 121.394 -0.816 . . . . 0.0 110.138 179.579 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -73.01 -10.91 60.3 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.423 -0.798 . . . . 0.0 110.991 179.591 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.596 HG23 ' O ' ' A' ' 16' ' ' ASN . 61.6 t -104.43 -36.11 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 120.832 -1.167 . . . . 0.0 109.925 179.487 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.96 -36.92 70.0 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.525 -0.734 . . . . 0.0 110.863 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -61.96 -31.61 71.98 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.156 -0.965 . . . . 0.0 110.156 179.823 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -92.11 10.34 29.71 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.443 -0.786 . . . . 0.0 110.616 179.134 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -105.48 23.06 14.39 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.152 -0.967 . . . . 0.0 110.399 179.702 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -159.31 44.08 0.45 Allowed Glycine 0 N--CA 1.493 2.488 0 N-CA-C 109.721 -1.351 . . . . 0.0 109.721 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -152.72 22.12 0.6 Allowed 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.54 -0.977 . . . . 0.0 111.019 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.503 ' HB2' ' HD3' ' A' ' 28' ' ' PRO . 4.7 m -74.56 -52.75 3.65 Favored Pre-proline 0 N--CA 1.499 1.977 0 O-C-N 121.142 -0.974 . . . . 0.0 111.243 -179.816 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.503 ' HD3' ' HB2' ' A' ' 27' ' ' SER . 44.9 Cg_endo -71.52 -9.65 25.48 Favored 'Trans proline' 0 N--CA 1.49 1.322 0 O-C-N 123.429 1.226 . . . . 0.0 111.243 179.855 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -94.03 -9.09 37.92 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.333 -0.854 . . . . 0.0 110.662 179.595 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 33.8 mm -118.03 -37.12 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 O-C-N 121.176 -0.952 . . . . 0.0 110.48 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 13.4 t -63.52 -24.43 67.81 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 121.349 -0.844 . . . . 0.0 111.252 -179.901 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 24.9 mmtt -99.12 -2.82 36.03 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.236 -0.915 . . . . 0.0 111.125 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 34.6 m-85 -107.94 0.29 21.86 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.313 -0.867 . . . . 0.0 111.16 -179.782 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.539 ' O ' HG12 ' A' ' 35' ' ' VAL . 47.1 t -121.56 -58.7 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.14 -0.975 . . . . 0.0 109.938 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.604 ' O ' HG13 ' A' ' 35' ' ' VAL . 0.4 OUTLIER 55.63 20.42 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.252 0 O-C-N 121.907 -0.495 . . . . 0.0 111.513 179.933 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.49 ' H ' HG12 ' A' ' 34' ' ' VAL . 0.4 OUTLIER . . . . . 0 N--CA 1.5 2.072 0 CA-C-O 117.682 -1.152 . . . . 0.0 110.446 179.587 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 15.8 p . . . . . 0 N--CA 1.495 1.779 0 CA-C-O 121.046 0.451 . . . . 0.0 110.115 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -128.16 46.99 2.48 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.472 -0.767 . . . . 0.0 110.283 -179.672 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.507 HD21 ' HB3' ' A' ' 6' ' ' LEU . 6.5 tp -155.63 57.19 1.5 Allowed Pre-proline 0 N--CA 1.497 1.925 0 O-C-N 121.36 -0.837 . . . . 0.0 110.425 179.896 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.472 ' HD3' ' N ' ' A' ' 3' ' ' LEU . 46.3 Cg_endo -78.06 -9.0 16.69 Favored 'Trans proline' 0 C--N 1.312 -1.366 0 O-C-N 123.775 1.408 . . . . 0.0 111.507 -179.787 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.445 ' O ' ' HA3' ' A' ' 9' ' ' GLY . . . -103.79 -30.35 10.44 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.335 -0.853 . . . . 0.0 110.742 179.86 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.507 ' HB3' HD21 ' A' ' 3' ' ' LEU . 0.3 OUTLIER -89.64 -32.84 16.89 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.11 -0.994 . . . . 0.0 110.666 -179.886 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.45 ' OG ' HD23 ' A' ' 3' ' ' LEU . 43.0 m -79.95 -46.92 15.85 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.31 -0.869 . . . . 0.0 110.928 -179.684 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 11.8 p -125.62 26.63 6.68 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.503 -0.748 . . . . 0.0 111.264 -179.268 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.445 ' HA3' ' O ' ' A' ' 5' ' ' ALA . . . -102.47 -78.95 1.34 Allowed Glycine 0 N--CA 1.492 2.432 0 N-CA-C 108.417 -1.873 . . . . 0.0 108.417 179.137 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -77.17 -34.87 56.32 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.549 -0.971 . . . . 0.0 109.754 178.924 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 5.6 tp -62.98 -44.63 95.52 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.443 -0.785 . . . . 0.0 109.969 179.49 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -64.05 -39.24 93.64 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.575 -0.703 . . . . 0.0 109.996 179.472 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.4 tp -68.42 -34.96 76.94 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.47 -0.769 . . . . 0.0 110.366 179.659 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' HIS . . . . . 0.491 ' CD2' HG21 ' A' ' 18' ' ' VAL . 12.5 t-80 -59.77 -61.82 2.33 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.316 -0.865 . . . . 0.0 109.575 179.504 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.45 ' O ' ' HB2' ' A' ' 19' ' ' ASP . 2.8 tp60 -59.2 -26.44 64.84 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.388 -0.82 . . . . 0.0 110.639 179.492 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.613 ' O ' HG23 ' A' ' 20' ' ' VAL . 1.6 t30 -78.02 -42.63 31.9 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.3 -0.875 . . . . 0.0 110.722 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.406 ' O ' ' HB ' ' A' ' 20' ' ' VAL . 83.7 mt -82.69 -36.48 13.36 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.002 0 O-C-N 121.226 -0.921 . . . . 0.0 110.647 -179.646 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.491 HG21 ' CD2' ' A' ' 14' ' ' HIS . 48.1 t -64.67 -34.69 71.6 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 O-C-N 121.203 -0.936 . . . . 0.0 110.493 -179.864 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.544 ' HA ' ' CD2' ' A' ' 22' ' ' TYR . 0.1 OUTLIER -85.81 18.38 2.95 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.319 -0.863 . . . . 0.0 111.04 179.674 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.613 HG23 ' O ' ' A' ' 16' ' ' ASN . 13.1 t -100.42 -44.89 11.55 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.109 -0.995 . . . . 0.0 110.251 179.705 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 6.5 mp0 -59.15 -26.65 64.94 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.695 -0.628 . . . . 0.0 110.687 179.878 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' TYR . . . . . 0.544 ' CD2' ' HA ' ' A' ' 19' ' ' ASP . 6.9 m-30 -69.06 -47.13 66.09 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.287 -0.883 . . . . 0.0 109.573 179.687 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -77.94 -32.73 51.7 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.691 -0.631 . . . . 0.0 110.161 179.702 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 55.3 m-85 -111.95 54.97 0.68 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.444 -0.785 . . . . 0.0 109.966 179.783 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -130.95 -69.48 0.1 Allowed Glycine 0 N--CA 1.496 2.636 0 N-CA-C 110.277 -1.129 . . . . 0.0 110.277 -179.539 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 8.7 mt 53.87 30.39 11.41 Favored 'General case' 0 N--CA 1.503 2.219 0 O-C-N 121.76 -0.847 . . . . 0.0 110.773 -179.284 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.604 ' HB2' ' HD3' ' A' ' 28' ' ' PRO . 2.2 m -61.82 -51.73 73.71 Favored Pre-proline 0 N--CA 1.497 1.88 0 O-C-N 121.296 -0.878 . . . . 0.0 110.926 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.604 ' HD3' ' HB2' ' A' ' 27' ' ' SER . 43.4 Cg_endo -69.56 -28.5 26.14 Favored 'Trans proline' 0 N--CA 1.49 1.27 0 O-C-N 123.299 1.157 . . . . 0.0 110.924 179.851 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.43 -36.77 83.45 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.591 -0.693 . . . . 0.0 110.432 179.65 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 35.5 mt -92.27 -36.28 7.6 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 O-C-N 121.327 -0.858 . . . . 0.0 110.219 179.787 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 92.0 m -68.45 -39.79 81.35 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.562 -0.711 . . . . 0.0 110.462 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 4.1 tttt -86.21 19.87 2.54 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.26 -0.9 . . . . 0.0 110.84 179.611 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -116.31 -18.22 10.55 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.207 -0.933 . . . . 0.0 110.856 179.786 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 26.5 t -121.31 -104.81 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.124 -0.985 . . . . 0.0 110.002 -179.843 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 52.1 t 50.45 66.35 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.204 0 O-C-N 121.22 -0.925 . . . . 0.0 110.053 -179.696 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.501 2.09 0 CA-C-O 118.177 -0.916 . . . . 0.0 110.75 -179.57 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 71.1 m . . . . . 0 N--CA 1.495 1.789 0 CA-C-O 121.03 0.443 . . . . 0.0 110.183 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.449 ' HB3' ' HD2' ' A' ' 4' ' ' PRO . 0.2 OUTLIER -155.48 -172.18 4.06 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.497 -0.752 . . . . 0.0 110.394 -179.862 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.509 ' CB ' ' HD3' ' A' ' 4' ' ' PRO . 0.4 OUTLIER -75.78 -52.31 2.76 Favored Pre-proline 0 N--CA 1.499 1.998 0 O-C-N 121.483 -0.761 . . . . 0.0 110.775 -179.962 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.509 ' HD3' ' CB ' ' A' ' 3' ' ' LEU . 46.6 Cg_endo -89.84 -166.13 0.21 Allowed 'Trans proline' 0 C--N 1.319 -0.987 0 O-C-N 123.516 1.272 . . . . 0.0 110.179 179.904 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -161.09 45.84 0.19 Allowed 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.379 -0.826 . . . . 0.0 110.727 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -78.28 -54.48 6.16 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.286 -0.884 . . . . 0.0 109.898 179.676 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.5 m -123.43 55.15 1.24 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.558 -0.714 . . . . 0.0 109.465 179.393 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 2.0 m -126.9 15.88 7.4 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.463 -0.773 . . . . 0.0 110.903 -179.399 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -105.27 -80.93 1.42 Allowed Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.013 -1.635 . . . . 0.0 109.013 179.615 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.1 mp -64.08 -33.3 75.44 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.691 -0.887 . . . . 0.0 110.304 179.35 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 4.8 tp -65.49 -47.23 76.78 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.351 -0.843 . . . . 0.0 109.994 179.596 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -70.2 -43.74 70.1 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.379 -0.826 . . . . 0.0 110.453 179.789 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -61.69 -44.18 97.44 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.401 -0.812 . . . . 0.0 109.931 179.699 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' HIS . . . . . 0.481 ' CE1' HG21 ' A' ' 18' ' ' VAL . 69.9 t60 -65.14 -51.48 60.98 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.506 -0.746 . . . . 0.0 109.705 179.317 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.431 ' HA ' ' HB ' ' A' ' 18' ' ' VAL . 0.8 OUTLIER -56.87 -36.45 70.08 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.428 -0.795 . . . . 0.0 110.224 179.457 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 5.6 t30 -56.53 -41.9 77.54 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.339 -0.85 . . . . 0.0 109.993 179.2 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.434 ' O ' HG12 ' A' ' 20' ' ' VAL . 7.3 mt -86.28 -20.42 7.89 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 O-C-N 121.485 -0.759 . . . . 0.0 110.404 179.462 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.481 HG21 ' CE1' ' A' ' 14' ' ' HIS . 78.3 t -87.48 -12.92 10.55 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 O-C-N 121.27 -0.894 . . . . 0.0 110.331 179.631 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -118.14 24.15 11.16 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.385 -0.822 . . . . 0.0 110.137 179.257 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.449 HG13 ' N ' ' A' ' 21' ' ' GLN . 10.9 p -115.74 -40.6 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.045 0 O-C-N 121.296 -0.877 . . . . 0.0 110.427 179.914 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' GLN . . . . . 0.449 ' N ' HG13 ' A' ' 20' ' ' VAL . 1.5 mm100 -89.24 -7.8 54.79 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.523 -0.736 . . . . 0.0 110.686 179.868 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 23.6 m-85 -115.34 -14.51 11.63 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.359 -0.838 . . . . 0.0 110.735 -179.085 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -108.33 21.47 17.28 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.161 -0.962 . . . . 0.0 110.386 179.294 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -103.33 25.42 9.59 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.179 -0.951 . . . . 0.0 110.369 179.595 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 144.94 62.48 0.02 OUTLIER Glycine 0 N--CA 1.493 2.489 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -153.36 63.89 0.75 Allowed 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.539 -0.977 . . . . 0.0 110.118 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.533 ' HB2' ' HD3' ' A' ' 28' ' ' PRO . 2.3 m -68.08 -52.84 21.68 Favored Pre-proline 0 N--CA 1.498 1.933 0 O-C-N 121.498 -0.751 . . . . 0.0 110.972 -179.846 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.533 ' HD3' ' HB2' ' A' ' 27' ' ' SER . 49.3 Cg_endo -76.74 60.1 6.55 Favored 'Trans proline' 0 N--CA 1.487 1.131 0 O-C-N 123.462 1.243 . . . . 0.0 110.493 179.815 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -157.93 -57.32 0.08 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.399 -0.813 . . . . 0.0 110.102 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 82.1 mt -69.33 -22.8 25.99 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 O-C-N 121.437 -0.789 . . . . 0.0 110.418 179.64 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 24.5 p -61.7 -41.7 97.94 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.416 -0.803 . . . . 0.0 110.249 179.436 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.27 -24.26 64.86 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.521 -0.737 . . . . 0.0 110.418 179.611 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -80.96 -29.36 35.36 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.412 -0.805 . . . . 0.0 110.182 179.512 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 88.2 t -93.13 -38.67 10.21 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.453 -0.779 . . . . 0.0 110.519 -179.708 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.418 ' O ' ' HB2' ' A' ' 36' ' ' ARG . 11.7 t -102.32 12.04 7.37 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 O-C-N 121.315 -0.866 . . . . 0.0 111.049 -179.556 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.418 ' HB2' ' O ' ' A' ' 35' ' ' VAL . 1.8 mpp_? . . . . . 0 N--CA 1.505 2.278 0 O-C-N 121.318 -0.864 . . . . 0.0 111.196 179.75 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' SER . . . . . 0.549 ' C ' HD23 ' A' ' 3' ' ' LEU . 58.9 p . . . . . 0 N--CA 1.495 1.805 0 CA-C-O 120.945 0.402 . . . . 0.0 110.238 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 56.24 80.96 0.13 Allowed 'General case' 0 N--CA 1.502 2.151 0 CA-C-O 121.41 0.624 . . . . 0.0 110.698 179.679 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.549 HD23 ' C ' ' A' ' 1' ' ' SER . 0.5 OUTLIER -160.32 93.05 1.63 Allowed Pre-proline 0 N--CA 1.495 1.815 0 O-C-N 121.431 -0.793 . . . . 0.0 110.224 179.701 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -84.26 64.26 6.89 Favored 'Trans proline' 0 C--N 1.307 -1.61 0 O-C-N 124.022 1.538 . . . . 0.0 110.466 -179.817 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 52.01 33.88 12.77 Favored 'General case' 0 N--CA 1.502 2.134 0 O-C-N 121.7 -0.625 . . . . 0.0 111.043 -179.795 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 55.7 32.93 20.33 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.522 -0.736 . . . . 0.0 110.952 -179.925 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 23.5 m -88.7 -9.95 50.18 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.251 -0.905 . . . . 0.0 111.002 179.826 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 12.5 p -103.16 39.95 1.48 Allowed 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.245 -0.909 . . . . 0.0 110.283 179.74 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -100.36 -47.22 1.72 Allowed Glycine 0 N--CA 1.493 2.477 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 179.842 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 6.3 mt -74.88 -39.31 61.59 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.596 -0.944 . . . . 0.0 110.562 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 14.2 tp -58.14 -49.46 76.9 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.436 -0.79 . . . . 0.0 110.213 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 27.2 m-70 -63.21 -39.19 93.93 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.572 -0.705 . . . . 0.0 109.703 179.247 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 7.2 tp -63.17 -40.13 96.64 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.487 -0.758 . . . . 0.0 109.789 179.082 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' HIS . . . . . 0.519 ' NE2' HG21 ' A' ' 18' ' ' VAL . 68.2 t60 -58.75 -54.06 51.39 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.575 -0.703 . . . . 0.0 109.71 179.391 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.447 ' O ' ' HB2' ' A' ' 19' ' ' ASP . 23.3 tp60 -53.34 -38.64 63.43 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.643 -0.661 . . . . 0.0 110.015 179.45 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -66.81 -37.46 84.57 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.572 -0.705 . . . . 0.0 110.606 179.392 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.409 ' O ' HG12 ' A' ' 20' ' ' VAL . 93.1 mt -82.04 -16.42 11.89 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.073 0 O-C-N 121.35 -0.844 . . . . 0.0 110.588 179.833 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.519 HG21 ' NE2' ' A' ' 14' ' ' HIS . 84.6 t -94.67 -53.04 8.8 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 121.165 -0.959 . . . . 0.0 109.489 179.64 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.447 ' HB2' ' O ' ' A' ' 15' ' ' GLN . 0.7 OUTLIER -59.12 -17.42 26.53 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.737 -0.602 . . . . 0.0 111.316 179.543 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.409 HG12 ' O ' ' A' ' 17' ' ' ILE . 14.9 p -57.44 -27.31 28.54 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.006 0 O-C-N 120.846 -1.159 . . . . 0.0 111.578 -179.842 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -100.51 -15.94 17.69 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.321 -0.862 . . . . 0.0 111.574 -179.183 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 7.4 m-85 -112.01 -30.9 7.08 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.07 -1.018 . . . . 0.0 110.735 -179.121 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -87.97 16.26 6.2 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.184 -0.947 . . . . 0.0 110.806 179.35 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -98.6 29.98 3.46 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.048 -1.032 . . . . 0.0 110.622 179.737 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -98.6 17.81 57.85 Favored Glycine 0 N--CA 1.496 2.688 0 N-CA-C 110.424 -1.07 . . . . 0.0 110.424 179.871 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 5.0 mp 52.37 36.06 18.91 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 121.481 -1.011 . . . . 0.0 111.311 179.704 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.487 ' N ' ' HD2' ' A' ' 28' ' ' PRO . 0.7 OUTLIER -61.47 -54.32 53.53 Favored Pre-proline 0 N--CA 1.501 2.114 0 O-C-N 121.244 -0.91 . . . . 0.0 110.694 179.815 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.487 ' HD2' ' N ' ' A' ' 27' ' ' SER . 44.2 Cg_endo -71.39 -27.29 19.48 Favored 'Trans proline' 0 N--CA 1.487 1.126 0 O-C-N 123.481 1.253 . . . . 0.0 110.647 179.553 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.8 -36.24 78.52 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.585 -0.697 . . . . 0.0 110.181 179.497 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -84.15 -30.76 7.53 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 121.354 -0.841 . . . . 0.0 109.938 179.4 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 53.9 m -71.01 -43.73 67.32 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.545 -0.722 . . . . 0.0 109.722 179.349 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 17.5 tttt -88.41 43.4 1.13 Allowed 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.516 -0.74 . . . . 0.0 109.957 179.348 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 21.5 t80 -151.93 -53.45 0.12 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.571 -0.706 . . . . 0.0 109.423 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 53.5 t -94.66 -34.04 5.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.631 -0.668 . . . . 0.0 109.697 179.19 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 21.9 t -112.13 52.34 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 121.338 -0.852 . . . . 0.0 109.799 179.732 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.505 2.284 0 CA-C-O 118.827 -0.606 . . . . 0.0 110.925 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 38.0 m . . . . . 0 N--CA 1.494 1.772 0 CA-C-O 121.009 0.433 . . . . 0.0 110.229 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -131.93 -171.46 2.63 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.573 -0.705 . . . . 0.0 110.47 -179.84 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.638 ' HB3' ' HD3' ' A' ' 4' ' ' PRO . 0.1 OUTLIER -164.96 -58.09 0.01 OUTLIER Pre-proline 0 N--CA 1.498 1.956 0 O-C-N 121.71 -0.619 . . . . 0.0 110.359 179.844 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.638 ' HD3' ' HB3' ' A' ' 3' ' ' LEU . 44.1 Cg_endo -70.29 -20.88 31.8 Favored 'Trans proline' 0 N--CA 1.49 1.315 0 O-C-N 123.197 1.104 . . . . 0.0 111.061 179.614 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -70.59 -20.8 62.73 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.387 -0.821 . . . . 0.0 110.747 179.709 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 6.3 tp -96.42 42.38 1.09 Allowed 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.27 -0.894 . . . . 0.0 110.396 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 30.8 p -84.26 -27.25 28.03 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.232 -0.918 . . . . 0.0 110.764 179.765 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 1.3 m -102.42 44.52 1.01 Allowed 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.384 -0.822 . . . . 0.0 110.228 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -98.65 -56.21 1.04 Allowed Glycine 0 N--CA 1.493 2.458 0 N-CA-C 109.261 -1.536 . . . . 0.0 109.261 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.4 mt -61.74 -35.77 79.03 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.755 -0.85 . . . . 0.0 110.492 179.867 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.8 tt -58.17 -47.75 82.42 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.438 -0.789 . . . . 0.0 109.935 179.645 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 24.1 m-70 -75.52 -42.06 53.61 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.6 -0.688 . . . . 0.0 109.87 179.456 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 11.4 tp -58.83 -42.66 89.75 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.464 -0.773 . . . . 0.0 110.403 179.701 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' HIS . . . . . 0.53 ' NE2' HG21 ' A' ' 18' ' ' VAL . 6.1 t-80 -59.43 -51.84 68.18 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.563 -0.711 . . . . 0.0 109.933 179.591 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 34.3 tp60 -58.04 -36.53 72.87 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.622 -0.674 . . . . 0.0 110.392 179.731 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -66.42 -41.13 89.7 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.507 -0.745 . . . . 0.0 110.826 179.931 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 73.5 mt -76.15 -43.37 37.76 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 O-C-N 121.262 -0.899 . . . . 0.0 110.505 -179.55 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.53 HG21 ' NE2' ' A' ' 14' ' ' HIS . 38.0 t -67.72 -36.38 75.8 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 O-C-N 121.416 -0.803 . . . . 0.0 110.661 -179.873 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -66.99 -18.53 65.43 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.428 -0.795 . . . . 0.0 110.666 179.508 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 80.6 t -100.64 -35.84 4.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.026 -1.046 . . . . 0.0 109.323 179.096 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -67.23 -39.98 86.31 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.739 -0.601 . . . . 0.0 110.579 179.811 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' TYR . . . . . 0.43 ' CD1' ' C ' ' A' ' 22' ' ' TYR . 0.2 OUTLIER -63.02 -33.13 74.77 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.248 -0.907 . . . . 0.0 110.548 -179.792 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -87.91 -40.37 14.0 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.454 -0.779 . . . . 0.0 110.622 -179.819 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 33.0 m-85 -93.44 21.93 5.75 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.299 -0.875 . . . . 0.0 110.735 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -155.64 67.29 0.3 Allowed Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.317 -1.513 . . . . 0.0 109.317 179.865 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.0 tp -82.02 -35.7 28.55 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.561 -0.964 . . . . 0.0 110.383 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.561 ' HB2' ' HD3' ' A' ' 28' ' ' PRO . 43.4 m -56.91 -51.36 82.12 Favored Pre-proline 0 N--CA 1.498 1.965 0 O-C-N 121.644 -0.66 . . . . 0.0 110.822 179.72 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.561 ' HD3' ' HB2' ' A' ' 27' ' ' SER . 43.6 Cg_endo -69.74 -23.36 30.97 Favored 'Trans proline' 0 N--CA 1.489 1.237 0 O-C-N 123.408 1.215 . . . . 0.0 111.033 179.41 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -80.47 -42.81 21.92 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.452 -0.78 . . . . 0.0 110.581 179.821 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.406 HG22 ' O ' ' A' ' 27' ' ' SER . 11.9 tt -71.85 -29.13 32.46 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 O-C-N 121.324 -0.86 . . . . 0.0 111.083 -179.614 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 2.9 p -65.97 -37.03 84.93 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.317 -0.864 . . . . 0.0 109.909 179.547 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 9.6 tptp -87.0 -25.64 24.16 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.416 -0.803 . . . . 0.0 109.796 178.987 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 71.1 t80 -68.16 -41.1 82.05 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.464 -0.773 . . . . 0.0 110.456 179.656 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.776 HG13 HG23 ' A' ' 35' ' ' VAL . 7.9 p -67.23 -31.73 54.39 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 O-C-N 121.335 -0.853 . . . . 0.0 110.405 179.693 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.776 HG23 HG13 ' A' ' 34' ' ' VAL . 85.1 t -96.36 -4.14 10.15 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 O-C-N 121.346 -0.846 . . . . 0.0 110.69 179.671 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 10.6 mmt85 . . . . . 0 N--CA 1.501 2.116 0 O-C-N 121.57 -0.706 . . . . 0.0 110.482 -179.933 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 13.4 m . . . . . 0 N--CA 1.496 1.833 0 CA-C-O 121.223 0.535 . . . . 0.0 109.954 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -138.88 -170.37 2.84 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.497 -0.752 . . . . 0.0 110.269 -179.54 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.433 ' N ' ' HD3' ' A' ' 4' ' ' PRO . 0.3 OUTLIER 54.17 63.4 7.59 Favored Pre-proline 0 N--CA 1.502 2.152 0 O-C-N 121.696 -0.627 . . . . 0.0 110.892 179.949 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.433 ' HD3' ' N ' ' A' ' 3' ' ' LEU . 47.7 Cg_endo -83.17 63.14 7.7 Favored 'Trans proline' 0 C--N 1.312 -1.376 0 O-C-N 123.779 1.41 . . . . 0.0 110.494 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -122.2 55.95 1.12 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.394 -0.816 . . . . 0.0 110.092 179.871 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -77.73 -57.7 3.67 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.441 -0.787 . . . . 0.0 110.117 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 75.3 m -139.58 -88.05 0.2 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.412 -0.805 . . . . 0.0 110.13 179.864 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 3.9 m -148.94 54.94 0.99 Allowed 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.383 -0.823 . . . . 0.0 109.965 179.904 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -103.68 -85.26 1.85 Allowed Glycine 0 N--CA 1.495 2.617 0 N-CA-C 109.851 -1.3 . . . . 0.0 109.851 -179.619 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.406 HD22 ' CB ' ' A' ' 4' ' ' PRO . 1.1 mp -58.73 -39.7 81.6 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.654 -0.909 . . . . 0.0 110.383 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -58.25 -48.37 80.63 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.526 -0.734 . . . . 0.0 109.829 179.392 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -66.76 -43.19 84.72 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.652 -0.655 . . . . 0.0 109.681 179.24 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.0 tt -58.07 -41.0 82.45 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.661 -0.649 . . . . 0.0 110.028 179.38 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' HIS . . . . . 0.433 ' CE1' HG21 ' A' ' 18' ' ' VAL . 82.9 t60 -59.31 -46.0 89.78 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.529 -0.732 . . . . 0.0 109.808 179.368 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.435 ' O ' ' HB2' ' A' ' 19' ' ' ASP . 0.4 OUTLIER -65.91 -34.27 77.73 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.501 -0.749 . . . . 0.0 109.662 179.193 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -64.94 -14.99 61.58 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.372 -0.83 . . . . 0.0 110.596 179.15 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 38.5 mm -107.81 -38.51 4.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.356 -0.84 . . . . 0.0 109.66 179.652 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.433 HG21 ' CE1' ' A' ' 14' ' ' HIS . 71.4 t -83.89 -42.6 17.37 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 O-C-N 121.495 -0.753 . . . . 0.0 110.743 -179.714 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.466 ' HA ' ' CD2' ' A' ' 22' ' ' TYR . 0.2 OUTLIER -77.23 -2.8 36.48 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.551 -0.718 . . . . 0.0 111.452 -179.663 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 63.2 t -108.68 -28.37 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 120.833 -1.167 . . . . 0.0 110.263 179.458 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 15.2 mt-30 -79.61 -37.39 36.25 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.169 -0.957 . . . . 0.0 110.216 179.438 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' TYR . . . . . 0.466 ' CD2' ' HA ' ' A' ' 19' ' ' ASP . 0.6 OUTLIER -64.08 -32.25 73.74 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.484 -0.76 . . . . 0.0 110.458 179.839 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -84.82 -13.74 50.15 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.5 -0.75 . . . . 0.0 110.991 179.837 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -98.9 43.03 1.07 Allowed 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.094 -1.004 . . . . 0.0 110.342 -180.0 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -160.56 50.67 0.36 Allowed Glycine 0 N--CA 1.494 2.547 0 N-CA-C 109.749 -1.341 . . . . 0.0 109.749 179.861 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.3 mp -112.05 -8.91 14.02 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.312 -1.11 . . . . 0.0 111.213 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.534 ' HB2' ' HD3' ' A' ' 28' ' ' PRO . 26.5 m -61.61 -51.04 79.57 Favored Pre-proline 0 N--CA 1.499 1.999 0 O-C-N 121.223 -0.923 . . . . 0.0 111.105 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.534 ' HD3' ' HB2' ' A' ' 27' ' ' SER . 45.1 Cg_endo -70.72 -17.77 32.96 Favored 'Trans proline' 0 N--CA 1.49 1.269 0 O-C-N 123.417 1.22 . . . . 0.0 111.224 179.823 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -80.32 -41.38 24.94 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.265 -0.897 . . . . 0.0 110.501 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 32.3 mm -69.64 -43.23 80.43 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 O-C-N 121.345 -0.847 . . . . 0.0 110.718 -179.852 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.542 ' HA ' HG12 ' A' ' 34' ' ' VAL . 12.1 t -63.25 -31.78 73.02 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.475 -0.766 . . . . 0.0 110.626 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 45.0 tttt -73.49 -29.11 62.29 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.284 -0.885 . . . . 0.0 109.937 179.201 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 24.4 t80 -83.02 -45.05 14.53 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.566 -0.709 . . . . 0.0 109.701 179.282 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.92 HG13 HG23 ' A' ' 35' ' ' VAL . 3.4 p -79.89 170.13 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 O-C-N 121.547 -0.721 . . . . 0.0 110.115 179.731 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.92 HG23 HG13 ' A' ' 34' ' ' VAL . 38.8 t 60.19 75.92 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.215 0 O-C-N 121.597 -0.689 . . . . 0.0 110.176 -179.723 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 14.1 ttp180 . . . . . 0 N--CA 1.496 1.826 0 CA-C-O 118.246 -0.883 . . . . 0.0 110.261 -179.963 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' SER . . . . . 0.444 ' O ' ' HB2' ' A' ' 2' ' ' ASP . 23.9 m . . . . . 0 N--CA 1.496 1.832 0 CA-C-O 120.803 0.335 . . . . 0.0 110.167 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.444 ' HB2' ' O ' ' A' ' 1' ' ' SER . 17.8 m-20 61.67 177.42 0.12 Allowed 'General case' 0 N--CA 1.502 2.166 0 CA-C-O 121.348 0.594 . . . . 0.0 110.946 -179.816 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.439 ' N ' ' HD3' ' A' ' 4' ' ' PRO . 0.4 OUTLIER 52.09 66.45 5.07 Favored Pre-proline 0 N--CA 1.5 2.06 0 O-C-N 121.684 -0.635 . . . . 0.0 110.63 -179.859 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.439 ' HD3' ' N ' ' A' ' 3' ' ' LEU . 46.2 Cg_endo -92.07 -157.58 0.06 OUTLIER 'Trans proline' 0 C--N 1.311 -1.396 0 C-N-CA 121.787 1.658 . . . . 0.0 110.531 -179.802 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 52.55 37.38 22.96 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.545 -0.722 . . . . 0.0 111.165 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 54.27 34.93 21.52 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.563 -0.71 . . . . 0.0 110.811 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 7.6 t 53.32 34.85 18.81 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.546 -0.721 . . . . 0.0 111.313 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 14.4 t -160.98 33.0 0.15 Allowed 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.148 -0.97 . . . . 0.0 110.914 179.752 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -67.28 -52.19 33.17 Favored Glycine 0 N--CA 1.496 2.696 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 179.617 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -65.94 -40.46 91.37 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.533 -0.981 . . . . 0.0 109.92 179.559 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.9 tt -61.01 -44.99 96.61 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.579 -0.7 . . . . 0.0 109.776 179.347 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -68.32 -44.47 75.31 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.578 -0.701 . . . . 0.0 109.763 179.409 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -63.35 -37.36 86.95 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.544 -0.722 . . . . 0.0 110.049 179.434 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' HIS . . . . . 0.465 ' CD2' HG21 ' A' ' 18' ' ' VAL . 14.1 t-80 -57.07 -58.08 9.75 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.576 -0.702 . . . . 0.0 109.645 179.538 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.424 ' O ' ' HB2' ' A' ' 19' ' ' ASP . 0.1 OUTLIER -59.78 -38.95 83.3 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.353 -0.842 . . . . 0.0 110.031 179.19 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -59.22 -43.84 92.3 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.399 -0.813 . . . . 0.0 110.603 179.674 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 22.2 mm -81.87 -36.06 13.95 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 O-C-N 121.232 -0.917 . . . . 0.0 110.47 179.867 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.595 ' HA ' ' CE1' ' A' ' 22' ' ' TYR . 69.7 t -75.71 -8.6 11.85 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 O-C-N 121.493 -0.754 . . . . 0.0 111.663 -179.469 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.424 ' HB2' ' O ' ' A' ' 15' ' ' GLN . 0.4 OUTLIER -119.56 27.93 8.47 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 120.942 -1.099 . . . . 0.0 110.93 179.781 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 42.4 t -130.81 -56.91 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 O-C-N 121.097 -1.002 . . . . 0.0 109.983 179.579 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -65.24 -10.38 31.48 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.745 -0.597 . . . . 0.0 110.9 179.52 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' TYR . . . . . 0.595 ' CE1' ' HA ' ' A' ' 18' ' ' VAL . 34.0 m-85 -103.85 -1.64 27.48 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.231 -0.918 . . . . 0.0 110.82 -179.539 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -132.33 26.33 4.48 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.233 -0.917 . . . . 0.0 110.582 179.807 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -120.62 15.63 11.94 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.145 -0.972 . . . . 0.0 111.009 179.864 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -117.33 37.85 3.18 Favored Glycine 0 N--CA 1.495 2.614 0 N-CA-C 109.986 -1.246 . . . . 0.0 109.986 179.837 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.422 ' HA ' HD12 ' A' ' 30' ' ' ILE . 1.2 mt -114.24 22.45 13.77 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.402 -1.058 . . . . 0.0 110.425 179.658 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.45 ' CB ' ' CD ' ' A' ' 28' ' ' PRO . 0.0 OUTLIER -164.18 -61.49 0.01 OUTLIER Pre-proline 0 N--CA 1.498 1.934 0 O-C-N 121.416 -0.803 . . . . 0.0 110.144 179.828 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.45 ' CD ' ' CB ' ' A' ' 27' ' ' SER . 46.0 Cg_endo -71.85 -17.02 29.35 Favored 'Trans proline' 0 N--CA 1.489 1.252 0 O-C-N 123.08 1.042 . . . . 0.0 110.944 179.284 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -100.46 -12.09 19.63 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.4 -0.813 . . . . 0.0 111.002 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.422 HD12 ' HA ' ' A' ' 26' ' ' LEU . 73.6 mt -118.82 -49.08 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.177 -0.952 . . . . 0.0 110.231 -179.768 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 2.4 m -69.98 -31.15 68.71 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.595 -0.69 . . . . 0.0 110.504 -179.854 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.436 ' HG3' ' HA ' ' A' ' 28' ' ' PRO . 12.8 mmtp -87.83 6.2 36.5 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.259 -0.9 . . . . 0.0 110.797 179.635 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -103.33 -41.25 6.09 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.286 -0.884 . . . . 0.0 110.066 179.752 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 16.6 t -89.41 54.01 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 121.446 -0.784 . . . . 0.0 109.451 179.469 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.409 ' O ' HG13 ' A' ' 35' ' ' VAL . 8.8 p -157.79 35.62 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 121.356 -0.84 . . . . 0.0 110.292 -179.663 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.496 1.855 0 CA-C-O 117.838 -1.077 . . . . 0.0 110.313 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.494 1.763 0 CA-C-O 120.965 0.412 . . . . 0.0 110.186 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -116.84 45.93 1.75 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.53 -0.731 . . . . 0.0 110.125 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.452 ' N ' ' HD3' ' A' ' 4' ' ' PRO . 0.7 OUTLIER -153.5 64.76 5.12 Favored Pre-proline 0 N--CA 1.496 1.829 0 O-C-N 121.54 -0.725 . . . . 0.0 110.157 179.941 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.452 ' HD3' ' N ' ' A' ' 3' ' ' LEU . 47.0 Cg_endo -87.53 74.57 2.45 Favored 'Trans proline' 0 C--N 1.311 -1.43 0 C-N-CA 121.523 1.482 . . . . 0.0 110.543 -179.609 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -115.45 -55.64 2.43 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.436 -0.79 . . . . 0.0 110.412 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER 54.15 43.45 30.64 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.642 -0.661 . . . . 0.0 110.758 179.967 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 12.5 m -80.32 -9.22 59.74 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.33 -0.856 . . . . 0.0 111.151 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.564 HG22 ' HB2' ' A' ' 12' ' ' HIS . 5.6 m 60.54 78.94 0.26 Allowed 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.579 -0.701 . . . . 0.0 110.287 -179.89 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -103.17 -78.39 1.28 Allowed Glycine 0 N--CA 1.495 2.606 0 N-CA-C 109.32 -1.512 . . . . 0.0 109.32 179.804 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.456 ' HA ' HD22 ' A' ' 10' ' ' LEU . 0.2 OUTLIER -61.06 -41.56 96.84 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.504 -0.997 . . . . 0.0 110.038 179.485 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.471 HD22 ' HA ' ' A' ' 11' ' ' LEU . 0.2 OUTLIER -59.26 -42.01 90.17 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.563 -0.711 . . . . 0.0 109.796 179.371 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 12' ' ' HIS . . . . . 0.564 ' HB2' HG22 ' A' ' 8' ' ' THR . 6.5 t-80 -65.27 -37.46 87.25 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.594 -0.691 . . . . 0.0 109.833 179.242 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.466 ' HA ' HD22 ' A' ' 13' ' ' LEU . 0.2 OUTLIER -61.77 -42.53 99.11 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.465 -0.772 . . . . 0.0 109.399 179.006 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 14' ' ' HIS . . . . . 0.443 ' NE2' HG21 ' A' ' 18' ' ' VAL . 4.7 t-80 -67.08 -48.07 69.33 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.642 -0.661 . . . . 0.0 109.403 178.98 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 30.5 mm100 -60.17 -34.49 73.66 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.558 -0.714 . . . . 0.0 109.988 179.385 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.49 ' O ' HG23 ' A' ' 20' ' ' VAL . 10.1 t30 -61.98 -50.35 72.43 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.429 -0.794 . . . . 0.0 110.137 179.421 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 49.7 mt -71.13 -19.47 21.07 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 O-C-N 121.262 -0.899 . . . . 0.0 110.793 179.783 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.443 HG21 ' NE2' ' A' ' 14' ' ' HIS . 47.0 t -97.24 -8.79 9.16 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 O-C-N 121.258 -0.901 . . . . 0.0 111.232 -179.592 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -123.03 27.84 7.47 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.06 -1.025 . . . . 0.0 110.886 179.592 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.49 HG23 ' O ' ' A' ' 16' ' ' ASN . 39.3 t -124.31 -56.48 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 O-C-N 121.14 -0.975 . . . . 0.0 109.381 179.254 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 14.2 mp0 -68.11 -15.67 63.69 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.824 -0.547 . . . . 0.0 110.595 179.33 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' TYR . . . . . 0.425 ' CE2' ' HA ' ' A' ' 18' ' ' VAL . 17.6 m-85 -105.33 -42.36 5.27 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.374 -0.829 . . . . 0.0 110.143 -179.637 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.58 -32.44 64.14 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.462 -0.774 . . . . 0.0 110.34 179.796 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -97.1 40.59 1.14 Allowed 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.292 -0.88 . . . . 0.0 110.38 179.523 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -81.32 -33.16 29.35 Favored Glycine 0 N--CA 1.497 2.734 0 N-CA-C 110.149 -1.18 . . . . 0.0 110.149 179.87 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 59.9 38.74 20.99 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.562 -0.963 . . . . 0.0 110.609 -179.895 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.513 ' CB ' ' CD ' ' A' ' 28' ' ' PRO . 0.4 OUTLIER -169.77 -63.04 0.01 OUTLIER Pre-proline 0 N--CA 1.498 1.944 0 O-C-N 121.54 -0.725 . . . . 0.0 110.186 179.69 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.513 ' CD ' ' CB ' ' A' ' 27' ' ' SER . 43.3 Cg_endo -69.48 -27.33 27.93 Favored 'Trans proline' 0 N--CA 1.49 1.265 0 O-C-N 123.393 1.207 . . . . 0.0 110.76 179.664 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.76 -37.22 83.47 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.579 -0.7 . . . . 0.0 110.289 179.51 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 58.9 mt -79.25 -39.42 21.06 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 121.466 -0.771 . . . . 0.0 109.873 179.52 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 99.8 m -65.0 -45.02 87.33 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.58 -0.7 . . . . 0.0 109.965 179.524 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -67.03 -20.99 65.94 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.485 -0.759 . . . . 0.0 110.785 179.651 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -72.65 -24.09 61.0 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.361 -0.837 . . . . 0.0 110.543 179.615 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 55.6 t -110.29 -65.97 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.266 -0.896 . . . . 0.0 110.275 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 36.6 t 54.2 72.55 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.159 0 O-C-N 121.693 -0.629 . . . . 0.0 110.167 -179.724 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 1.5 ttp180 . . . . . 0 N--CA 1.502 2.133 0 CA-C-O 118.171 -0.919 . . . . 0.0 110.721 -179.735 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 22.0 m . . . . . 0 N--CA 1.494 1.746 0 CA-C-O 120.838 0.351 . . . . 0.0 110.172 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.602 ' HB3' ' HA2' ' A' ' 9' ' ' GLY . 21.9 m-20 52.16 36.42 19.1 Favored 'General case' 0 N--CA 1.502 2.141 0 CA-C-O 121.305 0.574 . . . . 0.0 110.929 -179.813 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.609 ' HB2' ' HD3' ' A' ' 4' ' ' PRO . 7.7 mt -77.58 -51.11 1.92 Allowed Pre-proline 0 N--CA 1.497 1.922 0 O-C-N 121.286 -0.884 . . . . 0.0 110.825 -179.939 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.609 ' HD3' ' HB2' ' A' ' 3' ' ' LEU . 53.2 Cg_endo -84.08 18.22 1.57 Allowed 'Trans proline' 0 N--CA 1.484 0.945 0 O-C-N 123.382 1.201 . . . . 0.0 111.441 179.543 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 55.95 34.83 24.39 Favored 'General case' 0 N--CA 1.503 2.2 0 O-C-N 121.317 -0.864 . . . . 0.0 111.094 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.577 HD12 ' HG2' ' A' ' 4' ' ' PRO . 12.7 mt -73.31 -32.13 64.42 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.406 -0.809 . . . . 0.0 110.769 -179.917 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 37.4 m -123.48 -77.12 0.59 Allowed 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.371 -0.831 . . . . 0.0 110.504 -179.903 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -126.67 35.44 4.63 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.374 -0.829 . . . . 0.0 110.564 -179.828 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.602 ' HA2' ' HB3' ' A' ' 2' ' ' ASP . . . -71.72 -58.75 5.16 Favored Glycine 0 N--CA 1.493 2.492 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 179.66 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.36 -39.17 89.64 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.636 -0.92 . . . . 0.0 110.284 179.725 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.8 tt -59.03 -48.36 81.86 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.446 -0.784 . . . . 0.0 109.783 179.433 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 21.7 m170 -69.16 -44.3 72.56 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.679 -0.638 . . . . 0.0 109.672 179.213 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.7 mt -56.88 -41.87 78.8 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.605 -0.685 . . . . 0.0 110.06 179.489 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' HIS . . . . . 0.602 ' O ' HG23 ' A' ' 18' ' ' VAL . 5.7 t-80 -63.17 -46.86 85.17 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.652 -0.655 . . . . 0.0 109.812 179.321 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 25.2 tp60 -54.1 -41.88 68.75 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.645 -0.659 . . . . 0.0 110.698 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.48 ' O ' HG23 ' A' ' 20' ' ' VAL . 7.5 t-20 -66.95 -47.82 70.45 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.395 -0.815 . . . . 0.0 110.384 179.781 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 74.4 mt -57.94 -38.6 67.38 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.111 0 O-C-N 121.422 -0.799 . . . . 0.0 109.91 179.83 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.602 HG23 ' O ' ' A' ' 14' ' ' HIS . 47.5 t -72.22 -35.88 54.17 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.528 -0.732 . . . . 0.0 109.706 179.302 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -68.8 -15.52 63.53 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.734 -0.604 . . . . 0.0 110.966 179.516 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.48 HG23 ' O ' ' A' ' 16' ' ' ASN . 47.7 t -102.56 -40.68 7.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.135 -0.978 . . . . 0.0 109.481 179.322 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.11 -39.44 94.04 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.689 -0.632 . . . . 0.0 110.75 179.883 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -63.49 -29.23 70.53 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.302 -0.873 . . . . 0.0 110.665 -179.83 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -103.6 17.97 22.92 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.362 -0.836 . . . . 0.0 111.032 179.709 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -118.53 24.33 10.97 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.116 -0.99 . . . . 0.0 110.672 179.82 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 61.51 39.87 97.92 Favored Glycine 0 N--CA 1.496 2.699 0 N-CA-C 110.153 -1.179 . . . . 0.0 110.153 179.821 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 23.8 mt -122.08 4.74 9.84 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.235 -1.156 . . . . 0.0 111.371 -179.851 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.523 ' HB2' ' HD3' ' A' ' 28' ' ' PRO . 3.0 m -69.82 -59.44 4.53 Favored Pre-proline 0 N--CA 1.498 1.933 0 O-C-N 121.015 -1.053 . . . . 0.0 110.416 179.86 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.523 ' HD3' ' HB2' ' A' ' 27' ' ' SER . 45.8 Cg_endo -71.52 -25.73 20.82 Favored 'Trans proline' 0 N--CA 1.488 1.165 0 O-C-N 123.395 1.208 . . . . 0.0 110.62 179.402 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.29 -35.64 81.49 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.584 -0.697 . . . . 0.0 110.597 179.734 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 26.1 mm -79.54 -38.41 19.54 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 O-C-N 121.323 -0.861 . . . . 0.0 110.165 179.809 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 24.4 m -62.19 -38.65 89.94 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.432 -0.793 . . . . 0.0 109.958 179.623 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.7 tmtt? -69.92 -35.7 74.78 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.291 -0.88 . . . . 0.0 110.206 179.482 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 80.6 t80 -76.61 -41.1 47.26 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.587 -0.696 . . . . 0.0 110.118 179.671 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 47.1 t -98.66 79.03 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.458 -0.776 . . . . 0.0 109.837 179.871 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 4.9 p -138.32 17.83 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 O-C-N 121.42 -0.8 . . . . 0.0 110.97 -179.777 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 30.8 mtp180 . . . . . 0 N--CA 1.495 1.8 0 O-C-N 121.185 -0.947 . . . . 0.0 110.303 179.921 . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 4.2 p . . . . . 0 N--CA 1.497 1.88 0 CA-C-O 121.139 0.495 . . . . 0.0 110.31 . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -143.3 151.87 41.0 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.526 -0.734 . . . . 0.0 110.333 -179.913 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.438 ' N ' ' HD3' ' A' ' 4' ' ' PRO . 0.3 OUTLIER -143.91 66.31 14.76 Favored Pre-proline 0 N--CA 1.497 1.881 0 O-C-N 121.467 -0.771 . . . . 0.0 110.426 179.899 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.438 ' HD3' ' N ' ' A' ' 3' ' ' LEU . 48.1 Cg_endo -89.61 -151.66 0.04 OUTLIER 'Trans proline' 0 C--N 1.31 -1.456 0 C-N-CA 121.618 1.545 . . . . 0.0 109.991 179.942 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -61.87 -32.46 72.81 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.215 -0.928 . . . . 0.0 110.711 179.777 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.2 tp 58.49 27.1 15.09 Favored 'General case' 0 N--CA 1.503 2.178 0 O-C-N 121.59 -0.694 . . . . 0.0 111.248 179.994 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 4.2 m -112.05 -46.05 3.25 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.002 -1.061 . . . . 0.0 110.398 179.852 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 69.7 p -113.44 47.73 1.12 Allowed 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.533 -0.729 . . . . 0.0 110.211 179.808 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -95.71 -74.49 1.22 Allowed Glycine 0 N--CA 1.494 2.515 0 N-CA-C 109.034 -1.626 . . . . 0.0 109.034 179.721 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 10.5 tp -87.81 -39.0 15.24 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.568 -0.96 . . . . 0.0 109.89 179.386 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.2 tt -59.63 -48.81 80.21 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.52 -0.737 . . . . 0.0 110.277 179.779 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 7.4 t-80 -61.57 -40.66 95.54 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.514 -0.741 . . . . 0.0 110.306 179.884 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 5.2 tp -56.5 -43.03 79.3 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.422 -0.799 . . . . 0.0 109.614 179.247 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 14' ' ' HIS . . . . . 0.519 ' NE2' HG21 ' A' ' 18' ' ' VAL . 76.4 t60 -66.77 -45.87 77.11 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.677 -0.639 . . . . 0.0 109.289 178.935 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 3.7 mm-40 -62.24 -35.84 80.17 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.548 -0.72 . . . . 0.0 110.081 179.247 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -60.5 -38.35 84.06 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.519 -0.738 . . . . 0.0 110.421 179.617 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.555 ' O ' HG12 ' A' ' 20' ' ' VAL . 28.9 mt -86.16 -36.88 11.09 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 O-C-N 121.347 -0.846 . . . . 0.0 110.221 179.958 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.519 HG21 ' NE2' ' A' ' 14' ' ' HIS . 55.1 t -70.77 -34.11 55.19 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 O-C-N 121.324 -0.86 . . . . 0.0 110.512 179.888 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.515 ' HA ' ' CD1' ' A' ' 22' ' ' TYR . 1.2 t70 -89.37 14.39 11.3 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.379 -0.826 . . . . 0.0 111.352 -179.914 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.555 HG12 ' O ' ' A' ' 17' ' ' ILE . 0.8 OUTLIER -118.93 -20.51 5.0 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 120.916 -1.115 . . . . 0.0 110.773 179.256 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -100.2 -29.22 12.6 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.269 -0.894 . . . . 0.0 110.311 179.78 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 22' ' ' TYR . . . . . 0.515 ' CD1' ' HA ' ' A' ' 19' ' ' ASP . 2.9 p90 -64.09 -22.97 67.15 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.413 -0.805 . . . . 0.0 110.89 179.891 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 1.9 ttp -93.6 -29.12 15.64 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.228 -0.92 . . . . 0.0 110.703 -179.975 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 41.3 m-85 -95.76 39.92 1.13 Allowed 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.281 -0.887 . . . . 0.0 110.649 179.999 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -83.01 -27.43 41.0 Favored Glycine 0 N--CA 1.495 2.62 0 N-CA-C 110.361 -1.096 . . . . 0.0 110.361 -179.872 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.484 HD13 ' HA ' ' A' ' 26' ' ' LEU . 3.7 mm? -97.31 42.7 1.08 Allowed 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.227 -1.161 . . . . 0.0 110.48 -179.876 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.677 ' HB3' ' HD3' ' A' ' 28' ' ' PRO . 8.0 t -65.02 -52.95 45.41 Favored Pre-proline 0 N--CA 1.497 1.884 0 O-C-N 121.25 -0.906 . . . . 0.0 110.429 179.731 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.677 ' HD3' ' HB3' ' A' ' 27' ' ' SER . 53.2 Cg_endo -81.19 51.71 4.03 Favored 'Trans proline' 0 N--CA 1.484 0.954 0 O-C-N 123.191 1.101 . . . . 0.0 110.508 179.26 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -152.06 -59.36 0.15 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.306 -0.871 . . . . 0.0 109.767 179.855 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 15.8 mt -68.05 -35.53 72.05 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 O-C-N 121.553 -0.717 . . . . 0.0 109.793 179.432 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 1.8 m -70.58 -45.62 65.01 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.672 -0.643 . . . . 0.0 109.715 179.468 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 3.4 mttm -60.37 -32.14 71.0 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.65 -0.656 . . . . 0.0 110.404 179.638 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 88.9 t80 -72.97 -36.61 67.15 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.638 -0.663 . . . . 0.0 110.333 179.615 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 75.8 t -76.79 -23.96 15.33 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 O-C-N 121.422 -0.798 . . . . 0.0 110.842 -179.885 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 25.6 t -104.2 58.87 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 O-C-N 121.212 -0.93 . . . . 0.0 109.918 179.988 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.497 1.919 0 CA-C-O 117.838 -1.077 . . . . 0.0 110.54 179.863 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 21.4 p . . . . . 0 N--CA 1.495 1.787 0 CA-C-O 121.008 0.432 . . . . 0.0 110.179 . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 26.5 m-20 -119.47 33.11 5.77 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.483 -0.761 . . . . 0.0 110.648 -179.793 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.569 ' HB3' ' HD3' ' A' ' 4' ' ' PRO . 0.9 OUTLIER -80.12 -50.95 1.13 Allowed Pre-proline 0 N--CA 1.497 1.891 0 O-C-N 121.411 -0.805 . . . . 0.0 110.84 179.837 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.569 ' HD3' ' HB3' ' A' ' 3' ' ' LEU . 51.3 Cg_endo -81.23 54.04 5.01 Favored 'Trans proline' 0 N--CA 1.485 0.984 0 O-C-N 123.365 1.192 . . . . 0.0 110.808 179.938 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -102.02 -42.61 6.04 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.12 -0.988 . . . . 0.0 110.252 179.757 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.442 HD13 ' HA ' ' A' ' 6' ' ' LEU . 0.8 OUTLIER -96.15 36.83 1.29 Allowed 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.383 -0.823 . . . . 0.0 110.412 179.858 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 49.5 m -94.24 10.47 33.88 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.289 -0.882 . . . . 0.0 110.806 179.648 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 21.9 p -116.76 25.77 10.31 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.239 -0.913 . . . . 0.0 110.333 179.619 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -63.3 -50.99 58.27 Favored Glycine 0 N--CA 1.496 2.638 0 N-CA-C 110.211 -1.155 . . . . 0.0 110.211 -179.664 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.431 ' HA ' HD13 ' A' ' 10' ' ' LEU . 3.5 mm? -64.37 -45.38 87.99 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.438 -1.036 . . . . 0.0 110.409 -179.958 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 13.9 tp -61.41 -44.83 96.46 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.518 -0.739 . . . . 0.0 110.085 179.668 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -64.03 -38.5 91.29 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.547 -0.721 . . . . 0.0 109.794 179.361 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 12.1 tp -60.14 -41.4 92.64 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.46 -0.775 . . . . 0.0 109.771 179.122 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 6.7 t-160 -62.5 -50.77 70.08 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.589 -0.694 . . . . 0.0 109.656 179.288 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 22.5 tp60 -57.72 -36.29 71.82 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.56 -0.713 . . . . 0.0 110.291 179.549 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.629 ' O ' HG23 ' A' ' 20' ' ' VAL . 0.7 OUTLIER -64.38 -35.86 82.28 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.446 -0.784 . . . . 0.0 110.796 179.696 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 34.3 mt -88.0 -32.37 6.07 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 121.236 -0.915 . . . . 0.0 110.675 -179.639 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -71.37 -42.8 73.78 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 121.284 -0.885 . . . . 0.0 110.224 -179.95 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.685 ' HA ' ' CD2' ' A' ' 22' ' ' TYR . 1.1 t70 -63.33 -24.45 67.86 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.427 -0.796 . . . . 0.0 110.814 179.585 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.629 HG23 ' O ' ' A' ' 16' ' ' ASN . 44.5 t -60.38 -39.99 82.67 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 121.444 -0.785 . . . . 0.0 110.59 179.705 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 8.2 mm100 -64.81 -21.35 66.77 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.398 -0.814 . . . . 0.0 110.747 179.841 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 22' ' ' TYR . . . . . 0.685 ' CD2' ' HA ' ' A' ' 19' ' ' ASP . 1.5 m-85 -92.86 -49.56 5.99 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.176 -0.952 . . . . 0.0 109.526 179.766 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -72.02 -39.51 69.13 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.287 -0.883 . . . . 0.0 110.123 179.56 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -101.51 48.11 0.89 Allowed 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.539 -0.725 . . . . 0.0 109.93 179.648 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -179.95 -51.3 0.08 OUTLIER Glycine 0 N--CA 1.495 2.578 0 N-CA-C 109.902 -1.279 . . . . 0.0 109.902 -179.918 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.904 ' HG ' ' HB3' ' A' ' 29' ' ' ALA . 0.5 OUTLIER -94.78 23.36 5.52 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.504 -0.998 . . . . 0.0 111.369 -179.801 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.543 ' HB3' ' HD3' ' A' ' 28' ' ' PRO . 12.8 t -62.75 -49.5 82.21 Favored Pre-proline 0 N--CA 1.501 2.116 0 O-C-N 121.119 -0.988 . . . . 0.0 111.185 179.738 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.543 ' HD3' ' HB3' ' A' ' 27' ' ' SER . 47.0 Cg_endo -72.76 -9.63 24.04 Favored 'Trans proline' 0 N--CA 1.489 1.246 0 O-C-N 123.314 1.165 . . . . 0.0 111.468 -179.858 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.904 ' HB3' ' HG ' ' A' ' 26' ' ' LEU . . . -99.72 -48.22 4.79 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.278 -0.889 . . . . 0.0 110.372 179.899 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.634 ' HB ' HD23 ' A' ' 26' ' ' LEU . 16.8 tt -62.08 -25.42 37.39 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 O-C-N 121.434 -0.791 . . . . 0.0 111.297 -179.789 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 6.1 t -68.46 -28.47 67.07 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.269 -0.894 . . . . 0.0 110.507 179.831 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -111.15 20.82 17.02 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.388 -0.82 . . . . 0.0 110.237 179.293 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -121.7 -45.75 2.27 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.335 -0.853 . . . . 0.0 110.447 -179.925 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 93.6 t -64.87 -31.18 52.73 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 O-C-N 121.351 -0.843 . . . . 0.0 110.124 179.837 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 15.3 t -96.22 54.35 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 121.495 -0.753 . . . . 0.0 109.293 179.54 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.5 2.04 0 CA-C-O 117.874 -1.06 . . . . 0.0 110.476 -179.82 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 12.4 m . . . . . 0 N--CA 1.495 1.796 0 CA-C-O 121.267 0.556 . . . . 0.0 109.923 . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -138.12 164.13 29.9 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.47 -0.769 . . . . 0.0 110.339 -179.471 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.543 ' N ' ' HD3' ' A' ' 4' ' ' PRO . 5.5 tp -149.14 58.99 3.76 Favored Pre-proline 0 N--CA 1.495 1.815 0 O-C-N 121.574 -0.704 . . . . 0.0 110.404 179.782 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.543 ' HD3' ' N ' ' A' ' 3' ' ' LEU . 49.2 Cg_endo -88.09 -151.54 0.04 OUTLIER 'Trans proline' 0 C--N 1.316 -1.176 0 C-N-CA 121.376 1.384 . . . . 0.0 110.246 179.984 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -130.53 -53.99 1.09 Allowed 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.144 -0.973 . . . . 0.0 110.321 179.934 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -66.39 -35.12 79.53 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.483 -0.76 . . . . 0.0 110.593 179.981 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.4 m -91.29 18.74 6.67 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.281 -0.887 . . . . 0.0 110.932 179.652 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.551 HG22 ' HB2' ' A' ' 12' ' ' HIS . 22.4 m -114.62 47.33 1.26 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.147 -0.971 . . . . 0.0 109.895 179.637 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -103.21 -76.66 1.15 Allowed Glycine 0 N--CA 1.493 2.448 0 N-CA-C 108.771 -1.732 . . . . 0.0 108.771 179.688 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.1 mp -64.14 -41.21 97.28 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.697 -0.884 . . . . 0.0 109.958 179.335 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.8 tt -58.2 -46.54 85.65 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.622 -0.674 . . . . 0.0 110.02 179.514 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 12' ' ' HIS . . . . . 0.551 ' HB2' HG22 ' A' ' 8' ' ' THR . 50.7 t60 -62.61 -39.59 94.26 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.683 -0.636 . . . . 0.0 109.755 179.312 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 6.8 tp -61.93 -39.74 93.09 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.557 -0.715 . . . . 0.0 110.251 179.501 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 14' ' ' HIS . . . . . 0.546 ' NE2' HG21 ' A' ' 18' ' ' VAL . 5.8 t-80 -60.94 -53.05 62.08 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.571 -0.706 . . . . 0.0 109.865 179.633 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -56.8 -36.92 70.46 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.571 -0.706 . . . . 0.0 110.226 179.688 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.437 ' O ' ' HB ' ' A' ' 20' ' ' VAL . 0.7 OUTLIER -64.63 -47.8 77.2 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.378 -0.826 . . . . 0.0 110.194 179.429 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.477 ' O ' HG12 ' A' ' 20' ' ' VAL . 68.6 mt -68.85 -36.78 75.76 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.042 0 O-C-N 121.447 -0.783 . . . . 0.0 110.494 179.909 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.546 HG21 ' NE2' ' A' ' 14' ' ' HIS . 21.0 t -75.47 -19.9 15.95 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 121.268 -0.895 . . . . 0.0 110.383 179.906 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.59 ' HA ' ' CD1' ' A' ' 22' ' ' TYR . 0.8 OUTLIER -107.85 20.94 18.13 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.355 -0.84 . . . . 0.0 111.018 179.51 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.477 HG12 ' O ' ' A' ' 17' ' ' ILE . 3.7 p -117.58 -32.97 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 O-C-N 120.812 -1.18 . . . . 0.0 111.065 179.448 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 6.1 mt-30 -88.08 -35.09 17.69 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.306 -0.871 . . . . 0.0 110.108 179.699 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 22' ' ' TYR . . . . . 0.59 ' CD1' ' HA ' ' A' ' 19' ' ' ASP . 1.5 p90 -62.49 -28.59 69.94 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.374 -0.829 . . . . 0.0 110.395 179.626 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 3.6 ttp -90.16 0.22 57.28 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.35 -0.844 . . . . 0.0 111.081 179.752 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -107.96 22.48 15.9 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.143 -0.973 . . . . 0.0 110.817 179.859 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -118.28 12.37 12.64 Favored Glycine 0 N--CA 1.495 2.599 0 N-CA-C 110.044 -1.222 . . . . 0.0 110.044 179.475 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.912 ' HB3' ' HB3' ' A' ' 29' ' ' ALA . 1.4 mp -140.4 66.87 1.37 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.269 -1.136 . . . . 0.0 109.697 179.986 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.485 ' N ' ' HD2' ' A' ' 28' ' ' PRO . 0.1 OUTLIER -58.12 -52.46 74.37 Favored Pre-proline 0 N--CA 1.5 2.056 0 O-C-N 121.575 -0.703 . . . . 0.0 111.497 -179.56 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.485 ' HD2' ' N ' ' A' ' 27' ' ' SER . 44.9 Cg_endo -71.15 -12.45 30.22 Favored 'Trans proline' 0 N--CA 1.492 1.42 0 O-C-N 123.46 1.242 . . . . 0.0 111.761 -179.669 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.912 ' HB3' ' HB3' ' A' ' 26' ' ' LEU . . . -98.36 -40.41 8.32 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.265 -0.897 . . . . 0.0 110.299 179.769 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 5.9 tp -71.18 -24.34 24.1 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 O-C-N 121.414 -0.804 . . . . 0.0 110.798 179.878 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 1.9 p -64.64 -42.22 95.61 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.46 -0.775 . . . . 0.0 110.1 179.621 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 2.3 tptm -93.27 26.61 2.84 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.544 -0.722 . . . . 0.0 110.119 179.273 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 10.8 t80 -124.46 -47.81 1.84 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.485 -0.759 . . . . 0.0 110.245 -179.913 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 93.8 t -81.89 103.52 9.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.458 -0.776 . . . . 0.0 109.89 179.954 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 6.7 p -132.66 21.0 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 121.461 -0.774 . . . . 0.0 110.839 -179.921 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.496 1.836 0 CA-C-O 117.866 -1.064 . . . . 0.0 110.481 179.873 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 3.7 p . . . . . 0 N--CA 1.496 1.853 0 CA-C-O 121.042 0.449 . . . . 0.0 110.475 . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -143.11 135.46 27.3 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.427 -0.796 . . . . 0.0 110.532 -179.898 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.556 ' CB ' ' HD3' ' A' ' 4' ' ' PRO . 0.5 OUTLIER -92.97 -57.45 0.23 Allowed Pre-proline 0 N--CA 1.496 1.858 0 O-C-N 121.497 -0.752 . . . . 0.0 110.415 179.518 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.556 ' HD3' ' CB ' ' A' ' 3' ' ' LEU . 51.7 Cg_endo -83.89 60.28 6.43 Favored 'Trans proline' 0 N--CA 1.483 0.87 0 O-C-N 123.417 1.219 . . . . 0.0 110.18 179.49 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -84.18 -54.65 4.67 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.347 -0.846 . . . . 0.0 110.561 -179.53 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 3.3 tp -151.73 23.24 0.69 Allowed 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.392 -0.817 . . . . 0.0 111.318 -179.725 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 20.0 m 46.83 47.64 15.24 Favored 'General case' 0 N--CA 1.504 2.254 0 O-C-N 121.292 -0.88 . . . . 0.0 111.038 179.718 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 13.4 p -102.54 36.25 2.22 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.307 -0.87 . . . . 0.0 110.747 -179.716 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -92.56 -86.62 1.54 Allowed Glycine 0 N--CA 1.491 2.349 0 N-CA-C 108.649 -1.78 . . . . 0.0 108.649 179.332 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 11.2 tp -80.77 -32.22 35.58 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.619 -0.93 . . . . 0.0 110.072 179.28 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.4 tt -60.88 -51.35 69.65 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.521 -0.737 . . . . 0.0 110.203 179.739 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 43.9 t60 -64.62 -37.61 88.17 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.56 -0.713 . . . . 0.0 110.307 179.646 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 6.7 tt -54.87 -39.02 68.23 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.493 -0.754 . . . . 0.0 110.269 179.65 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 14' ' ' HIS . . . . . 0.46 ' CE1' HG21 ' A' ' 18' ' ' VAL . 64.7 t60 -78.26 -51.29 10.37 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.427 -0.796 . . . . 0.0 109.847 179.474 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.407 ' O ' ' HB2' ' A' ' 19' ' ' ASP . 0.8 OUTLIER -58.74 -47.01 86.11 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.623 -0.673 . . . . 0.0 110.484 -179.93 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 4.3 t30 -54.29 -33.37 58.55 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.484 -0.76 . . . . 0.0 111.0 179.885 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 38.4 mm -86.14 -45.51 16.85 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 121.122 -0.987 . . . . 0.0 110.073 179.816 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.46 HG21 ' CE1' ' A' ' 14' ' ' HIS . 52.7 t -63.6 -38.03 81.18 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 O-C-N 121.462 -0.774 . . . . 0.0 110.59 179.933 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.571 ' HA ' ' CD2' ' A' ' 22' ' ' TYR . 1.7 m-20 -71.45 -12.74 61.55 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.584 -0.698 . . . . 0.0 111.394 -179.885 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.458 ' O ' ' HB2' ' A' ' 24' ' ' TYR . 97.2 t -102.62 -5.42 9.28 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 120.816 -1.178 . . . . 0.0 110.282 179.461 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 15.6 mm-40 -101.84 -38.04 8.01 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.262 -0.899 . . . . 0.0 109.907 179.424 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 22' ' ' TYR . . . . . 0.571 ' CD2' ' HA ' ' A' ' 19' ' ' ASP . 1.4 p90 -65.15 -29.29 70.12 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.369 -0.832 . . . . 0.0 110.148 179.447 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -92.46 -32.55 14.85 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.535 -0.728 . . . . 0.0 110.589 -179.934 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.458 ' HB2' ' O ' ' A' ' 20' ' ' VAL . 88.9 m-85 -105.38 51.17 0.76 Allowed 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.278 -0.889 . . . . 0.0 110.038 -179.945 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 160.46 -40.15 0.44 Allowed Glycine 0 N--CA 1.495 2.613 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -179.72 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.471 ' HG ' ' HB3' ' A' ' 29' ' ' ALA . 0.1 OUTLIER 64.98 29.08 12.43 Favored 'General case' 0 N--CA 1.503 2.185 0 O-C-N 121.827 -0.807 . . . . 0.0 111.191 179.874 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.51 ' N ' ' HD2' ' A' ' 28' ' ' PRO . 0.0 OUTLIER -63.78 -51.79 62.53 Favored Pre-proline 0 N--CA 1.5 2.054 0 O-C-N 121.244 -0.91 . . . . 0.0 110.705 179.521 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.51 ' HD2' ' N ' ' A' ' 27' ' ' SER . 47.9 Cg_endo -73.46 -8.5 21.81 Favored 'Trans proline' 0 N--CA 1.489 1.261 0 O-C-N 123.434 1.228 . . . . 0.0 111.418 179.939 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.471 ' HB3' ' HG ' ' A' ' 26' ' ' LEU . . . -98.99 -45.68 5.87 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.232 -0.918 . . . . 0.0 110.196 179.842 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.521 HD13 ' O ' ' A' ' 30' ' ' ILE . 0.3 OUTLIER -61.73 -31.22 50.24 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 O-C-N 121.438 -0.789 . . . . 0.0 110.4 179.866 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 4.3 p -66.43 -30.01 70.27 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.497 -0.752 . . . . 0.0 110.222 179.276 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 11.1 ttpt -100.74 18.23 19.92 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.507 -0.746 . . . . 0.0 110.414 179.454 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -107.61 -35.02 6.83 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.363 -0.836 . . . . 0.0 109.975 179.687 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.767 HG12 HG23 ' A' ' 35' ' ' VAL . 46.0 t -85.81 159.53 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.522 -0.736 . . . . 0.0 109.572 179.694 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.767 HG23 HG12 ' A' ' 34' ' ' VAL . 12.7 t 59.76 56.75 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.122 0 O-C-N 121.602 -0.686 . . . . 0.0 109.98 -179.613 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.5 2.028 0 CA-C-O 117.697 -1.144 . . . . 0.0 110.498 -179.882 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 7.3 p . . . . . 0 N--CA 1.494 1.756 0 CA-C-O 121.069 0.461 . . . . 0.0 110.215 . . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -118.73 -167.27 1.35 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.647 -0.658 . . . . 0.0 109.974 -179.878 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER 51.25 71.66 1.46 Allowed Pre-proline 0 N--CA 1.5 2.026 0 O-C-N 121.684 -0.635 . . . . 0.0 110.621 179.971 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -89.56 -157.51 0.07 OUTLIER 'Trans proline' 0 C--N 1.308 -1.581 0 O-C-N 124.03 1.542 . . . . 0.0 110.186 -179.888 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -102.55 46.82 0.91 Allowed 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.385 -0.822 . . . . 0.0 110.139 179.743 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.6 mp -103.75 8.15 37.24 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.56 -0.713 . . . . 0.0 110.813 179.856 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 69.5 m -108.08 40.57 1.72 Allowed 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.169 -0.957 . . . . 0.0 110.096 179.631 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.52 HG22 ' HB2' ' A' ' 12' ' ' HIS . 90.4 m -129.9 -95.7 0.38 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.303 -0.873 . . . . 0.0 109.823 179.738 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.409 ' N ' HG22 ' A' ' 8' ' ' THR . . . 55.95 -103.34 0.23 Allowed Glycine 0 N--CA 1.497 2.721 0 N-CA-C 110.05 -1.22 . . . . 0.0 110.05 179.782 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -62.9 -31.46 72.53 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.569 -0.96 . . . . 0.0 110.473 179.711 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.463 ' HB2' ' HA ' ' A' ' 8' ' ' THR . 1.7 mp -56.4 -39.41 72.98 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.454 -0.779 . . . . 0.0 110.15 179.537 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 12' ' ' HIS . . . . . 0.52 ' HB2' HG22 ' A' ' 8' ' ' THR . 0.1 OUTLIER -85.14 -41.26 15.84 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.368 -0.832 . . . . 0.0 109.638 179.257 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 6.5 tt -56.34 -43.49 79.11 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.684 -0.635 . . . . 0.0 110.098 179.392 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 14' ' ' HIS . . . . . 0.46 ' CE1' HG21 ' A' ' 18' ' ' VAL . 66.2 t60 -64.68 -50.68 66.05 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.61 -0.681 . . . . 0.0 109.931 179.52 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -62.27 -36.36 81.82 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.465 -0.772 . . . . 0.0 110.025 179.484 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -57.11 -43.41 82.29 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.54 -0.725 . . . . 0.0 109.858 179.335 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 21.5 mm -80.82 -36.53 15.57 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 O-C-N 121.419 -0.801 . . . . 0.0 109.795 179.393 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.46 HG21 ' CE1' ' A' ' 14' ' ' HIS . 40.0 t -67.01 -21.53 28.39 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 O-C-N 121.444 -0.785 . . . . 0.0 110.977 179.983 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.599 ' HA ' ' CD1' ' A' ' 22' ' ' TYR . 0.4 OUTLIER -106.0 10.34 32.28 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.215 -0.928 . . . . 0.0 111.159 179.787 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.433 ' O ' ' HB2' ' A' ' 24' ' ' TYR . 0.8 OUTLIER -114.88 -26.67 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 O-C-N 120.847 -1.158 . . . . 0.0 110.505 179.306 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 41.4 mt-30 -87.98 -39.99 14.26 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.427 -0.795 . . . . 0.0 110.096 179.887 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 22' ' ' TYR . . . . . 0.599 ' CD1' ' HA ' ' A' ' 19' ' ' ASP . 1.8 p90 -60.99 -27.43 68.29 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.473 -0.767 . . . . 0.0 110.434 179.654 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 2.5 ttp -95.75 -28.06 14.95 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.378 -0.826 . . . . 0.0 111.109 -179.818 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.433 ' HB2' ' O ' ' A' ' 20' ' ' VAL . 55.9 m-85 -110.13 52.65 0.72 Allowed 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.128 -0.982 . . . . 0.0 110.419 -179.723 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 145.46 -22.88 1.86 Allowed Glycine 0 N--CA 1.496 2.676 0 N-CA-C 110.542 -1.023 . . . . 0.0 110.542 -180.0 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.406 ' O ' HD12 ' A' ' 30' ' ' ILE . 2.8 mp 58.29 40.41 24.61 Favored 'General case' 0 N--CA 1.502 2.131 0 O-C-N 121.468 -1.019 . . . . 0.0 110.798 -179.685 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.45 ' CB ' ' HD3' ' A' ' 28' ' ' PRO . 0.4 OUTLIER -60.71 -52.58 71.58 Favored Pre-proline 0 N--CA 1.499 2.013 0 O-C-N 121.351 -0.843 . . . . 0.0 110.027 179.409 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.45 ' HD3' ' CB ' ' A' ' 27' ' ' SER . 52.4 Cg_endo -80.85 44.16 1.69 Allowed 'Trans proline' 0 N--CA 1.485 1.017 0 O-C-N 123.514 1.271 . . . . 0.0 110.512 178.868 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -135.28 -54.69 0.8 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.242 -0.911 . . . . 0.0 109.353 179.789 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.406 HD12 ' O ' ' A' ' 26' ' ' LEU . 2.2 mp -68.42 -42.74 84.19 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 O-C-N 121.558 -0.714 . . . . 0.0 109.339 178.907 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 14.3 t -67.18 -26.59 66.71 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.733 -0.605 . . . . 0.0 109.989 179.136 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 7.9 mmpt? -78.74 -32.58 46.78 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.336 -0.852 . . . . 0.0 109.885 179.209 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 87.2 t80 -66.31 -29.17 69.32 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.63 -0.668 . . . . 0.0 110.05 179.213 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 88.7 t -61.89 -26.58 40.29 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 O-C-N 121.324 -0.86 . . . . 0.0 110.174 179.467 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.6 t -113.23 20.82 6.48 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 O-C-N 121.416 -0.803 . . . . 0.0 110.244 179.707 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 2.4 ttm-85 . . . . . 0 N--CA 1.496 1.842 0 CA-C-O 117.779 -1.105 . . . . 0.0 110.294 -179.946 . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 8.1 t . . . . . 0 N--CA 1.495 1.795 0 CA-C-O 121.045 0.45 . . . . 0.0 110.403 . . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -110.33 42.5 1.55 Allowed 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.554 -0.716 . . . . 0.0 110.397 179.986 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.466 ' N ' ' HD3' ' A' ' 4' ' ' PRO . 15.9 tp 49.45 64.07 9.2 Favored Pre-proline 0 N--CA 1.5 2.055 0 O-C-N 121.669 -0.644 . . . . 0.0 110.994 179.863 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.556 ' O ' ' HB3' ' A' ' 5' ' ' ALA . 46.6 Cg_endo -91.15 -161.11 0.09 OUTLIER 'Trans proline' 0 C--N 1.312 -1.367 0 O-C-N 123.835 1.44 . . . . 0.0 110.397 179.939 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.556 ' HB3' ' O ' ' A' ' 4' ' ' PRO . . . 66.81 0.95 2.07 Favored 'General case' 0 N--CA 1.506 2.348 0 O-C-N 121.734 -0.604 . . . . 0.0 111.969 -179.992 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -134.73 2.86 3.21 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 120.877 -1.14 . . . . 0.0 111.068 179.856 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 49.6 m -145.99 77.62 1.5 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.186 -0.946 . . . . 0.0 109.195 179.807 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.48 ' HB ' ' HB2' ' A' ' 12' ' ' HIS . 25.9 p 39.75 50.93 2.35 Favored 'General case' 0 N--CA 1.503 2.22 0 CA-C-O 121.275 0.559 . . . . 0.0 111.244 -179.487 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -89.44 -75.47 1.3 Allowed Glycine 0 N--CA 1.492 2.418 0 N-CA-C 108.657 -1.777 . . . . 0.0 108.657 179.659 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.4 pp -90.71 -25.38 20.06 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.589 -0.947 . . . . 0.0 110.036 178.96 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -67.86 -42.2 81.71 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.38 -0.825 . . . . 0.0 109.812 179.499 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 12' ' ' HIS . . . . . 0.48 ' HB2' ' HB ' ' A' ' 8' ' ' THR . 4.3 t-160 -63.4 -37.31 86.8 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.548 -0.72 . . . . 0.0 109.919 179.313 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.2 tt -57.27 -42.15 81.05 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.595 -0.69 . . . . 0.0 109.869 179.237 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 14' ' ' HIS . . . . . 0.548 ' NE2' HG21 ' A' ' 18' ' ' VAL . 4.8 t-80 -65.96 -53.71 35.55 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.613 -0.679 . . . . 0.0 109.459 179.063 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.407 ' O ' ' HB2' ' A' ' 19' ' ' ASP . 16.1 tp60 -58.72 -38.28 77.97 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.59 -0.694 . . . . 0.0 110.22 179.577 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 13.2 t30 -59.57 -42.1 91.71 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.61 -0.681 . . . . 0.0 110.595 179.764 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.526 ' O ' HG12 ' A' ' 20' ' ' VAL . 43.8 mt -79.52 -30.62 13.75 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 O-C-N 121.27 -0.894 . . . . 0.0 110.238 179.815 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.548 HG21 ' NE2' ' A' ' 14' ' ' HIS . 31.6 t -78.16 -27.02 14.55 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.227 -0.921 . . . . 0.0 110.203 179.628 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.539 ' HA ' ' CD1' ' A' ' 22' ' ' TYR . 0.9 OUTLIER -91.39 17.4 8.53 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.397 -0.814 . . . . 0.0 110.954 179.572 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.526 HG12 ' O ' ' A' ' 17' ' ' ILE . 1.0 OUTLIER -117.86 -31.62 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 120.967 -1.083 . . . . 0.0 110.441 179.294 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 27.5 mm100 -89.81 -30.75 17.75 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.365 -0.835 . . . . 0.0 110.458 179.867 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 22' ' ' TYR . . . . . 0.539 ' CD1' ' HA ' ' A' ' 19' ' ' ASP . 1.8 p90 -61.15 -28.5 69.16 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.357 -0.84 . . . . 0.0 110.202 179.732 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 5.9 ttt -75.93 -25.14 55.7 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.362 -0.836 . . . . 0.0 110.286 179.227 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 31.6 m-85 -110.01 31.43 5.87 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.504 -0.747 . . . . 0.0 110.412 179.815 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 175.77 69.82 0.05 OUTLIER Glycine 0 N--CA 1.494 2.553 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 -179.962 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -105.03 12.04 32.69 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.537 -0.978 . . . . 0.0 111.296 -179.825 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.541 ' N ' ' HD2' ' A' ' 28' ' ' PRO . 0.4 OUTLIER -56.74 -51.7 79.39 Favored Pre-proline 0 N--CA 1.499 2.002 0 O-C-N 121.268 -0.895 . . . . 0.0 110.515 179.374 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.541 ' HD2' ' N ' ' A' ' 27' ' ' SER . 42.7 Cg_endo -70.58 -28.57 21.16 Favored 'Trans proline' 0 N--CA 1.487 1.095 0 O-C-N 123.343 1.181 . . . . 0.0 110.115 179.31 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.407 ' O ' ' HB2' ' A' ' 33' ' ' TYR . . . -68.37 -38.55 81.49 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.591 -0.693 . . . . 0.0 110.107 179.345 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.439 HG22 ' O ' ' A' ' 27' ' ' SER . 6.0 tp -85.64 -29.05 6.27 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 121.446 -0.784 . . . . 0.0 110.605 179.646 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 77.7 m -75.13 -37.0 61.57 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.39 -0.819 . . . . 0.0 110.125 179.666 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 32.6 mtmt -89.82 22.26 3.2 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.36 -0.837 . . . . 0.0 110.57 179.495 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.407 ' HB2' ' O ' ' A' ' 29' ' ' ALA . 5.1 t80 -112.56 -48.27 3.02 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.265 -0.897 . . . . 0.0 109.868 179.751 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 94.8 t -84.02 -51.75 13.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.563 -0.711 . . . . 0.0 109.744 179.724 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.584 ' O ' ' HG3' ' A' ' 36' ' ' ARG . 18.7 t 52.7 43.82 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.111 0 O-C-N 121.675 -0.641 . . . . 0.0 110.467 179.955 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.584 ' HG3' ' O ' ' A' ' 35' ' ' VAL . 2.6 ptt85 . . . . . 0 N--CA 1.51 2.572 0 CA-C-O 117.886 -1.054 . . . . 0.0 112.336 179.964 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 48.8 m . . . . . 0 N--CA 1.495 1.788 0 CA-C-O 120.975 0.417 . . . . 0.0 110.116 . . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -148.49 164.29 34.61 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.548 -0.72 . . . . 0.0 110.612 -179.812 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.445 ' N ' ' HD2' ' A' ' 4' ' ' PRO . 1.0 OUTLIER -62.63 -51.99 68.33 Favored Pre-proline 0 N--CA 1.497 1.879 0 O-C-N 121.635 -0.666 . . . . 0.0 110.587 179.657 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.445 ' HD2' ' N ' ' A' ' 3' ' ' LEU . 52.3 Cg_endo -77.24 55.62 5.14 Favored 'Trans proline' 0 N--CA 1.489 1.208 0 O-C-N 123.543 1.286 . . . . 0.0 110.586 179.573 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -156.3 42.35 0.38 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.243 -0.911 . . . . 0.0 110.276 179.849 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -131.1 -57.35 1.03 Allowed 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.488 -0.758 . . . . 0.0 110.537 -179.864 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 20.6 m -131.38 18.09 4.87 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.424 -0.797 . . . . 0.0 111.313 -179.709 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 27.2 p -122.88 21.65 9.86 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.213 -0.929 . . . . 0.0 110.367 179.487 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -103.77 -77.01 1.15 Allowed Glycine 0 N--CA 1.493 2.435 0 N-CA-C 109.006 -1.638 . . . . 0.0 109.006 179.828 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -61.28 -41.0 96.21 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.715 -0.873 . . . . 0.0 110.114 179.464 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 4.5 tt -58.58 -47.17 85.18 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.482 -0.761 . . . . 0.0 109.879 179.466 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 14.1 m170 -66.01 -38.16 87.75 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.541 -0.724 . . . . 0.0 109.789 179.236 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -60.08 -40.36 89.29 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.538 -0.726 . . . . 0.0 109.86 179.313 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 14' ' ' HIS . . . . . 0.554 ' NE2' HG21 ' A' ' 18' ' ' VAL . 6.8 t-160 -62.94 -51.5 66.66 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.693 -0.629 . . . . 0.0 109.425 179.158 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 6.4 tp60 -61.84 -37.32 84.05 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.572 -0.705 . . . . 0.0 110.086 179.279 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -60.11 -35.39 75.13 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.654 -0.654 . . . . 0.0 110.621 179.662 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.538 ' O ' HG12 ' A' ' 20' ' ' VAL . 61.2 mt -88.23 -40.3 13.42 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 O-C-N 121.374 -0.829 . . . . 0.0 110.268 179.931 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.554 HG21 ' NE2' ' A' ' 14' ' ' HIS . 9.4 t -69.43 -33.54 57.89 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.875 0 O-C-N 121.378 -0.826 . . . . 0.0 110.61 -179.931 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.525 ' HA ' ' CD1' ' A' ' 22' ' ' TYR . 2.2 t70 -88.89 14.31 10.7 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.269 -0.894 . . . . 0.0 111.253 179.831 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.538 HG12 ' O ' ' A' ' 17' ' ' ILE . 0.5 OUTLIER -119.43 -23.83 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 120.785 -1.197 . . . . 0.0 110.833 179.386 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -100.72 -29.51 12.24 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.396 -0.815 . . . . 0.0 110.669 -179.924 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 22' ' ' TYR . . . . . 0.525 ' CD1' ' HA ' ' A' ' 19' ' ' ASP . 3.7 p90 -61.3 -28.25 69.06 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.332 -0.855 . . . . 0.0 110.206 179.582 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 2.2 tpp -86.17 -13.67 46.35 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.326 -0.859 . . . . 0.0 110.691 179.323 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 29.1 m-85 -115.1 25.98 10.47 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.205 -0.934 . . . . 0.0 110.861 -179.723 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -177.45 -70.83 0.06 OUTLIER Glycine 0 N--CA 1.495 2.6 0 C-N-CA 119.801 -1.19 . . . . 0.0 110.434 179.833 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.523 HD12 ' O ' ' A' ' 22' ' ' TYR . 0.2 OUTLIER 56.98 28.75 15.25 Favored 'General case' 0 N--CA 1.505 2.307 0 O-C-N 121.555 -0.968 . . . . 0.0 110.863 -179.409 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.523 ' N ' ' HD2' ' A' ' 28' ' ' PRO . 0.6 OUTLIER -67.93 -50.18 33.67 Favored Pre-proline 0 N--CA 1.501 2.102 0 O-C-N 121.239 -0.913 . . . . 0.0 111.401 -179.907 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.523 ' HD2' ' N ' ' A' ' 27' ' ' SER . 44.1 Cg_endo -71.08 -20.71 28.37 Favored 'Trans proline' 0 N--CA 1.489 1.243 0 O-C-N 123.247 1.13 . . . . 0.0 111.115 -179.884 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -77.18 -43.82 32.42 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.405 -0.809 . . . . 0.0 110.564 179.915 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.428 HG22 ' O ' ' A' ' 27' ' ' SER . 4.9 tp -72.02 -28.63 30.38 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 O-C-N 121.277 -0.89 . . . . 0.0 111.009 -179.814 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 3.3 p -77.21 -35.49 55.6 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.322 -0.861 . . . . 0.0 110.119 179.637 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -86.87 12.04 11.95 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.36 -0.838 . . . . 0.0 110.744 179.406 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 89.6 t80 -112.87 -38.91 4.4 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.188 -0.945 . . . . 0.0 110.366 179.654 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 38.5 t -94.21 92.5 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 O-C-N 121.403 -0.811 . . . . 0.0 110.075 -179.873 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 5.0 p -128.9 21.98 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 121.435 -0.791 . . . . 0.0 110.565 179.896 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? . . . . . 0 N--CA 1.496 1.857 0 CA-C-O 117.892 -1.051 . . . . 0.0 110.253 179.922 . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 9.6 p . . . . . 0 N--CA 1.496 1.862 0 CA-C-O 121.165 0.507 . . . . 0.0 110.357 . . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -88.04 81.52 7.42 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.409 -0.807 . . . . 0.0 110.291 -179.875 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.462 ' N ' ' HD2' ' A' ' 4' ' ' PRO . 0.4 OUTLIER -78.43 -55.1 1.11 Allowed Pre-proline 0 N--CA 1.498 1.944 0 O-C-N 121.514 -0.741 . . . . 0.0 110.579 179.899 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.462 ' HD2' ' N ' ' A' ' 3' ' ' LEU . 44.7 Cg_endo -71.64 -29.9 15.43 Favored 'Trans proline' 0 N--CA 1.488 1.185 0 O-C-N 123.532 1.28 . . . . 0.0 110.504 179.663 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -107.34 35.3 3.11 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.506 -0.746 . . . . 0.0 109.923 179.257 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.7 tt -72.16 -50.12 30.38 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.467 -0.77 . . . . 0.0 110.568 -179.857 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 78.2 p -138.69 32.74 2.24 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.317 -0.864 . . . . 0.0 110.937 -179.706 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 6.5 m 53.19 58.68 5.04 Favored 'General case' 0 N--CA 1.503 2.191 0 O-C-N 121.349 -0.844 . . . . 0.0 110.121 -179.886 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -108.02 -62.9 0.56 Allowed Glycine 0 N--CA 1.495 2.632 0 N-CA-C 109.767 -1.333 . . . . 0.0 109.767 -179.61 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.453 ' HA ' HD22 ' A' ' 10' ' ' LEU . 0.2 OUTLIER -60.86 -47.39 86.57 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.53 -0.983 . . . . 0.0 110.29 179.964 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 5.4 tt -58.25 -45.67 87.37 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.543 -0.723 . . . . 0.0 109.677 179.259 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 5.1 t-160 -68.11 -32.23 72.38 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.654 -0.654 . . . . 0.0 109.979 179.145 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.405 HD22 ' HA ' ' A' ' 13' ' ' LEU . 0.2 OUTLIER -61.08 -43.88 98.21 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.615 -0.678 . . . . 0.0 109.966 179.494 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 2.7 t-80 -61.17 -55.85 27.47 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.472 -0.768 . . . . 0.0 109.458 179.34 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.45 ' O ' ' HB2' ' A' ' 19' ' ' ASP . 3.3 tp60 -58.95 -37.77 77.5 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.585 -0.697 . . . . 0.0 110.296 179.746 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 14.8 t30 -63.31 -45.85 89.43 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.576 -0.703 . . . . 0.0 110.449 179.654 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.49 ' O ' HG12 ' A' ' 20' ' ' VAL . 27.7 mm -73.14 -32.59 39.25 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 O-C-N 121.242 -0.911 . . . . 0.0 109.961 179.58 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 52.2 t -75.12 -18.33 16.14 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 O-C-N 121.374 -0.829 . . . . 0.0 110.533 179.731 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.603 ' HA ' ' CD1' ' A' ' 22' ' ' TYR . 0.2 OUTLIER -103.35 19.44 19.68 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.263 -0.898 . . . . 0.0 110.795 179.266 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.49 HG12 ' O ' ' A' ' 17' ' ' ILE . 1.5 p -115.81 -35.63 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 120.784 -1.198 . . . . 0.0 110.65 179.473 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -83.49 -35.17 25.09 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.275 -0.891 . . . . 0.0 110.04 179.641 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 22' ' ' TYR . . . . . 0.603 ' CD1' ' HA ' ' A' ' 19' ' ' ASP . 1.2 p90 -64.63 -25.22 67.87 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.424 -0.797 . . . . 0.0 110.323 179.652 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -92.06 7.05 44.13 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.348 -0.845 . . . . 0.0 110.694 179.337 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -97.53 40.62 1.15 Allowed 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.108 -0.995 . . . . 0.0 110.255 179.72 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 68.21 23.12 74.76 Favored Glycine 0 N--CA 1.496 2.646 0 N-CA-C 110.394 -1.082 . . . . 0.0 110.394 179.969 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.76 ' HB3' ' HB3' ' A' ' 29' ' ' ALA . 79.6 mt 48.67 68.87 0.63 Allowed 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.682 -0.893 . . . . 0.0 110.331 179.997 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.554 ' HB2' ' HD3' ' A' ' 28' ' ' PRO . 3.6 m -52.53 -49.82 83.7 Favored Pre-proline 0 N--CA 1.5 2.058 0 O-C-N 121.673 -0.642 . . . . 0.0 111.555 -179.578 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.554 ' HD3' ' HB2' ' A' ' 27' ' ' SER . 44.3 Cg_endo -70.27 -12.56 32.16 Favored 'Trans proline' 0 N--CA 1.491 1.37 0 O-C-N 123.275 1.145 . . . . 0.0 111.613 -179.772 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.76 ' HB3' ' HB3' ' A' ' 26' ' ' LEU . . . -98.93 -41.41 7.61 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.305 -0.872 . . . . 0.0 110.249 179.635 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 16.7 tt -69.98 -23.36 25.33 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 O-C-N 121.422 -0.799 . . . . 0.0 110.951 -179.987 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 2.0 p -63.77 -46.14 86.61 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.387 -0.821 . . . . 0.0 110.158 179.689 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 5.9 mttp -90.13 18.97 5.34 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.546 -0.721 . . . . 0.0 110.306 179.258 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 13.0 t80 -116.25 -40.83 3.21 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.291 -0.881 . . . . 0.0 110.165 179.816 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 29.7 t -93.3 81.82 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.378 -0.826 . . . . 0.0 109.68 179.898 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 5.3 p -124.02 19.14 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 O-C-N 121.412 -0.805 . . . . 0.0 110.739 -179.835 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 7.0 ptt-85 . . . . . 0 N--CA 1.497 1.916 0 CA-C-O 117.825 -1.083 . . . . 0.0 110.802 179.722 . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 75.3 m . . . . . 0 N--CA 1.496 1.836 0 CA-C-O 121.126 0.489 . . . . 0.0 110.52 . . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -105.54 37.55 2.19 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.558 -0.714 . . . . 0.0 110.212 179.651 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.528 ' CB ' ' HD3' ' A' ' 4' ' ' PRO . 0.2 OUTLIER -74.92 -56.25 2.15 Favored Pre-proline 0 N--CA 1.498 1.942 0 O-C-N 121.21 -0.931 . . . . 0.0 110.463 179.841 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.528 ' HD3' ' CB ' ' A' ' 3' ' ' LEU . 52.3 Cg_endo -82.17 51.11 3.67 Favored 'Trans proline' 0 C--N 1.32 -0.947 0 O-C-N 123.525 1.277 . . . . 0.0 110.233 179.373 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -145.28 -52.82 0.28 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.356 -0.84 . . . . 0.0 110.292 -179.717 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 16.0 mt 53.0 43.06 32.23 Favored 'General case' 0 N--CA 1.503 2.182 0 O-C-N 121.662 -0.648 . . . . 0.0 110.726 179.884 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 9.2 t -144.14 -53.05 0.33 Allowed 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.434 -0.791 . . . . 0.0 110.084 179.972 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.55 ' HB ' ' HB2' ' A' ' 12' ' ' HIS . 0.8 OUTLIER -111.15 30.39 6.94 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.556 -0.715 . . . . 0.0 110.149 179.708 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -70.67 -74.01 0.73 Allowed Glycine 0 N--CA 1.493 2.45 0 N-CA-C 109.281 -1.527 . . . . 0.0 109.281 179.906 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 13.4 mt -85.72 -32.41 21.92 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.605 -0.938 . . . . 0.0 109.944 179.38 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 6.0 mp -60.14 -55.78 29.62 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.523 -0.736 . . . . 0.0 110.281 179.841 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 12' ' ' HIS . . . . . 0.55 ' HB2' ' HB ' ' A' ' 8' ' ' THR . 13.7 t-160 -60.35 -42.62 96.1 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.489 -0.757 . . . . 0.0 109.94 179.459 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 13.2 tp -59.82 -41.36 91.14 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.605 -0.684 . . . . 0.0 109.962 179.398 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 14' ' ' HIS . . . . . 0.508 ' NE2' HG21 ' A' ' 18' ' ' VAL . 51.4 t60 -63.03 -47.74 81.76 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.627 -0.671 . . . . 0.0 110.095 179.571 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 34.4 tp60 -56.17 -42.4 76.99 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.544 -0.723 . . . . 0.0 110.369 179.969 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.459 ' O ' ' HB ' ' A' ' 20' ' ' VAL . 8.4 t-20 -62.46 -48.98 77.25 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.282 -0.886 . . . . 0.0 110.377 179.637 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.513 ' O ' HG12 ' A' ' 20' ' ' VAL . 73.2 mt -65.73 -38.7 82.88 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.036 0 O-C-N 121.423 -0.798 . . . . 0.0 110.41 -179.958 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.508 HG21 ' NE2' ' A' ' 14' ' ' HIS . 21.3 t -70.92 -36.73 65.2 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 O-C-N 121.237 -0.914 . . . . 0.0 110.35 179.797 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.63 ' HA ' ' CD2' ' A' ' 22' ' ' TYR . 1.7 m-20 -85.73 1.72 48.34 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.498 -0.751 . . . . 0.0 111.477 179.976 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.513 HG12 ' O ' ' A' ' 17' ' ' ILE . 1.0 OUTLIER -108.35 -16.17 8.84 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 O-C-N 120.802 -1.186 . . . . 0.0 110.431 179.121 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 24.8 mt-30 -96.43 -37.92 10.24 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.469 -0.77 . . . . 0.0 110.15 179.888 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 22' ' ' TYR . . . . . 0.63 ' CD2' ' HA ' ' A' ' 19' ' ' ASP . 1.6 p90 -62.99 -32.75 74.17 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.46 -0.775 . . . . 0.0 110.228 179.693 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -72.91 -27.62 61.98 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.489 -0.757 . . . . 0.0 110.606 179.85 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 28.1 m-85 -99.12 24.08 8.3 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.326 -0.859 . . . . 0.0 110.802 179.958 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -131.01 -87.81 0.44 Allowed Glycine 0 N--CA 1.494 2.537 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 179.89 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 57.93 23.08 9.43 Favored 'General case' 0 N--CA 1.504 2.26 0 O-C-N 121.701 -0.882 . . . . 0.0 111.1 -179.77 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.51 ' CB ' ' CD ' ' A' ' 28' ' ' PRO . 0.4 OUTLIER -175.16 -62.58 0.0 OUTLIER Pre-proline 0 N--CA 1.497 1.904 0 O-C-N 121.416 -0.802 . . . . 0.0 110.093 179.599 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.51 ' CD ' ' CB ' ' A' ' 27' ' ' SER . 43.6 Cg_endo -70.24 -31.96 17.43 Favored 'Trans proline' 0 N--CA 1.488 1.195 0 O-C-N 123.318 1.168 . . . . 0.0 110.339 179.174 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.44 ' O ' ' HB2' ' A' ' 33' ' ' TYR . . . -72.04 -13.12 61.51 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.618 -0.676 . . . . 0.0 111.037 179.477 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.489 HG22 ' O ' ' A' ' 27' ' ' SER . 9.2 tp -114.03 -28.27 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 O-C-N 121.067 -1.021 . . . . 0.0 111.395 -179.73 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 2.0 t -96.08 -20.19 18.84 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.059 -1.026 . . . . 0.0 110.958 -179.977 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -114.41 17.96 17.15 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.095 -1.003 . . . . 0.0 110.544 179.691 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.44 ' HB2' ' O ' ' A' ' 29' ' ' ALA . 7.2 m-85 -129.56 21.41 5.56 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.286 -0.884 . . . . 0.0 110.801 -179.935 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.463 HG12 ' O ' ' A' ' 34' ' ' VAL . 21.3 t -122.92 35.52 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 121.285 -0.884 . . . . 0.0 110.094 -179.934 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 48.7 t -132.17 66.76 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 O-C-N 121.142 -0.974 . . . . 0.0 109.505 179.572 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.496 1.844 0 CA-C-O 118.233 -0.889 . . . . 0.0 110.362 -179.941 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.495 1.776 0 CA-C-O 120.899 0.38 . . . . 0.0 110.096 . . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -133.45 32.56 3.63 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.561 -0.712 . . . . 0.0 110.793 -179.704 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.411 ' N ' ' HD3' ' A' ' 4' ' ' PRO . 3.6 tp 50.01 62.21 12.25 Favored Pre-proline 0 N--CA 1.502 2.139 0 O-C-N 121.587 -0.695 . . . . 0.0 110.976 179.803 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.411 ' HD3' ' N ' ' A' ' 3' ' ' LEU . 47.9 Cg_endo -80.7 59.13 7.33 Favored 'Trans proline' 0 C--N 1.311 -1.433 0 O-C-N 123.85 1.447 . . . . 0.0 110.525 179.974 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -162.9 -46.64 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.402 -0.811 . . . . 0.0 110.476 179.889 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 56.44 36.64 27.87 Favored 'General case' 0 N--CA 1.502 2.155 0 O-C-N 121.743 -0.598 . . . . 0.0 110.373 -179.855 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.2 m 54.71 29.95 12.58 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.626 -0.671 . . . . 0.0 110.775 -179.541 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.414 ' O ' HG22 ' A' ' 8' ' ' THR . 52.6 m -118.26 1.87 11.9 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.325 -0.859 . . . . 0.0 110.614 179.685 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -105.32 -62.69 0.64 Allowed Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.302 -1.519 . . . . 0.0 109.302 179.804 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -59.97 -41.98 93.13 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.664 -0.904 . . . . 0.0 110.507 179.945 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -60.94 -50.33 73.85 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.459 -0.776 . . . . 0.0 110.003 179.675 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 3.8 m80 -63.82 -42.5 97.65 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.605 -0.685 . . . . 0.0 110.255 179.679 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 9.3 tp -60.65 -42.88 97.87 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.504 -0.748 . . . . 0.0 110.011 179.538 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 14' ' ' HIS . . . . . 0.548 ' NE2' HG21 ' A' ' 18' ' ' VAL . 66.6 t60 -59.64 -55.07 38.98 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.647 -0.658 . . . . 0.0 109.943 179.478 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -53.24 -37.29 61.93 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.631 -0.668 . . . . 0.0 110.383 179.699 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.539 ' O ' HG23 ' A' ' 20' ' ' VAL . 0.7 OUTLIER -65.98 -46.15 79.08 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.541 -0.724 . . . . 0.0 110.493 179.697 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 63.3 mt -72.47 -32.83 43.38 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.11 0 O-C-N 121.418 -0.801 . . . . 0.0 110.429 179.934 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.665 HG13 ' HE2' ' A' ' 22' ' ' TYR . 52.4 t -65.86 -48.18 82.96 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.491 -0.756 . . . . 0.0 110.328 -179.815 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -79.42 47.73 0.84 Allowed 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.145 -0.972 . . . . 0.0 110.855 179.953 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.539 HG23 ' O ' ' A' ' 16' ' ' ASN . 51.3 t -135.5 -46.9 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 O-C-N 121.335 -0.853 . . . . 0.0 109.536 179.319 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 32.2 mt-30 -85.84 -23.14 27.26 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.395 -0.815 . . . . 0.0 110.284 179.613 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 22' ' ' TYR . . . . . 0.665 ' HE2' HG13 ' A' ' 18' ' ' VAL . 2.6 m-85 -93.95 -33.27 13.53 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.259 -0.901 . . . . 0.0 109.866 -179.97 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -92.19 -37.35 12.76 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.318 -0.864 . . . . 0.0 110.023 179.585 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -102.48 19.65 18.53 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.399 -0.813 . . . . 0.0 111.066 179.839 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -163.95 33.54 0.28 Allowed Glycine 0 N--CA 1.496 2.689 0 C-N-CA 119.77 -1.205 . . . . 0.0 111.007 179.831 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -150.92 17.89 0.78 Allowed 'General case' 0 N--CA 1.5 2.064 0 O-C-N 120.839 -1.389 . . . . 0.0 111.557 179.519 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.649 ' HB2' ' HD3' ' A' ' 28' ' ' PRO . 2.5 m -106.48 -62.3 0.04 OUTLIER Pre-proline 0 N--CA 1.495 1.81 0 O-C-N 121.114 -0.991 . . . . 0.0 110.443 179.715 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.649 ' HD3' ' HB2' ' A' ' 27' ' ' SER . 53.6 Cg_endo -79.81 63.75 8.78 Favored 'Trans proline' 0 N--CA 1.484 0.92 0 O-C-N 123.239 1.126 . . . . 0.0 110.033 179.357 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -166.41 -46.6 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.524 -0.735 . . . . 0.0 110.298 -179.7 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 47.6 mm -81.51 -38.8 16.56 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 O-C-N 121.535 -0.728 . . . . 0.0 110.265 -179.9 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 82.5 m -70.87 -42.26 70.28 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.464 -0.773 . . . . 0.0 110.031 179.732 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 7.2 mttp -69.7 -15.67 63.21 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.442 -0.786 . . . . 0.0 110.753 179.379 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -70.21 -42.49 72.25 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.377 -0.827 . . . . 0.0 110.38 179.847 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.633 ' O ' HG12 ' A' ' 35' ' ' VAL . 26.6 t -104.09 18.07 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 121.457 -0.777 . . . . 0.0 110.347 179.729 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.633 HG12 ' O ' ' A' ' 34' ' ' VAL . 0.3 OUTLIER 52.05 23.67 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.316 0 O-C-N 121.602 -0.686 . . . . 0.0 111.421 -179.91 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.498 1.954 0 CA-C-O 117.82 -1.086 . . . . 0.0 110.526 179.624 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 4.0 p . . . . . 0 N--CA 1.496 1.862 0 CA-C-O 121.214 0.531 . . . . 0.0 109.945 . . . . . . . . . 0 0 . 1 . 031 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -116.42 86.88 2.57 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.515 -0.741 . . . . 0.0 110.277 -179.546 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.52 ' N ' ' HD3' ' A' ' 4' ' ' PRO . 0.5 OUTLIER -146.3 57.23 3.7 Favored Pre-proline 0 N--CA 1.496 1.853 0 O-C-N 121.548 -0.72 . . . . 0.0 110.529 179.873 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.52 ' HD3' ' N ' ' A' ' 3' ' ' LEU . 48.5 Cg_endo -81.19 -42.36 0.12 Allowed 'Trans proline' 0 C--N 1.314 -1.266 0 O-C-N 123.797 1.419 . . . . 0.0 111.224 179.991 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -155.16 -44.48 0.08 Allowed 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.528 -0.733 . . . . 0.0 110.654 -179.852 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.694 HD13 HD13 ' A' ' 11' ' ' LEU . 0.5 OUTLIER -154.12 -39.62 0.09 Allowed 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.291 -0.88 . . . . 0.0 111.402 -179.761 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 19.3 p 45.77 42.56 8.86 Favored 'General case' 0 N--CA 1.506 2.346 0 O-C-N 121.639 -0.663 . . . . 0.0 111.432 -179.801 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.585 ' H ' HD12 ' A' ' 6' ' ' LEU . 2.9 m 57.14 35.37 26.18 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.491 -0.756 . . . . 0.0 110.818 179.617 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -102.54 -86.41 1.94 Allowed Glycine 0 N--CA 1.491 2.363 0 N-CA-C 108.699 -1.76 . . . . 0.0 108.699 179.502 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -62.25 -36.99 83.73 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.611 -0.935 . . . . 0.0 109.921 179.064 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.694 HD13 HD13 ' A' ' 6' ' ' LEU . 0.8 OUTLIER -59.95 -47.41 85.92 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.553 -0.717 . . . . 0.0 110.096 179.43 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 26.5 t-80 -67.35 -43.92 80.32 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.518 -0.739 . . . . 0.0 109.531 179.272 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -59.95 -40.15 88.03 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.662 -0.649 . . . . 0.0 109.872 179.237 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 14' ' ' HIS . . . . . 0.714 ' O ' HG23 ' A' ' 18' ' ' VAL . 1.1 t-80 -58.68 -55.24 37.7 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.576 -0.703 . . . . 0.0 109.639 179.389 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.39 -37.36 72.56 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.611 -0.68 . . . . 0.0 110.58 179.895 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -59.58 -35.76 74.92 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.378 -0.826 . . . . 0.0 110.064 179.296 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 46.2 mm -82.58 -36.56 13.55 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.46 -0.775 . . . . 0.0 109.844 179.55 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.714 HG23 ' O ' ' A' ' 14' ' ' HIS . 61.2 t -61.55 -23.23 30.13 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.048 0 O-C-N 121.448 -0.783 . . . . 0.0 110.758 -179.979 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -86.81 -21.42 26.47 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.252 -0.905 . . . . 0.0 110.614 179.81 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.424 HG12 ' CE2' ' A' ' 24' ' ' TYR . 47.5 t -102.64 -43.35 9.26 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 O-C-N 121.112 -0.992 . . . . 0.0 109.595 179.346 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 21' ' ' GLN . . . . . 0.538 ' HG2' ' HB3' ' A' ' 27' ' ' SER . 26.9 tt0 -59.6 -41.05 89.45 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.715 -0.616 . . . . 0.0 110.626 179.901 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 22' ' ' TYR . . . . . 0.411 ' HB3' ' O ' ' A' ' 18' ' ' VAL . 0.1 OUTLIER -58.26 -34.73 70.81 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.148 -0.97 . . . . 0.0 111.108 -179.656 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 3.0 ttp -109.06 27.89 9.05 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.207 -0.933 . . . . 0.0 111.167 179.965 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.467 ' CB ' ' HB2' ' A' ' 27' ' ' SER . 0.2 OUTLIER -78.62 -4.05 46.95 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.279 -0.888 . . . . 0.0 110.686 179.166 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 108.8 -43.06 1.79 Allowed Glycine 0 N--CA 1.495 2.61 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 179.939 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -161.97 31.7 0.12 Allowed 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.591 -0.946 . . . . 0.0 110.498 179.987 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.538 ' HB3' ' HG2' ' A' ' 21' ' ' GLN . 0.3 OUTLIER -82.12 -40.39 0.94 Allowed Pre-proline 0 N--CA 1.496 1.867 0 O-C-N 121.445 -0.785 . . . . 0.0 112.012 -179.695 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.536 ' CD ' ' N ' ' A' ' 27' ' ' SER . 47.8 Cg_endo -75.86 64.56 6.79 Favored 'Trans proline' 0 N--CA 1.486 1.081 0 O-C-N 123.126 1.066 . . . . 0.0 110.614 -179.359 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -167.55 -49.67 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.708 -0.62 . . . . 0.0 109.789 179.892 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 49.2 mm -91.9 -29.88 4.66 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 121.612 -0.68 . . . . 0.0 110.23 179.633 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.425 HG21 ' NE2' ' A' ' 21' ' ' GLN . 31.9 m -61.35 -38.13 85.83 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.528 -0.733 . . . . 0.0 110.142 179.725 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.96 -27.53 64.81 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.394 -0.816 . . . . 0.0 110.47 179.609 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -78.77 -16.95 56.54 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.449 -0.782 . . . . 0.0 110.811 179.544 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.722 HG12 HG23 ' A' ' 35' ' ' VAL . 23.6 t -116.34 157.6 17.14 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 O-C-N 121.291 -0.881 . . . . 0.0 109.982 179.944 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.722 HG23 HG12 ' A' ' 34' ' ' VAL . 14.4 t 59.27 74.55 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.147 0 O-C-N 121.573 -0.704 . . . . 0.0 110.423 180.0 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.501 2.077 0 CA-C-O 118.367 -0.825 . . . . 0.0 110.873 179.993 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.494 1.761 0 CA-C-O 121.162 0.506 . . . . 0.0 110.017 . . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -150.47 130.65 13.59 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.46 -0.775 . . . . 0.0 110.31 -179.826 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -77.82 -52.39 1.63 Allowed Pre-proline 0 N--CA 1.499 2.0 0 O-C-N 121.442 -0.786 . . . . 0.0 111.182 -179.605 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -77.74 64.25 8.13 Favored 'Trans proline' 0 N--CA 1.486 1.086 0 O-C-N 123.399 1.21 . . . . 0.0 110.666 -179.788 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -84.31 -35.61 23.16 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.457 -0.777 . . . . 0.0 110.594 179.941 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 57.01 34.03 24.29 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.561 -0.712 . . . . 0.0 110.501 -179.767 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -100.45 37.52 1.67 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.45 -0.781 . . . . 0.0 110.305 179.858 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 2.4 m -121.21 13.54 11.19 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.266 -0.896 . . . . 0.0 110.609 179.866 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -100.44 -79.31 1.42 Allowed Glycine 0 N--CA 1.492 2.415 0 N-CA-C 109.262 -1.535 . . . . 0.0 109.262 -179.975 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -60.53 -34.83 74.69 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.595 -0.944 . . . . 0.0 110.287 179.7 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 6.4 tt -56.33 -45.19 80.44 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.577 -0.702 . . . . 0.0 110.153 179.503 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 27.6 m-70 -81.81 -42.55 19.53 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.438 -0.789 . . . . 0.0 110.008 179.521 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 7.2 tp -57.36 -37.32 72.42 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.65 -0.656 . . . . 0.0 110.484 179.801 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -56.83 -47.31 80.6 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.458 -0.776 . . . . 0.0 109.802 179.382 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 6.4 tp60 -59.53 -34.94 73.27 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.625 -0.672 . . . . 0.0 110.42 179.627 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 16.0 t30 -69.91 -35.21 74.41 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.459 -0.775 . . . . 0.0 110.403 179.551 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 32.5 mt -82.47 -16.07 11.76 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 O-C-N 121.241 -0.912 . . . . 0.0 110.879 179.962 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.63 HG12 ' HE2' ' A' ' 22' ' ' TYR . 74.7 t -99.38 -50.97 10.49 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.142 -0.974 . . . . 0.0 109.802 179.891 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.538 ' HA ' ' CD2' ' A' ' 22' ' ' TYR . 34.5 t0 -61.57 -21.7 64.53 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.602 -0.686 . . . . 0.0 110.604 179.376 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 8.3 p -52.85 -31.35 16.61 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.059 0 O-C-N 121.296 -0.878 . . . . 0.0 110.935 179.53 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -82.08 -21.92 36.57 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.374 -0.828 . . . . 0.0 110.861 179.996 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 22' ' ' TYR . . . . . 0.63 ' HE2' HG12 ' A' ' 18' ' ' VAL . 1.4 m-85 -100.66 -49.92 4.04 Favored 'General case' 0 N--CA 1.502 2.151 0 O-C-N 121.259 -0.901 . . . . 0.0 109.816 -179.814 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 23' ' ' MET . . . . . 0.692 ' HA ' ' HB2' ' A' ' 29' ' ' ALA . 0.1 OUTLIER -60.5 -38.3 83.91 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.395 -0.816 . . . . 0.0 109.982 179.421 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -89.42 15.76 8.67 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.461 -0.774 . . . . 0.0 110.708 179.298 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -90.91 -4.39 69.41 Favored Glycine 0 N--CA 1.495 2.629 0 N-CA-C 110.407 -1.077 . . . . 0.0 110.407 179.639 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 5.3 mp 54.46 48.58 20.24 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.322 -1.105 . . . . 0.0 111.194 179.809 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.58 ' HB3' ' HD3' ' A' ' 28' ' ' PRO . 3.7 t -164.21 -65.09 0.01 OUTLIER Pre-proline 0 N--CA 1.499 1.998 0 O-C-N 121.265 -0.897 . . . . 0.0 110.602 179.221 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.58 ' HD3' ' HB3' ' A' ' 27' ' ' SER . 47.1 Cg_endo -72.97 -20.54 21.9 Favored 'Trans proline' 0 N--CA 1.491 1.328 0 O-C-N 123.258 1.136 . . . . 0.0 111.113 179.888 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.692 ' HB2' ' HA ' ' A' ' 23' ' ' MET . . . -73.44 -45.06 56.63 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.448 -0.783 . . . . 0.0 110.202 179.887 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 3.2 mt -68.07 -36.4 75.27 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 O-C-N 121.422 -0.799 . . . . 0.0 110.564 -179.967 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 20.3 p -71.47 -32.19 68.0 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.477 -0.764 . . . . 0.0 110.316 179.703 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.4 tttt -90.42 18.53 6.08 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.415 -0.803 . . . . 0.0 110.814 179.763 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -111.51 -50.8 2.9 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.296 -0.878 . . . . 0.0 109.766 179.627 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 45.9 t -81.52 79.83 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 121.445 -0.784 . . . . 0.0 109.845 179.791 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 6.8 p -123.2 21.86 4.5 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 121.423 -0.798 . . . . 0.0 110.689 -179.954 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.497 1.906 0 O-C-N 121.27 -0.894 . . . . 0.0 110.3 179.627 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 2.5 t . . . . . 0 N--CA 1.494 1.733 0 CA-C-O 121.143 0.496 . . . . 0.0 110.137 . . . . . . . . . 0 0 . 1 . 033 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -109.23 21.2 17.42 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.507 -0.746 . . . . 0.0 110.492 179.932 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.411 ' N ' ' HD3' ' A' ' 4' ' ' PRO . 0.5 OUTLIER -158.0 58.42 1.4 Allowed Pre-proline 0 N--CA 1.495 1.823 0 O-C-N 121.392 -0.818 . . . . 0.0 109.95 179.865 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.411 ' HD3' ' N ' ' A' ' 3' ' ' LEU . 45.6 Cg_endo -75.04 -29.16 8.46 Favored 'Trans proline' 0 C--N 1.311 -1.404 0 O-C-N 123.793 1.417 . . . . 0.0 111.185 -179.628 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -154.72 -75.02 0.11 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.425 -0.797 . . . . 0.0 109.983 179.744 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.47 HD22 ' HA ' ' A' ' 6' ' ' LEU . 0.4 OUTLIER -168.86 -61.47 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.505 -0.747 . . . . 0.0 109.938 179.679 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 21.6 t -164.94 -65.13 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.492 -0.755 . . . . 0.0 110.189 179.779 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.605 HG22 ' HB2' ' A' ' 12' ' ' HIS . 1.5 m 58.15 45.39 17.62 Favored 'General case' 0 N--CA 1.502 2.165 0 O-C-N 121.889 -0.507 . . . . 0.0 110.657 179.84 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -105.47 -74.52 0.94 Allowed Glycine 0 N--CA 1.494 2.502 0 N-CA-C 109.237 -1.545 . . . . 0.0 109.237 179.786 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.442 ' HA ' HD13 ' A' ' 10' ' ' LEU . 3.1 mm? -70.1 -43.69 70.56 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.591 -0.947 . . . . 0.0 109.91 179.699 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 5.6 tt -58.35 -45.94 87.2 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.64 -0.663 . . . . 0.0 110.392 179.703 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 12' ' ' HIS . . . . . 0.605 ' HB2' HG22 ' A' ' 8' ' ' THR . 37.1 t60 -64.58 -40.62 95.87 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.473 -0.767 . . . . 0.0 110.2 179.765 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.713 ' HG ' HD13 ' A' ' 17' ' ' ILE . 3.2 tp -60.28 -40.6 90.97 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.448 -0.782 . . . . 0.0 110.108 179.406 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 14' ' ' HIS . . . . . 0.489 ' CD2' HG21 ' A' ' 18' ' ' VAL . 18.3 t-80 -60.19 -58.64 7.67 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.388 -0.82 . . . . 0.0 109.778 179.625 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.452 ' O ' ' HB2' ' A' ' 19' ' ' ASP . 0.7 OUTLIER -60.14 -26.04 65.97 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.452 -0.78 . . . . 0.0 110.692 179.613 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 -80.0 -46.38 16.72 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.35 -0.844 . . . . 0.0 110.577 -179.883 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.713 HD13 ' HG ' ' A' ' 13' ' ' LEU . 1.3 mp -76.7 -33.58 22.14 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 121.286 -0.884 . . . . 0.0 110.401 -179.809 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.489 HG21 ' CD2' ' A' ' 14' ' ' HIS . 50.7 t -70.52 -29.43 38.53 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 O-C-N 121.125 -0.984 . . . . 0.0 110.364 179.826 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.524 ' HA ' ' CD2' ' A' ' 22' ' ' TYR . 0.4 OUTLIER -88.26 3.27 50.14 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.461 -0.775 . . . . 0.0 111.211 179.772 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.546 HG12 ' O ' ' A' ' 17' ' ' ILE . 0.8 OUTLIER -113.06 -13.96 11.14 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 120.947 -1.096 . . . . 0.0 110.722 179.611 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 11.5 mt-30 -103.71 -35.05 8.37 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.286 -0.884 . . . . 0.0 110.559 -179.802 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 22' ' ' TYR . . . . . 0.524 ' CD2' ' HA ' ' A' ' 19' ' ' ASP . 2.1 p90 -56.7 -33.38 66.4 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.477 -0.765 . . . . 0.0 110.725 -179.841 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.48 -36.88 63.28 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.311 -0.868 . . . . 0.0 110.357 179.813 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -74.02 -10.27 59.47 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.486 -0.759 . . . . 0.0 111.236 179.85 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -92.48 10.62 73.83 Favored Glycine 0 N--CA 1.495 2.602 0 N-CA-C 110.224 -1.15 . . . . 0.0 110.224 179.646 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -147.27 25.98 1.09 Allowed 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.174 -1.192 . . . . 0.0 110.808 179.873 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.468 ' O ' HG22 ' A' ' 30' ' ' ILE . 0.0 OUTLIER -84.48 -56.5 0.41 Allowed Pre-proline 0 N--CA 1.499 2.019 0 O-C-N 121.2 -0.938 . . . . 0.0 110.223 179.823 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.443 ' HD3' ' CB ' ' A' ' 27' ' ' SER . 49.4 Cg_endo -77.58 -11.52 17.05 Favored 'Trans proline' 0 C--N 1.32 -0.926 0 O-C-N 123.32 1.168 . . . . 0.0 110.596 179.174 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -82.81 -43.55 16.54 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.274 -0.892 . . . . 0.0 110.33 179.935 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.468 HG22 ' O ' ' A' ' 27' ' ' SER . 4.0 tp -65.0 -30.5 50.56 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 O-C-N 121.498 -0.751 . . . . 0.0 110.674 -179.99 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 9.7 p -72.35 -25.73 61.65 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.376 -0.827 . . . . 0.0 110.229 179.345 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 2.5 tttm -99.24 16.39 23.05 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.389 -0.819 . . . . 0.0 110.643 179.63 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -110.19 -37.88 5.43 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.222 -0.923 . . . . 0.0 110.69 -179.759 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.496 ' O ' HG12 ' A' ' 35' ' ' VAL . 52.8 t -78.93 -45.9 24.22 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 O-C-N 121.421 -0.799 . . . . 0.0 110.224 -179.84 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.585 ' O ' HG13 ' A' ' 35' ' ' VAL . 0.4 OUTLIER 61.18 15.83 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.278 0 O-C-N 121.871 -0.518 . . . . 0.0 111.458 -179.899 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 77.5 mtm-85 . . . . . 0 N--CA 1.502 2.166 0 CA-C-O 117.657 -1.163 . . . . 0.0 110.442 179.638 . . . . . . . . 0 0 . 1 . 034 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 30.2 m . . . . . 0 N--CA 1.494 1.771 0 CA-C-O 121.075 0.464 . . . . 0.0 110.171 . . . . . . . . . 0 0 . 1 . 034 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -146.42 155.54 42.65 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.53 -0.731 . . . . 0.0 110.202 -179.945 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.547 ' CB ' ' HD3' ' A' ' 4' ' ' PRO . 0.1 OUTLIER -161.53 -61.68 0.02 OUTLIER Pre-proline 0 N--CA 1.497 1.887 0 O-C-N 121.554 -0.716 . . . . 0.0 110.761 179.94 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.547 ' HD3' ' CB ' ' A' ' 3' ' ' LEU . 50.8 Cg_endo -78.52 63.29 8.43 Favored 'Trans proline' 0 N--CA 1.486 1.071 0 O-C-N 123.417 1.22 . . . . 0.0 110.606 -179.979 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -93.93 -41.85 9.38 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.24 -0.912 . . . . 0.0 110.454 179.958 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.1 mt -120.37 -53.73 2.11 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.455 -0.778 . . . . 0.0 110.248 179.987 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.1 t 57.4 61.94 2.33 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.7 -0.625 . . . . 0.0 110.598 -179.9 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.408 HG22 ' CG ' ' A' ' 12' ' ' HIS . 6.9 m 54.42 55.37 8.15 Favored 'General case' 0 N--CA 1.503 2.216 0 O-C-N 121.671 -0.643 . . . . 0.0 110.821 179.69 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -102.98 -71.91 0.9 Allowed Glycine 0 N--CA 1.494 2.521 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 179.842 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.423 ' HA ' HD22 ' A' ' 10' ' ' LEU . 0.2 OUTLIER -62.34 -39.24 92.44 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.642 -0.917 . . . . 0.0 110.389 179.826 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 13.6 tp -58.68 -51.04 71.63 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.46 -0.775 . . . . 0.0 110.236 179.669 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 12' ' ' HIS . . . . . 0.408 ' CG ' HG22 ' A' ' 8' ' ' THR . 0.1 OUTLIER -65.15 -43.15 92.76 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.548 -0.72 . . . . 0.0 109.816 179.482 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -60.63 -39.7 89.23 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.535 -0.728 . . . . 0.0 109.953 179.241 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 14' ' ' HIS . . . . . 0.579 ' NE2' HG21 ' A' ' 18' ' ' VAL . 4.4 t-80 -59.31 -54.09 50.74 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.786 -0.572 . . . . 0.0 109.885 179.538 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.9 tp60 -57.31 -47.18 82.17 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.518 -0.739 . . . . 0.0 110.221 179.865 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -48.41 -45.89 36.64 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.496 -0.753 . . . . 0.0 110.519 179.512 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.434 HD13 ' HA ' ' A' ' 17' ' ' ILE . 18.4 mm -73.62 -42.37 55.35 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 121.37 -0.831 . . . . 0.0 110.114 179.653 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.579 HG21 ' NE2' ' A' ' 14' ' ' HIS . 40.5 t -65.67 -34.99 74.12 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 121.465 -0.772 . . . . 0.0 110.401 179.786 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 72.9 m-20 -67.59 -16.55 64.24 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.488 -0.758 . . . . 0.0 110.595 179.239 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 64.6 t -104.05 -37.83 4.68 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.044 -1.035 . . . . 0.0 109.261 179.148 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 33.5 mt-30 -68.05 -36.8 80.47 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.606 -0.684 . . . . 0.0 110.923 179.963 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -61.61 -29.78 70.27 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.08 -1.013 . . . . 0.0 110.486 -179.986 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 5.6 tpt -103.31 18.69 21.2 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.354 -0.841 . . . . 0.0 110.731 179.375 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -105.16 15.24 27.82 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.017 -1.052 . . . . 0.0 111.29 -179.998 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 62.91 32.53 84.26 Favored Glycine 0 N--CA 1.497 2.738 0 N-CA-C 110.602 -0.999 . . . . 0.0 110.602 179.564 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -93.97 -42.76 8.88 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.322 -1.105 . . . . 0.0 110.23 179.813 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.608 ' HB2' ' HD3' ' A' ' 28' ' ' PRO . 48.2 m -57.03 -50.66 86.92 Favored Pre-proline 0 N--CA 1.497 1.913 0 O-C-N 121.738 -0.601 . . . . 0.0 110.915 179.881 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.608 ' HD3' ' HB2' ' A' ' 27' ' ' SER . 47.7 Cg_endo -71.3 -7.83 22.14 Favored 'Trans proline' 0 N--CA 1.491 1.362 0 O-C-N 123.421 1.221 . . . . 0.0 111.592 179.83 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -98.05 -39.29 9.0 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.199 -0.938 . . . . 0.0 110.357 179.944 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 49.4 mt -76.14 -35.4 28.39 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 O-C-N 121.389 -0.819 . . . . 0.0 110.71 -179.802 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 8.8 p -60.94 -37.46 82.42 Favored 'General case' 0 N--CA 1.501 2.122 0 O-C-N 121.441 -0.787 . . . . 0.0 110.336 179.747 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 26.9 mttt -89.86 13.69 13.9 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.392 -0.818 . . . . 0.0 110.617 179.273 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -108.03 -47.88 3.48 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.305 -0.872 . . . . 0.0 110.067 179.743 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 25.8 t -81.12 72.86 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 O-C-N 121.541 -0.725 . . . . 0.0 109.537 179.77 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 21.9 t -126.16 63.46 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 121.478 -0.763 . . . . 0.0 110.081 -179.617 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.498 1.941 0 CA-C-O 118.294 -0.86 . . . . 0.0 110.258 179.941 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 16.7 t . . . . . 0 N--CA 1.495 1.801 0 CA-C-O 121.121 0.486 . . . . 0.0 110.446 . . . . . . . . . 0 0 . 1 . 035 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -154.24 164.52 38.43 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.625 -0.672 . . . . 0.0 110.198 179.949 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.508 ' N ' ' HD3' ' A' ' 4' ' ' PRO . 0.4 OUTLIER 50.89 57.48 17.31 Favored Pre-proline 0 N--CA 1.502 2.133 0 O-C-N 121.746 -0.596 . . . . 0.0 111.106 179.917 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.508 ' HD3' ' N ' ' A' ' 3' ' ' LEU . 49.2 Cg_endo -81.82 59.68 7.25 Favored 'Trans proline' 0 C--N 1.312 -1.348 0 O-C-N 123.707 1.372 . . . . 0.0 110.753 -179.914 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -89.3 -26.46 21.12 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.323 -0.861 . . . . 0.0 110.634 179.803 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER 55.91 29.07 13.51 Favored 'General case' 0 N--CA 1.503 2.196 0 O-C-N 121.649 -0.657 . . . . 0.0 110.951 -179.919 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -167.22 43.56 0.05 OUTLIER 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.361 -0.837 . . . . 0.0 110.377 179.686 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.56 ' CG2' ' HB2' ' A' ' 12' ' ' HIS . 97.4 m -141.96 -93.48 0.13 Allowed 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.176 -0.952 . . . . 0.0 109.806 179.915 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 56.19 -105.21 0.44 Allowed Glycine 0 N--CA 1.498 2.792 0 N-CA-C 110.221 -1.151 . . . . 0.0 110.221 179.61 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 10.6 tp -58.73 -31.61 68.46 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.638 -0.919 . . . . 0.0 110.568 179.79 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.446 ' HB2' ' HA ' ' A' ' 8' ' ' THR . 5.0 mp -56.91 -41.81 78.82 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.597 -0.689 . . . . 0.0 110.13 179.639 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 12' ' ' HIS . . . . . 0.56 ' HB2' ' CG2' ' A' ' 8' ' ' THR . 1.6 t-80 -80.05 -40.21 28.18 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.348 -0.845 . . . . 0.0 109.83 179.212 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.7 tt -60.49 -42.06 95.53 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.66 -0.65 . . . . 0.0 110.538 179.943 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 14' ' ' HIS . . . . . 0.539 ' CE1' HG21 ' A' ' 18' ' ' VAL . 86.5 t60 -61.52 -51.37 68.89 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.479 -0.763 . . . . 0.0 110.281 179.95 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 12.2 tp60 -62.21 -30.23 70.94 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.341 -0.849 . . . . 0.0 110.011 179.436 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -66.52 -24.95 66.46 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.293 -0.879 . . . . 0.0 110.297 179.144 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 61.7 mt -101.39 -27.56 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 121.205 -0.935 . . . . 0.0 110.342 179.68 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.539 HG21 ' CE1' ' A' ' 14' ' ' HIS . 93.5 t -95.92 -13.23 8.26 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 O-C-N 121.383 -0.823 . . . . 0.0 111.142 -179.647 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.428 ' O ' ' HG2' ' A' ' 23' ' ' MET . 0.2 OUTLIER -120.15 38.48 3.95 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.033 -1.042 . . . . 0.0 110.553 179.836 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 40.1 t -140.09 -55.73 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 O-C-N 121.355 -0.841 . . . . 0.0 109.857 179.949 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -65.2 -14.33 60.39 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.755 -0.591 . . . . 0.0 110.417 179.149 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 22' ' ' TYR . . . . . 0.477 ' HE2' ' HA ' ' A' ' 18' ' ' VAL . 26.9 m-85 -102.36 -22.65 14.07 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.48 -0.763 . . . . 0.0 110.379 -179.424 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 23' ' ' MET . . . . . 0.428 ' HG2' ' O ' ' A' ' 19' ' ' ASP . 0.4 OUTLIER -96.93 -18.55 19.4 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.389 -0.819 . . . . 0.0 110.733 179.555 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -116.27 31.6 6.63 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.151 -0.968 . . . . 0.0 110.801 -179.887 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 149.92 76.79 0.02 OUTLIER Glycine 0 N--CA 1.494 2.548 0 N-CA-C 109.814 -1.314 . . . . 0.0 109.814 179.764 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -102.7 -2.03 28.95 Favored 'General case' 0 N--CA 1.499 2.025 0 O-C-N 121.494 -1.003 . . . . 0.0 111.306 179.821 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.519 ' N ' ' HD2' ' A' ' 28' ' ' PRO . 4.7 m -64.07 -52.19 57.47 Favored Pre-proline 0 N--CA 1.499 1.975 0 O-C-N 121.24 -0.912 . . . . 0.0 110.732 179.608 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.519 ' HD2' ' N ' ' A' ' 27' ' ' SER . 44.3 Cg_endo -71.27 -17.88 30.67 Favored 'Trans proline' 0 N--CA 1.489 1.207 0 O-C-N 123.413 1.217 . . . . 0.0 110.795 179.477 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -77.28 -28.19 53.36 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.454 -0.779 . . . . 0.0 110.263 179.547 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 89.6 mt -90.08 -29.07 4.96 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 121.3 -0.875 . . . . 0.0 110.605 179.961 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 32.6 p -65.02 -50.19 67.23 Favored 'General case' 0 N--CA 1.502 2.144 0 O-C-N 121.279 -0.888 . . . . 0.0 110.069 179.656 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.88 -17.04 64.36 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.447 -0.783 . . . . 0.0 110.439 179.226 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 81.8 t80 -82.18 -34.92 28.84 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.364 -0.835 . . . . 0.0 110.124 179.543 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 97.3 t -83.46 -41.2 16.66 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 121.465 -0.772 . . . . 0.0 110.338 -179.982 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.3 p -92.14 -11.01 9.55 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 O-C-N 121.299 -0.875 . . . . 0.0 111.17 179.934 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 8.9 ttp85 . . . . . 0 N--CA 1.504 2.226 0 CA-C-O 118.08 -0.962 . . . . 0.0 111.091 179.983 . . . . . . . . 0 0 . 1 . 036 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 50.0 m . . . . . 0 N--CA 1.495 1.778 0 CA-C-O 120.968 0.413 . . . . 0.0 110.144 . . . . . . . . . 0 0 . 1 . 036 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -130.09 161.86 30.09 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.603 -0.686 . . . . 0.0 110.212 -179.965 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER 57.81 78.1 0.38 Allowed Pre-proline 0 N--CA 1.499 2.006 0 O-C-N 121.758 -0.589 . . . . 0.0 110.35 -179.881 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -91.47 -161.8 0.1 OUTLIER 'Trans proline' 0 C--N 1.309 -1.512 0 C-N-CA 121.894 1.729 . . . . 0.0 110.524 -179.769 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -168.0 87.11 0.23 Allowed 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.47 -0.769 . . . . 0.0 109.709 179.94 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -98.31 26.88 5.04 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.54 -0.725 . . . . 0.0 111.149 -179.566 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 68.7 m 48.89 59.07 4.68 Favored 'General case' 0 N--CA 1.502 2.141 0 O-C-N 121.458 -0.776 . . . . 0.0 110.891 179.533 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 22.6 p -111.05 30.87 6.49 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.352 -0.842 . . . . 0.0 110.694 -179.837 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -100.95 -86.66 1.94 Allowed Glycine 0 N--CA 1.493 2.462 0 N-CA-C 108.951 -1.66 . . . . 0.0 108.951 179.838 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.1 mp -57.91 -37.52 74.2 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.651 -0.911 . . . . 0.0 110.111 179.501 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.411 HD13 ' HA ' ' A' ' 11' ' ' LEU . 0.5 OUTLIER -57.14 -44.48 83.41 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.64 -0.663 . . . . 0.0 110.035 179.412 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 7.1 m170 -67.74 -43.76 79.18 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.582 -0.699 . . . . 0.0 110.227 179.636 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.2 tt -55.2 -44.42 75.31 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.646 -0.659 . . . . 0.0 110.456 179.956 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 -60.35 -50.04 75.2 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.506 -0.746 . . . . 0.0 109.689 179.504 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 16.4 mm100 -64.69 -35.67 81.8 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.542 -0.724 . . . . 0.0 110.065 179.646 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -61.94 -38.06 87.05 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.576 -0.703 . . . . 0.0 110.6 179.658 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.412 HD13 ' HA ' ' A' ' 17' ' ' ILE . 24.1 mm -83.23 -45.17 18.86 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 O-C-N 121.37 -0.831 . . . . 0.0 110.341 -179.834 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 64.3 t -63.4 -35.69 73.29 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 O-C-N 121.497 -0.752 . . . . 0.0 110.712 -179.797 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -68.94 -24.84 64.32 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.385 -0.822 . . . . 0.0 110.733 -179.992 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 48.8 t -96.65 -36.98 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 120.968 -1.082 . . . . 0.0 109.494 179.327 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.1 -39.43 94.67 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.718 -0.614 . . . . 0.0 110.545 179.616 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 22' ' ' TYR . . . . . 0.434 ' CD1' ' C ' ' A' ' 22' ' ' TYR . 0.1 OUTLIER -66.46 -30.92 71.38 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.25 -0.907 . . . . 0.0 110.234 179.827 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 1.5 ttp -90.52 -31.55 16.7 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.345 -0.847 . . . . 0.0 110.972 -179.856 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 41.4 m-85 -102.59 25.66 8.85 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.179 -0.951 . . . . 0.0 111.157 -179.512 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -158.3 49.37 0.42 Allowed Glycine 0 N--CA 1.495 2.577 0 N-CA-C 109.995 -1.242 . . . . 0.0 109.995 179.746 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.409 HD13 ' O ' ' A' ' 22' ' ' TYR . 0.4 OUTLIER -128.29 29.46 5.34 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.37 -1.077 . . . . 0.0 110.505 179.828 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.556 ' HB2' ' HD3' ' A' ' 28' ' ' PRO . 0.7 OUTLIER -86.2 -49.85 0.51 Allowed Pre-proline 0 N--CA 1.5 2.049 0 O-C-N 121.453 -0.779 . . . . 0.0 111.268 -179.751 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.556 ' HD3' ' HB2' ' A' ' 27' ' ' SER . 50.5 Cg_endo -77.21 64.52 7.87 Favored 'Trans proline' 0 N--CA 1.487 1.13 0 O-C-N 123.395 1.208 . . . . 0.0 110.55 -179.635 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -167.34 -49.48 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.644 -0.66 . . . . 0.0 109.729 179.864 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.41 ' O ' HG23 ' A' ' 34' ' ' VAL . 46.4 mm -79.11 -38.12 20.06 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 121.562 -0.711 . . . . 0.0 110.113 179.758 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 29.7 p -65.01 -45.29 86.16 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.522 -0.736 . . . . 0.0 109.979 179.59 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 24.7 mmtt -64.69 -27.68 69.08 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.644 -0.66 . . . . 0.0 110.221 179.385 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -69.14 -35.39 76.32 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.463 -0.773 . . . . 0.0 109.801 179.212 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.509 HG12 HG23 ' A' ' 35' ' ' VAL . 21.9 t -84.94 164.99 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 121.53 -0.731 . . . . 0.0 109.504 179.448 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.509 HG23 HG12 ' A' ' 34' ' ' VAL . 11.3 t 59.04 66.68 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.149 0 O-C-N 121.591 -0.693 . . . . 0.0 110.058 -179.867 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.778 0 CA-C-O 118.414 -0.803 . . . . 0.0 110.532 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 2.57 0 N-CA-C 109.807 -1.317 . . . . 0.0 109.807 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 12.6 mt -58.3 -40.71 82.7 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.683 -0.892 . . . . 0.0 110.465 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 5.1 tt -57.54 -50.42 73.14 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.49 -0.756 . . . . 0.0 109.943 179.602 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 8.6 m170 -61.06 -41.95 97.56 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.692 -0.63 . . . . 0.0 110.074 179.515 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 9.4 tp -58.12 -42.67 86.24 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.641 -0.662 . . . . 0.0 110.199 179.518 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . 0.505 ' CE1' HG21 ' A' ' 18' ' ' VAL . 74.7 t60 -61.02 -49.16 78.53 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.713 -0.617 . . . . 0.0 110.001 179.596 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 15.8 mm-40 -60.08 -37.82 81.06 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.505 -0.747 . . . . 0.0 110.267 179.677 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -62.28 -39.75 93.97 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.498 -0.751 . . . . 0.0 110.377 179.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 56.4 mt -79.65 -44.08 23.31 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 O-C-N 121.317 -0.864 . . . . 0.0 110.203 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.505 HG21 ' CE1' ' A' ' 14' ' ' HIS . 49.9 t -66.65 -17.91 23.31 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 O-C-N 121.558 -0.714 . . . . 0.0 111.134 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -98.53 -6.23 30.6 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.141 -0.974 . . . . 0.0 111.053 179.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 75.7 t . . . . . 0 N--CA 1.498 1.936 0 O-C-N 120.935 -1.103 . . . . 0.0 110.282 179.615 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.504 2.245 0 CA-C-O 120.981 0.419 . . . . 0.0 111.253 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.434 ' N ' ' HD2' ' A' ' 28' ' ' PRO . 0.0 OUTLIER -59.45 -57.02 30.05 Favored Pre-proline 0 N--CA 1.501 2.097 0 O-C-N 121.306 -0.871 . . . . 0.0 110.616 179.815 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.434 ' HD2' ' N ' ' A' ' 27' ' ' SER . 45.7 Cg_endo -71.52 -27.53 18.76 Favored 'Trans proline' 0 N--CA 1.487 1.114 0 O-C-N 123.485 1.255 . . . . 0.0 110.895 179.681 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.36 -52.51 61.41 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.446 -0.784 . . . . 0.0 110.746 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 34.8 mm -60.52 -35.85 66.0 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.12 0 O-C-N 121.411 -0.806 . . . . 0.0 110.559 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 73.4 m -61.11 -27.82 68.65 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.541 -0.724 . . . . 0.0 110.566 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.36 7.52 33.34 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.299 -0.876 . . . . 0.0 110.689 179.559 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -101.22 -39.31 7.7 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.36 -0.837 . . . . 0.0 110.161 179.716 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 92.2 t . . . . . 0 N--CA 1.496 1.856 0 O-C-N 121.445 -0.784 . . . . 0.0 110.367 179.828 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 2.685 0 N-CA-C 109.165 -1.574 . . . . 0.0 109.165 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 7.1 tp -81.73 -31.73 31.9 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.606 -0.938 . . . . 0.0 109.91 179.153 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -56.03 -47.59 77.56 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.535 -0.728 . . . . 0.0 110.256 179.73 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -57.36 -42.99 83.14 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.547 -0.721 . . . . 0.0 110.036 179.46 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.1 tt -60.96 -41.46 96.38 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.676 -0.64 . . . . 0.0 110.224 179.451 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . 0.607 ' NE2' HG21 ' A' ' 18' ' ' VAL . 67.9 t60 -60.8 -50.23 74.3 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.399 -0.813 . . . . 0.0 109.721 179.408 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 51.8 mm-40 -58.56 -35.89 73.08 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.531 -0.731 . . . . 0.0 110.007 179.382 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -58.54 -36.11 73.37 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.621 -0.674 . . . . 0.0 110.133 179.234 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.579 ' O ' HG12 ' A' ' 20' ' ' VAL . 7.4 mt -88.17 -31.81 5.83 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 O-C-N 121.515 -0.741 . . . . 0.0 109.96 179.502 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.607 HG21 ' NE2' ' A' ' 14' ' ' HIS . 54.9 t -68.6 -37.38 77.57 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 121.378 -0.826 . . . . 0.0 110.301 179.855 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -82.95 4.43 25.87 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.563 -0.71 . . . . 0.0 111.471 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.579 HG12 ' O ' ' A' ' 17' ' ' ILE . 0.8 OUTLIER . . . . . 0 N--CA 1.498 1.955 0 O-C-N 120.737 -1.227 . . . . 0.0 110.653 179.373 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.501 2.085 0 CA-C-O 121.1 0.476 . . . . 0.0 110.675 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.44 ' HB2' ' HD3' ' A' ' 28' ' ' PRO . 1.2 m -77.82 -51.77 1.73 Allowed Pre-proline 0 N--CA 1.497 1.913 0 O-C-N 121.297 -0.877 . . . . 0.0 111.064 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.44 ' HD3' ' HB2' ' A' ' 27' ' ' SER . 49.5 Cg_endo -76.93 61.43 7.12 Favored 'Trans proline' 0 N--CA 1.487 1.13 0 O-C-N 123.446 1.235 . . . . 0.0 110.317 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -167.35 -51.9 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.515 -0.741 . . . . 0.0 109.944 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 80.3 mt -68.35 -24.99 30.32 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 O-C-N 121.535 -0.728 . . . . 0.0 110.22 179.497 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 19.5 p -65.98 -41.83 90.63 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.448 -0.782 . . . . 0.0 110.211 179.471 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 5.9 tmtt? -70.2 -10.82 60.04 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.549 -0.72 . . . . 0.0 110.935 179.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 8.6 t80 -70.24 -43.25 70.97 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.316 -0.865 . . . . 0.0 110.361 179.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.501 ' O ' HG12 ' A' ' 34' ' ' VAL . 38.8 t . . . . . 0 N--CA 1.498 1.936 0 O-C-N 121.35 -0.844 . . . . 0.0 110.263 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.331 0 N-CA-C 108.49 -1.844 . . . . 0.0 108.49 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 7.4 mt -81.09 -35.57 31.52 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.67 -0.9 . . . . 0.0 109.878 179.192 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 2.5 tt -59.21 -42.9 92.03 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.633 -0.667 . . . . 0.0 110.069 179.507 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -76.35 -33.21 58.97 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.524 -0.735 . . . . 0.0 110.105 179.429 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.402 HD22 ' HA ' ' A' ' 13' ' ' LEU . 0.1 OUTLIER -57.09 -47.72 80.34 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.445 -0.784 . . . . 0.0 110.472 179.912 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . 0.416 ' CE1' HG21 ' A' ' 18' ' ' VAL . 77.4 t60 -61.39 -52.21 65.55 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.381 -0.824 . . . . 0.0 109.823 179.625 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 4.3 tp-100 -60.02 -37.63 80.31 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.523 -0.735 . . . . 0.0 110.222 179.542 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -62.43 -39.42 93.27 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.573 -0.704 . . . . 0.0 110.665 179.676 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 76.5 mt -81.6 -41.82 18.97 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 O-C-N 121.166 -0.959 . . . . 0.0 110.29 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.416 HG21 ' CE1' ' A' ' 14' ' ' HIS . 76.8 t -65.26 -44.83 94.97 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 O-C-N 121.392 -0.818 . . . . 0.0 110.439 -179.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -65.73 -16.11 63.47 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.742 -0.599 . . . . 0.0 111.46 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 94.9 t . . . . . 0 N--CA 1.494 1.757 0 O-C-N 120.74 -1.225 . . . . 0.0 109.86 179.495 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 10.6 mt . . . . . 0 N--CA 1.503 2.195 0 CA-C-O 121.079 0.466 . . . . 0.0 111.105 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.632 ' HB2' ' HD3' ' A' ' 28' ' ' PRO . 2.2 m -59.29 -56.28 37.57 Favored Pre-proline 0 N--CA 1.497 1.887 0 O-C-N 121.277 -0.89 . . . . 0.0 110.592 -179.851 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.632 ' HD3' ' HB2' ' A' ' 27' ' ' SER . 53.2 Cg_endo -80.42 53.87 4.96 Favored 'Trans proline' 0 N--CA 1.485 1.018 0 O-C-N 123.386 1.203 . . . . 0.0 110.434 179.329 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -155.44 -54.11 0.09 Allowed 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.304 -0.873 . . . . 0.0 110.029 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 10.0 mt -79.48 -32.17 14.54 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 O-C-N 121.415 -0.803 . . . . 0.0 110.439 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 16.1 m -61.17 -38.59 87.02 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.553 -0.717 . . . . 0.0 110.333 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 2.1 pttt -93.2 18.37 9.56 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.467 -0.77 . . . . 0.0 110.606 179.394 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -113.39 -50.02 2.88 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.265 -0.897 . . . . 0.0 109.952 179.773 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 74.0 t . . . . . 0 N--CA 1.497 1.895 0 O-C-N 121.479 -0.763 . . . . 0.0 109.893 179.728 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 2.64 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -58.48 -35.24 71.89 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.682 -0.893 . . . . 0.0 110.207 179.629 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 4.8 tt -57.18 -46.28 82.96 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.471 -0.768 . . . . 0.0 109.965 179.464 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 22.3 m-70 -68.44 -42.73 78.43 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.527 -0.733 . . . . 0.0 109.877 179.449 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -60.35 -38.79 84.95 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.63 -0.669 . . . . 0.0 109.778 179.225 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . 0.519 ' NE2' HG21 ' A' ' 18' ' ' VAL . 71.5 t60 -63.9 -52.72 58.61 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.627 -0.671 . . . . 0.0 109.624 179.255 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 29.9 tp60 -54.65 -39.04 67.61 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.697 -0.627 . . . . 0.0 110.149 179.559 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.614 ' O ' HG23 ' A' ' 20' ' ' VAL . 1.8 t30 -58.12 -49.07 78.25 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.554 -0.717 . . . . 0.0 110.327 179.558 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 29.2 mt -72.09 -33.47 47.11 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.073 0 O-C-N 121.449 -0.782 . . . . 0.0 110.226 179.714 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.519 HG21 ' NE2' ' A' ' 14' ' ' HIS . 73.5 t -75.69 -10.92 13.84 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.093 0 O-C-N 121.51 -0.744 . . . . 0.0 111.086 179.825 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -111.49 20.96 16.7 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.892 -1.13 . . . . 0.0 110.674 179.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.614 HG23 ' O ' ' A' ' 16' ' ' ASN . 73.0 t . . . . . 0 N--CA 1.497 1.896 0 O-C-N 121.139 -0.976 . . . . 0.0 109.721 179.481 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.1 mp . . . . . 0 N--CA 1.496 1.827 0 CA-C-O 120.798 0.333 . . . . 0.0 110.925 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.508 ' N ' ' HD2' ' A' ' 28' ' ' PRO . 0.8 OUTLIER -56.62 -52.8 70.73 Favored Pre-proline 0 N--CA 1.498 1.947 0 O-C-N 121.3 -0.875 . . . . 0.0 110.486 179.528 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.508 ' HD2' ' N ' ' A' ' 27' ' ' SER . 45.8 Cg_endo -71.79 -26.7 18.85 Favored 'Trans proline' 0 N--CA 1.488 1.185 0 O-C-N 123.53 1.279 . . . . 0.0 110.789 179.314 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -71.09 -33.52 70.27 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.495 -0.753 . . . . 0.0 110.507 179.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -84.97 -11.25 11.52 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 O-C-N 121.269 -0.894 . . . . 0.0 110.976 179.851 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 24.0 p -101.8 -38.89 7.65 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.08 -1.013 . . . . 0.0 110.532 179.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 2.1 tptt -90.23 39.11 0.95 Allowed 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.378 -0.826 . . . . 0.0 110.574 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -149.55 -49.93 0.14 Allowed 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.34 -0.85 . . . . 0.0 109.882 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 16.1 t . . . . . 0 N--CA 1.495 1.81 0 CA-C-O 121.416 0.627 . . . . 0.0 109.668 179.847 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.555 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 2.1 pp -66.64 -31.15 71.64 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.58 -0.953 . . . . 0.0 110.597 179.791 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.92 -44.31 93.28 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.202 -0.936 . . . . 0.0 109.973 179.663 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 5.5 m80 -70.34 -37.1 74.61 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.516 -0.74 . . . . 0.0 109.942 179.337 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.9 tp -59.6 -40.12 86.43 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.532 -0.73 . . . . 0.0 110.561 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . 0.412 ' CD2' HG21 ' A' ' 18' ' ' VAL . 3.3 t-80 -54.74 -51.91 64.17 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.611 -0.68 . . . . 0.0 109.958 179.771 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 12.1 tp-100 -62.63 -32.31 73.31 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.48 -0.763 . . . . 0.0 110.507 179.772 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -72.12 -47.68 49.41 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.314 -0.866 . . . . 0.0 110.559 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 39.0 mm -71.65 -40.41 70.64 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 O-C-N 121.408 -0.808 . . . . 0.0 110.429 -179.772 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.412 HG21 ' CD2' ' A' ' 14' ' ' HIS . 38.3 t -62.19 -30.1 48.06 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 O-C-N 121.36 -0.838 . . . . 0.0 110.199 179.771 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -76.8 -15.65 59.68 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.503 -0.748 . . . . 0.0 110.85 179.382 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 92.7 t . . . . . 0 N--CA 1.494 1.742 0 O-C-N 121.057 -1.027 . . . . 0.0 109.884 179.618 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.3 mp . . . . . 0 N--CA 1.495 1.812 0 CA-C-O 120.681 0.277 . . . . 0.0 111.195 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.625 ' HB3' ' HD3' ' A' ' 28' ' ' PRO . 0.5 OUTLIER -62.81 -53.37 56.71 Favored Pre-proline 0 N--CA 1.498 1.931 0 O-C-N 121.154 -0.966 . . . . 0.0 110.374 179.474 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.782 ' HA ' HG22 ' A' ' 31' ' ' THR . 45.7 Cg_endo -73.07 -31.33 9.81 Favored 'Trans proline' 0 N--CA 1.487 1.122 0 O-C-N 123.491 1.259 . . . . 0.0 110.69 179.681 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.55 -24.48 67.54 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.618 -0.676 . . . . 0.0 111.279 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 47.5 mm -105.63 -30.11 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 O-C-N 121.113 -0.992 . . . . 0.0 111.119 -179.62 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.782 HG22 ' HA ' ' A' ' 28' ' ' PRO . 4.8 t -85.17 -30.97 23.51 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.159 -0.963 . . . . 0.0 110.867 -179.796 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.3 tttt -89.4 10.88 20.92 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.193 -0.942 . . . . 0.0 110.979 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 6.8 m-85 -114.07 -38.43 4.17 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.105 -0.997 . . . . 0.0 110.539 179.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 60.8 t . . . . . 0 N--CA 1.494 1.728 0 O-C-N 121.312 -0.867 . . . . 0.0 109.696 179.852 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 2.673 0 N-CA-C 109.272 -1.531 . . . . 0.0 109.272 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.463 HD13 ' HA ' ' A' ' 10' ' ' LEU . 0.4 OUTLIER -63.09 -35.64 80.95 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.652 -0.91 . . . . 0.0 109.972 179.371 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -56.98 -48.19 79.01 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.53 -0.731 . . . . 0.0 109.87 179.378 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 7.1 m-70 -63.88 -39.36 94.0 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.715 -0.616 . . . . 0.0 109.738 179.129 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 9.1 tp -58.96 -41.87 88.53 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.64 -0.663 . . . . 0.0 110.109 179.333 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . 0.531 ' NE2' HG21 ' A' ' 18' ' ' VAL . 5.7 t-160 -62.16 -52.04 65.43 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.543 -0.723 . . . . 0.0 109.258 179.149 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 27.3 tp60 -58.72 -36.53 74.43 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.625 -0.672 . . . . 0.0 110.021 179.186 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -61.73 -45.31 94.48 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.643 -0.661 . . . . 0.0 110.474 179.731 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.462 ' O ' HG12 ' A' ' 20' ' ' VAL . 38.8 mt -73.27 -37.5 52.03 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.018 0 O-C-N 121.352 -0.842 . . . . 0.0 109.84 179.637 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.531 HG21 ' NE2' ' A' ' 14' ' ' HIS . 54.8 t -75.73 -3.92 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 O-C-N 121.475 -0.766 . . . . 0.0 110.658 179.473 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -120.79 5.41 10.49 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.188 -0.945 . . . . 0.0 110.57 179.136 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.462 HG12 ' O ' ' A' ' 17' ' ' ILE . 5.5 p . . . . . 0 N--CA 1.499 1.999 0 O-C-N 120.905 -1.122 . . . . 0.0 110.866 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.504 2.228 0 CA-C-O 121.088 0.47 . . . . 0.0 111.231 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.488 ' H ' ' HD2' ' A' ' 28' ' ' PRO . 0.5 OUTLIER -99.21 -63.98 0.08 OUTLIER Pre-proline 0 N--CA 1.497 1.887 0 O-C-N 121.184 -0.947 . . . . 0.0 110.571 179.69 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.488 ' HD2' ' H ' ' A' ' 27' ' ' SER . 41.8 Cg_endo -67.66 -25.04 40.69 Favored 'Trans proline' 0 N--CA 1.489 1.235 0 O-C-N 123.222 1.117 . . . . 0.0 110.876 179.812 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.76 -32.16 73.54 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.37 -0.831 . . . . 0.0 110.312 179.292 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 97.1 mt -99.68 -42.34 10.38 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 121.501 -0.749 . . . . 0.0 110.035 179.675 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 62.8 m -63.88 -38.24 90.38 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.665 -0.647 . . . . 0.0 110.612 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 13.2 tttt -89.31 15.29 9.29 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.231 -0.918 . . . . 0.0 110.68 179.558 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 9.7 t80 -106.63 -44.09 4.56 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.296 -0.877 . . . . 0.0 110.019 179.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.9 t . . . . . 0 N--CA 1.496 1.862 0 O-C-N 121.383 -0.823 . . . . 0.0 109.734 179.805 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.427 0 N-CA-C 109.032 -1.627 . . . . 0.0 109.032 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.5 mt -62.8 -41.99 99.52 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.616 -0.932 . . . . 0.0 110.17 179.665 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 15.6 tp -59.45 -43.61 93.15 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.464 -0.772 . . . . 0.0 109.814 179.378 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 6.9 m170 -65.35 -44.94 86.08 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.628 -0.67 . . . . 0.0 109.748 179.271 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.91 -33.91 76.62 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.472 -0.767 . . . . 0.0 109.969 179.31 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . 0.517 ' NE2' HG21 ' A' ' 18' ' ' VAL . 8.1 t-160 -63.0 -51.7 65.84 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.625 -0.672 . . . . 0.0 109.88 179.549 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.46 ' O ' ' HB2' ' A' ' 19' ' ' ASP . 0.3 OUTLIER -61.75 -36.03 79.81 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.496 -0.752 . . . . 0.0 109.993 179.497 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -59.36 -43.61 92.81 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.473 -0.767 . . . . 0.0 110.289 179.445 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.503 ' O ' HG12 ' A' ' 20' ' ' VAL . 61.1 mt -81.87 -26.25 9.58 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.925 0 O-C-N 121.395 -0.816 . . . . 0.0 110.624 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.517 HG21 ' NE2' ' A' ' 14' ' ' HIS . 49.7 t -85.65 -7.44 10.92 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 121.031 -1.043 . . . . 0.0 110.693 179.79 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.46 ' HB2' ' O ' ' A' ' 15' ' ' GLN . 0.5 OUTLIER -122.53 32.24 5.83 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.101 -0.999 . . . . 0.0 109.667 178.896 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.503 HG12 ' O ' ' A' ' 17' ' ' ILE . 13.0 p . . . . . 0 N--CA 1.5 2.052 0 O-C-N 121.416 -0.802 . . . . 0.0 110.646 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.6 mp . . . . . 0 N--CA 1.502 2.148 0 CA-C-O 120.827 0.346 . . . . 0.0 111.549 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.473 ' N ' ' HD2' ' A' ' 28' ' ' PRO . 1.4 m -69.88 -55.43 8.73 Favored Pre-proline 0 N--CA 1.498 1.939 0 O-C-N 121.113 -0.992 . . . . 0.0 110.27 179.333 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.473 ' HD2' ' N ' ' A' ' 27' ' ' SER . 45.6 Cg_endo -71.61 -20.23 27.07 Favored 'Trans proline' 0 N--CA 1.487 1.1 0 O-C-N 123.451 1.237 . . . . 0.0 110.681 179.182 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -70.85 -37.89 73.16 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.48 -0.763 . . . . 0.0 110.216 179.585 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 28.5 mm -74.35 -39.93 49.2 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 O-C-N 121.518 -0.739 . . . . 0.0 110.061 179.625 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 44.9 p -69.22 -39.48 78.53 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.381 -0.825 . . . . 0.0 110.206 179.692 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 26.9 mmtt -71.91 -29.77 64.67 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.428 -0.795 . . . . 0.0 110.638 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 92.4 t80 -86.44 -47.4 9.34 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.399 -0.813 . . . . 0.0 110.319 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 47.2 t . . . . . 0 N--CA 1.496 1.865 0 O-C-N 121.448 -0.783 . . . . 0.0 109.831 -179.894 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.376 0 N-CA-C 108.626 -1.789 . . . . 0.0 108.626 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 8.9 tp -73.49 -36.82 65.85 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.648 -0.913 . . . . 0.0 109.876 179.335 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 11.5 tp -64.56 -44.1 91.82 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.377 -0.827 . . . . 0.0 109.839 179.506 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -63.76 -42.92 97.73 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.59 -0.693 . . . . 0.0 109.832 179.443 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 5.2 tp -63.88 -40.72 97.19 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.542 -0.724 . . . . 0.0 110.238 179.505 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . 0.497 ' NE2' HG21 ' A' ' 18' ' ' VAL . 7.3 t-80 -57.4 -54.22 49.33 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.643 -0.661 . . . . 0.0 109.922 179.685 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.447 ' O ' ' HB2' ' A' ' 19' ' ' ASP . 19.5 tp60 -55.57 -40.14 71.6 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.672 -0.642 . . . . 0.0 110.089 179.577 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -66.67 -40.8 88.75 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.348 -0.845 . . . . 0.0 110.68 179.686 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.413 ' O ' HG12 ' A' ' 20' ' ' VAL . 85.6 mt -77.07 -21.53 14.5 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 O-C-N 121.395 -0.816 . . . . 0.0 110.858 -179.81 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.497 HG21 ' NE2' ' A' ' 14' ' ' HIS . 24.3 t -93.16 -33.61 5.43 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 O-C-N 121.205 -0.934 . . . . 0.0 110.082 179.828 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.447 ' HB2' ' O ' ' A' ' 15' ' ' GLN . 2.4 m-20 -87.75 28.84 0.96 Allowed 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.278 -0.889 . . . . 0.0 110.439 179.271 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.413 HG12 ' O ' ' A' ' 17' ' ' ILE . 12.5 p . . . . . 0 N--CA 1.495 1.825 0 O-C-N 121.242 -0.911 . . . . 0.0 110.344 179.577 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.495 1.807 0 CA-C-O 121.106 0.479 . . . . 0.0 110.192 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.404 ' CB ' ' HD3' ' A' ' 28' ' ' PRO . 0.4 OUTLIER -60.28 -54.34 56.1 Favored Pre-proline 0 N--CA 1.498 1.939 0 O-C-N 121.397 -0.814 . . . . 0.0 110.656 -179.909 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.404 ' HD3' ' CB ' ' A' ' 27' ' ' SER . 49.9 Cg_endo -77.61 55.32 5.13 Favored 'Trans proline' 0 N--CA 1.487 1.119 0 O-C-N 123.393 1.207 . . . . 0.0 110.318 179.473 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -162.74 -49.18 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.59 -0.694 . . . . 0.0 109.78 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 21.8 mt -83.13 -34.1 10.87 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 121.624 -0.673 . . . . 0.0 110.224 179.592 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 43.7 m -61.6 -43.35 99.03 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.568 -0.707 . . . . 0.0 109.931 179.48 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.8 tttp -70.51 -23.52 62.67 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.549 -0.719 . . . . 0.0 110.496 179.332 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -75.43 -27.58 59.03 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.415 -0.803 . . . . 0.0 110.365 179.646 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 57.9 t . . . . . 0 N--CA 1.497 1.884 0 O-C-N 121.269 -0.895 . . . . 0.0 110.543 -179.749 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.503 0 N-CA-C 109.275 -1.53 . . . . 0.0 109.275 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 8.0 tp -66.74 -32.03 73.06 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.577 -0.955 . . . . 0.0 110.237 179.475 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.415 HD22 ' HA ' ' A' ' 11' ' ' LEU . 0.1 OUTLIER -58.19 -43.09 87.39 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.45 -0.781 . . . . 0.0 110.024 179.551 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -59.02 -43.75 91.61 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.6 -0.688 . . . . 0.0 109.696 179.29 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.2 tt -61.99 -38.39 88.42 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.751 -0.593 . . . . 0.0 110.057 179.207 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . 0.591 ' NE2' HG21 ' A' ' 18' ' ' VAL . 2.8 t-80 -61.38 -52.85 62.92 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.517 -0.74 . . . . 0.0 109.745 179.4 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.406 ' O ' ' HB2' ' A' ' 19' ' ' ASP . 3.3 tp-100 -59.96 -36.35 76.9 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.516 -0.74 . . . . 0.0 110.227 179.669 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 9.9 t30 -59.48 -34.04 72.08 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.533 -0.729 . . . . 0.0 110.475 179.471 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.467 ' O ' HG12 ' A' ' 20' ' ' VAL . 38.0 mt -94.4 -36.84 7.38 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 121.398 -0.814 . . . . 0.0 110.317 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.591 HG21 ' NE2' ' A' ' 14' ' ' HIS . 92.0 t -74.2 -7.83 10.59 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.086 0 O-C-N 121.343 -0.848 . . . . 0.0 111.011 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.406 ' HB2' ' O ' ' A' ' 15' ' ' GLN . 1.0 OUTLIER -119.83 8.08 11.07 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.167 -0.958 . . . . 0.0 110.809 179.434 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.467 HG12 ' O ' ' A' ' 17' ' ' ILE . 9.2 p . . . . . 0 N--CA 1.498 1.959 0 O-C-N 120.982 -1.074 . . . . 0.0 110.874 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.0 mp . . . . . 0 N--CA 1.495 1.823 0 CA-C-O 121.311 0.577 . . . . 0.0 109.891 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.621 ' HB3' ' HD3' ' A' ' 28' ' ' PRO . 4.6 t -53.27 -55.82 30.44 Favored Pre-proline 0 N--CA 1.497 1.892 0 O-C-N 121.625 -0.672 . . . . 0.0 110.645 -179.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.621 ' HD3' ' HB3' ' A' ' 27' ' ' SER . 52.3 Cg_endo -77.37 59.27 6.6 Favored 'Trans proline' 0 N--CA 1.487 1.114 0 O-C-N 123.448 1.236 . . . . 0.0 110.075 179.247 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -167.87 -50.07 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.533 -0.73 . . . . 0.0 110.001 -179.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 15.6 mt -78.43 -33.71 17.56 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 O-C-N 121.483 -0.761 . . . . 0.0 110.299 179.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 7.9 p -61.33 -39.62 91.2 Favored 'General case' 0 N--CA 1.5 2.025 0 O-C-N 121.703 -0.623 . . . . 0.0 110.301 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -91.77 19.51 6.43 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.344 -0.848 . . . . 0.0 110.493 179.272 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 71.3 t80 -115.5 -47.03 2.84 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.366 -0.834 . . . . 0.0 109.989 179.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 59.5 t . . . . . 0 N--CA 1.497 1.879 0 O-C-N 121.341 -0.85 . . . . 0.0 109.845 179.838 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.469 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -62.21 -47.2 85.51 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.632 -0.922 . . . . 0.0 110.609 -179.832 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -58.58 -51.62 69.13 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.487 -0.758 . . . . 0.0 110.2 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -62.74 -40.82 98.41 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.653 -0.654 . . . . 0.0 110.037 179.558 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.7 tt -56.88 -42.2 79.39 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.642 -0.661 . . . . 0.0 110.13 179.588 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 7.2 t-80 -60.81 -49.07 78.98 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.521 -0.737 . . . . 0.0 109.799 179.412 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.457 ' O ' ' HB2' ' A' ' 19' ' ' ASP . 17.8 mm-40 -67.17 -36.17 81.24 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.544 -0.722 . . . . 0.0 109.76 179.318 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -63.68 -18.32 63.87 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.501 -0.749 . . . . 0.0 110.905 179.487 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 87.2 mt -104.74 -46.53 9.47 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.082 -1.011 . . . . 0.0 109.908 179.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 54.0 t -71.21 -36.73 63.4 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 O-C-N 121.403 -0.811 . . . . 0.0 110.969 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.457 ' HB2' ' O ' ' A' ' 15' ' ' GLN . 0.3 OUTLIER -86.55 -1.94 58.06 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.398 -0.814 . . . . 0.0 111.41 -179.537 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 70.6 t . . . . . 0 N--CA 1.495 1.804 0 O-C-N 120.83 -1.169 . . . . 0.0 109.78 179.354 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.544 ' HB3' ' HB3' ' A' ' 29' ' ' ALA . 3.4 mp . . . . . 0 N--CA 1.501 2.086 0 CA-C-O 121.156 0.503 . . . . 0.0 110.818 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.483 ' HB2' ' HD3' ' A' ' 28' ' ' PRO . 3.1 m -56.18 -55.09 45.6 Favored Pre-proline 0 N--CA 1.499 1.998 0 O-C-N 121.527 -0.733 . . . . 0.0 111.094 -179.726 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.483 ' HD3' ' HB2' ' A' ' 27' ' ' SER . 46.3 Cg_endo -72.2 -27.06 17.13 Favored 'Trans proline' 0 N--CA 1.489 1.217 0 O-C-N 123.398 1.209 . . . . 0.0 111.068 179.827 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.544 ' HB3' ' HB3' ' A' ' 26' ' ' LEU . . . -72.87 -39.98 66.01 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.417 -0.802 . . . . 0.0 110.633 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 5.7 tt -79.49 -11.63 13.02 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 O-C-N 121.341 -0.849 . . . . 0.0 111.467 -179.691 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 23.3 p -101.0 -37.19 8.73 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.099 -1.001 . . . . 0.0 110.537 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 6.9 tptp -91.6 45.93 1.26 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.267 -0.896 . . . . 0.0 109.964 179.672 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -146.91 -53.59 0.23 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.549 -0.719 . . . . 0.0 109.739 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.498 ' O ' HG12 ' A' ' 34' ' ' VAL . 49.0 t . . . . . 0 N--CA 1.496 1.874 0 O-C-N 121.443 -0.786 . . . . 0.0 109.75 179.612 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.548 0 N-CA-C 109.841 -1.304 . . . . 0.0 109.841 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -57.71 -38.54 75.44 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.65 -0.912 . . . . 0.0 110.8 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -56.82 -51.05 70.48 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.497 -0.752 . . . . 0.0 110.371 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 3.8 t60 -75.56 -30.8 59.79 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.284 -0.885 . . . . 0.0 110.103 179.39 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 61.1 tp -55.3 -41.88 72.94 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.472 -0.768 . . . . 0.0 109.962 179.578 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . 0.406 ' NE2' HG21 ' A' ' 18' ' ' VAL . 2.6 t-80 -61.92 -46.44 89.32 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.608 -0.682 . . . . 0.0 109.665 179.222 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 28.3 mm-40 -60.51 -37.48 81.27 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.658 -0.651 . . . . 0.0 110.093 179.587 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -67.78 -47.98 67.61 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.548 -0.72 . . . . 0.0 110.386 179.651 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 74.8 mt -65.45 -48.57 82.49 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.99 0 O-C-N 121.393 -0.817 . . . . 0.0 109.991 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.406 HG21 ' NE2' ' A' ' 14' ' ' HIS . 27.2 t -61.97 -31.92 52.69 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 O-C-N 121.437 -0.789 . . . . 0.0 109.938 179.549 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -63.95 -25.4 68.12 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.631 -0.668 . . . . 0.0 109.963 178.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 61.2 t . . . . . 0 N--CA 1.491 1.624 0 O-C-N 121.107 -0.996 . . . . 0.0 109.479 179.036 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.593 HD13 ' HB3' ' A' ' 29' ' ' ALA . 1.2 mm? . . . . . 0 N--CA 1.502 2.17 0 CA-C-O 120.907 0.384 . . . . 0.0 111.254 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.479 ' N ' ' HD2' ' A' ' 28' ' ' PRO . 1.4 m -80.57 -54.82 0.77 Allowed Pre-proline 0 N--CA 1.498 1.958 0 O-C-N 121.238 -0.913 . . . . 0.0 110.801 179.796 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.479 ' HD2' ' N ' ' A' ' 27' ' ' SER . 43.8 Cg_endo -70.14 -11.83 31.06 Favored 'Trans proline' 0 N--CA 1.49 1.275 0 O-C-N 123.259 1.136 . . . . 0.0 111.172 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.593 ' HB3' HD13 ' A' ' 26' ' ' LEU . . . -90.21 -27.34 19.6 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.248 -0.907 . . . . 0.0 110.366 179.454 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 43.4 mm -104.77 -45.26 9.01 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 121.315 -0.866 . . . . 0.0 110.325 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 23.9 m -70.39 -34.55 72.69 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.602 -0.686 . . . . 0.0 110.84 -179.775 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 6.6 tttp -89.9 16.63 7.85 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.085 -1.009 . . . . 0.0 110.684 179.428 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -109.4 -40.88 4.77 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.292 -0.88 . . . . 0.0 109.987 179.496 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 87.2 t . . . . . 0 N--CA 1.496 1.837 0 O-C-N 121.437 -0.789 . . . . 0.0 110.018 179.848 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.41 0 N-CA-C 108.724 -1.751 . . . . 0.0 108.724 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.62 -39.08 93.47 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.649 -0.912 . . . . 0.0 109.738 179.141 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -58.31 -47.81 82.5 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.699 -0.625 . . . . 0.0 109.585 179.132 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 20.1 t-160 -67.81 -45.01 75.95 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.736 -0.602 . . . . 0.0 109.844 179.357 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 11.8 tp -57.25 -41.84 80.37 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.558 -0.714 . . . . 0.0 110.035 179.534 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . 0.544 ' NE2' HG21 ' A' ' 18' ' ' VAL . 6.6 t-80 -61.06 -47.03 88.24 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.624 -0.672 . . . . 0.0 109.826 179.436 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 33.9 tp60 -55.88 -45.28 78.61 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.639 -0.663 . . . . 0.0 110.252 179.71 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.596 ' O ' HG23 ' A' ' 20' ' ' VAL . 9.5 t-20 -63.74 -52.36 60.79 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.326 -0.859 . . . . 0.0 110.732 179.773 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 83.5 mt -57.75 -43.48 84.02 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.119 0 O-C-N 121.345 -0.847 . . . . 0.0 110.374 -179.737 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.544 HG21 ' NE2' ' A' ' 14' ' ' HIS . 17.9 t -71.51 -32.54 46.47 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 O-C-N 121.394 -0.816 . . . . 0.0 110.138 179.579 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -73.01 -10.91 60.3 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.423 -0.798 . . . . 0.0 110.991 179.591 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.596 HG23 ' O ' ' A' ' 16' ' ' ASN . 61.6 t . . . . . 0 N--CA 1.493 1.707 0 O-C-N 120.832 -1.167 . . . . 0.0 109.925 179.487 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.5 2.038 0 CA-C-O 120.861 0.363 . . . . 0.0 111.019 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.503 ' HB2' ' HD3' ' A' ' 28' ' ' PRO . 4.7 m -74.56 -52.75 3.65 Favored Pre-proline 0 N--CA 1.499 1.977 0 O-C-N 121.142 -0.974 . . . . 0.0 111.243 -179.816 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.503 ' HD3' ' HB2' ' A' ' 27' ' ' SER . 44.9 Cg_endo -71.52 -9.65 25.48 Favored 'Trans proline' 0 N--CA 1.49 1.322 0 O-C-N 123.429 1.226 . . . . 0.0 111.243 179.855 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -94.03 -9.09 37.92 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.333 -0.854 . . . . 0.0 110.662 179.595 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 33.8 mm -118.03 -37.12 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 O-C-N 121.176 -0.952 . . . . 0.0 110.48 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 13.4 t -63.52 -24.43 67.81 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 121.349 -0.844 . . . . 0.0 111.252 -179.901 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 24.9 mmtt -99.12 -2.82 36.03 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.236 -0.915 . . . . 0.0 111.125 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 34.6 m-85 -107.94 0.29 21.86 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.313 -0.867 . . . . 0.0 111.16 -179.782 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 47.1 t . . . . . 0 N--CA 1.496 1.845 0 O-C-N 121.14 -0.975 . . . . 0.0 109.938 -179.979 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.432 0 N-CA-C 108.417 -1.873 . . . . 0.0 108.417 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -77.17 -34.87 56.32 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.549 -0.971 . . . . 0.0 109.754 178.924 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 5.6 tp -62.98 -44.63 95.52 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.443 -0.785 . . . . 0.0 109.969 179.49 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -64.05 -39.24 93.64 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.575 -0.703 . . . . 0.0 109.996 179.472 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.4 tp -68.42 -34.96 76.94 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.47 -0.769 . . . . 0.0 110.366 179.659 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . 0.491 ' CD2' HG21 ' A' ' 18' ' ' VAL . 12.5 t-80 -59.77 -61.82 2.33 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.316 -0.865 . . . . 0.0 109.575 179.504 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.45 ' O ' ' HB2' ' A' ' 19' ' ' ASP . 2.8 tp60 -59.2 -26.44 64.84 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.388 -0.82 . . . . 0.0 110.639 179.492 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.613 ' O ' HG23 ' A' ' 20' ' ' VAL . 1.6 t30 -78.02 -42.63 31.9 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.3 -0.875 . . . . 0.0 110.722 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.406 ' O ' ' HB ' ' A' ' 20' ' ' VAL . 83.7 mt -82.69 -36.48 13.36 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.002 0 O-C-N 121.226 -0.921 . . . . 0.0 110.647 -179.646 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.491 HG21 ' CD2' ' A' ' 14' ' ' HIS . 48.1 t -64.67 -34.69 71.6 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 O-C-N 121.203 -0.936 . . . . 0.0 110.493 -179.864 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.45 ' HB2' ' O ' ' A' ' 15' ' ' GLN . 0.1 OUTLIER -85.81 18.38 2.95 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.319 -0.863 . . . . 0.0 111.04 179.674 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.613 HG23 ' O ' ' A' ' 16' ' ' ASN . 13.1 t . . . . . 0 N--CA 1.494 1.769 0 O-C-N 121.109 -0.995 . . . . 0.0 110.251 179.705 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 8.7 mt . . . . . 0 N--CA 1.503 2.219 0 CA-C-O 121.191 0.52 . . . . 0.0 110.773 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.604 ' HB2' ' HD3' ' A' ' 28' ' ' PRO . 2.2 m -61.82 -51.73 73.71 Favored Pre-proline 0 N--CA 1.497 1.88 0 O-C-N 121.296 -0.878 . . . . 0.0 110.926 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.604 ' HD3' ' HB2' ' A' ' 27' ' ' SER . 43.4 Cg_endo -69.56 -28.5 26.14 Favored 'Trans proline' 0 N--CA 1.49 1.27 0 O-C-N 123.299 1.157 . . . . 0.0 110.924 179.851 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.43 -36.77 83.45 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.591 -0.693 . . . . 0.0 110.432 179.65 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 35.5 mt -92.27 -36.28 7.6 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 O-C-N 121.327 -0.858 . . . . 0.0 110.219 179.787 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 92.0 m -68.45 -39.79 81.35 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.562 -0.711 . . . . 0.0 110.462 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 4.1 tttt -86.21 19.87 2.54 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.26 -0.9 . . . . 0.0 110.84 179.611 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -116.31 -18.22 10.55 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.207 -0.933 . . . . 0.0 110.856 179.786 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 26.5 t . . . . . 0 N--CA 1.496 1.845 0 O-C-N 121.124 -0.985 . . . . 0.0 110.002 -179.843 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.372 0 N-CA-C 109.013 -1.635 . . . . 0.0 109.013 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.1 mp -64.08 -33.3 75.44 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.691 -0.887 . . . . 0.0 110.304 179.35 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 4.8 tp -65.49 -47.23 76.78 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.351 -0.843 . . . . 0.0 109.994 179.596 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -70.2 -43.74 70.1 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.379 -0.826 . . . . 0.0 110.453 179.789 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -61.69 -44.18 97.44 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.401 -0.812 . . . . 0.0 109.931 179.699 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . 0.481 ' CE1' HG21 ' A' ' 18' ' ' VAL . 69.9 t60 -65.14 -51.48 60.98 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.506 -0.746 . . . . 0.0 109.705 179.317 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.431 ' HA ' ' HB ' ' A' ' 18' ' ' VAL . 0.8 OUTLIER -56.87 -36.45 70.08 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.428 -0.795 . . . . 0.0 110.224 179.457 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 5.6 t30 -56.53 -41.9 77.54 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.339 -0.85 . . . . 0.0 109.993 179.2 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.434 ' O ' HG12 ' A' ' 20' ' ' VAL . 7.3 mt -86.28 -20.42 7.89 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 O-C-N 121.485 -0.759 . . . . 0.0 110.404 179.462 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.481 HG21 ' CE1' ' A' ' 14' ' ' HIS . 78.3 t -87.48 -12.92 10.55 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 O-C-N 121.27 -0.894 . . . . 0.0 110.331 179.631 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -118.14 24.15 11.16 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.385 -0.822 . . . . 0.0 110.137 179.257 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.434 HG12 ' O ' ' A' ' 17' ' ' ILE . 10.9 p . . . . . 0 N--CA 1.5 2.045 0 O-C-N 121.296 -0.877 . . . . 0.0 110.427 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.498 1.935 0 CA-C-O 121.36 0.6 . . . . 0.0 110.118 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.533 ' HB2' ' HD3' ' A' ' 28' ' ' PRO . 2.3 m -68.08 -52.84 21.68 Favored Pre-proline 0 N--CA 1.498 1.933 0 O-C-N 121.498 -0.751 . . . . 0.0 110.972 -179.846 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.533 ' HD3' ' HB2' ' A' ' 27' ' ' SER . 49.3 Cg_endo -76.74 60.1 6.55 Favored 'Trans proline' 0 N--CA 1.487 1.131 0 O-C-N 123.462 1.243 . . . . 0.0 110.493 179.815 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -157.93 -57.32 0.08 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.399 -0.813 . . . . 0.0 110.102 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 82.1 mt -69.33 -22.8 25.99 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 O-C-N 121.437 -0.789 . . . . 0.0 110.418 179.64 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 24.5 p -61.7 -41.7 97.94 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.416 -0.803 . . . . 0.0 110.249 179.436 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.27 -24.26 64.86 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.521 -0.737 . . . . 0.0 110.418 179.611 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -80.96 -29.36 35.36 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.412 -0.805 . . . . 0.0 110.182 179.512 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 88.2 t . . . . . 0 N--CA 1.497 1.876 0 O-C-N 121.453 -0.779 . . . . 0.0 110.519 -179.708 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.477 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 6.3 mt -74.88 -39.31 61.59 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.596 -0.944 . . . . 0.0 110.562 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 14.2 tp -58.14 -49.46 76.9 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.436 -0.79 . . . . 0.0 110.213 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 27.2 m-70 -63.21 -39.19 93.93 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.572 -0.705 . . . . 0.0 109.703 179.247 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 7.2 tp -63.17 -40.13 96.64 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.487 -0.758 . . . . 0.0 109.789 179.082 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . 0.519 ' NE2' HG21 ' A' ' 18' ' ' VAL . 68.2 t60 -58.75 -54.06 51.39 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.575 -0.703 . . . . 0.0 109.71 179.391 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.447 ' O ' ' HB2' ' A' ' 19' ' ' ASP . 23.3 tp60 -53.34 -38.64 63.43 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.643 -0.661 . . . . 0.0 110.015 179.45 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -66.81 -37.46 84.57 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.572 -0.705 . . . . 0.0 110.606 179.392 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.409 ' O ' HG12 ' A' ' 20' ' ' VAL . 93.1 mt -82.04 -16.42 11.89 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.073 0 O-C-N 121.35 -0.844 . . . . 0.0 110.588 179.833 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.519 HG21 ' NE2' ' A' ' 14' ' ' HIS . 84.6 t -94.67 -53.04 8.8 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 121.165 -0.959 . . . . 0.0 109.489 179.64 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.447 ' HB2' ' O ' ' A' ' 15' ' ' GLN . 0.7 OUTLIER -59.12 -17.42 26.53 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.737 -0.602 . . . . 0.0 111.316 179.543 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.409 HG12 ' O ' ' A' ' 17' ' ' ILE . 14.9 p . . . . . 0 N--CA 1.499 2.006 0 O-C-N 120.846 -1.159 . . . . 0.0 111.578 -179.842 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 5.0 mp . . . . . 0 N--CA 1.502 2.157 0 CA-C-O 120.953 0.406 . . . . 0.0 111.311 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.487 ' N ' ' HD2' ' A' ' 28' ' ' PRO . 0.7 OUTLIER -61.47 -54.32 53.53 Favored Pre-proline 0 N--CA 1.501 2.114 0 O-C-N 121.244 -0.91 . . . . 0.0 110.694 179.815 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.487 ' HD2' ' N ' ' A' ' 27' ' ' SER . 44.2 Cg_endo -71.39 -27.29 19.48 Favored 'Trans proline' 0 N--CA 1.487 1.126 0 O-C-N 123.481 1.253 . . . . 0.0 110.647 179.553 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.8 -36.24 78.52 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.585 -0.697 . . . . 0.0 110.181 179.497 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -84.15 -30.76 7.53 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 121.354 -0.841 . . . . 0.0 109.938 179.4 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 53.9 m -71.01 -43.73 67.32 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.545 -0.722 . . . . 0.0 109.722 179.349 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 17.5 tttt -88.41 43.4 1.13 Allowed 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.516 -0.74 . . . . 0.0 109.957 179.348 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 21.5 t80 -151.93 -53.45 0.12 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.571 -0.706 . . . . 0.0 109.423 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 53.5 t . . . . . 0 N--CA 1.494 1.732 0 O-C-N 121.631 -0.668 . . . . 0.0 109.697 179.19 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.458 0 N-CA-C 109.261 -1.536 . . . . 0.0 109.261 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.4 mt -61.74 -35.77 79.03 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.755 -0.85 . . . . 0.0 110.492 179.867 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.8 tt -58.17 -47.75 82.42 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.438 -0.789 . . . . 0.0 109.935 179.645 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 24.1 m-70 -75.52 -42.06 53.61 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.6 -0.688 . . . . 0.0 109.87 179.456 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 11.4 tp -58.83 -42.66 89.75 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.464 -0.773 . . . . 0.0 110.403 179.701 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . 0.53 ' NE2' HG21 ' A' ' 18' ' ' VAL . 6.1 t-80 -59.43 -51.84 68.18 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.563 -0.711 . . . . 0.0 109.933 179.591 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 34.3 tp60 -58.04 -36.53 72.87 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.622 -0.674 . . . . 0.0 110.392 179.731 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -66.42 -41.13 89.7 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.507 -0.745 . . . . 0.0 110.826 179.931 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 73.5 mt -76.15 -43.37 37.76 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 O-C-N 121.262 -0.899 . . . . 0.0 110.505 -179.55 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.53 HG21 ' NE2' ' A' ' 14' ' ' HIS . 38.0 t -67.72 -36.38 75.8 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 O-C-N 121.416 -0.803 . . . . 0.0 110.661 -179.873 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -66.99 -18.53 65.43 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.428 -0.795 . . . . 0.0 110.666 179.508 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 80.6 t . . . . . 0 N--CA 1.494 1.765 0 O-C-N 121.026 -1.046 . . . . 0.0 109.323 179.096 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.0 tp . . . . . 0 N--CA 1.496 1.869 0 CA-C-O 120.931 0.396 . . . . 0.0 110.383 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.561 ' HB2' ' HD3' ' A' ' 28' ' ' PRO . 43.4 m -56.91 -51.36 82.12 Favored Pre-proline 0 N--CA 1.498 1.965 0 O-C-N 121.644 -0.66 . . . . 0.0 110.822 179.72 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.561 ' HD3' ' HB2' ' A' ' 27' ' ' SER . 43.6 Cg_endo -69.74 -23.36 30.97 Favored 'Trans proline' 0 N--CA 1.489 1.237 0 O-C-N 123.408 1.215 . . . . 0.0 111.033 179.41 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -80.47 -42.81 21.92 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.452 -0.78 . . . . 0.0 110.581 179.821 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.406 HG22 ' O ' ' A' ' 27' ' ' SER . 11.9 tt -71.85 -29.13 32.46 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 O-C-N 121.324 -0.86 . . . . 0.0 111.083 -179.614 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 2.9 p -65.97 -37.03 84.93 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.317 -0.864 . . . . 0.0 109.909 179.547 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 9.6 tptp -87.0 -25.64 24.16 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.416 -0.803 . . . . 0.0 109.796 178.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 71.1 t80 -68.16 -41.1 82.05 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.464 -0.773 . . . . 0.0 110.456 179.656 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.9 p . . . . . 0 N--CA 1.499 1.982 0 O-C-N 121.335 -0.853 . . . . 0.0 110.405 179.693 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 2.617 0 N-CA-C 109.851 -1.3 . . . . 0.0 109.851 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.1 mp -58.73 -39.7 81.6 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.654 -0.909 . . . . 0.0 110.383 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -58.25 -48.37 80.63 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.526 -0.734 . . . . 0.0 109.829 179.392 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -66.76 -43.19 84.72 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.652 -0.655 . . . . 0.0 109.681 179.24 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.0 tt -58.07 -41.0 82.45 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.661 -0.649 . . . . 0.0 110.028 179.38 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . 0.433 ' CE1' HG21 ' A' ' 18' ' ' VAL . 82.9 t60 -59.31 -46.0 89.78 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.529 -0.732 . . . . 0.0 109.808 179.368 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.435 ' O ' ' HB2' ' A' ' 19' ' ' ASP . 0.4 OUTLIER -65.91 -34.27 77.73 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.501 -0.749 . . . . 0.0 109.662 179.193 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -64.94 -14.99 61.58 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.372 -0.83 . . . . 0.0 110.596 179.15 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 38.5 mm -107.81 -38.51 4.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.356 -0.84 . . . . 0.0 109.66 179.652 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.433 HG21 ' CE1' ' A' ' 14' ' ' HIS . 71.4 t -83.89 -42.6 17.37 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 O-C-N 121.495 -0.753 . . . . 0.0 110.743 -179.714 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.435 ' HB2' ' O ' ' A' ' 15' ' ' GLN . 0.2 OUTLIER -77.23 -2.8 36.48 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.551 -0.718 . . . . 0.0 111.452 -179.663 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 63.2 t . . . . . 0 N--CA 1.495 1.788 0 O-C-N 120.833 -1.167 . . . . 0.0 110.263 179.458 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.3 mp . . . . . 0 N--CA 1.498 1.971 0 CA-C-O 120.689 0.281 . . . . 0.0 111.213 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.534 ' HB2' ' HD3' ' A' ' 28' ' ' PRO . 26.5 m -61.61 -51.04 79.57 Favored Pre-proline 0 N--CA 1.499 1.999 0 O-C-N 121.223 -0.923 . . . . 0.0 111.105 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.534 ' HD3' ' HB2' ' A' ' 27' ' ' SER . 45.1 Cg_endo -70.72 -17.77 32.96 Favored 'Trans proline' 0 N--CA 1.49 1.269 0 O-C-N 123.417 1.22 . . . . 0.0 111.224 179.823 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -80.32 -41.38 24.94 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.265 -0.897 . . . . 0.0 110.501 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 32.3 mm -69.64 -43.23 80.43 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 O-C-N 121.345 -0.847 . . . . 0.0 110.718 -179.852 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.542 ' HA ' HG12 ' A' ' 34' ' ' VAL . 12.1 t -63.25 -31.78 73.02 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.475 -0.766 . . . . 0.0 110.626 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 45.0 tttt -73.49 -29.11 62.29 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.284 -0.885 . . . . 0.0 109.937 179.201 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 24.4 t80 -83.02 -45.05 14.53 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.566 -0.709 . . . . 0.0 109.701 179.282 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.542 HG12 ' HA ' ' A' ' 31' ' ' THR . 3.4 p . . . . . 0 N--CA 1.497 1.88 0 O-C-N 121.547 -0.721 . . . . 0.0 110.115 179.731 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 2.696 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -65.94 -40.46 91.37 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.533 -0.981 . . . . 0.0 109.92 179.559 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.9 tt -61.01 -44.99 96.61 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.579 -0.7 . . . . 0.0 109.776 179.347 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -68.32 -44.47 75.31 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.578 -0.701 . . . . 0.0 109.763 179.409 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -63.35 -37.36 86.95 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.544 -0.722 . . . . 0.0 110.049 179.434 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . 0.465 ' CD2' HG21 ' A' ' 18' ' ' VAL . 14.1 t-80 -57.07 -58.08 9.75 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.576 -0.702 . . . . 0.0 109.645 179.538 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.424 ' O ' ' HB2' ' A' ' 19' ' ' ASP . 0.1 OUTLIER -59.78 -38.95 83.3 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.353 -0.842 . . . . 0.0 110.031 179.19 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -59.22 -43.84 92.3 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.399 -0.813 . . . . 0.0 110.603 179.674 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 22.2 mm -81.87 -36.06 13.95 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 O-C-N 121.232 -0.917 . . . . 0.0 110.47 179.867 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.465 HG21 ' CD2' ' A' ' 14' ' ' HIS . 69.7 t -75.71 -8.6 11.85 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 O-C-N 121.493 -0.754 . . . . 0.0 111.663 -179.469 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.424 ' HB2' ' O ' ' A' ' 15' ' ' GLN . 0.4 OUTLIER -119.56 27.93 8.47 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 120.942 -1.099 . . . . 0.0 110.93 179.781 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 42.4 t . . . . . 0 N--CA 1.499 2.001 0 O-C-N 121.097 -1.002 . . . . 0.0 109.983 179.579 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.422 ' HA ' HD12 ' A' ' 30' ' ' ILE . 1.2 mt . . . . . 0 N--CA 1.497 1.894 0 CA-C-O 121.042 0.449 . . . . 0.0 110.425 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.45 ' CB ' ' CD ' ' A' ' 28' ' ' PRO . 0.0 OUTLIER -164.18 -61.49 0.01 OUTLIER Pre-proline 0 N--CA 1.498 1.934 0 O-C-N 121.416 -0.803 . . . . 0.0 110.144 179.828 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.45 ' CD ' ' CB ' ' A' ' 27' ' ' SER . 46.0 Cg_endo -71.85 -17.02 29.35 Favored 'Trans proline' 0 N--CA 1.489 1.252 0 O-C-N 123.08 1.042 . . . . 0.0 110.944 179.284 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -100.46 -12.09 19.63 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.4 -0.813 . . . . 0.0 111.002 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.422 HD12 ' HA ' ' A' ' 26' ' ' LEU . 73.6 mt -118.82 -49.08 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.177 -0.952 . . . . 0.0 110.231 -179.768 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 2.4 m -69.98 -31.15 68.71 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.595 -0.69 . . . . 0.0 110.504 -179.854 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.436 ' HG3' ' HA ' ' A' ' 28' ' ' PRO . 12.8 mmtp -87.83 6.2 36.5 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.259 -0.9 . . . . 0.0 110.797 179.635 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -103.33 -41.25 6.09 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.286 -0.884 . . . . 0.0 110.066 179.752 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 16.6 t . . . . . 0 N--CA 1.496 1.864 0 O-C-N 121.446 -0.784 . . . . 0.0 109.451 179.469 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 2.606 0 N-CA-C 109.32 -1.512 . . . . 0.0 109.32 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.456 HD22 ' HA ' ' A' ' 10' ' ' LEU . 0.2 OUTLIER -61.06 -41.56 96.84 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.504 -0.997 . . . . 0.0 110.038 179.485 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.471 HD22 ' HA ' ' A' ' 11' ' ' LEU . 0.2 OUTLIER -59.26 -42.01 90.17 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.563 -0.711 . . . . 0.0 109.796 179.371 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 6.5 t-80 -65.27 -37.46 87.25 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.594 -0.691 . . . . 0.0 109.833 179.242 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.466 HD22 ' HA ' ' A' ' 13' ' ' LEU . 0.2 OUTLIER -61.77 -42.53 99.11 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.465 -0.772 . . . . 0.0 109.399 179.006 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . 0.443 ' NE2' HG21 ' A' ' 18' ' ' VAL . 4.7 t-80 -67.08 -48.07 69.33 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.642 -0.661 . . . . 0.0 109.403 178.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 30.5 mm100 -60.17 -34.49 73.66 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.558 -0.714 . . . . 0.0 109.988 179.385 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.49 ' O ' HG23 ' A' ' 20' ' ' VAL . 10.1 t30 -61.98 -50.35 72.43 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.429 -0.794 . . . . 0.0 110.137 179.421 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 49.7 mt -71.13 -19.47 21.07 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 O-C-N 121.262 -0.899 . . . . 0.0 110.793 179.783 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.443 HG21 ' NE2' ' A' ' 14' ' ' HIS . 47.0 t -97.24 -8.79 9.16 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 O-C-N 121.258 -0.901 . . . . 0.0 111.232 -179.592 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -123.03 27.84 7.47 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.06 -1.025 . . . . 0.0 110.886 179.592 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.49 HG23 ' O ' ' A' ' 16' ' ' ASN . 39.3 t . . . . . 0 N--CA 1.497 1.906 0 O-C-N 121.14 -0.975 . . . . 0.0 109.381 179.254 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.501 2.115 0 CA-C-O 121.117 0.484 . . . . 0.0 110.609 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.513 ' CB ' ' CD ' ' A' ' 28' ' ' PRO . 0.4 OUTLIER -169.77 -63.04 0.01 OUTLIER Pre-proline 0 N--CA 1.498 1.944 0 O-C-N 121.54 -0.725 . . . . 0.0 110.186 179.69 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.513 ' CD ' ' CB ' ' A' ' 27' ' ' SER . 43.3 Cg_endo -69.48 -27.33 27.93 Favored 'Trans proline' 0 N--CA 1.49 1.265 0 O-C-N 123.393 1.207 . . . . 0.0 110.76 179.664 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.76 -37.22 83.47 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.579 -0.7 . . . . 0.0 110.289 179.51 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 58.9 mt -79.25 -39.42 21.06 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 121.466 -0.771 . . . . 0.0 109.873 179.52 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 99.8 m -65.0 -45.02 87.33 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.58 -0.7 . . . . 0.0 109.965 179.524 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -67.03 -20.99 65.94 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.485 -0.759 . . . . 0.0 110.785 179.651 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -72.65 -24.09 61.0 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.361 -0.837 . . . . 0.0 110.543 179.615 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 55.6 t . . . . . 0 N--CA 1.495 1.806 0 O-C-N 121.266 -0.896 . . . . 0.0 110.275 -179.965 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.492 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.36 -39.17 89.64 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.636 -0.92 . . . . 0.0 110.284 179.725 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.8 tt -59.03 -48.36 81.86 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.446 -0.784 . . . . 0.0 109.783 179.433 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 21.7 m170 -69.16 -44.3 72.56 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.679 -0.638 . . . . 0.0 109.672 179.213 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.7 mt -56.88 -41.87 78.8 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.605 -0.685 . . . . 0.0 110.06 179.489 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . 0.602 ' O ' HG23 ' A' ' 18' ' ' VAL . 5.7 t-80 -63.17 -46.86 85.17 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.652 -0.655 . . . . 0.0 109.812 179.321 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 25.2 tp60 -54.1 -41.88 68.75 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.645 -0.659 . . . . 0.0 110.698 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.48 ' O ' HG23 ' A' ' 20' ' ' VAL . 7.5 t-20 -66.95 -47.82 70.45 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.395 -0.815 . . . . 0.0 110.384 179.781 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 74.4 mt -57.94 -38.6 67.38 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.111 0 O-C-N 121.422 -0.799 . . . . 0.0 109.91 179.83 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.602 HG23 ' O ' ' A' ' 14' ' ' HIS . 47.5 t -72.22 -35.88 54.17 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.528 -0.732 . . . . 0.0 109.706 179.302 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -68.8 -15.52 63.53 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.734 -0.604 . . . . 0.0 110.966 179.516 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.48 HG23 ' O ' ' A' ' 16' ' ' ASN . 47.7 t . . . . . 0 N--CA 1.493 1.722 0 O-C-N 121.135 -0.978 . . . . 0.0 109.481 179.322 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 23.8 mt . . . . . 0 N--CA 1.498 1.952 0 CA-C-O 120.618 0.246 . . . . 0.0 111.371 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.523 ' HB2' ' HD3' ' A' ' 28' ' ' PRO . 3.0 m -69.82 -59.44 4.53 Favored Pre-proline 0 N--CA 1.498 1.933 0 O-C-N 121.015 -1.053 . . . . 0.0 110.416 179.86 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.523 ' HD3' ' HB2' ' A' ' 27' ' ' SER . 45.8 Cg_endo -71.52 -25.73 20.82 Favored 'Trans proline' 0 N--CA 1.488 1.165 0 O-C-N 123.395 1.208 . . . . 0.0 110.62 179.402 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.29 -35.64 81.49 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.584 -0.697 . . . . 0.0 110.597 179.734 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 26.1 mm -79.54 -38.41 19.54 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 O-C-N 121.323 -0.861 . . . . 0.0 110.165 179.809 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 24.4 m -62.19 -38.65 89.94 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.432 -0.793 . . . . 0.0 109.958 179.623 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.7 tmtt? -69.92 -35.7 74.78 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.291 -0.88 . . . . 0.0 110.206 179.482 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 80.6 t80 -76.61 -41.1 47.26 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.587 -0.696 . . . . 0.0 110.118 179.671 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 47.1 t . . . . . 0 N--CA 1.495 1.796 0 O-C-N 121.458 -0.776 . . . . 0.0 109.837 179.871 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.515 0 N-CA-C 109.034 -1.626 . . . . 0.0 109.034 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 10.5 tp -87.81 -39.0 15.24 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.568 -0.96 . . . . 0.0 109.89 179.386 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.2 tt -59.63 -48.81 80.21 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.52 -0.737 . . . . 0.0 110.277 179.779 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 7.4 t-80 -61.57 -40.66 95.54 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.514 -0.741 . . . . 0.0 110.306 179.884 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 5.2 tp -56.5 -43.03 79.3 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.422 -0.799 . . . . 0.0 109.614 179.247 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . 0.519 ' NE2' HG21 ' A' ' 18' ' ' VAL . 76.4 t60 -66.77 -45.87 77.11 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.677 -0.639 . . . . 0.0 109.289 178.935 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 3.7 mm-40 -62.24 -35.84 80.17 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.548 -0.72 . . . . 0.0 110.081 179.247 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -60.5 -38.35 84.06 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.519 -0.738 . . . . 0.0 110.421 179.617 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.555 ' O ' HG12 ' A' ' 20' ' ' VAL . 28.9 mt -86.16 -36.88 11.09 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 O-C-N 121.347 -0.846 . . . . 0.0 110.221 179.958 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.519 HG21 ' NE2' ' A' ' 14' ' ' HIS . 55.1 t -70.77 -34.11 55.19 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 O-C-N 121.324 -0.86 . . . . 0.0 110.512 179.888 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -89.37 14.39 11.3 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.379 -0.826 . . . . 0.0 111.352 -179.914 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.555 HG12 ' O ' ' A' ' 17' ' ' ILE . 0.8 OUTLIER . . . . . 0 N--CA 1.496 1.857 0 O-C-N 120.916 -1.115 . . . . 0.0 110.773 179.256 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.484 HD13 ' HA ' ' A' ' 26' ' ' LEU . 3.7 mm? . . . . . 0 N--CA 1.498 1.973 0 CA-C-O 121.051 0.453 . . . . 0.0 110.48 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.677 ' HB3' ' HD3' ' A' ' 28' ' ' PRO . 8.0 t -65.02 -52.95 45.41 Favored Pre-proline 0 N--CA 1.497 1.884 0 O-C-N 121.25 -0.906 . . . . 0.0 110.429 179.731 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.677 ' HD3' ' HB3' ' A' ' 27' ' ' SER . 53.2 Cg_endo -81.19 51.71 4.03 Favored 'Trans proline' 0 N--CA 1.484 0.954 0 O-C-N 123.191 1.101 . . . . 0.0 110.508 179.26 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -152.06 -59.36 0.15 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.306 -0.871 . . . . 0.0 109.767 179.855 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 15.8 mt -68.05 -35.53 72.05 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 O-C-N 121.553 -0.717 . . . . 0.0 109.793 179.432 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 1.8 m -70.58 -45.62 65.01 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.672 -0.643 . . . . 0.0 109.715 179.468 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 3.4 mttm -60.37 -32.14 71.0 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.65 -0.656 . . . . 0.0 110.404 179.638 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 88.9 t80 -72.97 -36.61 67.15 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.638 -0.663 . . . . 0.0 110.333 179.615 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 75.8 t . . . . . 0 N--CA 1.499 2.008 0 O-C-N 121.422 -0.798 . . . . 0.0 110.842 -179.885 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 2.638 0 N-CA-C 110.211 -1.155 . . . . 0.0 110.211 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.431 HD13 ' HA ' ' A' ' 10' ' ' LEU . 3.5 mm? -64.37 -45.38 87.99 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.438 -1.036 . . . . 0.0 110.409 -179.958 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 13.9 tp -61.41 -44.83 96.46 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.518 -0.739 . . . . 0.0 110.085 179.668 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -64.03 -38.5 91.29 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.547 -0.721 . . . . 0.0 109.794 179.361 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 12.1 tp -60.14 -41.4 92.64 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.46 -0.775 . . . . 0.0 109.771 179.122 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 6.7 t-160 -62.5 -50.77 70.08 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.589 -0.694 . . . . 0.0 109.656 179.288 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 22.5 tp60 -57.72 -36.29 71.82 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.56 -0.713 . . . . 0.0 110.291 179.549 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.629 ' O ' HG23 ' A' ' 20' ' ' VAL . 0.7 OUTLIER -64.38 -35.86 82.28 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.446 -0.784 . . . . 0.0 110.796 179.696 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 34.3 mt -88.0 -32.37 6.07 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 121.236 -0.915 . . . . 0.0 110.675 -179.639 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -71.37 -42.8 73.78 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 121.284 -0.885 . . . . 0.0 110.224 -179.95 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -63.33 -24.45 67.86 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.427 -0.796 . . . . 0.0 110.814 179.585 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.629 HG23 ' O ' ' A' ' 16' ' ' ASN . 44.5 t . . . . . 0 N--CA 1.498 1.943 0 O-C-N 121.444 -0.785 . . . . 0.0 110.59 179.705 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.904 ' HG ' ' HB3' ' A' ' 29' ' ' ALA . 0.5 OUTLIER . . . . . 0 N--CA 1.497 1.906 0 CA-C-O 120.729 0.3 . . . . 0.0 111.369 . . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.543 ' HB3' ' HD3' ' A' ' 28' ' ' PRO . 12.8 t -62.75 -49.5 82.21 Favored Pre-proline 0 N--CA 1.501 2.116 0 O-C-N 121.119 -0.988 . . . . 0.0 111.185 179.738 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.543 ' HD3' ' HB3' ' A' ' 27' ' ' SER . 47.0 Cg_endo -72.76 -9.63 24.04 Favored 'Trans proline' 0 N--CA 1.489 1.246 0 O-C-N 123.314 1.165 . . . . 0.0 111.468 -179.858 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.904 ' HB3' ' HG ' ' A' ' 26' ' ' LEU . . . -99.72 -48.22 4.79 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.278 -0.889 . . . . 0.0 110.372 179.899 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.634 ' HB ' HD23 ' A' ' 26' ' ' LEU . 16.8 tt -62.08 -25.42 37.39 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 O-C-N 121.434 -0.791 . . . . 0.0 111.297 -179.789 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 6.1 t -68.46 -28.47 67.07 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.269 -0.894 . . . . 0.0 110.507 179.831 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -111.15 20.82 17.02 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.388 -0.82 . . . . 0.0 110.237 179.293 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -121.7 -45.75 2.27 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.335 -0.853 . . . . 0.0 110.447 -179.925 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 93.6 t . . . . . 0 N--CA 1.499 1.994 0 O-C-N 121.351 -0.843 . . . . 0.0 110.124 179.837 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.448 0 N-CA-C 108.771 -1.732 . . . . 0.0 108.771 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.1 mp -64.14 -41.21 97.28 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.697 -0.884 . . . . 0.0 109.958 179.335 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.8 tt -58.2 -46.54 85.65 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.622 -0.674 . . . . 0.0 110.02 179.514 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 50.7 t60 -62.61 -39.59 94.26 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.683 -0.636 . . . . 0.0 109.755 179.312 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 6.8 tp -61.93 -39.74 93.09 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.557 -0.715 . . . . 0.0 110.251 179.501 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . 0.546 ' NE2' HG21 ' A' ' 18' ' ' VAL . 5.8 t-80 -60.94 -53.05 62.08 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.571 -0.706 . . . . 0.0 109.865 179.633 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -56.8 -36.92 70.46 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.571 -0.706 . . . . 0.0 110.226 179.688 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.437 ' O ' ' HB ' ' A' ' 20' ' ' VAL . 0.7 OUTLIER -64.63 -47.8 77.2 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.378 -0.826 . . . . 0.0 110.194 179.429 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.477 ' O ' HG12 ' A' ' 20' ' ' VAL . 68.6 mt -68.85 -36.78 75.76 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.042 0 O-C-N 121.447 -0.783 . . . . 0.0 110.494 179.909 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.546 HG21 ' NE2' ' A' ' 14' ' ' HIS . 21.0 t -75.47 -19.9 15.95 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 121.268 -0.895 . . . . 0.0 110.383 179.906 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -107.85 20.94 18.13 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.355 -0.84 . . . . 0.0 111.018 179.51 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.477 HG12 ' O ' ' A' ' 17' ' ' ILE . 3.7 p . . . . . 0 N--CA 1.497 1.917 0 O-C-N 120.812 -1.18 . . . . 0.0 111.065 179.448 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.912 ' HB3' ' HB3' ' A' ' 29' ' ' ALA . 1.4 mp . . . . . 0 N--CA 1.494 1.749 0 CA-C-O 121.332 0.587 . . . . 0.0 109.697 . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.485 ' N ' ' HD2' ' A' ' 28' ' ' PRO . 0.1 OUTLIER -58.12 -52.46 74.37 Favored Pre-proline 0 N--CA 1.5 2.056 0 O-C-N 121.575 -0.703 . . . . 0.0 111.497 -179.56 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.485 ' HD2' ' N ' ' A' ' 27' ' ' SER . 44.9 Cg_endo -71.15 -12.45 30.22 Favored 'Trans proline' 0 N--CA 1.492 1.42 0 O-C-N 123.46 1.242 . . . . 0.0 111.761 -179.669 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.912 ' HB3' ' HB3' ' A' ' 26' ' ' LEU . . . -98.36 -40.41 8.32 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.265 -0.897 . . . . 0.0 110.299 179.769 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 5.9 tp -71.18 -24.34 24.1 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 O-C-N 121.414 -0.804 . . . . 0.0 110.798 179.878 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 1.9 p -64.64 -42.22 95.61 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.46 -0.775 . . . . 0.0 110.1 179.621 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 2.3 tptm -93.27 26.61 2.84 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.544 -0.722 . . . . 0.0 110.119 179.273 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 10.8 t80 -124.46 -47.81 1.84 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.485 -0.759 . . . . 0.0 110.245 -179.913 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 93.8 t . . . . . 0 N--CA 1.495 1.821 0 O-C-N 121.458 -0.776 . . . . 0.0 109.89 179.954 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.349 0 N-CA-C 108.649 -1.78 . . . . 0.0 108.649 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 11.2 tp -80.77 -32.22 35.58 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.619 -0.93 . . . . 0.0 110.072 179.28 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.4 tt -60.88 -51.35 69.65 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.521 -0.737 . . . . 0.0 110.203 179.739 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 43.9 t60 -64.62 -37.61 88.17 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.56 -0.713 . . . . 0.0 110.307 179.646 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 6.7 tt -54.87 -39.02 68.23 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.493 -0.754 . . . . 0.0 110.269 179.65 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . 0.46 ' CE1' HG21 ' A' ' 18' ' ' VAL . 64.7 t60 -78.26 -51.29 10.37 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.427 -0.796 . . . . 0.0 109.847 179.474 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.407 ' O ' ' HB2' ' A' ' 19' ' ' ASP . 0.8 OUTLIER -58.74 -47.01 86.11 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.623 -0.673 . . . . 0.0 110.484 -179.93 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 4.3 t30 -54.29 -33.37 58.55 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.484 -0.76 . . . . 0.0 111.0 179.885 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 38.4 mm -86.14 -45.51 16.85 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 121.122 -0.987 . . . . 0.0 110.073 179.816 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.46 HG21 ' CE1' ' A' ' 14' ' ' HIS . 52.7 t -63.6 -38.03 81.18 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 O-C-N 121.462 -0.774 . . . . 0.0 110.59 179.933 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.407 ' HB2' ' O ' ' A' ' 15' ' ' GLN . 1.7 m-20 -71.45 -12.74 61.55 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.584 -0.698 . . . . 0.0 111.394 -179.885 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 97.2 t . . . . . 0 N--CA 1.495 1.786 0 O-C-N 120.816 -1.178 . . . . 0.0 110.282 179.461 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.471 ' HG ' ' HB3' ' A' ' 29' ' ' ALA . 0.1 OUTLIER . . . . . 0 N--CA 1.503 2.185 0 CA-C-O 121.065 0.46 . . . . 0.0 111.191 . . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.51 ' N ' ' HD2' ' A' ' 28' ' ' PRO . 0.0 OUTLIER -63.78 -51.79 62.53 Favored Pre-proline 0 N--CA 1.5 2.054 0 O-C-N 121.244 -0.91 . . . . 0.0 110.705 179.521 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.51 ' HD2' ' N ' ' A' ' 27' ' ' SER . 47.9 Cg_endo -73.46 -8.5 21.81 Favored 'Trans proline' 0 N--CA 1.489 1.261 0 O-C-N 123.434 1.228 . . . . 0.0 111.418 179.939 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.471 ' HB3' ' HG ' ' A' ' 26' ' ' LEU . . . -98.99 -45.68 5.87 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.232 -0.918 . . . . 0.0 110.196 179.842 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.521 HD13 ' O ' ' A' ' 30' ' ' ILE . 0.3 OUTLIER -61.73 -31.22 50.24 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 O-C-N 121.438 -0.789 . . . . 0.0 110.4 179.866 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 4.3 p -66.43 -30.01 70.27 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.497 -0.752 . . . . 0.0 110.222 179.276 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 11.1 ttpt -100.74 18.23 19.92 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.507 -0.746 . . . . 0.0 110.414 179.454 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -107.61 -35.02 6.83 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.363 -0.836 . . . . 0.0 109.975 179.687 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 46.0 t . . . . . 0 N--CA 1.495 1.787 0 O-C-N 121.522 -0.736 . . . . 0.0 109.572 179.694 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 2.721 0 N-CA-C 110.05 -1.22 . . . . 0.0 110.05 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -62.9 -31.46 72.53 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.569 -0.96 . . . . 0.0 110.473 179.711 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.7 mp -56.4 -39.41 72.98 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.454 -0.779 . . . . 0.0 110.15 179.537 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -85.14 -41.26 15.84 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.368 -0.832 . . . . 0.0 109.638 179.257 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 6.5 tt -56.34 -43.49 79.11 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.684 -0.635 . . . . 0.0 110.098 179.392 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . 0.46 ' CE1' HG21 ' A' ' 18' ' ' VAL . 66.2 t60 -64.68 -50.68 66.05 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.61 -0.681 . . . . 0.0 109.931 179.52 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -62.27 -36.36 81.82 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.465 -0.772 . . . . 0.0 110.025 179.484 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -57.11 -43.41 82.29 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.54 -0.725 . . . . 0.0 109.858 179.335 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 21.5 mm -80.82 -36.53 15.57 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 O-C-N 121.419 -0.801 . . . . 0.0 109.795 179.393 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.46 HG21 ' CE1' ' A' ' 14' ' ' HIS . 40.0 t -67.01 -21.53 28.39 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 O-C-N 121.444 -0.785 . . . . 0.0 110.977 179.983 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -106.0 10.34 32.28 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.215 -0.928 . . . . 0.0 111.159 179.787 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.497 1.896 0 O-C-N 120.847 -1.158 . . . . 0.0 110.505 179.306 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.406 ' O ' HD12 ' A' ' 30' ' ' ILE . 2.8 mp . . . . . 0 N--CA 1.502 2.131 0 CA-C-O 121.155 0.502 . . . . 0.0 110.798 . . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.45 ' CB ' ' HD3' ' A' ' 28' ' ' PRO . 0.4 OUTLIER -60.71 -52.58 71.58 Favored Pre-proline 0 N--CA 1.499 2.013 0 O-C-N 121.351 -0.843 . . . . 0.0 110.027 179.409 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.45 ' HD3' ' CB ' ' A' ' 27' ' ' SER . 52.4 Cg_endo -80.85 44.16 1.69 Allowed 'Trans proline' 0 N--CA 1.485 1.017 0 O-C-N 123.514 1.271 . . . . 0.0 110.512 178.868 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -135.28 -54.69 0.8 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.242 -0.911 . . . . 0.0 109.353 179.789 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.406 HD12 ' O ' ' A' ' 26' ' ' LEU . 2.2 mp -68.42 -42.74 84.19 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 O-C-N 121.558 -0.714 . . . . 0.0 109.339 178.907 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 14.3 t -67.18 -26.59 66.71 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.733 -0.605 . . . . 0.0 109.989 179.136 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 7.9 mmpt? -78.74 -32.58 46.78 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.336 -0.852 . . . . 0.0 109.885 179.209 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 87.2 t80 -66.31 -29.17 69.32 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.63 -0.668 . . . . 0.0 110.05 179.213 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 88.7 t . . . . . 0 N--CA 1.498 1.955 0 O-C-N 121.324 -0.86 . . . . 0.0 110.174 179.467 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.418 0 N-CA-C 108.657 -1.777 . . . . 0.0 108.657 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.4 pp -90.71 -25.38 20.06 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.589 -0.947 . . . . 0.0 110.036 178.96 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -67.86 -42.2 81.71 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.38 -0.825 . . . . 0.0 109.812 179.499 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 4.3 t-160 -63.4 -37.31 86.8 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.548 -0.72 . . . . 0.0 109.919 179.313 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.2 tt -57.27 -42.15 81.05 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.595 -0.69 . . . . 0.0 109.869 179.237 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . 0.548 ' NE2' HG21 ' A' ' 18' ' ' VAL . 4.8 t-80 -65.96 -53.71 35.55 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.613 -0.679 . . . . 0.0 109.459 179.063 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.407 ' O ' ' HB2' ' A' ' 19' ' ' ASP . 16.1 tp60 -58.72 -38.28 77.97 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.59 -0.694 . . . . 0.0 110.22 179.577 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 13.2 t30 -59.57 -42.1 91.71 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.61 -0.681 . . . . 0.0 110.595 179.764 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.526 ' O ' HG12 ' A' ' 20' ' ' VAL . 43.8 mt -79.52 -30.62 13.75 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 O-C-N 121.27 -0.894 . . . . 0.0 110.238 179.815 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.548 HG21 ' NE2' ' A' ' 14' ' ' HIS . 31.6 t -78.16 -27.02 14.55 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.227 -0.921 . . . . 0.0 110.203 179.628 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.407 ' HB2' ' O ' ' A' ' 15' ' ' GLN . 0.9 OUTLIER -91.39 17.4 8.53 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.397 -0.814 . . . . 0.0 110.954 179.572 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.526 HG12 ' O ' ' A' ' 17' ' ' ILE . 1.0 OUTLIER . . . . . 0 N--CA 1.494 1.76 0 O-C-N 120.967 -1.083 . . . . 0.0 110.441 179.294 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.498 1.961 0 CA-C-O 120.724 0.297 . . . . 0.0 111.296 . . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.541 ' N ' ' HD2' ' A' ' 28' ' ' PRO . 0.4 OUTLIER -56.74 -51.7 79.39 Favored Pre-proline 0 N--CA 1.499 2.002 0 O-C-N 121.268 -0.895 . . . . 0.0 110.515 179.374 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.541 ' HD2' ' N ' ' A' ' 27' ' ' SER . 42.7 Cg_endo -70.58 -28.57 21.16 Favored 'Trans proline' 0 N--CA 1.487 1.095 0 O-C-N 123.343 1.181 . . . . 0.0 110.115 179.31 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.407 ' O ' ' HB2' ' A' ' 33' ' ' TYR . . . -68.37 -38.55 81.49 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.591 -0.693 . . . . 0.0 110.107 179.345 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.439 HG22 ' O ' ' A' ' 27' ' ' SER . 6.0 tp -85.64 -29.05 6.27 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 121.446 -0.784 . . . . 0.0 110.605 179.646 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 77.7 m -75.13 -37.0 61.57 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.39 -0.819 . . . . 0.0 110.125 179.666 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 32.6 mtmt -89.82 22.26 3.2 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.36 -0.837 . . . . 0.0 110.57 179.495 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.407 ' HB2' ' O ' ' A' ' 29' ' ' ALA . 5.1 t80 -112.56 -48.27 3.02 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.265 -0.897 . . . . 0.0 109.868 179.751 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 94.8 t . . . . . 0 N--CA 1.494 1.732 0 O-C-N 121.563 -0.711 . . . . 0.0 109.744 179.724 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.435 0 N-CA-C 109.006 -1.638 . . . . 0.0 109.006 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -61.28 -41.0 96.21 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.715 -0.873 . . . . 0.0 110.114 179.464 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 4.5 tt -58.58 -47.17 85.18 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.482 -0.761 . . . . 0.0 109.879 179.466 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 14.1 m170 -66.01 -38.16 87.75 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.541 -0.724 . . . . 0.0 109.789 179.236 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -60.08 -40.36 89.29 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.538 -0.726 . . . . 0.0 109.86 179.313 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . 0.554 ' NE2' HG21 ' A' ' 18' ' ' VAL . 6.8 t-160 -62.94 -51.5 66.66 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.693 -0.629 . . . . 0.0 109.425 179.158 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 6.4 tp60 -61.84 -37.32 84.05 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.572 -0.705 . . . . 0.0 110.086 179.279 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -60.11 -35.39 75.13 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.654 -0.654 . . . . 0.0 110.621 179.662 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.538 ' O ' HG12 ' A' ' 20' ' ' VAL . 61.2 mt -88.23 -40.3 13.42 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 O-C-N 121.374 -0.829 . . . . 0.0 110.268 179.931 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.554 HG21 ' NE2' ' A' ' 14' ' ' HIS . 9.4 t -69.43 -33.54 57.89 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.875 0 O-C-N 121.378 -0.826 . . . . 0.0 110.61 -179.931 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -88.89 14.31 10.7 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.269 -0.894 . . . . 0.0 111.253 179.831 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.538 HG12 ' O ' ' A' ' 17' ' ' ILE . 0.5 OUTLIER . . . . . 0 N--CA 1.496 1.873 0 O-C-N 120.785 -1.197 . . . . 0.0 110.833 179.386 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.505 2.307 0 CA-C-O 121.017 0.436 . . . . 0.0 110.863 . . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.523 ' N ' ' HD2' ' A' ' 28' ' ' PRO . 0.6 OUTLIER -67.93 -50.18 33.67 Favored Pre-proline 0 N--CA 1.501 2.102 0 O-C-N 121.239 -0.913 . . . . 0.0 111.401 -179.907 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.523 ' HD2' ' N ' ' A' ' 27' ' ' SER . 44.1 Cg_endo -71.08 -20.71 28.37 Favored 'Trans proline' 0 N--CA 1.489 1.243 0 O-C-N 123.247 1.13 . . . . 0.0 111.115 -179.884 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -77.18 -43.82 32.42 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.405 -0.809 . . . . 0.0 110.564 179.915 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.428 HG22 ' O ' ' A' ' 27' ' ' SER . 4.9 tp -72.02 -28.63 30.38 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 O-C-N 121.277 -0.89 . . . . 0.0 111.009 -179.814 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 3.3 p -77.21 -35.49 55.6 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.322 -0.861 . . . . 0.0 110.119 179.637 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -86.87 12.04 11.95 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.36 -0.838 . . . . 0.0 110.744 179.406 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 89.6 t80 -112.87 -38.91 4.4 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.188 -0.945 . . . . 0.0 110.366 179.654 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 38.5 t . . . . . 0 N--CA 1.496 1.874 0 O-C-N 121.403 -0.811 . . . . 0.0 110.075 -179.873 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 2.632 0 N-CA-C 109.767 -1.333 . . . . 0.0 109.767 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.453 HD22 ' HA ' ' A' ' 10' ' ' LEU . 0.2 OUTLIER -60.86 -47.39 86.57 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.53 -0.983 . . . . 0.0 110.29 179.964 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 5.4 tt -58.25 -45.67 87.37 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.543 -0.723 . . . . 0.0 109.677 179.259 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 5.1 t-160 -68.11 -32.23 72.38 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.654 -0.654 . . . . 0.0 109.979 179.145 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.405 HD22 ' HA ' ' A' ' 13' ' ' LEU . 0.2 OUTLIER -61.08 -43.88 98.21 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.615 -0.678 . . . . 0.0 109.966 179.494 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 2.7 t-80 -61.17 -55.85 27.47 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.472 -0.768 . . . . 0.0 109.458 179.34 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.45 ' O ' ' HB2' ' A' ' 19' ' ' ASP . 3.3 tp60 -58.95 -37.77 77.5 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.585 -0.697 . . . . 0.0 110.296 179.746 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 14.8 t30 -63.31 -45.85 89.43 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.576 -0.703 . . . . 0.0 110.449 179.654 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.49 ' O ' HG12 ' A' ' 20' ' ' VAL . 27.7 mm -73.14 -32.59 39.25 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 O-C-N 121.242 -0.911 . . . . 0.0 109.961 179.58 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 52.2 t -75.12 -18.33 16.14 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 O-C-N 121.374 -0.829 . . . . 0.0 110.533 179.731 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.45 ' HB2' ' O ' ' A' ' 15' ' ' GLN . 0.2 OUTLIER -103.35 19.44 19.68 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.263 -0.898 . . . . 0.0 110.795 179.266 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.49 HG12 ' O ' ' A' ' 17' ' ' ILE . 1.5 p . . . . . 0 N--CA 1.495 1.801 0 O-C-N 120.784 -1.198 . . . . 0.0 110.65 179.473 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.76 ' HB3' ' HB3' ' A' ' 29' ' ' ALA . 79.6 mt . . . . . 0 N--CA 1.499 1.986 0 CA-C-O 121.307 0.575 . . . . 0.0 110.331 . . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.554 ' HB2' ' HD3' ' A' ' 28' ' ' PRO . 3.6 m -52.53 -49.82 83.7 Favored Pre-proline 0 N--CA 1.5 2.058 0 O-C-N 121.673 -0.642 . . . . 0.0 111.555 -179.578 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.554 ' HD3' ' HB2' ' A' ' 27' ' ' SER . 44.3 Cg_endo -70.27 -12.56 32.16 Favored 'Trans proline' 0 N--CA 1.491 1.37 0 O-C-N 123.275 1.145 . . . . 0.0 111.613 -179.772 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.76 ' HB3' ' HB3' ' A' ' 26' ' ' LEU . . . -98.93 -41.41 7.61 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.305 -0.872 . . . . 0.0 110.249 179.635 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 16.7 tt -69.98 -23.36 25.33 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 O-C-N 121.422 -0.799 . . . . 0.0 110.951 -179.987 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 2.0 p -63.77 -46.14 86.61 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.387 -0.821 . . . . 0.0 110.158 179.689 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 5.9 mttp -90.13 18.97 5.34 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.546 -0.721 . . . . 0.0 110.306 179.258 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 13.0 t80 -116.25 -40.83 3.21 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.291 -0.881 . . . . 0.0 110.165 179.816 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 29.7 t . . . . . 0 N--CA 1.494 1.76 0 O-C-N 121.378 -0.826 . . . . 0.0 109.68 179.898 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.45 0 N-CA-C 109.281 -1.527 . . . . 0.0 109.281 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 13.4 mt -85.72 -32.41 21.92 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.605 -0.938 . . . . 0.0 109.944 179.38 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 6.0 mp -60.14 -55.78 29.62 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.523 -0.736 . . . . 0.0 110.281 179.841 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 13.7 t-160 -60.35 -42.62 96.1 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.489 -0.757 . . . . 0.0 109.94 179.459 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 13.2 tp -59.82 -41.36 91.14 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.605 -0.684 . . . . 0.0 109.962 179.398 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . 0.508 ' NE2' HG21 ' A' ' 18' ' ' VAL . 51.4 t60 -63.03 -47.74 81.76 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.627 -0.671 . . . . 0.0 110.095 179.571 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 34.4 tp60 -56.17 -42.4 76.99 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.544 -0.723 . . . . 0.0 110.369 179.969 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.459 ' O ' ' HB ' ' A' ' 20' ' ' VAL . 8.4 t-20 -62.46 -48.98 77.25 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.282 -0.886 . . . . 0.0 110.377 179.637 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.513 ' O ' HG12 ' A' ' 20' ' ' VAL . 73.2 mt -65.73 -38.7 82.88 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.036 0 O-C-N 121.423 -0.798 . . . . 0.0 110.41 -179.958 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.508 HG21 ' NE2' ' A' ' 14' ' ' HIS . 21.3 t -70.92 -36.73 65.2 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 O-C-N 121.237 -0.914 . . . . 0.0 110.35 179.797 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -85.73 1.72 48.34 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.498 -0.751 . . . . 0.0 111.477 179.976 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.513 HG12 ' O ' ' A' ' 17' ' ' ILE . 1.0 OUTLIER . . . . . 0 N--CA 1.497 1.882 0 O-C-N 120.802 -1.186 . . . . 0.0 110.431 179.121 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.504 2.26 0 CA-C-O 120.83 0.348 . . . . 0.0 111.1 . . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.51 ' CB ' ' CD ' ' A' ' 28' ' ' PRO . 0.4 OUTLIER -175.16 -62.58 0.0 OUTLIER Pre-proline 0 N--CA 1.497 1.904 0 O-C-N 121.416 -0.802 . . . . 0.0 110.093 179.599 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.51 ' CD ' ' CB ' ' A' ' 27' ' ' SER . 43.6 Cg_endo -70.24 -31.96 17.43 Favored 'Trans proline' 0 N--CA 1.488 1.195 0 O-C-N 123.318 1.168 . . . . 0.0 110.339 179.174 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.44 ' O ' ' HB2' ' A' ' 33' ' ' TYR . . . -72.04 -13.12 61.51 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.618 -0.676 . . . . 0.0 111.037 179.477 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.489 HG22 ' O ' ' A' ' 27' ' ' SER . 9.2 tp -114.03 -28.27 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 O-C-N 121.067 -1.021 . . . . 0.0 111.395 -179.73 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 2.0 t -96.08 -20.19 18.84 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.059 -1.026 . . . . 0.0 110.958 -179.977 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -114.41 17.96 17.15 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.095 -1.003 . . . . 0.0 110.544 179.691 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.44 ' HB2' ' O ' ' A' ' 29' ' ' ALA . 7.2 m-85 -129.56 21.41 5.56 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.286 -0.884 . . . . 0.0 110.801 -179.935 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.463 ' O ' HG12 ' A' ' 34' ' ' VAL . 21.3 t . . . . . 0 N--CA 1.496 1.857 0 O-C-N 121.285 -0.884 . . . . 0.0 110.094 -179.934 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.355 0 N-CA-C 109.302 -1.519 . . . . 0.0 109.302 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -59.97 -41.98 93.13 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.664 -0.904 . . . . 0.0 110.507 179.945 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -60.94 -50.33 73.85 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.459 -0.776 . . . . 0.0 110.003 179.675 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 3.8 m80 -63.82 -42.5 97.65 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.605 -0.685 . . . . 0.0 110.255 179.679 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 9.3 tp -60.65 -42.88 97.87 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.504 -0.748 . . . . 0.0 110.011 179.538 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . 0.548 ' NE2' HG21 ' A' ' 18' ' ' VAL . 66.6 t60 -59.64 -55.07 38.98 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.647 -0.658 . . . . 0.0 109.943 179.478 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -53.24 -37.29 61.93 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.631 -0.668 . . . . 0.0 110.383 179.699 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.539 ' O ' HG23 ' A' ' 20' ' ' VAL . 0.7 OUTLIER -65.98 -46.15 79.08 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.541 -0.724 . . . . 0.0 110.493 179.697 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 63.3 mt -72.47 -32.83 43.38 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.11 0 O-C-N 121.418 -0.801 . . . . 0.0 110.429 179.934 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.548 HG21 ' NE2' ' A' ' 14' ' ' HIS . 52.4 t -65.86 -48.18 82.96 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.491 -0.756 . . . . 0.0 110.328 -179.815 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -79.42 47.73 0.84 Allowed 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.145 -0.972 . . . . 0.0 110.855 179.953 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.539 HG23 ' O ' ' A' ' 16' ' ' ASN . 51.3 t . . . . . 0 N--CA 1.496 1.843 0 O-C-N 121.335 -0.853 . . . . 0.0 109.536 179.319 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.5 2.064 0 CA-C-O 120.744 0.307 . . . . 0.0 111.557 . . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.649 ' HB2' ' HD3' ' A' ' 28' ' ' PRO . 2.5 m -106.48 -62.3 0.04 OUTLIER Pre-proline 0 N--CA 1.495 1.81 0 O-C-N 121.114 -0.991 . . . . 0.0 110.443 179.715 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.649 ' HD3' ' HB2' ' A' ' 27' ' ' SER . 53.6 Cg_endo -79.81 63.75 8.78 Favored 'Trans proline' 0 N--CA 1.484 0.92 0 O-C-N 123.239 1.126 . . . . 0.0 110.033 179.357 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -166.41 -46.6 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.524 -0.735 . . . . 0.0 110.298 -179.7 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 47.6 mm -81.51 -38.8 16.56 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 O-C-N 121.535 -0.728 . . . . 0.0 110.265 -179.9 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 82.5 m -70.87 -42.26 70.28 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.464 -0.773 . . . . 0.0 110.031 179.732 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 7.2 mttp -69.7 -15.67 63.21 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.442 -0.786 . . . . 0.0 110.753 179.379 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -70.21 -42.49 72.25 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.377 -0.827 . . . . 0.0 110.38 179.847 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.522 ' O ' HG12 ' A' ' 34' ' ' VAL . 26.6 t . . . . . 0 N--CA 1.497 1.9 0 O-C-N 121.457 -0.777 . . . . 0.0 110.347 179.729 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.363 0 N-CA-C 108.699 -1.76 . . . . 0.0 108.699 . . . . . . . . . 0 0 . 1 . 031 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -62.25 -36.99 83.73 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.611 -0.935 . . . . 0.0 109.921 179.064 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -59.95 -47.41 85.92 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.553 -0.717 . . . . 0.0 110.096 179.43 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 26.5 t-80 -67.35 -43.92 80.32 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.518 -0.739 . . . . 0.0 109.531 179.272 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -59.95 -40.15 88.03 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.662 -0.649 . . . . 0.0 109.872 179.237 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . 0.714 ' O ' HG23 ' A' ' 18' ' ' VAL . 1.1 t-80 -58.68 -55.24 37.7 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.576 -0.703 . . . . 0.0 109.639 179.389 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.39 -37.36 72.56 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.611 -0.68 . . . . 0.0 110.58 179.895 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -59.58 -35.76 74.92 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.378 -0.826 . . . . 0.0 110.064 179.296 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 46.2 mm -82.58 -36.56 13.55 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.46 -0.775 . . . . 0.0 109.844 179.55 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.714 HG23 ' O ' ' A' ' 14' ' ' HIS . 61.2 t -61.55 -23.23 30.13 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.048 0 O-C-N 121.448 -0.783 . . . . 0.0 110.758 -179.979 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -86.81 -21.42 26.47 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.252 -0.905 . . . . 0.0 110.614 179.81 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 47.5 t . . . . . 0 N--CA 1.496 1.868 0 O-C-N 121.112 -0.992 . . . . 0.0 109.595 179.346 . . . . . . . . 0 0 . 1 . 031 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.499 2.003 0 CA-C-O 121.273 0.558 . . . . 0.0 110.498 . . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.536 ' N ' ' CD ' ' A' ' 28' ' ' PRO . 0.3 OUTLIER -82.12 -40.39 0.94 Allowed Pre-proline 0 N--CA 1.496 1.867 0 O-C-N 121.445 -0.785 . . . . 0.0 112.012 -179.695 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.536 ' CD ' ' N ' ' A' ' 27' ' ' SER . 47.8 Cg_endo -75.86 64.56 6.79 Favored 'Trans proline' 0 N--CA 1.486 1.081 0 O-C-N 123.126 1.066 . . . . 0.0 110.614 -179.359 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -167.55 -49.67 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.708 -0.62 . . . . 0.0 109.789 179.892 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 49.2 mm -91.9 -29.88 4.66 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 121.612 -0.68 . . . . 0.0 110.23 179.633 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 31.9 m -61.35 -38.13 85.83 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.528 -0.733 . . . . 0.0 110.142 179.725 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.96 -27.53 64.81 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.394 -0.816 . . . . 0.0 110.47 179.609 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -78.77 -16.95 56.54 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.449 -0.782 . . . . 0.0 110.811 179.544 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 23.6 t . . . . . 0 N--CA 1.498 1.948 0 O-C-N 121.291 -0.881 . . . . 0.0 109.982 179.944 . . . . . . . . 0 0 . 1 . 032 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.415 0 N-CA-C 109.262 -1.535 . . . . 0.0 109.262 . . . . . . . . . 0 0 . 1 . 032 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -60.53 -34.83 74.69 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.595 -0.944 . . . . 0.0 110.287 179.7 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 6.4 tt -56.33 -45.19 80.44 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.577 -0.702 . . . . 0.0 110.153 179.503 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 27.6 m-70 -81.81 -42.55 19.53 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.438 -0.789 . . . . 0.0 110.008 179.521 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 7.2 tp -57.36 -37.32 72.42 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.65 -0.656 . . . . 0.0 110.484 179.801 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -56.83 -47.31 80.6 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.458 -0.776 . . . . 0.0 109.802 179.382 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 6.4 tp60 -59.53 -34.94 73.27 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.625 -0.672 . . . . 0.0 110.42 179.627 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 16.0 t30 -69.91 -35.21 74.41 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.459 -0.775 . . . . 0.0 110.403 179.551 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 32.5 mt -82.47 -16.07 11.76 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 O-C-N 121.241 -0.912 . . . . 0.0 110.879 179.962 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 74.7 t -99.38 -50.97 10.49 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.142 -0.974 . . . . 0.0 109.802 179.891 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 34.5 t0 -61.57 -21.7 64.53 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.602 -0.686 . . . . 0.0 110.604 179.376 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 8.3 p . . . . . 0 N--CA 1.5 2.059 0 O-C-N 121.296 -0.878 . . . . 0.0 110.935 179.53 . . . . . . . . 0 0 . 1 . 032 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 5.3 mp . . . . . 0 N--CA 1.5 2.036 0 CA-C-O 121.177 0.513 . . . . 0.0 111.194 . . . . . . . . . 0 0 . 1 . 032 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.58 ' HB3' ' HD3' ' A' ' 28' ' ' PRO . 3.7 t -164.21 -65.09 0.01 OUTLIER Pre-proline 0 N--CA 1.499 1.998 0 O-C-N 121.265 -0.897 . . . . 0.0 110.602 179.221 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.58 ' HD3' ' HB3' ' A' ' 27' ' ' SER . 47.1 Cg_endo -72.97 -20.54 21.9 Favored 'Trans proline' 0 N--CA 1.491 1.328 0 O-C-N 123.258 1.136 . . . . 0.0 111.113 179.888 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -73.44 -45.06 56.63 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.448 -0.783 . . . . 0.0 110.202 179.887 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 3.2 mt -68.07 -36.4 75.27 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 O-C-N 121.422 -0.799 . . . . 0.0 110.564 -179.967 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 20.3 p -71.47 -32.19 68.0 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.477 -0.764 . . . . 0.0 110.316 179.703 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.4 tttt -90.42 18.53 6.08 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.415 -0.803 . . . . 0.0 110.814 179.763 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -111.51 -50.8 2.9 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.296 -0.878 . . . . 0.0 109.766 179.627 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 45.9 t . . . . . 0 N--CA 1.496 1.826 0 O-C-N 121.445 -0.784 . . . . 0.0 109.845 179.791 . . . . . . . . 0 0 . 1 . 033 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.502 0 N-CA-C 109.237 -1.545 . . . . 0.0 109.237 . . . . . . . . . 0 0 . 1 . 033 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.442 HD13 ' HA ' ' A' ' 10' ' ' LEU . 3.1 mm? -70.1 -43.69 70.56 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.591 -0.947 . . . . 0.0 109.91 179.699 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 5.6 tt -58.35 -45.94 87.2 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.64 -0.663 . . . . 0.0 110.392 179.703 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 37.1 t60 -64.58 -40.62 95.87 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.473 -0.767 . . . . 0.0 110.2 179.765 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.713 ' HG ' HD13 ' A' ' 17' ' ' ILE . 3.2 tp -60.28 -40.6 90.97 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.448 -0.782 . . . . 0.0 110.108 179.406 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . 0.489 ' CD2' HG21 ' A' ' 18' ' ' VAL . 18.3 t-80 -60.19 -58.64 7.67 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.388 -0.82 . . . . 0.0 109.778 179.625 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.452 ' O ' ' HB2' ' A' ' 19' ' ' ASP . 0.7 OUTLIER -60.14 -26.04 65.97 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.452 -0.78 . . . . 0.0 110.692 179.613 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 -80.0 -46.38 16.72 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.35 -0.844 . . . . 0.0 110.577 -179.883 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.713 HD13 ' HG ' ' A' ' 13' ' ' LEU . 1.3 mp -76.7 -33.58 22.14 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 121.286 -0.884 . . . . 0.0 110.401 -179.809 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.489 HG21 ' CD2' ' A' ' 14' ' ' HIS . 50.7 t -70.52 -29.43 38.53 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 O-C-N 121.125 -0.984 . . . . 0.0 110.364 179.826 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.452 ' HB2' ' O ' ' A' ' 15' ' ' GLN . 0.4 OUTLIER -88.26 3.27 50.14 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.461 -0.775 . . . . 0.0 111.211 179.772 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.546 HG12 ' O ' ' A' ' 17' ' ' ILE . 0.8 OUTLIER . . . . . 0 N--CA 1.496 1.828 0 O-C-N 120.947 -1.096 . . . . 0.0 110.722 179.611 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.496 1.863 0 CA-C-O 120.896 0.379 . . . . 0.0 110.808 . . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.468 ' O ' HG22 ' A' ' 30' ' ' ILE . 0.0 OUTLIER -84.48 -56.5 0.41 Allowed Pre-proline 0 N--CA 1.499 2.019 0 O-C-N 121.2 -0.938 . . . . 0.0 110.223 179.823 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.443 ' HD3' ' CB ' ' A' ' 27' ' ' SER . 49.4 Cg_endo -77.58 -11.52 17.05 Favored 'Trans proline' 0 C--N 1.32 -0.926 0 O-C-N 123.32 1.168 . . . . 0.0 110.596 179.174 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -82.81 -43.55 16.54 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.274 -0.892 . . . . 0.0 110.33 179.935 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.468 HG22 ' O ' ' A' ' 27' ' ' SER . 4.0 tp -65.0 -30.5 50.56 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 O-C-N 121.498 -0.751 . . . . 0.0 110.674 -179.99 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 9.7 p -72.35 -25.73 61.65 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.376 -0.827 . . . . 0.0 110.229 179.345 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 2.5 tttm -99.24 16.39 23.05 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.389 -0.819 . . . . 0.0 110.643 179.63 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -110.19 -37.88 5.43 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.222 -0.923 . . . . 0.0 110.69 -179.759 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 52.8 t . . . . . 0 N--CA 1.498 1.961 0 O-C-N 121.421 -0.799 . . . . 0.0 110.224 -179.84 . . . . . . . . 0 0 . 1 . 034 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.521 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 . . . . . . . . . 0 0 . 1 . 034 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.423 HD22 ' HA ' ' A' ' 10' ' ' LEU . 0.2 OUTLIER -62.34 -39.24 92.44 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.642 -0.917 . . . . 0.0 110.389 179.826 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 13.6 tp -58.68 -51.04 71.63 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.46 -0.775 . . . . 0.0 110.236 179.669 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -65.15 -43.15 92.76 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.548 -0.72 . . . . 0.0 109.816 179.482 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -60.63 -39.7 89.23 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.535 -0.728 . . . . 0.0 109.953 179.241 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . 0.579 ' NE2' HG21 ' A' ' 18' ' ' VAL . 4.4 t-80 -59.31 -54.09 50.74 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.786 -0.572 . . . . 0.0 109.885 179.538 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.9 tp60 -57.31 -47.18 82.17 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.518 -0.739 . . . . 0.0 110.221 179.865 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -48.41 -45.89 36.64 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.496 -0.753 . . . . 0.0 110.519 179.512 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.434 HD13 ' HA ' ' A' ' 17' ' ' ILE . 18.4 mm -73.62 -42.37 55.35 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 121.37 -0.831 . . . . 0.0 110.114 179.653 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.579 HG21 ' NE2' ' A' ' 14' ' ' HIS . 40.5 t -65.67 -34.99 74.12 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 121.465 -0.772 . . . . 0.0 110.401 179.786 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 72.9 m-20 -67.59 -16.55 64.24 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.488 -0.758 . . . . 0.0 110.595 179.239 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 64.6 t . . . . . 0 N--CA 1.494 1.738 0 O-C-N 121.044 -1.035 . . . . 0.0 109.261 179.148 . . . . . . . . 0 0 . 1 . 034 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.497 1.886 0 CA-C-O 121.106 0.479 . . . . 0.0 110.23 . . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.608 ' HB2' ' HD3' ' A' ' 28' ' ' PRO . 48.2 m -57.03 -50.66 86.92 Favored Pre-proline 0 N--CA 1.497 1.913 0 O-C-N 121.738 -0.601 . . . . 0.0 110.915 179.881 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.608 ' HD3' ' HB2' ' A' ' 27' ' ' SER . 47.7 Cg_endo -71.3 -7.83 22.14 Favored 'Trans proline' 0 N--CA 1.491 1.362 0 O-C-N 123.421 1.221 . . . . 0.0 111.592 179.83 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -98.05 -39.29 9.0 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.199 -0.938 . . . . 0.0 110.357 179.944 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 49.4 mt -76.14 -35.4 28.39 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 O-C-N 121.389 -0.819 . . . . 0.0 110.71 -179.802 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 8.8 p -60.94 -37.46 82.42 Favored 'General case' 0 N--CA 1.501 2.122 0 O-C-N 121.441 -0.787 . . . . 0.0 110.336 179.747 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 26.9 mttt -89.86 13.69 13.9 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.392 -0.818 . . . . 0.0 110.617 179.273 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -108.03 -47.88 3.48 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.305 -0.872 . . . . 0.0 110.067 179.743 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 25.8 t . . . . . 0 N--CA 1.498 1.947 0 O-C-N 121.541 -0.725 . . . . 0.0 109.537 179.77 . . . . . . . . 0 0 . 1 . 035 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.498 2.792 0 N-CA-C 110.221 -1.151 . . . . 0.0 110.221 . . . . . . . . . 0 0 . 1 . 035 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 10.6 tp -58.73 -31.61 68.46 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.638 -0.919 . . . . 0.0 110.568 179.79 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 5.0 mp -56.91 -41.81 78.82 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.597 -0.689 . . . . 0.0 110.13 179.639 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 -80.05 -40.21 28.18 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.348 -0.845 . . . . 0.0 109.83 179.212 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.7 tt -60.49 -42.06 95.53 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.66 -0.65 . . . . 0.0 110.538 179.943 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . 0.539 ' CE1' HG21 ' A' ' 18' ' ' VAL . 86.5 t60 -61.52 -51.37 68.89 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.479 -0.763 . . . . 0.0 110.281 179.95 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 12.2 tp60 -62.21 -30.23 70.94 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.341 -0.849 . . . . 0.0 110.011 179.436 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -66.52 -24.95 66.46 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.293 -0.879 . . . . 0.0 110.297 179.144 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 61.7 mt -101.39 -27.56 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 121.205 -0.935 . . . . 0.0 110.342 179.68 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.539 HG21 ' CE1' ' A' ' 14' ' ' HIS . 93.5 t -95.92 -13.23 8.26 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 O-C-N 121.383 -0.823 . . . . 0.0 111.142 -179.647 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -120.15 38.48 3.95 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.033 -1.042 . . . . 0.0 110.553 179.836 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 40.1 t . . . . . 0 N--CA 1.497 1.923 0 O-C-N 121.355 -0.841 . . . . 0.0 109.857 179.949 . . . . . . . . 0 0 . 1 . 035 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.499 2.025 0 CA-C-O 120.63 0.252 . . . . 0.0 111.306 . . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.519 ' N ' ' HD2' ' A' ' 28' ' ' PRO . 4.7 m -64.07 -52.19 57.47 Favored Pre-proline 0 N--CA 1.499 1.975 0 O-C-N 121.24 -0.912 . . . . 0.0 110.732 179.608 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.519 ' HD2' ' N ' ' A' ' 27' ' ' SER . 44.3 Cg_endo -71.27 -17.88 30.67 Favored 'Trans proline' 0 N--CA 1.489 1.207 0 O-C-N 123.413 1.217 . . . . 0.0 110.795 179.477 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -77.28 -28.19 53.36 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.454 -0.779 . . . . 0.0 110.263 179.547 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 89.6 mt -90.08 -29.07 4.96 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 121.3 -0.875 . . . . 0.0 110.605 179.961 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 32.6 p -65.02 -50.19 67.23 Favored 'General case' 0 N--CA 1.502 2.144 0 O-C-N 121.279 -0.888 . . . . 0.0 110.069 179.656 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.88 -17.04 64.36 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.447 -0.783 . . . . 0.0 110.439 179.226 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 81.8 t80 -82.18 -34.92 28.84 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.364 -0.835 . . . . 0.0 110.124 179.543 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 97.3 t . . . . . 0 N--CA 1.495 1.822 0 O-C-N 121.465 -0.772 . . . . 0.0 110.338 -179.982 . . . . . . . . 0 0 . 1 . 036 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.462 0 N-CA-C 108.951 -1.66 . . . . 0.0 108.951 . . . . . . . . . 0 0 . 1 . 036 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.1 mp -57.91 -37.52 74.2 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.651 -0.911 . . . . 0.0 110.111 179.501 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.411 HD13 ' HA ' ' A' ' 11' ' ' LEU . 0.5 OUTLIER -57.14 -44.48 83.41 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.64 -0.663 . . . . 0.0 110.035 179.412 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 7.1 m170 -67.74 -43.76 79.18 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.582 -0.699 . . . . 0.0 110.227 179.636 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.2 tt -55.2 -44.42 75.31 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.646 -0.659 . . . . 0.0 110.456 179.956 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 -60.35 -50.04 75.2 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.506 -0.746 . . . . 0.0 109.689 179.504 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 16.4 mm100 -64.69 -35.67 81.8 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.542 -0.724 . . . . 0.0 110.065 179.646 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -61.94 -38.06 87.05 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.576 -0.703 . . . . 0.0 110.6 179.658 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.412 HD13 ' HA ' ' A' ' 17' ' ' ILE . 24.1 mm -83.23 -45.17 18.86 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 O-C-N 121.37 -0.831 . . . . 0.0 110.341 -179.834 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 64.3 t -63.4 -35.69 73.29 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 O-C-N 121.497 -0.752 . . . . 0.0 110.712 -179.797 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -68.94 -24.84 64.32 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.385 -0.822 . . . . 0.0 110.733 -179.992 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 48.8 t . . . . . 0 N--CA 1.492 1.648 0 O-C-N 120.968 -1.082 . . . . 0.0 109.494 179.327 . . . . . . . . 0 0 . 1 . 036 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.497 1.902 0 CA-C-O 121.048 0.452 . . . . 0.0 110.505 . . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.556 ' HB2' ' HD3' ' A' ' 28' ' ' PRO . 0.7 OUTLIER -86.2 -49.85 0.51 Allowed Pre-proline 0 N--CA 1.5 2.049 0 O-C-N 121.453 -0.779 . . . . 0.0 111.268 -179.751 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.556 ' HD3' ' HB2' ' A' ' 27' ' ' SER . 50.5 Cg_endo -77.21 64.52 7.87 Favored 'Trans proline' 0 N--CA 1.487 1.13 0 O-C-N 123.395 1.208 . . . . 0.0 110.55 -179.635 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -167.34 -49.48 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.644 -0.66 . . . . 0.0 109.729 179.864 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.41 ' O ' HG23 ' A' ' 34' ' ' VAL . 46.4 mm -79.11 -38.12 20.06 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 121.562 -0.711 . . . . 0.0 110.113 179.758 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 29.7 p -65.01 -45.29 86.16 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.522 -0.736 . . . . 0.0 109.979 179.59 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 24.7 mmtt -64.69 -27.68 69.08 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.644 -0.66 . . . . 0.0 110.221 179.385 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -69.14 -35.39 76.32 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.463 -0.773 . . . . 0.0 109.801 179.212 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.41 HG23 ' O ' ' A' ' 30' ' ' ILE . 21.9 t . . . . . 0 N--CA 1.495 1.81 0 O-C-N 121.53 -0.731 . . . . 0.0 109.504 179.448 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . 0.438 ' O ' ' HB2' ' A' ' 2' ' ' ASP . 20.9 m . . . . . 0 N--CA 1.495 1.818 0 N-CA-C 110.169 -0.308 . . . . 0.0 110.169 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.438 ' HB2' ' O ' ' A' ' 1' ' ' SER . 16.4 m-20 62.18 173.27 0.13 Allowed 'General case' 0 N--CA 1.502 2.166 0 CA-C-O 121.42 0.628 . . . . 0.0 111.137 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 52.4 66.78 4.6 Favored Pre-proline 0 N--CA 1.501 2.085 0 O-C-N 121.607 -0.683 . . . . 0.0 110.697 -179.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -79.22 60.49 7.82 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 O-C-N 123.937 1.493 . . . . 0.0 110.562 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -154.26 -54.87 0.1 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.557 -0.714 . . . . 0.0 109.834 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 57.79 26.03 12.65 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 121.834 -0.542 . . . . 0.0 111.327 179.797 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 16.5 m -116.05 26.09 10.21 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.075 -1.016 . . . . 0.0 110.462 179.627 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 18.2 p -141.56 58.64 1.51 Allowed 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.352 -0.842 . . . . 0.0 109.93 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -85.18 -64.85 1.5 Allowed Glycine 0 N--CA 1.495 2.57 0 N-CA-C 109.807 -1.317 . . . . 0.0 109.807 -179.623 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 12.6 mt -58.3 -40.71 82.7 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.683 -0.892 . . . . 0.0 110.465 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 5.1 tt -57.54 -50.42 73.14 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.49 -0.756 . . . . 0.0 109.943 179.602 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 8.6 m170 -61.06 -41.95 97.56 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.692 -0.63 . . . . 0.0 110.074 179.515 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 9.4 tp -58.12 -42.67 86.24 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.641 -0.662 . . . . 0.0 110.199 179.518 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . 0.505 ' CE1' HG21 ' A' ' 18' ' ' VAL . 74.7 t60 -61.02 -49.16 78.53 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.713 -0.617 . . . . 0.0 110.001 179.596 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 15.8 mm-40 -60.08 -37.82 81.06 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.505 -0.747 . . . . 0.0 110.267 179.677 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -62.28 -39.75 93.97 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.498 -0.751 . . . . 0.0 110.377 179.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 56.4 mt -79.65 -44.08 23.31 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 O-C-N 121.317 -0.864 . . . . 0.0 110.203 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.505 HG21 ' CE1' ' A' ' 14' ' ' HIS . 49.9 t -66.65 -17.91 23.31 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 O-C-N 121.558 -0.714 . . . . 0.0 111.134 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -98.53 -6.23 30.6 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.141 -0.974 . . . . 0.0 111.053 179.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 75.7 t -116.36 -50.69 4.59 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 O-C-N 120.935 -1.103 . . . . 0.0 110.282 179.615 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.59 -27.09 69.0 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.648 -0.657 . . . . 0.0 110.743 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -63.31 -31.22 72.32 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.298 -0.876 . . . . 0.0 110.159 179.702 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -98.17 -27.92 13.96 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.394 -0.816 . . . . 0.0 110.705 179.536 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 52.0 m-85 -108.05 27.57 9.13 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.232 -0.917 . . . . 0.0 110.956 -179.611 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -88.0 -62.97 1.4 Allowed Glycine 0 N--CA 1.494 2.526 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER 51.36 32.68 8.79 Favored 'General case' 0 N--CA 1.504 2.245 0 O-C-N 121.976 -0.72 . . . . 0.0 111.253 179.792 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.434 ' N ' ' HD2' ' A' ' 28' ' ' PRO . 0.0 OUTLIER -59.45 -57.02 30.05 Favored Pre-proline 0 N--CA 1.501 2.097 0 O-C-N 121.306 -0.871 . . . . 0.0 110.616 179.815 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.434 ' HD2' ' N ' ' A' ' 27' ' ' SER . 45.7 Cg_endo -71.52 -27.53 18.76 Favored 'Trans proline' 0 N--CA 1.487 1.114 0 O-C-N 123.485 1.255 . . . . 0.0 110.895 179.681 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.36 -52.51 61.41 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.446 -0.784 . . . . 0.0 110.746 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 34.8 mm -60.52 -35.85 66.0 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.12 0 O-C-N 121.411 -0.806 . . . . 0.0 110.559 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 73.4 m -61.11 -27.82 68.65 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.541 -0.724 . . . . 0.0 110.566 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.36 7.52 33.34 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.299 -0.876 . . . . 0.0 110.689 179.559 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -101.22 -39.31 7.7 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.36 -0.837 . . . . 0.0 110.161 179.716 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 92.2 t -71.82 -23.61 22.36 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 121.445 -0.784 . . . . 0.0 110.367 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.2 p -107.65 8.18 9.48 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 O-C-N 121.23 -0.919 . . . . 0.0 111.208 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.497 1.903 0 CA-C-O 117.908 -1.044 . . . . 0.0 110.477 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 7.6 p . . . . . 0 N--CA 1.495 1.81 0 CA-C-O 121.182 0.515 . . . . 0.0 110.183 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -115.88 -0.86 12.72 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.532 -0.73 . . . . 0.0 111.352 -179.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 50.58 69.65 2.48 Favored Pre-proline 0 N--CA 1.503 2.21 0 O-C-N 121.489 -0.757 . . . . 0.0 111.332 179.51 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.433 ' O ' ' HB3' ' A' ' 5' ' ' ALA . 48.3 Cg_endo -86.59 52.5 2.75 Favored 'Trans proline' 0 C--N 1.31 -1.456 0 C-N-CA 121.524 1.483 . . . . 0.0 110.811 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.433 ' HB3' ' O ' ' A' ' 4' ' ' PRO . . . 59.15 19.6 7.56 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 121.462 -0.774 . . . . 0.0 111.375 -179.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 2.0 mt -120.18 10.59 11.4 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.145 -0.972 . . . . 0.0 110.657 179.56 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 91.5 p -159.84 52.82 0.35 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.226 -0.921 . . . . 0.0 109.876 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 5.8 t -125.54 22.46 7.63 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.193 -0.942 . . . . 0.0 111.044 -179.551 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -62.21 -54.96 30.68 Favored Glycine 0 N--CA 1.496 2.685 0 N-CA-C 109.165 -1.574 . . . . 0.0 109.165 179.405 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 7.1 tp -81.73 -31.73 31.9 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.606 -0.938 . . . . 0.0 109.91 179.153 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -56.03 -47.59 77.56 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.535 -0.728 . . . . 0.0 110.256 179.73 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -57.36 -42.99 83.14 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.547 -0.721 . . . . 0.0 110.036 179.46 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.1 tt -60.96 -41.46 96.38 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.676 -0.64 . . . . 0.0 110.224 179.451 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . 0.607 ' NE2' HG21 ' A' ' 18' ' ' VAL . 67.9 t60 -60.8 -50.23 74.3 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.399 -0.813 . . . . 0.0 109.721 179.408 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 51.8 mm-40 -58.56 -35.89 73.08 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.531 -0.731 . . . . 0.0 110.007 179.382 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -58.54 -36.11 73.37 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.621 -0.674 . . . . 0.0 110.133 179.234 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.579 ' O ' HG12 ' A' ' 20' ' ' VAL . 7.4 mt -88.17 -31.81 5.83 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 O-C-N 121.515 -0.741 . . . . 0.0 109.96 179.502 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.607 HG21 ' NE2' ' A' ' 14' ' ' HIS . 54.9 t -68.6 -37.38 77.57 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 121.378 -0.826 . . . . 0.0 110.301 179.855 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.58 ' HA ' ' CD2' ' A' ' 22' ' ' TYR . 0.6 OUTLIER -82.95 4.43 25.87 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.563 -0.71 . . . . 0.0 111.471 -179.985 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.579 HG12 ' O ' ' A' ' 17' ' ' ILE . 0.8 OUTLIER -113.52 -14.14 11.03 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 O-C-N 120.737 -1.227 . . . . 0.0 110.653 179.373 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 29.3 mt-30 -102.13 -32.68 9.99 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.415 -0.803 . . . . 0.0 110.539 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . 0.58 ' CD2' ' HA ' ' A' ' 19' ' ' ASP . 2.7 p90 -62.23 -25.04 67.59 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.266 -0.896 . . . . 0.0 110.978 -179.753 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 5.8 tmm? -88.91 -36.4 15.95 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.115 -0.991 . . . . 0.0 110.721 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 48.5 m-85 -88.1 -30.89 19.53 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.379 -0.826 . . . . 0.0 111.797 -179.075 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -124.86 26.2 5.68 Favored Glycine 0 N--CA 1.497 2.763 0 C-N-CA 119.921 -1.133 . . . . 0.0 111.395 -179.108 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.562 ' HB2' ' HA ' ' A' ' 22' ' ' TYR . 0.2 OUTLIER -159.9 33.84 0.18 Allowed 'General case' 0 N--CA 1.501 2.085 0 O-C-N 120.899 -1.354 . . . . 0.0 110.675 179.475 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.44 ' HB2' ' HD3' ' A' ' 28' ' ' PRO . 1.2 m -77.82 -51.77 1.73 Allowed Pre-proline 0 N--CA 1.497 1.913 0 O-C-N 121.297 -0.877 . . . . 0.0 111.064 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.44 ' HD3' ' HB2' ' A' ' 27' ' ' SER . 49.5 Cg_endo -76.93 61.43 7.12 Favored 'Trans proline' 0 N--CA 1.487 1.13 0 O-C-N 123.446 1.235 . . . . 0.0 110.317 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -167.35 -51.9 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.515 -0.741 . . . . 0.0 109.944 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 80.3 mt -68.35 -24.99 30.32 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 O-C-N 121.535 -0.728 . . . . 0.0 110.22 179.497 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 19.5 p -65.98 -41.83 90.63 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.448 -0.782 . . . . 0.0 110.211 179.471 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 5.9 tmtt? -70.2 -10.82 60.04 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.549 -0.72 . . . . 0.0 110.935 179.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 8.6 t80 -70.24 -43.25 70.97 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.316 -0.865 . . . . 0.0 110.361 179.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.501 ' O ' HG12 ' A' ' 34' ' ' VAL . 38.8 t -94.68 45.46 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 O-C-N 121.35 -0.844 . . . . 0.0 110.263 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.541 ' O ' HG12 ' A' ' 35' ' ' VAL . 59.5 t -139.97 52.8 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 O-C-N 121.154 -0.966 . . . . 0.0 109.471 179.499 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.751 0 CA-C-O 117.842 -1.075 . . . . 0.0 110.434 -179.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 13.4 m . . . . . 0 N--CA 1.497 1.911 0 CA-C-O 121.242 0.544 . . . . 0.0 110.01 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -132.62 40.0 3.31 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.4 -0.812 . . . . 0.0 110.588 -179.36 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.49 ' N ' ' HD3' ' A' ' 4' ' ' PRO . 0.2 OUTLIER 50.16 60.72 14.73 Favored Pre-proline 0 N--CA 1.503 2.183 0 O-C-N 121.626 -0.671 . . . . 0.0 110.941 179.893 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.49 ' HD3' ' N ' ' A' ' 3' ' ' LEU . 50.2 Cg_endo -85.1 37.64 0.61 Allowed 'Trans proline' 0 C--N 1.313 -1.303 0 O-C-N 123.646 1.34 . . . . 0.0 111.144 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -162.04 37.99 0.12 Allowed 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.272 -0.892 . . . . 0.0 110.474 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.588 HD12 ' HB2' ' A' ' 7' ' ' SER . 1.9 pp -63.47 -31.07 72.12 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.368 -0.833 . . . . 0.0 110.741 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.588 ' HB2' HD12 ' A' ' 6' ' ' LEU . 5.2 t -133.19 15.06 4.18 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.273 -0.892 . . . . 0.0 110.726 179.546 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.463 ' HB ' ' CG ' ' A' ' 12' ' ' HIS . 21.8 p -135.79 52.55 1.99 Allowed 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.123 -0.986 . . . . 0.0 110.088 179.871 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -92.17 -77.49 1.36 Allowed Glycine 0 N--CA 1.491 2.331 0 N-CA-C 108.49 -1.844 . . . . 0.0 108.49 179.449 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 7.4 mt -81.09 -35.57 31.52 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.67 -0.9 . . . . 0.0 109.878 179.192 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 2.5 tt -59.21 -42.9 92.03 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.633 -0.667 . . . . 0.0 110.069 179.507 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . 0.463 ' CG ' ' HB ' ' A' ' 8' ' ' THR . 0.0 OUTLIER -76.35 -33.21 58.97 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.524 -0.735 . . . . 0.0 110.105 179.429 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.402 HD22 ' HA ' ' A' ' 13' ' ' LEU . 0.1 OUTLIER -57.09 -47.72 80.34 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.445 -0.784 . . . . 0.0 110.472 179.912 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . 0.416 ' CE1' HG21 ' A' ' 18' ' ' VAL . 77.4 t60 -61.39 -52.21 65.55 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.381 -0.824 . . . . 0.0 109.823 179.625 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 4.3 tp-100 -60.02 -37.63 80.31 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.523 -0.735 . . . . 0.0 110.222 179.542 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -62.43 -39.42 93.27 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.573 -0.704 . . . . 0.0 110.665 179.676 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 76.5 mt -81.6 -41.82 18.97 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 O-C-N 121.166 -0.959 . . . . 0.0 110.29 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.416 HG21 ' CE1' ' A' ' 14' ' ' HIS . 76.8 t -65.26 -44.83 94.97 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 O-C-N 121.392 -0.818 . . . . 0.0 110.439 -179.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -65.73 -16.11 63.47 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.742 -0.599 . . . . 0.0 111.46 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 94.9 t -102.66 -38.21 5.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 120.74 -1.225 . . . . 0.0 109.86 179.495 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -66.53 -37.48 85.1 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.521 -0.737 . . . . 0.0 110.682 179.785 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -63.68 -34.44 77.87 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.227 -0.921 . . . . 0.0 110.286 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -96.2 21.33 9.05 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.377 -0.827 . . . . 0.0 110.651 179.452 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -109.52 33.55 4.28 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.157 -0.964 . . . . 0.0 110.51 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -121.21 -100.35 1.7 Allowed Glycine 0 N--CA 1.493 2.492 0 N-CA-C 109.317 -1.513 . . . . 0.0 109.317 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 10.6 mt 49.27 42.14 21.33 Favored 'General case' 0 N--CA 1.503 2.195 0 O-C-N 121.869 -0.783 . . . . 0.0 111.105 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.632 ' HB2' ' HD3' ' A' ' 28' ' ' PRO . 2.2 m -59.29 -56.28 37.57 Favored Pre-proline 0 N--CA 1.497 1.887 0 O-C-N 121.277 -0.89 . . . . 0.0 110.592 -179.851 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.632 ' HD3' ' HB2' ' A' ' 27' ' ' SER . 53.2 Cg_endo -80.42 53.87 4.96 Favored 'Trans proline' 0 N--CA 1.485 1.018 0 O-C-N 123.386 1.203 . . . . 0.0 110.434 179.329 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -155.44 -54.11 0.09 Allowed 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.304 -0.873 . . . . 0.0 110.029 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 10.0 mt -79.48 -32.17 14.54 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 O-C-N 121.415 -0.803 . . . . 0.0 110.439 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 16.1 m -61.17 -38.59 87.02 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.553 -0.717 . . . . 0.0 110.333 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 2.1 pttt -93.2 18.37 9.56 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.467 -0.77 . . . . 0.0 110.606 179.394 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -113.39 -50.02 2.88 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.265 -0.897 . . . . 0.0 109.952 179.773 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 74.0 t -85.17 -55.06 7.29 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 121.479 -0.763 . . . . 0.0 109.893 179.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.4 t 56.28 41.86 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.141 0 O-C-N 121.741 -0.6 . . . . 0.0 110.421 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.503 2.182 0 CA-C-O 118.074 -0.965 . . . . 0.0 111.288 179.644 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 46.2 m . . . . . 0 N--CA 1.494 1.732 0 CA-C-O 121.01 0.433 . . . . 0.0 110.13 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -125.99 38.03 4.23 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.461 -0.774 . . . . 0.0 110.744 -179.821 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.54 ' CB ' ' HD3' ' A' ' 4' ' ' PRO . 0.9 OUTLIER -71.09 -53.73 8.03 Favored Pre-proline 0 N--CA 1.496 1.846 0 O-C-N 121.222 -0.924 . . . . 0.0 110.018 179.309 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.54 ' HD3' ' CB ' ' A' ' 3' ' ' LEU . 52.3 Cg_endo -86.87 16.56 1.94 Allowed 'Trans proline' 0 CA--C 1.544 1.005 0 O-C-N 123.49 1.258 . . . . 0.0 111.307 179.34 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.432 ' HB3' ' O ' ' A' ' 4' ' ' PRO . . . 59.46 17.52 6.07 Favored 'General case' 0 N--CA 1.505 2.315 0 O-C-N 121.37 -0.831 . . . . 0.0 111.728 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 51.39 39.06 23.44 Favored 'General case' 0 N--CA 1.504 2.227 0 O-C-N 121.259 -0.901 . . . . 0.0 111.779 179.558 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 43.3 t 55.88 76.69 0.27 Allowed 'General case' 0 N--CA 1.502 2.162 0 O-C-N 121.487 -0.758 . . . . 0.0 111.188 179.397 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 2.0 p -117.61 17.3 14.47 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.277 -0.889 . . . . 0.0 111.104 179.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -65.08 -66.11 2.62 Favored Glycine 0 N--CA 1.496 2.64 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -58.48 -35.24 71.89 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.682 -0.893 . . . . 0.0 110.207 179.629 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 4.8 tt -57.18 -46.28 82.96 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.471 -0.768 . . . . 0.0 109.965 179.464 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 22.3 m-70 -68.44 -42.73 78.43 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.527 -0.733 . . . . 0.0 109.877 179.449 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -60.35 -38.79 84.95 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.63 -0.669 . . . . 0.0 109.778 179.225 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . 0.519 ' NE2' HG21 ' A' ' 18' ' ' VAL . 71.5 t60 -63.9 -52.72 58.61 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.627 -0.671 . . . . 0.0 109.624 179.255 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 29.9 tp60 -54.65 -39.04 67.61 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.697 -0.627 . . . . 0.0 110.149 179.559 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.614 ' O ' HG23 ' A' ' 20' ' ' VAL . 1.8 t30 -58.12 -49.07 78.25 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.554 -0.717 . . . . 0.0 110.327 179.558 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 29.2 mt -72.09 -33.47 47.11 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.073 0 O-C-N 121.449 -0.782 . . . . 0.0 110.226 179.714 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.519 HG21 ' NE2' ' A' ' 14' ' ' HIS . 73.5 t -75.69 -10.92 13.84 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.093 0 O-C-N 121.51 -0.744 . . . . 0.0 111.086 179.825 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.578 ' HA ' ' HB2' ' A' ' 23' ' ' MET . 0.9 OUTLIER -111.49 20.96 16.7 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.892 -1.13 . . . . 0.0 110.674 179.886 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.614 HG23 ' O ' ' A' ' 16' ' ' ASN . 73.0 t -120.09 -54.38 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 O-C-N 121.139 -0.976 . . . . 0.0 109.721 179.481 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 42.4 mt-30 -82.4 -16.21 49.88 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.743 -0.598 . . . . 0.0 110.376 179.643 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . 0.502 ' CD1' ' HA ' ' A' ' 18' ' ' VAL . 18.7 m-85 -108.39 -46.26 3.73 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.463 -0.773 . . . . 0.0 110.353 -179.01 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . 0.578 ' HB2' ' HA ' ' A' ' 19' ' ' ASP . 0.2 OUTLIER -68.08 -31.08 70.46 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.522 -0.736 . . . . 0.0 110.662 179.944 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.446 ' HB2' ' O ' ' A' ' 20' ' ' VAL . 0.3 OUTLIER -90.28 42.42 1.1 Allowed 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.179 -0.95 . . . . 0.0 110.261 179.594 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -159.18 45.84 0.44 Allowed Glycine 0 N--CA 1.494 2.525 0 N-CA-C 109.326 -1.51 . . . . 0.0 109.326 179.646 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.1 mp -107.76 18.31 21.5 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.402 -1.058 . . . . 0.0 110.925 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.508 ' N ' ' HD2' ' A' ' 28' ' ' PRO . 0.8 OUTLIER -56.62 -52.8 70.73 Favored Pre-proline 0 N--CA 1.498 1.947 0 O-C-N 121.3 -0.875 . . . . 0.0 110.486 179.528 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.508 ' HD2' ' N ' ' A' ' 27' ' ' SER . 45.8 Cg_endo -71.79 -26.7 18.85 Favored 'Trans proline' 0 N--CA 1.488 1.185 0 O-C-N 123.53 1.279 . . . . 0.0 110.789 179.314 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -71.09 -33.52 70.27 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.495 -0.753 . . . . 0.0 110.507 179.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -84.97 -11.25 11.52 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 O-C-N 121.269 -0.894 . . . . 0.0 110.976 179.851 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 24.0 p -101.8 -38.89 7.65 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.08 -1.013 . . . . 0.0 110.532 179.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 2.1 tptt -90.23 39.11 0.95 Allowed 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.378 -0.826 . . . . 0.0 110.574 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -149.55 -49.93 0.14 Allowed 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.34 -0.85 . . . . 0.0 109.882 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 16.1 t -80.88 73.26 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 CA-C-O 121.416 0.627 . . . . 0.0 109.668 179.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.426 ' O ' HG12 ' A' ' 35' ' ' VAL . 18.3 t -129.6 41.11 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 O-C-N 121.59 -0.694 . . . . 0.0 109.724 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.499 1.992 0 CA-C-O 117.821 -1.085 . . . . 0.0 110.871 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 9.5 p . . . . . 0 N--CA 1.494 1.765 0 CA-C-O 121.013 0.435 . . . . 0.0 110.276 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -142.08 176.78 8.69 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.523 -0.736 . . . . 0.0 110.292 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.471 ' CB ' ' HD3' ' A' ' 4' ' ' PRO . 0.3 OUTLIER -57.83 -53.61 63.95 Favored Pre-proline 0 N--CA 1.502 2.147 0 O-C-N 121.531 -0.731 . . . . 0.0 111.374 -179.449 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.471 ' HD3' ' CB ' ' A' ' 3' ' ' LEU . 48.9 Cg_endo -81.74 -153.22 0.04 OUTLIER 'Trans proline' 0 C--N 1.319 -1.021 0 O-C-N 123.477 1.251 . . . . 0.0 110.029 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -167.59 -75.11 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.325 -0.86 . . . . 0.0 110.371 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.1 pp -103.73 -19.12 14.42 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.4 -0.813 . . . . 0.0 111.104 -179.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 69.7 m -99.64 48.04 0.94 Allowed 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.202 -0.936 . . . . 0.0 110.105 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 5.6 t -124.35 9.72 8.54 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.363 -0.836 . . . . 0.0 111.166 -179.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -77.48 -55.1 4.38 Favored Glycine 0 N--CA 1.494 2.555 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 179.795 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 2.1 pp -66.64 -31.15 71.64 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.58 -0.953 . . . . 0.0 110.597 179.791 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.92 -44.31 93.28 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.202 -0.936 . . . . 0.0 109.973 179.663 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 5.5 m80 -70.34 -37.1 74.61 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.516 -0.74 . . . . 0.0 109.942 179.337 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.9 tp -59.6 -40.12 86.43 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.532 -0.73 . . . . 0.0 110.561 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . 0.412 ' CD2' HG21 ' A' ' 18' ' ' VAL . 3.3 t-80 -54.74 -51.91 64.17 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.611 -0.68 . . . . 0.0 109.958 179.771 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 12.1 tp-100 -62.63 -32.31 73.31 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.48 -0.763 . . . . 0.0 110.507 179.772 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -72.12 -47.68 49.41 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.314 -0.866 . . . . 0.0 110.559 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 39.0 mm -71.65 -40.41 70.64 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 O-C-N 121.408 -0.808 . . . . 0.0 110.429 -179.772 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.412 HG21 ' CD2' ' A' ' 14' ' ' HIS . 38.3 t -62.19 -30.1 48.06 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 O-C-N 121.36 -0.838 . . . . 0.0 110.199 179.771 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -76.8 -15.65 59.68 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.503 -0.748 . . . . 0.0 110.85 179.382 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 92.7 t -103.4 -37.61 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.057 -1.027 . . . . 0.0 109.884 179.618 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . 0.508 ' CG ' ' HB3' ' A' ' 26' ' ' LEU . 8.1 tt0 -67.54 -35.27 78.75 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.511 -0.743 . . . . 0.0 110.614 179.85 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -68.61 -36.7 79.02 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.254 -0.903 . . . . 0.0 109.873 179.646 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 1.2 tmt? -77.08 -32.14 56.5 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.58 -0.7 . . . . 0.0 110.695 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.462 ' HB3' HD13 ' A' ' 26' ' ' LEU . 1.8 m-85 -78.7 3.4 16.59 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.249 -0.907 . . . . 0.0 110.964 179.644 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 70.16 37.7 72.38 Favored Glycine 0 N--CA 1.493 2.471 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -179.817 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.508 ' HB3' ' CG ' ' A' ' 21' ' ' GLN . 2.3 mp -112.76 11.24 19.34 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.385 -1.068 . . . . 0.0 111.195 -179.731 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.625 ' HB3' ' HD3' ' A' ' 28' ' ' PRO . 0.5 OUTLIER -62.81 -53.37 56.71 Favored Pre-proline 0 N--CA 1.498 1.931 0 O-C-N 121.154 -0.966 . . . . 0.0 110.374 179.474 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.782 ' HA ' HG22 ' A' ' 31' ' ' THR . 45.7 Cg_endo -73.07 -31.33 9.81 Favored 'Trans proline' 0 N--CA 1.487 1.122 0 O-C-N 123.491 1.259 . . . . 0.0 110.69 179.681 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.55 -24.48 67.54 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.618 -0.676 . . . . 0.0 111.279 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 47.5 mm -105.63 -30.11 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 O-C-N 121.113 -0.992 . . . . 0.0 111.119 -179.62 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.782 HG22 ' HA ' ' A' ' 28' ' ' PRO . 4.8 t -85.17 -30.97 23.51 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.159 -0.963 . . . . 0.0 110.867 -179.796 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.3 tttt -89.4 10.88 20.92 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.193 -0.942 . . . . 0.0 110.979 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 6.8 m-85 -114.07 -38.43 4.17 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.105 -0.997 . . . . 0.0 110.539 179.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.497 ' O ' HG12 ' A' ' 35' ' ' VAL . 60.8 t -89.31 -91.9 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.312 -0.867 . . . . 0.0 109.696 179.852 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.497 HG12 ' O ' ' A' ' 34' ' ' VAL . 9.8 p 37.79 37.95 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.51 2.528 0 CA-C-O 121.467 0.651 . . . . 0.0 111.803 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.819 0 CA-C-O 117.94 -1.029 . . . . 0.0 110.293 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 24.3 t . . . . . 0 N--CA 1.495 1.811 0 CA-C-O 121.167 0.508 . . . . 0.0 110.41 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -145.85 144.39 30.21 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.43 -0.794 . . . . 0.0 110.303 179.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 18.2 tp -151.09 77.98 7.38 Favored Pre-proline 0 N--CA 1.495 1.802 0 O-C-N 121.5 -0.75 . . . . 0.0 110.15 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -90.09 -154.81 0.05 OUTLIER 'Trans proline' 0 C--N 1.309 -1.508 0 C-N-CA 121.726 1.617 . . . . 0.0 110.426 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -161.09 90.25 0.82 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.283 -0.886 . . . . 0.0 109.798 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 60.68 34.0 20.12 Favored 'General case' 0 N--CA 1.503 2.213 0 O-C-N 121.806 -0.559 . . . . 0.0 110.636 -179.588 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 22.8 t -151.87 64.58 0.85 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.452 -0.78 . . . . 0.0 109.614 179.697 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -108.27 9.02 28.04 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.293 -0.879 . . . . 0.0 111.11 -179.495 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -65.55 -54.89 23.41 Favored Glycine 0 N--CA 1.496 2.673 0 N-CA-C 109.272 -1.531 . . . . 0.0 109.272 179.684 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.463 HD13 ' HA ' ' A' ' 10' ' ' LEU . 0.4 OUTLIER -63.09 -35.64 80.95 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.652 -0.91 . . . . 0.0 109.972 179.371 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -56.98 -48.19 79.01 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.53 -0.731 . . . . 0.0 109.87 179.378 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 7.1 m-70 -63.88 -39.36 94.0 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.715 -0.616 . . . . 0.0 109.738 179.129 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 9.1 tp -58.96 -41.87 88.53 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.64 -0.663 . . . . 0.0 110.109 179.333 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . 0.531 ' NE2' HG21 ' A' ' 18' ' ' VAL . 5.7 t-160 -62.16 -52.04 65.43 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.543 -0.723 . . . . 0.0 109.258 179.149 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 27.3 tp60 -58.72 -36.53 74.43 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.625 -0.672 . . . . 0.0 110.021 179.186 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -61.73 -45.31 94.48 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.643 -0.661 . . . . 0.0 110.474 179.731 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.462 ' O ' HG12 ' A' ' 20' ' ' VAL . 38.8 mt -73.27 -37.5 52.03 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.018 0 O-C-N 121.352 -0.842 . . . . 0.0 109.84 179.637 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.531 HG21 ' NE2' ' A' ' 14' ' ' HIS . 54.8 t -75.73 -3.92 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 O-C-N 121.475 -0.766 . . . . 0.0 110.658 179.473 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -120.79 5.41 10.49 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.188 -0.945 . . . . 0.0 110.57 179.136 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.462 HG12 ' O ' ' A' ' 17' ' ' ILE . 5.5 p -102.68 -31.16 2.97 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 O-C-N 120.905 -1.122 . . . . 0.0 110.866 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -97.45 6.98 47.37 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.296 -0.878 . . . . 0.0 110.639 179.896 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . 0.442 ' CD2' ' N ' ' A' ' 22' ' ' TYR . 4.9 m-85 -133.08 -49.11 0.86 Allowed 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.4 -0.812 . . . . 0.0 109.316 -179.255 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.51 -31.78 63.89 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.51 -0.744 . . . . 0.0 109.549 178.734 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -85.19 4.65 33.58 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.392 -0.817 . . . . 0.0 110.973 179.485 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -84.47 -37.05 11.18 Favored Glycine 0 N--CA 1.493 2.489 0 N-CA-C 109.729 -1.348 . . . . 0.0 109.729 179.711 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 56.94 34.25 24.57 Favored 'General case' 0 N--CA 1.504 2.228 0 O-C-N 121.754 -0.851 . . . . 0.0 111.231 179.856 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.488 ' H ' ' HD2' ' A' ' 28' ' ' PRO . 0.5 OUTLIER -99.21 -63.98 0.08 OUTLIER Pre-proline 0 N--CA 1.497 1.887 0 O-C-N 121.184 -0.947 . . . . 0.0 110.571 179.69 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.488 ' HD2' ' H ' ' A' ' 27' ' ' SER . 41.8 Cg_endo -67.66 -25.04 40.69 Favored 'Trans proline' 0 N--CA 1.489 1.235 0 O-C-N 123.222 1.117 . . . . 0.0 110.876 179.812 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.76 -32.16 73.54 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.37 -0.831 . . . . 0.0 110.312 179.292 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 97.1 mt -99.68 -42.34 10.38 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 121.501 -0.749 . . . . 0.0 110.035 179.675 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 62.8 m -63.88 -38.24 90.38 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.665 -0.647 . . . . 0.0 110.612 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 13.2 tttt -89.31 15.29 9.29 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.231 -0.918 . . . . 0.0 110.68 179.558 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 9.7 t80 -106.63 -44.09 4.56 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.296 -0.877 . . . . 0.0 110.019 179.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.9 t -83.88 67.31 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 O-C-N 121.383 -0.823 . . . . 0.0 109.734 179.805 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 23.1 t -127.99 60.14 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 121.433 -0.792 . . . . 0.0 109.628 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 3.0 tpm_? . . . . . 0 N--CA 1.493 1.706 0 CA-C-O 117.817 -1.087 . . . . 0.0 110.476 -179.854 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 2.4 p . . . . . 0 N--CA 1.495 1.806 0 CA-C-O 121.152 0.501 . . . . 0.0 110.052 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -133.91 -173.25 3.2 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.487 -0.758 . . . . 0.0 110.366 -179.607 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.472 ' CB ' ' HD3' ' A' ' 4' ' ' PRO . 0.3 OUTLIER -60.42 -50.04 87.51 Favored Pre-proline 0 N--CA 1.501 2.106 0 O-C-N 121.484 -0.76 . . . . 0.0 111.263 -179.658 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.472 ' HD3' ' CB ' ' A' ' 3' ' ' LEU . 47.1 Cg_endo -88.36 -157.11 0.06 OUTLIER 'Trans proline' 0 C--N 1.318 -1.051 0 O-C-N 123.45 1.237 . . . . 0.0 110.416 -179.821 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -128.93 -59.61 1.12 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.228 -0.92 . . . . 0.0 110.215 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -112.3 39.95 2.33 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.424 -0.797 . . . . 0.0 109.97 179.625 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 5.1 t 54.37 72.37 0.46 Allowed 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.695 -0.628 . . . . 0.0 110.178 -179.704 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.424 HG22 ' CD2' ' A' ' 12' ' ' HIS . 1.4 m -86.88 40.07 0.88 Allowed 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.356 -0.84 . . . . 0.0 110.478 -179.871 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -106.17 -52.19 0.79 Allowed Glycine 0 N--CA 1.492 2.427 0 N-CA-C 109.032 -1.627 . . . . 0.0 109.032 179.545 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.5 mt -62.8 -41.99 99.52 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.616 -0.932 . . . . 0.0 110.17 179.665 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 15.6 tp -59.45 -43.61 93.15 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.464 -0.772 . . . . 0.0 109.814 179.378 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . 0.424 ' CD2' HG22 ' A' ' 8' ' ' THR . 6.9 m170 -65.35 -44.94 86.08 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.628 -0.67 . . . . 0.0 109.748 179.271 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.91 -33.91 76.62 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.472 -0.767 . . . . 0.0 109.969 179.31 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . 0.517 ' NE2' HG21 ' A' ' 18' ' ' VAL . 8.1 t-160 -63.0 -51.7 65.84 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.625 -0.672 . . . . 0.0 109.88 179.549 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.46 ' O ' ' HB2' ' A' ' 19' ' ' ASP . 0.3 OUTLIER -61.75 -36.03 79.81 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.496 -0.752 . . . . 0.0 109.993 179.497 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -59.36 -43.61 92.81 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.473 -0.767 . . . . 0.0 110.289 179.445 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.503 ' O ' HG12 ' A' ' 20' ' ' VAL . 61.1 mt -81.87 -26.25 9.58 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.925 0 O-C-N 121.395 -0.816 . . . . 0.0 110.624 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.517 HG21 ' NE2' ' A' ' 14' ' ' HIS . 49.7 t -85.65 -7.44 10.92 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 121.031 -1.043 . . . . 0.0 110.693 179.79 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.46 ' HB2' ' O ' ' A' ' 15' ' ' GLN . 0.5 OUTLIER -122.53 32.24 5.83 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.101 -0.999 . . . . 0.0 109.667 178.896 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.507 ' HA ' ' HG2' ' A' ' 23' ' ' MET . 13.0 p -123.81 -44.11 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 O-C-N 121.416 -0.802 . . . . 0.0 110.646 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . 0.5 ' N ' HG13 ' A' ' 20' ' ' VAL . 28.4 mt-30 -78.35 -12.89 60.03 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.348 -0.845 . . . . 0.0 110.134 179.35 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . 0.4 ' CD1' ' N ' ' A' ' 22' ' ' TYR . 10.4 m-85 -104.44 -25.43 12.81 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.657 -0.652 . . . . 0.0 109.704 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . 0.507 ' HG2' ' HA ' ' A' ' 20' ' ' VAL . 0.5 OUTLIER -80.98 -21.25 40.46 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.385 -0.822 . . . . 0.0 110.376 179.292 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -110.44 20.17 18.02 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.23 -0.919 . . . . 0.0 110.891 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -81.1 -38.64 14.72 Favored Glycine 0 N--CA 1.496 2.686 0 N-CA-C 109.786 -1.325 . . . . 0.0 109.786 179.767 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.6 mp 58.25 26.07 13.43 Favored 'General case' 0 N--CA 1.502 2.148 0 O-C-N 121.688 -0.889 . . . . 0.0 111.549 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.473 ' N ' ' HD2' ' A' ' 28' ' ' PRO . 1.4 m -69.88 -55.43 8.73 Favored Pre-proline 0 N--CA 1.498 1.939 0 O-C-N 121.113 -0.992 . . . . 0.0 110.27 179.333 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.473 ' HD2' ' N ' ' A' ' 27' ' ' SER . 45.6 Cg_endo -71.61 -20.23 27.07 Favored 'Trans proline' 0 N--CA 1.487 1.1 0 O-C-N 123.451 1.237 . . . . 0.0 110.681 179.182 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -70.85 -37.89 73.16 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.48 -0.763 . . . . 0.0 110.216 179.585 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 28.5 mm -74.35 -39.93 49.2 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 O-C-N 121.518 -0.739 . . . . 0.0 110.061 179.625 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 44.9 p -69.22 -39.48 78.53 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.381 -0.825 . . . . 0.0 110.206 179.692 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 26.9 mmtt -71.91 -29.77 64.67 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.428 -0.795 . . . . 0.0 110.638 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 92.4 t80 -86.44 -47.4 9.34 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.399 -0.813 . . . . 0.0 110.319 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 47.2 t -80.14 82.15 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 121.448 -0.783 . . . . 0.0 109.831 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.446 HG22 ' O ' ' A' ' 35' ' ' VAL . 9.6 p -157.04 36.75 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 CA-C-O 121.6 0.714 . . . . 0.0 109.926 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 19.9 mmt85 . . . . . 0 N--CA 1.497 1.881 0 CA-C-O 118.032 -0.985 . . . . 0.0 110.212 -179.733 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 47.1 m . . . . . 0 N--CA 1.495 1.784 0 CA-C-O 121.104 0.478 . . . . 0.0 110.067 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -128.7 131.35 47.95 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.545 -0.722 . . . . 0.0 110.259 -179.823 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.577 ' CB ' ' HD3' ' A' ' 4' ' ' PRO . 1.1 mp -99.97 -55.65 0.16 Allowed Pre-proline 0 N--CA 1.496 1.846 0 O-C-N 121.611 -0.68 . . . . 0.0 110.958 -179.846 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.577 ' HD3' ' CB ' ' A' ' 3' ' ' LEU . 47.5 Cg_endo -89.75 -159.85 0.09 OUTLIER 'Trans proline' 0 C--N 1.319 -0.979 0 O-C-N 123.317 1.167 . . . . 0.0 110.342 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -153.23 59.01 0.77 Allowed 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.31 -0.869 . . . . 0.0 110.048 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.706 HD11 HD22 ' A' ' 10' ' ' LEU . 3.1 tp -101.62 -33.6 9.83 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.448 -0.783 . . . . 0.0 110.964 -179.672 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 22.6 t -60.27 -44.42 95.33 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.437 -0.79 . . . . 0.0 111.035 -179.549 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 32.1 p -120.82 8.74 10.57 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.426 -0.796 . . . . 0.0 111.316 -179.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -107.85 -67.53 0.63 Allowed Glycine 0 N--CA 1.492 2.376 0 N-CA-C 108.626 -1.789 . . . . 0.0 108.626 179.604 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.706 HD22 HD11 ' A' ' 6' ' ' LEU . 8.9 tp -73.49 -36.82 65.85 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.648 -0.913 . . . . 0.0 109.876 179.335 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 11.5 tp -64.56 -44.1 91.82 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.377 -0.827 . . . . 0.0 109.839 179.506 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -63.76 -42.92 97.73 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.59 -0.693 . . . . 0.0 109.832 179.443 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 5.2 tp -63.88 -40.72 97.19 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.542 -0.724 . . . . 0.0 110.238 179.505 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . 0.497 ' NE2' HG21 ' A' ' 18' ' ' VAL . 7.3 t-80 -57.4 -54.22 49.33 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.643 -0.661 . . . . 0.0 109.922 179.685 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.447 ' O ' ' HB2' ' A' ' 19' ' ' ASP . 19.5 tp60 -55.57 -40.14 71.6 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.672 -0.642 . . . . 0.0 110.089 179.577 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -66.67 -40.8 88.75 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.348 -0.845 . . . . 0.0 110.68 179.686 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.413 ' O ' HG12 ' A' ' 20' ' ' VAL . 85.6 mt -77.07 -21.53 14.5 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 O-C-N 121.395 -0.816 . . . . 0.0 110.858 -179.81 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.497 HG21 ' NE2' ' A' ' 14' ' ' HIS . 24.3 t -93.16 -33.61 5.43 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 O-C-N 121.205 -0.934 . . . . 0.0 110.082 179.828 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.447 ' HB2' ' O ' ' A' ' 15' ' ' GLN . 2.4 m-20 -87.75 28.84 0.96 Allowed 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.278 -0.889 . . . . 0.0 110.439 179.271 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.413 HG12 ' O ' ' A' ' 17' ' ' ILE . 12.5 p -103.53 -28.31 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.825 0 O-C-N 121.242 -0.911 . . . . 0.0 110.344 179.577 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . 0.469 ' HG2' HG21 ' A' ' 30' ' ' ILE . 13.6 mt-30 -101.78 -27.56 12.95 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.595 -0.691 . . . . 0.0 110.559 -179.711 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -101.14 -26.7 13.59 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.363 -0.836 . . . . 0.0 110.64 -179.187 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -97.43 16.5 20.0 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.228 -0.92 . . . . 0.0 111.3 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -97.53 13.77 28.83 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 120.867 -1.146 . . . . 0.0 111.035 179.699 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 73.56 31.45 60.75 Favored Glycine 0 N--CA 1.494 2.519 0 N-CA-C 109.71 -1.356 . . . . 0.0 109.71 -179.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -147.81 43.75 1.08 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.428 -1.042 . . . . 0.0 110.192 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.404 ' CB ' ' HD3' ' A' ' 28' ' ' PRO . 0.4 OUTLIER -60.28 -54.34 56.1 Favored Pre-proline 0 N--CA 1.498 1.939 0 O-C-N 121.397 -0.814 . . . . 0.0 110.656 -179.909 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.404 ' HD3' ' CB ' ' A' ' 27' ' ' SER . 49.9 Cg_endo -77.61 55.32 5.13 Favored 'Trans proline' 0 N--CA 1.487 1.119 0 O-C-N 123.393 1.207 . . . . 0.0 110.318 179.473 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -162.74 -49.18 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.59 -0.694 . . . . 0.0 109.78 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.469 HG21 ' HG2' ' A' ' 21' ' ' GLN . 21.8 mt -83.13 -34.1 10.87 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 121.624 -0.673 . . . . 0.0 110.224 179.592 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 43.7 m -61.6 -43.35 99.03 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.568 -0.707 . . . . 0.0 109.931 179.48 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.8 tttp -70.51 -23.52 62.67 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.549 -0.719 . . . . 0.0 110.496 179.332 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -75.43 -27.58 59.03 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.415 -0.803 . . . . 0.0 110.365 179.646 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 57.9 t -96.37 -44.71 12.9 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 O-C-N 121.269 -0.895 . . . . 0.0 110.543 -179.749 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 37.5 t 55.63 70.14 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.142 0 O-C-N 121.603 -0.686 . . . . 0.0 110.006 -179.68 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 2.5 ttp180 . . . . . 0 N--CA 1.495 1.778 0 CA-C-O 117.887 -1.054 . . . . 0.0 110.426 -179.907 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 60.1 p . . . . . 0 N--CA 1.495 1.815 0 CA-C-O 121.102 0.477 . . . . 0.0 110.309 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 35.7 m-20 -95.53 118.95 33.18 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.322 -0.861 . . . . 0.0 110.282 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.484 ' N ' ' HD2' ' A' ' 4' ' ' PRO . 3.0 mp -59.17 -51.18 83.48 Favored Pre-proline 0 N--CA 1.5 2.07 0 O-C-N 121.661 -0.65 . . . . 0.0 110.573 179.751 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.484 ' HD2' ' N ' ' A' ' 3' ' ' LEU . 50.1 Cg_endo -76.21 60.63 6.36 Favored 'Trans proline' 0 N--CA 1.486 1.087 0 O-C-N 123.535 1.282 . . . . 0.0 110.293 179.555 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -162.78 -53.6 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.417 -0.802 . . . . 0.0 110.129 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.2 pp -102.85 -17.86 15.35 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.55 -0.719 . . . . 0.0 111.092 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.469 ' O ' HG22 ' A' ' 8' ' ' THR . 10.1 m -85.18 -58.45 2.68 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.175 -0.953 . . . . 0.0 109.887 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.469 HG22 ' O ' ' A' ' 7' ' ' SER . 12.0 t 37.15 42.54 0.28 Allowed 'General case' 0 N--CA 1.504 2.241 0 CA-C-O 121.32 0.581 . . . . 0.0 111.906 179.701 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -94.73 -84.82 1.65 Allowed Glycine 0 N--CA 1.494 2.503 0 N-CA-C 109.275 -1.53 . . . . 0.0 109.275 179.564 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 8.0 tp -66.74 -32.03 73.06 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.577 -0.955 . . . . 0.0 110.237 179.475 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.415 HD22 ' HA ' ' A' ' 11' ' ' LEU . 0.1 OUTLIER -58.19 -43.09 87.39 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.45 -0.781 . . . . 0.0 110.024 179.551 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -59.02 -43.75 91.61 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.6 -0.688 . . . . 0.0 109.696 179.29 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.2 tt -61.99 -38.39 88.42 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.751 -0.593 . . . . 0.0 110.057 179.207 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . 0.591 ' NE2' HG21 ' A' ' 18' ' ' VAL . 2.8 t-80 -61.38 -52.85 62.92 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.517 -0.74 . . . . 0.0 109.745 179.4 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.406 ' O ' ' HB2' ' A' ' 19' ' ' ASP . 3.3 tp-100 -59.96 -36.35 76.9 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.516 -0.74 . . . . 0.0 110.227 179.669 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 9.9 t30 -59.48 -34.04 72.08 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.533 -0.729 . . . . 0.0 110.475 179.471 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.467 ' O ' HG12 ' A' ' 20' ' ' VAL . 38.0 mt -94.4 -36.84 7.38 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 121.398 -0.814 . . . . 0.0 110.317 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.591 HG21 ' NE2' ' A' ' 14' ' ' HIS . 92.0 t -74.2 -7.83 10.59 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.086 0 O-C-N 121.343 -0.848 . . . . 0.0 111.011 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.406 ' HB2' ' O ' ' A' ' 15' ' ' GLN . 1.0 OUTLIER -119.83 8.08 11.07 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.167 -0.958 . . . . 0.0 110.809 179.434 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.467 HG12 ' O ' ' A' ' 17' ' ' ILE . 9.2 p -105.93 -35.82 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 O-C-N 120.982 -1.074 . . . . 0.0 110.874 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -97.47 1.7 49.41 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.379 -0.826 . . . . 0.0 110.517 179.81 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 13.2 m-85 -127.37 -47.01 1.46 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.317 -0.865 . . . . 0.0 109.58 -179.334 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -75.43 -25.76 57.77 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.487 -0.758 . . . . 0.0 110.124 178.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -95.44 40.53 1.11 Allowed 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.31 -0.869 . . . . 0.0 110.513 179.786 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -76.42 -39.3 31.07 Favored Glycine 0 N--CA 1.496 2.681 0 N-CA-C 109.847 -1.301 . . . . 0.0 109.847 179.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.0 mp -93.88 48.97 1.3 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.322 -1.105 . . . . 0.0 109.891 179.773 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.621 ' HB3' ' HD3' ' A' ' 28' ' ' PRO . 4.6 t -53.27 -55.82 30.44 Favored Pre-proline 0 N--CA 1.497 1.892 0 O-C-N 121.625 -0.672 . . . . 0.0 110.645 -179.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.621 ' HD3' ' HB3' ' A' ' 27' ' ' SER . 52.3 Cg_endo -77.37 59.27 6.6 Favored 'Trans proline' 0 N--CA 1.487 1.114 0 O-C-N 123.448 1.236 . . . . 0.0 110.075 179.247 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -167.87 -50.07 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.533 -0.73 . . . . 0.0 110.001 -179.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 15.6 mt -78.43 -33.71 17.56 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 O-C-N 121.483 -0.761 . . . . 0.0 110.299 179.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 7.9 p -61.33 -39.62 91.2 Favored 'General case' 0 N--CA 1.5 2.025 0 O-C-N 121.703 -0.623 . . . . 0.0 110.301 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -91.77 19.51 6.43 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.344 -0.848 . . . . 0.0 110.493 179.272 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 71.3 t80 -115.5 -47.03 2.84 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.366 -0.834 . . . . 0.0 109.989 179.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 59.5 t -81.0 115.44 23.59 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 121.341 -0.85 . . . . 0.0 109.845 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 5.2 p -129.5 28.91 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 O-C-N 121.562 -0.712 . . . . 0.0 110.416 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 5.6 tmm_? . . . . . 0 N--CA 1.495 1.813 0 CA-C-O 117.881 -1.057 . . . . 0.0 110.352 179.871 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 2.1 p . . . . . 0 N--CA 1.496 1.828 0 CA-C-O 121.233 0.54 . . . . 0.0 110.096 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -128.04 135.3 49.68 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.415 -0.803 . . . . 0.0 110.269 -179.573 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.506 ' N ' ' HD3' ' A' ' 4' ' ' PRO . 0.6 OUTLIER 51.85 56.32 15.9 Favored Pre-proline 0 N--CA 1.5 2.055 0 O-C-N 121.79 -0.569 . . . . 0.0 111.072 -179.956 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.506 ' HD3' ' N ' ' A' ' 3' ' ' LEU . 49.0 Cg_endo -80.57 58.75 7.16 Favored 'Trans proline' 0 C--N 1.313 -1.294 0 O-C-N 123.709 1.373 . . . . 0.0 110.575 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -168.7 -54.69 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.366 -0.834 . . . . 0.0 110.408 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -104.52 41.12 1.36 Allowed 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.416 -0.802 . . . . 0.0 110.559 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 61.9 p -77.47 -19.91 55.2 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.318 -0.864 . . . . 0.0 110.835 179.599 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.452 HG23 ' O ' ' A' ' 8' ' ' THR . 8.8 t -115.48 57.56 0.74 Allowed 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.399 -0.813 . . . . 0.0 110.013 179.685 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -104.35 -62.93 0.67 Allowed Glycine 0 N--CA 1.493 2.469 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -62.21 -47.2 85.51 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.632 -0.922 . . . . 0.0 110.609 -179.832 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -58.58 -51.62 69.13 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.487 -0.758 . . . . 0.0 110.2 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -62.74 -40.82 98.41 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.653 -0.654 . . . . 0.0 110.037 179.558 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.7 tt -56.88 -42.2 79.39 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.642 -0.661 . . . . 0.0 110.13 179.588 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 7.2 t-80 -60.81 -49.07 78.98 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.521 -0.737 . . . . 0.0 109.799 179.412 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.457 ' O ' ' HB2' ' A' ' 19' ' ' ASP . 17.8 mm-40 -67.17 -36.17 81.24 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.544 -0.722 . . . . 0.0 109.76 179.318 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -63.68 -18.32 63.87 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.501 -0.749 . . . . 0.0 110.905 179.487 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 87.2 mt -104.74 -46.53 9.47 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.082 -1.011 . . . . 0.0 109.908 179.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 54.0 t -71.21 -36.73 63.4 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 O-C-N 121.403 -0.811 . . . . 0.0 110.969 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.457 ' HB2' ' O ' ' A' ' 15' ' ' GLN . 0.3 OUTLIER -86.55 -1.94 58.06 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.398 -0.814 . . . . 0.0 111.41 -179.537 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 70.6 t -113.51 -51.87 5.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 120.83 -1.169 . . . . 0.0 109.78 179.354 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 8.1 tp-100 -57.72 -34.11 69.13 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.595 -0.691 . . . . 0.0 110.923 179.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -61.83 -31.23 71.45 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.254 -0.904 . . . . 0.0 110.457 179.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -109.13 11.46 25.59 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.341 -0.849 . . . . 0.0 110.891 179.467 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -122.09 34.05 5.29 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.16 -0.962 . . . . 0.0 110.183 179.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -87.04 -68.32 1.33 Allowed Glycine 0 N--CA 1.494 2.503 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.544 ' HB3' ' HB3' ' A' ' 29' ' ' ALA . 3.4 mp 50.45 44.13 26.96 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.784 -0.833 . . . . 0.0 110.818 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.483 ' HB2' ' HD3' ' A' ' 28' ' ' PRO . 3.1 m -56.18 -55.09 45.6 Favored Pre-proline 0 N--CA 1.499 1.998 0 O-C-N 121.527 -0.733 . . . . 0.0 111.094 -179.726 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.483 ' HD3' ' HB2' ' A' ' 27' ' ' SER . 46.3 Cg_endo -72.2 -27.06 17.13 Favored 'Trans proline' 0 N--CA 1.489 1.217 0 O-C-N 123.398 1.209 . . . . 0.0 111.068 179.827 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.544 ' HB3' ' HB3' ' A' ' 26' ' ' LEU . . . -72.87 -39.98 66.01 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.417 -0.802 . . . . 0.0 110.633 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 5.7 tt -79.49 -11.63 13.02 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 O-C-N 121.341 -0.849 . . . . 0.0 111.467 -179.691 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 23.3 p -101.0 -37.19 8.73 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.099 -1.001 . . . . 0.0 110.537 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 6.9 tptp -91.6 45.93 1.26 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.267 -0.896 . . . . 0.0 109.964 179.672 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -146.91 -53.59 0.23 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.549 -0.719 . . . . 0.0 109.739 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.498 ' O ' HG12 ' A' ' 34' ' ' VAL . 49.0 t -91.67 52.57 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 O-C-N 121.443 -0.786 . . . . 0.0 109.75 179.612 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 22.3 m -144.45 22.92 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.098 0 O-C-N 121.307 -0.871 . . . . 0.0 110.89 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.502 2.171 0 CA-C-O 118.255 -0.878 . . . . 0.0 111.083 -179.839 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.494 1.754 0 CA-C-O 121.069 0.461 . . . . 0.0 110.483 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -153.1 160.49 42.92 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.515 -0.74 . . . . 0.0 110.504 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.476 ' N ' ' HD3' ' A' ' 4' ' ' PRO . 0.4 OUTLIER 52.85 59.3 13.9 Favored Pre-proline 0 N--CA 1.501 2.095 0 O-C-N 121.778 -0.576 . . . . 0.0 111.153 -179.973 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.476 ' HD3' ' N ' ' A' ' 3' ' ' LEU . 46.8 Cg_endo -82.28 60.47 7.38 Favored 'Trans proline' 0 C--N 1.313 -1.305 0 O-C-N 123.742 1.391 . . . . 0.0 110.399 179.843 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -108.53 52.07 0.72 Allowed 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.454 -0.779 . . . . 0.0 110.088 179.801 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.2 tt -112.74 -58.02 2.2 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.445 -0.784 . . . . 0.0 110.601 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -165.58 50.13 0.09 Allowed 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.393 -0.817 . . . . 0.0 110.938 -179.847 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.457 HG22 ' HB2' ' A' ' 12' ' ' HIS . 0.2 OUTLIER 53.24 70.52 0.58 Allowed 'General case' 0 N--CA 1.504 2.258 0 O-C-N 121.418 -0.801 . . . . 0.0 110.244 179.652 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -79.99 -90.49 0.47 Allowed Glycine 0 N--CA 1.494 2.548 0 N-CA-C 109.841 -1.304 . . . . 0.0 109.841 -179.613 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -57.71 -38.54 75.44 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.65 -0.912 . . . . 0.0 110.8 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -56.82 -51.05 70.48 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.497 -0.752 . . . . 0.0 110.371 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . 0.457 ' HB2' HG22 ' A' ' 8' ' ' THR . 3.8 t60 -75.56 -30.8 59.79 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.284 -0.885 . . . . 0.0 110.103 179.39 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 61.1 tp -55.3 -41.88 72.94 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.472 -0.768 . . . . 0.0 109.962 179.578 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . 0.406 ' NE2' HG21 ' A' ' 18' ' ' VAL . 2.6 t-80 -61.92 -46.44 89.32 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.608 -0.682 . . . . 0.0 109.665 179.222 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 28.3 mm-40 -60.51 -37.48 81.27 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.658 -0.651 . . . . 0.0 110.093 179.587 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -67.78 -47.98 67.61 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.548 -0.72 . . . . 0.0 110.386 179.651 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 74.8 mt -65.45 -48.57 82.49 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.99 0 O-C-N 121.393 -0.817 . . . . 0.0 109.991 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.406 HG21 ' NE2' ' A' ' 14' ' ' HIS . 27.2 t -61.97 -31.92 52.69 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 O-C-N 121.437 -0.789 . . . . 0.0 109.938 179.549 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.405 ' HA ' ' HD2' ' A' ' 22' ' ' TYR . 29.1 t70 -63.95 -25.4 68.12 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.631 -0.668 . . . . 0.0 109.963 178.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 61.2 t -92.02 -30.43 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.107 -0.996 . . . . 0.0 109.479 179.036 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -69.28 -39.93 78.06 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.585 -0.697 . . . . 0.0 110.317 179.663 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . 0.458 ' CD1' ' C ' ' A' ' 22' ' ' TYR . 0.1 OUTLIER -67.84 -31.27 71.0 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.296 -0.878 . . . . 0.0 110.118 179.672 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 2.5 ttt -84.8 -40.94 16.6 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.442 -0.786 . . . . 0.0 110.609 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 11.4 m-85 -99.63 25.43 7.14 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.264 -0.898 . . . . 0.0 110.959 -179.83 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -87.84 -34.11 10.39 Favored Glycine 0 N--CA 1.496 2.684 0 N-CA-C 109.894 -1.282 . . . . 0.0 109.894 179.788 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.593 HD13 ' HB3' ' A' ' 29' ' ' ALA . 1.2 mm? 58.96 25.68 14.07 Favored 'General case' 0 N--CA 1.502 2.17 0 O-C-N 121.616 -0.932 . . . . 0.0 111.254 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.479 ' N ' ' HD2' ' A' ' 28' ' ' PRO . 1.4 m -80.57 -54.82 0.77 Allowed Pre-proline 0 N--CA 1.498 1.958 0 O-C-N 121.238 -0.913 . . . . 0.0 110.801 179.796 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.479 ' HD2' ' N ' ' A' ' 27' ' ' SER . 43.8 Cg_endo -70.14 -11.83 31.06 Favored 'Trans proline' 0 N--CA 1.49 1.275 0 O-C-N 123.259 1.136 . . . . 0.0 111.172 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.593 ' HB3' HD13 ' A' ' 26' ' ' LEU . . . -90.21 -27.34 19.6 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.248 -0.907 . . . . 0.0 110.366 179.454 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 43.4 mm -104.77 -45.26 9.01 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 121.315 -0.866 . . . . 0.0 110.325 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 23.9 m -70.39 -34.55 72.69 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.602 -0.686 . . . . 0.0 110.84 -179.775 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 6.6 tttp -89.9 16.63 7.85 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.085 -1.009 . . . . 0.0 110.684 179.428 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -109.4 -40.88 4.77 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.292 -0.88 . . . . 0.0 109.987 179.496 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 87.2 t -108.21 98.09 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 121.437 -0.789 . . . . 0.0 110.018 179.848 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 26.3 t -128.05 63.86 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 O-C-N 121.542 -0.724 . . . . 0.0 109.683 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.495 1.816 0 CA-C-O 118.223 -0.894 . . . . 0.0 110.259 -179.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 9.2 t . . . . . 0 N--CA 1.496 1.829 0 CA-C-O 121.211 0.529 . . . . 0.0 109.945 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -135.16 77.39 1.67 Allowed 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.447 -0.783 . . . . 0.0 110.211 -179.657 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.423 ' HB3' ' HD3' ' A' ' 4' ' ' PRO . 0.4 OUTLIER -77.22 -54.02 1.57 Allowed Pre-proline 0 N--CA 1.499 1.991 0 O-C-N 121.474 -0.766 . . . . 0.0 110.933 -179.853 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.423 ' HD3' ' HB3' ' A' ' 3' ' ' LEU . 51.4 Cg_endo -77.96 61.45 7.65 Favored 'Trans proline' 0 N--CA 1.487 1.141 0 O-C-N 123.477 1.251 . . . . 0.0 110.464 -179.928 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -87.27 -49.96 6.91 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.328 -0.858 . . . . 0.0 110.589 -179.795 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -143.36 -68.35 0.34 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.36 -0.838 . . . . 0.0 110.516 -179.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 69.3 m -145.13 66.7 1.24 Allowed 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.248 -0.908 . . . . 0.0 110.378 -179.73 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.422 HG22 ' HB2' ' A' ' 12' ' ' HIS . 6.4 m -97.93 41.95 1.11 Allowed 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.254 -0.904 . . . . 0.0 110.327 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -102.87 -88.81 2.07 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 108.724 -1.751 . . . . 0.0 108.724 179.531 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.62 -39.08 93.47 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.649 -0.912 . . . . 0.0 109.738 179.141 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -58.31 -47.81 82.5 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.699 -0.625 . . . . 0.0 109.585 179.132 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . 0.422 ' HB2' HG22 ' A' ' 8' ' ' THR . 20.1 t-160 -67.81 -45.01 75.95 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.736 -0.602 . . . . 0.0 109.844 179.357 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 11.8 tp -57.25 -41.84 80.37 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.558 -0.714 . . . . 0.0 110.035 179.534 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . 0.544 ' NE2' HG21 ' A' ' 18' ' ' VAL . 6.6 t-80 -61.06 -47.03 88.24 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.624 -0.672 . . . . 0.0 109.826 179.436 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 33.9 tp60 -55.88 -45.28 78.61 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.639 -0.663 . . . . 0.0 110.252 179.71 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.596 ' O ' HG23 ' A' ' 20' ' ' VAL . 9.5 t-20 -63.74 -52.36 60.79 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.326 -0.859 . . . . 0.0 110.732 179.773 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 83.5 mt -57.75 -43.48 84.02 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.119 0 O-C-N 121.345 -0.847 . . . . 0.0 110.374 -179.737 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.544 HG21 ' NE2' ' A' ' 14' ' ' HIS . 17.9 t -71.51 -32.54 46.47 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 O-C-N 121.394 -0.816 . . . . 0.0 110.138 179.579 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -73.01 -10.91 60.3 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.423 -0.798 . . . . 0.0 110.991 179.591 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.596 HG23 ' O ' ' A' ' 16' ' ' ASN . 61.6 t -104.43 -36.11 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 120.832 -1.167 . . . . 0.0 109.925 179.487 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.96 -36.92 70.0 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.525 -0.734 . . . . 0.0 110.863 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -61.96 -31.61 71.98 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.156 -0.965 . . . . 0.0 110.156 179.823 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -92.11 10.34 29.71 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.443 -0.786 . . . . 0.0 110.616 179.134 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -105.48 23.06 14.39 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.152 -0.967 . . . . 0.0 110.399 179.702 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -159.31 44.08 0.45 Allowed Glycine 0 N--CA 1.493 2.488 0 N-CA-C 109.721 -1.351 . . . . 0.0 109.721 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -152.72 22.12 0.6 Allowed 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.54 -0.977 . . . . 0.0 111.019 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.503 ' HB2' ' HD3' ' A' ' 28' ' ' PRO . 4.7 m -74.56 -52.75 3.65 Favored Pre-proline 0 N--CA 1.499 1.977 0 O-C-N 121.142 -0.974 . . . . 0.0 111.243 -179.816 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.503 ' HD3' ' HB2' ' A' ' 27' ' ' SER . 44.9 Cg_endo -71.52 -9.65 25.48 Favored 'Trans proline' 0 N--CA 1.49 1.322 0 O-C-N 123.429 1.226 . . . . 0.0 111.243 179.855 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -94.03 -9.09 37.92 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.333 -0.854 . . . . 0.0 110.662 179.595 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 33.8 mm -118.03 -37.12 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 O-C-N 121.176 -0.952 . . . . 0.0 110.48 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 13.4 t -63.52 -24.43 67.81 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 121.349 -0.844 . . . . 0.0 111.252 -179.901 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 24.9 mmtt -99.12 -2.82 36.03 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.236 -0.915 . . . . 0.0 111.125 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 34.6 m-85 -107.94 0.29 21.86 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.313 -0.867 . . . . 0.0 111.16 -179.782 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.539 ' O ' HG12 ' A' ' 35' ' ' VAL . 47.1 t -121.56 -58.7 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.14 -0.975 . . . . 0.0 109.938 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.604 ' O ' HG13 ' A' ' 35' ' ' VAL . 0.4 OUTLIER 55.63 20.42 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.252 0 O-C-N 121.907 -0.495 . . . . 0.0 111.513 179.933 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.49 ' H ' HG12 ' A' ' 34' ' ' VAL . 0.4 OUTLIER . . . . . 0 N--CA 1.5 2.072 0 CA-C-O 117.682 -1.152 . . . . 0.0 110.446 179.587 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 15.8 p . . . . . 0 N--CA 1.495 1.779 0 CA-C-O 121.046 0.451 . . . . 0.0 110.115 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -128.16 46.99 2.48 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.472 -0.767 . . . . 0.0 110.283 -179.672 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.507 HD21 ' HB3' ' A' ' 6' ' ' LEU . 6.5 tp -155.63 57.19 1.5 Allowed Pre-proline 0 N--CA 1.497 1.925 0 O-C-N 121.36 -0.837 . . . . 0.0 110.425 179.896 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.472 ' HD3' ' N ' ' A' ' 3' ' ' LEU . 46.3 Cg_endo -78.06 -9.0 16.69 Favored 'Trans proline' 0 C--N 1.312 -1.366 0 O-C-N 123.775 1.408 . . . . 0.0 111.507 -179.787 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.445 ' O ' ' HA3' ' A' ' 9' ' ' GLY . . . -103.79 -30.35 10.44 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.335 -0.853 . . . . 0.0 110.742 179.86 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.507 ' HB3' HD21 ' A' ' 3' ' ' LEU . 0.3 OUTLIER -89.64 -32.84 16.89 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.11 -0.994 . . . . 0.0 110.666 -179.886 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.45 ' OG ' HD23 ' A' ' 3' ' ' LEU . 43.0 m -79.95 -46.92 15.85 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.31 -0.869 . . . . 0.0 110.928 -179.684 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 11.8 p -125.62 26.63 6.68 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.503 -0.748 . . . . 0.0 111.264 -179.268 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.445 ' HA3' ' O ' ' A' ' 5' ' ' ALA . . . -102.47 -78.95 1.34 Allowed Glycine 0 N--CA 1.492 2.432 0 N-CA-C 108.417 -1.873 . . . . 0.0 108.417 179.137 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -77.17 -34.87 56.32 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.549 -0.971 . . . . 0.0 109.754 178.924 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 5.6 tp -62.98 -44.63 95.52 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.443 -0.785 . . . . 0.0 109.969 179.49 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -64.05 -39.24 93.64 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.575 -0.703 . . . . 0.0 109.996 179.472 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.4 tp -68.42 -34.96 76.94 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.47 -0.769 . . . . 0.0 110.366 179.659 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . 0.491 ' CD2' HG21 ' A' ' 18' ' ' VAL . 12.5 t-80 -59.77 -61.82 2.33 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.316 -0.865 . . . . 0.0 109.575 179.504 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.45 ' O ' ' HB2' ' A' ' 19' ' ' ASP . 2.8 tp60 -59.2 -26.44 64.84 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.388 -0.82 . . . . 0.0 110.639 179.492 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.613 ' O ' HG23 ' A' ' 20' ' ' VAL . 1.6 t30 -78.02 -42.63 31.9 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.3 -0.875 . . . . 0.0 110.722 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.406 ' O ' ' HB ' ' A' ' 20' ' ' VAL . 83.7 mt -82.69 -36.48 13.36 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.002 0 O-C-N 121.226 -0.921 . . . . 0.0 110.647 -179.646 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.491 HG21 ' CD2' ' A' ' 14' ' ' HIS . 48.1 t -64.67 -34.69 71.6 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 O-C-N 121.203 -0.936 . . . . 0.0 110.493 -179.864 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.544 ' HA ' ' CD2' ' A' ' 22' ' ' TYR . 0.1 OUTLIER -85.81 18.38 2.95 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.319 -0.863 . . . . 0.0 111.04 179.674 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.613 HG23 ' O ' ' A' ' 16' ' ' ASN . 13.1 t -100.42 -44.89 11.55 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.109 -0.995 . . . . 0.0 110.251 179.705 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 6.5 mp0 -59.15 -26.65 64.94 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.695 -0.628 . . . . 0.0 110.687 179.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . 0.544 ' CD2' ' HA ' ' A' ' 19' ' ' ASP . 6.9 m-30 -69.06 -47.13 66.09 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.287 -0.883 . . . . 0.0 109.573 179.687 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -77.94 -32.73 51.7 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.691 -0.631 . . . . 0.0 110.161 179.702 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 55.3 m-85 -111.95 54.97 0.68 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.444 -0.785 . . . . 0.0 109.966 179.783 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -130.95 -69.48 0.1 Allowed Glycine 0 N--CA 1.496 2.636 0 N-CA-C 110.277 -1.129 . . . . 0.0 110.277 -179.539 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 8.7 mt 53.87 30.39 11.41 Favored 'General case' 0 N--CA 1.503 2.219 0 O-C-N 121.76 -0.847 . . . . 0.0 110.773 -179.284 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.604 ' HB2' ' HD3' ' A' ' 28' ' ' PRO . 2.2 m -61.82 -51.73 73.71 Favored Pre-proline 0 N--CA 1.497 1.88 0 O-C-N 121.296 -0.878 . . . . 0.0 110.926 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.604 ' HD3' ' HB2' ' A' ' 27' ' ' SER . 43.4 Cg_endo -69.56 -28.5 26.14 Favored 'Trans proline' 0 N--CA 1.49 1.27 0 O-C-N 123.299 1.157 . . . . 0.0 110.924 179.851 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.43 -36.77 83.45 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.591 -0.693 . . . . 0.0 110.432 179.65 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 35.5 mt -92.27 -36.28 7.6 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 O-C-N 121.327 -0.858 . . . . 0.0 110.219 179.787 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 92.0 m -68.45 -39.79 81.35 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.562 -0.711 . . . . 0.0 110.462 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 4.1 tttt -86.21 19.87 2.54 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.26 -0.9 . . . . 0.0 110.84 179.611 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -116.31 -18.22 10.55 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.207 -0.933 . . . . 0.0 110.856 179.786 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 26.5 t -121.31 -104.81 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.124 -0.985 . . . . 0.0 110.002 -179.843 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 52.1 t 50.45 66.35 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.204 0 O-C-N 121.22 -0.925 . . . . 0.0 110.053 -179.696 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.501 2.09 0 CA-C-O 118.177 -0.916 . . . . 0.0 110.75 -179.57 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 71.1 m . . . . . 0 N--CA 1.495 1.789 0 CA-C-O 121.03 0.443 . . . . 0.0 110.183 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.449 ' HB3' ' HD2' ' A' ' 4' ' ' PRO . 0.2 OUTLIER -155.48 -172.18 4.06 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.497 -0.752 . . . . 0.0 110.394 -179.862 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.509 ' CB ' ' HD3' ' A' ' 4' ' ' PRO . 0.4 OUTLIER -75.78 -52.31 2.76 Favored Pre-proline 0 N--CA 1.499 1.998 0 O-C-N 121.483 -0.761 . . . . 0.0 110.775 -179.962 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.509 ' HD3' ' CB ' ' A' ' 3' ' ' LEU . 46.6 Cg_endo -89.84 -166.13 0.21 Allowed 'Trans proline' 0 C--N 1.319 -0.987 0 O-C-N 123.516 1.272 . . . . 0.0 110.179 179.904 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -161.09 45.84 0.19 Allowed 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.379 -0.826 . . . . 0.0 110.727 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -78.28 -54.48 6.16 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.286 -0.884 . . . . 0.0 109.898 179.676 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.5 m -123.43 55.15 1.24 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.558 -0.714 . . . . 0.0 109.465 179.393 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 2.0 m -126.9 15.88 7.4 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.463 -0.773 . . . . 0.0 110.903 -179.399 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -105.27 -80.93 1.42 Allowed Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.013 -1.635 . . . . 0.0 109.013 179.615 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.1 mp -64.08 -33.3 75.44 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.691 -0.887 . . . . 0.0 110.304 179.35 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 4.8 tp -65.49 -47.23 76.78 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.351 -0.843 . . . . 0.0 109.994 179.596 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -70.2 -43.74 70.1 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.379 -0.826 . . . . 0.0 110.453 179.789 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -61.69 -44.18 97.44 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.401 -0.812 . . . . 0.0 109.931 179.699 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . 0.481 ' CE1' HG21 ' A' ' 18' ' ' VAL . 69.9 t60 -65.14 -51.48 60.98 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.506 -0.746 . . . . 0.0 109.705 179.317 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.431 ' HA ' ' HB ' ' A' ' 18' ' ' VAL . 0.8 OUTLIER -56.87 -36.45 70.08 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.428 -0.795 . . . . 0.0 110.224 179.457 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 5.6 t30 -56.53 -41.9 77.54 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.339 -0.85 . . . . 0.0 109.993 179.2 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.434 ' O ' HG12 ' A' ' 20' ' ' VAL . 7.3 mt -86.28 -20.42 7.89 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 O-C-N 121.485 -0.759 . . . . 0.0 110.404 179.462 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.481 HG21 ' CE1' ' A' ' 14' ' ' HIS . 78.3 t -87.48 -12.92 10.55 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 O-C-N 121.27 -0.894 . . . . 0.0 110.331 179.631 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -118.14 24.15 11.16 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.385 -0.822 . . . . 0.0 110.137 179.257 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.449 HG13 ' N ' ' A' ' 21' ' ' GLN . 10.9 p -115.74 -40.6 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.045 0 O-C-N 121.296 -0.877 . . . . 0.0 110.427 179.914 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . 0.449 ' N ' HG13 ' A' ' 20' ' ' VAL . 1.5 mm100 -89.24 -7.8 54.79 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.523 -0.736 . . . . 0.0 110.686 179.868 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 23.6 m-85 -115.34 -14.51 11.63 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.359 -0.838 . . . . 0.0 110.735 -179.085 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -108.33 21.47 17.28 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.161 -0.962 . . . . 0.0 110.386 179.294 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -103.33 25.42 9.59 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.179 -0.951 . . . . 0.0 110.369 179.595 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 144.94 62.48 0.02 OUTLIER Glycine 0 N--CA 1.493 2.489 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -153.36 63.89 0.75 Allowed 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.539 -0.977 . . . . 0.0 110.118 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.533 ' HB2' ' HD3' ' A' ' 28' ' ' PRO . 2.3 m -68.08 -52.84 21.68 Favored Pre-proline 0 N--CA 1.498 1.933 0 O-C-N 121.498 -0.751 . . . . 0.0 110.972 -179.846 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.533 ' HD3' ' HB2' ' A' ' 27' ' ' SER . 49.3 Cg_endo -76.74 60.1 6.55 Favored 'Trans proline' 0 N--CA 1.487 1.131 0 O-C-N 123.462 1.243 . . . . 0.0 110.493 179.815 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -157.93 -57.32 0.08 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.399 -0.813 . . . . 0.0 110.102 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 82.1 mt -69.33 -22.8 25.99 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 O-C-N 121.437 -0.789 . . . . 0.0 110.418 179.64 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 24.5 p -61.7 -41.7 97.94 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.416 -0.803 . . . . 0.0 110.249 179.436 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.27 -24.26 64.86 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.521 -0.737 . . . . 0.0 110.418 179.611 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -80.96 -29.36 35.36 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.412 -0.805 . . . . 0.0 110.182 179.512 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 88.2 t -93.13 -38.67 10.21 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.453 -0.779 . . . . 0.0 110.519 -179.708 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.418 ' O ' ' HB2' ' A' ' 36' ' ' ARG . 11.7 t -102.32 12.04 7.37 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 O-C-N 121.315 -0.866 . . . . 0.0 111.049 -179.556 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.418 ' HB2' ' O ' ' A' ' 35' ' ' VAL . 1.8 mpp_? . . . . . 0 N--CA 1.505 2.278 0 O-C-N 121.318 -0.864 . . . . 0.0 111.196 179.75 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . 0.549 ' C ' HD23 ' A' ' 3' ' ' LEU . 58.9 p . . . . . 0 N--CA 1.495 1.805 0 CA-C-O 120.945 0.402 . . . . 0.0 110.238 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 56.24 80.96 0.13 Allowed 'General case' 0 N--CA 1.502 2.151 0 CA-C-O 121.41 0.624 . . . . 0.0 110.698 179.679 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.549 HD23 ' C ' ' A' ' 1' ' ' SER . 0.5 OUTLIER -160.32 93.05 1.63 Allowed Pre-proline 0 N--CA 1.495 1.815 0 O-C-N 121.431 -0.793 . . . . 0.0 110.224 179.701 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -84.26 64.26 6.89 Favored 'Trans proline' 0 C--N 1.307 -1.61 0 O-C-N 124.022 1.538 . . . . 0.0 110.466 -179.817 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 52.01 33.88 12.77 Favored 'General case' 0 N--CA 1.502 2.134 0 O-C-N 121.7 -0.625 . . . . 0.0 111.043 -179.795 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 55.7 32.93 20.33 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.522 -0.736 . . . . 0.0 110.952 -179.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 23.5 m -88.7 -9.95 50.18 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.251 -0.905 . . . . 0.0 111.002 179.826 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 12.5 p -103.16 39.95 1.48 Allowed 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.245 -0.909 . . . . 0.0 110.283 179.74 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -100.36 -47.22 1.72 Allowed Glycine 0 N--CA 1.493 2.477 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 179.842 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 6.3 mt -74.88 -39.31 61.59 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.596 -0.944 . . . . 0.0 110.562 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 14.2 tp -58.14 -49.46 76.9 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.436 -0.79 . . . . 0.0 110.213 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 27.2 m-70 -63.21 -39.19 93.93 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.572 -0.705 . . . . 0.0 109.703 179.247 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 7.2 tp -63.17 -40.13 96.64 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.487 -0.758 . . . . 0.0 109.789 179.082 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . 0.519 ' NE2' HG21 ' A' ' 18' ' ' VAL . 68.2 t60 -58.75 -54.06 51.39 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.575 -0.703 . . . . 0.0 109.71 179.391 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.447 ' O ' ' HB2' ' A' ' 19' ' ' ASP . 23.3 tp60 -53.34 -38.64 63.43 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.643 -0.661 . . . . 0.0 110.015 179.45 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -66.81 -37.46 84.57 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.572 -0.705 . . . . 0.0 110.606 179.392 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.409 ' O ' HG12 ' A' ' 20' ' ' VAL . 93.1 mt -82.04 -16.42 11.89 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.073 0 O-C-N 121.35 -0.844 . . . . 0.0 110.588 179.833 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.519 HG21 ' NE2' ' A' ' 14' ' ' HIS . 84.6 t -94.67 -53.04 8.8 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 121.165 -0.959 . . . . 0.0 109.489 179.64 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.447 ' HB2' ' O ' ' A' ' 15' ' ' GLN . 0.7 OUTLIER -59.12 -17.42 26.53 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.737 -0.602 . . . . 0.0 111.316 179.543 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.409 HG12 ' O ' ' A' ' 17' ' ' ILE . 14.9 p -57.44 -27.31 28.54 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.006 0 O-C-N 120.846 -1.159 . . . . 0.0 111.578 -179.842 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -100.51 -15.94 17.69 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.321 -0.862 . . . . 0.0 111.574 -179.183 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 7.4 m-85 -112.01 -30.9 7.08 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.07 -1.018 . . . . 0.0 110.735 -179.121 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -87.97 16.26 6.2 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.184 -0.947 . . . . 0.0 110.806 179.35 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -98.6 29.98 3.46 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.048 -1.032 . . . . 0.0 110.622 179.737 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -98.6 17.81 57.85 Favored Glycine 0 N--CA 1.496 2.688 0 N-CA-C 110.424 -1.07 . . . . 0.0 110.424 179.871 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 5.0 mp 52.37 36.06 18.91 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 121.481 -1.011 . . . . 0.0 111.311 179.704 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.487 ' N ' ' HD2' ' A' ' 28' ' ' PRO . 0.7 OUTLIER -61.47 -54.32 53.53 Favored Pre-proline 0 N--CA 1.501 2.114 0 O-C-N 121.244 -0.91 . . . . 0.0 110.694 179.815 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.487 ' HD2' ' N ' ' A' ' 27' ' ' SER . 44.2 Cg_endo -71.39 -27.29 19.48 Favored 'Trans proline' 0 N--CA 1.487 1.126 0 O-C-N 123.481 1.253 . . . . 0.0 110.647 179.553 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.8 -36.24 78.52 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.585 -0.697 . . . . 0.0 110.181 179.497 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -84.15 -30.76 7.53 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 121.354 -0.841 . . . . 0.0 109.938 179.4 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 53.9 m -71.01 -43.73 67.32 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.545 -0.722 . . . . 0.0 109.722 179.349 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 17.5 tttt -88.41 43.4 1.13 Allowed 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.516 -0.74 . . . . 0.0 109.957 179.348 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 21.5 t80 -151.93 -53.45 0.12 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.571 -0.706 . . . . 0.0 109.423 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 53.5 t -94.66 -34.04 5.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.631 -0.668 . . . . 0.0 109.697 179.19 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 21.9 t -112.13 52.34 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 121.338 -0.852 . . . . 0.0 109.799 179.732 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.505 2.284 0 CA-C-O 118.827 -0.606 . . . . 0.0 110.925 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 38.0 m . . . . . 0 N--CA 1.494 1.772 0 CA-C-O 121.009 0.433 . . . . 0.0 110.229 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -131.93 -171.46 2.63 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.573 -0.705 . . . . 0.0 110.47 -179.84 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.638 ' HB3' ' HD3' ' A' ' 4' ' ' PRO . 0.1 OUTLIER -164.96 -58.09 0.01 OUTLIER Pre-proline 0 N--CA 1.498 1.956 0 O-C-N 121.71 -0.619 . . . . 0.0 110.359 179.844 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.638 ' HD3' ' HB3' ' A' ' 3' ' ' LEU . 44.1 Cg_endo -70.29 -20.88 31.8 Favored 'Trans proline' 0 N--CA 1.49 1.315 0 O-C-N 123.197 1.104 . . . . 0.0 111.061 179.614 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -70.59 -20.8 62.73 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.387 -0.821 . . . . 0.0 110.747 179.709 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 6.3 tp -96.42 42.38 1.09 Allowed 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.27 -0.894 . . . . 0.0 110.396 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 30.8 p -84.26 -27.25 28.03 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.232 -0.918 . . . . 0.0 110.764 179.765 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 1.3 m -102.42 44.52 1.01 Allowed 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.384 -0.822 . . . . 0.0 110.228 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -98.65 -56.21 1.04 Allowed Glycine 0 N--CA 1.493 2.458 0 N-CA-C 109.261 -1.536 . . . . 0.0 109.261 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.4 mt -61.74 -35.77 79.03 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.755 -0.85 . . . . 0.0 110.492 179.867 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.8 tt -58.17 -47.75 82.42 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.438 -0.789 . . . . 0.0 109.935 179.645 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 24.1 m-70 -75.52 -42.06 53.61 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.6 -0.688 . . . . 0.0 109.87 179.456 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 11.4 tp -58.83 -42.66 89.75 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.464 -0.773 . . . . 0.0 110.403 179.701 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . 0.53 ' NE2' HG21 ' A' ' 18' ' ' VAL . 6.1 t-80 -59.43 -51.84 68.18 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.563 -0.711 . . . . 0.0 109.933 179.591 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 34.3 tp60 -58.04 -36.53 72.87 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.622 -0.674 . . . . 0.0 110.392 179.731 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -66.42 -41.13 89.7 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.507 -0.745 . . . . 0.0 110.826 179.931 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 73.5 mt -76.15 -43.37 37.76 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 O-C-N 121.262 -0.899 . . . . 0.0 110.505 -179.55 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.53 HG21 ' NE2' ' A' ' 14' ' ' HIS . 38.0 t -67.72 -36.38 75.8 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 O-C-N 121.416 -0.803 . . . . 0.0 110.661 -179.873 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -66.99 -18.53 65.43 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.428 -0.795 . . . . 0.0 110.666 179.508 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 80.6 t -100.64 -35.84 4.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.026 -1.046 . . . . 0.0 109.323 179.096 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -67.23 -39.98 86.31 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.739 -0.601 . . . . 0.0 110.579 179.811 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . 0.43 ' CD1' ' C ' ' A' ' 22' ' ' TYR . 0.2 OUTLIER -63.02 -33.13 74.77 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.248 -0.907 . . . . 0.0 110.548 -179.792 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -87.91 -40.37 14.0 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.454 -0.779 . . . . 0.0 110.622 -179.819 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 33.0 m-85 -93.44 21.93 5.75 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.299 -0.875 . . . . 0.0 110.735 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -155.64 67.29 0.3 Allowed Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.317 -1.513 . . . . 0.0 109.317 179.865 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.0 tp -82.02 -35.7 28.55 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.561 -0.964 . . . . 0.0 110.383 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.561 ' HB2' ' HD3' ' A' ' 28' ' ' PRO . 43.4 m -56.91 -51.36 82.12 Favored Pre-proline 0 N--CA 1.498 1.965 0 O-C-N 121.644 -0.66 . . . . 0.0 110.822 179.72 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.561 ' HD3' ' HB2' ' A' ' 27' ' ' SER . 43.6 Cg_endo -69.74 -23.36 30.97 Favored 'Trans proline' 0 N--CA 1.489 1.237 0 O-C-N 123.408 1.215 . . . . 0.0 111.033 179.41 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -80.47 -42.81 21.92 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.452 -0.78 . . . . 0.0 110.581 179.821 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.406 HG22 ' O ' ' A' ' 27' ' ' SER . 11.9 tt -71.85 -29.13 32.46 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 O-C-N 121.324 -0.86 . . . . 0.0 111.083 -179.614 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 2.9 p -65.97 -37.03 84.93 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.317 -0.864 . . . . 0.0 109.909 179.547 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 9.6 tptp -87.0 -25.64 24.16 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.416 -0.803 . . . . 0.0 109.796 178.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 71.1 t80 -68.16 -41.1 82.05 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.464 -0.773 . . . . 0.0 110.456 179.656 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.776 HG13 HG23 ' A' ' 35' ' ' VAL . 7.9 p -67.23 -31.73 54.39 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 O-C-N 121.335 -0.853 . . . . 0.0 110.405 179.693 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.776 HG23 HG13 ' A' ' 34' ' ' VAL . 85.1 t -96.36 -4.14 10.15 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 O-C-N 121.346 -0.846 . . . . 0.0 110.69 179.671 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 10.6 mmt85 . . . . . 0 N--CA 1.501 2.116 0 O-C-N 121.57 -0.706 . . . . 0.0 110.482 -179.933 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 13.4 m . . . . . 0 N--CA 1.496 1.833 0 CA-C-O 121.223 0.535 . . . . 0.0 109.954 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -138.88 -170.37 2.84 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.497 -0.752 . . . . 0.0 110.269 -179.54 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.433 ' N ' ' HD3' ' A' ' 4' ' ' PRO . 0.3 OUTLIER 54.17 63.4 7.59 Favored Pre-proline 0 N--CA 1.502 2.152 0 O-C-N 121.696 -0.627 . . . . 0.0 110.892 179.949 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.433 ' HD3' ' N ' ' A' ' 3' ' ' LEU . 47.7 Cg_endo -83.17 63.14 7.7 Favored 'Trans proline' 0 C--N 1.312 -1.376 0 O-C-N 123.779 1.41 . . . . 0.0 110.494 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -122.2 55.95 1.12 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.394 -0.816 . . . . 0.0 110.092 179.871 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -77.73 -57.7 3.67 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.441 -0.787 . . . . 0.0 110.117 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 75.3 m -139.58 -88.05 0.2 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.412 -0.805 . . . . 0.0 110.13 179.864 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 3.9 m -148.94 54.94 0.99 Allowed 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.383 -0.823 . . . . 0.0 109.965 179.904 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -103.68 -85.26 1.85 Allowed Glycine 0 N--CA 1.495 2.617 0 N-CA-C 109.851 -1.3 . . . . 0.0 109.851 -179.619 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.406 HD22 ' CB ' ' A' ' 4' ' ' PRO . 1.1 mp -58.73 -39.7 81.6 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.654 -0.909 . . . . 0.0 110.383 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -58.25 -48.37 80.63 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.526 -0.734 . . . . 0.0 109.829 179.392 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -66.76 -43.19 84.72 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.652 -0.655 . . . . 0.0 109.681 179.24 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.0 tt -58.07 -41.0 82.45 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.661 -0.649 . . . . 0.0 110.028 179.38 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . 0.433 ' CE1' HG21 ' A' ' 18' ' ' VAL . 82.9 t60 -59.31 -46.0 89.78 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.529 -0.732 . . . . 0.0 109.808 179.368 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.435 ' O ' ' HB2' ' A' ' 19' ' ' ASP . 0.4 OUTLIER -65.91 -34.27 77.73 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.501 -0.749 . . . . 0.0 109.662 179.193 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -64.94 -14.99 61.58 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.372 -0.83 . . . . 0.0 110.596 179.15 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 38.5 mm -107.81 -38.51 4.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.356 -0.84 . . . . 0.0 109.66 179.652 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.433 HG21 ' CE1' ' A' ' 14' ' ' HIS . 71.4 t -83.89 -42.6 17.37 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 O-C-N 121.495 -0.753 . . . . 0.0 110.743 -179.714 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.466 ' HA ' ' CD2' ' A' ' 22' ' ' TYR . 0.2 OUTLIER -77.23 -2.8 36.48 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.551 -0.718 . . . . 0.0 111.452 -179.663 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 63.2 t -108.68 -28.37 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 120.833 -1.167 . . . . 0.0 110.263 179.458 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 15.2 mt-30 -79.61 -37.39 36.25 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.169 -0.957 . . . . 0.0 110.216 179.438 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . 0.466 ' CD2' ' HA ' ' A' ' 19' ' ' ASP . 0.6 OUTLIER -64.08 -32.25 73.74 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.484 -0.76 . . . . 0.0 110.458 179.839 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -84.82 -13.74 50.15 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.5 -0.75 . . . . 0.0 110.991 179.837 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -98.9 43.03 1.07 Allowed 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.094 -1.004 . . . . 0.0 110.342 -180.0 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -160.56 50.67 0.36 Allowed Glycine 0 N--CA 1.494 2.547 0 N-CA-C 109.749 -1.341 . . . . 0.0 109.749 179.861 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.3 mp -112.05 -8.91 14.02 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.312 -1.11 . . . . 0.0 111.213 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.534 ' HB2' ' HD3' ' A' ' 28' ' ' PRO . 26.5 m -61.61 -51.04 79.57 Favored Pre-proline 0 N--CA 1.499 1.999 0 O-C-N 121.223 -0.923 . . . . 0.0 111.105 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.534 ' HD3' ' HB2' ' A' ' 27' ' ' SER . 45.1 Cg_endo -70.72 -17.77 32.96 Favored 'Trans proline' 0 N--CA 1.49 1.269 0 O-C-N 123.417 1.22 . . . . 0.0 111.224 179.823 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -80.32 -41.38 24.94 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.265 -0.897 . . . . 0.0 110.501 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 32.3 mm -69.64 -43.23 80.43 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 O-C-N 121.345 -0.847 . . . . 0.0 110.718 -179.852 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.542 ' HA ' HG12 ' A' ' 34' ' ' VAL . 12.1 t -63.25 -31.78 73.02 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.475 -0.766 . . . . 0.0 110.626 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 45.0 tttt -73.49 -29.11 62.29 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.284 -0.885 . . . . 0.0 109.937 179.201 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 24.4 t80 -83.02 -45.05 14.53 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.566 -0.709 . . . . 0.0 109.701 179.282 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.92 HG13 HG23 ' A' ' 35' ' ' VAL . 3.4 p -79.89 170.13 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 O-C-N 121.547 -0.721 . . . . 0.0 110.115 179.731 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.92 HG23 HG13 ' A' ' 34' ' ' VAL . 38.8 t 60.19 75.92 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.215 0 O-C-N 121.597 -0.689 . . . . 0.0 110.176 -179.723 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 14.1 ttp180 . . . . . 0 N--CA 1.496 1.826 0 CA-C-O 118.246 -0.883 . . . . 0.0 110.261 -179.963 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . 0.444 ' O ' ' HB2' ' A' ' 2' ' ' ASP . 23.9 m . . . . . 0 N--CA 1.496 1.832 0 CA-C-O 120.803 0.335 . . . . 0.0 110.167 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.444 ' HB2' ' O ' ' A' ' 1' ' ' SER . 17.8 m-20 61.67 177.42 0.12 Allowed 'General case' 0 N--CA 1.502 2.166 0 CA-C-O 121.348 0.594 . . . . 0.0 110.946 -179.816 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.439 ' N ' ' HD3' ' A' ' 4' ' ' PRO . 0.4 OUTLIER 52.09 66.45 5.07 Favored Pre-proline 0 N--CA 1.5 2.06 0 O-C-N 121.684 -0.635 . . . . 0.0 110.63 -179.859 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.439 ' HD3' ' N ' ' A' ' 3' ' ' LEU . 46.2 Cg_endo -92.07 -157.58 0.06 OUTLIER 'Trans proline' 0 C--N 1.311 -1.396 0 C-N-CA 121.787 1.658 . . . . 0.0 110.531 -179.802 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 52.55 37.38 22.96 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.545 -0.722 . . . . 0.0 111.165 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 54.27 34.93 21.52 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.563 -0.71 . . . . 0.0 110.811 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 7.6 t 53.32 34.85 18.81 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.546 -0.721 . . . . 0.0 111.313 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 14.4 t -160.98 33.0 0.15 Allowed 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.148 -0.97 . . . . 0.0 110.914 179.752 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -67.28 -52.19 33.17 Favored Glycine 0 N--CA 1.496 2.696 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 179.617 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -65.94 -40.46 91.37 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.533 -0.981 . . . . 0.0 109.92 179.559 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.9 tt -61.01 -44.99 96.61 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.579 -0.7 . . . . 0.0 109.776 179.347 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -68.32 -44.47 75.31 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.578 -0.701 . . . . 0.0 109.763 179.409 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -63.35 -37.36 86.95 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.544 -0.722 . . . . 0.0 110.049 179.434 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . 0.465 ' CD2' HG21 ' A' ' 18' ' ' VAL . 14.1 t-80 -57.07 -58.08 9.75 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.576 -0.702 . . . . 0.0 109.645 179.538 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.424 ' O ' ' HB2' ' A' ' 19' ' ' ASP . 0.1 OUTLIER -59.78 -38.95 83.3 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.353 -0.842 . . . . 0.0 110.031 179.19 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -59.22 -43.84 92.3 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.399 -0.813 . . . . 0.0 110.603 179.674 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 22.2 mm -81.87 -36.06 13.95 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 O-C-N 121.232 -0.917 . . . . 0.0 110.47 179.867 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.595 ' HA ' ' CE1' ' A' ' 22' ' ' TYR . 69.7 t -75.71 -8.6 11.85 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 O-C-N 121.493 -0.754 . . . . 0.0 111.663 -179.469 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.424 ' HB2' ' O ' ' A' ' 15' ' ' GLN . 0.4 OUTLIER -119.56 27.93 8.47 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 120.942 -1.099 . . . . 0.0 110.93 179.781 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 42.4 t -130.81 -56.91 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 O-C-N 121.097 -1.002 . . . . 0.0 109.983 179.579 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -65.24 -10.38 31.48 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.745 -0.597 . . . . 0.0 110.9 179.52 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . 0.595 ' CE1' ' HA ' ' A' ' 18' ' ' VAL . 34.0 m-85 -103.85 -1.64 27.48 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.231 -0.918 . . . . 0.0 110.82 -179.539 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -132.33 26.33 4.48 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.233 -0.917 . . . . 0.0 110.582 179.807 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -120.62 15.63 11.94 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.145 -0.972 . . . . 0.0 111.009 179.864 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -117.33 37.85 3.18 Favored Glycine 0 N--CA 1.495 2.614 0 N-CA-C 109.986 -1.246 . . . . 0.0 109.986 179.837 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.422 ' HA ' HD12 ' A' ' 30' ' ' ILE . 1.2 mt -114.24 22.45 13.77 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.402 -1.058 . . . . 0.0 110.425 179.658 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.45 ' CB ' ' CD ' ' A' ' 28' ' ' PRO . 0.0 OUTLIER -164.18 -61.49 0.01 OUTLIER Pre-proline 0 N--CA 1.498 1.934 0 O-C-N 121.416 -0.803 . . . . 0.0 110.144 179.828 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.45 ' CD ' ' CB ' ' A' ' 27' ' ' SER . 46.0 Cg_endo -71.85 -17.02 29.35 Favored 'Trans proline' 0 N--CA 1.489 1.252 0 O-C-N 123.08 1.042 . . . . 0.0 110.944 179.284 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -100.46 -12.09 19.63 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.4 -0.813 . . . . 0.0 111.002 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.422 HD12 ' HA ' ' A' ' 26' ' ' LEU . 73.6 mt -118.82 -49.08 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.177 -0.952 . . . . 0.0 110.231 -179.768 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 2.4 m -69.98 -31.15 68.71 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.595 -0.69 . . . . 0.0 110.504 -179.854 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.436 ' HG3' ' HA ' ' A' ' 28' ' ' PRO . 12.8 mmtp -87.83 6.2 36.5 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.259 -0.9 . . . . 0.0 110.797 179.635 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -103.33 -41.25 6.09 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.286 -0.884 . . . . 0.0 110.066 179.752 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 16.6 t -89.41 54.01 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 121.446 -0.784 . . . . 0.0 109.451 179.469 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.409 ' O ' HG13 ' A' ' 35' ' ' VAL . 8.8 p -157.79 35.62 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 121.356 -0.84 . . . . 0.0 110.292 -179.663 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.496 1.855 0 CA-C-O 117.838 -1.077 . . . . 0.0 110.313 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.494 1.763 0 CA-C-O 120.965 0.412 . . . . 0.0 110.186 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -116.84 45.93 1.75 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.53 -0.731 . . . . 0.0 110.125 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.452 ' N ' ' HD3' ' A' ' 4' ' ' PRO . 0.7 OUTLIER -153.5 64.76 5.12 Favored Pre-proline 0 N--CA 1.496 1.829 0 O-C-N 121.54 -0.725 . . . . 0.0 110.157 179.941 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.452 ' HD3' ' N ' ' A' ' 3' ' ' LEU . 47.0 Cg_endo -87.53 74.57 2.45 Favored 'Trans proline' 0 C--N 1.311 -1.43 0 C-N-CA 121.523 1.482 . . . . 0.0 110.543 -179.609 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -115.45 -55.64 2.43 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.436 -0.79 . . . . 0.0 110.412 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER 54.15 43.45 30.64 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.642 -0.661 . . . . 0.0 110.758 179.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 12.5 m -80.32 -9.22 59.74 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.33 -0.856 . . . . 0.0 111.151 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.564 HG22 ' HB2' ' A' ' 12' ' ' HIS . 5.6 m 60.54 78.94 0.26 Allowed 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.579 -0.701 . . . . 0.0 110.287 -179.89 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -103.17 -78.39 1.28 Allowed Glycine 0 N--CA 1.495 2.606 0 N-CA-C 109.32 -1.512 . . . . 0.0 109.32 179.804 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.456 HD22 ' HA ' ' A' ' 10' ' ' LEU . 0.2 OUTLIER -61.06 -41.56 96.84 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.504 -0.997 . . . . 0.0 110.038 179.485 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.471 HD22 ' HA ' ' A' ' 11' ' ' LEU . 0.2 OUTLIER -59.26 -42.01 90.17 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.563 -0.711 . . . . 0.0 109.796 179.371 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . 0.564 ' HB2' HG22 ' A' ' 8' ' ' THR . 6.5 t-80 -65.27 -37.46 87.25 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.594 -0.691 . . . . 0.0 109.833 179.242 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.466 HD22 ' HA ' ' A' ' 13' ' ' LEU . 0.2 OUTLIER -61.77 -42.53 99.11 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.465 -0.772 . . . . 0.0 109.399 179.006 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . 0.443 ' NE2' HG21 ' A' ' 18' ' ' VAL . 4.7 t-80 -67.08 -48.07 69.33 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.642 -0.661 . . . . 0.0 109.403 178.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 30.5 mm100 -60.17 -34.49 73.66 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.558 -0.714 . . . . 0.0 109.988 179.385 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.49 ' O ' HG23 ' A' ' 20' ' ' VAL . 10.1 t30 -61.98 -50.35 72.43 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.429 -0.794 . . . . 0.0 110.137 179.421 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 49.7 mt -71.13 -19.47 21.07 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 O-C-N 121.262 -0.899 . . . . 0.0 110.793 179.783 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.443 HG21 ' NE2' ' A' ' 14' ' ' HIS . 47.0 t -97.24 -8.79 9.16 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 O-C-N 121.258 -0.901 . . . . 0.0 111.232 -179.592 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -123.03 27.84 7.47 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.06 -1.025 . . . . 0.0 110.886 179.592 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.49 HG23 ' O ' ' A' ' 16' ' ' ASN . 39.3 t -124.31 -56.48 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 O-C-N 121.14 -0.975 . . . . 0.0 109.381 179.254 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 14.2 mp0 -68.11 -15.67 63.69 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.824 -0.547 . . . . 0.0 110.595 179.33 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . 0.425 ' CE2' ' HA ' ' A' ' 18' ' ' VAL . 17.6 m-85 -105.33 -42.36 5.27 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.374 -0.829 . . . . 0.0 110.143 -179.637 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.58 -32.44 64.14 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.462 -0.774 . . . . 0.0 110.34 179.796 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -97.1 40.59 1.14 Allowed 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.292 -0.88 . . . . 0.0 110.38 179.523 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -81.32 -33.16 29.35 Favored Glycine 0 N--CA 1.497 2.734 0 N-CA-C 110.149 -1.18 . . . . 0.0 110.149 179.87 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 59.9 38.74 20.99 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.562 -0.963 . . . . 0.0 110.609 -179.895 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.513 ' CB ' ' CD ' ' A' ' 28' ' ' PRO . 0.4 OUTLIER -169.77 -63.04 0.01 OUTLIER Pre-proline 0 N--CA 1.498 1.944 0 O-C-N 121.54 -0.725 . . . . 0.0 110.186 179.69 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.513 ' CD ' ' CB ' ' A' ' 27' ' ' SER . 43.3 Cg_endo -69.48 -27.33 27.93 Favored 'Trans proline' 0 N--CA 1.49 1.265 0 O-C-N 123.393 1.207 . . . . 0.0 110.76 179.664 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.76 -37.22 83.47 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.579 -0.7 . . . . 0.0 110.289 179.51 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 58.9 mt -79.25 -39.42 21.06 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 121.466 -0.771 . . . . 0.0 109.873 179.52 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 99.8 m -65.0 -45.02 87.33 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.58 -0.7 . . . . 0.0 109.965 179.524 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -67.03 -20.99 65.94 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.485 -0.759 . . . . 0.0 110.785 179.651 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -72.65 -24.09 61.0 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.361 -0.837 . . . . 0.0 110.543 179.615 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 55.6 t -110.29 -65.97 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.266 -0.896 . . . . 0.0 110.275 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 36.6 t 54.2 72.55 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.159 0 O-C-N 121.693 -0.629 . . . . 0.0 110.167 -179.724 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 1.5 ttp180 . . . . . 0 N--CA 1.502 2.133 0 CA-C-O 118.171 -0.919 . . . . 0.0 110.721 -179.735 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 22.0 m . . . . . 0 N--CA 1.494 1.746 0 CA-C-O 120.838 0.351 . . . . 0.0 110.172 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.602 ' HB3' ' HA2' ' A' ' 9' ' ' GLY . 21.9 m-20 52.16 36.42 19.1 Favored 'General case' 0 N--CA 1.502 2.141 0 CA-C-O 121.305 0.574 . . . . 0.0 110.929 -179.813 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.609 ' HB2' ' HD3' ' A' ' 4' ' ' PRO . 7.7 mt -77.58 -51.11 1.92 Allowed Pre-proline 0 N--CA 1.497 1.922 0 O-C-N 121.286 -0.884 . . . . 0.0 110.825 -179.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.609 ' HD3' ' HB2' ' A' ' 3' ' ' LEU . 53.2 Cg_endo -84.08 18.22 1.57 Allowed 'Trans proline' 0 N--CA 1.484 0.945 0 O-C-N 123.382 1.201 . . . . 0.0 111.441 179.543 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 55.95 34.83 24.39 Favored 'General case' 0 N--CA 1.503 2.2 0 O-C-N 121.317 -0.864 . . . . 0.0 111.094 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.577 HD12 ' HG2' ' A' ' 4' ' ' PRO . 12.7 mt -73.31 -32.13 64.42 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.406 -0.809 . . . . 0.0 110.769 -179.917 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 37.4 m -123.48 -77.12 0.59 Allowed 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.371 -0.831 . . . . 0.0 110.504 -179.903 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -126.67 35.44 4.63 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.374 -0.829 . . . . 0.0 110.564 -179.828 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.602 ' HA2' ' HB3' ' A' ' 2' ' ' ASP . . . -71.72 -58.75 5.16 Favored Glycine 0 N--CA 1.493 2.492 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 179.66 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.36 -39.17 89.64 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.636 -0.92 . . . . 0.0 110.284 179.725 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.8 tt -59.03 -48.36 81.86 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.446 -0.784 . . . . 0.0 109.783 179.433 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 21.7 m170 -69.16 -44.3 72.56 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.679 -0.638 . . . . 0.0 109.672 179.213 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.7 mt -56.88 -41.87 78.8 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.605 -0.685 . . . . 0.0 110.06 179.489 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . 0.602 ' O ' HG23 ' A' ' 18' ' ' VAL . 5.7 t-80 -63.17 -46.86 85.17 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.652 -0.655 . . . . 0.0 109.812 179.321 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 25.2 tp60 -54.1 -41.88 68.75 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.645 -0.659 . . . . 0.0 110.698 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.48 ' O ' HG23 ' A' ' 20' ' ' VAL . 7.5 t-20 -66.95 -47.82 70.45 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.395 -0.815 . . . . 0.0 110.384 179.781 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 74.4 mt -57.94 -38.6 67.38 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.111 0 O-C-N 121.422 -0.799 . . . . 0.0 109.91 179.83 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.602 HG23 ' O ' ' A' ' 14' ' ' HIS . 47.5 t -72.22 -35.88 54.17 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.528 -0.732 . . . . 0.0 109.706 179.302 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -68.8 -15.52 63.53 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.734 -0.604 . . . . 0.0 110.966 179.516 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.48 HG23 ' O ' ' A' ' 16' ' ' ASN . 47.7 t -102.56 -40.68 7.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.135 -0.978 . . . . 0.0 109.481 179.322 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.11 -39.44 94.04 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.689 -0.632 . . . . 0.0 110.75 179.883 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -63.49 -29.23 70.53 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.302 -0.873 . . . . 0.0 110.665 -179.83 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -103.6 17.97 22.92 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.362 -0.836 . . . . 0.0 111.032 179.709 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -118.53 24.33 10.97 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.116 -0.99 . . . . 0.0 110.672 179.82 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 61.51 39.87 97.92 Favored Glycine 0 N--CA 1.496 2.699 0 N-CA-C 110.153 -1.179 . . . . 0.0 110.153 179.821 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 23.8 mt -122.08 4.74 9.84 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.235 -1.156 . . . . 0.0 111.371 -179.851 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.523 ' HB2' ' HD3' ' A' ' 28' ' ' PRO . 3.0 m -69.82 -59.44 4.53 Favored Pre-proline 0 N--CA 1.498 1.933 0 O-C-N 121.015 -1.053 . . . . 0.0 110.416 179.86 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.523 ' HD3' ' HB2' ' A' ' 27' ' ' SER . 45.8 Cg_endo -71.52 -25.73 20.82 Favored 'Trans proline' 0 N--CA 1.488 1.165 0 O-C-N 123.395 1.208 . . . . 0.0 110.62 179.402 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.29 -35.64 81.49 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.584 -0.697 . . . . 0.0 110.597 179.734 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 26.1 mm -79.54 -38.41 19.54 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 O-C-N 121.323 -0.861 . . . . 0.0 110.165 179.809 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 24.4 m -62.19 -38.65 89.94 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.432 -0.793 . . . . 0.0 109.958 179.623 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.7 tmtt? -69.92 -35.7 74.78 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.291 -0.88 . . . . 0.0 110.206 179.482 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 80.6 t80 -76.61 -41.1 47.26 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.587 -0.696 . . . . 0.0 110.118 179.671 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 47.1 t -98.66 79.03 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.458 -0.776 . . . . 0.0 109.837 179.871 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 4.9 p -138.32 17.83 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 O-C-N 121.42 -0.8 . . . . 0.0 110.97 -179.777 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 30.8 mtp180 . . . . . 0 N--CA 1.495 1.8 0 O-C-N 121.185 -0.947 . . . . 0.0 110.303 179.921 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 4.2 p . . . . . 0 N--CA 1.497 1.88 0 CA-C-O 121.139 0.495 . . . . 0.0 110.31 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -143.3 151.87 41.0 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.526 -0.734 . . . . 0.0 110.333 -179.913 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.438 ' N ' ' HD3' ' A' ' 4' ' ' PRO . 0.3 OUTLIER -143.91 66.31 14.76 Favored Pre-proline 0 N--CA 1.497 1.881 0 O-C-N 121.467 -0.771 . . . . 0.0 110.426 179.899 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.438 ' HD3' ' N ' ' A' ' 3' ' ' LEU . 48.1 Cg_endo -89.61 -151.66 0.04 OUTLIER 'Trans proline' 0 C--N 1.31 -1.456 0 C-N-CA 121.618 1.545 . . . . 0.0 109.991 179.942 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -61.87 -32.46 72.81 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.215 -0.928 . . . . 0.0 110.711 179.777 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.2 tp 58.49 27.1 15.09 Favored 'General case' 0 N--CA 1.503 2.178 0 O-C-N 121.59 -0.694 . . . . 0.0 111.248 179.994 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 4.2 m -112.05 -46.05 3.25 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.002 -1.061 . . . . 0.0 110.398 179.852 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 69.7 p -113.44 47.73 1.12 Allowed 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.533 -0.729 . . . . 0.0 110.211 179.808 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -95.71 -74.49 1.22 Allowed Glycine 0 N--CA 1.494 2.515 0 N-CA-C 109.034 -1.626 . . . . 0.0 109.034 179.721 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 10.5 tp -87.81 -39.0 15.24 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.568 -0.96 . . . . 0.0 109.89 179.386 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.2 tt -59.63 -48.81 80.21 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.52 -0.737 . . . . 0.0 110.277 179.779 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 7.4 t-80 -61.57 -40.66 95.54 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.514 -0.741 . . . . 0.0 110.306 179.884 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 5.2 tp -56.5 -43.03 79.3 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.422 -0.799 . . . . 0.0 109.614 179.247 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . 0.519 ' NE2' HG21 ' A' ' 18' ' ' VAL . 76.4 t60 -66.77 -45.87 77.11 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.677 -0.639 . . . . 0.0 109.289 178.935 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 3.7 mm-40 -62.24 -35.84 80.17 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.548 -0.72 . . . . 0.0 110.081 179.247 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -60.5 -38.35 84.06 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.519 -0.738 . . . . 0.0 110.421 179.617 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.555 ' O ' HG12 ' A' ' 20' ' ' VAL . 28.9 mt -86.16 -36.88 11.09 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 O-C-N 121.347 -0.846 . . . . 0.0 110.221 179.958 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.519 HG21 ' NE2' ' A' ' 14' ' ' HIS . 55.1 t -70.77 -34.11 55.19 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 O-C-N 121.324 -0.86 . . . . 0.0 110.512 179.888 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.515 ' HA ' ' CD1' ' A' ' 22' ' ' TYR . 1.2 t70 -89.37 14.39 11.3 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.379 -0.826 . . . . 0.0 111.352 -179.914 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.555 HG12 ' O ' ' A' ' 17' ' ' ILE . 0.8 OUTLIER -118.93 -20.51 5.0 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 120.916 -1.115 . . . . 0.0 110.773 179.256 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -100.2 -29.22 12.6 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.269 -0.894 . . . . 0.0 110.311 179.78 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . 0.515 ' CD1' ' HA ' ' A' ' 19' ' ' ASP . 2.9 p90 -64.09 -22.97 67.15 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.413 -0.805 . . . . 0.0 110.89 179.891 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 1.9 ttp -93.6 -29.12 15.64 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.228 -0.92 . . . . 0.0 110.703 -179.975 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 41.3 m-85 -95.76 39.92 1.13 Allowed 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.281 -0.887 . . . . 0.0 110.649 179.999 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -83.01 -27.43 41.0 Favored Glycine 0 N--CA 1.495 2.62 0 N-CA-C 110.361 -1.096 . . . . 0.0 110.361 -179.872 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.484 HD13 ' HA ' ' A' ' 26' ' ' LEU . 3.7 mm? -97.31 42.7 1.08 Allowed 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.227 -1.161 . . . . 0.0 110.48 -179.876 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.677 ' HB3' ' HD3' ' A' ' 28' ' ' PRO . 8.0 t -65.02 -52.95 45.41 Favored Pre-proline 0 N--CA 1.497 1.884 0 O-C-N 121.25 -0.906 . . . . 0.0 110.429 179.731 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.677 ' HD3' ' HB3' ' A' ' 27' ' ' SER . 53.2 Cg_endo -81.19 51.71 4.03 Favored 'Trans proline' 0 N--CA 1.484 0.954 0 O-C-N 123.191 1.101 . . . . 0.0 110.508 179.26 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -152.06 -59.36 0.15 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.306 -0.871 . . . . 0.0 109.767 179.855 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 15.8 mt -68.05 -35.53 72.05 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 O-C-N 121.553 -0.717 . . . . 0.0 109.793 179.432 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 1.8 m -70.58 -45.62 65.01 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.672 -0.643 . . . . 0.0 109.715 179.468 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 3.4 mttm -60.37 -32.14 71.0 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.65 -0.656 . . . . 0.0 110.404 179.638 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 88.9 t80 -72.97 -36.61 67.15 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.638 -0.663 . . . . 0.0 110.333 179.615 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 75.8 t -76.79 -23.96 15.33 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 O-C-N 121.422 -0.798 . . . . 0.0 110.842 -179.885 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 25.6 t -104.2 58.87 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 O-C-N 121.212 -0.93 . . . . 0.0 109.918 179.988 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.497 1.919 0 CA-C-O 117.838 -1.077 . . . . 0.0 110.54 179.863 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 21.4 p . . . . . 0 N--CA 1.495 1.787 0 CA-C-O 121.008 0.432 . . . . 0.0 110.179 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 26.5 m-20 -119.47 33.11 5.77 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.483 -0.761 . . . . 0.0 110.648 -179.793 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.569 ' HB3' ' HD3' ' A' ' 4' ' ' PRO . 0.9 OUTLIER -80.12 -50.95 1.13 Allowed Pre-proline 0 N--CA 1.497 1.891 0 O-C-N 121.411 -0.805 . . . . 0.0 110.84 179.837 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.569 ' HD3' ' HB3' ' A' ' 3' ' ' LEU . 51.3 Cg_endo -81.23 54.04 5.01 Favored 'Trans proline' 0 N--CA 1.485 0.984 0 O-C-N 123.365 1.192 . . . . 0.0 110.808 179.938 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -102.02 -42.61 6.04 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.12 -0.988 . . . . 0.0 110.252 179.757 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.442 HD13 ' HA ' ' A' ' 6' ' ' LEU . 0.8 OUTLIER -96.15 36.83 1.29 Allowed 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.383 -0.823 . . . . 0.0 110.412 179.858 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 49.5 m -94.24 10.47 33.88 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.289 -0.882 . . . . 0.0 110.806 179.648 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 21.9 p -116.76 25.77 10.31 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.239 -0.913 . . . . 0.0 110.333 179.619 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -63.3 -50.99 58.27 Favored Glycine 0 N--CA 1.496 2.638 0 N-CA-C 110.211 -1.155 . . . . 0.0 110.211 -179.664 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.431 HD13 ' HA ' ' A' ' 10' ' ' LEU . 3.5 mm? -64.37 -45.38 87.99 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.438 -1.036 . . . . 0.0 110.409 -179.958 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 13.9 tp -61.41 -44.83 96.46 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.518 -0.739 . . . . 0.0 110.085 179.668 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -64.03 -38.5 91.29 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.547 -0.721 . . . . 0.0 109.794 179.361 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 12.1 tp -60.14 -41.4 92.64 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.46 -0.775 . . . . 0.0 109.771 179.122 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 6.7 t-160 -62.5 -50.77 70.08 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.589 -0.694 . . . . 0.0 109.656 179.288 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 22.5 tp60 -57.72 -36.29 71.82 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.56 -0.713 . . . . 0.0 110.291 179.549 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.629 ' O ' HG23 ' A' ' 20' ' ' VAL . 0.7 OUTLIER -64.38 -35.86 82.28 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.446 -0.784 . . . . 0.0 110.796 179.696 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 34.3 mt -88.0 -32.37 6.07 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 121.236 -0.915 . . . . 0.0 110.675 -179.639 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -71.37 -42.8 73.78 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 121.284 -0.885 . . . . 0.0 110.224 -179.95 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.685 ' HA ' ' CD2' ' A' ' 22' ' ' TYR . 1.1 t70 -63.33 -24.45 67.86 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.427 -0.796 . . . . 0.0 110.814 179.585 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.629 HG23 ' O ' ' A' ' 16' ' ' ASN . 44.5 t -60.38 -39.99 82.67 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 121.444 -0.785 . . . . 0.0 110.59 179.705 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 8.2 mm100 -64.81 -21.35 66.77 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.398 -0.814 . . . . 0.0 110.747 179.841 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . 0.685 ' CD2' ' HA ' ' A' ' 19' ' ' ASP . 1.5 m-85 -92.86 -49.56 5.99 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.176 -0.952 . . . . 0.0 109.526 179.766 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -72.02 -39.51 69.13 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.287 -0.883 . . . . 0.0 110.123 179.56 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -101.51 48.11 0.89 Allowed 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.539 -0.725 . . . . 0.0 109.93 179.648 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -179.95 -51.3 0.08 OUTLIER Glycine 0 N--CA 1.495 2.578 0 N-CA-C 109.902 -1.279 . . . . 0.0 109.902 -179.918 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.904 ' HG ' ' HB3' ' A' ' 29' ' ' ALA . 0.5 OUTLIER -94.78 23.36 5.52 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.504 -0.998 . . . . 0.0 111.369 -179.801 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.543 ' HB3' ' HD3' ' A' ' 28' ' ' PRO . 12.8 t -62.75 -49.5 82.21 Favored Pre-proline 0 N--CA 1.501 2.116 0 O-C-N 121.119 -0.988 . . . . 0.0 111.185 179.738 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.543 ' HD3' ' HB3' ' A' ' 27' ' ' SER . 47.0 Cg_endo -72.76 -9.63 24.04 Favored 'Trans proline' 0 N--CA 1.489 1.246 0 O-C-N 123.314 1.165 . . . . 0.0 111.468 -179.858 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.904 ' HB3' ' HG ' ' A' ' 26' ' ' LEU . . . -99.72 -48.22 4.79 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.278 -0.889 . . . . 0.0 110.372 179.899 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.634 ' HB ' HD23 ' A' ' 26' ' ' LEU . 16.8 tt -62.08 -25.42 37.39 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 O-C-N 121.434 -0.791 . . . . 0.0 111.297 -179.789 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 6.1 t -68.46 -28.47 67.07 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.269 -0.894 . . . . 0.0 110.507 179.831 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -111.15 20.82 17.02 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.388 -0.82 . . . . 0.0 110.237 179.293 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -121.7 -45.75 2.27 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.335 -0.853 . . . . 0.0 110.447 -179.925 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 93.6 t -64.87 -31.18 52.73 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 O-C-N 121.351 -0.843 . . . . 0.0 110.124 179.837 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 15.3 t -96.22 54.35 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 121.495 -0.753 . . . . 0.0 109.293 179.54 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.5 2.04 0 CA-C-O 117.874 -1.06 . . . . 0.0 110.476 -179.82 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 12.4 m . . . . . 0 N--CA 1.495 1.796 0 CA-C-O 121.267 0.556 . . . . 0.0 109.923 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -138.12 164.13 29.9 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.47 -0.769 . . . . 0.0 110.339 -179.471 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.543 ' N ' ' HD3' ' A' ' 4' ' ' PRO . 5.5 tp -149.14 58.99 3.76 Favored Pre-proline 0 N--CA 1.495 1.815 0 O-C-N 121.574 -0.704 . . . . 0.0 110.404 179.782 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.543 ' HD3' ' N ' ' A' ' 3' ' ' LEU . 49.2 Cg_endo -88.09 -151.54 0.04 OUTLIER 'Trans proline' 0 C--N 1.316 -1.176 0 C-N-CA 121.376 1.384 . . . . 0.0 110.246 179.984 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -130.53 -53.99 1.09 Allowed 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.144 -0.973 . . . . 0.0 110.321 179.934 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -66.39 -35.12 79.53 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.483 -0.76 . . . . 0.0 110.593 179.981 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.4 m -91.29 18.74 6.67 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.281 -0.887 . . . . 0.0 110.932 179.652 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.551 HG22 ' HB2' ' A' ' 12' ' ' HIS . 22.4 m -114.62 47.33 1.26 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.147 -0.971 . . . . 0.0 109.895 179.637 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -103.21 -76.66 1.15 Allowed Glycine 0 N--CA 1.493 2.448 0 N-CA-C 108.771 -1.732 . . . . 0.0 108.771 179.688 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.1 mp -64.14 -41.21 97.28 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.697 -0.884 . . . . 0.0 109.958 179.335 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.8 tt -58.2 -46.54 85.65 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.622 -0.674 . . . . 0.0 110.02 179.514 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . 0.551 ' HB2' HG22 ' A' ' 8' ' ' THR . 50.7 t60 -62.61 -39.59 94.26 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.683 -0.636 . . . . 0.0 109.755 179.312 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 6.8 tp -61.93 -39.74 93.09 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.557 -0.715 . . . . 0.0 110.251 179.501 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . 0.546 ' NE2' HG21 ' A' ' 18' ' ' VAL . 5.8 t-80 -60.94 -53.05 62.08 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.571 -0.706 . . . . 0.0 109.865 179.633 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -56.8 -36.92 70.46 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.571 -0.706 . . . . 0.0 110.226 179.688 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.437 ' O ' ' HB ' ' A' ' 20' ' ' VAL . 0.7 OUTLIER -64.63 -47.8 77.2 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.378 -0.826 . . . . 0.0 110.194 179.429 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.477 ' O ' HG12 ' A' ' 20' ' ' VAL . 68.6 mt -68.85 -36.78 75.76 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.042 0 O-C-N 121.447 -0.783 . . . . 0.0 110.494 179.909 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.546 HG21 ' NE2' ' A' ' 14' ' ' HIS . 21.0 t -75.47 -19.9 15.95 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 121.268 -0.895 . . . . 0.0 110.383 179.906 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.59 ' HA ' ' CD1' ' A' ' 22' ' ' TYR . 0.8 OUTLIER -107.85 20.94 18.13 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.355 -0.84 . . . . 0.0 111.018 179.51 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.477 HG12 ' O ' ' A' ' 17' ' ' ILE . 3.7 p -117.58 -32.97 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 O-C-N 120.812 -1.18 . . . . 0.0 111.065 179.448 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 6.1 mt-30 -88.08 -35.09 17.69 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.306 -0.871 . . . . 0.0 110.108 179.699 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . 0.59 ' CD1' ' HA ' ' A' ' 19' ' ' ASP . 1.5 p90 -62.49 -28.59 69.94 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.374 -0.829 . . . . 0.0 110.395 179.626 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 3.6 ttp -90.16 0.22 57.28 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.35 -0.844 . . . . 0.0 111.081 179.752 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -107.96 22.48 15.9 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.143 -0.973 . . . . 0.0 110.817 179.859 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -118.28 12.37 12.64 Favored Glycine 0 N--CA 1.495 2.599 0 N-CA-C 110.044 -1.222 . . . . 0.0 110.044 179.475 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.912 ' HB3' ' HB3' ' A' ' 29' ' ' ALA . 1.4 mp -140.4 66.87 1.37 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.269 -1.136 . . . . 0.0 109.697 179.986 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.485 ' N ' ' HD2' ' A' ' 28' ' ' PRO . 0.1 OUTLIER -58.12 -52.46 74.37 Favored Pre-proline 0 N--CA 1.5 2.056 0 O-C-N 121.575 -0.703 . . . . 0.0 111.497 -179.56 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.485 ' HD2' ' N ' ' A' ' 27' ' ' SER . 44.9 Cg_endo -71.15 -12.45 30.22 Favored 'Trans proline' 0 N--CA 1.492 1.42 0 O-C-N 123.46 1.242 . . . . 0.0 111.761 -179.669 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.912 ' HB3' ' HB3' ' A' ' 26' ' ' LEU . . . -98.36 -40.41 8.32 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.265 -0.897 . . . . 0.0 110.299 179.769 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 5.9 tp -71.18 -24.34 24.1 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 O-C-N 121.414 -0.804 . . . . 0.0 110.798 179.878 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 1.9 p -64.64 -42.22 95.61 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.46 -0.775 . . . . 0.0 110.1 179.621 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 2.3 tptm -93.27 26.61 2.84 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.544 -0.722 . . . . 0.0 110.119 179.273 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 10.8 t80 -124.46 -47.81 1.84 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.485 -0.759 . . . . 0.0 110.245 -179.913 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 93.8 t -81.89 103.52 9.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.458 -0.776 . . . . 0.0 109.89 179.954 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 6.7 p -132.66 21.0 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 121.461 -0.774 . . . . 0.0 110.839 -179.921 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.496 1.836 0 CA-C-O 117.866 -1.064 . . . . 0.0 110.481 179.873 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 3.7 p . . . . . 0 N--CA 1.496 1.853 0 CA-C-O 121.042 0.449 . . . . 0.0 110.475 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -143.11 135.46 27.3 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.427 -0.796 . . . . 0.0 110.532 -179.898 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.556 ' CB ' ' HD3' ' A' ' 4' ' ' PRO . 0.5 OUTLIER -92.97 -57.45 0.23 Allowed Pre-proline 0 N--CA 1.496 1.858 0 O-C-N 121.497 -0.752 . . . . 0.0 110.415 179.518 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.556 ' HD3' ' CB ' ' A' ' 3' ' ' LEU . 51.7 Cg_endo -83.89 60.28 6.43 Favored 'Trans proline' 0 N--CA 1.483 0.87 0 O-C-N 123.417 1.219 . . . . 0.0 110.18 179.49 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -84.18 -54.65 4.67 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.347 -0.846 . . . . 0.0 110.561 -179.53 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 3.3 tp -151.73 23.24 0.69 Allowed 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.392 -0.817 . . . . 0.0 111.318 -179.725 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 20.0 m 46.83 47.64 15.24 Favored 'General case' 0 N--CA 1.504 2.254 0 O-C-N 121.292 -0.88 . . . . 0.0 111.038 179.718 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 13.4 p -102.54 36.25 2.22 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.307 -0.87 . . . . 0.0 110.747 -179.716 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -92.56 -86.62 1.54 Allowed Glycine 0 N--CA 1.491 2.349 0 N-CA-C 108.649 -1.78 . . . . 0.0 108.649 179.332 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 11.2 tp -80.77 -32.22 35.58 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.619 -0.93 . . . . 0.0 110.072 179.28 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.4 tt -60.88 -51.35 69.65 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.521 -0.737 . . . . 0.0 110.203 179.739 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 43.9 t60 -64.62 -37.61 88.17 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.56 -0.713 . . . . 0.0 110.307 179.646 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 6.7 tt -54.87 -39.02 68.23 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.493 -0.754 . . . . 0.0 110.269 179.65 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . 0.46 ' CE1' HG21 ' A' ' 18' ' ' VAL . 64.7 t60 -78.26 -51.29 10.37 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.427 -0.796 . . . . 0.0 109.847 179.474 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.407 ' O ' ' HB2' ' A' ' 19' ' ' ASP . 0.8 OUTLIER -58.74 -47.01 86.11 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.623 -0.673 . . . . 0.0 110.484 -179.93 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 4.3 t30 -54.29 -33.37 58.55 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.484 -0.76 . . . . 0.0 111.0 179.885 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 38.4 mm -86.14 -45.51 16.85 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 121.122 -0.987 . . . . 0.0 110.073 179.816 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.46 HG21 ' CE1' ' A' ' 14' ' ' HIS . 52.7 t -63.6 -38.03 81.18 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 O-C-N 121.462 -0.774 . . . . 0.0 110.59 179.933 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.571 ' HA ' ' CD2' ' A' ' 22' ' ' TYR . 1.7 m-20 -71.45 -12.74 61.55 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.584 -0.698 . . . . 0.0 111.394 -179.885 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.458 ' O ' ' HB2' ' A' ' 24' ' ' TYR . 97.2 t -102.62 -5.42 9.28 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 120.816 -1.178 . . . . 0.0 110.282 179.461 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 15.6 mm-40 -101.84 -38.04 8.01 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.262 -0.899 . . . . 0.0 109.907 179.424 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . 0.571 ' CD2' ' HA ' ' A' ' 19' ' ' ASP . 1.4 p90 -65.15 -29.29 70.12 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.369 -0.832 . . . . 0.0 110.148 179.447 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -92.46 -32.55 14.85 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.535 -0.728 . . . . 0.0 110.589 -179.934 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.458 ' HB2' ' O ' ' A' ' 20' ' ' VAL . 88.9 m-85 -105.38 51.17 0.76 Allowed 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.278 -0.889 . . . . 0.0 110.038 -179.945 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 160.46 -40.15 0.44 Allowed Glycine 0 N--CA 1.495 2.613 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -179.72 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.471 ' HG ' ' HB3' ' A' ' 29' ' ' ALA . 0.1 OUTLIER 64.98 29.08 12.43 Favored 'General case' 0 N--CA 1.503 2.185 0 O-C-N 121.827 -0.807 . . . . 0.0 111.191 179.874 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.51 ' N ' ' HD2' ' A' ' 28' ' ' PRO . 0.0 OUTLIER -63.78 -51.79 62.53 Favored Pre-proline 0 N--CA 1.5 2.054 0 O-C-N 121.244 -0.91 . . . . 0.0 110.705 179.521 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.51 ' HD2' ' N ' ' A' ' 27' ' ' SER . 47.9 Cg_endo -73.46 -8.5 21.81 Favored 'Trans proline' 0 N--CA 1.489 1.261 0 O-C-N 123.434 1.228 . . . . 0.0 111.418 179.939 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.471 ' HB3' ' HG ' ' A' ' 26' ' ' LEU . . . -98.99 -45.68 5.87 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.232 -0.918 . . . . 0.0 110.196 179.842 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.521 HD13 ' O ' ' A' ' 30' ' ' ILE . 0.3 OUTLIER -61.73 -31.22 50.24 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 O-C-N 121.438 -0.789 . . . . 0.0 110.4 179.866 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 4.3 p -66.43 -30.01 70.27 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.497 -0.752 . . . . 0.0 110.222 179.276 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 11.1 ttpt -100.74 18.23 19.92 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.507 -0.746 . . . . 0.0 110.414 179.454 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -107.61 -35.02 6.83 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.363 -0.836 . . . . 0.0 109.975 179.687 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.767 HG12 HG23 ' A' ' 35' ' ' VAL . 46.0 t -85.81 159.53 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.522 -0.736 . . . . 0.0 109.572 179.694 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.767 HG23 HG12 ' A' ' 34' ' ' VAL . 12.7 t 59.76 56.75 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.122 0 O-C-N 121.602 -0.686 . . . . 0.0 109.98 -179.613 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.5 2.028 0 CA-C-O 117.697 -1.144 . . . . 0.0 110.498 -179.882 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 7.3 p . . . . . 0 N--CA 1.494 1.756 0 CA-C-O 121.069 0.461 . . . . 0.0 110.215 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -118.73 -167.27 1.35 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.647 -0.658 . . . . 0.0 109.974 -179.878 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER 51.25 71.66 1.46 Allowed Pre-proline 0 N--CA 1.5 2.026 0 O-C-N 121.684 -0.635 . . . . 0.0 110.621 179.971 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -89.56 -157.51 0.07 OUTLIER 'Trans proline' 0 C--N 1.308 -1.581 0 O-C-N 124.03 1.542 . . . . 0.0 110.186 -179.888 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -102.55 46.82 0.91 Allowed 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.385 -0.822 . . . . 0.0 110.139 179.743 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.6 mp -103.75 8.15 37.24 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.56 -0.713 . . . . 0.0 110.813 179.856 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 69.5 m -108.08 40.57 1.72 Allowed 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.169 -0.957 . . . . 0.0 110.096 179.631 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.52 HG22 ' HB2' ' A' ' 12' ' ' HIS . 90.4 m -129.9 -95.7 0.38 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.303 -0.873 . . . . 0.0 109.823 179.738 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.409 ' N ' HG22 ' A' ' 8' ' ' THR . . . 55.95 -103.34 0.23 Allowed Glycine 0 N--CA 1.497 2.721 0 N-CA-C 110.05 -1.22 . . . . 0.0 110.05 179.782 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -62.9 -31.46 72.53 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.569 -0.96 . . . . 0.0 110.473 179.711 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.463 ' HB2' ' HA ' ' A' ' 8' ' ' THR . 1.7 mp -56.4 -39.41 72.98 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.454 -0.779 . . . . 0.0 110.15 179.537 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . 0.52 ' HB2' HG22 ' A' ' 8' ' ' THR . 0.1 OUTLIER -85.14 -41.26 15.84 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.368 -0.832 . . . . 0.0 109.638 179.257 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 6.5 tt -56.34 -43.49 79.11 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.684 -0.635 . . . . 0.0 110.098 179.392 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . 0.46 ' CE1' HG21 ' A' ' 18' ' ' VAL . 66.2 t60 -64.68 -50.68 66.05 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.61 -0.681 . . . . 0.0 109.931 179.52 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -62.27 -36.36 81.82 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.465 -0.772 . . . . 0.0 110.025 179.484 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -57.11 -43.41 82.29 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.54 -0.725 . . . . 0.0 109.858 179.335 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 21.5 mm -80.82 -36.53 15.57 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 O-C-N 121.419 -0.801 . . . . 0.0 109.795 179.393 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.46 HG21 ' CE1' ' A' ' 14' ' ' HIS . 40.0 t -67.01 -21.53 28.39 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 O-C-N 121.444 -0.785 . . . . 0.0 110.977 179.983 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.599 ' HA ' ' CD1' ' A' ' 22' ' ' TYR . 0.4 OUTLIER -106.0 10.34 32.28 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.215 -0.928 . . . . 0.0 111.159 179.787 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.433 ' O ' ' HB2' ' A' ' 24' ' ' TYR . 0.8 OUTLIER -114.88 -26.67 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 O-C-N 120.847 -1.158 . . . . 0.0 110.505 179.306 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 41.4 mt-30 -87.98 -39.99 14.26 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.427 -0.795 . . . . 0.0 110.096 179.887 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . 0.599 ' CD1' ' HA ' ' A' ' 19' ' ' ASP . 1.8 p90 -60.99 -27.43 68.29 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.473 -0.767 . . . . 0.0 110.434 179.654 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 2.5 ttp -95.75 -28.06 14.95 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.378 -0.826 . . . . 0.0 111.109 -179.818 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.433 ' HB2' ' O ' ' A' ' 20' ' ' VAL . 55.9 m-85 -110.13 52.65 0.72 Allowed 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.128 -0.982 . . . . 0.0 110.419 -179.723 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 145.46 -22.88 1.86 Allowed Glycine 0 N--CA 1.496 2.676 0 N-CA-C 110.542 -1.023 . . . . 0.0 110.542 -180.0 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.406 ' O ' HD12 ' A' ' 30' ' ' ILE . 2.8 mp 58.29 40.41 24.61 Favored 'General case' 0 N--CA 1.502 2.131 0 O-C-N 121.468 -1.019 . . . . 0.0 110.798 -179.685 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.45 ' CB ' ' HD3' ' A' ' 28' ' ' PRO . 0.4 OUTLIER -60.71 -52.58 71.58 Favored Pre-proline 0 N--CA 1.499 2.013 0 O-C-N 121.351 -0.843 . . . . 0.0 110.027 179.409 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.45 ' HD3' ' CB ' ' A' ' 27' ' ' SER . 52.4 Cg_endo -80.85 44.16 1.69 Allowed 'Trans proline' 0 N--CA 1.485 1.017 0 O-C-N 123.514 1.271 . . . . 0.0 110.512 178.868 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -135.28 -54.69 0.8 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.242 -0.911 . . . . 0.0 109.353 179.789 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.406 HD12 ' O ' ' A' ' 26' ' ' LEU . 2.2 mp -68.42 -42.74 84.19 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 O-C-N 121.558 -0.714 . . . . 0.0 109.339 178.907 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 14.3 t -67.18 -26.59 66.71 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.733 -0.605 . . . . 0.0 109.989 179.136 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 7.9 mmpt? -78.74 -32.58 46.78 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.336 -0.852 . . . . 0.0 109.885 179.209 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 87.2 t80 -66.31 -29.17 69.32 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.63 -0.668 . . . . 0.0 110.05 179.213 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 88.7 t -61.89 -26.58 40.29 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 O-C-N 121.324 -0.86 . . . . 0.0 110.174 179.467 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.6 t -113.23 20.82 6.48 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 O-C-N 121.416 -0.803 . . . . 0.0 110.244 179.707 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 2.4 ttm-85 . . . . . 0 N--CA 1.496 1.842 0 CA-C-O 117.779 -1.105 . . . . 0.0 110.294 -179.946 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 8.1 t . . . . . 0 N--CA 1.495 1.795 0 CA-C-O 121.045 0.45 . . . . 0.0 110.403 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -110.33 42.5 1.55 Allowed 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.554 -0.716 . . . . 0.0 110.397 179.986 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.466 ' N ' ' HD3' ' A' ' 4' ' ' PRO . 15.9 tp 49.45 64.07 9.2 Favored Pre-proline 0 N--CA 1.5 2.055 0 O-C-N 121.669 -0.644 . . . . 0.0 110.994 179.863 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.556 ' O ' ' HB3' ' A' ' 5' ' ' ALA . 46.6 Cg_endo -91.15 -161.11 0.09 OUTLIER 'Trans proline' 0 C--N 1.312 -1.367 0 O-C-N 123.835 1.44 . . . . 0.0 110.397 179.939 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.556 ' HB3' ' O ' ' A' ' 4' ' ' PRO . . . 66.81 0.95 2.07 Favored 'General case' 0 N--CA 1.506 2.348 0 O-C-N 121.734 -0.604 . . . . 0.0 111.969 -179.992 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -134.73 2.86 3.21 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 120.877 -1.14 . . . . 0.0 111.068 179.856 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 49.6 m -145.99 77.62 1.5 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.186 -0.946 . . . . 0.0 109.195 179.807 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.48 ' HB ' ' HB2' ' A' ' 12' ' ' HIS . 25.9 p 39.75 50.93 2.35 Favored 'General case' 0 N--CA 1.503 2.22 0 CA-C-O 121.275 0.559 . . . . 0.0 111.244 -179.487 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -89.44 -75.47 1.3 Allowed Glycine 0 N--CA 1.492 2.418 0 N-CA-C 108.657 -1.777 . . . . 0.0 108.657 179.659 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.4 pp -90.71 -25.38 20.06 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.589 -0.947 . . . . 0.0 110.036 178.96 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -67.86 -42.2 81.71 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.38 -0.825 . . . . 0.0 109.812 179.499 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . 0.48 ' HB2' ' HB ' ' A' ' 8' ' ' THR . 4.3 t-160 -63.4 -37.31 86.8 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.548 -0.72 . . . . 0.0 109.919 179.313 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.2 tt -57.27 -42.15 81.05 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.595 -0.69 . . . . 0.0 109.869 179.237 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . 0.548 ' NE2' HG21 ' A' ' 18' ' ' VAL . 4.8 t-80 -65.96 -53.71 35.55 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.613 -0.679 . . . . 0.0 109.459 179.063 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.407 ' O ' ' HB2' ' A' ' 19' ' ' ASP . 16.1 tp60 -58.72 -38.28 77.97 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.59 -0.694 . . . . 0.0 110.22 179.577 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 13.2 t30 -59.57 -42.1 91.71 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.61 -0.681 . . . . 0.0 110.595 179.764 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.526 ' O ' HG12 ' A' ' 20' ' ' VAL . 43.8 mt -79.52 -30.62 13.75 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 O-C-N 121.27 -0.894 . . . . 0.0 110.238 179.815 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.548 HG21 ' NE2' ' A' ' 14' ' ' HIS . 31.6 t -78.16 -27.02 14.55 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.227 -0.921 . . . . 0.0 110.203 179.628 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.539 ' HA ' ' CD1' ' A' ' 22' ' ' TYR . 0.9 OUTLIER -91.39 17.4 8.53 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.397 -0.814 . . . . 0.0 110.954 179.572 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.526 HG12 ' O ' ' A' ' 17' ' ' ILE . 1.0 OUTLIER -117.86 -31.62 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 120.967 -1.083 . . . . 0.0 110.441 179.294 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 27.5 mm100 -89.81 -30.75 17.75 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.365 -0.835 . . . . 0.0 110.458 179.867 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . 0.539 ' CD1' ' HA ' ' A' ' 19' ' ' ASP . 1.8 p90 -61.15 -28.5 69.16 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.357 -0.84 . . . . 0.0 110.202 179.732 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 5.9 ttt -75.93 -25.14 55.7 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.362 -0.836 . . . . 0.0 110.286 179.227 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 31.6 m-85 -110.01 31.43 5.87 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.504 -0.747 . . . . 0.0 110.412 179.815 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 175.77 69.82 0.05 OUTLIER Glycine 0 N--CA 1.494 2.553 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 -179.962 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -105.03 12.04 32.69 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.537 -0.978 . . . . 0.0 111.296 -179.825 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.541 ' N ' ' HD2' ' A' ' 28' ' ' PRO . 0.4 OUTLIER -56.74 -51.7 79.39 Favored Pre-proline 0 N--CA 1.499 2.002 0 O-C-N 121.268 -0.895 . . . . 0.0 110.515 179.374 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.541 ' HD2' ' N ' ' A' ' 27' ' ' SER . 42.7 Cg_endo -70.58 -28.57 21.16 Favored 'Trans proline' 0 N--CA 1.487 1.095 0 O-C-N 123.343 1.181 . . . . 0.0 110.115 179.31 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.407 ' O ' ' HB2' ' A' ' 33' ' ' TYR . . . -68.37 -38.55 81.49 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.591 -0.693 . . . . 0.0 110.107 179.345 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.439 HG22 ' O ' ' A' ' 27' ' ' SER . 6.0 tp -85.64 -29.05 6.27 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 121.446 -0.784 . . . . 0.0 110.605 179.646 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 77.7 m -75.13 -37.0 61.57 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.39 -0.819 . . . . 0.0 110.125 179.666 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 32.6 mtmt -89.82 22.26 3.2 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.36 -0.837 . . . . 0.0 110.57 179.495 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.407 ' HB2' ' O ' ' A' ' 29' ' ' ALA . 5.1 t80 -112.56 -48.27 3.02 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.265 -0.897 . . . . 0.0 109.868 179.751 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 94.8 t -84.02 -51.75 13.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.563 -0.711 . . . . 0.0 109.744 179.724 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.584 ' O ' ' HG3' ' A' ' 36' ' ' ARG . 18.7 t 52.7 43.82 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.111 0 O-C-N 121.675 -0.641 . . . . 0.0 110.467 179.955 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.584 ' HG3' ' O ' ' A' ' 35' ' ' VAL . 2.6 ptt85 . . . . . 0 N--CA 1.51 2.572 0 CA-C-O 117.886 -1.054 . . . . 0.0 112.336 179.964 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 48.8 m . . . . . 0 N--CA 1.495 1.788 0 CA-C-O 120.975 0.417 . . . . 0.0 110.116 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -148.49 164.29 34.61 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.548 -0.72 . . . . 0.0 110.612 -179.812 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.445 ' N ' ' HD2' ' A' ' 4' ' ' PRO . 1.0 OUTLIER -62.63 -51.99 68.33 Favored Pre-proline 0 N--CA 1.497 1.879 0 O-C-N 121.635 -0.666 . . . . 0.0 110.587 179.657 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.445 ' HD2' ' N ' ' A' ' 3' ' ' LEU . 52.3 Cg_endo -77.24 55.62 5.14 Favored 'Trans proline' 0 N--CA 1.489 1.208 0 O-C-N 123.543 1.286 . . . . 0.0 110.586 179.573 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -156.3 42.35 0.38 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.243 -0.911 . . . . 0.0 110.276 179.849 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -131.1 -57.35 1.03 Allowed 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.488 -0.758 . . . . 0.0 110.537 -179.864 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 20.6 m -131.38 18.09 4.87 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.424 -0.797 . . . . 0.0 111.313 -179.709 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 27.2 p -122.88 21.65 9.86 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.213 -0.929 . . . . 0.0 110.367 179.487 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -103.77 -77.01 1.15 Allowed Glycine 0 N--CA 1.493 2.435 0 N-CA-C 109.006 -1.638 . . . . 0.0 109.006 179.828 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -61.28 -41.0 96.21 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.715 -0.873 . . . . 0.0 110.114 179.464 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 4.5 tt -58.58 -47.17 85.18 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.482 -0.761 . . . . 0.0 109.879 179.466 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 14.1 m170 -66.01 -38.16 87.75 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.541 -0.724 . . . . 0.0 109.789 179.236 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -60.08 -40.36 89.29 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.538 -0.726 . . . . 0.0 109.86 179.313 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . 0.554 ' NE2' HG21 ' A' ' 18' ' ' VAL . 6.8 t-160 -62.94 -51.5 66.66 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.693 -0.629 . . . . 0.0 109.425 179.158 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 6.4 tp60 -61.84 -37.32 84.05 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.572 -0.705 . . . . 0.0 110.086 179.279 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -60.11 -35.39 75.13 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.654 -0.654 . . . . 0.0 110.621 179.662 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.538 ' O ' HG12 ' A' ' 20' ' ' VAL . 61.2 mt -88.23 -40.3 13.42 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 O-C-N 121.374 -0.829 . . . . 0.0 110.268 179.931 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.554 HG21 ' NE2' ' A' ' 14' ' ' HIS . 9.4 t -69.43 -33.54 57.89 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.875 0 O-C-N 121.378 -0.826 . . . . 0.0 110.61 -179.931 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.525 ' HA ' ' CD1' ' A' ' 22' ' ' TYR . 2.2 t70 -88.89 14.31 10.7 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.269 -0.894 . . . . 0.0 111.253 179.831 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.538 HG12 ' O ' ' A' ' 17' ' ' ILE . 0.5 OUTLIER -119.43 -23.83 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 120.785 -1.197 . . . . 0.0 110.833 179.386 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -100.72 -29.51 12.24 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.396 -0.815 . . . . 0.0 110.669 -179.924 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . 0.525 ' CD1' ' HA ' ' A' ' 19' ' ' ASP . 3.7 p90 -61.3 -28.25 69.06 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.332 -0.855 . . . . 0.0 110.206 179.582 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 2.2 tpp -86.17 -13.67 46.35 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.326 -0.859 . . . . 0.0 110.691 179.323 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 29.1 m-85 -115.1 25.98 10.47 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.205 -0.934 . . . . 0.0 110.861 -179.723 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -177.45 -70.83 0.06 OUTLIER Glycine 0 N--CA 1.495 2.6 0 C-N-CA 119.801 -1.19 . . . . 0.0 110.434 179.833 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.523 HD12 ' O ' ' A' ' 22' ' ' TYR . 0.2 OUTLIER 56.98 28.75 15.25 Favored 'General case' 0 N--CA 1.505 2.307 0 O-C-N 121.555 -0.968 . . . . 0.0 110.863 -179.409 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.523 ' N ' ' HD2' ' A' ' 28' ' ' PRO . 0.6 OUTLIER -67.93 -50.18 33.67 Favored Pre-proline 0 N--CA 1.501 2.102 0 O-C-N 121.239 -0.913 . . . . 0.0 111.401 -179.907 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.523 ' HD2' ' N ' ' A' ' 27' ' ' SER . 44.1 Cg_endo -71.08 -20.71 28.37 Favored 'Trans proline' 0 N--CA 1.489 1.243 0 O-C-N 123.247 1.13 . . . . 0.0 111.115 -179.884 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -77.18 -43.82 32.42 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.405 -0.809 . . . . 0.0 110.564 179.915 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.428 HG22 ' O ' ' A' ' 27' ' ' SER . 4.9 tp -72.02 -28.63 30.38 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 O-C-N 121.277 -0.89 . . . . 0.0 111.009 -179.814 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 3.3 p -77.21 -35.49 55.6 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.322 -0.861 . . . . 0.0 110.119 179.637 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -86.87 12.04 11.95 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.36 -0.838 . . . . 0.0 110.744 179.406 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 89.6 t80 -112.87 -38.91 4.4 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.188 -0.945 . . . . 0.0 110.366 179.654 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 38.5 t -94.21 92.5 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 O-C-N 121.403 -0.811 . . . . 0.0 110.075 -179.873 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 5.0 p -128.9 21.98 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 121.435 -0.791 . . . . 0.0 110.565 179.896 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? . . . . . 0 N--CA 1.496 1.857 0 CA-C-O 117.892 -1.051 . . . . 0.0 110.253 179.922 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 9.6 p . . . . . 0 N--CA 1.496 1.862 0 CA-C-O 121.165 0.507 . . . . 0.0 110.357 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -88.04 81.52 7.42 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.409 -0.807 . . . . 0.0 110.291 -179.875 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.462 ' N ' ' HD2' ' A' ' 4' ' ' PRO . 0.4 OUTLIER -78.43 -55.1 1.11 Allowed Pre-proline 0 N--CA 1.498 1.944 0 O-C-N 121.514 -0.741 . . . . 0.0 110.579 179.899 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.462 ' HD2' ' N ' ' A' ' 3' ' ' LEU . 44.7 Cg_endo -71.64 -29.9 15.43 Favored 'Trans proline' 0 N--CA 1.488 1.185 0 O-C-N 123.532 1.28 . . . . 0.0 110.504 179.663 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -107.34 35.3 3.11 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.506 -0.746 . . . . 0.0 109.923 179.257 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.7 tt -72.16 -50.12 30.38 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.467 -0.77 . . . . 0.0 110.568 -179.857 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 78.2 p -138.69 32.74 2.24 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.317 -0.864 . . . . 0.0 110.937 -179.706 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 6.5 m 53.19 58.68 5.04 Favored 'General case' 0 N--CA 1.503 2.191 0 O-C-N 121.349 -0.844 . . . . 0.0 110.121 -179.886 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -108.02 -62.9 0.56 Allowed Glycine 0 N--CA 1.495 2.632 0 N-CA-C 109.767 -1.333 . . . . 0.0 109.767 -179.61 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.453 HD22 ' HA ' ' A' ' 10' ' ' LEU . 0.2 OUTLIER -60.86 -47.39 86.57 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.53 -0.983 . . . . 0.0 110.29 179.964 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 5.4 tt -58.25 -45.67 87.37 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.543 -0.723 . . . . 0.0 109.677 179.259 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 5.1 t-160 -68.11 -32.23 72.38 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.654 -0.654 . . . . 0.0 109.979 179.145 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.405 HD22 ' HA ' ' A' ' 13' ' ' LEU . 0.2 OUTLIER -61.08 -43.88 98.21 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.615 -0.678 . . . . 0.0 109.966 179.494 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 2.7 t-80 -61.17 -55.85 27.47 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.472 -0.768 . . . . 0.0 109.458 179.34 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.45 ' O ' ' HB2' ' A' ' 19' ' ' ASP . 3.3 tp60 -58.95 -37.77 77.5 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.585 -0.697 . . . . 0.0 110.296 179.746 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 14.8 t30 -63.31 -45.85 89.43 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.576 -0.703 . . . . 0.0 110.449 179.654 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.49 ' O ' HG12 ' A' ' 20' ' ' VAL . 27.7 mm -73.14 -32.59 39.25 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 O-C-N 121.242 -0.911 . . . . 0.0 109.961 179.58 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 52.2 t -75.12 -18.33 16.14 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 O-C-N 121.374 -0.829 . . . . 0.0 110.533 179.731 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.603 ' HA ' ' CD1' ' A' ' 22' ' ' TYR . 0.2 OUTLIER -103.35 19.44 19.68 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.263 -0.898 . . . . 0.0 110.795 179.266 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.49 HG12 ' O ' ' A' ' 17' ' ' ILE . 1.5 p -115.81 -35.63 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 120.784 -1.198 . . . . 0.0 110.65 179.473 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -83.49 -35.17 25.09 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.275 -0.891 . . . . 0.0 110.04 179.641 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . 0.603 ' CD1' ' HA ' ' A' ' 19' ' ' ASP . 1.2 p90 -64.63 -25.22 67.87 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.424 -0.797 . . . . 0.0 110.323 179.652 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -92.06 7.05 44.13 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.348 -0.845 . . . . 0.0 110.694 179.337 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -97.53 40.62 1.15 Allowed 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.108 -0.995 . . . . 0.0 110.255 179.72 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 68.21 23.12 74.76 Favored Glycine 0 N--CA 1.496 2.646 0 N-CA-C 110.394 -1.082 . . . . 0.0 110.394 179.969 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.76 ' HB3' ' HB3' ' A' ' 29' ' ' ALA . 79.6 mt 48.67 68.87 0.63 Allowed 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.682 -0.893 . . . . 0.0 110.331 179.997 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.554 ' HB2' ' HD3' ' A' ' 28' ' ' PRO . 3.6 m -52.53 -49.82 83.7 Favored Pre-proline 0 N--CA 1.5 2.058 0 O-C-N 121.673 -0.642 . . . . 0.0 111.555 -179.578 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.554 ' HD3' ' HB2' ' A' ' 27' ' ' SER . 44.3 Cg_endo -70.27 -12.56 32.16 Favored 'Trans proline' 0 N--CA 1.491 1.37 0 O-C-N 123.275 1.145 . . . . 0.0 111.613 -179.772 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.76 ' HB3' ' HB3' ' A' ' 26' ' ' LEU . . . -98.93 -41.41 7.61 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.305 -0.872 . . . . 0.0 110.249 179.635 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 16.7 tt -69.98 -23.36 25.33 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 O-C-N 121.422 -0.799 . . . . 0.0 110.951 -179.987 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 2.0 p -63.77 -46.14 86.61 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.387 -0.821 . . . . 0.0 110.158 179.689 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 5.9 mttp -90.13 18.97 5.34 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.546 -0.721 . . . . 0.0 110.306 179.258 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 13.0 t80 -116.25 -40.83 3.21 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.291 -0.881 . . . . 0.0 110.165 179.816 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 29.7 t -93.3 81.82 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.378 -0.826 . . . . 0.0 109.68 179.898 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 5.3 p -124.02 19.14 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 O-C-N 121.412 -0.805 . . . . 0.0 110.739 -179.835 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 7.0 ptt-85 . . . . . 0 N--CA 1.497 1.916 0 CA-C-O 117.825 -1.083 . . . . 0.0 110.802 179.722 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 75.3 m . . . . . 0 N--CA 1.496 1.836 0 CA-C-O 121.126 0.489 . . . . 0.0 110.52 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -105.54 37.55 2.19 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.558 -0.714 . . . . 0.0 110.212 179.651 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.528 ' CB ' ' HD3' ' A' ' 4' ' ' PRO . 0.2 OUTLIER -74.92 -56.25 2.15 Favored Pre-proline 0 N--CA 1.498 1.942 0 O-C-N 121.21 -0.931 . . . . 0.0 110.463 179.841 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.528 ' HD3' ' CB ' ' A' ' 3' ' ' LEU . 52.3 Cg_endo -82.17 51.11 3.67 Favored 'Trans proline' 0 C--N 1.32 -0.947 0 O-C-N 123.525 1.277 . . . . 0.0 110.233 179.373 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -145.28 -52.82 0.28 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.356 -0.84 . . . . 0.0 110.292 -179.717 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 16.0 mt 53.0 43.06 32.23 Favored 'General case' 0 N--CA 1.503 2.182 0 O-C-N 121.662 -0.648 . . . . 0.0 110.726 179.884 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 9.2 t -144.14 -53.05 0.33 Allowed 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.434 -0.791 . . . . 0.0 110.084 179.972 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.55 ' HB ' ' HB2' ' A' ' 12' ' ' HIS . 0.8 OUTLIER -111.15 30.39 6.94 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.556 -0.715 . . . . 0.0 110.149 179.708 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -70.67 -74.01 0.73 Allowed Glycine 0 N--CA 1.493 2.45 0 N-CA-C 109.281 -1.527 . . . . 0.0 109.281 179.906 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 13.4 mt -85.72 -32.41 21.92 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.605 -0.938 . . . . 0.0 109.944 179.38 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 6.0 mp -60.14 -55.78 29.62 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.523 -0.736 . . . . 0.0 110.281 179.841 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . 0.55 ' HB2' ' HB ' ' A' ' 8' ' ' THR . 13.7 t-160 -60.35 -42.62 96.1 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.489 -0.757 . . . . 0.0 109.94 179.459 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 13.2 tp -59.82 -41.36 91.14 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.605 -0.684 . . . . 0.0 109.962 179.398 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . 0.508 ' NE2' HG21 ' A' ' 18' ' ' VAL . 51.4 t60 -63.03 -47.74 81.76 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.627 -0.671 . . . . 0.0 110.095 179.571 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 34.4 tp60 -56.17 -42.4 76.99 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.544 -0.723 . . . . 0.0 110.369 179.969 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.459 ' O ' ' HB ' ' A' ' 20' ' ' VAL . 8.4 t-20 -62.46 -48.98 77.25 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.282 -0.886 . . . . 0.0 110.377 179.637 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.513 ' O ' HG12 ' A' ' 20' ' ' VAL . 73.2 mt -65.73 -38.7 82.88 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.036 0 O-C-N 121.423 -0.798 . . . . 0.0 110.41 -179.958 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.508 HG21 ' NE2' ' A' ' 14' ' ' HIS . 21.3 t -70.92 -36.73 65.2 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 O-C-N 121.237 -0.914 . . . . 0.0 110.35 179.797 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.63 ' HA ' ' CD2' ' A' ' 22' ' ' TYR . 1.7 m-20 -85.73 1.72 48.34 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.498 -0.751 . . . . 0.0 111.477 179.976 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.513 HG12 ' O ' ' A' ' 17' ' ' ILE . 1.0 OUTLIER -108.35 -16.17 8.84 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 O-C-N 120.802 -1.186 . . . . 0.0 110.431 179.121 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 24.8 mt-30 -96.43 -37.92 10.24 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.469 -0.77 . . . . 0.0 110.15 179.888 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . 0.63 ' CD2' ' HA ' ' A' ' 19' ' ' ASP . 1.6 p90 -62.99 -32.75 74.17 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.46 -0.775 . . . . 0.0 110.228 179.693 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -72.91 -27.62 61.98 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.489 -0.757 . . . . 0.0 110.606 179.85 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 28.1 m-85 -99.12 24.08 8.3 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.326 -0.859 . . . . 0.0 110.802 179.958 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -131.01 -87.81 0.44 Allowed Glycine 0 N--CA 1.494 2.537 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 179.89 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 57.93 23.08 9.43 Favored 'General case' 0 N--CA 1.504 2.26 0 O-C-N 121.701 -0.882 . . . . 0.0 111.1 -179.77 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.51 ' CB ' ' CD ' ' A' ' 28' ' ' PRO . 0.4 OUTLIER -175.16 -62.58 0.0 OUTLIER Pre-proline 0 N--CA 1.497 1.904 0 O-C-N 121.416 -0.802 . . . . 0.0 110.093 179.599 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.51 ' CD ' ' CB ' ' A' ' 27' ' ' SER . 43.6 Cg_endo -70.24 -31.96 17.43 Favored 'Trans proline' 0 N--CA 1.488 1.195 0 O-C-N 123.318 1.168 . . . . 0.0 110.339 179.174 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.44 ' O ' ' HB2' ' A' ' 33' ' ' TYR . . . -72.04 -13.12 61.51 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.618 -0.676 . . . . 0.0 111.037 179.477 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.489 HG22 ' O ' ' A' ' 27' ' ' SER . 9.2 tp -114.03 -28.27 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 O-C-N 121.067 -1.021 . . . . 0.0 111.395 -179.73 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 2.0 t -96.08 -20.19 18.84 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.059 -1.026 . . . . 0.0 110.958 -179.977 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -114.41 17.96 17.15 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.095 -1.003 . . . . 0.0 110.544 179.691 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.44 ' HB2' ' O ' ' A' ' 29' ' ' ALA . 7.2 m-85 -129.56 21.41 5.56 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.286 -0.884 . . . . 0.0 110.801 -179.935 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.463 ' O ' HG12 ' A' ' 34' ' ' VAL . 21.3 t -122.92 35.52 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 121.285 -0.884 . . . . 0.0 110.094 -179.934 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 48.7 t -132.17 66.76 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 O-C-N 121.142 -0.974 . . . . 0.0 109.505 179.572 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.496 1.844 0 CA-C-O 118.233 -0.889 . . . . 0.0 110.362 -179.941 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.495 1.776 0 CA-C-O 120.899 0.38 . . . . 0.0 110.096 . . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -133.45 32.56 3.63 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.561 -0.712 . . . . 0.0 110.793 -179.704 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.411 ' N ' ' HD3' ' A' ' 4' ' ' PRO . 3.6 tp 50.01 62.21 12.25 Favored Pre-proline 0 N--CA 1.502 2.139 0 O-C-N 121.587 -0.695 . . . . 0.0 110.976 179.803 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.411 ' HD3' ' N ' ' A' ' 3' ' ' LEU . 47.9 Cg_endo -80.7 59.13 7.33 Favored 'Trans proline' 0 C--N 1.311 -1.433 0 O-C-N 123.85 1.447 . . . . 0.0 110.525 179.974 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -162.9 -46.64 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.402 -0.811 . . . . 0.0 110.476 179.889 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 56.44 36.64 27.87 Favored 'General case' 0 N--CA 1.502 2.155 0 O-C-N 121.743 -0.598 . . . . 0.0 110.373 -179.855 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.2 m 54.71 29.95 12.58 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.626 -0.671 . . . . 0.0 110.775 -179.541 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.414 ' O ' HG22 ' A' ' 8' ' ' THR . 52.6 m -118.26 1.87 11.9 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.325 -0.859 . . . . 0.0 110.614 179.685 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -105.32 -62.69 0.64 Allowed Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.302 -1.519 . . . . 0.0 109.302 179.804 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -59.97 -41.98 93.13 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.664 -0.904 . . . . 0.0 110.507 179.945 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -60.94 -50.33 73.85 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.459 -0.776 . . . . 0.0 110.003 179.675 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 3.8 m80 -63.82 -42.5 97.65 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.605 -0.685 . . . . 0.0 110.255 179.679 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 9.3 tp -60.65 -42.88 97.87 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.504 -0.748 . . . . 0.0 110.011 179.538 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . 0.548 ' NE2' HG21 ' A' ' 18' ' ' VAL . 66.6 t60 -59.64 -55.07 38.98 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.647 -0.658 . . . . 0.0 109.943 179.478 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -53.24 -37.29 61.93 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.631 -0.668 . . . . 0.0 110.383 179.699 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.539 ' O ' HG23 ' A' ' 20' ' ' VAL . 0.7 OUTLIER -65.98 -46.15 79.08 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.541 -0.724 . . . . 0.0 110.493 179.697 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 63.3 mt -72.47 -32.83 43.38 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.11 0 O-C-N 121.418 -0.801 . . . . 0.0 110.429 179.934 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.665 HG13 ' HE2' ' A' ' 22' ' ' TYR . 52.4 t -65.86 -48.18 82.96 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.491 -0.756 . . . . 0.0 110.328 -179.815 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -79.42 47.73 0.84 Allowed 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.145 -0.972 . . . . 0.0 110.855 179.953 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.539 HG23 ' O ' ' A' ' 16' ' ' ASN . 51.3 t -135.5 -46.9 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 O-C-N 121.335 -0.853 . . . . 0.0 109.536 179.319 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 32.2 mt-30 -85.84 -23.14 27.26 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.395 -0.815 . . . . 0.0 110.284 179.613 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . 0.665 ' HE2' HG13 ' A' ' 18' ' ' VAL . 2.6 m-85 -93.95 -33.27 13.53 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.259 -0.901 . . . . 0.0 109.866 -179.97 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -92.19 -37.35 12.76 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.318 -0.864 . . . . 0.0 110.023 179.585 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -102.48 19.65 18.53 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.399 -0.813 . . . . 0.0 111.066 179.839 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -163.95 33.54 0.28 Allowed Glycine 0 N--CA 1.496 2.689 0 C-N-CA 119.77 -1.205 . . . . 0.0 111.007 179.831 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -150.92 17.89 0.78 Allowed 'General case' 0 N--CA 1.5 2.064 0 O-C-N 120.839 -1.389 . . . . 0.0 111.557 179.519 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.649 ' HB2' ' HD3' ' A' ' 28' ' ' PRO . 2.5 m -106.48 -62.3 0.04 OUTLIER Pre-proline 0 N--CA 1.495 1.81 0 O-C-N 121.114 -0.991 . . . . 0.0 110.443 179.715 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.649 ' HD3' ' HB2' ' A' ' 27' ' ' SER . 53.6 Cg_endo -79.81 63.75 8.78 Favored 'Trans proline' 0 N--CA 1.484 0.92 0 O-C-N 123.239 1.126 . . . . 0.0 110.033 179.357 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -166.41 -46.6 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.524 -0.735 . . . . 0.0 110.298 -179.7 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 47.6 mm -81.51 -38.8 16.56 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 O-C-N 121.535 -0.728 . . . . 0.0 110.265 -179.9 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 82.5 m -70.87 -42.26 70.28 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.464 -0.773 . . . . 0.0 110.031 179.732 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 7.2 mttp -69.7 -15.67 63.21 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.442 -0.786 . . . . 0.0 110.753 179.379 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -70.21 -42.49 72.25 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.377 -0.827 . . . . 0.0 110.38 179.847 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.633 ' O ' HG12 ' A' ' 35' ' ' VAL . 26.6 t -104.09 18.07 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 121.457 -0.777 . . . . 0.0 110.347 179.729 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.633 HG12 ' O ' ' A' ' 34' ' ' VAL . 0.3 OUTLIER 52.05 23.67 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.316 0 O-C-N 121.602 -0.686 . . . . 0.0 111.421 -179.91 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.498 1.954 0 CA-C-O 117.82 -1.086 . . . . 0.0 110.526 179.624 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 4.0 p . . . . . 0 N--CA 1.496 1.862 0 CA-C-O 121.214 0.531 . . . . 0.0 109.945 . . . . . . . . . 0 0 . 1 . 031 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -116.42 86.88 2.57 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.515 -0.741 . . . . 0.0 110.277 -179.546 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.52 ' N ' ' HD3' ' A' ' 4' ' ' PRO . 0.5 OUTLIER -146.3 57.23 3.7 Favored Pre-proline 0 N--CA 1.496 1.853 0 O-C-N 121.548 -0.72 . . . . 0.0 110.529 179.873 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.52 ' HD3' ' N ' ' A' ' 3' ' ' LEU . 48.5 Cg_endo -81.19 -42.36 0.12 Allowed 'Trans proline' 0 C--N 1.314 -1.266 0 O-C-N 123.797 1.419 . . . . 0.0 111.224 179.991 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -155.16 -44.48 0.08 Allowed 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.528 -0.733 . . . . 0.0 110.654 -179.852 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.694 HD13 HD13 ' A' ' 11' ' ' LEU . 0.5 OUTLIER -154.12 -39.62 0.09 Allowed 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.291 -0.88 . . . . 0.0 111.402 -179.761 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 19.3 p 45.77 42.56 8.86 Favored 'General case' 0 N--CA 1.506 2.346 0 O-C-N 121.639 -0.663 . . . . 0.0 111.432 -179.801 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.585 ' H ' HD12 ' A' ' 6' ' ' LEU . 2.9 m 57.14 35.37 26.18 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.491 -0.756 . . . . 0.0 110.818 179.617 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -102.54 -86.41 1.94 Allowed Glycine 0 N--CA 1.491 2.363 0 N-CA-C 108.699 -1.76 . . . . 0.0 108.699 179.502 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -62.25 -36.99 83.73 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.611 -0.935 . . . . 0.0 109.921 179.064 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.694 HD13 HD13 ' A' ' 6' ' ' LEU . 0.8 OUTLIER -59.95 -47.41 85.92 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.553 -0.717 . . . . 0.0 110.096 179.43 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 26.5 t-80 -67.35 -43.92 80.32 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.518 -0.739 . . . . 0.0 109.531 179.272 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -59.95 -40.15 88.03 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.662 -0.649 . . . . 0.0 109.872 179.237 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . 0.714 ' O ' HG23 ' A' ' 18' ' ' VAL . 1.1 t-80 -58.68 -55.24 37.7 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.576 -0.703 . . . . 0.0 109.639 179.389 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.39 -37.36 72.56 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.611 -0.68 . . . . 0.0 110.58 179.895 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -59.58 -35.76 74.92 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.378 -0.826 . . . . 0.0 110.064 179.296 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 46.2 mm -82.58 -36.56 13.55 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.46 -0.775 . . . . 0.0 109.844 179.55 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.714 HG23 ' O ' ' A' ' 14' ' ' HIS . 61.2 t -61.55 -23.23 30.13 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.048 0 O-C-N 121.448 -0.783 . . . . 0.0 110.758 -179.979 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -86.81 -21.42 26.47 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.252 -0.905 . . . . 0.0 110.614 179.81 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.424 HG12 ' CE2' ' A' ' 24' ' ' TYR . 47.5 t -102.64 -43.35 9.26 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 O-C-N 121.112 -0.992 . . . . 0.0 109.595 179.346 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . 0.538 ' HG2' ' HB3' ' A' ' 27' ' ' SER . 26.9 tt0 -59.6 -41.05 89.45 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.715 -0.616 . . . . 0.0 110.626 179.901 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . 0.411 ' HB3' ' O ' ' A' ' 18' ' ' VAL . 0.1 OUTLIER -58.26 -34.73 70.81 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.148 -0.97 . . . . 0.0 111.108 -179.656 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 3.0 ttp -109.06 27.89 9.05 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.207 -0.933 . . . . 0.0 111.167 179.965 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.467 ' CB ' ' HB2' ' A' ' 27' ' ' SER . 0.2 OUTLIER -78.62 -4.05 46.95 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.279 -0.888 . . . . 0.0 110.686 179.166 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 108.8 -43.06 1.79 Allowed Glycine 0 N--CA 1.495 2.61 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 179.939 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -161.97 31.7 0.12 Allowed 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.591 -0.946 . . . . 0.0 110.498 179.987 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.538 ' HB3' ' HG2' ' A' ' 21' ' ' GLN . 0.3 OUTLIER -82.12 -40.39 0.94 Allowed Pre-proline 0 N--CA 1.496 1.867 0 O-C-N 121.445 -0.785 . . . . 0.0 112.012 -179.695 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.536 ' CD ' ' N ' ' A' ' 27' ' ' SER . 47.8 Cg_endo -75.86 64.56 6.79 Favored 'Trans proline' 0 N--CA 1.486 1.081 0 O-C-N 123.126 1.066 . . . . 0.0 110.614 -179.359 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -167.55 -49.67 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.708 -0.62 . . . . 0.0 109.789 179.892 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 49.2 mm -91.9 -29.88 4.66 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 121.612 -0.68 . . . . 0.0 110.23 179.633 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.425 HG21 ' NE2' ' A' ' 21' ' ' GLN . 31.9 m -61.35 -38.13 85.83 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.528 -0.733 . . . . 0.0 110.142 179.725 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.96 -27.53 64.81 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.394 -0.816 . . . . 0.0 110.47 179.609 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -78.77 -16.95 56.54 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.449 -0.782 . . . . 0.0 110.811 179.544 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.722 HG12 HG23 ' A' ' 35' ' ' VAL . 23.6 t -116.34 157.6 17.14 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 O-C-N 121.291 -0.881 . . . . 0.0 109.982 179.944 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.722 HG23 HG12 ' A' ' 34' ' ' VAL . 14.4 t 59.27 74.55 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.147 0 O-C-N 121.573 -0.704 . . . . 0.0 110.423 180.0 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.501 2.077 0 CA-C-O 118.367 -0.825 . . . . 0.0 110.873 179.993 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.494 1.761 0 CA-C-O 121.162 0.506 . . . . 0.0 110.017 . . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -150.47 130.65 13.59 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.46 -0.775 . . . . 0.0 110.31 -179.826 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -77.82 -52.39 1.63 Allowed Pre-proline 0 N--CA 1.499 2.0 0 O-C-N 121.442 -0.786 . . . . 0.0 111.182 -179.605 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -77.74 64.25 8.13 Favored 'Trans proline' 0 N--CA 1.486 1.086 0 O-C-N 123.399 1.21 . . . . 0.0 110.666 -179.788 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -84.31 -35.61 23.16 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.457 -0.777 . . . . 0.0 110.594 179.941 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 57.01 34.03 24.29 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.561 -0.712 . . . . 0.0 110.501 -179.767 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -100.45 37.52 1.67 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.45 -0.781 . . . . 0.0 110.305 179.858 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 2.4 m -121.21 13.54 11.19 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.266 -0.896 . . . . 0.0 110.609 179.866 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -100.44 -79.31 1.42 Allowed Glycine 0 N--CA 1.492 2.415 0 N-CA-C 109.262 -1.535 . . . . 0.0 109.262 -179.975 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -60.53 -34.83 74.69 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.595 -0.944 . . . . 0.0 110.287 179.7 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 6.4 tt -56.33 -45.19 80.44 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.577 -0.702 . . . . 0.0 110.153 179.503 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 27.6 m-70 -81.81 -42.55 19.53 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.438 -0.789 . . . . 0.0 110.008 179.521 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 7.2 tp -57.36 -37.32 72.42 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.65 -0.656 . . . . 0.0 110.484 179.801 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -56.83 -47.31 80.6 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.458 -0.776 . . . . 0.0 109.802 179.382 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 6.4 tp60 -59.53 -34.94 73.27 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.625 -0.672 . . . . 0.0 110.42 179.627 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 16.0 t30 -69.91 -35.21 74.41 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.459 -0.775 . . . . 0.0 110.403 179.551 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 32.5 mt -82.47 -16.07 11.76 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 O-C-N 121.241 -0.912 . . . . 0.0 110.879 179.962 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.63 HG12 ' HE2' ' A' ' 22' ' ' TYR . 74.7 t -99.38 -50.97 10.49 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.142 -0.974 . . . . 0.0 109.802 179.891 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.538 ' HA ' ' CD2' ' A' ' 22' ' ' TYR . 34.5 t0 -61.57 -21.7 64.53 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.602 -0.686 . . . . 0.0 110.604 179.376 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 8.3 p -52.85 -31.35 16.61 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.059 0 O-C-N 121.296 -0.878 . . . . 0.0 110.935 179.53 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -82.08 -21.92 36.57 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.374 -0.828 . . . . 0.0 110.861 179.996 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . 0.63 ' HE2' HG12 ' A' ' 18' ' ' VAL . 1.4 m-85 -100.66 -49.92 4.04 Favored 'General case' 0 N--CA 1.502 2.151 0 O-C-N 121.259 -0.901 . . . . 0.0 109.816 -179.814 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . 0.692 ' HA ' ' HB2' ' A' ' 29' ' ' ALA . 0.1 OUTLIER -60.5 -38.3 83.91 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.395 -0.816 . . . . 0.0 109.982 179.421 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -89.42 15.76 8.67 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.461 -0.774 . . . . 0.0 110.708 179.298 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -90.91 -4.39 69.41 Favored Glycine 0 N--CA 1.495 2.629 0 N-CA-C 110.407 -1.077 . . . . 0.0 110.407 179.639 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 5.3 mp 54.46 48.58 20.24 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.322 -1.105 . . . . 0.0 111.194 179.809 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.58 ' HB3' ' HD3' ' A' ' 28' ' ' PRO . 3.7 t -164.21 -65.09 0.01 OUTLIER Pre-proline 0 N--CA 1.499 1.998 0 O-C-N 121.265 -0.897 . . . . 0.0 110.602 179.221 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.58 ' HD3' ' HB3' ' A' ' 27' ' ' SER . 47.1 Cg_endo -72.97 -20.54 21.9 Favored 'Trans proline' 0 N--CA 1.491 1.328 0 O-C-N 123.258 1.136 . . . . 0.0 111.113 179.888 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.692 ' HB2' ' HA ' ' A' ' 23' ' ' MET . . . -73.44 -45.06 56.63 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.448 -0.783 . . . . 0.0 110.202 179.887 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 3.2 mt -68.07 -36.4 75.27 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 O-C-N 121.422 -0.799 . . . . 0.0 110.564 -179.967 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 20.3 p -71.47 -32.19 68.0 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.477 -0.764 . . . . 0.0 110.316 179.703 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.4 tttt -90.42 18.53 6.08 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.415 -0.803 . . . . 0.0 110.814 179.763 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -111.51 -50.8 2.9 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.296 -0.878 . . . . 0.0 109.766 179.627 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 45.9 t -81.52 79.83 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 121.445 -0.784 . . . . 0.0 109.845 179.791 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 6.8 p -123.2 21.86 4.5 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 121.423 -0.798 . . . . 0.0 110.689 -179.954 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.497 1.906 0 O-C-N 121.27 -0.894 . . . . 0.0 110.3 179.627 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 2.5 t . . . . . 0 N--CA 1.494 1.733 0 CA-C-O 121.143 0.496 . . . . 0.0 110.137 . . . . . . . . . 0 0 . 1 . 033 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -109.23 21.2 17.42 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.507 -0.746 . . . . 0.0 110.492 179.932 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.411 ' N ' ' HD3' ' A' ' 4' ' ' PRO . 0.5 OUTLIER -158.0 58.42 1.4 Allowed Pre-proline 0 N--CA 1.495 1.823 0 O-C-N 121.392 -0.818 . . . . 0.0 109.95 179.865 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.411 ' HD3' ' N ' ' A' ' 3' ' ' LEU . 45.6 Cg_endo -75.04 -29.16 8.46 Favored 'Trans proline' 0 C--N 1.311 -1.404 0 O-C-N 123.793 1.417 . . . . 0.0 111.185 -179.628 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -154.72 -75.02 0.11 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.425 -0.797 . . . . 0.0 109.983 179.744 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.47 HD22 ' HA ' ' A' ' 6' ' ' LEU . 0.4 OUTLIER -168.86 -61.47 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.505 -0.747 . . . . 0.0 109.938 179.679 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 21.6 t -164.94 -65.13 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.492 -0.755 . . . . 0.0 110.189 179.779 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.605 HG22 ' HB2' ' A' ' 12' ' ' HIS . 1.5 m 58.15 45.39 17.62 Favored 'General case' 0 N--CA 1.502 2.165 0 O-C-N 121.889 -0.507 . . . . 0.0 110.657 179.84 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -105.47 -74.52 0.94 Allowed Glycine 0 N--CA 1.494 2.502 0 N-CA-C 109.237 -1.545 . . . . 0.0 109.237 179.786 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.442 HD13 ' HA ' ' A' ' 10' ' ' LEU . 3.1 mm? -70.1 -43.69 70.56 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.591 -0.947 . . . . 0.0 109.91 179.699 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 5.6 tt -58.35 -45.94 87.2 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.64 -0.663 . . . . 0.0 110.392 179.703 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . 0.605 ' HB2' HG22 ' A' ' 8' ' ' THR . 37.1 t60 -64.58 -40.62 95.87 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.473 -0.767 . . . . 0.0 110.2 179.765 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.713 ' HG ' HD13 ' A' ' 17' ' ' ILE . 3.2 tp -60.28 -40.6 90.97 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.448 -0.782 . . . . 0.0 110.108 179.406 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . 0.489 ' CD2' HG21 ' A' ' 18' ' ' VAL . 18.3 t-80 -60.19 -58.64 7.67 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.388 -0.82 . . . . 0.0 109.778 179.625 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.452 ' O ' ' HB2' ' A' ' 19' ' ' ASP . 0.7 OUTLIER -60.14 -26.04 65.97 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.452 -0.78 . . . . 0.0 110.692 179.613 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 -80.0 -46.38 16.72 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.35 -0.844 . . . . 0.0 110.577 -179.883 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.713 HD13 ' HG ' ' A' ' 13' ' ' LEU . 1.3 mp -76.7 -33.58 22.14 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 121.286 -0.884 . . . . 0.0 110.401 -179.809 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.489 HG21 ' CD2' ' A' ' 14' ' ' HIS . 50.7 t -70.52 -29.43 38.53 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 O-C-N 121.125 -0.984 . . . . 0.0 110.364 179.826 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.524 ' HA ' ' CD2' ' A' ' 22' ' ' TYR . 0.4 OUTLIER -88.26 3.27 50.14 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.461 -0.775 . . . . 0.0 111.211 179.772 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.546 HG12 ' O ' ' A' ' 17' ' ' ILE . 0.8 OUTLIER -113.06 -13.96 11.14 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 120.947 -1.096 . . . . 0.0 110.722 179.611 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 11.5 mt-30 -103.71 -35.05 8.37 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.286 -0.884 . . . . 0.0 110.559 -179.802 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . 0.524 ' CD2' ' HA ' ' A' ' 19' ' ' ASP . 2.1 p90 -56.7 -33.38 66.4 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.477 -0.765 . . . . 0.0 110.725 -179.841 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.48 -36.88 63.28 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.311 -0.868 . . . . 0.0 110.357 179.813 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -74.02 -10.27 59.47 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.486 -0.759 . . . . 0.0 111.236 179.85 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -92.48 10.62 73.83 Favored Glycine 0 N--CA 1.495 2.602 0 N-CA-C 110.224 -1.15 . . . . 0.0 110.224 179.646 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -147.27 25.98 1.09 Allowed 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.174 -1.192 . . . . 0.0 110.808 179.873 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.468 ' O ' HG22 ' A' ' 30' ' ' ILE . 0.0 OUTLIER -84.48 -56.5 0.41 Allowed Pre-proline 0 N--CA 1.499 2.019 0 O-C-N 121.2 -0.938 . . . . 0.0 110.223 179.823 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.443 ' HD3' ' CB ' ' A' ' 27' ' ' SER . 49.4 Cg_endo -77.58 -11.52 17.05 Favored 'Trans proline' 0 C--N 1.32 -0.926 0 O-C-N 123.32 1.168 . . . . 0.0 110.596 179.174 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -82.81 -43.55 16.54 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.274 -0.892 . . . . 0.0 110.33 179.935 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.468 HG22 ' O ' ' A' ' 27' ' ' SER . 4.0 tp -65.0 -30.5 50.56 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 O-C-N 121.498 -0.751 . . . . 0.0 110.674 -179.99 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 9.7 p -72.35 -25.73 61.65 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.376 -0.827 . . . . 0.0 110.229 179.345 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 2.5 tttm -99.24 16.39 23.05 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.389 -0.819 . . . . 0.0 110.643 179.63 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -110.19 -37.88 5.43 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.222 -0.923 . . . . 0.0 110.69 -179.759 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.496 ' O ' HG12 ' A' ' 35' ' ' VAL . 52.8 t -78.93 -45.9 24.22 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 O-C-N 121.421 -0.799 . . . . 0.0 110.224 -179.84 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.585 ' O ' HG13 ' A' ' 35' ' ' VAL . 0.4 OUTLIER 61.18 15.83 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.278 0 O-C-N 121.871 -0.518 . . . . 0.0 111.458 -179.899 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 77.5 mtm-85 . . . . . 0 N--CA 1.502 2.166 0 CA-C-O 117.657 -1.163 . . . . 0.0 110.442 179.638 . . . . . . . . 0 0 . 1 . 034 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 30.2 m . . . . . 0 N--CA 1.494 1.771 0 CA-C-O 121.075 0.464 . . . . 0.0 110.171 . . . . . . . . . 0 0 . 1 . 034 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -146.42 155.54 42.65 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.53 -0.731 . . . . 0.0 110.202 -179.945 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.547 ' CB ' ' HD3' ' A' ' 4' ' ' PRO . 0.1 OUTLIER -161.53 -61.68 0.02 OUTLIER Pre-proline 0 N--CA 1.497 1.887 0 O-C-N 121.554 -0.716 . . . . 0.0 110.761 179.94 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.547 ' HD3' ' CB ' ' A' ' 3' ' ' LEU . 50.8 Cg_endo -78.52 63.29 8.43 Favored 'Trans proline' 0 N--CA 1.486 1.071 0 O-C-N 123.417 1.22 . . . . 0.0 110.606 -179.979 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -93.93 -41.85 9.38 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.24 -0.912 . . . . 0.0 110.454 179.958 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.1 mt -120.37 -53.73 2.11 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.455 -0.778 . . . . 0.0 110.248 179.987 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.1 t 57.4 61.94 2.33 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.7 -0.625 . . . . 0.0 110.598 -179.9 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.408 HG22 ' CG ' ' A' ' 12' ' ' HIS . 6.9 m 54.42 55.37 8.15 Favored 'General case' 0 N--CA 1.503 2.216 0 O-C-N 121.671 -0.643 . . . . 0.0 110.821 179.69 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -102.98 -71.91 0.9 Allowed Glycine 0 N--CA 1.494 2.521 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 179.842 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.423 HD22 ' HA ' ' A' ' 10' ' ' LEU . 0.2 OUTLIER -62.34 -39.24 92.44 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.642 -0.917 . . . . 0.0 110.389 179.826 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 13.6 tp -58.68 -51.04 71.63 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.46 -0.775 . . . . 0.0 110.236 179.669 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . 0.408 ' CG ' HG22 ' A' ' 8' ' ' THR . 0.1 OUTLIER -65.15 -43.15 92.76 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.548 -0.72 . . . . 0.0 109.816 179.482 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -60.63 -39.7 89.23 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.535 -0.728 . . . . 0.0 109.953 179.241 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . 0.579 ' NE2' HG21 ' A' ' 18' ' ' VAL . 4.4 t-80 -59.31 -54.09 50.74 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.786 -0.572 . . . . 0.0 109.885 179.538 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.9 tp60 -57.31 -47.18 82.17 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.518 -0.739 . . . . 0.0 110.221 179.865 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -48.41 -45.89 36.64 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.496 -0.753 . . . . 0.0 110.519 179.512 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.434 HD13 ' HA ' ' A' ' 17' ' ' ILE . 18.4 mm -73.62 -42.37 55.35 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 121.37 -0.831 . . . . 0.0 110.114 179.653 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.579 HG21 ' NE2' ' A' ' 14' ' ' HIS . 40.5 t -65.67 -34.99 74.12 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 121.465 -0.772 . . . . 0.0 110.401 179.786 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 72.9 m-20 -67.59 -16.55 64.24 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.488 -0.758 . . . . 0.0 110.595 179.239 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 64.6 t -104.05 -37.83 4.68 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.044 -1.035 . . . . 0.0 109.261 179.148 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 33.5 mt-30 -68.05 -36.8 80.47 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.606 -0.684 . . . . 0.0 110.923 179.963 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -61.61 -29.78 70.27 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.08 -1.013 . . . . 0.0 110.486 -179.986 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 5.6 tpt -103.31 18.69 21.2 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.354 -0.841 . . . . 0.0 110.731 179.375 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -105.16 15.24 27.82 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.017 -1.052 . . . . 0.0 111.29 -179.998 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 62.91 32.53 84.26 Favored Glycine 0 N--CA 1.497 2.738 0 N-CA-C 110.602 -0.999 . . . . 0.0 110.602 179.564 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -93.97 -42.76 8.88 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.322 -1.105 . . . . 0.0 110.23 179.813 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.608 ' HB2' ' HD3' ' A' ' 28' ' ' PRO . 48.2 m -57.03 -50.66 86.92 Favored Pre-proline 0 N--CA 1.497 1.913 0 O-C-N 121.738 -0.601 . . . . 0.0 110.915 179.881 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.608 ' HD3' ' HB2' ' A' ' 27' ' ' SER . 47.7 Cg_endo -71.3 -7.83 22.14 Favored 'Trans proline' 0 N--CA 1.491 1.362 0 O-C-N 123.421 1.221 . . . . 0.0 111.592 179.83 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -98.05 -39.29 9.0 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.199 -0.938 . . . . 0.0 110.357 179.944 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 49.4 mt -76.14 -35.4 28.39 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 O-C-N 121.389 -0.819 . . . . 0.0 110.71 -179.802 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 8.8 p -60.94 -37.46 82.42 Favored 'General case' 0 N--CA 1.501 2.122 0 O-C-N 121.441 -0.787 . . . . 0.0 110.336 179.747 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 26.9 mttt -89.86 13.69 13.9 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.392 -0.818 . . . . 0.0 110.617 179.273 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -108.03 -47.88 3.48 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.305 -0.872 . . . . 0.0 110.067 179.743 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 25.8 t -81.12 72.86 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 O-C-N 121.541 -0.725 . . . . 0.0 109.537 179.77 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 21.9 t -126.16 63.46 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 121.478 -0.763 . . . . 0.0 110.081 -179.617 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.498 1.941 0 CA-C-O 118.294 -0.86 . . . . 0.0 110.258 179.941 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 16.7 t . . . . . 0 N--CA 1.495 1.801 0 CA-C-O 121.121 0.486 . . . . 0.0 110.446 . . . . . . . . . 0 0 . 1 . 035 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -154.24 164.52 38.43 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.625 -0.672 . . . . 0.0 110.198 179.949 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.508 ' N ' ' HD3' ' A' ' 4' ' ' PRO . 0.4 OUTLIER 50.89 57.48 17.31 Favored Pre-proline 0 N--CA 1.502 2.133 0 O-C-N 121.746 -0.596 . . . . 0.0 111.106 179.917 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.508 ' HD3' ' N ' ' A' ' 3' ' ' LEU . 49.2 Cg_endo -81.82 59.68 7.25 Favored 'Trans proline' 0 C--N 1.312 -1.348 0 O-C-N 123.707 1.372 . . . . 0.0 110.753 -179.914 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -89.3 -26.46 21.12 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.323 -0.861 . . . . 0.0 110.634 179.803 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER 55.91 29.07 13.51 Favored 'General case' 0 N--CA 1.503 2.196 0 O-C-N 121.649 -0.657 . . . . 0.0 110.951 -179.919 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -167.22 43.56 0.05 OUTLIER 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.361 -0.837 . . . . 0.0 110.377 179.686 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.56 ' CG2' ' HB2' ' A' ' 12' ' ' HIS . 97.4 m -141.96 -93.48 0.13 Allowed 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.176 -0.952 . . . . 0.0 109.806 179.915 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 56.19 -105.21 0.44 Allowed Glycine 0 N--CA 1.498 2.792 0 N-CA-C 110.221 -1.151 . . . . 0.0 110.221 179.61 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 10.6 tp -58.73 -31.61 68.46 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.638 -0.919 . . . . 0.0 110.568 179.79 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.446 ' HB2' ' HA ' ' A' ' 8' ' ' THR . 5.0 mp -56.91 -41.81 78.82 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.597 -0.689 . . . . 0.0 110.13 179.639 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . 0.56 ' HB2' ' CG2' ' A' ' 8' ' ' THR . 1.6 t-80 -80.05 -40.21 28.18 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.348 -0.845 . . . . 0.0 109.83 179.212 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.7 tt -60.49 -42.06 95.53 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.66 -0.65 . . . . 0.0 110.538 179.943 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . 0.539 ' CE1' HG21 ' A' ' 18' ' ' VAL . 86.5 t60 -61.52 -51.37 68.89 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.479 -0.763 . . . . 0.0 110.281 179.95 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 12.2 tp60 -62.21 -30.23 70.94 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.341 -0.849 . . . . 0.0 110.011 179.436 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -66.52 -24.95 66.46 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.293 -0.879 . . . . 0.0 110.297 179.144 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 61.7 mt -101.39 -27.56 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 121.205 -0.935 . . . . 0.0 110.342 179.68 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.539 HG21 ' CE1' ' A' ' 14' ' ' HIS . 93.5 t -95.92 -13.23 8.26 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 O-C-N 121.383 -0.823 . . . . 0.0 111.142 -179.647 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.428 ' O ' ' HG2' ' A' ' 23' ' ' MET . 0.2 OUTLIER -120.15 38.48 3.95 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.033 -1.042 . . . . 0.0 110.553 179.836 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 40.1 t -140.09 -55.73 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 O-C-N 121.355 -0.841 . . . . 0.0 109.857 179.949 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -65.2 -14.33 60.39 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.755 -0.591 . . . . 0.0 110.417 179.149 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . 0.477 ' HE2' ' HA ' ' A' ' 18' ' ' VAL . 26.9 m-85 -102.36 -22.65 14.07 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.48 -0.763 . . . . 0.0 110.379 -179.424 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . 0.428 ' HG2' ' O ' ' A' ' 19' ' ' ASP . 0.4 OUTLIER -96.93 -18.55 19.4 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.389 -0.819 . . . . 0.0 110.733 179.555 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -116.27 31.6 6.63 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.151 -0.968 . . . . 0.0 110.801 -179.887 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 149.92 76.79 0.02 OUTLIER Glycine 0 N--CA 1.494 2.548 0 N-CA-C 109.814 -1.314 . . . . 0.0 109.814 179.764 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -102.7 -2.03 28.95 Favored 'General case' 0 N--CA 1.499 2.025 0 O-C-N 121.494 -1.003 . . . . 0.0 111.306 179.821 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.519 ' N ' ' HD2' ' A' ' 28' ' ' PRO . 4.7 m -64.07 -52.19 57.47 Favored Pre-proline 0 N--CA 1.499 1.975 0 O-C-N 121.24 -0.912 . . . . 0.0 110.732 179.608 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.519 ' HD2' ' N ' ' A' ' 27' ' ' SER . 44.3 Cg_endo -71.27 -17.88 30.67 Favored 'Trans proline' 0 N--CA 1.489 1.207 0 O-C-N 123.413 1.217 . . . . 0.0 110.795 179.477 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -77.28 -28.19 53.36 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.454 -0.779 . . . . 0.0 110.263 179.547 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 89.6 mt -90.08 -29.07 4.96 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 121.3 -0.875 . . . . 0.0 110.605 179.961 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 32.6 p -65.02 -50.19 67.23 Favored 'General case' 0 N--CA 1.502 2.144 0 O-C-N 121.279 -0.888 . . . . 0.0 110.069 179.656 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.88 -17.04 64.36 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.447 -0.783 . . . . 0.0 110.439 179.226 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 81.8 t80 -82.18 -34.92 28.84 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.364 -0.835 . . . . 0.0 110.124 179.543 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 97.3 t -83.46 -41.2 16.66 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 121.465 -0.772 . . . . 0.0 110.338 -179.982 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.3 p -92.14 -11.01 9.55 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 O-C-N 121.299 -0.875 . . . . 0.0 111.17 179.934 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 8.9 ttp85 . . . . . 0 N--CA 1.504 2.226 0 CA-C-O 118.08 -0.962 . . . . 0.0 111.091 179.983 . . . . . . . . 0 0 . 1 . 036 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 50.0 m . . . . . 0 N--CA 1.495 1.778 0 CA-C-O 120.968 0.413 . . . . 0.0 110.144 . . . . . . . . . 0 0 . 1 . 036 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -130.09 161.86 30.09 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.603 -0.686 . . . . 0.0 110.212 -179.965 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER 57.81 78.1 0.38 Allowed Pre-proline 0 N--CA 1.499 2.006 0 O-C-N 121.758 -0.589 . . . . 0.0 110.35 -179.881 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -91.47 -161.8 0.1 OUTLIER 'Trans proline' 0 C--N 1.309 -1.512 0 C-N-CA 121.894 1.729 . . . . 0.0 110.524 -179.769 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -168.0 87.11 0.23 Allowed 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.47 -0.769 . . . . 0.0 109.709 179.94 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -98.31 26.88 5.04 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.54 -0.725 . . . . 0.0 111.149 -179.566 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 68.7 m 48.89 59.07 4.68 Favored 'General case' 0 N--CA 1.502 2.141 0 O-C-N 121.458 -0.776 . . . . 0.0 110.891 179.533 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 22.6 p -111.05 30.87 6.49 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.352 -0.842 . . . . 0.0 110.694 -179.837 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -100.95 -86.66 1.94 Allowed Glycine 0 N--CA 1.493 2.462 0 N-CA-C 108.951 -1.66 . . . . 0.0 108.951 179.838 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.1 mp -57.91 -37.52 74.2 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.651 -0.911 . . . . 0.0 110.111 179.501 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.411 HD13 ' HA ' ' A' ' 11' ' ' LEU . 0.5 OUTLIER -57.14 -44.48 83.41 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.64 -0.663 . . . . 0.0 110.035 179.412 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 7.1 m170 -67.74 -43.76 79.18 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.582 -0.699 . . . . 0.0 110.227 179.636 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.2 tt -55.2 -44.42 75.31 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.646 -0.659 . . . . 0.0 110.456 179.956 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 -60.35 -50.04 75.2 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.506 -0.746 . . . . 0.0 109.689 179.504 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 16.4 mm100 -64.69 -35.67 81.8 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.542 -0.724 . . . . 0.0 110.065 179.646 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -61.94 -38.06 87.05 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.576 -0.703 . . . . 0.0 110.6 179.658 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.412 HD13 ' HA ' ' A' ' 17' ' ' ILE . 24.1 mm -83.23 -45.17 18.86 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 O-C-N 121.37 -0.831 . . . . 0.0 110.341 -179.834 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 64.3 t -63.4 -35.69 73.29 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 O-C-N 121.497 -0.752 . . . . 0.0 110.712 -179.797 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -68.94 -24.84 64.32 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.385 -0.822 . . . . 0.0 110.733 -179.992 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 48.8 t -96.65 -36.98 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 120.968 -1.082 . . . . 0.0 109.494 179.327 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.1 -39.43 94.67 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.718 -0.614 . . . . 0.0 110.545 179.616 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . 0.434 ' CD1' ' C ' ' A' ' 22' ' ' TYR . 0.1 OUTLIER -66.46 -30.92 71.38 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.25 -0.907 . . . . 0.0 110.234 179.827 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 1.5 ttp -90.52 -31.55 16.7 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.345 -0.847 . . . . 0.0 110.972 -179.856 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 41.4 m-85 -102.59 25.66 8.85 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.179 -0.951 . . . . 0.0 111.157 -179.512 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -158.3 49.37 0.42 Allowed Glycine 0 N--CA 1.495 2.577 0 N-CA-C 109.995 -1.242 . . . . 0.0 109.995 179.746 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.409 HD13 ' O ' ' A' ' 22' ' ' TYR . 0.4 OUTLIER -128.29 29.46 5.34 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.37 -1.077 . . . . 0.0 110.505 179.828 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.556 ' HB2' ' HD3' ' A' ' 28' ' ' PRO . 0.7 OUTLIER -86.2 -49.85 0.51 Allowed Pre-proline 0 N--CA 1.5 2.049 0 O-C-N 121.453 -0.779 . . . . 0.0 111.268 -179.751 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.556 ' HD3' ' HB2' ' A' ' 27' ' ' SER . 50.5 Cg_endo -77.21 64.52 7.87 Favored 'Trans proline' 0 N--CA 1.487 1.13 0 O-C-N 123.395 1.208 . . . . 0.0 110.55 -179.635 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -167.34 -49.48 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.644 -0.66 . . . . 0.0 109.729 179.864 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.41 ' O ' HG23 ' A' ' 34' ' ' VAL . 46.4 mm -79.11 -38.12 20.06 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 121.562 -0.711 . . . . 0.0 110.113 179.758 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 29.7 p -65.01 -45.29 86.16 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.522 -0.736 . . . . 0.0 109.979 179.59 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 24.7 mmtt -64.69 -27.68 69.08 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.644 -0.66 . . . . 0.0 110.221 179.385 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -69.14 -35.39 76.32 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.463 -0.773 . . . . 0.0 109.801 179.212 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.509 HG12 HG23 ' A' ' 35' ' ' VAL . 21.9 t -84.94 164.99 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 121.53 -0.731 . . . . 0.0 109.504 179.448 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.509 HG23 HG12 ' A' ' 34' ' ' VAL . 11.3 t 59.04 66.68 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.149 0 O-C-N 121.591 -0.693 . . . . 0.0 110.058 -179.867 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.778 0 CA-C-O 118.414 -0.803 . . . . 0.0 110.532 -179.889 . . . . . . . . 1 1 . 1 stop_ save_